[{"model": "papers.paper", "pk": 1004032, "fields": {"authors": ["MarcoBianchi"], "affiliation": "University of Milan", "venue": "Nature", "doi": "10.1038/nature09475", "abstract": "", "year": 2010, "title": "Erratum: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature (2002) 418 (191-195))", "keywords": ["Chromatin protein", "Cell biology", "HMGB1", "Chemistry", "Inflammation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 18.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 15.915, "citationsperpaper_1": 16.118, "citationsperpaper_2": 16.255, "citationsperpaper_3": 16.982, "citationsperpaper_4": 17.373, "citationsperpaper_5": 18.085, "citationsperyear_0": 26.714, "citationsperyear_1": 28.345, "citationsperyear_2": 29.8, "citationsperyear_3": 30.677, "citationsperyear_4": 32.031, "citationsperyear_5": 32.333, "totalcitations_0": 748.0, "totalcitations_1": 822.0, "totalcitations_2": 894.0, "totalcitations_3": 951.0, "totalcitations_4": 1025.0, "totalcitations_5": 1067.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 55.0, "totalpapers_3": 56.0, "totalpapers_4": 59.0, "totalpapers_5": 59.0, "authorage_0": 27.0, "authorage_1": 28.0, "authorage_2": 29.0, "authorage_3": 30.0, "authorage_4": 31.0, "authorage_5": 32.0, "recentcoauthors_0": 63.0, "recentcoauthors_1": 84.0, "recentcoauthors_2": 95.0, "recentcoauthors_3": 57.0, "recentcoauthors_4": 85.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.9230769231, "venuehindexmean_1": 127.6666666667, "venuehindexmean_2": 131.0, "venuehindexmean_3": 133.7333333333, "venuehindexmean_4": 136.1333333333, "venuehindexmean_5": 138.2666666667, "totalvenues_0": 13.0, "totalvenues_1": 15.0, "totalvenues_2": 15.0, "totalvenues_3": 15.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 10.8929697171, "pagerank_1": 11.5873015852, "pagerank_2": 12.404028856, "pagerank_3": 12.1426486289, "pagerank_4": 13.1293760083, "pagerank_5": 12.6050372002}}, {"model": "papers.paper", "pk": 1004032, "fields": {"authors": ["MarcoBianchi"], "affiliation": "University of Pavia", "venue": "Nature", "doi": "10.1038/nature09475", "abstract": "", "year": 2010, "title": "Erratum: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature (2002) 418 (191-195))", "keywords": ["Chromatin protein", "Cell biology", "HMGB1", "Chemistry", "Inflammation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 18.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 15.915, "citationsperpaper_1": 16.118, "citationsperpaper_2": 16.255, "citationsperpaper_3": 16.982, "citationsperpaper_4": 17.373, "citationsperpaper_5": 18.085, "citationsperyear_0": 26.714, "citationsperyear_1": 28.345, "citationsperyear_2": 29.8, "citationsperyear_3": 30.677, "citationsperyear_4": 32.031, "citationsperyear_5": 32.333, "totalcitations_0": 748.0, "totalcitations_1": 822.0, "totalcitations_2": 894.0, "totalcitations_3": 951.0, "totalcitations_4": 1025.0, "totalcitations_5": 1067.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 55.0, "totalpapers_3": 56.0, "totalpapers_4": 59.0, "totalpapers_5": 59.0, "authorage_0": 27.0, "authorage_1": 28.0, "authorage_2": 29.0, "authorage_3": 30.0, "authorage_4": 31.0, "authorage_5": 32.0, "recentcoauthors_0": 63.0, "recentcoauthors_1": 84.0, "recentcoauthors_2": 95.0, "recentcoauthors_3": 57.0, "recentcoauthors_4": 85.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.9230769231, "venuehindexmean_1": 127.6666666667, "venuehindexmean_2": 131.0, "venuehindexmean_3": 133.7333333333, "venuehindexmean_4": 136.1333333333, "venuehindexmean_5": 138.2666666667, "totalvenues_0": 13.0, "totalvenues_1": 15.0, "totalvenues_2": 15.0, "totalvenues_3": 15.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 10.8929697171, "pagerank_1": 11.5873015852, "pagerank_2": 12.404028856, "pagerank_3": 12.1426486289, "pagerank_4": 13.1293760083, "pagerank_5": 12.6050372002}}, {"model": "papers.paper", "pk": 1004032, "fields": {"authors": ["MarcoBianchi"], "affiliation": "Yale University", "venue": "Nature", "doi": "10.1038/nature09475", "abstract": "", "year": 2010, "title": "Erratum: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature (2002) 418 (191-195))", "keywords": ["Chromatin protein", "Cell biology", "HMGB1", "Chemistry", "Inflammation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 18.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 15.915, "citationsperpaper_1": 16.118, "citationsperpaper_2": 16.255, "citationsperpaper_3": 16.982, "citationsperpaper_4": 17.373, "citationsperpaper_5": 18.085, "citationsperyear_0": 26.714, "citationsperyear_1": 28.345, "citationsperyear_2": 29.8, "citationsperyear_3": 30.677, "citationsperyear_4": 32.031, "citationsperyear_5": 32.333, "totalcitations_0": 748.0, "totalcitations_1": 822.0, "totalcitations_2": 894.0, "totalcitations_3": 951.0, "totalcitations_4": 1025.0, "totalcitations_5": 1067.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 55.0, "totalpapers_3": 56.0, "totalpapers_4": 59.0, "totalpapers_5": 59.0, "authorage_0": 27.0, "authorage_1": 28.0, "authorage_2": 29.0, "authorage_3": 30.0, "authorage_4": 31.0, "authorage_5": 32.0, "recentcoauthors_0": 63.0, "recentcoauthors_1": 84.0, "recentcoauthors_2": 95.0, "recentcoauthors_3": 57.0, "recentcoauthors_4": 85.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.9230769231, "venuehindexmean_1": 127.6666666667, "venuehindexmean_2": 131.0, "venuehindexmean_3": 133.7333333333, "venuehindexmean_4": 136.1333333333, "venuehindexmean_5": 138.2666666667, "totalvenues_0": 13.0, "totalvenues_1": 15.0, "totalvenues_2": 15.0, "totalvenues_3": 15.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 10.8929697171, "pagerank_1": 11.5873015852, "pagerank_2": 12.404028856, "pagerank_3": 12.1426486289, "pagerank_4": 13.1293760083, "pagerank_5": 12.6050372002}}, {"model": "papers.paper", "pk": 1004032, "fields": {"authors": ["MarcoBianchi"], "affiliation": "Vita-Salute San Raffaele University", "venue": "Nature", "doi": "10.1038/nature09475", "abstract": "", "year": 2010, "title": "Erratum: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation (Nature (2002) 418 (191-195))", "keywords": ["Chromatin protein", "Cell biology", "HMGB1", "Chemistry", "Inflammation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 18.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 15.915, "citationsperpaper_1": 16.118, "citationsperpaper_2": 16.255, "citationsperpaper_3": 16.982, "citationsperpaper_4": 17.373, "citationsperpaper_5": 18.085, "citationsperyear_0": 26.714, "citationsperyear_1": 28.345, "citationsperyear_2": 29.8, "citationsperyear_3": 30.677, "citationsperyear_4": 32.031, "citationsperyear_5": 32.333, "totalcitations_0": 748.0, "totalcitations_1": 822.0, "totalcitations_2": 894.0, "totalcitations_3": 951.0, "totalcitations_4": 1025.0, "totalcitations_5": 1067.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 55.0, "totalpapers_3": 56.0, "totalpapers_4": 59.0, "totalpapers_5": 59.0, "authorage_0": 27.0, "authorage_1": 28.0, "authorage_2": 29.0, "authorage_3": 30.0, "authorage_4": 31.0, "authorage_5": 32.0, "recentcoauthors_0": 63.0, "recentcoauthors_1": 84.0, "recentcoauthors_2": 95.0, "recentcoauthors_3": 57.0, "recentcoauthors_4": 85.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.9230769231, "venuehindexmean_1": 127.6666666667, "venuehindexmean_2": 131.0, "venuehindexmean_3": 133.7333333333, "venuehindexmean_4": 136.1333333333, "venuehindexmean_5": 138.2666666667, "totalvenues_0": 13.0, "totalvenues_1": 15.0, "totalvenues_2": 15.0, "totalvenues_3": 15.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 10.8929697171, "pagerank_1": 11.5873015852, "pagerank_2": 12.404028856, "pagerank_3": 12.1426486289, "pagerank_4": 13.1293760083, "pagerank_5": 12.6050372002}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["AdrianBird", "Robert S.Illingworth", "ShaunWebb", "John P.Thomson", "JackyGuy", "Aimee MDeaton", "Peter JSkene", "ThomasClouaire", "Alastair R. W.Kerr", "JimSelfridge"], "affiliation": "University of Edinburgh", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 5.1, "hindex_1": 5.6, "hindex_2": 5.8, "hindex_3": 6.3, "hindex_4": 6.4, "hindex_5": 6.8, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 13.8527, "citationsperpaper_1": 21.6493, "citationsperpaper_2": 21.353, "citationsperpaper_3": 25.1848, "citationsperpaper_4": 26.665, "citationsperpaper_5": 28.1472, "citationsperyear_0": 15.2287, "citationsperyear_1": 19.2345, "citationsperyear_2": 19.3317, "citationsperyear_3": 20.2093, "citationsperyear_4": 20.6189, "citationsperyear_5": 20.4986, "totalcitations_0": 345.3, "totalcitations_1": 389.3, "totalcitations_2": 417.0, "totalcitations_3": 453.3, "totalcitations_4": 485.5, "totalcitations_5": 511.1, "totalpapers_0": 9.6, "totalpapers_1": 10.2, "totalpapers_2": 11.2, "totalpapers_3": 11.7, "totalpapers_4": 12.2, "totalpapers_5": 12.5, "authorage_0": 14.7, "authorage_1": 15.7, "authorage_2": 16.7, "authorage_3": 17.7, "authorage_4": 18.7, "authorage_5": 19.7, "recentcoauthors_0": 42.7, "recentcoauthors_1": 44.5, "recentcoauthors_2": 16.0, "recentcoauthors_3": 17.2, "recentcoauthors_4": 6.5, "recentcoauthors_5": 3.8, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 176.1386363636, "venuehindexmean_1": 173.0616666667, "venuehindexmean_2": 166.8708333333, "venuehindexmean_3": 166.1139102564, "venuehindexmean_4": 166.8057692308, "venuehindexmean_5": 169.6045512821, "totalvenues_0": 3.6, "totalvenues_1": 3.8, "totalvenues_2": 4.5, "totalvenues_3": 4.8, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.2115403584, "pagerank_1": 2.2517046846, "pagerank_2": 2.462770999, "pagerank_3": 2.5283957338, "pagerank_4": 2.5421158596, "pagerank_5": 2.5471877813}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["K.James", "RobertAndrews", "Daniel J.Turner"], "affiliation": "Wellcome Trust Sanger Institute", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 8.3333333333, "hindex_1": 9.3333333333, "hindex_2": 10.6666666667, "hindex_3": 11.6666666667, "hindex_4": 13.0, "hindex_5": 13.6666666667, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 35.5613333333, "citationsperpaper_1": 42.4306666667, "citationsperpaper_2": 42.417, "citationsperpaper_3": 40.8746666667, "citationsperpaper_4": 43.908, "citationsperpaper_5": 47.4966666667, "citationsperyear_0": 21.908, "citationsperyear_1": 28.01, "citationsperyear_2": 32.9053333333, "citationsperyear_3": 35.482, "citationsperyear_4": 37.2343333333, "citationsperyear_5": 38.662, "totalcitations_0": 515.0, "totalcitations_1": 635.6666666667, "totalcitations_2": 743.3333333333, "totalcitations_3": 822.6666666667, "totalcitations_4": 896.6666666667, "totalcitations_5": 963.6666666667, "totalpapers_0": 14.3333333333, "totalpapers_1": 15.0, "totalpapers_2": 17.3333333333, "totalpapers_3": 19.3333333333, "totalpapers_4": 19.6666666667, "totalpapers_5": 19.6666666667, "authorage_0": 20.6666666667, "authorage_1": 21.6666666667, "authorage_2": 22.6666666667, "authorage_3": 23.6666666667, "authorage_4": 24.6666666667, "authorage_5": 25.6666666667, "recentcoauthors_0": 56.0, "recentcoauthors_1": 57.0, "recentcoauthors_2": 139.6666666667, "recentcoauthors_3": 339.3333333333, "recentcoauthors_4": 210.3333333333, "recentcoauthors_5": 3.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.7222222222, "venuehindexmean_1": 119.8777777778, "venuehindexmean_2": 121.4523809524, "venuehindexmean_3": 125.880952381, "venuehindexmean_4": 129.4523809524, "venuehindexmean_5": 132.9841269841, "totalvenues_0": 5.3333333333, "totalvenues_1": 5.6666666667, "totalvenues_2": 6.3333333333, "totalvenues_3": 6.3333333333, "totalvenues_4": 6.3333333333, "totalvenues_5": 6.3333333333, "pagerank_0": 7.9452539842, "pagerank_1": 7.8264893984, "pagerank_2": 8.9877749707, "pagerank_3": 10.5243859458, "pagerank_4": 10.335424558, "pagerank_5": 10.0055839278}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["ThomasClouaire"], "affiliation": "Centre national de la recherche scientifique", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 8.0, "citationsperpaper_1": 17.0, "citationsperpaper_2": 14.333, "citationsperpaper_3": 18.667, "citationsperpaper_4": 22.333, "citationsperpaper_5": 17.5, "citationsperyear_0": 2.667, "citationsperyear_1": 4.857, "citationsperyear_2": 5.375, "citationsperyear_3": 6.222, "citationsperyear_4": 6.7, "citationsperyear_5": 6.364, "totalcitations_0": 16.0, "totalcitations_1": 34.0, "totalcitations_2": 43.0, "totalcitations_3": 56.0, "totalcitations_4": 67.0, "totalcitations_5": 70.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 4.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 192.6666666667, "venuehindexmean_3": 196.6666666667, "venuehindexmean_4": 199.6666666667, "venuehindexmean_5": 202.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.6514480347, "pagerank_1": 0.6263701204, "pagerank_2": 0.8314313325, "pagerank_3": 0.8083755694, "pagerank_4": 0.8010213892, "pagerank_5": 1.1998765235}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["ThomasClouaire"], "affiliation": "Paul Sabatier University", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 8.0, "citationsperpaper_1": 17.0, "citationsperpaper_2": 14.333, "citationsperpaper_3": 18.667, "citationsperpaper_4": 22.333, "citationsperpaper_5": 17.5, "citationsperyear_0": 2.667, "citationsperyear_1": 4.857, "citationsperyear_2": 5.375, "citationsperyear_3": 6.222, "citationsperyear_4": 6.7, "citationsperyear_5": 6.364, "totalcitations_0": 16.0, "totalcitations_1": 34.0, "totalcitations_2": 43.0, "totalcitations_3": 56.0, "totalcitations_4": 67.0, "totalcitations_5": 70.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 4.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 192.6666666667, "venuehindexmean_3": 196.6666666667, "venuehindexmean_4": 199.6666666667, "venuehindexmean_5": 202.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.6514480347, "pagerank_1": 0.6263701204, "pagerank_2": 0.8314313325, "pagerank_3": 0.8083755694, "pagerank_4": 0.8010213892, "pagerank_5": 1.1998765235}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["AdrianBird"], "affiliation": "Yale University", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 28.0, "hindex_1": 30.0, "hindex_2": 31.0, "hindex_3": 31.0, "hindex_4": 31.0, "hindex_5": 32.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 46.939, "citationsperpaper_1": 47.71, "citationsperpaper_2": 48.211, "citationsperpaper_3": 48.784, "citationsperpaper_4": 50.919, "citationsperpaper_5": 52.027, "citationsperyear_0": 81.526, "citationsperyear_1": 84.41, "citationsperyear_2": 85.575, "citationsperyear_3": 88.049, "citationsperyear_4": 89.714, "citationsperyear_5": 90.744, "totalcitations_0": 3098.0, "totalcitations_1": 3292.0, "totalcitations_2": 3423.0, "totalcitations_3": 3610.0, "totalcitations_4": 3768.0, "totalcitations_5": 3902.0, "totalpapers_0": 66.0, "totalpapers_1": 69.0, "totalpapers_2": 71.0, "totalpapers_3": 74.0, "totalpapers_4": 74.0, "totalpapers_5": 75.0, "authorage_0": 37.0, "authorage_1": 38.0, "authorage_2": 39.0, "authorage_3": 40.0, "authorage_4": 41.0, "authorage_5": 42.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 78.0, "recentcoauthors_3": 86.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.6363636364, "venuehindexmean_1": 143.0, "venuehindexmean_2": 140.1666666667, "venuehindexmean_3": 137.2307692308, "venuehindexmean_4": 140.3076923077, "venuehindexmean_5": 143.1538461538, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 8.6790207559, "pagerank_1": 8.6985283253, "pagerank_2": 9.4434346341, "pagerank_3": 9.7896687042, "pagerank_4": 9.549318103, "pagerank_5": 9.3338194393}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["K.James", "AdrianBird"], "affiliation": "Wellcome Trust", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 21.0, "hindex_1": 22.5, "hindex_2": 23.0, "hindex_3": 23.0, "hindex_4": 23.5, "hindex_5": 24.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 48.252, "citationsperpaper_1": 52.42, "citationsperpaper_2": 55.7575, "citationsperpaper_3": 58.0875, "citationsperpaper_4": 61.0465, "citationsperpaper_5": 62.796, "citationsperyear_0": 54.019, "citationsperyear_1": 57.137, "citationsperyear_2": 58.9655, "citationsperyear_3": 60.8725, "citationsperyear_4": 62.272, "citationsperyear_5": 62.997, "totalcitations_0": 2119.0, "totalcitations_1": 2303.0, "totalcitations_2": 2439.5, "totalcitations_3": 2580.0, "totalcitations_4": 2702.5, "totalcitations_5": 2797.0, "totalpapers_0": 44.5, "totalpapers_1": 46.0, "totalpapers_2": 47.0, "totalpapers_3": 48.5, "totalpapers_4": 48.5, "totalpapers_5": 49.0, "authorage_0": 39.5, "authorage_1": 40.5, "authorage_2": 41.5, "authorage_3": 42.5, "authorage_4": 43.5, "authorage_5": 44.5, "recentcoauthors_0": 32.0, "recentcoauthors_1": 32.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 43.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 0.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 136.9848484848, "venuehindexmean_1": 140.5833333333, "venuehindexmean_2": 141.75, "venuehindexmean_3": 142.4487179487, "venuehindexmean_4": 145.8205128205, "venuehindexmean_5": 149.0769230769, "totalvenues_0": 8.5, "totalvenues_1": 8.5, "totalvenues_2": 9.0, "totalvenues_3": 9.5, "totalvenues_4": 9.5, "totalvenues_5": 9.5, "pagerank_0": 12.0381789702, "pagerank_1": 11.8577004174, "pagerank_2": 12.0472545949, "pagerank_3": 12.120299793, "pagerank_4": 11.8556217166, "pagerank_5": 11.5859517658}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["AdrianBird"], "affiliation": "Western General Hospital", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 28.0, "hindex_1": 30.0, "hindex_2": 31.0, "hindex_3": 31.0, "hindex_4": 31.0, "hindex_5": 32.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 46.939, "citationsperpaper_1": 47.71, "citationsperpaper_2": 48.211, "citationsperpaper_3": 48.784, "citationsperpaper_4": 50.919, "citationsperpaper_5": 52.027, "citationsperyear_0": 81.526, "citationsperyear_1": 84.41, "citationsperyear_2": 85.575, "citationsperyear_3": 88.049, "citationsperyear_4": 89.714, "citationsperyear_5": 90.744, "totalcitations_0": 3098.0, "totalcitations_1": 3292.0, "totalcitations_2": 3423.0, "totalcitations_3": 3610.0, "totalcitations_4": 3768.0, "totalcitations_5": 3902.0, "totalpapers_0": 66.0, "totalpapers_1": 69.0, "totalpapers_2": 71.0, "totalpapers_3": 74.0, "totalpapers_4": 74.0, "totalpapers_5": 75.0, "authorage_0": 37.0, "authorage_1": 38.0, "authorage_2": 39.0, "authorage_3": 40.0, "authorage_4": 41.0, "authorage_5": 42.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 78.0, "recentcoauthors_3": 86.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.6363636364, "venuehindexmean_1": 143.0, "venuehindexmean_2": 140.1666666667, "venuehindexmean_3": 137.2307692308, "venuehindexmean_4": 140.3076923077, "venuehindexmean_5": 143.1538461538, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 8.6790207559, "pagerank_1": 8.6985283253, "pagerank_2": 9.4434346341, "pagerank_3": 9.7896687042, "pagerank_4": 9.549318103, "pagerank_5": 9.3338194393}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["AdrianBird"], "affiliation": "Research Institute of Molecular Pathology", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 28.0, "hindex_1": 30.0, "hindex_2": 31.0, "hindex_3": 31.0, "hindex_4": 31.0, "hindex_5": 32.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 46.939, "citationsperpaper_1": 47.71, "citationsperpaper_2": 48.211, "citationsperpaper_3": 48.784, "citationsperpaper_4": 50.919, "citationsperpaper_5": 52.027, "citationsperyear_0": 81.526, "citationsperyear_1": 84.41, "citationsperyear_2": 85.575, "citationsperyear_3": 88.049, "citationsperyear_4": 89.714, "citationsperyear_5": 90.744, "totalcitations_0": 3098.0, "totalcitations_1": 3292.0, "totalcitations_2": 3423.0, "totalcitations_3": 3610.0, "totalcitations_4": 3768.0, "totalcitations_5": 3902.0, "totalpapers_0": 66.0, "totalpapers_1": 69.0, "totalpapers_2": 71.0, "totalpapers_3": 74.0, "totalpapers_4": 74.0, "totalpapers_5": 75.0, "authorage_0": 37.0, "authorage_1": 38.0, "authorage_2": 39.0, "authorage_3": 40.0, "authorage_4": 41.0, "authorage_5": 42.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 78.0, "recentcoauthors_3": 86.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.6363636364, "venuehindexmean_1": 143.0, "venuehindexmean_2": 140.1666666667, "venuehindexmean_3": 137.2307692308, "venuehindexmean_4": 140.3076923077, "venuehindexmean_5": 143.1538461538, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 8.6790207559, "pagerank_1": 8.6985283253, "pagerank_2": 9.4434346341, "pagerank_3": 9.7896687042, "pagerank_4": 9.549318103, "pagerank_5": 9.3338194393}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["AdrianBird"], "affiliation": "University of Cambridge", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 28.0, "hindex_1": 30.0, "hindex_2": 31.0, "hindex_3": 31.0, "hindex_4": 31.0, "hindex_5": 32.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 46.939, "citationsperpaper_1": 47.71, "citationsperpaper_2": 48.211, "citationsperpaper_3": 48.784, "citationsperpaper_4": 50.919, "citationsperpaper_5": 52.027, "citationsperyear_0": 81.526, "citationsperyear_1": 84.41, "citationsperyear_2": 85.575, "citationsperyear_3": 88.049, "citationsperyear_4": 89.714, "citationsperyear_5": 90.744, "totalcitations_0": 3098.0, "totalcitations_1": 3292.0, "totalcitations_2": 3423.0, "totalcitations_3": 3610.0, "totalcitations_4": 3768.0, "totalcitations_5": 3902.0, "totalpapers_0": 66.0, "totalpapers_1": 69.0, "totalpapers_2": 71.0, "totalpapers_3": 74.0, "totalpapers_4": 74.0, "totalpapers_5": 75.0, "authorage_0": 37.0, "authorage_1": 38.0, "authorage_2": 39.0, "authorage_3": 40.0, "authorage_4": 41.0, "authorage_5": 42.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 78.0, "recentcoauthors_3": 86.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.6363636364, "venuehindexmean_1": 143.0, "venuehindexmean_2": 140.1666666667, "venuehindexmean_3": 137.2307692308, "venuehindexmean_4": 140.3076923077, "venuehindexmean_5": 143.1538461538, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 8.6790207559, "pagerank_1": 8.6985283253, "pagerank_2": 9.4434346341, "pagerank_3": 9.7896687042, "pagerank_4": 9.549318103, "pagerank_5": 9.3338194393}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["AdrianBird"], "affiliation": "University of Sydney", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 28.0, "hindex_1": 30.0, "hindex_2": 31.0, "hindex_3": 31.0, "hindex_4": 31.0, "hindex_5": 32.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 46.939, "citationsperpaper_1": 47.71, "citationsperpaper_2": 48.211, "citationsperpaper_3": 48.784, "citationsperpaper_4": 50.919, "citationsperpaper_5": 52.027, "citationsperyear_0": 81.526, "citationsperyear_1": 84.41, "citationsperyear_2": 85.575, "citationsperyear_3": 88.049, "citationsperyear_4": 89.714, "citationsperyear_5": 90.744, "totalcitations_0": 3098.0, "totalcitations_1": 3292.0, "totalcitations_2": 3423.0, "totalcitations_3": 3610.0, "totalcitations_4": 3768.0, "totalcitations_5": 3902.0, "totalpapers_0": 66.0, "totalpapers_1": 69.0, "totalpapers_2": 71.0, "totalpapers_3": 74.0, "totalpapers_4": 74.0, "totalpapers_5": 75.0, "authorage_0": 37.0, "authorage_1": 38.0, "authorage_2": 39.0, "authorage_3": 40.0, "authorage_4": 41.0, "authorage_5": 42.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 78.0, "recentcoauthors_3": 86.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.6363636364, "venuehindexmean_1": 143.0, "venuehindexmean_2": 140.1666666667, "venuehindexmean_3": 137.2307692308, "venuehindexmean_4": 140.3076923077, "venuehindexmean_5": 143.1538461538, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 8.6790207559, "pagerank_1": 8.6985283253, "pagerank_2": 9.4434346341, "pagerank_3": 9.7896687042, "pagerank_4": 9.549318103, "pagerank_5": 9.3338194393}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["Aimee MDeaton"], "affiliation": "Amgen", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 9.0, "citationsperpaper_1": 17.0, "citationsperpaper_2": 25.0, "citationsperpaper_3": 36.5, "citationsperpaper_4": 46.5, "citationsperpaper_5": 53.0, "citationsperyear_0": 9.0, "citationsperyear_1": 17.0, "citationsperyear_2": 16.667, "citationsperyear_3": 18.25, "citationsperyear_4": 18.6, "citationsperyear_5": 17.667, "totalcitations_0": 9.0, "totalcitations_1": 34.0, "totalcitations_2": 50.0, "totalcitations_3": 73.0, "totalcitations_4": 93.0, "totalcitations_5": 106.0, "totalpapers_0": 1.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 199.5, "venuehindexmean_2": 202.5, "venuehindexmean_3": 207.5, "venuehindexmean_4": 210.5, "venuehindexmean_5": 213.0, "totalvenues_0": 1.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.4417424514, "pagerank_1": 0.4618206837, "pagerank_2": 0.4385694228, "pagerank_3": 0.4282683351, "pagerank_4": 0.4255315728, "pagerank_5": 0.4211380325}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["Robert S.Illingworth"], "affiliation": "Medical Research Council", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 5.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 10.667, "citationsperpaper_1": 21.333, "citationsperpaper_2": 20.0, "citationsperpaper_3": 24.5, "citationsperpaper_4": 19.0, "citationsperpaper_5": 19.143, "citationsperyear_0": 10.667, "citationsperyear_1": 16.0, "citationsperyear_2": 16.0, "citationsperyear_3": 16.333, "citationsperyear_4": 16.286, "citationsperyear_5": 16.75, "totalcitations_0": 32.0, "totalcitations_1": 64.0, "totalcitations_2": 80.0, "totalcitations_3": 98.0, "totalcitations_4": 114.0, "totalcitations_5": 134.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 6.0, "totalpapers_5": 7.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 21.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 12.0, "recentcoauthors_5": 19.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 107.0, "venuehindexmean_1": 111.3333333333, "venuehindexmean_2": 120.75, "venuehindexmean_3": 125.25, "venuehindexmean_4": 153.4, "venuehindexmean_5": 156.4, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 0.8576162269, "pagerank_1": 0.8362634587, "pagerank_2": 1.0069770053, "pagerank_3": 0.9793828093, "pagerank_4": 1.3763189456, "pagerank_5": 1.5092964434}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["K.James"], "affiliation": "J. Craig Venter Institute", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 14.0, "hindex_1": 15.0, "hindex_2": 15.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 16.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 49.565, "citationsperpaper_1": 57.13, "citationsperpaper_2": 63.304, "citationsperpaper_3": 67.391, "citationsperpaper_4": 71.174, "citationsperpaper_5": 73.565, "citationsperyear_0": 26.512, "citationsperyear_1": 29.864, "citationsperyear_2": 32.356, "citationsperyear_3": 33.696, "citationsperyear_4": 34.83, "citationsperyear_5": 35.25, "totalcitations_0": 1140.0, "totalcitations_1": 1314.0, "totalcitations_2": 1456.0, "totalcitations_3": 1550.0, "totalcitations_4": 1637.0, "totalcitations_5": 1692.0, "totalpapers_0": 23.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 23.0, "totalpapers_4": 23.0, "totalpapers_5": 23.0, "authorage_0": 42.0, "authorage_1": 43.0, "authorage_2": 44.0, "authorage_3": 45.0, "authorage_4": 46.0, "authorage_5": 47.0, "recentcoauthors_0": 43.0, "recentcoauthors_1": 29.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.3333333333, "venuehindexmean_1": 138.1666666667, "venuehindexmean_2": 143.3333333333, "venuehindexmean_3": 147.6666666667, "venuehindexmean_4": 151.3333333333, "venuehindexmean_5": 155.0, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 15.3973371844, "pagerank_1": 15.0168725094, "pagerank_2": 14.6510745556, "pagerank_3": 14.4509308818, "pagerank_4": 14.1619253303, "pagerank_5": 13.8380840923}}, {"model": "papers.paper", "pk": 1003938, "fields": {"authors": ["Peter JSkene"], "affiliation": "Fred Hutchinson Cancer Research Center", "venue": "Nature", "doi": "10.1038/nature08924", "abstract": "Most human gene promoters are embedded within CpG islands that lack DNA methylation and coincide with sites at which histone H3 lysine 4 is trimethylated (H3K4me3 sites). Here, a zinc-finger protein, Cfp1, is found to be associated with non-methylated CpG islands and H3K4me3 sites throughout the genome in the mouse brain. A primary function of non-methylated CpG islands might be to genetically determine the local chromatin modification state by interaction with Cfp1 and perhaps other CpG-binding proteins.", "year": 2010, "title": "CpG islands influence chromatin structure via the CpG-binding protein Cfp1", "keywords": ["H3K4me3", "Chromatin", "CpG site", "Histone", "DNA methylation", "Genetics", "Biology", "Histone H3 Lysine 4", "Methylation", "Chromatin immunoprecipitation"], "citations_0": 9.0, "citations_1": 18.0, "citations_2": 8.0, "citations_3": 9.0, "citations_4": 8.0, "citations_5": 2.0, "timescaledpagerank_0": 0.4183751326, "timescaledpagerank_1": 1.8000871931, "timescaledpagerank_2": 1.7985630484, "timescaledpagerank_3": 1.8507114116, "timescaledpagerank_4": 1.8725443318, "timescaledpagerank_5": 1.7529973051, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 34.0, "adopters_1": 117.0, "adopters_2": 72.0, "adopters_3": 52.0, "adopters_4": 52.0, "adopters_5": 0.0, "citationsperpaper_0": 9.0, "citationsperpaper_1": 27.0, "citationsperpaper_2": 17.5, "citationsperpaper_3": 24.0, "citationsperpaper_4": 19.667, "citationsperpaper_5": 20.333, "citationsperyear_0": 9.0, "citationsperyear_1": 13.5, "citationsperyear_2": 11.667, "citationsperyear_3": 12.0, "citationsperyear_4": 11.8, "citationsperyear_5": 10.167, "totalcitations_0": 9.0, "totalcitations_1": 27.0, "totalcitations_2": 35.0, "totalcitations_3": 48.0, "totalcitations_4": 59.0, "totalcitations_5": 61.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 202.5, "venuehindexmean_3": 207.5, "venuehindexmean_4": 161.0, "venuehindexmean_5": 163.3333333333, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.4417424486, "pagerank_1": 0.4300147713, "pagerank_2": 0.6435541215, "pagerank_3": 0.6251417734, "pagerank_4": 0.642174544, "pagerank_5": 0.6360577535}}, {"model": "papers.paper", "pk": 1003242, "fields": {"authors": ["GenevievePatenaude"], "affiliation": "University of Edinburgh", "venue": "Nature", "doi": "10.1038/466030a", "abstract": "Lessons on the risks and opportunities of climate change should be directed at future executives, given that many companies rival nations in greenhouse-gas emissions, says Genevieve Patenaude.", "year": 2010, "title": "Climate class for business schools", "keywords": ["Environmental resource management", "Climate change", "Natural resource economics", "Business"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1004084, "fields": {"authors": ["Mark D.Zoback"], "affiliation": "United States Geological Survey", "venue": "Nature", "doi": "10.1038/466568a", "abstract": "The heartland of the United States lies within a tectonic plate, certain regions of which have experienced large and geologically recent earthquakes. Explanations for those events are still being sought.", "year": 2010, "title": "Earthquakes: Climate and intraplate shocks", "keywords": ["Plate tectonics", "Molecular interactions", "Seismology", "Climate change", "Computational biology", "Environmental science", "Intraplate earthquake"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.556, "citationsperpaper_1": 3.833, "citationsperpaper_2": 3.6, "citationsperpaper_3": 3.75, "citationsperpaper_4": 3.75, "citationsperpaper_5": 3.762, "citationsperyear_0": 2.0, "citationsperyear_1": 2.091, "citationsperyear_2": 2.118, "citationsperyear_3": 2.143, "citationsperyear_4": 2.083, "citationsperyear_5": 2.135, "totalcitations_0": 64.0, "totalcitations_1": 69.0, "totalcitations_2": 72.0, "totalcitations_3": 75.0, "totalcitations_4": 75.0, "totalcitations_5": 79.0, "totalpapers_0": 18.0, "totalpapers_1": 18.0, "totalpapers_2": 20.0, "totalpapers_3": 20.0, "totalpapers_4": 20.0, "totalpapers_5": 21.0, "authorage_0": 31.0, "authorage_1": 32.0, "authorage_2": 33.0, "authorage_3": 34.0, "authorage_4": 35.0, "authorage_5": 36.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 2.0, "recentcoauthors_3": 2.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 3.9933813788, "pagerank_1": 3.9805607086, "pagerank_2": 4.2054822141, "pagerank_3": 4.0259808573, "pagerank_4": 4.0187810745, "pagerank_5": 4.0192077487}}, {"model": "papers.paper", "pk": 1004084, "fields": {"authors": ["Mark D.Zoback"], "affiliation": "Stanford University", "venue": "Nature", "doi": "10.1038/466568a", "abstract": "The heartland of the United States lies within a tectonic plate, certain regions of which have experienced large and geologically recent earthquakes. Explanations for those events are still being sought.", "year": 2010, "title": "Earthquakes: Climate and intraplate shocks", "keywords": ["Plate tectonics", "Molecular interactions", "Seismology", "Climate change", "Computational biology", "Environmental science", "Intraplate earthquake"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.556, "citationsperpaper_1": 3.833, "citationsperpaper_2": 3.6, "citationsperpaper_3": 3.75, "citationsperpaper_4": 3.75, "citationsperpaper_5": 3.762, "citationsperyear_0": 2.0, "citationsperyear_1": 2.091, "citationsperyear_2": 2.118, "citationsperyear_3": 2.143, "citationsperyear_4": 2.083, "citationsperyear_5": 2.135, "totalcitations_0": 64.0, "totalcitations_1": 69.0, "totalcitations_2": 72.0, "totalcitations_3": 75.0, "totalcitations_4": 75.0, "totalcitations_5": 79.0, "totalpapers_0": 18.0, "totalpapers_1": 18.0, "totalpapers_2": 20.0, "totalpapers_3": 20.0, "totalpapers_4": 20.0, "totalpapers_5": 21.0, "authorage_0": 31.0, "authorage_1": 32.0, "authorage_2": 33.0, "authorage_3": 34.0, "authorage_4": 35.0, "authorage_5": 36.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 2.0, "recentcoauthors_3": 2.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 3.9933813788, "pagerank_1": 3.9805607086, "pagerank_2": 4.2054822141, "pagerank_3": 4.0259808573, "pagerank_4": 4.0187810745, "pagerank_5": 4.0192077487}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Todd D.Westergard", "Emily H.Cheng", "Tej K.Pandita", "ShugakuTakeda", "HanLiu", "James J.Hsieh"], "affiliation": "Washington University in St. Louis", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 4.8333333333, "hindex_1": 5.6666666667, "hindex_2": 6.0, "hindex_3": 6.8333333333, "hindex_4": 7.3333333333, "hindex_5": 7.8333333333, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 12.8508333333, "citationsperpaper_1": 13.6325, "citationsperpaper_2": 13.6703333333, "citationsperpaper_3": 13.5615, "citationsperpaper_4": 14.3216666667, "citationsperpaper_5": 13.844, "citationsperyear_0": 19.113, "citationsperyear_1": 20.2823333333, "citationsperyear_2": 20.7015, "citationsperyear_3": 21.9061666667, "citationsperyear_4": 22.7216666667, "citationsperyear_5": 23.2255, "totalcitations_0": 287.8333333333, "totalcitations_1": 322.3333333333, "totalcitations_2": 351.6666666667, "totalcitations_3": 390.6666666667, "totalcitations_4": 426.3333333333, "totalcitations_5": 457.8333333333, "totalpapers_0": 15.1666666667, "totalpapers_1": 16.5, "totalpapers_2": 18.0, "totalpapers_3": 20.8333333333, "totalpapers_4": 22.0, "totalpapers_5": 25.6666666667, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 39.0, "recentcoauthors_1": 37.5, "recentcoauthors_2": 27.8333333333, "recentcoauthors_3": 85.3333333333, "recentcoauthors_4": 120.1666666667, "recentcoauthors_5": 117.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 140.4416666667, "venuehindexmean_1": 141.3292929293, "venuehindexmean_2": 142.7580808081, "venuehindexmean_3": 133.1057387057, "venuehindexmean_4": 132.0165140415, "venuehindexmean_5": 130.654527417, "totalvenues_0": 7.3333333333, "totalvenues_1": 7.6666666667, "totalvenues_2": 8.0, "totalvenues_3": 9.3333333333, "totalvenues_4": 9.8333333333, "totalvenues_5": 10.5, "pagerank_0": 3.6179919376, "pagerank_1": 3.9550883223, "pagerank_2": 4.0088331485, "pagerank_3": 4.4537925584, "pagerank_4": 4.628406226, "pagerank_5": 5.5510523511}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["HanLiu", "Todd D.Westergard", "James J.Hsieh"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 3.3333333333, "hindex_1": 4.3333333333, "hindex_2": 4.3333333333, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.3333333333, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 5.1656666667, "citationsperpaper_1": 5.935, "citationsperpaper_2": 6.2143333333, "citationsperpaper_3": 6.3803333333, "citationsperpaper_4": 7.3743333333, "citationsperpaper_5": 7.265, "citationsperyear_0": 6.557, "citationsperyear_1": 7.741, "citationsperyear_2": 7.9296666667, "citationsperyear_3": 9.1666666667, "citationsperyear_4": 10.6033333333, "citationsperyear_5": 11.2483333333, "totalcitations_0": 86.6666666667, "totalcitations_1": 106.6666666667, "totalcitations_2": 118.6666666667, "totalcitations_3": 144.3333333333, "totalcitations_4": 178.6666666667, "totalcitations_5": 200.6666666667, "totalpapers_0": 12.3333333333, "totalpapers_1": 13.6666666667, "totalpapers_2": 14.3333333333, "totalpapers_3": 17.3333333333, "totalpapers_4": 18.6666666667, "totalpapers_5": 22.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 36.3333333333, "recentcoauthors_1": 37.0, "recentcoauthors_2": 25.6666666667, "recentcoauthors_3": 130.6666666667, "recentcoauthors_4": 210.0, "recentcoauthors_5": 180.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.5, "venuehindexmean_1": 139.0555555556, "venuehindexmean_2": 140.3050505051, "venuehindexmean_3": 131.974969475, "venuehindexmean_4": 128.9441391941, "venuehindexmean_5": 129.1607142857, "totalvenues_0": 6.6666666667, "totalvenues_1": 7.0, "totalvenues_2": 7.3333333333, "totalvenues_3": 8.6666666667, "totalvenues_4": 9.3333333333, "totalvenues_5": 10.0, "pagerank_0": 2.5171765384, "pagerank_1": 2.9643708481, "pagerank_2": 2.852620202, "pagerank_3": 3.6365430359, "pagerank_4": 4.0485261007, "pagerank_5": 4.9063342083}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Emily H.Cheng", "James J.Hsieh"], "affiliation": "Cornell University", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 9.5, "hindex_1": 10.0, "hindex_2": 10.5, "hindex_3": 11.5, "hindex_4": 12.0, "hindex_5": 12.5, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 28.4465, "citationsperpaper_1": 28.8045, "citationsperpaper_2": 28.711, "citationsperpaper_3": 27.1965, "citationsperpaper_4": 28.622, "citationsperpaper_5": 28.345, "citationsperyear_0": 44.102, "citationsperyear_1": 45.247, "citationsperyear_2": 45.7475, "citationsperyear_3": 47.514, "citationsperyear_4": 49.0105, "citationsperyear_5": 49.5725, "totalcitations_0": 675.0, "totalcitations_1": 739.0, "totalcitations_2": 793.5, "totalcitations_3": 873.0, "totalcitations_4": 952.0, "totalcitations_5": 1013.5, "totalpapers_0": 22.0, "totalpapers_1": 24.0, "totalpapers_2": 26.0, "totalpapers_3": 31.0, "totalpapers_4": 32.5, "totalpapers_5": 35.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 54.5, "recentcoauthors_2": 42.5, "recentcoauthors_3": 205.0, "recentcoauthors_4": 311.0, "recentcoauthors_5": 261.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 142.75, "venuehindexmean_1": 144.8045454545, "venuehindexmean_2": 143.3825757576, "venuehindexmean_3": 136.1291208791, "venuehindexmean_4": 136.5102564103, "venuehindexmean_5": 138.2452380952, "totalvenues_0": 10.0, "totalvenues_1": 10.5, "totalvenues_2": 11.5, "totalvenues_3": 13.5, "totalvenues_4": 14.0, "totalvenues_5": 14.5, "pagerank_0": 4.7900524589, "pagerank_1": 5.2843659668, "pagerank_2": 5.3462063794, "pagerank_3": 6.5888701817, "pagerank_4": 7.0793434624, "pagerank_5": 8.0076618294}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["HanLiu", "ShugakuTakeda", "Emily H.Cheng", "James J.Hsieh"], "affiliation": "Memorial Sloan Kettering Cancer Center", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 5.25, "hindex_1": 6.0, "hindex_2": 6.25, "hindex_3": 7.25, "hindex_4": 7.75, "hindex_5": 8.25, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 15.13975, "citationsperpaper_1": 15.77375, "citationsperpaper_2": 15.793, "citationsperpaper_3": 15.212, "citationsperpaper_4": 16.272, "citationsperpaper_5": 16.06425, "citationsperyear_0": 23.351, "citationsperyear_1": 24.4985, "citationsperyear_2": 24.695, "citationsperyear_3": 26.16325, "citationsperyear_4": 27.19975, "citationsperyear_5": 27.71125, "totalcitations_0": 344.0, "totalcitations_1": 380.75, "totalcitations_2": 409.5, "totalcitations_3": 455.75, "totalcitations_4": 500.25, "totalcitations_5": 536.0, "totalpapers_0": 14.75, "totalpapers_1": 16.25, "totalpapers_2": 17.5, "totalpapers_3": 21.5, "totalpapers_4": 22.5, "totalpapers_5": 25.75, "authorage_0": 9.5, "authorage_1": 10.5, "authorage_2": 11.5, "authorage_3": 12.5, "authorage_4": 13.5, "authorage_5": 14.5, "recentcoauthors_0": 37.5, "recentcoauthors_1": 42.75, "recentcoauthors_2": 30.0, "recentcoauthors_3": 120.75, "recentcoauthors_4": 175.25, "recentcoauthors_5": 144.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 142.2875, "venuehindexmean_1": 144.6022727273, "venuehindexmean_2": 145.2287878788, "venuehindexmean_3": 129.3919413919, "venuehindexmean_4": 128.8176282051, "venuehindexmean_5": 129.3994047619, "totalvenues_0": 7.25, "totalvenues_1": 7.5, "totalvenues_2": 8.0, "totalvenues_3": 10.0, "totalvenues_4": 10.5, "totalvenues_5": 11.0, "pagerank_0": 3.1828499058, "pagerank_1": 3.6157939298, "pagerank_2": 3.5931574856, "pagerank_3": 4.3945876911, "pagerank_4": 4.6170616426, "pagerank_5": 5.3710254502}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Emily H.Cheng", "James J.Hsieh"], "affiliation": "Johns Hopkins University", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 9.5, "hindex_1": 10.0, "hindex_2": 10.5, "hindex_3": 11.5, "hindex_4": 12.0, "hindex_5": 12.5, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 28.4465, "citationsperpaper_1": 28.8045, "citationsperpaper_2": 28.711, "citationsperpaper_3": 27.1965, "citationsperpaper_4": 28.622, "citationsperpaper_5": 28.345, "citationsperyear_0": 44.102, "citationsperyear_1": 45.247, "citationsperyear_2": 45.7475, "citationsperyear_3": 47.514, "citationsperyear_4": 49.0105, "citationsperyear_5": 49.5725, "totalcitations_0": 675.0, "totalcitations_1": 739.0, "totalcitations_2": 793.5, "totalcitations_3": 873.0, "totalcitations_4": 952.0, "totalcitations_5": 1013.5, "totalpapers_0": 22.0, "totalpapers_1": 24.0, "totalpapers_2": 26.0, "totalpapers_3": 31.0, "totalpapers_4": 32.5, "totalpapers_5": 35.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 54.5, "recentcoauthors_2": 42.5, "recentcoauthors_3": 205.0, "recentcoauthors_4": 311.0, "recentcoauthors_5": 261.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 142.75, "venuehindexmean_1": 144.8045454545, "venuehindexmean_2": 143.3825757576, "venuehindexmean_3": 136.1291208791, "venuehindexmean_4": 136.5102564103, "venuehindexmean_5": 138.2452380952, "totalvenues_0": 10.0, "totalvenues_1": 10.5, "totalvenues_2": 11.5, "totalvenues_3": 13.5, "totalvenues_4": 14.0, "totalvenues_5": 14.5, "pagerank_0": 4.7900524589, "pagerank_1": 5.2843659668, "pagerank_2": 5.3462063794, "pagerank_3": 6.5888701817, "pagerank_4": 7.0793434624, "pagerank_5": 8.0076618294}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Emily H.Cheng", "James J.Hsieh"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 9.5, "hindex_1": 10.0, "hindex_2": 10.5, "hindex_3": 11.5, "hindex_4": 12.0, "hindex_5": 12.5, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 28.4465, "citationsperpaper_1": 28.8045, "citationsperpaper_2": 28.711, "citationsperpaper_3": 27.1965, "citationsperpaper_4": 28.622, "citationsperpaper_5": 28.345, "citationsperyear_0": 44.102, "citationsperyear_1": 45.247, "citationsperyear_2": 45.7475, "citationsperyear_3": 47.514, "citationsperyear_4": 49.0105, "citationsperyear_5": 49.5725, "totalcitations_0": 675.0, "totalcitations_1": 739.0, "totalcitations_2": 793.5, "totalcitations_3": 873.0, "totalcitations_4": 952.0, "totalcitations_5": 1013.5, "totalpapers_0": 22.0, "totalpapers_1": 24.0, "totalpapers_2": 26.0, "totalpapers_3": 31.0, "totalpapers_4": 32.5, "totalpapers_5": 35.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 54.5, "recentcoauthors_2": 42.5, "recentcoauthors_3": 205.0, "recentcoauthors_4": 311.0, "recentcoauthors_5": 261.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 142.75, "venuehindexmean_1": 144.8045454545, "venuehindexmean_2": 143.3825757576, "venuehindexmean_3": 136.1291208791, "venuehindexmean_4": 136.5102564103, "venuehindexmean_5": 138.2452380952, "totalvenues_0": 10.0, "totalvenues_1": 10.5, "totalvenues_2": 11.5, "totalvenues_3": 13.5, "totalvenues_4": 14.0, "totalvenues_5": 14.5, "pagerank_0": 4.7900524589, "pagerank_1": 5.2843659668, "pagerank_2": 5.3462063794, "pagerank_3": 6.5888701817, "pagerank_4": 7.0793434624, "pagerank_5": 8.0076618294}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["HanLiu"], "affiliation": "Shanghai Jiao Tong University", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 1.333, "citationsperpaper_1": 2.2, "citationsperpaper_2": 2.5, "citationsperpaper_3": 3.0, "citationsperpaper_4": 3.571, "citationsperpaper_5": 3.105, "citationsperyear_0": 2.4, "citationsperyear_1": 3.667, "citationsperyear_2": 3.571, "citationsperyear_3": 4.875, "citationsperyear_4": 5.556, "citationsperyear_5": 5.9, "totalcitations_0": 12.0, "totalcitations_1": 22.0, "totalcitations_2": 25.0, "totalcitations_3": 39.0, "totalcitations_4": 50.0, "totalcitations_5": 59.0, "totalpapers_0": 9.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 13.0, "totalpapers_4": 14.0, "totalpapers_5": 19.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 16.0, "recentcoauthors_3": 35.0, "recentcoauthors_4": 44.0, "recentcoauthors_5": 34.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.4, "venuehindexmean_1": 143.8, "venuehindexmean_2": 146.4, "venuehindexmean_3": 124.1428571429, "venuehindexmean_4": 119.25, "venuehindexmean_5": 121.25, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 1.668373019, "pagerank_1": 2.033691201, "pagerank_2": 1.8867379985, "pagerank_3": 2.2613364192, "pagerank_4": 2.2906916091, "pagerank_5": 3.1335117238}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Tej K.Pandita"], "affiliation": "Columbia University", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 14.435, "citationsperpaper_1": 16.0, "citationsperpaper_2": 15.75, "citationsperpaper_3": 16.621, "citationsperpaper_4": 16.387, "citationsperpaper_5": 13.974, "citationsperyear_0": 17.474, "citationsperyear_1": 19.2, "citationsperyear_2": 21.0, "citationsperyear_3": 21.909, "citationsperyear_4": 22.087, "citationsperyear_5": 22.708, "totalcitations_0": 332.0, "totalcitations_1": 384.0, "totalcitations_2": 441.0, "totalcitations_3": 482.0, "totalcitations_4": 508.0, "totalcitations_5": 545.0, "totalpapers_0": 23.0, "totalpapers_1": 24.0, "totalpapers_2": 28.0, "totalpapers_3": 29.0, "totalpapers_4": 31.0, "totalpapers_5": 39.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 31.0, "recentcoauthors_3": 29.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 114.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.1, "venuehindexmean_1": 139.9, "venuehindexmean_2": 143.3, "venuehindexmean_3": 145.9, "venuehindexmean_4": 148.4, "venuehindexmean_5": 140.4545454545, "totalvenues_0": 10.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 7.0889291369, "pagerank_1": 7.0300909486, "pagerank_2": 7.6054930619, "pagerank_3": 7.4187272629, "pagerank_4": 7.5130856591, "pagerank_5": 9.995724778}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Tej K.Pandita"], "affiliation": "University of Texas at Dallas", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 14.435, "citationsperpaper_1": 16.0, "citationsperpaper_2": 15.75, "citationsperpaper_3": 16.621, "citationsperpaper_4": 16.387, "citationsperpaper_5": 13.974, "citationsperyear_0": 17.474, "citationsperyear_1": 19.2, "citationsperyear_2": 21.0, "citationsperyear_3": 21.909, "citationsperyear_4": 22.087, "citationsperyear_5": 22.708, "totalcitations_0": 332.0, "totalcitations_1": 384.0, "totalcitations_2": 441.0, "totalcitations_3": 482.0, "totalcitations_4": 508.0, "totalcitations_5": 545.0, "totalpapers_0": 23.0, "totalpapers_1": 24.0, "totalpapers_2": 28.0, "totalpapers_3": 29.0, "totalpapers_4": 31.0, "totalpapers_5": 39.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 31.0, "recentcoauthors_3": 29.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 114.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.1, "venuehindexmean_1": 139.9, "venuehindexmean_2": 143.3, "venuehindexmean_3": 145.9, "venuehindexmean_4": 148.4, "venuehindexmean_5": 140.4545454545, "totalvenues_0": 10.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 7.0889291369, "pagerank_1": 7.0300909486, "pagerank_2": 7.6054930619, "pagerank_3": 7.4187272629, "pagerank_4": 7.5130856591, "pagerank_5": 9.995724778}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Emily H.Cheng", "Tej K.Pandita"], "affiliation": "Baylor College of Medicine", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 9.0, "hindex_1": 9.5, "hindex_2": 10.5, "hindex_3": 11.5, "hindex_4": 11.5, "hindex_5": 12.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 29.6375, "citationsperpaper_1": 30.352, "citationsperpaper_2": 30.0645, "citationsperpaper_3": 29.3865, "citationsperpaper_4": 29.767, "citationsperpaper_5": 28.4035, "citationsperyear_0": 46.1035, "citationsperyear_1": 47.319, "citationsperyear_2": 48.353, "citationsperyear_3": 49.5935, "citationsperyear_4": 49.649, "citationsperyear_5": 49.904, "totalcitations_0": 726.5, "totalcitations_1": 795.5, "totalcitations_2": 864.0, "totalcitations_3": 936.5, "totalcitations_4": 987.5, "totalcitations_5": 1043.5, "totalpapers_0": 24.0, "totalpapers_1": 25.5, "totalpapers_2": 28.5, "totalpapers_3": 31.0, "totalpapers_4": 32.5, "totalpapers_5": 37.5, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 41.5, "recentcoauthors_2": 35.5, "recentcoauthors_3": 41.0, "recentcoauthors_4": 28.0, "recentcoauthors_5": 71.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 140.95, "venuehindexmean_1": 142.9045454545, "venuehindexmean_2": 143.9416666667, "venuehindexmean_3": 140.7714285714, "venuehindexmean_4": 141.1333333333, "venuehindexmean_5": 138.2939393939, "totalvenues_0": 10.0, "totalvenues_1": 10.5, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.5, "totalvenues_5": 13.0, "pagerank_0": 6.3367501621, "pagerank_1": 6.4883324024, "pagerank_2": 6.8508295502, "pagerank_3": 6.8369261307, "pagerank_4": 6.8029955089, "pagerank_5": 8.1260225318}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["RakeshKumar", "Tej K.Pandita"], "affiliation": "University of Texas Southwestern Medical Center", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.5, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.5, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 7.2175, "citationsperpaper_1": 11.0, "citationsperpaper_2": 10.875, "citationsperpaper_3": 12.8105, "citationsperpaper_4": 14.1935, "citationsperpaper_5": 13.987, "citationsperyear_0": 8.737, "citationsperyear_1": 11.1, "citationsperyear_2": 11.5, "citationsperyear_3": 12.0795, "citationsperyear_4": 12.2435, "citationsperyear_5": 12.5205, "totalcitations_0": 166.0, "totalcitations_1": 195.0, "totalcitations_2": 223.5, "totalcitations_3": 245.5, "totalcitations_4": 260.0, "totalcitations_5": 279.5, "totalpapers_0": 12.0, "totalpapers_1": 12.5, "totalpapers_2": 14.5, "totalpapers_3": 15.0, "totalpapers_4": 16.0, "totalpapers_5": 20.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 30.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 15.5, "recentcoauthors_3": 14.5, "recentcoauthors_4": 5.5, "recentcoauthors_5": 57.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 198.55, "venuehindexmean_1": 201.95, "venuehindexmean_2": 206.15, "venuehindexmean_3": 210.45, "venuehindexmean_4": 214.2, "venuehindexmean_5": 212.2272727273, "totalvenues_0": 5.5, "totalvenues_1": 5.5, "totalvenues_2": 5.5, "totalvenues_3": 5.5, "totalvenues_4": 5.5, "totalvenues_5": 6.0, "pagerank_0": 3.7232317167, "pagerank_1": 3.6868624664, "pagerank_2": 3.9687573018, "pagerank_3": 3.8588460379, "pagerank_4": 3.9019485401, "pagerank_5": 5.1409752446}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Tej K.Pandita"], "affiliation": "Houston Methodist Hospital", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 14.435, "citationsperpaper_1": 16.0, "citationsperpaper_2": 15.75, "citationsperpaper_3": 16.621, "citationsperpaper_4": 16.387, "citationsperpaper_5": 13.974, "citationsperyear_0": 17.474, "citationsperyear_1": 19.2, "citationsperyear_2": 21.0, "citationsperyear_3": 21.909, "citationsperyear_4": 22.087, "citationsperyear_5": 22.708, "totalcitations_0": 332.0, "totalcitations_1": 384.0, "totalcitations_2": 441.0, "totalcitations_3": 482.0, "totalcitations_4": 508.0, "totalcitations_5": 545.0, "totalpapers_0": 23.0, "totalpapers_1": 24.0, "totalpapers_2": 28.0, "totalpapers_3": 29.0, "totalpapers_4": 31.0, "totalpapers_5": 39.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 31.0, "recentcoauthors_3": 29.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 114.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.1, "venuehindexmean_1": 139.9, "venuehindexmean_2": 143.3, "venuehindexmean_3": 145.9, "venuehindexmean_4": 148.4, "venuehindexmean_5": 140.4545454545, "totalvenues_0": 10.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 7.0889291369, "pagerank_1": 7.0300909486, "pagerank_2": 7.6054930619, "pagerank_3": 7.4187272629, "pagerank_4": 7.5130856591, "pagerank_5": 9.995724778}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Emily H.Cheng"], "affiliation": "Brigham and Women's Hospital", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 12.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 44.84, "citationsperpaper_1": 44.704, "citationsperpaper_2": 44.379, "citationsperpaper_3": 42.152, "citationsperpaper_4": 43.147, "citationsperpaper_5": 42.833, "citationsperyear_0": 74.733, "citationsperyear_1": 75.438, "citationsperyear_2": 75.706, "citationsperyear_3": 77.278, "citationsperyear_4": 77.211, "citationsperyear_5": 77.1, "totalcitations_0": 1121.0, "totalcitations_1": 1207.0, "totalcitations_2": 1287.0, "totalcitations_3": 1391.0, "totalcitations_4": 1467.0, "totalcitations_5": 1542.0, "totalpapers_0": 25.0, "totalpapers_1": 27.0, "totalpapers_2": 29.0, "totalpapers_3": 33.0, "totalpapers_4": 34.0, "totalpapers_5": 36.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 51.0, "recentcoauthors_1": 52.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 45.0, "recentcoauthors_5": 29.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 144.8, "venuehindexmean_1": 145.9090909091, "venuehindexmean_2": 144.5833333333, "venuehindexmean_3": 135.6428571429, "venuehindexmean_4": 133.8666666667, "venuehindexmean_5": 136.1333333333, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 14.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 5.5845711873, "pagerank_1": 5.9465738563, "pagerank_2": 6.0961660386, "pagerank_3": 6.2551249984, "pagerank_4": 6.0929053587, "pagerank_5": 6.2563202857}}, {"model": "papers.paper", "pk": 1003196, "fields": {"authors": ["Eric J.Brown"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature09350", "abstract": "The S-phase checkpoint in mitosis, activated by DNA damage, maintains genome stability by allowing the cell time to repair the damage before it progresses through the cell cycle. Liu et al. now report that the MLL (mixed lineage leukaemia) gene, frequently translocated in leukaemia, is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the checkpoint kinase ATR, causing it to accumulate on chromatin and to methylate histone H3 at lysine residue 4. This histone modification blocks activation of late replication origins. MLL translocations disrupt this pathway and promote genomic instability. Cell cycle checkpoints, such as the S-phase checkpoint, delay cell division to give the cell time to repair any damaged DNA. Here it is shown that the MLL gene \u2014 frequently disrupted in leukaemia \u2014 is part of the S-phase checkpoint. When DNA is damaged, MLL is phosphorylated by the ATR protein, causing MLL to accumulate on chromatin and methylate histone H3 on lysine 4. This delays DNA replication. MLL translocations, such as those that occur in leukaemia, disrupt this pathway and cause genomic instability. Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors1,2. Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity3,4. Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias5,6,7,8,9. Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll\u2212/\u2212 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or \u0394SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll\u2013CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.", "year": 2010, "title": "Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint", "keywords": ["Chromatin", "Genome instability", "Cell cycle checkpoint", "Histone", "Biology", "Cell cycle", "Cancer research", "DNA damage", "G2-M DNA damage checkpoint", "DNA replication"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 0.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.169813274, "timescaledpagerank_2": 0.0556641411, "timescaledpagerank_3": 0.1212323274, "timescaledpagerank_4": 0.1268583913, "timescaledpagerank_5": 0.1266018923, "hindex_0": 18.0, "hindex_1": 19.0, "hindex_2": 19.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 47.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 40.0, "adopters_5": 0.0, "citationsperpaper_0": 20.019, "citationsperpaper_1": 21.315, "citationsperpaper_2": 22.429, "citationsperpaper_3": 23.22, "citationsperpaper_4": 24.267, "citationsperpaper_5": 25.1, "citationsperyear_0": 34.226, "citationsperyear_1": 35.969, "citationsperyear_2": 38.061, "citationsperyear_3": 40.294, "citationsperyear_4": 41.6, "citationsperyear_5": 41.833, "totalcitations_0": 1061.0, "totalcitations_1": 1151.0, "totalcitations_2": 1256.0, "totalcitations_3": 1370.0, "totalcitations_4": 1456.0, "totalcitations_5": 1506.0, "totalpapers_0": 53.0, "totalpapers_1": 54.0, "totalpapers_2": 56.0, "totalpapers_3": 59.0, "totalpapers_4": 60.0, "totalpapers_5": 60.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 24.0, "recentcoauthors_2": 17.0, "recentcoauthors_3": 32.0, "recentcoauthors_4": 24.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.0, "venuehindexmean_1": 130.7142857143, "venuehindexmean_2": 134.0714285714, "venuehindexmean_3": 136.8571428571, "venuehindexmean_4": 135.0, "venuehindexmean_5": 137.5333333333, "totalvenues_0": 14.0, "totalvenues_1": 14.0, "totalvenues_2": 14.0, "totalvenues_3": 14.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 10.8279620497, "pagerank_1": 10.6073322078, "pagerank_2": 10.5258510505, "pagerank_3": 10.9585483006, "pagerank_4": 10.7649793234, "pagerank_5": 10.4697160357}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["AndrejShevchenko", "RuediAebersold"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 26.5, "hindex_1": 27.5, "hindex_2": 28.0, "hindex_3": 29.0, "hindex_4": 30.5, "hindex_5": 31.5, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 39.9385, "citationsperpaper_1": 39.646, "citationsperpaper_2": 39.2395, "citationsperpaper_3": 38.638, "citationsperpaper_4": 37.589, "citationsperpaper_5": 38.015, "citationsperyear_0": 154.455, "citationsperyear_1": 155.4275, "citationsperyear_2": 155.353, "citationsperyear_3": 156.9165, "citationsperyear_4": 157.552, "citationsperyear_5": 159.509, "totalcitations_0": 2925.0, "totalcitations_1": 3117.5, "totalcitations_2": 3295.5, "totalcitations_3": 3512.0, "totalcitations_4": 3710.5, "totalcitations_5": 3949.0, "totalpapers_0": 85.0, "totalpapers_1": 90.5, "totalpapers_2": 97.0, "totalpapers_3": 107.0, "totalpapers_4": 117.0, "totalpapers_5": 123.0, "authorage_0": 19.5, "authorage_1": 20.5, "authorage_2": 21.5, "authorage_3": 22.5, "authorage_4": 23.5, "authorage_5": 24.5, "recentcoauthors_0": 171.0, "recentcoauthors_1": 126.5, "recentcoauthors_2": 114.0, "recentcoauthors_3": 163.5, "recentcoauthors_4": 194.0, "recentcoauthors_5": 160.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.5972222222, "venuehindexmean_1": 117.18125, "venuehindexmean_2": 118.5833333333, "venuehindexmean_3": 120.1306818182, "venuehindexmean_4": 120.2540106952, "venuehindexmean_5": 121.2132352941, "totalvenues_0": 17.0, "totalvenues_1": 18.0, "totalvenues_2": 18.5, "totalvenues_3": 19.0, "totalvenues_4": 19.5, "totalvenues_5": 20.5, "pagerank_0": 21.6490344684, "pagerank_1": 22.6566638541, "pagerank_2": 23.7141607752, "pagerank_3": 25.9826395548, "pagerank_4": 27.7362398335, "pagerank_5": 28.54650459}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["AndrejShevchenko", "KaiSimons"], "affiliation": "European Bioinformatics Institute", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 38.0, "hindex_1": 38.0, "hindex_2": 38.5, "hindex_3": 39.0, "hindex_4": 40.0, "hindex_5": 40.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 53.7265, "citationsperpaper_1": 52.388, "citationsperpaper_2": 52.1695, "citationsperpaper_3": 52.652, "citationsperpaper_4": 52.2655, "citationsperpaper_5": 52.4305, "citationsperyear_0": 190.4615, "citationsperyear_1": 189.9065, "citationsperyear_2": 188.365, "citationsperyear_3": 187.0, "citationsperyear_4": 184.659, "citationsperyear_5": 182.2975, "totalcitations_0": 5048.0, "totalcitations_1": 5242.0, "totalcitations_2": 5422.5, "totalcitations_3": 5588.0, "totalcitations_4": 5723.5, "totalcitations_5": 5848.5, "totalpapers_0": 95.0, "totalpapers_1": 101.5, "totalpapers_2": 105.0, "totalpapers_3": 106.5, "totalpapers_4": 109.0, "totalpapers_5": 111.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 103.0, "recentcoauthors_1": 74.5, "recentcoauthors_2": 57.5, "recentcoauthors_3": 40.0, "recentcoauthors_4": 35.0, "recentcoauthors_5": 32.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.425, "venuehindexmean_1": 134.78125, "venuehindexmean_2": 138.5681818182, "venuehindexmean_3": 141.7897727273, "venuehindexmean_4": 141.6176470588, "venuehindexmean_5": 144.2700534759, "totalvenues_0": 13.0, "totalvenues_1": 13.5, "totalvenues_2": 13.5, "totalvenues_3": 13.5, "totalvenues_4": 14.0, "totalvenues_5": 14.0, "pagerank_0": 17.8614414723, "pagerank_1": 18.3608415491, "pagerank_2": 18.7221667411, "pagerank_3": 18.6755740078, "pagerank_4": 18.8332287881, "pagerank_5": 18.668776724}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Christer S.Ejsing", "KaiSimons", "BerndBodenmiller", "RuediAebersold", "AndrejShevchenko", "Sean R.Collins", "David K.Breslow", "Jonathan S.Weissman"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 19.625, "hindex_1": 20.5, "hindex_2": 21.75, "hindex_3": 22.75, "hindex_4": 23.625, "hindex_5": 24.625, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 30.880625, "citationsperpaper_1": 31.079, "citationsperpaper_2": 34.119875, "citationsperpaper_3": 35.327875, "citationsperpaper_4": 37.167375, "citationsperpaper_5": 38.482375, "citationsperyear_0": 93.0535, "citationsperyear_1": 97.796875, "citationsperyear_2": 102.612875, "citationsperyear_3": 106.6455, "citationsperyear_4": 110.440375, "citationsperyear_5": 112.938625, "totalcitations_0": 2074.0, "totalcitations_1": 2242.875, "totalcitations_2": 2424.25, "totalcitations_3": 2610.125, "totalcitations_4": 2797.25, "totalcitations_5": 2970.875, "totalpapers_0": 52.5, "totalpapers_1": 57.125, "totalpapers_2": 60.375, "totalpapers_3": 64.875, "totalpapers_4": 69.875, "totalpapers_5": 73.5, "authorage_0": 14.75, "authorage_1": 15.75, "authorage_2": 16.75, "authorage_3": 17.75, "authorage_4": 18.75, "authorage_5": 19.75, "recentcoauthors_0": 85.625, "recentcoauthors_1": 68.375, "recentcoauthors_2": 61.875, "recentcoauthors_3": 74.0, "recentcoauthors_4": 87.0, "recentcoauthors_5": 83.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.8915445665, "venuehindexmean_1": 130.7628605769, "venuehindexmean_2": 133.1328879454, "venuehindexmean_3": 134.7837594697, "venuehindexmean_4": 135.829474896, "venuehindexmean_5": 135.4255908544, "totalvenues_0": 10.125, "totalvenues_1": 10.875, "totalvenues_2": 11.125, "totalvenues_3": 11.875, "totalvenues_4": 12.25, "totalvenues_5": 13.0, "pagerank_0": 11.4354326585, "pagerank_1": 12.1207131959, "pagerank_2": 12.6560715778, "pagerank_3": 13.5174127966, "pagerank_4": 14.3776343557, "pagerank_5": 14.7901360084}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Sean R.Collins", "David K.Breslow", "BerndBodenmiller"], "affiliation": "Stanford University", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 7.0, "hindex_1": 7.6666666667, "hindex_2": 9.3333333333, "hindex_3": 10.0, "hindex_4": 10.6666666667, "hindex_5": 11.3333333333, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 23.1166666667, "citationsperpaper_1": 23.4633333333, "citationsperpaper_2": 29.4313333333, "citationsperpaper_3": 31.979, "citationsperpaper_4": 36.8946666667, "citationsperpaper_5": 39.498, "citationsperyear_0": 34.9806666667, "citationsperyear_1": 40.2726666667, "citationsperyear_2": 45.768, "citationsperyear_3": 48.7156666667, "citationsperyear_4": 51.2666666667, "citationsperyear_5": 51.791, "totalcitations_0": 252.0, "totalcitations_1": 328.6666666667, "totalcitations_2": 416.6666666667, "totalcitations_3": 491.6666666667, "totalcitations_4": 566.6666666667, "totalcitations_5": 622.0, "totalpapers_0": 11.3333333333, "totalpapers_1": 13.0, "totalpapers_2": 14.0, "totalpapers_3": 15.0, "totalpapers_4": 15.6666666667, "totalpapers_5": 16.6666666667, "authorage_0": 5.3333333333, "authorage_1": 6.3333333333, "authorage_2": 7.3333333333, "authorage_3": 8.3333333333, "authorage_4": 9.3333333333, "authorage_5": 10.3333333333, "recentcoauthors_0": 45.6666666667, "recentcoauthors_1": 34.3333333333, "recentcoauthors_2": 22.3333333333, "recentcoauthors_3": 13.3333333333, "recentcoauthors_4": 9.3333333333, "recentcoauthors_5": 15.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 144.0119047619, "venuehindexmean_1": 139.0416666667, "venuehindexmean_2": 140.8888888889, "venuehindexmean_3": 144.9972222222, "venuehindexmean_4": 148.412962963, "venuehindexmean_5": 148.3666666667, "totalvenues_0": 5.6666666667, "totalvenues_1": 6.6666666667, "totalvenues_2": 7.0, "totalvenues_3": 7.3333333333, "totalvenues_4": 7.3333333333, "totalvenues_5": 8.0, "pagerank_0": 3.7047779323, "pagerank_1": 4.0599973918, "pagerank_2": 4.1793736347, "pagerank_3": 4.17256906, "pagerank_4": 4.1970095774, "pagerank_5": 4.2511465227}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["BerndBodenmiller", "RuediAebersold"], "affiliation": "University of Zurich", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 16.5, "hindex_1": 18.0, "hindex_2": 19.5, "hindex_3": 20.5, "hindex_4": 21.5, "hindex_5": 23.5, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 15.5585, "citationsperpaper_1": 17.547, "citationsperpaper_2": 18.76, "citationsperpaper_3": 19.113, "citationsperpaper_4": 19.622, "citationsperpaper_5": 20.865, "citationsperyear_0": 61.622, "citationsperyear_1": 66.548, "citationsperyear_2": 71.1875, "citationsperyear_3": 75.778, "citationsperyear_4": 80.0835, "citationsperyear_5": 85.6205, "totalcitations_0": 1475.5, "totalcitations_1": 1612.5, "totalcitations_2": 1759.5, "totalcitations_3": 1932.0, "totalcitations_4": 2104.5, "totalcitations_5": 2321.5, "totalpapers_0": 64.0, "totalpapers_1": 68.0, "totalpapers_2": 74.0, "totalpapers_3": 83.5, "totalpapers_4": 92.5, "totalpapers_5": 98.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 149.5, "recentcoauthors_1": 119.5, "recentcoauthors_2": 105.5, "recentcoauthors_3": 150.5, "recentcoauthors_4": 172.5, "recentcoauthors_5": 158.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.8472222222, "venuehindexmean_1": 129.525, "venuehindexmean_2": 127.1666666667, "venuehindexmean_3": 128.9015151515, "venuehindexmean_4": 132.0808080808, "venuehindexmean_5": 132.475, "totalvenues_0": 13.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 15.5, "totalvenues_4": 15.5, "totalvenues_5": 17.0, "pagerank_0": 16.008490506, "pagerank_1": 17.0139821078, "pagerank_2": 18.0540370616, "pagerank_3": 20.1252232067, "pagerank_4": 21.6182835573, "pagerank_5": 22.6939693237}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["BerndBodenmiller", "RuediAebersold"], "affiliation": "\u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 16.5, "hindex_1": 18.0, "hindex_2": 19.5, "hindex_3": 20.5, "hindex_4": 21.5, "hindex_5": 23.5, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 15.5585, "citationsperpaper_1": 17.547, "citationsperpaper_2": 18.76, "citationsperpaper_3": 19.113, "citationsperpaper_4": 19.622, "citationsperpaper_5": 20.865, "citationsperyear_0": 61.622, "citationsperyear_1": 66.548, "citationsperyear_2": 71.1875, "citationsperyear_3": 75.778, "citationsperyear_4": 80.0835, "citationsperyear_5": 85.6205, "totalcitations_0": 1475.5, "totalcitations_1": 1612.5, "totalcitations_2": 1759.5, "totalcitations_3": 1932.0, "totalcitations_4": 2104.5, "totalcitations_5": 2321.5, "totalpapers_0": 64.0, "totalpapers_1": 68.0, "totalpapers_2": 74.0, "totalpapers_3": 83.5, "totalpapers_4": 92.5, "totalpapers_5": 98.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 149.5, "recentcoauthors_1": 119.5, "recentcoauthors_2": 105.5, "recentcoauthors_3": 150.5, "recentcoauthors_4": 172.5, "recentcoauthors_5": 158.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.8472222222, "venuehindexmean_1": 129.525, "venuehindexmean_2": 127.1666666667, "venuehindexmean_3": 128.9015151515, "venuehindexmean_4": 132.0808080808, "venuehindexmean_5": 132.475, "totalvenues_0": 13.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 15.5, "totalvenues_4": 15.5, "totalvenues_5": 17.0, "pagerank_0": 16.008490506, "pagerank_1": 17.0139821078, "pagerank_2": 18.0540370616, "pagerank_3": 20.1252232067, "pagerank_4": 21.6182835573, "pagerank_5": 22.6939693237}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["BerndBodenmiller", "RuediAebersold"], "affiliation": "ETH Zurich", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 16.5, "hindex_1": 18.0, "hindex_2": 19.5, "hindex_3": 20.5, "hindex_4": 21.5, "hindex_5": 23.5, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 15.5585, "citationsperpaper_1": 17.547, "citationsperpaper_2": 18.76, "citationsperpaper_3": 19.113, "citationsperpaper_4": 19.622, "citationsperpaper_5": 20.865, "citationsperyear_0": 61.622, "citationsperyear_1": 66.548, "citationsperyear_2": 71.1875, "citationsperyear_3": 75.778, "citationsperyear_4": 80.0835, "citationsperyear_5": 85.6205, "totalcitations_0": 1475.5, "totalcitations_1": 1612.5, "totalcitations_2": 1759.5, "totalcitations_3": 1932.0, "totalcitations_4": 2104.5, "totalcitations_5": 2321.5, "totalpapers_0": 64.0, "totalpapers_1": 68.0, "totalpapers_2": 74.0, "totalpapers_3": 83.5, "totalpapers_4": 92.5, "totalpapers_5": 98.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 149.5, "recentcoauthors_1": 119.5, "recentcoauthors_2": 105.5, "recentcoauthors_3": 150.5, "recentcoauthors_4": 172.5, "recentcoauthors_5": 158.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.8472222222, "venuehindexmean_1": 129.525, "venuehindexmean_2": 127.1666666667, "venuehindexmean_3": 128.9015151515, "venuehindexmean_4": 132.0808080808, "venuehindexmean_5": 132.475, "totalvenues_0": 13.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 15.5, "totalvenues_4": 15.5, "totalvenues_5": 17.0, "pagerank_0": 16.008490506, "pagerank_1": 17.0139821078, "pagerank_2": 18.0540370616, "pagerank_3": 20.1252232067, "pagerank_4": 21.6182835573, "pagerank_5": 22.6939693237}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["KaiSimons"], "affiliation": "Dresden University of Technology", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 50.0, "hindex_1": 50.0, "hindex_2": 50.0, "hindex_3": 51.0, "hindex_4": 51.0, "hindex_5": 51.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 52.36, "citationsperpaper_1": 50.655, "citationsperpaper_2": 50.913, "citationsperpaper_3": 52.195, "citationsperpaper_4": 52.913, "citationsperpaper_5": 53.132, "citationsperyear_0": 182.59, "citationsperyear_1": 183.625, "citationsperyear_2": 185.024, "citationsperyear_3": 185.167, "citationsperyear_4": 184.581, "citationsperyear_5": 183.545, "totalcitations_0": 7121.0, "totalcitations_1": 7345.0, "totalcitations_2": 7586.0, "totalcitations_3": 7777.0, "totalcitations_4": 7937.0, "totalcitations_5": 8076.0, "totalpapers_0": 136.0, "totalpapers_1": 145.0, "totalpapers_2": 149.0, "totalpapers_3": 149.0, "totalpapers_4": 150.0, "totalpapers_5": 152.0, "authorage_0": 38.0, "authorage_1": 39.0, "authorage_2": 40.0, "authorage_3": 41.0, "authorage_4": 42.0, "authorage_5": 43.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 72.0, "recentcoauthors_3": 29.0, "recentcoauthors_4": 3.0, "recentcoauthors_5": 16.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 155.1, "venuehindexmean_1": 146.0, "venuehindexmean_2": 149.6363636364, "venuehindexmean_3": 152.4545454545, "venuehindexmean_4": 155.0, "venuehindexmean_5": 157.3636363636, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 11.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 21.0161024154, "pagerank_1": 21.7968357961, "pagerank_2": 22.1620602188, "pagerank_3": 21.5777477464, "pagerank_4": 21.0084890818, "pagerank_5": 20.7515027892}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Sean R.Collins", "David K.Breslow", "Jonathan S.Weissman"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 14.3333333333, "hindex_1": 15.6666666667, "hindex_2": 17.3333333333, "hindex_3": 18.6666666667, "hindex_4": 19.6666666667, "hindex_5": 20.6666666667, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 34.0333333333, "citationsperpaper_1": 33.554, "citationsperpaper_2": 39.8666666667, "citationsperpaper_3": 42.1826666667, "citationsperpaper_4": 46.4656666667, "citationsperpaper_5": 48.7303333333, "citationsperyear_0": 77.6583333333, "citationsperyear_1": 86.447, "citationsperyear_2": 96.34, "citationsperyear_3": 104.6026666667, "citationsperyear_4": 112.861, "citationsperyear_5": 117.1133333333, "totalcitations_0": 1164.6666666667, "totalcitations_1": 1384.3333333333, "totalcitations_2": 1638.3333333333, "totalcitations_3": 1901.0, "totalcitations_4": 2184.0, "totalcitations_5": 2410.3333333333, "totalpapers_0": 31.3333333333, "totalpapers_1": 36.0, "totalpapers_2": 38.3333333333, "totalpapers_3": 42.6666666667, "totalpapers_4": 48.0, "totalpapers_5": 52.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 42.0, "recentcoauthors_1": 39.0, "recentcoauthors_2": 52.6666666667, "recentcoauthors_3": 64.6666666667, "recentcoauthors_4": 86.3333333333, "recentcoauthors_5": 90.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.0054945055, "venuehindexmean_1": 128.8301282051, "venuehindexmean_2": 133.1025641026, "venuehindexmean_3": 136.0458333333, "venuehindexmean_4": 135.912962963, "venuehindexmean_5": 135.3789473684, "totalvenues_0": 7.3333333333, "totalvenues_1": 8.3333333333, "totalvenues_2": 8.3333333333, "totalvenues_3": 9.6666666667, "totalvenues_4": 10.3333333333, "totalvenues_5": 11.0, "pagerank_0": 7.1374564385, "pagerank_1": 7.8795032926, "pagerank_2": 8.4047690231, "pagerank_3": 9.2018225134, "pagerank_4": 10.3521171492, "pagerank_5": 10.8122814268}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Sean R.Collins"], "affiliation": "University of California, Davis", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 12.0, "hindex_1": 13.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 16.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 30.684, "citationsperpaper_1": 34.667, "citationsperpaper_2": 40.227, "citationsperpaper_3": 46.545, "citationsperpaper_4": 52.0, "citationsperpaper_5": 52.565, "citationsperyear_0": 72.875, "citationsperyear_1": 80.889, "citationsperyear_2": 88.5, "citationsperyear_3": 93.091, "citationsperyear_4": 95.333, "citationsperyear_5": 93.0, "totalcitations_0": 583.0, "totalcitations_1": 728.0, "totalcitations_2": 885.0, "totalcitations_3": 1024.0, "totalcitations_4": 1144.0, "totalcitations_5": 1209.0, "totalpapers_0": 19.0, "totalpapers_1": 21.0, "totalpapers_2": 22.0, "totalpapers_3": 22.0, "totalpapers_4": 22.0, "totalpapers_5": 23.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 42.0, "recentcoauthors_1": 28.0, "recentcoauthors_2": 31.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.2857142857, "venuehindexmean_1": 145.375, "venuehindexmean_2": 150.0, "venuehindexmean_3": 154.125, "venuehindexmean_4": 157.75, "venuehindexmean_5": 153.0, "totalvenues_0": 7.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 9.0, "pagerank_0": 6.7869838505, "pagerank_1": 7.2634869483, "pagerank_2": 7.3441278378, "pagerank_3": 7.0682356656, "pagerank_4": 6.8126973686, "pagerank_5": 6.5862564786}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Sean R.Collins", "Jonathan S.Weissman", "RuediAebersold"], "affiliation": "University of California, San Francisco", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 22.3333333333, "hindex_1": 24.3333333333, "hindex_2": 25.6666666667, "hindex_3": 27.3333333333, "hindex_4": 28.6666666667, "hindex_5": 30.3333333333, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 31.517, "citationsperpaper_1": 33.3443333333, "citationsperpaper_2": 36.351, "citationsperpaper_3": 38.4606666667, "citationsperpaper_4": 39.9856666667, "citationsperpaper_5": 40.664, "citationsperyear_0": 108.0506666667, "citationsperyear_1": 117.5026666667, "citationsperyear_2": 127.5303333333, "citationsperyear_3": 137.436, "citationsperyear_4": 146.761, "citationsperyear_5": 153.4026666667, "totalcitations_0": 2090.6666666667, "totalcitations_1": 2373.3333333333, "totalcitations_2": 2689.6666666667, "totalcitations_3": 3038.6666666667, "totalcitations_4": 3401.6666666667, "totalcitations_5": 3739.0, "totalpapers_0": 69.0, "totalpapers_1": 75.3333333333, "totalpapers_2": 81.0, "totalpapers_3": 90.6666666667, "totalpapers_4": 101.3333333333, "totalpapers_5": 108.6666666667, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 93.6666666667, "recentcoauthors_2": 111.0, "recentcoauthors_3": 155.3333333333, "recentcoauthors_4": 192.0, "recentcoauthors_5": 181.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 123.6536426536, "venuehindexmean_1": 124.5967948718, "venuehindexmean_2": 126.9914529915, "venuehindexmean_3": 128.3579545455, "venuehindexmean_4": 128.1372053872, "venuehindexmean_5": 126.3289473684, "totalvenues_0": 12.6666666667, "totalvenues_1": 13.6666666667, "totalvenues_2": 14.0, "totalvenues_3": 15.3333333333, "totalvenues_4": 16.0, "totalvenues_5": 17.3333333333, "pagerank_0": 16.3673334604, "pagerank_1": 17.5833229554, "pagerank_2": 18.7094627087, "pagerank_3": 20.8021474797, "pagerank_4": 22.8381957328, "pagerank_5": 23.8858666127}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Christer S.Ejsing"], "affiliation": "University of Southern Denmark", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 5.0, "hindex_1": 5.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 6.375, "citationsperpaper_1": 8.1, "citationsperpaper_2": 11.5, "citationsperpaper_3": 12.545, "citationsperpaper_4": 14.167, "citationsperpaper_5": 15.077, "citationsperyear_0": 7.286, "citationsperyear_1": 10.125, "citationsperyear_2": 12.778, "citationsperyear_3": 13.8, "citationsperyear_4": 15.455, "citationsperyear_5": 16.333, "totalcitations_0": 51.0, "totalcitations_1": 81.0, "totalcitations_2": 115.0, "totalcitations_3": 138.0, "totalcitations_4": 170.0, "totalcitations_5": 196.0, "totalpapers_0": 8.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 11.0, "totalpapers_4": 12.0, "totalpapers_5": 13.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 54.0, "recentcoauthors_1": 42.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 17.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.5714285714, "venuehindexmean_1": 131.0, "venuehindexmean_2": 134.2857142857, "venuehindexmean_3": 128.75, "venuehindexmean_4": 131.5, "venuehindexmean_5": 123.7777777778, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 9.0, "pagerank_0": 2.3312279961, "pagerank_1": 2.5775483758, "pagerank_2": 2.4818579475, "pagerank_3": 2.9322404034, "pagerank_4": 3.0616987071, "pagerank_5": 3.1587516918}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["RuediAebersold"], "affiliation": "Wellcome Trust", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 27.0, "hindex_1": 29.0, "hindex_2": 29.0, "hindex_3": 31.0, "hindex_4": 32.0, "hindex_5": 34.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 24.784, "citationsperpaper_1": 25.171, "citationsperpaper_2": 25.053, "citationsperpaper_3": 24.167, "citationsperpaper_4": 23.56, "citationsperpaper_5": 24.301, "citationsperyear_0": 110.577, "citationsperyear_1": 114.667, "citationsperyear_2": 119.0, "citationsperyear_3": 125.0, "citationsperyear_4": 130.367, "citationsperyear_5": 137.968, "totalcitations_0": 2875.0, "totalcitations_1": 3096.0, "totalcitations_2": 3332.0, "totalcitations_3": 3625.0, "totalcitations_4": 3911.0, "totalcitations_5": 4277.0, "totalpapers_0": 116.0, "totalpapers_1": 123.0, "totalpapers_2": 133.0, "totalpapers_3": 150.0, "totalpapers_4": 166.0, "totalpapers_5": 176.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 211.0, "recentcoauthors_1": 181.0, "recentcoauthors_2": 185.0, "recentcoauthors_3": 276.0, "recentcoauthors_4": 321.0, "recentcoauthors_5": 272.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.4444444444, "venuehindexmean_1": 110.8, "venuehindexmean_2": 109.6666666667, "venuehindexmean_3": 109.1363636364, "venuehindexmean_4": 112.2727272727, "venuehindexmean_5": 111.25, "totalvenues_0": 18.0, "totalvenues_1": 20.0, "totalvenues_2": 21.0, "totalvenues_3": 22.0, "totalvenues_4": 22.0, "totalvenues_5": 24.0, "pagerank_0": 28.5912884077, "pagerank_1": 30.3884804062, "pagerank_2": 32.1460482869, "pagerank_3": 36.1918788404, "pagerank_4": 38.8145111727, "pagerank_5": 40.5069585214}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["RuediAebersold"], "affiliation": "Fred Hutchinson Cancer Research Center", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 27.0, "hindex_1": 29.0, "hindex_2": 29.0, "hindex_3": 31.0, "hindex_4": 32.0, "hindex_5": 34.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 24.784, "citationsperpaper_1": 25.171, "citationsperpaper_2": 25.053, "citationsperpaper_3": 24.167, "citationsperpaper_4": 23.56, "citationsperpaper_5": 24.301, "citationsperyear_0": 110.577, "citationsperyear_1": 114.667, "citationsperyear_2": 119.0, "citationsperyear_3": 125.0, "citationsperyear_4": 130.367, "citationsperyear_5": 137.968, "totalcitations_0": 2875.0, "totalcitations_1": 3096.0, "totalcitations_2": 3332.0, "totalcitations_3": 3625.0, "totalcitations_4": 3911.0, "totalcitations_5": 4277.0, "totalpapers_0": 116.0, "totalpapers_1": 123.0, "totalpapers_2": 133.0, "totalpapers_3": 150.0, "totalpapers_4": 166.0, "totalpapers_5": 176.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 211.0, "recentcoauthors_1": 181.0, "recentcoauthors_2": 185.0, "recentcoauthors_3": 276.0, "recentcoauthors_4": 321.0, "recentcoauthors_5": 272.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.4444444444, "venuehindexmean_1": 110.8, "venuehindexmean_2": 109.6666666667, "venuehindexmean_3": 109.1363636364, "venuehindexmean_4": 112.2727272727, "venuehindexmean_5": 111.25, "totalvenues_0": 18.0, "totalvenues_1": 20.0, "totalvenues_2": 21.0, "totalvenues_3": 22.0, "totalvenues_4": 22.0, "totalvenues_5": 24.0, "pagerank_0": 28.5912884077, "pagerank_1": 30.3884804062, "pagerank_2": 32.1460482869, "pagerank_3": 36.1918788404, "pagerank_4": 38.8145111727, "pagerank_5": 40.5069585214}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["RuediAebersold"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 27.0, "hindex_1": 29.0, "hindex_2": 29.0, "hindex_3": 31.0, "hindex_4": 32.0, "hindex_5": 34.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 24.784, "citationsperpaper_1": 25.171, "citationsperpaper_2": 25.053, "citationsperpaper_3": 24.167, "citationsperpaper_4": 23.56, "citationsperpaper_5": 24.301, "citationsperyear_0": 110.577, "citationsperyear_1": 114.667, "citationsperyear_2": 119.0, "citationsperyear_3": 125.0, "citationsperyear_4": 130.367, "citationsperyear_5": 137.968, "totalcitations_0": 2875.0, "totalcitations_1": 3096.0, "totalcitations_2": 3332.0, "totalcitations_3": 3625.0, "totalcitations_4": 3911.0, "totalcitations_5": 4277.0, "totalpapers_0": 116.0, "totalpapers_1": 123.0, "totalpapers_2": 133.0, "totalpapers_3": 150.0, "totalpapers_4": 166.0, "totalpapers_5": 176.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 211.0, "recentcoauthors_1": 181.0, "recentcoauthors_2": 185.0, "recentcoauthors_3": 276.0, "recentcoauthors_4": 321.0, "recentcoauthors_5": 272.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.4444444444, "venuehindexmean_1": 110.8, "venuehindexmean_2": 109.6666666667, "venuehindexmean_3": 109.1363636364, "venuehindexmean_4": 112.2727272727, "venuehindexmean_5": 111.25, "totalvenues_0": 18.0, "totalvenues_1": 20.0, "totalvenues_2": 21.0, "totalvenues_3": 22.0, "totalvenues_4": 22.0, "totalvenues_5": 24.0, "pagerank_0": 28.5912884077, "pagerank_1": 30.3884804062, "pagerank_2": 32.1460482869, "pagerank_3": 36.1918788404, "pagerank_4": 38.8145111727, "pagerank_5": 40.5069585214}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Jonathan S.Weissman"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 28.0, "hindex_1": 31.0, "hindex_2": 34.0, "hindex_3": 36.0, "hindex_4": 38.0, "hindex_5": 41.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 39.083, "citationsperpaper_1": 40.195, "citationsperpaper_2": 43.773, "citationsperpaper_3": 44.67, "citationsperpaper_4": 44.397, "citationsperpaper_5": 45.126, "citationsperyear_0": 140.7, "citationsperyear_1": 156.952, "citationsperyear_2": 175.091, "citationsperyear_3": 194.217, "citationsperyear_4": 214.583, "citationsperyear_5": 229.24, "totalcitations_0": 2814.0, "totalcitations_1": 3296.0, "totalcitations_2": 3852.0, "totalcitations_3": 4467.0, "totalcitations_4": 5150.0, "totalcitations_5": 5731.0, "totalpapers_0": 72.0, "totalpapers_1": 82.0, "totalpapers_2": 88.0, "totalpapers_3": 100.0, "totalpapers_4": 116.0, "totalpapers_5": 127.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 77.0, "recentcoauthors_1": 72.0, "recentcoauthors_2": 117.0, "recentcoauthors_3": 179.0, "recentcoauthors_4": 255.0, "recentcoauthors_5": 269.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.2307692308, "venuehindexmean_1": 117.6153846154, "venuehindexmean_2": 121.3076923077, "venuehindexmean_3": 121.8125, "venuehindexmean_4": 114.3888888889, "venuehindexmean_5": 114.7368421053, "totalvenues_0": 13.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 16.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 13.7237281231, "pagerank_1": 15.0980015118, "pagerank_2": 16.6382120015, "pagerank_3": 19.1463279332, "pagerank_4": 22.8873786571, "pagerank_5": 24.5643848381}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Jonathan S.Weissman"], "affiliation": "University of California, Berkeley", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 28.0, "hindex_1": 31.0, "hindex_2": 34.0, "hindex_3": 36.0, "hindex_4": 38.0, "hindex_5": 41.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 39.083, "citationsperpaper_1": 40.195, "citationsperpaper_2": 43.773, "citationsperpaper_3": 44.67, "citationsperpaper_4": 44.397, "citationsperpaper_5": 45.126, "citationsperyear_0": 140.7, "citationsperyear_1": 156.952, "citationsperyear_2": 175.091, "citationsperyear_3": 194.217, "citationsperyear_4": 214.583, "citationsperyear_5": 229.24, "totalcitations_0": 2814.0, "totalcitations_1": 3296.0, "totalcitations_2": 3852.0, "totalcitations_3": 4467.0, "totalcitations_4": 5150.0, "totalcitations_5": 5731.0, "totalpapers_0": 72.0, "totalpapers_1": 82.0, "totalpapers_2": 88.0, "totalpapers_3": 100.0, "totalpapers_4": 116.0, "totalpapers_5": 127.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 77.0, "recentcoauthors_1": 72.0, "recentcoauthors_2": 117.0, "recentcoauthors_3": 179.0, "recentcoauthors_4": 255.0, "recentcoauthors_5": 269.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.2307692308, "venuehindexmean_1": 117.6153846154, "venuehindexmean_2": 121.3076923077, "venuehindexmean_3": 121.8125, "venuehindexmean_4": 114.3888888889, "venuehindexmean_5": 114.7368421053, "totalvenues_0": 13.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 16.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 13.7237281231, "pagerank_1": 15.0980015118, "pagerank_2": 16.6382120015, "pagerank_3": 19.1463279332, "pagerank_4": 22.8873786571, "pagerank_5": 24.5643848381}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["Jonathan S.Weissman"], "affiliation": "Massachusetts Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 28.0, "hindex_1": 31.0, "hindex_2": 34.0, "hindex_3": 36.0, "hindex_4": 38.0, "hindex_5": 41.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 39.083, "citationsperpaper_1": 40.195, "citationsperpaper_2": 43.773, "citationsperpaper_3": 44.67, "citationsperpaper_4": 44.397, "citationsperpaper_5": 45.126, "citationsperyear_0": 140.7, "citationsperyear_1": 156.952, "citationsperyear_2": 175.091, "citationsperyear_3": 194.217, "citationsperyear_4": 214.583, "citationsperyear_5": 229.24, "totalcitations_0": 2814.0, "totalcitations_1": 3296.0, "totalcitations_2": 3852.0, "totalcitations_3": 4467.0, "totalcitations_4": 5150.0, "totalcitations_5": 5731.0, "totalpapers_0": 72.0, "totalpapers_1": 82.0, "totalpapers_2": 88.0, "totalpapers_3": 100.0, "totalpapers_4": 116.0, "totalpapers_5": 127.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 77.0, "recentcoauthors_1": 72.0, "recentcoauthors_2": 117.0, "recentcoauthors_3": 179.0, "recentcoauthors_4": 255.0, "recentcoauthors_5": 269.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.2307692308, "venuehindexmean_1": 117.6153846154, "venuehindexmean_2": 121.3076923077, "venuehindexmean_3": 121.8125, "venuehindexmean_4": 114.3888888889, "venuehindexmean_5": 114.7368421053, "totalvenues_0": 13.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 16.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 13.7237281231, "pagerank_1": 15.0980015118, "pagerank_2": 16.6382120015, "pagerank_3": 19.1463279332, "pagerank_4": 22.8873786571, "pagerank_5": 24.5643848381}}, {"model": "papers.paper", "pk": 1003097, "fields": {"authors": ["David K.Breslow", "Jonathan S.Weissman"], "affiliation": "Yale University", "venue": "Nature", "doi": "10.1038/nature08787", "abstract": "Despite the essential roles of sphingolipids as both structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM/ORMDL genes, a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.", "year": 2010, "title": "Orm family proteins mediate sphingolipid homeostasis", "keywords": ["Cell signaling", "Gene family", "Conserved sequence", "Signal transduction", "Sphingolipid", "Genetics", "Regulatory Pathway", "Biology", "Functional genomics", "Serine C-palmitoyltransferase"], "citations_0": 6.0, "citations_1": 2.0, "citations_2": 11.0, "citations_3": 6.0, "citations_4": 9.0, "citations_5": 9.0, "timescaledpagerank_0": 1.0311502389, "timescaledpagerank_1": 1.1825094429, "timescaledpagerank_2": 1.8147499043, "timescaledpagerank_3": 2.1582611032, "timescaledpagerank_4": 2.2568871129, "timescaledpagerank_5": 2.246987561, "hindex_0": 15.5, "hindex_1": 17.0, "hindex_2": 19.0, "hindex_3": 20.5, "hindex_4": 21.5, "hindex_5": 23.0, "adopters_0": 18.0, "adopters_1": 11.0, "adopters_2": 76.0, "adopters_3": 32.0, "adopters_4": 43.0, "adopters_5": 0.0, "citationsperpaper_0": 35.708, "citationsperpaper_1": 32.9975, "citationsperpaper_2": 39.6865, "citationsperpaper_3": 40.0015, "citationsperpaper_4": 43.6985, "citationsperpaper_5": 46.813, "citationsperyear_0": 80.05, "citationsperyear_1": 89.226, "citationsperyear_2": 100.26, "citationsperyear_3": 110.3585, "citationsperyear_4": 121.625, "citationsperyear_5": 129.17, "totalcitations_0": 1455.5, "totalcitations_1": 1712.5, "totalcitations_2": 2015.0, "totalcitations_3": 2339.5, "totalcitations_4": 2704.0, "totalcitations_5": 3011.0, "totalpapers_0": 37.5, "totalpapers_1": 43.5, "totalpapers_2": 46.5, "totalpapers_3": 53.0, "totalpapers_4": 61.0, "totalpapers_5": 66.5, "authorage_0": 11.5, "authorage_1": 12.5, "authorage_2": 13.5, "authorage_3": 14.5, "authorage_4": 15.5, "authorage_5": 16.5, "recentcoauthors_0": 42.0, "recentcoauthors_1": 44.5, "recentcoauthors_2": 63.5, "recentcoauthors_3": 91.5, "recentcoauthors_4": 129.5, "recentcoauthors_5": 134.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 129.3653846154, "venuehindexmean_1": 120.5576923077, "venuehindexmean_2": 124.6538461538, "venuehindexmean_3": 127.00625, "venuehindexmean_4": 124.9944444444, "venuehindexmean_5": 126.5684210526, "totalvenues_0": 7.5, "totalvenues_1": 8.5, "totalvenues_2": 8.5, "totalvenues_3": 10.5, "totalvenues_4": 11.5, "totalvenues_5": 12.0, "pagerank_0": 7.3126927325, "pagerank_1": 8.1875114647, "pagerank_2": 8.9350896158, "pagerank_3": 10.2686159373, "pagerank_4": 12.1218270394, "pagerank_5": 12.9252939009}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene", "Jason F.Kreisberg", "KimStopak", "Ya-LinChiu"], "affiliation": "University of California, San Francisco", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 11.5, "hindex_1": 11.75, "hindex_2": 11.75, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.25, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 21.969, "citationsperpaper_1": 22.44325, "citationsperpaper_2": 23.04225, "citationsperpaper_3": 22.5025, "citationsperpaper_4": 22.7145, "citationsperpaper_5": 23.30775, "citationsperyear_0": 36.9585, "citationsperyear_1": 36.018, "citationsperyear_2": 35.26125, "citationsperyear_3": 34.42975, "citationsperyear_4": 33.90925, "citationsperyear_5": 33.50125, "totalcitations_0": 1031.25, "totalcitations_1": 1059.25, "totalcitations_2": 1086.5, "totalcitations_3": 1108.75, "totalcitations_4": 1139.0, "totalcitations_5": 1165.5, "totalpapers_0": 35.0, "totalpapers_1": 36.0, "totalpapers_2": 36.25, "totalpapers_3": 37.75, "totalpapers_4": 38.5, "totalpapers_5": 39.0, "authorage_0": 13.25, "authorage_1": 14.25, "authorage_2": 15.25, "authorage_3": 16.25, "authorage_4": 17.25, "authorage_5": 18.25, "recentcoauthors_0": 41.75, "recentcoauthors_1": 21.25, "recentcoauthors_2": 12.25, "recentcoauthors_3": 17.75, "recentcoauthors_4": 18.5, "recentcoauthors_5": 8.25, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 163.9850877193, "venuehindexmean_1": 166.6776315789, "venuehindexmean_2": 170.0254385965, "venuehindexmean_3": 168.0635964912, "venuehindexmean_4": 169.4125, "venuehindexmean_5": 171.9916666667, "totalvenues_0": 7.25, "totalvenues_1": 7.25, "totalvenues_2": 7.25, "totalvenues_3": 7.5, "totalvenues_4": 7.75, "totalvenues_5": 7.75, "pagerank_0": 7.3273240267, "pagerank_1": 7.4080250487, "pagerank_2": 7.2626314159, "pagerank_3": 7.4442582289, "pagerank_4": 7.3559022968, "pagerank_5": 7.2547117423}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Jason F.Kreisberg"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 5.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 17.143, "citationsperpaper_1": 18.286, "citationsperpaper_2": 19.571, "citationsperpaper_3": 17.75, "citationsperpaper_4": 17.875, "citationsperpaper_5": 18.75, "citationsperyear_0": 12.0, "citationsperyear_1": 11.636, "citationsperyear_2": 11.417, "citationsperyear_3": 10.923, "citationsperyear_4": 10.214, "citationsperyear_5": 10.0, "totalcitations_0": 120.0, "totalcitations_1": 128.0, "totalcitations_2": 137.0, "totalcitations_3": 142.0, "totalcitations_4": 143.0, "totalcitations_5": 150.0, "totalpapers_0": 7.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 8.0, "totalpapers_4": 8.0, "totalpapers_5": 8.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 27.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 18.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 148.8, "venuehindexmean_1": 152.0, "venuehindexmean_2": 155.4, "venuehindexmean_3": 138.0, "venuehindexmean_4": 141.0, "venuehindexmean_5": 143.8333333333, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 1.5809015947, "pagerank_1": 1.5420984895, "pagerank_2": 1.4967998298, "pagerank_3": 1.967329801, "pagerank_4": 1.9305683022, "pagerank_5": 1.9043948454}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Jason F.Kreisberg"], "affiliation": "Genome Institute of Singapore", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 5.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 17.143, "citationsperpaper_1": 18.286, "citationsperpaper_2": 19.571, "citationsperpaper_3": 17.75, "citationsperpaper_4": 17.875, "citationsperpaper_5": 18.75, "citationsperyear_0": 12.0, "citationsperyear_1": 11.636, "citationsperyear_2": 11.417, "citationsperyear_3": 10.923, "citationsperyear_4": 10.214, "citationsperyear_5": 10.0, "totalcitations_0": 120.0, "totalcitations_1": 128.0, "totalcitations_2": 137.0, "totalcitations_3": 142.0, "totalcitations_4": 143.0, "totalcitations_5": 150.0, "totalpapers_0": 7.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 8.0, "totalpapers_4": 8.0, "totalpapers_5": 8.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 27.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 18.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 148.8, "venuehindexmean_1": 152.0, "venuehindexmean_2": 155.4, "venuehindexmean_3": 138.0, "venuehindexmean_4": 141.0, "venuehindexmean_5": 143.8333333333, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 1.5809015947, "pagerank_1": 1.5420984895, "pagerank_2": 1.4967998298, "pagerank_3": 1.967329801, "pagerank_4": 1.9305683022, "pagerank_5": 1.9043948454}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 36.0, "hindex_1": 37.0, "hindex_2": 37.0, "hindex_3": 38.0, "hindex_4": 38.0, "hindex_5": 39.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 30.8, "citationsperpaper_1": 30.62, "citationsperpaper_2": 31.131, "citationsperpaper_3": 30.593, "citationsperpaper_4": 30.783, "citationsperpaper_5": 31.014, "citationsperyear_0": 110.0, "citationsperyear_1": 109.722, "citationsperyear_2": 109.378, "citationsperyear_3": 108.684, "citationsperyear_4": 108.923, "citationsperyear_5": 108.55, "totalcitations_0": 3850.0, "totalcitations_1": 3950.0, "totalcitations_2": 4047.0, "totalcitations_3": 4130.0, "totalcitations_4": 4248.0, "totalcitations_5": 4342.0, "totalpapers_0": 125.0, "totalpapers_1": 129.0, "totalpapers_2": 130.0, "totalpapers_3": 135.0, "totalpapers_4": 138.0, "totalpapers_5": 140.0, "authorage_0": 34.0, "authorage_1": 35.0, "authorage_2": 36.0, "authorage_3": 37.0, "authorage_4": 38.0, "authorage_5": 39.0, "recentcoauthors_0": 130.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4736842105, "venuehindexmean_1": 122.2105263158, "venuehindexmean_2": 125.3684210526, "venuehindexmean_3": 128.4210526316, "venuehindexmean_4": 125.65, "venuehindexmean_5": 128.3, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 26.2122603149, "pagerank_1": 26.6041257279, "pagerank_2": 26.1013599709, "pagerank_3": 26.3905668111, "pagerank_4": 26.103100705, "pagerank_5": 25.7505217298}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene"], "affiliation": "University of California, Davis", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 36.0, "hindex_1": 37.0, "hindex_2": 37.0, "hindex_3": 38.0, "hindex_4": 38.0, "hindex_5": 39.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 30.8, "citationsperpaper_1": 30.62, "citationsperpaper_2": 31.131, "citationsperpaper_3": 30.593, "citationsperpaper_4": 30.783, "citationsperpaper_5": 31.014, "citationsperyear_0": 110.0, "citationsperyear_1": 109.722, "citationsperyear_2": 109.378, "citationsperyear_3": 108.684, "citationsperyear_4": 108.923, "citationsperyear_5": 108.55, "totalcitations_0": 3850.0, "totalcitations_1": 3950.0, "totalcitations_2": 4047.0, "totalcitations_3": 4130.0, "totalcitations_4": 4248.0, "totalcitations_5": 4342.0, "totalpapers_0": 125.0, "totalpapers_1": 129.0, "totalpapers_2": 130.0, "totalpapers_3": 135.0, "totalpapers_4": 138.0, "totalpapers_5": 140.0, "authorage_0": 34.0, "authorage_1": 35.0, "authorage_2": 36.0, "authorage_3": 37.0, "authorage_4": 38.0, "authorage_5": 39.0, "recentcoauthors_0": 130.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4736842105, "venuehindexmean_1": 122.2105263158, "venuehindexmean_2": 125.3684210526, "venuehindexmean_3": 128.4210526316, "venuehindexmean_4": 125.65, "venuehindexmean_5": 128.3, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 26.2122603149, "pagerank_1": 26.6041257279, "pagerank_2": 26.1013599709, "pagerank_3": 26.3905668111, "pagerank_4": 26.103100705, "pagerank_5": 25.7505217298}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 36.0, "hindex_1": 37.0, "hindex_2": 37.0, "hindex_3": 38.0, "hindex_4": 38.0, "hindex_5": 39.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 30.8, "citationsperpaper_1": 30.62, "citationsperpaper_2": 31.131, "citationsperpaper_3": 30.593, "citationsperpaper_4": 30.783, "citationsperpaper_5": 31.014, "citationsperyear_0": 110.0, "citationsperyear_1": 109.722, "citationsperyear_2": 109.378, "citationsperyear_3": 108.684, "citationsperyear_4": 108.923, "citationsperyear_5": 108.55, "totalcitations_0": 3850.0, "totalcitations_1": 3950.0, "totalcitations_2": 4047.0, "totalcitations_3": 4130.0, "totalcitations_4": 4248.0, "totalcitations_5": 4342.0, "totalpapers_0": 125.0, "totalpapers_1": 129.0, "totalpapers_2": 130.0, "totalpapers_3": 135.0, "totalpapers_4": 138.0, "totalpapers_5": 140.0, "authorage_0": 34.0, "authorage_1": 35.0, "authorage_2": 36.0, "authorage_3": 37.0, "authorage_4": 38.0, "authorage_5": 39.0, "recentcoauthors_0": 130.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4736842105, "venuehindexmean_1": 122.2105263158, "venuehindexmean_2": 125.3684210526, "venuehindexmean_3": 128.4210526316, "venuehindexmean_4": 125.65, "venuehindexmean_5": 128.3, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 26.2122603149, "pagerank_1": 26.6041257279, "pagerank_2": 26.1013599709, "pagerank_3": 26.3905668111, "pagerank_4": 26.103100705, "pagerank_5": 25.7505217298}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene"], "affiliation": "Gladstone Institutes", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 36.0, "hindex_1": 37.0, "hindex_2": 37.0, "hindex_3": 38.0, "hindex_4": 38.0, "hindex_5": 39.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 30.8, "citationsperpaper_1": 30.62, "citationsperpaper_2": 31.131, "citationsperpaper_3": 30.593, "citationsperpaper_4": 30.783, "citationsperpaper_5": 31.014, "citationsperyear_0": 110.0, "citationsperyear_1": 109.722, "citationsperyear_2": 109.378, "citationsperyear_3": 108.684, "citationsperyear_4": 108.923, "citationsperyear_5": 108.55, "totalcitations_0": 3850.0, "totalcitations_1": 3950.0, "totalcitations_2": 4047.0, "totalcitations_3": 4130.0, "totalcitations_4": 4248.0, "totalcitations_5": 4342.0, "totalpapers_0": 125.0, "totalpapers_1": 129.0, "totalpapers_2": 130.0, "totalpapers_3": 135.0, "totalpapers_4": 138.0, "totalpapers_5": 140.0, "authorage_0": 34.0, "authorage_1": 35.0, "authorage_2": 36.0, "authorage_3": 37.0, "authorage_4": 38.0, "authorage_5": 39.0, "recentcoauthors_0": 130.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4736842105, "venuehindexmean_1": 122.2105263158, "venuehindexmean_2": 125.3684210526, "venuehindexmean_3": 128.4210526316, "venuehindexmean_4": 125.65, "venuehindexmean_5": 128.3, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 26.2122603149, "pagerank_1": 26.6041257279, "pagerank_2": 26.1013599709, "pagerank_3": 26.3905668111, "pagerank_4": 26.103100705, "pagerank_5": 25.7505217298}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene"], "affiliation": "Duke University", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 36.0, "hindex_1": 37.0, "hindex_2": 37.0, "hindex_3": 38.0, "hindex_4": 38.0, "hindex_5": 39.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 30.8, "citationsperpaper_1": 30.62, "citationsperpaper_2": 31.131, "citationsperpaper_3": 30.593, "citationsperpaper_4": 30.783, "citationsperpaper_5": 31.014, "citationsperyear_0": 110.0, "citationsperyear_1": 109.722, "citationsperyear_2": 109.378, "citationsperyear_3": 108.684, "citationsperyear_4": 108.923, "citationsperyear_5": 108.55, "totalcitations_0": 3850.0, "totalcitations_1": 3950.0, "totalcitations_2": 4047.0, "totalcitations_3": 4130.0, "totalcitations_4": 4248.0, "totalcitations_5": 4342.0, "totalpapers_0": 125.0, "totalpapers_1": 129.0, "totalpapers_2": 130.0, "totalpapers_3": 135.0, "totalpapers_4": 138.0, "totalpapers_5": 140.0, "authorage_0": 34.0, "authorage_1": 35.0, "authorage_2": 36.0, "authorage_3": 37.0, "authorage_4": 38.0, "authorage_5": 39.0, "recentcoauthors_0": 130.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4736842105, "venuehindexmean_1": 122.2105263158, "venuehindexmean_2": 125.3684210526, "venuehindexmean_3": 128.4210526316, "venuehindexmean_4": 125.65, "venuehindexmean_5": 128.3, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 26.2122603149, "pagerank_1": 26.6041257279, "pagerank_2": 26.1013599709, "pagerank_3": 26.3905668111, "pagerank_4": 26.103100705, "pagerank_5": 25.7505217298}}, {"model": "papers.paper", "pk": 1003384, "fields": {"authors": ["Warner C.Greene"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature09254", "abstract": "The authors wish to retract this Letter because they have been unable to reproduce the experiments demonstrating APOBEC3G functions as a post-entry restriction factor in resting CD4 T cells...", "year": 2010, "title": "Retraction Note: Cellular APOBEC3G restricts HIV-1 infection in resting CD4 + T cells", "keywords": ["Wish", "Neuroscience", "Biology", "Restriction factor", "APOBEC3G"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 36.0, "hindex_1": 37.0, "hindex_2": 37.0, "hindex_3": 38.0, "hindex_4": 38.0, "hindex_5": 39.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 30.8, "citationsperpaper_1": 30.62, "citationsperpaper_2": 31.131, "citationsperpaper_3": 30.593, "citationsperpaper_4": 30.783, "citationsperpaper_5": 31.014, "citationsperyear_0": 110.0, "citationsperyear_1": 109.722, "citationsperyear_2": 109.378, "citationsperyear_3": 108.684, "citationsperyear_4": 108.923, "citationsperyear_5": 108.55, "totalcitations_0": 3850.0, "totalcitations_1": 3950.0, "totalcitations_2": 4047.0, "totalcitations_3": 4130.0, "totalcitations_4": 4248.0, "totalcitations_5": 4342.0, "totalpapers_0": 125.0, "totalpapers_1": 129.0, "totalpapers_2": 130.0, "totalpapers_3": 135.0, "totalpapers_4": 138.0, "totalpapers_5": 140.0, "authorage_0": 34.0, "authorage_1": 35.0, "authorage_2": 36.0, "authorage_3": 37.0, "authorage_4": 38.0, "authorage_5": 39.0, "recentcoauthors_0": 130.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 53.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4736842105, "venuehindexmean_1": 122.2105263158, "venuehindexmean_2": 125.3684210526, "venuehindexmean_3": 128.4210526316, "venuehindexmean_4": 125.65, "venuehindexmean_5": 128.3, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 26.2122603149, "pagerank_1": 26.6041257279, "pagerank_2": 26.1013599709, "pagerank_3": 26.3905668111, "pagerank_4": 26.103100705, "pagerank_5": 25.7505217298}}, {"model": "papers.paper", "pk": 1003058, "fields": {"authors": ["T.Stalcup"], "affiliation": "W.M. Keck Observatory", "venue": "Nature", "doi": "10.1038/nature09311", "abstract": "To determine the influence of the environment on star formation, we need to study the process in the extreme conditions of massive young star clusters (~10^4 solar masses) near the centre of our own Galaxy. Observations must be carried out in the near infrared because of very high extinction in visible light within the Galactic plane. We need high resolution to identify cluster members from their peculiar motions, and because most such clusters span more than 1\u2032, efficient observation demands a wide field of view. There is at present no space-based facility that meets all these criteria. Ground-based telescopes can in principle make such observations when fitted with ground-layer adaptive optics (GLAO), which removes the optical aberration caused by atmospheric turbulence up to an altitude of ~500\u2009m (refs 7\u201310). A GLAO system that uses multiple laser guide stars has been developed at the 6.5-m MMT telescope, in Arizona. In previous tests, the system improved the resolution of the telescope by 30\u201350%, limited by wavefront error in the optics, but that was insufficient to allow rapid determination of cluster membership. Here we report observations of the core of the globular cluster M3 made after commissioning a sensor to monitor and remove slowly varying aberration in the optics. In natural seeing of 0.7\u2032\u2032, the point spread function at 2.2-\u03bcm wavelength was sharpened uniformly to 0.3\u2032\u2032 over a field of at least 2\u2032. The wide-field resolution was enhanced by a factor of two to three over previous work, with better uniformity, and extends to a wavelength of 1.2\u2009\u03bcm. Entire stellar clusters may be examined in a single pointing, and cluster membership can be determined from two such observations separated by just one year.", "year": 2010, "title": "A ground-layer adaptive optics system with multiple laser guide stars", "keywords": ["Optics", "Adaptive optics", "Point spread function", "Star formation", "Globular cluster", "Astronomy", "Optical aberration", "Physics", "Wavefront", "Telescope", "Galaxy"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.8058137976, "pagerank_1": 0.8054053727, "pagerank_2": 0.8041505671, "pagerank_3": 0.8023740756, "pagerank_4": 0.8022826346, "pagerank_5": 0.7907001198}}, {"model": "papers.paper", "pk": 1003058, "fields": {"authors": ["KeithPowell", "Donald W.McCarthy", "N. M.Milton", "EduardoBendek", "MichaelHart", "CraigKulesa"], "affiliation": "University of Arizona", "venue": "Nature", "doi": "10.1038/nature09311", "abstract": "To determine the influence of the environment on star formation, we need to study the process in the extreme conditions of massive young star clusters (~10^4 solar masses) near the centre of our own Galaxy. Observations must be carried out in the near infrared because of very high extinction in visible light within the Galactic plane. We need high resolution to identify cluster members from their peculiar motions, and because most such clusters span more than 1\u2032, efficient observation demands a wide field of view. There is at present no space-based facility that meets all these criteria. Ground-based telescopes can in principle make such observations when fitted with ground-layer adaptive optics (GLAO), which removes the optical aberration caused by atmospheric turbulence up to an altitude of ~500\u2009m (refs 7\u201310). A GLAO system that uses multiple laser guide stars has been developed at the 6.5-m MMT telescope, in Arizona. In previous tests, the system improved the resolution of the telescope by 30\u201350%, limited by wavefront error in the optics, but that was insufficient to allow rapid determination of cluster membership. Here we report observations of the core of the globular cluster M3 made after commissioning a sensor to monitor and remove slowly varying aberration in the optics. In natural seeing of 0.7\u2032\u2032, the point spread function at 2.2-\u03bcm wavelength was sharpened uniformly to 0.3\u2032\u2032 over a field of at least 2\u2032. The wide-field resolution was enhanced by a factor of two to three over previous work, with better uniformity, and extends to a wavelength of 1.2\u2009\u03bcm. Entire stellar clusters may be examined in a single pointing, and cluster membership can be determined from two such observations separated by just one year.", "year": 2010, "title": "A ground-layer adaptive optics system with multiple laser guide stars", "keywords": ["Optics", "Adaptive optics", "Point spread function", "Star formation", "Globular cluster", "Astronomy", "Optical aberration", "Physics", "Wavefront", "Telescope", "Galaxy"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.1666666667, "hindex_1": 0.1666666667, "hindex_2": 0.1666666667, "hindex_3": 0.1666666667, "hindex_4": 0.1666666667, "hindex_5": 0.1666666667, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0555, "citationsperpaper_1": 0.0555, "citationsperpaper_2": 0.0555, "citationsperpaper_3": 0.0555, "citationsperpaper_4": 0.0555, "citationsperpaper_5": 0.0555, "citationsperyear_0": 0.0043333333, "citationsperyear_1": 0.0041666667, "citationsperyear_2": 0.004, "citationsperyear_3": 0.004, "citationsperyear_4": 0.0038333333, "citationsperyear_5": 0.0038333333, "totalcitations_0": 0.1666666667, "totalcitations_1": 0.1666666667, "totalcitations_2": 0.1666666667, "totalcitations_3": 0.1666666667, "totalcitations_4": 0.1666666667, "totalcitations_5": 0.1666666667, "totalpapers_0": 1.3333333333, "totalpapers_1": 1.3333333333, "totalpapers_2": 1.3333333333, "totalpapers_3": 1.3333333333, "totalpapers_4": 1.3333333333, "totalpapers_5": 1.3333333333, "authorage_0": 6.3333333333, "authorage_1": 7.3333333333, "authorage_2": 8.3333333333, "authorage_3": 9.3333333333, "authorage_4": 10.3333333333, "authorage_5": 11.3333333333, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 257.75, "venuehindexmean_1": 261.75, "venuehindexmean_2": 267.0, "venuehindexmean_3": 273.0, "venuehindexmean_4": 277.8333333333, "venuehindexmean_5": 281.9166666667, "totalvenues_0": 1.1666666667, "totalvenues_1": 1.1666666667, "totalvenues_2": 1.1666666667, "totalvenues_3": 1.1666666667, "totalvenues_4": 1.1666666667, "totalvenues_5": 1.1666666667, "pagerank_0": 0.8802749237, "pagerank_1": 0.8795569144, "pagerank_2": 0.8774041891, "pagerank_3": 0.8742524459, "pagerank_4": 0.8741009852, "pagerank_5": 0.8547948635}}, {"model": "papers.paper", "pk": 1003058, "fields": {"authors": ["ChristophBaranec"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature09311", "abstract": "To determine the influence of the environment on star formation, we need to study the process in the extreme conditions of massive young star clusters (~10^4 solar masses) near the centre of our own Galaxy. Observations must be carried out in the near infrared because of very high extinction in visible light within the Galactic plane. We need high resolution to identify cluster members from their peculiar motions, and because most such clusters span more than 1\u2032, efficient observation demands a wide field of view. There is at present no space-based facility that meets all these criteria. Ground-based telescopes can in principle make such observations when fitted with ground-layer adaptive optics (GLAO), which removes the optical aberration caused by atmospheric turbulence up to an altitude of ~500\u2009m (refs 7\u201310). A GLAO system that uses multiple laser guide stars has been developed at the 6.5-m MMT telescope, in Arizona. In previous tests, the system improved the resolution of the telescope by 30\u201350%, limited by wavefront error in the optics, but that was insufficient to allow rapid determination of cluster membership. Here we report observations of the core of the globular cluster M3 made after commissioning a sensor to monitor and remove slowly varying aberration in the optics. In natural seeing of 0.7\u2032\u2032, the point spread function at 2.2-\u03bcm wavelength was sharpened uniformly to 0.3\u2032\u2032 over a field of at least 2\u2032. The wide-field resolution was enhanced by a factor of two to three over previous work, with better uniformity, and extends to a wavelength of 1.2\u2009\u03bcm. Entire stellar clusters may be examined in a single pointing, and cluster membership can be determined from two such observations separated by just one year.", "year": 2010, "title": "A ground-layer adaptive optics system with multiple laser guide stars", "keywords": ["Optics", "Adaptive optics", "Point spread function", "Star formation", "Globular cluster", "Astronomy", "Optical aberration", "Physics", "Wavefront", "Telescope", "Galaxy"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.8058137976, "pagerank_1": 0.8054053727, "pagerank_2": 0.8041505671, "pagerank_3": 0.8023740756, "pagerank_4": 0.8022826346, "pagerank_5": 0.7907001198}}, {"model": "papers.paper", "pk": 1003339, "fields": {"authors": ["PaoloGuidetti", "JoachimClaudet"], "affiliation": "University of Salento", "venue": "Nature", "doi": "10.1038/464673b", "abstract": "", "year": 2010, "title": "Fishermen contribute to protection of marine reserves.", "keywords": ["Fishery", "Molecular interactions", "Marine reserve", "Computational biology", "Environmental science"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 2.1962401567, "timescaledpagerank_1": 1.6694579662, "timescaledpagerank_2": 1.097548266, "timescaledpagerank_3": 0.7580924103, "timescaledpagerank_4": 0.5378044948, "timescaledpagerank_5": 0.3928030121, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 2.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 1.0, "citationsperpaper_2": 1.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 1.0, "citationsperpaper_5": 1.0, "citationsperyear_0": 1.0, "citationsperyear_1": 0.5, "citationsperyear_2": 0.333, "citationsperyear_3": 0.25, "citationsperyear_4": 0.2, "citationsperyear_5": 0.167, "totalcitations_0": 1.0, "totalcitations_1": 1.0, "totalcitations_2": 1.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.9670543998, "pagerank_1": 0.9670543998, "pagerank_2": 0.9670543998, "pagerank_3": 0.9670543998, "pagerank_4": 0.9670543998, "pagerank_5": 0.9670543998}}, {"model": "papers.paper", "pk": 1003773, "fields": {"authors": ["Michael A.Goldman"], "affiliation": "San Francisco State University", "venue": "Nature", "doi": "10.1038/4641129a", "abstract": "Engineering biological systems and organisms is a costly team effort and may be incompatible with an open-source regulatory environment, finds Michael A. Goldman.", "year": 2010, "title": "Building life from the bottom up", "keywords": ["Engineering", "Top-down and bottom-up design", "Architectural engineering"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3975749542, "timescaledpagerank_2": 0.1648598117, "timescaledpagerank_3": 0.0341268559, "timescaledpagerank_4": 0.0453119131, "timescaledpagerank_5": 0.09457186, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.176, "citationsperpaper_1": 0.2, "citationsperpaper_2": 0.19, "citationsperpaper_3": 0.182, "citationsperpaper_4": 0.174, "citationsperpaper_5": 0.167, "citationsperyear_0": 0.125, "citationsperyear_1": 0.16, "citationsperyear_2": 0.154, "citationsperyear_3": 0.148, "citationsperyear_4": 0.143, "citationsperyear_5": 0.138, "totalcitations_0": 3.0, "totalcitations_1": 4.0, "totalcitations_2": 4.0, "totalcitations_3": 4.0, "totalcitations_4": 4.0, "totalcitations_5": 4.0, "totalpapers_0": 17.0, "totalpapers_1": 20.0, "totalpapers_2": 21.0, "totalpapers_3": 22.0, "totalpapers_4": 23.0, "totalpapers_5": 24.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 168.75, "venuehindexmean_1": 172.25, "venuehindexmean_2": 177.5, "venuehindexmean_3": 182.25, "venuehindexmean_4": 185.75, "venuehindexmean_5": 189.5, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 0.4046483153, "pagerank_1": 0.3966574787, "pagerank_2": 0.3883437547, "pagerank_3": 0.3835019755, "pagerank_4": 0.3787934176, "pagerank_5": 0.3747053319}}, {"model": "papers.paper", "pk": 1003773, "fields": {"authors": ["Michael A.Goldman"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/4641129a", "abstract": "Engineering biological systems and organisms is a costly team effort and may be incompatible with an open-source regulatory environment, finds Michael A. Goldman.", "year": 2010, "title": "Building life from the bottom up", "keywords": ["Engineering", "Top-down and bottom-up design", "Architectural engineering"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3975749542, "timescaledpagerank_2": 0.1648598117, "timescaledpagerank_3": 0.0341268559, "timescaledpagerank_4": 0.0453119131, "timescaledpagerank_5": 0.09457186, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.176, "citationsperpaper_1": 0.2, "citationsperpaper_2": 0.19, "citationsperpaper_3": 0.182, "citationsperpaper_4": 0.174, "citationsperpaper_5": 0.167, "citationsperyear_0": 0.125, "citationsperyear_1": 0.16, "citationsperyear_2": 0.154, "citationsperyear_3": 0.148, "citationsperyear_4": 0.143, "citationsperyear_5": 0.138, "totalcitations_0": 3.0, "totalcitations_1": 4.0, "totalcitations_2": 4.0, "totalcitations_3": 4.0, "totalcitations_4": 4.0, "totalcitations_5": 4.0, "totalpapers_0": 17.0, "totalpapers_1": 20.0, "totalpapers_2": 21.0, "totalpapers_3": 22.0, "totalpapers_4": 23.0, "totalpapers_5": 24.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 168.75, "venuehindexmean_1": 172.25, "venuehindexmean_2": 177.5, "venuehindexmean_3": 182.25, "venuehindexmean_4": 185.75, "venuehindexmean_5": 189.5, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 0.4046483153, "pagerank_1": 0.3966574787, "pagerank_2": 0.3883437547, "pagerank_3": 0.3835019755, "pagerank_4": 0.3787934176, "pagerank_5": 0.3747053319}}, {"model": "papers.paper", "pk": 1003046, "fields": {"authors": ["MartaVolonteri"], "affiliation": "Institut d'Astrophysique de Paris", "venue": "Nature", "doi": "10.1038/4661049a", "abstract": "The means by which supermassive black holes form and grow have remained largely unclear. Numerical simulations show that the collision of massive galaxies can naturally lead to the creation of these objects.", "year": 2010, "title": "Astrophysics: Making black holes from scratch", "keywords": ["Intermediate-mass black hole", "Astrophysics", "Black hole", "Scratch", "Quasi-star", "Physics", "Supermassive black hole", "Galaxy", "Binary black hole"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.5, "citationsperpaper_2": 0.333, "citationsperpaper_3": 0.333, "citationsperpaper_4": 0.333, "citationsperpaper_5": 1.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.5, "citationsperyear_2": 0.333, "citationsperyear_3": 0.25, "citationsperyear_4": 0.2, "citationsperyear_5": 0.5, "totalcitations_0": 0.0, "totalcitations_1": 1.0, "totalcitations_2": 1.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 3.0, "totalpapers_0": 1.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.15, "pagerank_1": 0.3684172527, "pagerank_2": 0.3642391741, "pagerank_3": 0.3613921268, "pagerank_4": 0.3569435079, "pagerank_5": 0.3538073786}}, {"model": "papers.paper", "pk": 1003046, "fields": {"authors": ["MartaVolonteri"], "affiliation": "University of Michigan", "venue": "Nature", "doi": "10.1038/4661049a", "abstract": "The means by which supermassive black holes form and grow have remained largely unclear. Numerical simulations show that the collision of massive galaxies can naturally lead to the creation of these objects.", "year": 2010, "title": "Astrophysics: Making black holes from scratch", "keywords": ["Intermediate-mass black hole", "Astrophysics", "Black hole", "Scratch", "Quasi-star", "Physics", "Supermassive black hole", "Galaxy", "Binary black hole"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.5, "citationsperpaper_2": 0.333, "citationsperpaper_3": 0.333, "citationsperpaper_4": 0.333, "citationsperpaper_5": 1.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.5, "citationsperyear_2": 0.333, "citationsperyear_3": 0.25, "citationsperyear_4": 0.2, "citationsperyear_5": 0.5, "totalcitations_0": 0.0, "totalcitations_1": 1.0, "totalcitations_2": 1.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 3.0, "totalpapers_0": 1.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.15, "pagerank_1": 0.3684172527, "pagerank_2": 0.3642391741, "pagerank_3": 0.3613921268, "pagerank_4": 0.3569435079, "pagerank_5": 0.3538073786}}, {"model": "papers.paper", "pk": 1003798, "fields": {"authors": ["J. AdamLangley"], "affiliation": "Villanova University", "venue": "Nature", "doi": "10.1038/nature09176", "abstract": "The prevailing hypothesis of progressive nitrogen limitation states that the scarcity of soil resources, such as nitrogen, limits the response of ecosystems to elevated atmospheric carbon dioxide. It follows that adding nitrogen to soil should enhance total plant productivity in response to carbon dioxide fertilization in natural ecosystems. But there is little empirical evidence to support this hypothesis. This study finds that nitrogen addition initially enhances the carbon dioxide stimulation of plant productivity, but also promotes the encroachment of C4 grasses, the plant species at the study site that respond less strongly to elevated carbon dioxide concentrations. Overall, the observed shift in the plant community ultimately suppresses the carbon dioxide stimulation of plant productivity. The authors conclude that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated carbon dioxide concentrations. Models that incorporate a positive effect of anthropogenic N on the elevated carbon dioxide response may overestimate future carbon uptake in terrestrial wildlands. It remains uncertain whether added nitrogen enhances total plant productivity in response to CO2-fertilisation in natural ecosystems. Here the authors show that nitrogen addition initially enhances the CO2-stimulation of plant productivity but also promotes the encroachment of plant species that respond less strongly to elevated CO2 concentrations. Overall, the observed shift in the plant community ultimately suppresses the CO2-stimulation of plant productivity. Terrestrial ecosystems gain carbon through photosynthesis and lose it mostly in the form of carbon dioxide (CO2). The extent to which the biosphere can act as a buffer against rising atmospheric CO2 concentration in global climate change projections remains uncertain at the present stage1,2,3,4. Biogeochemical theory predicts that soil nitrogen (N) scarcity may limit natural ecosystem response to elevated CO2 concentration, diminishing the CO2-fertilization effect on terrestrial plant productivity in unmanaged ecosystems3,4,5,6,7. Recent models have incorporated such carbon\u2013nitrogen interactions and suggest that anthropogenic N sources could help sustain the future CO2-fertilization effect8,9. However, conclusive demonstration that added N enhances plant productivity in response to CO2-fertilization in natural ecosystems remains elusive. Here we manipulated atmospheric CO2 concentration and soil N availability in a herbaceous brackish wetland where plant community composition is dominated by a C3 sedge and C4 grasses, and is capable of responding rapidly to environmental change10. We found that N addition enhanced the CO2-stimulation of plant productivity in the first year of a multi-year experiment, indicating N-limitation of the CO2 response. But we also found that N addition strongly promotes the encroachment of C4 plant species that respond less strongly to elevated CO2 concentrations. Overall, we found that the observed shift in the plant community composition ultimately suppresses the CO2-stimulation of plant productivity by the third and fourth years. Although extensive research has shown that global change factors such as elevated CO2 concentrations and N pollution affect plant species differently11,12,13 and that they may drive plant community changes14,15,16,17, we demonstrate that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated CO2 concentrations. Moreover, we suggest that trade-offs between the abilities of plant taxa to respond positively to different perturbations may constrain natural ecosystem response to global change.", "year": 2010, "title": "Ecosystem response to elevated CO2 levels limited by nitrogen-induced plant species shift.", "keywords": ["Halophyte", "Terrestrial ecosystem", "Perennial plant", "Plant community", "Ecosystem", "Carbon dioxide", "Ecology", "Environmental science", "Carbon dioxide in Earth's atmosphere", "Terrestrial plant"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3093408675, "timescaledpagerank_4": 0.2664768606, "timescaledpagerank_5": 0.1068117732, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.5, "citationsperpaper_1": 0.5, "citationsperpaper_2": 1.0, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 3.0, "citationsperyear_0": 0.5, "citationsperyear_1": 0.333, "citationsperyear_2": 0.5, "citationsperyear_3": 0.8, "citationsperyear_4": 0.667, "citationsperyear_5": 0.857, "totalcitations_0": 1.0, "totalcitations_1": 1.0, "totalcitations_2": 2.0, "totalcitations_3": 4.0, "totalcitations_4": 4.0, "totalcitations_5": 6.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 1.0, "authorage_1": 2.0, "authorage_2": 3.0, "authorage_3": 4.0, "authorage_4": 5.0, "authorage_5": 6.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.8442861574, "pagerank_1": 0.8245181974, "pagerank_2": 0.8155690358, "pagerank_3": 0.8183276521, "pagerank_4": 0.8120300389, "pagerank_5": 0.6385266105}}, {"model": "papers.paper", "pk": 1003798, "fields": {"authors": ["J. AdamLangley", "J. PatrickMegonigal"], "affiliation": "Smithsonian Environmental Research Center", "venue": "Nature", "doi": "10.1038/nature09176", "abstract": "The prevailing hypothesis of progressive nitrogen limitation states that the scarcity of soil resources, such as nitrogen, limits the response of ecosystems to elevated atmospheric carbon dioxide. It follows that adding nitrogen to soil should enhance total plant productivity in response to carbon dioxide fertilization in natural ecosystems. But there is little empirical evidence to support this hypothesis. This study finds that nitrogen addition initially enhances the carbon dioxide stimulation of plant productivity, but also promotes the encroachment of C4 grasses, the plant species at the study site that respond less strongly to elevated carbon dioxide concentrations. Overall, the observed shift in the plant community ultimately suppresses the carbon dioxide stimulation of plant productivity. The authors conclude that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated carbon dioxide concentrations. Models that incorporate a positive effect of anthropogenic N on the elevated carbon dioxide response may overestimate future carbon uptake in terrestrial wildlands. It remains uncertain whether added nitrogen enhances total plant productivity in response to CO2-fertilisation in natural ecosystems. Here the authors show that nitrogen addition initially enhances the CO2-stimulation of plant productivity but also promotes the encroachment of plant species that respond less strongly to elevated CO2 concentrations. Overall, the observed shift in the plant community ultimately suppresses the CO2-stimulation of plant productivity. Terrestrial ecosystems gain carbon through photosynthesis and lose it mostly in the form of carbon dioxide (CO2). The extent to which the biosphere can act as a buffer against rising atmospheric CO2 concentration in global climate change projections remains uncertain at the present stage1,2,3,4. Biogeochemical theory predicts that soil nitrogen (N) scarcity may limit natural ecosystem response to elevated CO2 concentration, diminishing the CO2-fertilization effect on terrestrial plant productivity in unmanaged ecosystems3,4,5,6,7. Recent models have incorporated such carbon\u2013nitrogen interactions and suggest that anthropogenic N sources could help sustain the future CO2-fertilization effect8,9. However, conclusive demonstration that added N enhances plant productivity in response to CO2-fertilization in natural ecosystems remains elusive. Here we manipulated atmospheric CO2 concentration and soil N availability in a herbaceous brackish wetland where plant community composition is dominated by a C3 sedge and C4 grasses, and is capable of responding rapidly to environmental change10. We found that N addition enhanced the CO2-stimulation of plant productivity in the first year of a multi-year experiment, indicating N-limitation of the CO2 response. But we also found that N addition strongly promotes the encroachment of C4 plant species that respond less strongly to elevated CO2 concentrations. Overall, we found that the observed shift in the plant community composition ultimately suppresses the CO2-stimulation of plant productivity by the third and fourth years. Although extensive research has shown that global change factors such as elevated CO2 concentrations and N pollution affect plant species differently11,12,13 and that they may drive plant community changes14,15,16,17, we demonstrate that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated CO2 concentrations. Moreover, we suggest that trade-offs between the abilities of plant taxa to respond positively to different perturbations may constrain natural ecosystem response to global change.", "year": 2010, "title": "Ecosystem response to elevated CO2 levels limited by nitrogen-induced plant species shift.", "keywords": ["Halophyte", "Terrestrial ecosystem", "Perennial plant", "Plant community", "Ecosystem", "Carbon dioxide", "Ecology", "Environmental science", "Carbon dioxide in Earth's atmosphere", "Terrestrial plant"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3093408675, "timescaledpagerank_4": 0.2664768606, "timescaledpagerank_5": 0.1068117732, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.5, "hindex_3": 1.5, "hindex_4": 1.5, "hindex_5": 2.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.25, "citationsperpaper_1": 1.25, "citationsperpaper_2": 1.8335, "citationsperpaper_3": 2.25, "citationsperpaper_4": 2.625, "citationsperpaper_5": 3.75, "citationsperyear_0": 1.0, "citationsperyear_1": 0.7665, "citationsperyear_2": 0.9165, "citationsperyear_3": 1.1145, "citationsperyear_4": 1.146, "citationsperyear_5": 1.4285, "totalcitations_0": 3.5, "totalcitations_1": 3.5, "totalcitations_2": 5.0, "totalcitations_3": 7.0, "totalcitations_4": 8.5, "totalcitations_5": 12.0, "totalpapers_0": 2.5, "totalpapers_1": 2.5, "totalpapers_2": 2.5, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.5, "recentcoauthors_4": 0.5, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.9896719099, "pagerank_1": 0.9540556434, "pagerank_2": 0.939562405, "pagerank_3": 1.0109949846, "pagerank_4": 0.9984728838, "pagerank_5": 0.8020346341}}, {"model": "papers.paper", "pk": 1003798, "fields": {"authors": ["J. PatrickMegonigal"], "affiliation": "Smithsonian Institution", "venue": "Nature", "doi": "10.1038/nature09176", "abstract": "The prevailing hypothesis of progressive nitrogen limitation states that the scarcity of soil resources, such as nitrogen, limits the response of ecosystems to elevated atmospheric carbon dioxide. It follows that adding nitrogen to soil should enhance total plant productivity in response to carbon dioxide fertilization in natural ecosystems. But there is little empirical evidence to support this hypothesis. This study finds that nitrogen addition initially enhances the carbon dioxide stimulation of plant productivity, but also promotes the encroachment of C4 grasses, the plant species at the study site that respond less strongly to elevated carbon dioxide concentrations. Overall, the observed shift in the plant community ultimately suppresses the carbon dioxide stimulation of plant productivity. The authors conclude that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated carbon dioxide concentrations. Models that incorporate a positive effect of anthropogenic N on the elevated carbon dioxide response may overestimate future carbon uptake in terrestrial wildlands. It remains uncertain whether added nitrogen enhances total plant productivity in response to CO2-fertilisation in natural ecosystems. Here the authors show that nitrogen addition initially enhances the CO2-stimulation of plant productivity but also promotes the encroachment of plant species that respond less strongly to elevated CO2 concentrations. Overall, the observed shift in the plant community ultimately suppresses the CO2-stimulation of plant productivity. Terrestrial ecosystems gain carbon through photosynthesis and lose it mostly in the form of carbon dioxide (CO2). The extent to which the biosphere can act as a buffer against rising atmospheric CO2 concentration in global climate change projections remains uncertain at the present stage1,2,3,4. Biogeochemical theory predicts that soil nitrogen (N) scarcity may limit natural ecosystem response to elevated CO2 concentration, diminishing the CO2-fertilization effect on terrestrial plant productivity in unmanaged ecosystems3,4,5,6,7. Recent models have incorporated such carbon\u2013nitrogen interactions and suggest that anthropogenic N sources could help sustain the future CO2-fertilization effect8,9. However, conclusive demonstration that added N enhances plant productivity in response to CO2-fertilization in natural ecosystems remains elusive. Here we manipulated atmospheric CO2 concentration and soil N availability in a herbaceous brackish wetland where plant community composition is dominated by a C3 sedge and C4 grasses, and is capable of responding rapidly to environmental change10. We found that N addition enhanced the CO2-stimulation of plant productivity in the first year of a multi-year experiment, indicating N-limitation of the CO2 response. But we also found that N addition strongly promotes the encroachment of C4 plant species that respond less strongly to elevated CO2 concentrations. Overall, we found that the observed shift in the plant community composition ultimately suppresses the CO2-stimulation of plant productivity by the third and fourth years. Although extensive research has shown that global change factors such as elevated CO2 concentrations and N pollution affect plant species differently11,12,13 and that they may drive plant community changes14,15,16,17, we demonstrate that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated CO2 concentrations. Moreover, we suggest that trade-offs between the abilities of plant taxa to respond positively to different perturbations may constrain natural ecosystem response to global change.", "year": 2010, "title": "Ecosystem response to elevated CO2 levels limited by nitrogen-induced plant species shift.", "keywords": ["Halophyte", "Terrestrial ecosystem", "Perennial plant", "Plant community", "Ecosystem", "Carbon dioxide", "Ecology", "Environmental science", "Carbon dioxide in Earth's atmosphere", "Terrestrial plant"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3093408675, "timescaledpagerank_4": 0.2664768606, "timescaledpagerank_5": 0.1068117732, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.667, "citationsperpaper_3": 2.5, "citationsperpaper_4": 3.25, "citationsperpaper_5": 4.5, "citationsperyear_0": 1.5, "citationsperyear_1": 1.2, "citationsperyear_2": 1.333, "citationsperyear_3": 1.429, "citationsperyear_4": 1.625, "citationsperyear_5": 2.0, "totalcitations_0": 6.0, "totalcitations_1": 6.0, "totalcitations_2": 8.0, "totalcitations_3": 10.0, "totalcitations_4": 13.0, "totalcitations_5": 18.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 1.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.1350576624, "pagerank_1": 1.0835930895, "pagerank_2": 1.0635557741, "pagerank_3": 1.2036623172, "pagerank_4": 1.1849157286, "pagerank_5": 0.9655426577}}, {"model": "papers.paper", "pk": 1003181, "fields": {"authors": ["Erik M.Conway"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/465686a", "abstract": "As climate scientists battle climate sceptics, they should note that we have been here before, say Naomi Oreskes and Erik M. Conway. History holds lessons for how researchers can get their message across.", "year": 2010, "title": "Defeating the merchants of doubt", "keywords": ["Battle", "Political science", "Meteorology", "Public opinion", "Global warming", "Climate change", "Environmental ethics", "Skepticism"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 1.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 4.8919473059, "timescaledpagerank_1": 3.8191194552, "timescaledpagerank_2": 4.2502980587, "timescaledpagerank_3": 3.2052999866, "timescaledpagerank_4": 2.508902267, "timescaledpagerank_5": 2.5612187096, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 5.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 1.0, "citationsperpaper_2": 1.5, "citationsperpaper_3": 1.5, "citationsperpaper_4": 1.5, "citationsperpaper_5": 2.5, "citationsperyear_0": 2.0, "citationsperyear_1": 1.0, "citationsperyear_2": 1.0, "citationsperyear_3": 0.75, "citationsperyear_4": 0.6, "citationsperyear_5": 0.833, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 3.0, "totalcitations_3": 3.0, "totalcitations_4": 3.0, "totalcitations_5": 5.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 2.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.455172902, "pagerank_1": 0.3805322551, "pagerank_2": 0.3803917683, "pagerank_3": 0.3832342263, "pagerank_4": 0.3838816573, "pagerank_5": 0.3835666724}}, {"model": "papers.paper", "pk": 1003181, "fields": {"authors": ["NaomiOreskes"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/465686a", "abstract": "As climate scientists battle climate sceptics, they should note that we have been here before, say Naomi Oreskes and Erik M. Conway. History holds lessons for how researchers can get their message across.", "year": 2010, "title": "Defeating the merchants of doubt", "keywords": ["Battle", "Political science", "Meteorology", "Public opinion", "Global warming", "Climate change", "Environmental ethics", "Skepticism"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 1.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 4.8919473059, "timescaledpagerank_1": 3.8191194552, "timescaledpagerank_2": 4.2502980587, "timescaledpagerank_3": 3.2052999866, "timescaledpagerank_4": 2.508902267, "timescaledpagerank_5": 2.5612187096, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 5.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.889, "citationsperpaper_1": 1.8, "citationsperpaper_2": 2.0, "citationsperpaper_3": 1.667, "citationsperpaper_4": 1.75, "citationsperpaper_5": 2.083, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 1.053, "citationsperyear_3": 1.0, "citationsperyear_4": 1.0, "citationsperyear_5": 1.136, "totalcitations_0": 17.0, "totalcitations_1": 18.0, "totalcitations_2": 20.0, "totalcitations_3": 20.0, "totalcitations_4": 21.0, "totalcitations_5": 25.0, "totalpapers_0": 9.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.719228785, "pagerank_1": 0.6794359381, "pagerank_2": 0.6789987977, "pagerank_3": 0.6874593184, "pagerank_4": 0.6893655897, "pagerank_5": 0.6884016098}}, {"model": "papers.paper", "pk": 1003181, "fields": {"authors": ["NaomiOreskes"], "affiliation": "Dartmouth College", "venue": "Nature", "doi": "10.1038/465686a", "abstract": "As climate scientists battle climate sceptics, they should note that we have been here before, say Naomi Oreskes and Erik M. Conway. History holds lessons for how researchers can get their message across.", "year": 2010, "title": "Defeating the merchants of doubt", "keywords": ["Battle", "Political science", "Meteorology", "Public opinion", "Global warming", "Climate change", "Environmental ethics", "Skepticism"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 1.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 4.8919473059, "timescaledpagerank_1": 3.8191194552, "timescaledpagerank_2": 4.2502980587, "timescaledpagerank_3": 3.2052999866, "timescaledpagerank_4": 2.508902267, "timescaledpagerank_5": 2.5612187096, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 5.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.889, "citationsperpaper_1": 1.8, "citationsperpaper_2": 2.0, "citationsperpaper_3": 1.667, "citationsperpaper_4": 1.75, "citationsperpaper_5": 2.083, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 1.053, "citationsperyear_3": 1.0, "citationsperyear_4": 1.0, "citationsperyear_5": 1.136, "totalcitations_0": 17.0, "totalcitations_1": 18.0, "totalcitations_2": 20.0, "totalcitations_3": 20.0, "totalcitations_4": 21.0, "totalcitations_5": 25.0, "totalpapers_0": 9.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.719228785, "pagerank_1": 0.6794359381, "pagerank_2": 0.6789987977, "pagerank_3": 0.6874593184, "pagerank_4": 0.6893655897, "pagerank_5": 0.6884016098}}, {"model": "papers.paper", "pk": 1003181, "fields": {"authors": ["NaomiOreskes"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/465686a", "abstract": "As climate scientists battle climate sceptics, they should note that we have been here before, say Naomi Oreskes and Erik M. Conway. History holds lessons for how researchers can get their message across.", "year": 2010, "title": "Defeating the merchants of doubt", "keywords": ["Battle", "Political science", "Meteorology", "Public opinion", "Global warming", "Climate change", "Environmental ethics", "Skepticism"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 1.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 4.8919473059, "timescaledpagerank_1": 3.8191194552, "timescaledpagerank_2": 4.2502980587, "timescaledpagerank_3": 3.2052999866, "timescaledpagerank_4": 2.508902267, "timescaledpagerank_5": 2.5612187096, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 5.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.889, "citationsperpaper_1": 1.8, "citationsperpaper_2": 2.0, "citationsperpaper_3": 1.667, "citationsperpaper_4": 1.75, "citationsperpaper_5": 2.083, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 1.053, "citationsperyear_3": 1.0, "citationsperyear_4": 1.0, "citationsperyear_5": 1.136, "totalcitations_0": 17.0, "totalcitations_1": 18.0, "totalcitations_2": 20.0, "totalcitations_3": 20.0, "totalcitations_4": 21.0, "totalcitations_5": 25.0, "totalpapers_0": 9.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.719228785, "pagerank_1": 0.6794359381, "pagerank_2": 0.6789987977, "pagerank_3": 0.6874593184, "pagerank_4": 0.6893655897, "pagerank_5": 0.6884016098}}, {"model": "papers.paper", "pk": 1003850, "fields": {"authors": ["RodneyCroteau"], "affiliation": "Washington State University", "venue": "Nature", "doi": "10.1038/nature09628", "abstract": "The first step in the biosynthesis of the anticancer compound Taxol (paclitaxel) and many other natural C20 diterpenes is the cyclization of an isoprenoid, catalysed by taxadiene synthase. The X-ray crystal structure of this enzyme from the Pacific yew has now been determined. Its C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain adopt the fold of a class II terpenoid cyclase. This suggests that this enzyme could be the ancestral progenitor of all terpenoid cyclases. The first X-ray crystal structure of a diterpene cyclase is reported \u2014 this enzyme, taxadiene synthase, catalyses the cyclization of an isoprenoid in the first committed step of the biosynthesis of the cancer chemotherapeutic drug Taxol. The C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain together adopt the fold of a class II terpenoid cyclase. It is proposed that this enzyme could be the ancestral progenitor of all terpenoid cyclases. With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization1 and shows remarkable efficacy in cancer chemotherapy2. The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)3 is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5),11(12)diene4, which is catalysed by taxadiene synthase5. The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids6. We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82\u2009A resolution) and 2-fluorogeranylgeranyl diphosphate (2.25\u2009A resolution). The TXS structure reveals a modular assembly of three \u03b1-helical domains. The carboxy-terminal catalytic domain is a class\u2009I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third \u2018insertion\u2019 domain together adopt the fold of a vestigial class\u2009II terpenoid cyclase. A class\u2009II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.", "year": 2010, "title": "Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis", "keywords": ["Stereochemistry", "Taxadiene synthase", "Biochemistry", "ATP synthase", "Diterpene", "Cyclase", "Taxadiene", "Chemistry", "Terpenoid", "Isomerase", "Lyase"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 6.0, "citations_3": 0.0, "citations_4": 3.0, "citations_5": 9.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.6326792694, "timescaledpagerank_2": 1.0961167847, "timescaledpagerank_3": 0.7896500538, "timescaledpagerank_4": 0.7920026699, "timescaledpagerank_5": 1.2744141526, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 23.0, "adopters_2": 54.0, "adopters_3": 0.0, "adopters_4": 12.0, "adopters_5": 0.0, "citationsperpaper_0": 7.745, "citationsperpaper_1": 8.442, "citationsperpaper_2": 9.654, "citationsperpaper_3": 9.904, "citationsperpaper_4": 10.404, "citationsperpaper_5": 10.679, "citationsperyear_0": 13.621, "citationsperyear_1": 14.633, "citationsperyear_2": 16.194, "citationsperyear_3": 16.094, "citationsperyear_4": 16.394, "citationsperyear_5": 16.647, "totalcitations_0": 395.0, "totalcitations_1": 439.0, "totalcitations_2": 502.0, "totalcitations_3": 515.0, "totalcitations_4": 541.0, "totalcitations_5": 566.0, "totalpapers_0": 51.0, "totalpapers_1": 52.0, "totalpapers_2": 52.0, "totalpapers_3": 52.0, "totalpapers_4": 52.0, "totalpapers_5": 53.0, "authorage_0": 28.0, "authorage_1": 29.0, "authorage_2": 30.0, "authorage_3": 31.0, "authorage_4": 32.0, "authorage_5": 33.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 3.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 121.6666666667, "venuehindexmean_1": 124.8333333333, "venuehindexmean_2": 128.5, "venuehindexmean_3": 132.0, "venuehindexmean_4": 135.3333333333, "venuehindexmean_5": 138.6666666667, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 11.2799167524, "pagerank_1": 11.2514637161, "pagerank_2": 10.962546131, "pagerank_3": 10.9153324224, "pagerank_4": 10.8026024434, "pagerank_5": 10.8093334996}}, {"model": "papers.paper", "pk": 1003850, "fields": {"authors": ["YinghuaJin", "Robert M.Coates"], "affiliation": "University of Illinois at Urbana\u2013Champaign", "venue": "Nature", "doi": "10.1038/nature09628", "abstract": "The first step in the biosynthesis of the anticancer compound Taxol (paclitaxel) and many other natural C20 diterpenes is the cyclization of an isoprenoid, catalysed by taxadiene synthase. The X-ray crystal structure of this enzyme from the Pacific yew has now been determined. Its C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain adopt the fold of a class II terpenoid cyclase. This suggests that this enzyme could be the ancestral progenitor of all terpenoid cyclases. The first X-ray crystal structure of a diterpene cyclase is reported \u2014 this enzyme, taxadiene synthase, catalyses the cyclization of an isoprenoid in the first committed step of the biosynthesis of the cancer chemotherapeutic drug Taxol. The C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain together adopt the fold of a class II terpenoid cyclase. It is proposed that this enzyme could be the ancestral progenitor of all terpenoid cyclases. With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization1 and shows remarkable efficacy in cancer chemotherapy2. The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)3 is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5),11(12)diene4, which is catalysed by taxadiene synthase5. The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids6. We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82\u2009A resolution) and 2-fluorogeranylgeranyl diphosphate (2.25\u2009A resolution). The TXS structure reveals a modular assembly of three \u03b1-helical domains. The carboxy-terminal catalytic domain is a class\u2009I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third \u2018insertion\u2019 domain together adopt the fold of a vestigial class\u2009II terpenoid cyclase. A class\u2009II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.", "year": 2010, "title": "Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis", "keywords": ["Stereochemistry", "Taxadiene synthase", "Biochemistry", "ATP synthase", "Diterpene", "Cyclase", "Taxadiene", "Chemistry", "Terpenoid", "Isomerase", "Lyase"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 6.0, "citations_3": 0.0, "citations_4": 3.0, "citations_5": 9.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.6326792694, "timescaledpagerank_2": 1.0961167847, "timescaledpagerank_3": 0.7896500538, "timescaledpagerank_4": 0.7920026699, "timescaledpagerank_5": 1.2744141526, "hindex_0": 2.5, "hindex_1": 3.0, "hindex_2": 3.5, "hindex_3": 3.5, "hindex_4": 3.5, "hindex_5": 3.5, "adopters_0": 0.0, "adopters_1": 23.0, "adopters_2": 54.0, "adopters_3": 0.0, "adopters_4": 12.0, "adopters_5": 0.0, "citationsperpaper_0": 3.0, "citationsperpaper_1": 5.159, "citationsperpaper_2": 7.3335, "citationsperpaper_3": 7.4585, "citationsperpaper_4": 9.2085, "citationsperpaper_5": 12.1665, "citationsperyear_0": 0.86, "citationsperyear_1": 1.465, "citationsperyear_2": 1.975, "citationsperyear_3": 1.866, "citationsperyear_4": 2.1165, "citationsperyear_5": 2.593, "totalcitations_0": 22.0, "totalcitations_1": 32.0, "totalcitations_2": 43.0, "totalcitations_3": 44.5, "totalcitations_4": 50.5, "totalcitations_5": 63.5, "totalpapers_0": 6.0, "totalpapers_1": 6.5, "totalpapers_2": 7.0, "totalpapers_3": 7.0, "totalpapers_4": 7.0, "totalpapers_5": 7.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 12.5, "recentcoauthors_3": 10.5, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.3571428571, "venuehindexmean_1": 131.3125, "venuehindexmean_2": 136.5, "venuehindexmean_3": 141.6875, "venuehindexmean_4": 146.375, "venuehindexmean_5": 151.0625, "totalvenues_0": 4.5, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.4753840152, "pagerank_1": 1.5308388768, "pagerank_2": 1.8328846045, "pagerank_3": 1.7944859282, "pagerank_4": 1.7574673543, "pagerank_5": 1.7213162723}}, {"model": "papers.paper", "pk": 1003850, "fields": {"authors": ["YinghuaJin"], "affiliation": "University of Colorado Boulder", "venue": "Nature", "doi": "10.1038/nature09628", "abstract": "The first step in the biosynthesis of the anticancer compound Taxol (paclitaxel) and many other natural C20 diterpenes is the cyclization of an isoprenoid, catalysed by taxadiene synthase. The X-ray crystal structure of this enzyme from the Pacific yew has now been determined. Its C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain adopt the fold of a class II terpenoid cyclase. This suggests that this enzyme could be the ancestral progenitor of all terpenoid cyclases. The first X-ray crystal structure of a diterpene cyclase is reported \u2014 this enzyme, taxadiene synthase, catalyses the cyclization of an isoprenoid in the first committed step of the biosynthesis of the cancer chemotherapeutic drug Taxol. The C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain together adopt the fold of a class II terpenoid cyclase. It is proposed that this enzyme could be the ancestral progenitor of all terpenoid cyclases. With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization1 and shows remarkable efficacy in cancer chemotherapy2. The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)3 is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5),11(12)diene4, which is catalysed by taxadiene synthase5. The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids6. We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82\u2009A resolution) and 2-fluorogeranylgeranyl diphosphate (2.25\u2009A resolution). The TXS structure reveals a modular assembly of three \u03b1-helical domains. The carboxy-terminal catalytic domain is a class\u2009I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third \u2018insertion\u2019 domain together adopt the fold of a vestigial class\u2009II terpenoid cyclase. A class\u2009II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.", "year": 2010, "title": "Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis", "keywords": ["Stereochemistry", "Taxadiene synthase", "Biochemistry", "ATP synthase", "Diterpene", "Cyclase", "Taxadiene", "Chemistry", "Terpenoid", "Isomerase", "Lyase"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 6.0, "citations_3": 0.0, "citations_4": 3.0, "citations_5": 9.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.6326792694, "timescaledpagerank_2": 1.0961167847, "timescaledpagerank_3": 0.7896500538, "timescaledpagerank_4": 0.7920026699, "timescaledpagerank_5": 1.2744141526, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 23.0, "adopters_2": 54.0, "adopters_3": 0.0, "adopters_4": 12.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 5.5, "citationsperpaper_2": 9.0, "citationsperpaper_3": 9.0, "citationsperpaper_4": 12.0, "citationsperpaper_5": 16.5, "citationsperyear_0": 0.667, "citationsperyear_1": 1.571, "citationsperyear_2": 2.25, "citationsperyear_3": 2.0, "citationsperyear_4": 2.4, "citationsperyear_5": 3.0, "totalcitations_0": 4.0, "totalcitations_1": 11.0, "totalcitations_2": 18.0, "totalcitations_3": 18.0, "totalcitations_4": 24.0, "totalcitations_5": 33.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 165.0, "venuehindexmean_1": 170.0, "venuehindexmean_2": 176.0, "venuehindexmean_3": 182.0, "venuehindexmean_4": 187.5, "venuehindexmean_5": 193.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.5682398646, "pagerank_1": 0.5318543933, "pagerank_2": 0.499158842, "pagerank_3": 0.4939223837, "pagerank_4": 0.4885245653, "pagerank_5": 0.4798308843}}, {"model": "papers.paper", "pk": 1003850, "fields": {"authors": ["David W.Christianson", "MustafaK\u00f6ksal"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature09628", "abstract": "The first step in the biosynthesis of the anticancer compound Taxol (paclitaxel) and many other natural C20 diterpenes is the cyclization of an isoprenoid, catalysed by taxadiene synthase. The X-ray crystal structure of this enzyme from the Pacific yew has now been determined. Its C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain adopt the fold of a class II terpenoid cyclase. This suggests that this enzyme could be the ancestral progenitor of all terpenoid cyclases. The first X-ray crystal structure of a diterpene cyclase is reported \u2014 this enzyme, taxadiene synthase, catalyses the cyclization of an isoprenoid in the first committed step of the biosynthesis of the cancer chemotherapeutic drug Taxol. The C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain together adopt the fold of a class II terpenoid cyclase. It is proposed that this enzyme could be the ancestral progenitor of all terpenoid cyclases. With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization1 and shows remarkable efficacy in cancer chemotherapy2. The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)3 is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5),11(12)diene4, which is catalysed by taxadiene synthase5. The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids6. We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82\u2009A resolution) and 2-fluorogeranylgeranyl diphosphate (2.25\u2009A resolution). The TXS structure reveals a modular assembly of three \u03b1-helical domains. The carboxy-terminal catalytic domain is a class\u2009I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third \u2018insertion\u2019 domain together adopt the fold of a vestigial class\u2009II terpenoid cyclase. A class\u2009II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.", "year": 2010, "title": "Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis", "keywords": ["Stereochemistry", "Taxadiene synthase", "Biochemistry", "ATP synthase", "Diterpene", "Cyclase", "Taxadiene", "Chemistry", "Terpenoid", "Isomerase", "Lyase"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 6.0, "citations_3": 0.0, "citations_4": 3.0, "citations_5": 9.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.6326792694, "timescaledpagerank_2": 1.0961167847, "timescaledpagerank_3": 0.7896500538, "timescaledpagerank_4": 0.7920026699, "timescaledpagerank_5": 1.2744141526, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 8.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 23.0, "adopters_2": 54.0, "adopters_3": 0.0, "adopters_4": 12.0, "adopters_5": 0.0, "citationsperpaper_0": 3.0175, "citationsperpaper_1": 5.4585, "citationsperpaper_2": 6.7065, "citationsperpaper_3": 6.8805, "citationsperpaper_4": 8.1695, "citationsperpaper_5": 11.029, "citationsperyear_0": 6.6155, "citationsperyear_1": 9.3795, "citationsperyear_2": 10.923, "citationsperyear_3": 10.3275, "citationsperyear_4": 10.7835, "citationsperyear_5": 12.078, "totalcitations_0": 172.0, "totalcitations_1": 197.0, "totalcitations_2": 222.5, "totalcitations_3": 237.0, "totalcitations_4": 258.5, "totalcitations_5": 289.0, "totalpapers_0": 29.0, "totalpapers_1": 31.0, "totalpapers_2": 33.0, "totalpapers_3": 33.5, "totalpapers_4": 33.5, "totalpapers_5": 33.5, "authorage_0": 12.5, "authorage_1": 13.5, "authorage_2": 14.5, "authorage_3": 15.5, "authorage_4": 16.5, "authorage_5": 17.5, "recentcoauthors_0": 10.5, "recentcoauthors_1": 14.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 31.5, "recentcoauthors_4": 3.5, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 195.25, "venuehindexmean_1": 134.4722222222, "venuehindexmean_2": 128.0, "venuehindexmean_3": 132.8333333333, "venuehindexmean_4": 137.3888888889, "venuehindexmean_5": 141.6111111111, "totalvenues_0": 4.5, "totalvenues_1": 5.5, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.525711886, "pagerank_1": 5.9036021485, "pagerank_2": 6.3994556269, "pagerank_3": 6.3769548757, "pagerank_4": 6.2257219194, "pagerank_5": 6.0351370824}}, {"model": "papers.paper", "pk": 1003850, "fields": {"authors": ["Robert M.Coates"], "affiliation": "University of Kentucky", "venue": "Nature", "doi": "10.1038/nature09628", "abstract": "The first step in the biosynthesis of the anticancer compound Taxol (paclitaxel) and many other natural C20 diterpenes is the cyclization of an isoprenoid, catalysed by taxadiene synthase. The X-ray crystal structure of this enzyme from the Pacific yew has now been determined. Its C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain adopt the fold of a class II terpenoid cyclase. This suggests that this enzyme could be the ancestral progenitor of all terpenoid cyclases. The first X-ray crystal structure of a diterpene cyclase is reported \u2014 this enzyme, taxadiene synthase, catalyses the cyclization of an isoprenoid in the first committed step of the biosynthesis of the cancer chemotherapeutic drug Taxol. The C-terminal catalytic domain binds and activates the substrate in a manner seen in class I terpenoid cyclases, but the N-terminal domain and a third 'insertion' domain together adopt the fold of a class II terpenoid cyclase. It is proposed that this enzyme could be the ancestral progenitor of all terpenoid cyclases. With more than 55,000 members identified so far in all forms of life, the family of terpene or terpenoid natural products represents the epitome of molecular biodiversity. A well-known and important member of this family is the polycyclic diterpenoid Taxol (paclitaxel), which promotes tubulin polymerization1 and shows remarkable efficacy in cancer chemotherapy2. The first committed step of Taxol biosynthesis in the Pacific yew (Taxus brevifolia)3 is the cyclization of the linear isoprenoid substrate geranylgeranyl diphosphate (GGPP) to form taxa-4(5),11(12)diene4, which is catalysed by taxadiene synthase5. The full-length form of this diterpene cyclase contains 862 residues, but a roughly 80-residue amino-terminal transit sequence is cleaved on maturation in plastids6. We now report the X-ray crystal structure of a truncation variant lacking the transit sequence and an additional 27 residues at the N terminus, hereafter designated TXS. Specifically, we have determined structures of TXS complexed with 13-aza-13,14-dihydrocopalyl diphosphate (1.82\u2009A resolution) and 2-fluorogeranylgeranyl diphosphate (2.25\u2009A resolution). The TXS structure reveals a modular assembly of three \u03b1-helical domains. The carboxy-terminal catalytic domain is a class\u2009I terpenoid cyclase, which binds and activates substrate GGPP with a three-metal ion cluster. The N-terminal domain and a third \u2018insertion\u2019 domain together adopt the fold of a vestigial class\u2009II terpenoid cyclase. A class\u2009II cyclase activates the isoprenoid substrate by protonation instead of ionization, and the TXS structure reveals a definitive connection between the two distinct cyclase classes in the evolution of terpenoid biosynthesis.", "year": 2010, "title": "Taxadiene synthase structure and evolution of modular architecture in terpene biosynthesis", "keywords": ["Stereochemistry", "Taxadiene synthase", "Biochemistry", "ATP synthase", "Diterpene", "Cyclase", "Taxadiene", "Chemistry", "Terpenoid", "Isomerase", "Lyase"], "citations_0": 0.0, "citations_1": 6.0, "citations_2": 6.0, "citations_3": 0.0, "citations_4": 3.0, "citations_5": 9.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.6326792694, "timescaledpagerank_2": 1.0961167847, "timescaledpagerank_3": 0.7896500538, "timescaledpagerank_4": 0.7920026699, "timescaledpagerank_5": 1.2744141526, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 23.0, "adopters_2": 54.0, "adopters_3": 0.0, "adopters_4": 12.0, "adopters_5": 0.0, "citationsperpaper_0": 4.0, "citationsperpaper_1": 4.818, "citationsperpaper_2": 5.667, "citationsperpaper_3": 5.917, "citationsperpaper_4": 6.417, "citationsperpaper_5": 7.833, "citationsperyear_0": 1.053, "citationsperyear_1": 1.359, "citationsperyear_2": 1.7, "citationsperyear_3": 1.732, "citationsperyear_4": 1.833, "citationsperyear_5": 2.186, "totalcitations_0": 40.0, "totalcitations_1": 53.0, "totalcitations_2": 68.0, "totalcitations_3": 71.0, "totalcitations_4": 77.0, "totalcitations_5": 94.0, "totalpapers_0": 10.0, "totalpapers_1": 11.0, "totalpapers_2": 12.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 37.0, "authorage_1": 38.0, "authorage_2": 39.0, "authorage_3": 40.0, "authorage_4": 41.0, "authorage_5": 42.0, "recentcoauthors_0": 6.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 25.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 97.7142857143, "venuehindexmean_1": 92.625, "venuehindexmean_2": 97.0, "venuehindexmean_3": 101.375, "venuehindexmean_4": 105.25, "venuehindexmean_5": 109.125, "totalvenues_0": 7.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 2.3825281657, "pagerank_1": 2.5298233603, "pagerank_2": 3.1666103669, "pagerank_3": 3.0950494727, "pagerank_4": 3.0264101432, "pagerank_5": 2.9628016604}}, {"model": "papers.paper", "pk": 1002975, "fields": {"authors": ["Lewis E.Kay"], "affiliation": "Hospital for Sick Children", "venue": "Nature", "doi": "10.1038/nature09444", "abstract": "The proteasome is a multi-protein complex that enzymatically degrades proteins. Proteolysis occurs in a barrel-shaped 20S core particle comprising three interconnected cavities, including a pair of antechambers in which substrates are held before degradation. These authors demonstrate that substrates interact actively with the antechamber walls and that the environment in this compartment is optimized to maintain the substrates in unfolded states so as to be accessible for hydrolysis.", "year": 2010, "title": "The proteasome antechamber maintains substrates in an unfolded state", "keywords": ["Biophysics", "Stereochemistry", "Protein folding", "Thermoplasma acidophilum", "Protein subunit", "Proteasome", "Unfolded protein response", "Chemistry", "Proteolysis", "Core Particle", "Antechamber"], "citations_0": 0.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0932364332, "timescaledpagerank_2": 0.1055004832, "timescaledpagerank_3": 0.2829853919, "timescaledpagerank_4": 0.3033158525, "timescaledpagerank_5": 0.3698818792, "hindex_0": 22.0, "hindex_1": 23.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 27.0, "hindex_5": 28.0, "adopters_0": 0.0, "adopters_1": 14.0, "adopters_2": 4.0, "adopters_3": 1.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 13.87, "citationsperpaper_1": 14.7, "citationsperpaper_2": 15.823, "citationsperpaper_3": 16.534, "citationsperpaper_4": 17.124, "citationsperpaper_5": 17.723, "citationsperyear_0": 63.8, "citationsperyear_1": 67.846, "citationsperyear_2": 72.667, "citationsperyear_3": 77.357, "citationsperyear_4": 80.897, "citationsperyear_5": 83.3, "totalcitations_0": 1595.0, "totalcitations_1": 1764.0, "totalcitations_2": 1962.0, "totalcitations_3": 2166.0, "totalcitations_4": 2346.0, "totalcitations_5": 2499.0, "totalpapers_0": 115.0, "totalpapers_1": 120.0, "totalpapers_2": 124.0, "totalpapers_3": 131.0, "totalpapers_4": 137.0, "totalpapers_5": 141.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 38.0, "recentcoauthors_1": 45.0, "recentcoauthors_2": 121.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 63.0, "recentcoauthors_5": 38.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6363636364, "venuehindexmean_1": 135.0, "venuehindexmean_2": 139.3636363636, "venuehindexmean_3": 140.6666666667, "venuehindexmean_4": 144.4166666667, "venuehindexmean_5": 147.9166666667, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 18.7404594557, "pagerank_1": 18.9451524623, "pagerank_2": 20.6886522341, "pagerank_3": 21.1561158326, "pagerank_4": 21.4594462062, "pagerank_5": 21.4186444358}}, {"model": "papers.paper", "pk": 1002975, "fields": {"authors": ["Lewis E.Kay", "Tomasz L.Religa", "Amy M.Ruschak"], "affiliation": "University of Toronto", "venue": "Nature", "doi": "10.1038/nature09444", "abstract": "The proteasome is a multi-protein complex that enzymatically degrades proteins. Proteolysis occurs in a barrel-shaped 20S core particle comprising three interconnected cavities, including a pair of antechambers in which substrates are held before degradation. These authors demonstrate that substrates interact actively with the antechamber walls and that the environment in this compartment is optimized to maintain the substrates in unfolded states so as to be accessible for hydrolysis.", "year": 2010, "title": "The proteasome antechamber maintains substrates in an unfolded state", "keywords": ["Biophysics", "Stereochemistry", "Protein folding", "Thermoplasma acidophilum", "Protein subunit", "Proteasome", "Unfolded protein response", "Chemistry", "Proteolysis", "Core Particle", "Antechamber"], "citations_0": 0.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0932364332, "timescaledpagerank_2": 0.1055004832, "timescaledpagerank_3": 0.2829853919, "timescaledpagerank_4": 0.3033158525, "timescaledpagerank_5": 0.3698818792, "hindex_0": 8.6666666667, "hindex_1": 9.3333333333, "hindex_2": 10.3333333333, "hindex_3": 11.3333333333, "hindex_4": 12.0, "hindex_5": 12.6666666667, "adopters_0": 0.0, "adopters_1": 14.0, "adopters_2": 4.0, "adopters_3": 1.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 6.5123333333, "citationsperpaper_1": 7.474, "citationsperpaper_2": 8.8743333333, "citationsperpaper_3": 9.678, "citationsperpaper_4": 10.7913333333, "citationsperpaper_5": 12.3243333333, "citationsperyear_0": 22.8856666667, "citationsperyear_1": 25.4486666667, "citationsperyear_2": 27.852, "citationsperyear_3": 30.2856666667, "citationsperyear_4": 31.911, "citationsperyear_5": 33.2946666667, "totalcitations_0": 543.0, "totalcitations_1": 607.6666666667, "totalcitations_2": 683.3333333333, "totalcitations_3": 762.0, "totalcitations_4": 832.0, "totalcitations_5": 894.0, "totalpapers_0": 40.6666666667, "totalpapers_1": 43.6666666667, "totalpapers_2": 45.3333333333, "totalpapers_3": 48.6666666667, "totalpapers_4": 50.6666666667, "totalpapers_5": 52.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 18.6666666667, "recentcoauthors_1": 26.3333333333, "recentcoauthors_2": 46.3333333333, "recentcoauthors_3": 56.6666666667, "recentcoauthors_4": 30.3333333333, "recentcoauthors_5": 12.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 191.4621212121, "venuehindexmean_1": 163.9166666667, "venuehindexmean_2": 169.2878787879, "venuehindexmean_3": 159.2888888889, "venuehindexmean_4": 163.5833333333, "venuehindexmean_5": 167.8833333333, "totalvenues_0": 5.3333333333, "totalvenues_1": 5.6666666667, "totalvenues_2": 5.6666666667, "totalvenues_3": 6.6666666667, "totalvenues_4": 6.6666666667, "totalvenues_5": 6.6666666667, "pagerank_0": 6.7513949808, "pagerank_1": 7.017314107, "pagerank_2": 7.5730934298, "pagerank_3": 7.9366561117, "pagerank_4": 8.0076014126, "pagerank_5": 7.9623442788}}, {"model": "papers.paper", "pk": 1002975, "fields": {"authors": ["Tomasz L.Religa"], "affiliation": "Medical Research Council", "venue": "Nature", "doi": "10.1038/nature09444", "abstract": "The proteasome is a multi-protein complex that enzymatically degrades proteins. Proteolysis occurs in a barrel-shaped 20S core particle comprising three interconnected cavities, including a pair of antechambers in which substrates are held before degradation. These authors demonstrate that substrates interact actively with the antechamber walls and that the environment in this compartment is optimized to maintain the substrates in unfolded states so as to be accessible for hydrolysis.", "year": 2010, "title": "The proteasome antechamber maintains substrates in an unfolded state", "keywords": ["Biophysics", "Stereochemistry", "Protein folding", "Thermoplasma acidophilum", "Protein subunit", "Proteasome", "Unfolded protein response", "Chemistry", "Proteolysis", "Core Particle", "Antechamber"], "citations_0": 0.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0932364332, "timescaledpagerank_2": 0.1055004832, "timescaledpagerank_3": 0.2829853919, "timescaledpagerank_4": 0.3033158525, "timescaledpagerank_5": 0.3698818792, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 14.0, "adopters_2": 4.0, "adopters_3": 1.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 5.667, "citationsperpaper_1": 6.222, "citationsperpaper_2": 8.3, "citationsperpaper_3": 9.167, "citationsperpaper_4": 11.583, "citationsperpaper_5": 13.917, "citationsperyear_0": 4.857, "citationsperyear_1": 7.0, "citationsperyear_2": 9.222, "citationsperyear_3": 11.0, "citationsperyear_4": 12.636, "citationsperyear_5": 13.917, "totalcitations_0": 34.0, "totalcitations_1": 56.0, "totalcitations_2": 83.0, "totalcitations_3": 110.0, "totalcitations_4": 139.0, "totalcitations_5": 167.0, "totalpapers_0": 6.0, "totalpapers_1": 9.0, "totalpapers_2": 10.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 14.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 182.75, "venuehindexmean_1": 186.75, "venuehindexmean_2": 192.5, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.1637599805, "pagerank_1": 1.6548226979, "pagerank_2": 1.5974042685, "pagerank_3": 1.776869181, "pagerank_4": 1.7221089783, "pagerank_5": 1.6752215576}}, {"model": "papers.paper", "pk": 1002975, "fields": {"authors": ["S.Breuer", "SusanneWitt"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature09444", "abstract": "The proteasome is a multi-protein complex that enzymatically degrades proteins. Proteolysis occurs in a barrel-shaped 20S core particle comprising three interconnected cavities, including a pair of antechambers in which substrates are held before degradation. These authors demonstrate that substrates interact actively with the antechamber walls and that the environment in this compartment is optimized to maintain the substrates in unfolded states so as to be accessible for hydrolysis.", "year": 2010, "title": "The proteasome antechamber maintains substrates in an unfolded state", "keywords": ["Biophysics", "Stereochemistry", "Protein folding", "Thermoplasma acidophilum", "Protein subunit", "Proteasome", "Unfolded protein response", "Chemistry", "Proteolysis", "Core Particle", "Antechamber"], "citations_0": 0.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0932364332, "timescaledpagerank_2": 0.1055004832, "timescaledpagerank_3": 0.2829853919, "timescaledpagerank_4": 0.3033158525, "timescaledpagerank_5": 0.3698818792, "hindex_0": 1.5, "hindex_1": 2.0, "hindex_2": 2.5, "hindex_3": 2.5, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 14.0, "adopters_2": 4.0, "adopters_3": 1.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 2.3, "citationsperpaper_1": 4.6, "citationsperpaper_2": 6.2, "citationsperpaper_3": 6.8, "citationsperpaper_4": 7.9, "citationsperpaper_5": 10.1, "citationsperyear_0": 1.0455, "citationsperyear_1": 2.0415, "citationsperyear_2": 2.2565, "citationsperyear_3": 2.107, "citationsperyear_4": 2.1665, "citationsperyear_5": 2.4275, "totalcitations_0": 11.5, "totalcitations_1": 17.0, "totalcitations_2": 21.0, "totalcitations_3": 22.0, "totalcitations_4": 25.5, "totalcitations_5": 30.5, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 10.5, "recentcoauthors_1": 4.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 229.5, "venuehindexmean_1": 232.75, "venuehindexmean_2": 237.0, "venuehindexmean_3": 241.75, "venuehindexmean_4": 245.5, "venuehindexmean_5": 248.75, "totalvenues_0": 1.5, "totalvenues_1": 1.5, "totalvenues_2": 1.5, "totalvenues_3": 1.5, "totalvenues_4": 1.5, "totalvenues_5": 1.5, "pagerank_0": 0.9341899322, "pagerank_1": 0.8865556684, "pagerank_2": 0.8552434802, "pagerank_3": 0.8097648131, "pagerank_4": 0.7963003006, "pagerank_5": 0.7790854489}}, {"model": "papers.paper", "pk": 1002975, "fields": {"authors": ["SusanneWitt"], "affiliation": "Stockholm University", "venue": "Nature", "doi": "10.1038/nature09444", "abstract": "The proteasome is a multi-protein complex that enzymatically degrades proteins. Proteolysis occurs in a barrel-shaped 20S core particle comprising three interconnected cavities, including a pair of antechambers in which substrates are held before degradation. These authors demonstrate that substrates interact actively with the antechamber walls and that the environment in this compartment is optimized to maintain the substrates in unfolded states so as to be accessible for hydrolysis.", "year": 2010, "title": "The proteasome antechamber maintains substrates in an unfolded state", "keywords": ["Biophysics", "Stereochemistry", "Protein folding", "Thermoplasma acidophilum", "Protein subunit", "Proteasome", "Unfolded protein response", "Chemistry", "Proteolysis", "Core Particle", "Antechamber"], "citations_0": 0.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0932364332, "timescaledpagerank_2": 0.1055004832, "timescaledpagerank_3": 0.2829853919, "timescaledpagerank_4": 0.3033158525, "timescaledpagerank_5": 0.3698818792, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 14.0, "adopters_2": 4.0, "adopters_3": 1.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 4.6, "citationsperpaper_1": 6.2, "citationsperpaper_2": 7.4, "citationsperpaper_3": 7.6, "citationsperpaper_4": 8.8, "citationsperpaper_5": 10.2, "citationsperyear_0": 2.091, "citationsperyear_1": 2.583, "citationsperyear_2": 2.846, "citationsperyear_3": 2.714, "citationsperyear_4": 2.933, "citationsperyear_5": 3.188, "totalcitations_0": 23.0, "totalcitations_1": 31.0, "totalcitations_2": 37.0, "totalcitations_3": 38.0, "totalcitations_4": 44.0, "totalcitations_5": 51.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 5.0, "totalpapers_4": 5.0, "totalpapers_5": 5.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 199.0, "venuehindexmean_1": 201.5, "venuehindexmean_2": 205.0, "venuehindexmean_3": 208.5, "venuehindexmean_4": 211.0, "venuehindexmean_5": 213.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.5184143593, "pagerank_1": 1.4510534991, "pagerank_2": 1.3994628552, "pagerank_3": 1.3392972152, "pagerank_4": 1.315762025, "pagerank_5": 1.2856288633}}, {"model": "papers.paper", "pk": 1003609, "fields": {"authors": ["David G.Spiller", "Michael R. H.White"], "affiliation": "University of Manchester", "venue": "Nature", "doi": "10.1038/nature09232", "abstract": "Populations of cells are almost always heterogeneous in function and fate. To understand the plasticity of cells, it is vital to measure quantitatively and dynamically the molecular processes that underlie cell-fate decisions in single cells. Early events in cell signalling often occur within seconds of the stimulus, whereas intracellular signalling processes and transcriptional changes can take minutes or hours. By contrast, cell-fate decisions, such as whether a cell divides, differentiates or dies, can take many hours or days. Multiparameter experimental and computational methods that integrate quantitative measurement and mathematical simulation of these noisy and complex processes are required to understand the highly dynamic mechanisms that control cell plasticity and fate.", "year": 2010, "title": "Measurement of single-cell dynamics", "keywords": ["Cell signaling", "Plasticity", "Neuroscience", "Developmental biology", "Cell", "Systems biology", "Biology", "Computational biology", "Stimulus (physiology)", "Cell cycle", "Structural biology"], "citations_0": 2.0, "citations_1": 7.0, "citations_2": 2.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.359357709, "timescaledpagerank_1": 0.6749941707, "timescaledpagerank_2": 0.539297525, "timescaledpagerank_3": 0.5407325168, "timescaledpagerank_4": 0.4664159234, "timescaledpagerank_5": 0.5425699875, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 8.5, "hindex_4": 8.5, "hindex_5": 8.5, "adopters_0": 7.0, "adopters_1": 23.0, "adopters_2": 11.0, "adopters_3": 16.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 7.5295, "citationsperpaper_1": 8.8805, "citationsperpaper_2": 10.128, "citationsperpaper_3": 11.1555, "citationsperpaper_4": 11.6525, "citationsperpaper_5": 11.73, "citationsperyear_0": 10.0815, "citationsperyear_1": 11.695, "citationsperyear_2": 12.522, "citationsperyear_3": 12.9985, "citationsperyear_4": 13.478, "citationsperyear_5": 13.4765, "totalcitations_0": 145.5, "totalcitations_1": 180.5, "totalcitations_2": 206.0, "totalcitations_3": 227.0, "totalcitations_4": 249.0, "totalcitations_5": 262.5, "totalpapers_0": 19.5, "totalpapers_1": 20.5, "totalpapers_2": 20.5, "totalpapers_3": 20.5, "totalpapers_4": 21.5, "totalpapers_5": 22.5, "authorage_0": 13.5, "authorage_1": 14.5, "authorage_2": 15.5, "authorage_3": 16.5, "authorage_4": 17.5, "authorage_5": 18.5, "recentcoauthors_0": 59.0, "recentcoauthors_1": 38.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 7.0, "recentcoauthors_5": 23.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.4, "venuehindexmean_1": 128.8636363636, "venuehindexmean_2": 132.3181818182, "venuehindexmean_3": 135.6363636364, "venuehindexmean_4": 138.3636363636, "venuehindexmean_5": 141.0, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 11.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 5.584758366, "pagerank_1": 5.7881447822, "pagerank_2": 5.5866629132, "pagerank_3": 5.4648807113, "pagerank_4": 5.6412806988, "pagerank_5": 5.9407547889}}, {"model": "papers.paper", "pk": 1003609, "fields": {"authors": ["Christopher D.Wood", "David G.Spiller", "Michael R. H.White"], "affiliation": "University of Liverpool", "venue": "Nature", "doi": "10.1038/nature09232", "abstract": "Populations of cells are almost always heterogeneous in function and fate. To understand the plasticity of cells, it is vital to measure quantitatively and dynamically the molecular processes that underlie cell-fate decisions in single cells. Early events in cell signalling often occur within seconds of the stimulus, whereas intracellular signalling processes and transcriptional changes can take minutes or hours. By contrast, cell-fate decisions, such as whether a cell divides, differentiates or dies, can take many hours or days. Multiparameter experimental and computational methods that integrate quantitative measurement and mathematical simulation of these noisy and complex processes are required to understand the highly dynamic mechanisms that control cell plasticity and fate.", "year": 2010, "title": "Measurement of single-cell dynamics", "keywords": ["Cell signaling", "Plasticity", "Neuroscience", "Developmental biology", "Cell", "Systems biology", "Biology", "Computational biology", "Stimulus (physiology)", "Cell cycle", "Structural biology"], "citations_0": 2.0, "citations_1": 7.0, "citations_2": 2.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.359357709, "timescaledpagerank_1": 0.6749941707, "timescaledpagerank_2": 0.539297525, "timescaledpagerank_3": 0.5407325168, "timescaledpagerank_4": 0.4664159234, "timescaledpagerank_5": 0.5425699875, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.3333333333, "hindex_4": 7.3333333333, "hindex_5": 7.3333333333, "adopters_0": 7.0, "adopters_1": 23.0, "adopters_2": 11.0, "adopters_3": 16.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 6.6863333333, "citationsperpaper_1": 8.0313333333, "citationsperpaper_2": 9.1963333333, "citationsperpaper_3": 10.1036666667, "citationsperpaper_4": 10.546, "citationsperpaper_5": 10.7643333333, "citationsperyear_0": 7.4903333333, "citationsperyear_1": 8.7013333333, "citationsperyear_2": 9.3256666667, "citationsperyear_3": 9.6656666667, "citationsperyear_4": 9.9656666667, "citationsperyear_5": 9.9656666667, "totalcitations_0": 107.0, "totalcitations_1": 133.0, "totalcitations_2": 152.0, "totalcitations_3": 167.3333333333, "totalcitations_4": 182.6666666667, "totalcitations_5": 192.6666666667, "totalpapers_0": 15.0, "totalpapers_1": 15.6666666667, "totalpapers_2": 15.6666666667, "totalpapers_3": 15.6666666667, "totalpapers_4": 16.3333333333, "totalpapers_5": 17.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 40.3333333333, "recentcoauthors_1": 26.3333333333, "recentcoauthors_2": 6.6666666667, "recentcoauthors_3": 0.0, "recentcoauthors_4": 4.6666666667, "recentcoauthors_5": 15.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 138.85, "venuehindexmean_1": 135.9090909091, "venuehindexmean_2": 139.2954545455, "venuehindexmean_3": 142.2575757576, "venuehindexmean_4": 144.9090909091, "venuehindexmean_5": 147.3333333333, "totalvenues_0": 8.0, "totalvenues_1": 8.6666666667, "totalvenues_2": 8.6666666667, "totalvenues_3": 8.6666666667, "totalvenues_4": 8.6666666667, "totalvenues_5": 8.6666666667, "pagerank_0": 4.1590686602, "pagerank_1": 4.2736285952, "pagerank_2": 4.1284750736, "pagerank_3": 4.0384844274, "pagerank_4": 4.1496845633, "pagerank_5": 4.3403518363}}, {"model": "papers.paper", "pk": 1003609, "fields": {"authors": ["Christopher D.Wood"], "affiliation": "National Autonomous University of Mexico", "venue": "Nature", "doi": "10.1038/nature09232", "abstract": "Populations of cells are almost always heterogeneous in function and fate. To understand the plasticity of cells, it is vital to measure quantitatively and dynamically the molecular processes that underlie cell-fate decisions in single cells. Early events in cell signalling often occur within seconds of the stimulus, whereas intracellular signalling processes and transcriptional changes can take minutes or hours. By contrast, cell-fate decisions, such as whether a cell divides, differentiates or dies, can take many hours or days. Multiparameter experimental and computational methods that integrate quantitative measurement and mathematical simulation of these noisy and complex processes are required to understand the highly dynamic mechanisms that control cell plasticity and fate.", "year": 2010, "title": "Measurement of single-cell dynamics", "keywords": ["Cell signaling", "Plasticity", "Neuroscience", "Developmental biology", "Cell", "Systems biology", "Biology", "Computational biology", "Stimulus (physiology)", "Cell cycle", "Structural biology"], "citations_0": 2.0, "citations_1": 7.0, "citations_2": 2.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.359357709, "timescaledpagerank_1": 0.6749941707, "timescaledpagerank_2": 0.539297525, "timescaledpagerank_3": 0.5407325168, "timescaledpagerank_4": 0.4664159234, "timescaledpagerank_5": 0.5425699875, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 7.0, "adopters_1": 23.0, "adopters_2": 11.0, "adopters_3": 16.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 5.0, "citationsperpaper_1": 6.333, "citationsperpaper_2": 7.333, "citationsperpaper_3": 8.0, "citationsperpaper_4": 8.333, "citationsperpaper_5": 8.833, "citationsperyear_0": 2.308, "citationsperyear_1": 2.714, "citationsperyear_2": 2.933, "citationsperyear_3": 3.0, "citationsperyear_4": 2.941, "citationsperyear_5": 2.944, "totalcitations_0": 30.0, "totalcitations_1": 38.0, "totalcitations_2": 44.0, "totalcitations_3": 48.0, "totalcitations_4": 50.0, "totalcitations_5": 53.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 3.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.75, "venuehindexmean_1": 150.0, "venuehindexmean_2": 153.25, "venuehindexmean_3": 155.5, "venuehindexmean_4": 158.0, "venuehindexmean_5": 160.0, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.3076892486, "pagerank_1": 1.2445962211, "pagerank_2": 1.2120993944, "pagerank_3": 1.1856918597, "pagerank_4": 1.1664922921, "pagerank_5": 1.1395459312}}, {"model": "papers.paper", "pk": 1003609, "fields": {"authors": ["Christopher D.Wood"], "affiliation": "Newcastle University", "venue": "Nature", "doi": "10.1038/nature09232", "abstract": "Populations of cells are almost always heterogeneous in function and fate. To understand the plasticity of cells, it is vital to measure quantitatively and dynamically the molecular processes that underlie cell-fate decisions in single cells. Early events in cell signalling often occur within seconds of the stimulus, whereas intracellular signalling processes and transcriptional changes can take minutes or hours. By contrast, cell-fate decisions, such as whether a cell divides, differentiates or dies, can take many hours or days. Multiparameter experimental and computational methods that integrate quantitative measurement and mathematical simulation of these noisy and complex processes are required to understand the highly dynamic mechanisms that control cell plasticity and fate.", "year": 2010, "title": "Measurement of single-cell dynamics", "keywords": ["Cell signaling", "Plasticity", "Neuroscience", "Developmental biology", "Cell", "Systems biology", "Biology", "Computational biology", "Stimulus (physiology)", "Cell cycle", "Structural biology"], "citations_0": 2.0, "citations_1": 7.0, "citations_2": 2.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.359357709, "timescaledpagerank_1": 0.6749941707, "timescaledpagerank_2": 0.539297525, "timescaledpagerank_3": 0.5407325168, "timescaledpagerank_4": 0.4664159234, "timescaledpagerank_5": 0.5425699875, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 7.0, "adopters_1": 23.0, "adopters_2": 11.0, "adopters_3": 16.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 5.0, "citationsperpaper_1": 6.333, "citationsperpaper_2": 7.333, "citationsperpaper_3": 8.0, "citationsperpaper_4": 8.333, "citationsperpaper_5": 8.833, "citationsperyear_0": 2.308, "citationsperyear_1": 2.714, "citationsperyear_2": 2.933, "citationsperyear_3": 3.0, "citationsperyear_4": 2.941, "citationsperyear_5": 2.944, "totalcitations_0": 30.0, "totalcitations_1": 38.0, "totalcitations_2": 44.0, "totalcitations_3": 48.0, "totalcitations_4": 50.0, "totalcitations_5": 53.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 3.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.75, "venuehindexmean_1": 150.0, "venuehindexmean_2": 153.25, "venuehindexmean_3": 155.5, "venuehindexmean_4": 158.0, "venuehindexmean_5": 160.0, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.3076892486, "pagerank_1": 1.2445962211, "pagerank_2": 1.2120993944, "pagerank_3": 1.1856918597, "pagerank_4": 1.1664922921, "pagerank_5": 1.1395459312}}, {"model": "papers.paper", "pk": 1003609, "fields": {"authors": ["David A.Rand"], "affiliation": "University of Warwick", "venue": "Nature", "doi": "10.1038/nature09232", "abstract": "Populations of cells are almost always heterogeneous in function and fate. To understand the plasticity of cells, it is vital to measure quantitatively and dynamically the molecular processes that underlie cell-fate decisions in single cells. Early events in cell signalling often occur within seconds of the stimulus, whereas intracellular signalling processes and transcriptional changes can take minutes or hours. By contrast, cell-fate decisions, such as whether a cell divides, differentiates or dies, can take many hours or days. Multiparameter experimental and computational methods that integrate quantitative measurement and mathematical simulation of these noisy and complex processes are required to understand the highly dynamic mechanisms that control cell plasticity and fate.", "year": 2010, "title": "Measurement of single-cell dynamics", "keywords": ["Cell signaling", "Plasticity", "Neuroscience", "Developmental biology", "Cell", "Systems biology", "Biology", "Computational biology", "Stimulus (physiology)", "Cell cycle", "Structural biology"], "citations_0": 2.0, "citations_1": 7.0, "citations_2": 2.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.359357709, "timescaledpagerank_1": 0.6749941707, "timescaledpagerank_2": 0.539297525, "timescaledpagerank_3": 0.5407325168, "timescaledpagerank_4": 0.4664159234, "timescaledpagerank_5": 0.5425699875, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 7.0, "adopters_1": 23.0, "adopters_2": 11.0, "adopters_3": 16.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 2.4, "citationsperpaper_1": 4.857, "citationsperpaper_2": 6.143, "citationsperpaper_3": 6.75, "citationsperpaper_4": 7.444, "citationsperpaper_5": 8.778, "citationsperyear_0": 1.0, "citationsperyear_1": 2.615, "citationsperyear_2": 3.071, "citationsperyear_3": 3.6, "citationsperyear_4": 4.188, "citationsperyear_5": 4.647, "totalcitations_0": 12.0, "totalcitations_1": 34.0, "totalcitations_2": 43.0, "totalcitations_3": 54.0, "totalcitations_4": 67.0, "totalcitations_5": 79.0, "totalpapers_0": 5.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 8.0, "totalpapers_4": 9.0, "totalpapers_5": 9.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 23.0, "recentcoauthors_2": 13.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 20.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 227.75, "venuehindexmean_1": 194.2, "venuehindexmean_2": 199.0, "venuehindexmean_3": 193.1666666667, "venuehindexmean_4": 196.1666666667, "venuehindexmean_5": 199.0, "totalvenues_0": 4.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 1.5970349593, "pagerank_1": 2.1173446665, "pagerank_2": 2.0617555319, "pagerank_3": 2.6158532385, "pagerank_4": 2.9821049708, "pagerank_5": 2.7948990779}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["ZhenbangChen", "AinaraEgia", "Pier PaoloPandolfi", "CaterinaNardella", "JulieTeruya-Feldstein", "GuocanWang", "Hui KuanLin", "CarlosCordon-Cardo"], "affiliation": "Memorial Sloan Kettering Cancer Center", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 14.5, "hindex_1": 16.25, "hindex_2": 17.5, "hindex_3": 17.875, "hindex_4": 18.625, "hindex_5": 19.25, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 15.227875, "citationsperpaper_1": 17.467125, "citationsperpaper_2": 18.626, "citationsperpaper_3": 19.637, "citationsperpaper_4": 20.452875, "citationsperpaper_5": 20.824875, "citationsperyear_0": 68.514125, "citationsperyear_1": 74.909, "citationsperyear_2": 79.984875, "citationsperyear_3": 84.558625, "citationsperyear_4": 86.476125, "citationsperyear_5": 86.9715, "totalcitations_0": 1236.0, "totalcitations_1": 1398.125, "totalcitations_2": 1559.375, "totalcitations_3": 1718.875, "totalcitations_4": 1851.625, "totalcitations_5": 1958.0, "totalpapers_0": 58.375, "totalpapers_1": 62.5, "totalpapers_2": 67.625, "totalpapers_3": 72.75, "totalpapers_4": 77.5, "totalpapers_5": 80.875, "authorage_0": 10.375, "authorage_1": 11.375, "authorage_2": 12.375, "authorage_3": 13.375, "authorage_4": 14.375, "authorage_5": 15.375, "recentcoauthors_0": 149.375, "recentcoauthors_1": 126.625, "recentcoauthors_2": 114.125, "recentcoauthors_3": 136.875, "recentcoauthors_4": 138.625, "recentcoauthors_5": 125.875, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 124.795313568, "venuehindexmean_1": 126.5079251571, "venuehindexmean_2": 133.5310207337, "venuehindexmean_3": 131.1139686533, "venuehindexmean_4": 128.8883940621, "venuehindexmean_5": 128.2968609424, "totalvenues_0": 11.0, "totalvenues_1": 11.5, "totalvenues_2": 12.25, "totalvenues_3": 12.875, "totalvenues_4": 13.625, "totalvenues_5": 13.75, "pagerank_0": 14.1700765617, "pagerank_1": 14.5478813182, "pagerank_2": 15.2961378089, "pagerank_3": 15.8956076118, "pagerank_4": 16.5222642699, "pagerank_5": 16.6976269214}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["AinaraEgia"], "affiliation": "Complutense University of Madrid", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 5.0, "hindex_1": 7.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.143, "citationsperpaper_1": 9.0, "citationsperpaper_2": 12.647, "citationsperpaper_3": 15.833, "citationsperpaper_4": 17.944, "citationsperpaper_5": 19.778, "citationsperyear_0": 17.2, "citationsperyear_1": 24.0, "citationsperyear_2": 30.714, "citationsperyear_3": 35.625, "citationsperyear_4": 35.889, "citationsperyear_5": 35.6, "totalcitations_0": 86.0, "totalcitations_1": 144.0, "totalcitations_2": 215.0, "totalcitations_3": 285.0, "totalcitations_4": 323.0, "totalcitations_5": 356.0, "totalpapers_0": 14.0, "totalpapers_1": 16.0, "totalpapers_2": 17.0, "totalpapers_3": 18.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 103.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 37.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 103.25, "venuehindexmean_1": 123.0, "venuehindexmean_2": 126.5555555556, "venuehindexmean_3": 129.6666666667, "venuehindexmean_4": 132.0, "venuehindexmean_5": 134.4444444444, "totalvenues_0": 8.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 4.1398414826, "pagerank_1": 4.3662239593, "pagerank_2": 4.5199734005, "pagerank_3": 4.6377697371, "pagerank_4": 4.3665242436, "pagerank_5": 4.0945686889}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["ZhenbangChen", "AinaraEgia", "Pier PaoloPandolfi", "GuocanWang", "CaterinaNardella"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 10.8, "hindex_1": 12.0, "hindex_2": 13.2, "hindex_3": 13.6, "hindex_4": 14.6, "hindex_5": 15.2, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 12.5032, "citationsperpaper_1": 15.8834, "citationsperpaper_2": 17.4014, "citationsperpaper_3": 18.7778, "citationsperpaper_4": 20.0944, "citationsperpaper_5": 20.4596, "citationsperyear_0": 62.5624, "citationsperyear_1": 69.4928, "citationsperyear_2": 74.6328, "citationsperyear_3": 79.2516, "citationsperyear_4": 80.4358, "citationsperyear_5": 80.3254, "totalcitations_0": 846.2, "totalcitations_1": 985.2, "totalcitations_2": 1125.8, "totalcitations_3": 1267.2, "totalcitations_4": 1376.4, "totalcitations_5": 1466.6, "totalpapers_0": 42.6, "totalpapers_1": 45.8, "totalpapers_2": 50.4, "totalpapers_3": 54.8, "totalpapers_4": 58.0, "totalpapers_5": 60.6, "authorage_0": 5.8, "authorage_1": 6.8, "authorage_2": 7.8, "authorage_3": 8.8, "authorage_4": 9.8, "authorage_5": 10.8, "recentcoauthors_0": 152.4, "recentcoauthors_1": 107.8, "recentcoauthors_2": 92.4, "recentcoauthors_3": 120.0, "recentcoauthors_4": 96.2, "recentcoauthors_5": 88.2, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.5071717172, "venuehindexmean_1": 126.4592132505, "venuehindexmean_2": 134.8, "venuehindexmean_3": 132.463, "venuehindexmean_4": 130.6556410256, "venuehindexmean_5": 128.1591880342, "totalvenues_0": 9.2, "totalvenues_1": 10.0, "totalvenues_2": 10.6, "totalvenues_3": 11.0, "totalvenues_4": 11.4, "totalvenues_5": 11.6, "pagerank_0": 10.1022173569, "pagerank_1": 10.233693883, "pagerank_2": 11.0899218379, "pagerank_3": 11.6189310253, "pagerank_4": 11.988717269, "pagerank_5": 12.1785342101}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["ZhenbangChen", "Pier PaoloPandolfi", "CaterinaNardella", "AinaraEgia"], "affiliation": "Beth Israel Deaconess Medical Center", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 13.0, "hindex_1": 14.5, "hindex_2": 15.75, "hindex_3": 16.25, "hindex_4": 17.0, "hindex_5": 17.75, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 14.379, "citationsperpaper_1": 17.60425, "citationsperpaper_2": 19.06425, "citationsperpaper_3": 20.8055, "citationsperpaper_4": 22.2965, "citationsperpaper_5": 23.04675, "citationsperyear_0": 76.328, "citationsperyear_1": 84.616, "citationsperyear_2": 90.6035, "citationsperyear_3": 95.8645, "citationsperyear_4": 97.253, "citationsperyear_5": 97.15675, "totalcitations_0": 1054.0, "totalcitations_1": 1224.75, "totalcitations_2": 1396.5, "totalcitations_3": 1568.0, "totalcitations_4": 1700.75, "totalcitations_5": 1810.5, "totalpapers_0": 52.5, "totalpapers_1": 56.5, "totalpapers_2": 62.0, "totalpapers_3": 67.0, "totalpapers_4": 70.75, "totalpapers_5": 73.5, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 181.75, "recentcoauthors_1": 128.75, "recentcoauthors_2": 109.75, "recentcoauthors_3": 134.75, "recentcoauthors_4": 107.5, "recentcoauthors_5": 94.75, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.7589646465, "venuehindexmean_1": 115.0740165631, "venuehindexmean_2": 117.5, "venuehindexmean_3": 119.95375, "venuehindexmean_4": 121.7195512821, "venuehindexmean_5": 124.1156517094, "totalvenues_0": 11.0, "totalvenues_1": 12.0, "totalvenues_2": 12.5, "totalvenues_3": 12.75, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 12.3732880175, "pagerank_1": 12.5528226411, "pagerank_2": 13.5536104277, "pagerank_3": 14.0458175358, "pagerank_4": 14.4906496053, "pagerank_5": 14.5795607451}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Chan HsinChan", "JingWang", "Szu WeiLee", "GuocanWang", "Wei LeiYang", "Hui KuanLin"], "affiliation": "University of Texas MD Anderson Cancer Center", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 3.3333333333, "hindex_1": 4.5, "hindex_2": 5.0, "hindex_3": 5.5, "hindex_4": 6.1666666667, "hindex_5": 6.6666666667, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 7.3396666667, "citationsperpaper_1": 9.8015, "citationsperpaper_2": 11.9138333333, "citationsperpaper_3": 13.8083333333, "citationsperpaper_4": 14.354, "citationsperpaper_5": 15.011, "citationsperyear_0": 12.257, "citationsperyear_1": 15.3696666667, "citationsperyear_2": 17.6368333333, "citationsperyear_3": 20.1773333333, "citationsperyear_4": 19.9625, "citationsperyear_5": 20.3366666667, "totalcitations_0": 90.3333333333, "totalcitations_1": 119.0, "totalcitations_2": 150.6666666667, "totalcitations_3": 190.5, "totalcitations_4": 211.5, "totalcitations_5": 239.3333333333, "totalpapers_0": 7.3333333333, "totalpapers_1": 10.0, "totalpapers_2": 12.8333333333, "totalpapers_3": 15.5, "totalpapers_4": 17.8333333333, "totalpapers_5": 21.1666666667, "authorage_0": 3.5, "authorage_1": 4.5, "authorage_2": 5.5, "authorage_3": 6.5, "authorage_4": 7.5, "authorage_5": 8.5, "recentcoauthors_0": 49.6666666667, "recentcoauthors_1": 71.0, "recentcoauthors_2": 82.0, "recentcoauthors_3": 83.3333333333, "recentcoauthors_4": 164.8333333333, "recentcoauthors_5": 224.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 178.9510582011, "venuehindexmean_1": 168.6564814815, "venuehindexmean_2": 181.265031265, "venuehindexmean_3": 176.3260582011, "venuehindexmean_4": 176.9591269841, "venuehindexmean_5": 175.5523809524, "totalvenues_0": 4.1666666667, "totalvenues_1": 5.1666666667, "totalvenues_2": 6.1666666667, "totalvenues_3": 6.6666666667, "totalvenues_4": 7.0, "totalvenues_5": 7.1666666667, "pagerank_0": 2.0888479658, "pagerank_1": 2.8364294707, "pagerank_2": 3.5526193279, "pagerank_3": 4.1657779419, "pagerank_4": 4.8788683541, "pagerank_5": 5.6340274054}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Hui KuanLin"], "affiliation": "Asia University (Taiwan)", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 8.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.238, "citationsperpaper_1": 19.692, "citationsperpaper_2": 19.4, "citationsperpaper_3": 19.114, "citationsperpaper_4": 18.308, "citationsperpaper_5": 19.05, "citationsperyear_0": 37.167, "citationsperyear_1": 39.385, "citationsperyear_2": 41.571, "citationsperyear_3": 44.6, "citationsperyear_4": 44.625, "citationsperyear_5": 44.824, "totalcitations_0": 446.0, "totalcitations_1": 512.0, "totalcitations_2": 582.0, "totalcitations_3": 669.0, "totalcitations_4": 714.0, "totalcitations_5": 762.0, "totalpapers_0": 21.0, "totalpapers_1": 26.0, "totalpapers_2": 30.0, "totalpapers_3": 35.0, "totalpapers_4": 39.0, "totalpapers_5": 40.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 81.0, "recentcoauthors_1": 102.0, "recentcoauthors_2": 115.0, "recentcoauthors_3": 137.0, "recentcoauthors_4": 136.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.7777777778, "venuehindexmean_1": 136.2222222222, "venuehindexmean_2": 146.2727272727, "venuehindexmean_3": 144.25, "venuehindexmean_4": 146.5833333333, "venuehindexmean_5": 148.6666666667, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 5.118681577, "pagerank_1": 6.2256702428, "pagerank_2": 7.1938572916, "pagerank_3": 8.8370419018, "pagerank_4": 9.5355197278, "pagerank_5": 9.7986594483}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Hui KuanLin"], "affiliation": "Wake Forest University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 8.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.238, "citationsperpaper_1": 19.692, "citationsperpaper_2": 19.4, "citationsperpaper_3": 19.114, "citationsperpaper_4": 18.308, "citationsperpaper_5": 19.05, "citationsperyear_0": 37.167, "citationsperyear_1": 39.385, "citationsperyear_2": 41.571, "citationsperyear_3": 44.6, "citationsperyear_4": 44.625, "citationsperyear_5": 44.824, "totalcitations_0": 446.0, "totalcitations_1": 512.0, "totalcitations_2": 582.0, "totalcitations_3": 669.0, "totalcitations_4": 714.0, "totalcitations_5": 762.0, "totalpapers_0": 21.0, "totalpapers_1": 26.0, "totalpapers_2": 30.0, "totalpapers_3": 35.0, "totalpapers_4": 39.0, "totalpapers_5": 40.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 81.0, "recentcoauthors_1": 102.0, "recentcoauthors_2": 115.0, "recentcoauthors_3": 137.0, "recentcoauthors_4": 136.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.7777777778, "venuehindexmean_1": 136.2222222222, "venuehindexmean_2": 146.2727272727, "venuehindexmean_3": 144.25, "venuehindexmean_4": 146.5833333333, "venuehindexmean_5": 148.6666666667, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 5.118681577, "pagerank_1": 6.2256702428, "pagerank_2": 7.1938572916, "pagerank_3": 8.8370419018, "pagerank_4": 9.5355197278, "pagerank_5": 9.7986594483}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Szu WeiLee", "Wei LeiYang", "Hui KuanLin"], "affiliation": "University of Texas Health Science Center at Houston", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 4.3333333333, "hindex_1": 6.3333333333, "hindex_2": 6.3333333333, "hindex_3": 7.3333333333, "hindex_4": 7.6666666667, "hindex_5": 8.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 9.7126666667, "citationsperpaper_1": 10.707, "citationsperpaper_2": 11.5776666667, "citationsperpaper_3": 13.5193333333, "citationsperpaper_4": 14.1656666667, "citationsperpaper_5": 15.261, "citationsperyear_0": 18.389, "citationsperyear_1": 22.795, "citationsperyear_2": 25.357, "citationsperyear_3": 28.4666666667, "citationsperyear_4": 27.6526666667, "citationsperyear_5": 27.0366666667, "totalcitations_0": 160.6666666667, "totalcitations_1": 199.6666666667, "totalcitations_2": 240.0, "totalcitations_3": 291.0, "totalcitations_4": 314.6666666667, "totalcitations_5": 338.6666666667, "totalpapers_0": 10.0, "totalpapers_1": 13.3333333333, "totalpapers_2": 16.0, "totalpapers_3": 18.0, "totalpapers_4": 19.3333333333, "totalpapers_5": 19.6666666667, "authorage_0": 4.3333333333, "authorage_1": 5.3333333333, "authorage_2": 6.3333333333, "authorage_3": 7.3333333333, "authorage_4": 8.3333333333, "authorage_5": 9.3333333333, "recentcoauthors_0": 61.3333333333, "recentcoauthors_1": 78.6666666667, "recentcoauthors_2": 80.3333333333, "recentcoauthors_3": 70.6666666667, "recentcoauthors_4": 49.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 171.2592592593, "venuehindexmean_1": 147.062962963, "venuehindexmean_2": 163.6782106782, "venuehindexmean_3": 157.8928571429, "venuehindexmean_4": 160.3849206349, "venuehindexmean_5": 162.7936507937, "totalvenues_0": 5.0, "totalvenues_1": 6.6666666667, "totalvenues_2": 8.0, "totalvenues_3": 8.6666666667, "totalvenues_4": 8.6666666667, "totalvenues_5": 8.6666666667, "pagerank_0": 2.7188833041, "pagerank_1": 3.5438685299, "pagerank_2": 4.2813592932, "pagerank_3": 4.8287798386, "pagerank_4": 4.9362510568, "pagerank_5": 4.9492688322}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Hui KuanLin"], "affiliation": "China Medical University (PRC)", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 8.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.238, "citationsperpaper_1": 19.692, "citationsperpaper_2": 19.4, "citationsperpaper_3": 19.114, "citationsperpaper_4": 18.308, "citationsperpaper_5": 19.05, "citationsperyear_0": 37.167, "citationsperyear_1": 39.385, "citationsperyear_2": 41.571, "citationsperyear_3": 44.6, "citationsperyear_4": 44.625, "citationsperyear_5": 44.824, "totalcitations_0": 446.0, "totalcitations_1": 512.0, "totalcitations_2": 582.0, "totalcitations_3": 669.0, "totalcitations_4": 714.0, "totalcitations_5": 762.0, "totalpapers_0": 21.0, "totalpapers_1": 26.0, "totalpapers_2": 30.0, "totalpapers_3": 35.0, "totalpapers_4": 39.0, "totalpapers_5": 40.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 81.0, "recentcoauthors_1": 102.0, "recentcoauthors_2": 115.0, "recentcoauthors_3": 137.0, "recentcoauthors_4": 136.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.7777777778, "venuehindexmean_1": 136.2222222222, "venuehindexmean_2": 146.2727272727, "venuehindexmean_3": 144.25, "venuehindexmean_4": 146.5833333333, "venuehindexmean_5": 148.6666666667, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 5.118681577, "pagerank_1": 6.2256702428, "pagerank_2": 7.1938572916, "pagerank_3": 8.8370419018, "pagerank_4": 9.5355197278, "pagerank_5": 9.7986594483}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Hui KuanLin"], "affiliation": "Wake Forest Baptist Medical Center", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 8.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.238, "citationsperpaper_1": 19.692, "citationsperpaper_2": 19.4, "citationsperpaper_3": 19.114, "citationsperpaper_4": 18.308, "citationsperpaper_5": 19.05, "citationsperyear_0": 37.167, "citationsperyear_1": 39.385, "citationsperyear_2": 41.571, "citationsperyear_3": 44.6, "citationsperyear_4": 44.625, "citationsperyear_5": 44.824, "totalcitations_0": 446.0, "totalcitations_1": 512.0, "totalcitations_2": 582.0, "totalcitations_3": 669.0, "totalcitations_4": 714.0, "totalcitations_5": 762.0, "totalpapers_0": 21.0, "totalpapers_1": 26.0, "totalpapers_2": 30.0, "totalpapers_3": 35.0, "totalpapers_4": 39.0, "totalpapers_5": 40.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 81.0, "recentcoauthors_1": 102.0, "recentcoauthors_2": 115.0, "recentcoauthors_3": 137.0, "recentcoauthors_4": 136.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.7777777778, "venuehindexmean_1": 136.2222222222, "venuehindexmean_2": 146.2727272727, "venuehindexmean_3": 144.25, "venuehindexmean_4": 146.5833333333, "venuehindexmean_5": 148.6666666667, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 5.118681577, "pagerank_1": 6.2256702428, "pagerank_2": 7.1938572916, "pagerank_3": 8.8370419018, "pagerank_4": 9.5355197278, "pagerank_5": 9.7986594483}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Pier PaoloPandolfi", "Hui KuanLin"], "affiliation": "Kettering University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 21.5, "hindex_1": 24.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 27.5, "hindex_5": 28.5, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.4755, "citationsperpaper_1": 21.3185, "citationsperpaper_2": 21.509, "citationsperpaper_3": 21.6925, "citationsperpaper_4": 21.452, "citationsperpaper_5": 22.0885, "citationsperyear_0": 121.7225, "citationsperyear_1": 130.1925, "citationsperyear_2": 138.2855, "citationsperyear_3": 145.9665, "citationsperyear_4": 149.767, "citationsperyear_5": 151.8685, "totalcitations_0": 2079.5, "totalcitations_1": 2355.5, "totalcitations_2": 2641.0, "totalcitations_3": 2931.5, "totalcitations_4": 3161.0, "totalcitations_5": 3358.5, "totalpapers_0": 96.0, "totalpapers_1": 104.5, "totalpapers_2": 114.5, "totalpapers_3": 124.5, "totalpapers_4": 133.5, "totalpapers_5": 138.5, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 254.5, "recentcoauthors_1": 220.0, "recentcoauthors_2": 215.0, "recentcoauthors_3": 244.5, "recentcoauthors_4": 227.5, "recentcoauthors_5": 205.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 124.0707070707, "venuehindexmean_1": 124.306763285, "venuehindexmean_2": 129.4488636364, "venuehindexmean_3": 128.845, "venuehindexmean_4": 130.0224358974, "venuehindexmean_5": 132.391025641, "totalvenues_0": 15.5, "totalvenues_1": 16.0, "totalvenues_2": 17.5, "totalvenues_3": 18.5, "totalvenues_4": 19.0, "totalvenues_5": 19.0, "pagerank_0": 21.5880752336, "pagerank_1": 22.4303252581, "pagerank_2": 24.1912159489, "pagerank_3": 25.4880531398, "pagerank_4": 26.9893128478, "pagerank_5": 27.449687774}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Hui KuanLin"], "affiliation": "University of Rochester", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 8.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.238, "citationsperpaper_1": 19.692, "citationsperpaper_2": 19.4, "citationsperpaper_3": 19.114, "citationsperpaper_4": 18.308, "citationsperpaper_5": 19.05, "citationsperyear_0": 37.167, "citationsperyear_1": 39.385, "citationsperyear_2": 41.571, "citationsperyear_3": 44.6, "citationsperyear_4": 44.625, "citationsperyear_5": 44.824, "totalcitations_0": 446.0, "totalcitations_1": 512.0, "totalcitations_2": 582.0, "totalcitations_3": 669.0, "totalcitations_4": 714.0, "totalcitations_5": 762.0, "totalpapers_0": 21.0, "totalpapers_1": 26.0, "totalpapers_2": 30.0, "totalpapers_3": 35.0, "totalpapers_4": 39.0, "totalpapers_5": 40.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 81.0, "recentcoauthors_1": 102.0, "recentcoauthors_2": 115.0, "recentcoauthors_3": 137.0, "recentcoauthors_4": 136.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.7777777778, "venuehindexmean_1": 136.2222222222, "venuehindexmean_2": 146.2727272727, "venuehindexmean_3": 144.25, "venuehindexmean_4": 146.5833333333, "venuehindexmean_5": 148.6666666667, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 5.118681577, "pagerank_1": 6.2256702428, "pagerank_2": 7.1938572916, "pagerank_3": 8.8370419018, "pagerank_4": 9.5355197278, "pagerank_5": 9.7986594483}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Szu WeiLee", "Wei LeiYang", "Hui KuanLin"], "affiliation": "University of Texas at Austin", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 4.3333333333, "hindex_1": 6.3333333333, "hindex_2": 6.3333333333, "hindex_3": 7.3333333333, "hindex_4": 7.6666666667, "hindex_5": 8.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 9.7126666667, "citationsperpaper_1": 10.707, "citationsperpaper_2": 11.5776666667, "citationsperpaper_3": 13.5193333333, "citationsperpaper_4": 14.1656666667, "citationsperpaper_5": 15.261, "citationsperyear_0": 18.389, "citationsperyear_1": 22.795, "citationsperyear_2": 25.357, "citationsperyear_3": 28.4666666667, "citationsperyear_4": 27.6526666667, "citationsperyear_5": 27.0366666667, "totalcitations_0": 160.6666666667, "totalcitations_1": 199.6666666667, "totalcitations_2": 240.0, "totalcitations_3": 291.0, "totalcitations_4": 314.6666666667, "totalcitations_5": 338.6666666667, "totalpapers_0": 10.0, "totalpapers_1": 13.3333333333, "totalpapers_2": 16.0, "totalpapers_3": 18.0, "totalpapers_4": 19.3333333333, "totalpapers_5": 19.6666666667, "authorage_0": 4.3333333333, "authorage_1": 5.3333333333, "authorage_2": 6.3333333333, "authorage_3": 7.3333333333, "authorage_4": 8.3333333333, "authorage_5": 9.3333333333, "recentcoauthors_0": 61.3333333333, "recentcoauthors_1": 78.6666666667, "recentcoauthors_2": 80.3333333333, "recentcoauthors_3": 70.6666666667, "recentcoauthors_4": 49.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 171.2592592593, "venuehindexmean_1": 147.062962963, "venuehindexmean_2": 163.6782106782, "venuehindexmean_3": 157.8928571429, "venuehindexmean_4": 160.3849206349, "venuehindexmean_5": 162.7936507937, "totalvenues_0": 5.0, "totalvenues_1": 6.6666666667, "totalvenues_2": 8.0, "totalvenues_3": 8.6666666667, "totalvenues_4": 8.6666666667, "totalvenues_5": 8.6666666667, "pagerank_0": 2.7188833041, "pagerank_1": 3.5438685299, "pagerank_2": 4.2813592932, "pagerank_3": 4.8287798386, "pagerank_4": 4.9362510568, "pagerank_5": 4.9492688322}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["CarlosCordon-Cardo"], "affiliation": "University of California, Los Angeles", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 37.0, "hindex_1": 40.0, "hindex_2": 41.0, "hindex_3": 41.0, "hindex_4": 41.0, "hindex_5": 42.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 28.164, "citationsperpaper_1": 29.591, "citationsperpaper_2": 30.757, "citationsperpaper_3": 31.491, "citationsperpaper_4": 31.907, "citationsperpaper_5": 31.716, "citationsperyear_0": 149.267, "citationsperyear_1": 156.548, "citationsperyear_2": 162.438, "citationsperyear_3": 167.0, "citationsperyear_4": 170.794, "citationsperyear_5": 172.171, "totalcitations_0": 4478.0, "totalcitations_1": 4853.0, "totalcitations_2": 5198.0, "totalcitations_3": 5511.0, "totalcitations_4": 5807.0, "totalcitations_5": 6026.0, "totalpapers_0": 159.0, "totalpapers_1": 164.0, "totalpapers_2": 169.0, "totalpapers_3": 175.0, "totalpapers_4": 182.0, "totalpapers_5": 190.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 241.0, "recentcoauthors_1": 214.0, "recentcoauthors_2": 129.0, "recentcoauthors_3": 128.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.2631578947, "venuehindexmean_1": 116.4736842105, "venuehindexmean_2": 119.8421052632, "venuehindexmean_3": 123.0526315789, "venuehindexmean_4": 118.6666666667, "venuehindexmean_5": 121.3333333333, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 21.0, "pagerank_0": 41.6921941418, "pagerank_1": 41.8356737726, "pagerank_2": 41.1033771267, "pagerank_3": 40.8212560881, "pagerank_4": 40.6534804613, "pagerank_5": 40.9638000924}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["CarlosCordon-Cardo"], "affiliation": "University of Southern California", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 37.0, "hindex_1": 40.0, "hindex_2": 41.0, "hindex_3": 41.0, "hindex_4": 41.0, "hindex_5": 42.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 28.164, "citationsperpaper_1": 29.591, "citationsperpaper_2": 30.757, "citationsperpaper_3": 31.491, "citationsperpaper_4": 31.907, "citationsperpaper_5": 31.716, "citationsperyear_0": 149.267, "citationsperyear_1": 156.548, "citationsperyear_2": 162.438, "citationsperyear_3": 167.0, "citationsperyear_4": 170.794, "citationsperyear_5": 172.171, "totalcitations_0": 4478.0, "totalcitations_1": 4853.0, "totalcitations_2": 5198.0, "totalcitations_3": 5511.0, "totalcitations_4": 5807.0, "totalcitations_5": 6026.0, "totalpapers_0": 159.0, "totalpapers_1": 164.0, "totalpapers_2": 169.0, "totalpapers_3": 175.0, "totalpapers_4": 182.0, "totalpapers_5": 190.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 241.0, "recentcoauthors_1": 214.0, "recentcoauthors_2": 129.0, "recentcoauthors_3": 128.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.2631578947, "venuehindexmean_1": 116.4736842105, "venuehindexmean_2": 119.8421052632, "venuehindexmean_3": 123.0526315789, "venuehindexmean_4": 118.6666666667, "venuehindexmean_5": 121.3333333333, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 21.0, "pagerank_0": 41.6921941418, "pagerank_1": 41.8356737726, "pagerank_2": 41.1033771267, "pagerank_3": 40.8212560881, "pagerank_4": 40.6534804613, "pagerank_5": 40.9638000924}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["CarlosCordon-Cardo"], "affiliation": "Columbia University Medical Center", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 37.0, "hindex_1": 40.0, "hindex_2": 41.0, "hindex_3": 41.0, "hindex_4": 41.0, "hindex_5": 42.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 28.164, "citationsperpaper_1": 29.591, "citationsperpaper_2": 30.757, "citationsperpaper_3": 31.491, "citationsperpaper_4": 31.907, "citationsperpaper_5": 31.716, "citationsperyear_0": 149.267, "citationsperyear_1": 156.548, "citationsperyear_2": 162.438, "citationsperyear_3": 167.0, "citationsperyear_4": 170.794, "citationsperyear_5": 172.171, "totalcitations_0": 4478.0, "totalcitations_1": 4853.0, "totalcitations_2": 5198.0, "totalcitations_3": 5511.0, "totalcitations_4": 5807.0, "totalcitations_5": 6026.0, "totalpapers_0": 159.0, "totalpapers_1": 164.0, "totalpapers_2": 169.0, "totalpapers_3": 175.0, "totalpapers_4": 182.0, "totalpapers_5": 190.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 241.0, "recentcoauthors_1": 214.0, "recentcoauthors_2": 129.0, "recentcoauthors_3": 128.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.2631578947, "venuehindexmean_1": 116.4736842105, "venuehindexmean_2": 119.8421052632, "venuehindexmean_3": 123.0526315789, "venuehindexmean_4": 118.6666666667, "venuehindexmean_5": 121.3333333333, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 21.0, "pagerank_0": 41.6921941418, "pagerank_1": 41.8356737726, "pagerank_2": 41.1033771267, "pagerank_3": 40.8212560881, "pagerank_4": 40.6534804613, "pagerank_5": 40.9638000924}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Pier PaoloPandolfi", "CarlosCordon-Cardo"], "affiliation": "Yeshiva University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 36.0, "hindex_1": 38.0, "hindex_2": 39.5, "hindex_3": 40.5, "hindex_4": 41.5, "hindex_5": 42.5, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 24.9385, "citationsperpaper_1": 26.268, "citationsperpaper_2": 27.1875, "citationsperpaper_3": 27.881, "citationsperpaper_4": 28.2515, "citationsperpaper_5": 28.4215, "citationsperyear_0": 177.7725, "citationsperyear_1": 188.774, "citationsperyear_2": 198.719, "citationsperyear_3": 207.1665, "citationsperyear_4": 212.8515, "citationsperyear_5": 215.542, "totalcitations_0": 4095.5, "totalcitations_1": 4526.0, "totalcitations_2": 4949.0, "totalcitations_3": 5352.5, "totalcitations_4": 5707.5, "totalcitations_5": 5990.5, "totalpapers_0": 165.0, "totalpapers_1": 173.5, "totalpapers_2": 184.0, "totalpapers_3": 194.5, "totalpapers_4": 205.0, "totalpapers_5": 213.5, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 334.5, "recentcoauthors_1": 276.0, "recentcoauthors_2": 222.0, "recentcoauthors_3": 240.0, "recentcoauthors_4": 237.5, "recentcoauthors_5": 268.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.8133971292, "venuehindexmean_1": 114.4324942792, "venuehindexmean_2": 116.2335526316, "venuehindexmean_3": 118.2463157895, "venuehindexmean_4": 116.0641025641, "venuehindexmean_5": 118.7243589744, "totalvenues_0": 20.5, "totalvenues_1": 21.0, "totalvenues_2": 21.5, "totalvenues_3": 22.0, "totalvenues_4": 23.5, "totalvenues_5": 23.5, "pagerank_0": 39.874831516, "pagerank_1": 40.235327023, "pagerank_2": 41.1459758665, "pagerank_3": 41.4801602329, "pagerank_4": 42.5482932145, "pagerank_5": 43.032258096}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["JulieTeruya-Feldstein", "CarlosCordon-Cardo"], "affiliation": "Icahn School of Medicine at Mount Sinai", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 29.0, "hindex_2": 31.0, "hindex_3": 31.5, "hindex_4": 31.5, "hindex_5": 32.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 19.0345, "citationsperpaper_1": 20.314, "citationsperpaper_2": 21.3005, "citationsperpaper_3": 22.0465, "citationsperpaper_4": 22.4215, "citationsperpaper_5": 22.6255, "citationsperyear_0": 99.067, "citationsperyear_1": 106.2115, "citationsperyear_2": 112.572, "citationsperyear_3": 117.8055, "citationsperyear_4": 122.5025, "citationsperyear_5": 124.6605, "totalcitations_0": 2605.5, "totalcitations_1": 2873.5, "totalcitations_2": 3132.0, "totalcitations_3": 3373.0, "totalcitations_4": 3608.5, "totalcitations_5": 3784.5, "totalpapers_0": 116.5, "totalpapers_1": 122.5, "totalpapers_2": 129.5, "totalpapers_3": 136.5, "totalpapers_4": 145.5, "totalpapers_5": 152.0, "authorage_0": 21.5, "authorage_1": 22.5, "authorage_2": 23.5, "authorage_3": 24.5, "authorage_4": 25.5, "authorage_5": 26.5, "recentcoauthors_0": 176.0, "recentcoauthors_1": 186.0, "recentcoauthors_2": 168.0, "recentcoauthors_3": 179.0, "recentcoauthors_4": 246.0, "recentcoauthors_5": 244.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.5244360902, "venuehindexmean_1": 121.772556391, "venuehindexmean_2": 123.9877192982, "venuehindexmean_3": 121.173374613, "venuehindexmean_4": 115.6228070175, "venuehindexmean_5": 118.4561403509, "totalvenues_0": 16.5, "totalvenues_1": 16.5, "totalvenues_2": 17.0, "totalvenues_3": 18.0, "totalvenues_4": 20.0, "totalvenues_5": 20.0, "pagerank_0": 28.865422066, "pagerank_1": 29.4944554439, "pagerank_2": 29.862817995, "pagerank_3": 30.1165819331, "pagerank_4": 31.3495040432, "pagerank_5": 31.4448424362}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["CarlosCordon-Cardo"], "affiliation": "Bristol-Myers Squibb", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 37.0, "hindex_1": 40.0, "hindex_2": 41.0, "hindex_3": 41.0, "hindex_4": 41.0, "hindex_5": 42.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 28.164, "citationsperpaper_1": 29.591, "citationsperpaper_2": 30.757, "citationsperpaper_3": 31.491, "citationsperpaper_4": 31.907, "citationsperpaper_5": 31.716, "citationsperyear_0": 149.267, "citationsperyear_1": 156.548, "citationsperyear_2": 162.438, "citationsperyear_3": 167.0, "citationsperyear_4": 170.794, "citationsperyear_5": 172.171, "totalcitations_0": 4478.0, "totalcitations_1": 4853.0, "totalcitations_2": 5198.0, "totalcitations_3": 5511.0, "totalcitations_4": 5807.0, "totalcitations_5": 6026.0, "totalpapers_0": 159.0, "totalpapers_1": 164.0, "totalpapers_2": 169.0, "totalpapers_3": 175.0, "totalpapers_4": 182.0, "totalpapers_5": 190.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 241.0, "recentcoauthors_1": 214.0, "recentcoauthors_2": 129.0, "recentcoauthors_3": 128.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.2631578947, "venuehindexmean_1": 116.4736842105, "venuehindexmean_2": 119.8421052632, "venuehindexmean_3": 123.0526315789, "venuehindexmean_4": 118.6666666667, "venuehindexmean_5": 121.3333333333, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 21.0, "pagerank_0": 41.6921941418, "pagerank_1": 41.8356737726, "pagerank_2": 41.1033771267, "pagerank_3": 40.8212560881, "pagerank_4": 40.6534804613, "pagerank_5": 40.9638000924}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["CarlosCordon-Cardo"], "affiliation": "Columbia University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 37.0, "hindex_1": 40.0, "hindex_2": 41.0, "hindex_3": 41.0, "hindex_4": 41.0, "hindex_5": 42.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 28.164, "citationsperpaper_1": 29.591, "citationsperpaper_2": 30.757, "citationsperpaper_3": 31.491, "citationsperpaper_4": 31.907, "citationsperpaper_5": 31.716, "citationsperyear_0": 149.267, "citationsperyear_1": 156.548, "citationsperyear_2": 162.438, "citationsperyear_3": 167.0, "citationsperyear_4": 170.794, "citationsperyear_5": 172.171, "totalcitations_0": 4478.0, "totalcitations_1": 4853.0, "totalcitations_2": 5198.0, "totalcitations_3": 5511.0, "totalcitations_4": 5807.0, "totalcitations_5": 6026.0, "totalpapers_0": 159.0, "totalpapers_1": 164.0, "totalpapers_2": 169.0, "totalpapers_3": 175.0, "totalpapers_4": 182.0, "totalpapers_5": 190.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 241.0, "recentcoauthors_1": 214.0, "recentcoauthors_2": 129.0, "recentcoauthors_3": 128.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.2631578947, "venuehindexmean_1": 116.4736842105, "venuehindexmean_2": 119.8421052632, "venuehindexmean_3": 123.0526315789, "venuehindexmean_4": 118.6666666667, "venuehindexmean_5": 121.3333333333, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 21.0, "pagerank_0": 41.6921941418, "pagerank_1": 41.8356737726, "pagerank_2": 41.1033771267, "pagerank_3": 40.8212560881, "pagerank_4": 40.6534804613, "pagerank_5": 40.9638000924}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["JulieTeruya-Feldstein", "Pier PaoloPandolfi", "CarlosCordon-Cardo"], "affiliation": "Cornell University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 29.6666666667, "hindex_1": 31.3333333333, "hindex_2": 33.3333333333, "hindex_3": 34.3333333333, "hindex_4": 35.0, "hindex_5": 35.6666666667, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 19.9273333333, "citationsperpaper_1": 21.191, "citationsperpaper_2": 22.073, "citationsperpaper_3": 22.788, "citationsperpaper_4": 23.1463333333, "citationsperpaper_5": 23.4593333333, "citationsperyear_0": 134.804, "citationsperyear_1": 144.4743333333, "citationsperyear_2": 153.3813333333, "citationsperyear_3": 160.9813333333, "citationsperyear_4": 166.638, "citationsperyear_5": 169.4113333333, "totalcitations_0": 2974.6666666667, "totalcitations_1": 3315.3333333333, "totalcitations_2": 3654.6666666667, "totalcitations_3": 3980.0, "totalcitations_4": 4275.0, "totalcitations_5": 4508.0, "totalpapers_0": 134.6666666667, "totalpapers_1": 142.6666666667, "totalpapers_2": 152.6666666667, "totalpapers_3": 162.3333333333, "totalpapers_4": 173.0, "totalpapers_5": 180.3333333333, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 260.0, "recentcoauthors_1": 236.6666666667, "recentcoauthors_2": 217.0, "recentcoauthors_3": 236.6666666667, "recentcoauthors_4": 270.3333333333, "recentcoauthors_5": 273.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.137502848, "venuehindexmean_1": 118.6454723766, "venuehindexmean_2": 120.2001461988, "venuehindexmean_3": 118.5955830753, "venuehindexmean_4": 114.9023841655, "venuehindexmean_5": 117.675888439, "totalvenues_0": 18.3333333333, "totalvenues_1": 18.6666666667, "totalvenues_2": 19.3333333333, "totalvenues_3": 20.3333333333, "totalvenues_4": 22.0, "totalvenues_5": 22.0, "pagerank_0": 31.9294376741, "pagerank_1": 32.5412970537, "pagerank_2": 33.6380701987, "pagerank_3": 34.1240760813, "pagerank_4": 35.714038018, "pagerank_5": 35.996800324}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["CarlosCordon-Cardo"], "affiliation": "New York University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 37.0, "hindex_1": 40.0, "hindex_2": 41.0, "hindex_3": 41.0, "hindex_4": 41.0, "hindex_5": 42.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 28.164, "citationsperpaper_1": 29.591, "citationsperpaper_2": 30.757, "citationsperpaper_3": 31.491, "citationsperpaper_4": 31.907, "citationsperpaper_5": 31.716, "citationsperyear_0": 149.267, "citationsperyear_1": 156.548, "citationsperyear_2": 162.438, "citationsperyear_3": 167.0, "citationsperyear_4": 170.794, "citationsperyear_5": 172.171, "totalcitations_0": 4478.0, "totalcitations_1": 4853.0, "totalcitations_2": 5198.0, "totalcitations_3": 5511.0, "totalcitations_4": 5807.0, "totalcitations_5": 6026.0, "totalpapers_0": 159.0, "totalpapers_1": 164.0, "totalpapers_2": 169.0, "totalpapers_3": 175.0, "totalpapers_4": 182.0, "totalpapers_5": 190.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 241.0, "recentcoauthors_1": 214.0, "recentcoauthors_2": 129.0, "recentcoauthors_3": 128.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 113.2631578947, "venuehindexmean_1": 116.4736842105, "venuehindexmean_2": 119.8421052632, "venuehindexmean_3": 123.0526315789, "venuehindexmean_4": 118.6666666667, "venuehindexmean_5": 121.3333333333, "totalvenues_0": 19.0, "totalvenues_1": 19.0, "totalvenues_2": 19.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 21.0, "pagerank_0": 41.6921941418, "pagerank_1": 41.8356737726, "pagerank_2": 41.1033771267, "pagerank_3": 40.8212560881, "pagerank_4": 40.6534804613, "pagerank_5": 40.9638000924}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["JulieTeruya-Feldstein"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 21.0, "hindex_3": 22.0, "hindex_4": 22.0, "hindex_5": 22.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 9.905, "citationsperpaper_1": 11.037, "citationsperpaper_2": 11.844, "citationsperpaper_3": 12.602, "citationsperpaper_4": 12.936, "citationsperpaper_5": 13.535, "citationsperyear_0": 48.867, "citationsperyear_1": 55.875, "citationsperyear_2": 62.706, "citationsperyear_3": 68.611, "citationsperyear_4": 74.211, "citationsperyear_5": 77.15, "totalcitations_0": 733.0, "totalcitations_1": 894.0, "totalcitations_2": 1066.0, "totalcitations_3": 1235.0, "totalcitations_4": 1410.0, "totalcitations_5": 1543.0, "totalpapers_0": 74.0, "totalpapers_1": 81.0, "totalpapers_2": 90.0, "totalpapers_3": 98.0, "totalpapers_4": 109.0, "totalpapers_5": 114.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 111.0, "recentcoauthors_1": 158.0, "recentcoauthors_2": 207.0, "recentcoauthors_3": 230.0, "recentcoauthors_4": 336.0, "recentcoauthors_5": 284.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 123.7857142857, "venuehindexmean_1": 127.0714285714, "venuehindexmean_2": 128.1333333333, "venuehindexmean_3": 119.2941176471, "venuehindexmean_4": 112.5789473684, "venuehindexmean_5": 115.5789473684, "totalvenues_0": 14.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 17.0, "totalvenues_4": 19.0, "totalvenues_5": 19.0, "pagerank_0": 16.0386499902, "pagerank_1": 17.1532371152, "pagerank_2": 18.6222588632, "pagerank_3": 19.4119077781, "pagerank_4": 22.045527625, "pagerank_5": 21.92588478}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["JulieTeruya-Feldstein"], "affiliation": "University of Barcelona", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 21.0, "hindex_3": 22.0, "hindex_4": 22.0, "hindex_5": 22.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 9.905, "citationsperpaper_1": 11.037, "citationsperpaper_2": 11.844, "citationsperpaper_3": 12.602, "citationsperpaper_4": 12.936, "citationsperpaper_5": 13.535, "citationsperyear_0": 48.867, "citationsperyear_1": 55.875, "citationsperyear_2": 62.706, "citationsperyear_3": 68.611, "citationsperyear_4": 74.211, "citationsperyear_5": 77.15, "totalcitations_0": 733.0, "totalcitations_1": 894.0, "totalcitations_2": 1066.0, "totalcitations_3": 1235.0, "totalcitations_4": 1410.0, "totalcitations_5": 1543.0, "totalpapers_0": 74.0, "totalpapers_1": 81.0, "totalpapers_2": 90.0, "totalpapers_3": 98.0, "totalpapers_4": 109.0, "totalpapers_5": 114.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 111.0, "recentcoauthors_1": 158.0, "recentcoauthors_2": 207.0, "recentcoauthors_3": 230.0, "recentcoauthors_4": 336.0, "recentcoauthors_5": 284.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 123.7857142857, "venuehindexmean_1": 127.0714285714, "venuehindexmean_2": 128.1333333333, "venuehindexmean_3": 119.2941176471, "venuehindexmean_4": 112.5789473684, "venuehindexmean_5": 115.5789473684, "totalvenues_0": 14.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 17.0, "totalvenues_4": 19.0, "totalvenues_5": 19.0, "pagerank_0": 16.0386499902, "pagerank_1": 17.1532371152, "pagerank_2": 18.6222588632, "pagerank_3": 19.4119077781, "pagerank_4": 22.045527625, "pagerank_5": 21.92588478}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["JulieTeruya-Feldstein"], "affiliation": "Mount Sinai Health System", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 17.0, "hindex_1": 18.0, "hindex_2": 21.0, "hindex_3": 22.0, "hindex_4": 22.0, "hindex_5": 22.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 9.905, "citationsperpaper_1": 11.037, "citationsperpaper_2": 11.844, "citationsperpaper_3": 12.602, "citationsperpaper_4": 12.936, "citationsperpaper_5": 13.535, "citationsperyear_0": 48.867, "citationsperyear_1": 55.875, "citationsperyear_2": 62.706, "citationsperyear_3": 68.611, "citationsperyear_4": 74.211, "citationsperyear_5": 77.15, "totalcitations_0": 733.0, "totalcitations_1": 894.0, "totalcitations_2": 1066.0, "totalcitations_3": 1235.0, "totalcitations_4": 1410.0, "totalcitations_5": 1543.0, "totalpapers_0": 74.0, "totalpapers_1": 81.0, "totalpapers_2": 90.0, "totalpapers_3": 98.0, "totalpapers_4": 109.0, "totalpapers_5": 114.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 111.0, "recentcoauthors_1": 158.0, "recentcoauthors_2": 207.0, "recentcoauthors_3": 230.0, "recentcoauthors_4": 336.0, "recentcoauthors_5": 284.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 123.7857142857, "venuehindexmean_1": 127.0714285714, "venuehindexmean_2": 128.1333333333, "venuehindexmean_3": 119.2941176471, "venuehindexmean_4": 112.5789473684, "venuehindexmean_5": 115.5789473684, "totalvenues_0": 14.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 17.0, "totalvenues_4": 19.0, "totalvenues_5": 19.0, "pagerank_0": 16.0386499902, "pagerank_1": 17.1532371152, "pagerank_2": 18.6222588632, "pagerank_3": 19.4119077781, "pagerank_4": 22.045527625, "pagerank_5": 21.92588478}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["JingWang"], "affiliation": "Sun Yat-sen University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 8.0, "hindex_5": 10.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.9, "citationsperpaper_1": 4.688, "citationsperpaper_2": 5.0, "citationsperpaper_3": 5.625, "citationsperpaper_4": 5.341, "citationsperpaper_5": 5.172, "citationsperyear_0": 4.875, "citationsperyear_1": 8.333, "citationsperyear_2": 12.0, "citationsperyear_3": 16.364, "citationsperyear_4": 18.25, "citationsperyear_5": 23.077, "totalcitations_0": 39.0, "totalcitations_1": 75.0, "totalcitations_2": 120.0, "totalcitations_3": 180.0, "totalcitations_4": 219.0, "totalcitations_5": 300.0, "totalpapers_0": 10.0, "totalpapers_1": 16.0, "totalpapers_2": 24.0, "totalpapers_3": 32.0, "totalpapers_4": 41.0, "totalpapers_5": 58.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 67.0, "recentcoauthors_1": 154.0, "recentcoauthors_2": 228.0, "recentcoauthors_3": 227.0, "recentcoauthors_4": 791.0, "recentcoauthors_5": 1204.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.4285714286, "venuehindexmean_1": 134.75, "venuehindexmean_2": 123.5555555556, "venuehindexmean_3": 126.7777777778, "venuehindexmean_4": 134.2, "venuehindexmean_5": 136.6, "totalvenues_0": 7.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 2.9187362044, "pagerank_1": 5.0098917968, "pagerank_2": 6.8397967845, "pagerank_3": 8.214742064, "pagerank_4": 12.1213303559, "pagerank_5": 16.0310639952}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["ZhenbangChen"], "affiliation": "Meharry Medical College", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 7.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 21.438, "citationsperpaper_1": 26.563, "citationsperpaper_2": 27.778, "citationsperpaper_3": 30.0, "citationsperpaper_4": 32.368, "citationsperpaper_5": 32.65, "citationsperyear_0": 57.167, "citationsperyear_1": 60.714, "citationsperyear_2": 62.5, "citationsperyear_3": 63.333, "citationsperyear_4": 61.5, "citationsperyear_5": 59.364, "totalcitations_0": 343.0, "totalcitations_1": 425.0, "totalcitations_2": 500.0, "totalcitations_3": 570.0, "totalcitations_4": 615.0, "totalcitations_5": 653.0, "totalpapers_0": 16.0, "totalpapers_1": 16.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 19.0, "totalpapers_5": 20.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 111.0, "recentcoauthors_1": 38.0, "recentcoauthors_2": 32.0, "recentcoauthors_3": 50.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 9.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 122.2222222222, "venuehindexmean_1": 125.3333333333, "venuehindexmean_2": 128.4444444444, "venuehindexmean_3": 131.3333333333, "venuehindexmean_4": 133.6666666667, "venuehindexmean_5": 135.7777777778, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 4.487901288, "pagerank_1": 4.2310609553, "pagerank_2": 4.7911763285, "pagerank_3": 4.9128616257, "pagerank_4": 4.5961776718, "pagerank_5": 4.6232680558}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Yamagata University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Albert Einstein College of Medicine", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Japanese Foundation for Cancer Research", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Tohoku University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Tokyo Medical and Dental University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Chiba University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Hoffmann-La Roche", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Washington University in St. Louis", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1004270, "fields": {"authors": ["Keiichi I.Nakayama"], "affiliation": "Kyushu University", "venue": "Nature", "doi": "10.1038/nature08815", "abstract": "Cellular senescence has been recently shown to have an important role in opposing tumour initiation and promotion. Senescence induced by oncogenes or by loss of tumour suppressor genes is thought to critically depend on induction of the p19Arf\u2013p53 pathway. The Skp2 E3-ubiquitin ligase can act as a proto-oncogene and its aberrant overexpression is frequently observed in human cancers. Here we show that although Skp2 inactivation on its own does not induce cellular senescence, aberrant proto-oncogenic signals as well as inactivation of tumour suppressor genes do trigger a potent, tumour-suppressive senescence response in mice and cells devoid of Skp2. Notably, Skp2 inactivation and oncogenic-stress-driven senescence neither elicit activation of the p19Arf\u2013p53 pathway nor DNA damage, but instead depend on Atf4, p27 and p21. We further demonstrate that genetic Skp2 inactivation evokes cellular senescence even in oncogenic conditions in which the p19Arf\u2013p53 response is impaired, whereas a Skp2\u2013SCF complex inhibitor can trigger cellular senescence in p53/Pten-deficient cells and tumour regression in preclinical studies. Our findings therefore provide proof-of-principle evidence that pharmacological inhibition of Skp2 may represent a general approach for cancer prevention and therapy. Recent studies suggest that cellular senescence \u2014 an irreversible form of cell-cycle arrest \u2014 can halt tumour growth in vitro. Hui-Kuan Lin et al. now identify a previously unknown pathway that drives senescence without the involvement of most of the known mediators of senescence. Instead, it signals via the transcription factor Atf6, and the cyclin-dependent kinase inhibitors p27 and p21. The pathway is uncovered by inactivation of the proto-oncogene Skp2, but only in the context of oncogenic signalling. Targeting the Skp2 complex pharmacologically restricts tumorigenesis by inducing cellular senescence, suggesting that such drugs may be effective in cancer prevention and therapy. Cellular senescence \u2014 an irreversible cell-cycle arrest \u2014 has been implicated in suppressing tumour formation or growth. A new cellular signalling pathway that drives senescence has now been identified. This pathway does not involve most known mediators of senescence, and instead signals via the proteins Atf4, p27 and p21. Inactivating the proto-oncogene Skp2 in the context of oncogenic signalling can induce senescence through this new pathway, indicating that drugs that target Skp2 might be useful in cancer treatment.", "year": 2010, "title": "Skp2 targeting suppresses tumorigenesis by Arf-p53 -independent cellular senescence", "keywords": ["Cell signaling", "Signal transduction", "Cell biology", "ATF4", "Tumor suppressor gene", "Biology", "Senescence", "Carcinogenesis", "Cell aging", "Transcription factor"], "citations_0": 6.0, "citations_1": 7.0, "citations_2": 8.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 3.492875192, "timescaledpagerank_1": 3.4487891018, "timescaledpagerank_2": 3.0787456019, "timescaledpagerank_3": 2.7320664196, "timescaledpagerank_4": 2.2073536664, "timescaledpagerank_5": 1.9462944285, "hindex_0": 27.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 30.0, "hindex_4": 30.0, "hindex_5": 31.0, "adopters_0": 22.0, "adopters_1": 55.0, "adopters_2": 119.0, "adopters_3": 57.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 20.928, "citationsperpaper_1": 21.008, "citationsperpaper_2": 21.488, "citationsperpaper_3": 21.659, "citationsperpaper_4": 21.949, "citationsperpaper_5": 22.141, "citationsperyear_0": 110.619, "citationsperyear_1": 114.591, "citationsperyear_2": 116.783, "citationsperyear_3": 119.125, "citationsperyear_4": 120.28, "citationsperyear_5": 120.923, "totalcitations_0": 2323.0, "totalcitations_1": 2521.0, "totalcitations_2": 2686.0, "totalcitations_3": 2859.0, "totalcitations_4": 3007.0, "totalcitations_5": 3144.0, "totalpapers_0": 111.0, "totalpapers_1": 120.0, "totalpapers_2": 125.0, "totalpapers_3": 132.0, "totalpapers_4": 137.0, "totalpapers_5": 142.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 133.0, "recentcoauthors_1": 144.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 96.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 68.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.6666666667, "venuehindexmean_1": 128.25, "venuehindexmean_2": 131.625, "venuehindexmean_3": 124.5, "venuehindexmean_4": 127.0, "venuehindexmean_5": 125.9473684211, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 29.0096667215, "pagerank_1": 30.5711122536, "pagerank_2": 30.9430911402, "pagerank_3": 31.1635307805, "pagerank_4": 30.754731821, "pagerank_5": 31.2890087002}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["RossMcLure", "JamesDunlop"], "affiliation": "University of Edinburgh", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.5, "hindex_3": 2.5, "hindex_4": 2.5, "hindex_5": 3.0, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.1665, "citationsperpaper_1": 3.25, "citationsperpaper_2": 4.818, "citationsperpaper_3": 6.0415, "citationsperpaper_4": 6.0415, "citationsperpaper_5": 6.1665, "citationsperyear_0": 1.1, "citationsperyear_1": 1.423, "citationsperyear_2": 1.7405, "citationsperyear_3": 1.875, "citationsperyear_4": 1.645, "citationsperyear_5": 1.533, "totalcitations_0": 15.5, "totalcitations_1": 19.0, "totalcitations_2": 23.0, "totalcitations_3": 28.5, "totalcitations_4": 28.5, "totalcitations_5": 30.0, "totalpapers_0": 5.0, "totalpapers_1": 5.5, "totalpapers_2": 6.0, "totalpapers_3": 6.5, "totalpapers_4": 6.5, "totalpapers_5": 6.5, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 48.0, "recentcoauthors_1": 48.0, "recentcoauthors_2": 38.5, "recentcoauthors_3": 70.0, "recentcoauthors_4": 31.5, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 253.25, "venuehindexmean_1": 257.25, "venuehindexmean_2": 263.0, "venuehindexmean_3": 269.0, "venuehindexmean_4": 273.5, "venuehindexmean_5": 277.75, "totalvenues_0": 1.5, "totalvenues_1": 1.5, "totalvenues_2": 1.5, "totalvenues_3": 1.5, "totalvenues_4": 1.5, "totalvenues_5": 1.5, "pagerank_0": 1.8593234866, "pagerank_1": 1.7604741406, "pagerank_2": 1.9812871539, "pagerank_3": 2.1597162058, "pagerank_4": 2.1507932643, "pagerank_5": 2.1406758629}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["Brant E.Robertson", "Richard S.Ellis", "Daniel P.Stark"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 2.0, "hindex_1": 2.3333333333, "hindex_2": 2.6666666667, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.8203333333, "citationsperpaper_1": 2.706, "citationsperpaper_2": 3.0963333333, "citationsperpaper_3": 4.2, "citationsperpaper_4": 4.2176666667, "citationsperpaper_5": 4.235, "citationsperyear_0": 1.2646666667, "citationsperyear_1": 1.4986666667, "citationsperyear_2": 1.9206666667, "citationsperyear_3": 2.2263333333, "citationsperyear_4": 1.9566666667, "citationsperyear_5": 1.7666666667, "totalcitations_0": 22.3333333333, "totalcitations_1": 24.6666666667, "totalcitations_2": 29.6666666667, "totalcitations_3": 33.6666666667, "totalcitations_4": 34.0, "totalcitations_5": 34.3333333333, "totalpapers_0": 8.0, "totalpapers_1": 8.0, "totalpapers_2": 8.6666666667, "totalpapers_3": 8.6666666667, "totalpapers_4": 8.6666666667, "totalpapers_5": 8.6666666667, "authorage_0": 12.3333333333, "authorage_1": 13.3333333333, "authorage_2": 14.3333333333, "authorage_3": 15.3333333333, "authorage_4": 16.3333333333, "authorage_5": 17.3333333333, "recentcoauthors_0": 18.6666666667, "recentcoauthors_1": 11.0, "recentcoauthors_2": 8.6666666667, "recentcoauthors_3": 8.6666666667, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 244.6666666667, "venuehindexmean_1": 248.3333333333, "venuehindexmean_2": 253.0, "venuehindexmean_3": 258.3333333333, "venuehindexmean_4": 263.0, "venuehindexmean_5": 266.6666666667, "totalvenues_0": 1.3333333333, "totalvenues_1": 1.3333333333, "totalvenues_2": 1.3333333333, "totalvenues_3": 1.3333333333, "totalvenues_4": 1.3333333333, "totalvenues_5": 1.3333333333, "pagerank_0": 2.127051696, "pagerank_1": 1.970619684, "pagerank_2": 2.0839724143, "pagerank_3": 1.9711060215, "pagerank_4": 1.9727367007, "pagerank_5": 1.9567765647}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["Daniel P.Stark"], "affiliation": "University of Arizona", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.25, "citationsperpaper_1": 1.75, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.6, "citationsperpaper_4": 2.6, "citationsperpaper_5": 2.6, "citationsperyear_0": 1.0, "citationsperyear_1": 1.167, "citationsperyear_2": 1.429, "citationsperyear_3": 1.625, "citationsperyear_4": 1.444, "citationsperyear_5": 1.3, "totalcitations_0": 5.0, "totalcitations_1": 7.0, "totalcitations_2": 10.0, "totalcitations_3": 13.0, "totalcitations_4": 13.0, "totalcitations_5": 13.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 5.0, "totalpapers_4": 5.0, "totalpapers_5": 5.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 25.0, "recentcoauthors_1": 25.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.1989178527, "pagerank_1": 1.1620952123, "pagerank_2": 1.0757613266, "pagerank_3": 0.9870817372, "pagerank_4": 0.988159856, "pagerank_5": 0.992416955}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["Daniel P.Stark", "Richard S.Ellis"], "affiliation": "University of Cambridge", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 2.5, "hindex_1": 3.0, "hindex_2": 3.5, "hindex_3": 3.5, "hindex_4": 3.5, "hindex_5": 3.5, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.2305, "citationsperpaper_1": 2.559, "citationsperpaper_2": 2.8945, "citationsperpaper_3": 3.3, "citationsperpaper_4": 3.3265, "citationsperpaper_5": 3.3525, "citationsperyear_0": 1.397, "citationsperyear_1": 1.498, "citationsperyear_2": 1.7145, "citationsperyear_3": 1.8395, "citationsperyear_4": 1.735, "citationsperyear_5": 1.65, "totalcitations_0": 33.0, "totalcitations_1": 35.5, "totalcitations_2": 41.0, "totalcitations_3": 44.5, "totalcitations_4": 45.0, "totalcitations_5": 45.5, "totalpapers_0": 11.5, "totalpapers_1": 11.5, "totalpapers_2": 12.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 18.5, "authorage_1": 19.5, "authorage_2": 20.5, "authorage_3": 21.5, "authorage_4": 22.5, "authorage_5": 23.5, "recentcoauthors_0": 26.0, "recentcoauthors_1": 14.5, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 237.0, "venuehindexmean_1": 240.5, "venuehindexmean_2": 245.0, "venuehindexmean_3": 250.0, "venuehindexmean_4": 254.5, "venuehindexmean_5": 258.0, "totalvenues_0": 1.5, "totalvenues_1": 1.5, "totalvenues_2": 1.5, "totalvenues_3": 1.5, "totalvenues_4": 1.5, "totalvenues_5": 1.5, "pagerank_0": 3.0444565398, "pagerank_1": 2.8127962628, "pagerank_2": 2.6418702584, "pagerank_3": 2.515746843, "pagerank_4": 2.510933616, "pagerank_5": 2.4938048076}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["Richard S.Ellis"], "affiliation": "Durham University", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.211, "citationsperpaper_1": 3.368, "citationsperpaper_2": 3.789, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.053, "citationsperpaper_5": 4.105, "citationsperyear_0": 1.794, "citationsperyear_1": 1.829, "citationsperyear_2": 2.0, "citationsperyear_3": 2.054, "citationsperyear_4": 2.026, "citationsperyear_5": 2.0, "totalcitations_0": 61.0, "totalcitations_1": 64.0, "totalcitations_2": 72.0, "totalcitations_3": 76.0, "totalcitations_4": 77.0, "totalcitations_5": 78.0, "totalpapers_0": 19.0, "totalpapers_1": 19.0, "totalpapers_2": 19.0, "totalpapers_3": 19.0, "totalpapers_4": 19.0, "totalpapers_5": 19.0, "authorage_0": 33.0, "authorage_1": 34.0, "authorage_2": 35.0, "authorage_3": 36.0, "authorage_4": 37.0, "authorage_5": 38.0, "recentcoauthors_0": 27.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 4.889995227, "pagerank_1": 4.4634973133, "pagerank_2": 4.2079791902, "pagerank_3": 4.0444119489, "pagerank_4": 4.0337073759, "pagerank_5": 3.9951926602}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["Richard S.Ellis"], "affiliation": "University College London", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.211, "citationsperpaper_1": 3.368, "citationsperpaper_2": 3.789, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.053, "citationsperpaper_5": 4.105, "citationsperyear_0": 1.794, "citationsperyear_1": 1.829, "citationsperyear_2": 2.0, "citationsperyear_3": 2.054, "citationsperyear_4": 2.026, "citationsperyear_5": 2.0, "totalcitations_0": 61.0, "totalcitations_1": 64.0, "totalcitations_2": 72.0, "totalcitations_3": 76.0, "totalcitations_4": 77.0, "totalcitations_5": 78.0, "totalpapers_0": 19.0, "totalpapers_1": 19.0, "totalpapers_2": 19.0, "totalpapers_3": 19.0, "totalpapers_4": 19.0, "totalpapers_5": 19.0, "authorage_0": 33.0, "authorage_1": 34.0, "authorage_2": 35.0, "authorage_3": 36.0, "authorage_4": 37.0, "authorage_5": 38.0, "recentcoauthors_0": 27.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 4.889995227, "pagerank_1": 4.4634973133, "pagerank_2": 4.2079791902, "pagerank_3": 4.0444119489, "pagerank_4": 4.0337073759, "pagerank_5": 3.9951926602}}, {"model": "papers.paper", "pk": 1003336, "fields": {"authors": ["JamesDunlop"], "affiliation": "Liverpool John Moores University", "venue": "Nature", "doi": "10.1038/nature09527", "abstract": "Star-forming galaxies trace cosmic history. Recent observational progress with the NASA Hubble Space Telescope has led to the discovery and study of the earliest known galaxies, which correspond to a period when the Universe was only ~800 million years old. Intense ultraviolet radiation from these early galaxies probably induced a major event in cosmic history: the reionization of intergalactic hydrogen.", "year": 2010, "title": "Early star-forming galaxies and the reionization of the Universe", "keywords": ["Quasar", "Astrophysics", "Cosmic microwave background", "Reionization", "Hubble Deep Field", "Hubble Ultra-Deep Field", "Luminous infrared galaxy", "Astronomy", "Observational cosmology", "Physics", "Galaxy"], "citations_0": 1.0, "citations_1": 2.0, "citations_2": 3.0, "citations_3": 2.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 2.108347178, "timescaledpagerank_2": 3.8259435211, "timescaledpagerank_3": 3.7388451551, "timescaledpagerank_4": 3.0061237326, "timescaledpagerank_5": 2.6742398302, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 5.0, "adopters_0": 2.0, "adopters_1": 13.0, "adopters_2": 38.0, "adopters_3": 64.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.333, "citationsperpaper_1": 3.5, "citationsperpaper_2": 3.636, "citationsperpaper_3": 4.083, "citationsperpaper_4": 4.083, "citationsperpaper_5": 4.333, "citationsperyear_0": 1.2, "citationsperyear_1": 1.346, "citationsperyear_2": 1.481, "citationsperyear_3": 1.75, "citationsperyear_4": 1.69, "citationsperyear_5": 1.733, "totalcitations_0": 30.0, "totalcitations_1": 35.0, "totalcitations_2": 40.0, "totalcitations_3": 49.0, "totalcitations_4": 49.0, "totalcitations_5": 52.0, "totalpapers_0": 9.0, "totalpapers_1": 10.0, "totalpapers_2": 11.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 92.0, "recentcoauthors_1": 92.0, "recentcoauthors_2": 77.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 63.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 3.4264049649, "pagerank_1": 3.2346817547, "pagerank_2": 3.7189202929, "pagerank_3": 4.083616603, "pagerank_4": 4.0654543607, "pagerank_5": 4.0457982022}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Luis A.Diaz"], "affiliation": "University of Turin", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 14.0, "hindex_1": 16.0, "hindex_2": 18.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 22.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 13.218, "citationsperpaper_1": 14.689, "citationsperpaper_2": 16.172, "citationsperpaper_3": 17.597, "citationsperpaper_4": 19.714, "citationsperpaper_5": 19.56, "citationsperyear_0": 24.233, "citationsperyear_1": 28.903, "citationsperyear_2": 32.344, "citationsperyear_3": 38.394, "citationsperyear_4": 44.647, "citationsperyear_5": 50.857, "totalcitations_0": 727.0, "totalcitations_1": 896.0, "totalcitations_2": 1035.0, "totalcitations_3": 1267.0, "totalcitations_4": 1518.0, "totalcitations_5": 1780.0, "totalpapers_0": 55.0, "totalpapers_1": 61.0, "totalpapers_2": 64.0, "totalpapers_3": 72.0, "totalpapers_4": 77.0, "totalpapers_5": 91.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 94.0, "recentcoauthors_1": 125.0, "recentcoauthors_2": 113.0, "recentcoauthors_3": 161.0, "recentcoauthors_4": 258.0, "recentcoauthors_5": 360.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6875, "venuehindexmean_1": 119.375, "venuehindexmean_2": 121.7058823529, "venuehindexmean_3": 118.3888888889, "venuehindexmean_4": 121.2222222222, "venuehindexmean_5": 124.1666666667, "totalvenues_0": 16.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 18.0, "pagerank_0": 13.5383151208, "pagerank_1": 14.6249145118, "pagerank_2": 14.5474640149, "pagerank_3": 16.3703603469, "pagerank_4": 17.8337148632, "pagerank_5": 20.8094139075}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Luis A.Diaz"], "affiliation": "University of Michigan", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 14.0, "hindex_1": 16.0, "hindex_2": 18.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 22.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 13.218, "citationsperpaper_1": 14.689, "citationsperpaper_2": 16.172, "citationsperpaper_3": 17.597, "citationsperpaper_4": 19.714, "citationsperpaper_5": 19.56, "citationsperyear_0": 24.233, "citationsperyear_1": 28.903, "citationsperyear_2": 32.344, "citationsperyear_3": 38.394, "citationsperyear_4": 44.647, "citationsperyear_5": 50.857, "totalcitations_0": 727.0, "totalcitations_1": 896.0, "totalcitations_2": 1035.0, "totalcitations_3": 1267.0, "totalcitations_4": 1518.0, "totalcitations_5": 1780.0, "totalpapers_0": 55.0, "totalpapers_1": 61.0, "totalpapers_2": 64.0, "totalpapers_3": 72.0, "totalpapers_4": 77.0, "totalpapers_5": 91.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 94.0, "recentcoauthors_1": 125.0, "recentcoauthors_2": 113.0, "recentcoauthors_3": 161.0, "recentcoauthors_4": 258.0, "recentcoauthors_5": 360.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6875, "venuehindexmean_1": 119.375, "venuehindexmean_2": 121.7058823529, "venuehindexmean_3": 118.3888888889, "venuehindexmean_4": 121.2222222222, "venuehindexmean_5": 124.1666666667, "totalvenues_0": 16.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 18.0, "pagerank_0": 13.5383151208, "pagerank_1": 14.6249145118, "pagerank_2": 14.5474640149, "pagerank_3": 16.3703603469, "pagerank_4": 17.8337148632, "pagerank_5": 20.8094139075}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Victor E.Velculescu", "Luis A.Diaz", "DevinDressman", "NickolasPapadopoulos"], "affiliation": "Johns Hopkins University School of Medicine", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 14.5, "hindex_1": 16.0, "hindex_2": 18.0, "hindex_3": 19.25, "hindex_4": 20.25, "hindex_5": 22.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 28.91, "citationsperpaper_1": 28.042, "citationsperpaper_2": 29.6845, "citationsperpaper_3": 30.926, "citationsperpaper_4": 32.96, "citationsperpaper_5": 33.34475, "citationsperyear_0": 65.56875, "citationsperyear_1": 70.84425, "citationsperyear_2": 76.486, "citationsperyear_3": 83.41775, "citationsperyear_4": 89.355, "citationsperyear_5": 95.445, "totalcitations_0": 1237.0, "totalcitations_1": 1415.25, "totalcitations_2": 1607.0, "totalcitations_3": 1846.5, "totalcitations_4": 2077.25, "totalcitations_5": 2325.5, "totalpapers_0": 37.25, "totalpapers_1": 43.0, "totalpapers_2": 46.5, "totalpapers_3": 52.0, "totalpapers_4": 56.0, "totalpapers_5": 63.5, "authorage_0": 17.5, "authorage_1": 18.5, "authorage_2": 19.5, "authorage_3": 20.5, "authorage_4": 21.5, "authorage_5": 22.5, "recentcoauthors_0": 187.0, "recentcoauthors_1": 226.5, "recentcoauthors_2": 138.5, "recentcoauthors_3": 138.75, "recentcoauthors_4": 190.0, "recentcoauthors_5": 226.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.0885416667, "venuehindexmean_1": 126.8116987179, "venuehindexmean_2": 128.9379174747, "venuehindexmean_3": 131.1132478632, "venuehindexmean_4": 134.6865079365, "venuehindexmean_5": 137.562099359, "totalvenues_0": 10.0, "totalvenues_1": 11.25, "totalvenues_2": 11.75, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.5, "pagerank_0": 10.9284651365, "pagerank_1": 12.2450586188, "pagerank_2": 12.2880416904, "pagerank_3": 13.5153721006, "pagerank_4": 14.4094577647, "pagerank_5": 15.7821061377}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Luis A.Diaz", "NickolasPapadopoulos"], "affiliation": "Swim Across America", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 14.5, "hindex_1": 16.0, "hindex_2": 18.5, "hindex_3": 20.0, "hindex_4": 21.0, "hindex_5": 23.5, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 28.6625, "citationsperpaper_1": 25.1735, "citationsperpaper_2": 25.935, "citationsperpaper_3": 26.377, "citationsperpaper_4": 27.162, "citationsperpaper_5": 27.2875, "citationsperyear_0": 46.422, "citationsperyear_1": 50.1095, "citationsperyear_2": 54.547, "citationsperyear_3": 61.8875, "citationsperyear_4": 68.7325, "citationsperyear_5": 76.4285, "totalcitations_0": 981.0, "totalcitations_1": 1125.5, "totalcitations_2": 1285.0, "totalcitations_3": 1530.0, "totalcitations_4": 1780.0, "totalcitations_5": 2063.0, "totalpapers_0": 41.5, "totalpapers_1": 49.5, "totalpapers_2": 53.5, "totalpapers_3": 61.5, "totalpapers_4": 68.0, "totalpapers_5": 79.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 114.5, "recentcoauthors_1": 200.5, "recentcoauthors_2": 187.0, "recentcoauthors_3": 185.0, "recentcoauthors_4": 284.0, "recentcoauthors_5": 346.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 130.34375, "venuehindexmean_1": 118.5336538462, "venuehindexmean_2": 118.3886554622, "venuehindexmean_3": 118.4444444444, "venuehindexmean_4": 121.5396825397, "venuehindexmean_5": 123.7395833333, "totalvenues_0": 12.5, "totalvenues_1": 14.5, "totalvenues_2": 15.5, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 17.0, "pagerank_0": 11.2434969989, "pagerank_1": 13.3378698566, "pagerank_2": 13.6176563154, "pagerank_3": 15.5181784174, "pagerank_4": 17.3571673197, "pagerank_5": 19.6473307246}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Christine A.Iacobuzio-Donahue", "Luis A.Diaz"], "affiliation": "Memorial Sloan Kettering Cancer Center", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 11.5, "hindex_1": 13.5, "hindex_2": 14.5, "hindex_3": 15.5, "hindex_4": 16.5, "hindex_5": 18.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 11.005, "citationsperpaper_1": 13.017, "citationsperpaper_2": 14.802, "citationsperpaper_3": 16.957, "citationsperpaper_4": 19.392, "citationsperpaper_5": 20.345, "citationsperyear_0": 21.7075, "citationsperyear_1": 28.16, "citationsperyear_2": 35.2875, "citationsperyear_3": 43.09, "citationsperyear_4": 49.657, "citationsperyear_5": 55.8035, "totalcitations_0": 469.0, "totalcitations_1": 612.5, "totalcitations_2": 766.0, "totalcitations_3": 968.0, "totalcitations_4": 1169.0, "totalcitations_5": 1376.0, "totalpapers_0": 39.5, "totalpapers_1": 45.0, "totalpapers_2": 50.5, "totalpapers_3": 56.5, "totalpapers_4": 60.0, "totalpapers_5": 68.5, "authorage_0": 19.5, "authorage_1": 20.5, "authorage_2": 21.5, "authorage_3": 22.5, "authorage_4": 23.5, "authorage_5": 24.5, "recentcoauthors_0": 129.5, "recentcoauthors_1": 118.0, "recentcoauthors_2": 244.0, "recentcoauthors_3": 262.5, "recentcoauthors_4": 166.0, "recentcoauthors_5": 212.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 150.96875, "venuehindexmean_1": 160.4875, "venuehindexmean_2": 163.9529411765, "venuehindexmean_3": 164.0944444444, "venuehindexmean_4": 155.6111111111, "venuehindexmean_5": 143.1458333333, "totalvenues_0": 10.0, "totalvenues_1": 10.5, "totalvenues_2": 11.0, "totalvenues_3": 11.5, "totalvenues_4": 12.0, "totalvenues_5": 13.0, "pagerank_0": 10.8637237758, "pagerank_1": 11.8566790009, "pagerank_2": 13.2757501691, "pagerank_3": 14.3146456883, "pagerank_4": 15.1319545973, "pagerank_5": 16.7856879058}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Luis A.Diaz"], "affiliation": "University of North Carolina at Chapel Hill", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 14.0, "hindex_1": 16.0, "hindex_2": 18.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 22.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 13.218, "citationsperpaper_1": 14.689, "citationsperpaper_2": 16.172, "citationsperpaper_3": 17.597, "citationsperpaper_4": 19.714, "citationsperpaper_5": 19.56, "citationsperyear_0": 24.233, "citationsperyear_1": 28.903, "citationsperyear_2": 32.344, "citationsperyear_3": 38.394, "citationsperyear_4": 44.647, "citationsperyear_5": 50.857, "totalcitations_0": 727.0, "totalcitations_1": 896.0, "totalcitations_2": 1035.0, "totalcitations_3": 1267.0, "totalcitations_4": 1518.0, "totalcitations_5": 1780.0, "totalpapers_0": 55.0, "totalpapers_1": 61.0, "totalpapers_2": 64.0, "totalpapers_3": 72.0, "totalpapers_4": 77.0, "totalpapers_5": 91.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 94.0, "recentcoauthors_1": 125.0, "recentcoauthors_2": 113.0, "recentcoauthors_3": 161.0, "recentcoauthors_4": 258.0, "recentcoauthors_5": 360.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6875, "venuehindexmean_1": 119.375, "venuehindexmean_2": 121.7058823529, "venuehindexmean_3": 118.3888888889, "venuehindexmean_4": 121.2222222222, "venuehindexmean_5": 124.1666666667, "totalvenues_0": 16.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 18.0, "pagerank_0": 13.5383151208, "pagerank_1": 14.6249145118, "pagerank_2": 14.5474640149, "pagerank_3": 16.3703603469, "pagerank_4": 17.8337148632, "pagerank_5": 20.8094139075}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Luis A.Diaz"], "affiliation": "Medical College of Wisconsin", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 14.0, "hindex_1": 16.0, "hindex_2": 18.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 22.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 13.218, "citationsperpaper_1": 14.689, "citationsperpaper_2": 16.172, "citationsperpaper_3": 17.597, "citationsperpaper_4": 19.714, "citationsperpaper_5": 19.56, "citationsperyear_0": 24.233, "citationsperyear_1": 28.903, "citationsperyear_2": 32.344, "citationsperyear_3": 38.394, "citationsperyear_4": 44.647, "citationsperyear_5": 50.857, "totalcitations_0": 727.0, "totalcitations_1": 896.0, "totalcitations_2": 1035.0, "totalcitations_3": 1267.0, "totalcitations_4": 1518.0, "totalcitations_5": 1780.0, "totalpapers_0": 55.0, "totalpapers_1": 61.0, "totalpapers_2": 64.0, "totalpapers_3": 72.0, "totalpapers_4": 77.0, "totalpapers_5": 91.0, "authorage_0": 29.0, "authorage_1": 30.0, "authorage_2": 31.0, "authorage_3": 32.0, "authorage_4": 33.0, "authorage_5": 34.0, "recentcoauthors_0": 94.0, "recentcoauthors_1": 125.0, "recentcoauthors_2": 113.0, "recentcoauthors_3": 161.0, "recentcoauthors_4": 258.0, "recentcoauthors_5": 360.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6875, "venuehindexmean_1": 119.375, "venuehindexmean_2": 121.7058823529, "venuehindexmean_3": 118.3888888889, "venuehindexmean_4": 121.2222222222, "venuehindexmean_5": 124.1666666667, "totalvenues_0": 16.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 18.0, "pagerank_0": 13.5383151208, "pagerank_1": 14.6249145118, "pagerank_2": 14.5474640149, "pagerank_3": 16.3703603469, "pagerank_4": 17.8337148632, "pagerank_5": 20.8094139075}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["JianWu", "Victor E.Velculescu", "Sanford D.Markowitz", "Luis A.Diaz", "YipingHe", "DevinDressman", "NickolasPapadopoulos", "BertVogelstein", "Kenneth W.Kinzler"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 11.0, "hindex_1": 12.3333333333, "hindex_2": 13.5555555556, "hindex_3": 14.6666666667, "hindex_4": 15.7777777778, "hindex_5": 16.8888888889, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 22.7547777778, "citationsperpaper_1": 22.8888888889, "citationsperpaper_2": 24.506, "citationsperpaper_3": 26.008, "citationsperpaper_4": 27.7255555556, "citationsperpaper_5": 28.6128888889, "citationsperyear_0": 45.852, "citationsperyear_1": 48.8335555556, "citationsperyear_2": 52.1874444444, "citationsperyear_3": 56.1977777778, "citationsperyear_4": 59.5764444444, "citationsperyear_5": 62.7296666667, "totalcitations_0": 873.3333333333, "totalcitations_1": 977.7777777778, "totalcitations_2": 1090.2222222222, "totalcitations_3": 1227.0, "totalcitations_4": 1358.4444444444, "totalcitations_5": 1494.5555555556, "totalpapers_0": 27.7777777778, "totalpapers_1": 31.4444444444, "totalpapers_2": 33.5555555556, "totalpapers_3": 36.6666666667, "totalpapers_4": 39.3333333333, "totalpapers_5": 43.4444444444, "authorage_0": 15.4444444444, "authorage_1": 16.4444444444, "authorage_2": 17.4444444444, "authorage_3": 18.4444444444, "authorage_4": 19.4444444444, "authorage_5": 20.4444444444, "recentcoauthors_0": 126.4444444444, "recentcoauthors_1": 142.2222222222, "recentcoauthors_2": 94.1111111111, "recentcoauthors_3": 78.6666666667, "recentcoauthors_4": 108.6666666667, "recentcoauthors_5": 125.4444444444, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 130.7383072175, "venuehindexmean_1": 127.2593304843, "venuehindexmean_2": 130.2427781369, "venuehindexmean_3": 132.6095916429, "venuehindexmean_4": 135.0913099246, "venuehindexmean_5": 138.1339970215, "totalvenues_0": 8.0, "totalvenues_1": 8.8888888889, "totalvenues_2": 9.1111111111, "totalvenues_3": 9.3333333333, "totalvenues_4": 9.5555555556, "totalvenues_5": 9.7777777778, "pagerank_0": 8.1179749502, "pagerank_1": 9.0106830723, "pagerank_2": 8.9682706508, "pagerank_3": 9.6245704628, "pagerank_4": 10.1439388609, "pagerank_5": 10.8347189814}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Christine A.Iacobuzio-Donahue", "JianWu", "Victor E.Velculescu", "Luis A.Diaz", "DevinDressman", "NickolasPapadopoulos", "YipingHe"], "affiliation": "Johns Hopkins University", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 11.2857142857, "hindex_1": 12.8571428571, "hindex_2": 14.2857142857, "hindex_3": 15.7142857143, "hindex_4": 17.0, "hindex_5": 18.2857142857, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 20.2998571429, "citationsperpaper_1": 20.1854285714, "citationsperpaper_2": 22.0844285714, "citationsperpaper_3": 24.0965714286, "citationsperpaper_4": 26.2164285714, "citationsperpaper_5": 27.6777142857, "citationsperyear_0": 43.9614285714, "citationsperyear_1": 48.7538571429, "citationsperyear_2": 54.6034285714, "citationsperyear_3": 61.1061428571, "citationsperyear_4": 66.4995714286, "citationsperyear_5": 71.5501428571, "totalcitations_0": 771.4285714286, "totalcitations_1": 900.1428571429, "totalcitations_2": 1050.5714285714, "totalcitations_3": 1232.5714285714, "totalcitations_4": 1407.1428571429, "totalcitations_5": 1589.2857142857, "totalpapers_0": 27.8571428571, "totalpapers_1": 33.0, "totalpapers_2": 36.7142857143, "totalpapers_3": 40.8571428571, "totalpapers_4": 44.1428571429, "totalpapers_5": 48.8571428571, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 157.8571428571, "recentcoauthors_1": 184.5714285714, "recentcoauthors_2": 169.5714285714, "recentcoauthors_3": 147.2857142857, "recentcoauthors_4": 143.5714285714, "recentcoauthors_5": 153.8571428571, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 140.7688492063, "venuehindexmean_1": 137.1114468864, "venuehindexmean_2": 140.1026195093, "venuehindexmean_3": 142.8504273504, "venuehindexmean_4": 142.5935889507, "venuehindexmean_5": 141.1139485514, "totalvenues_0": 8.1428571429, "totalvenues_1": 9.4285714286, "totalvenues_2": 9.7142857143, "totalvenues_3": 9.8571428571, "totalvenues_4": 10.1428571429, "totalvenues_5": 10.7142857143, "pagerank_0": 8.4498220858, "pagerank_1": 9.7740795037, "pagerank_2": 10.282556459, "pagerank_3": 11.1726744401, "pagerank_4": 11.9221974688, "pagerank_5": 12.6781024117}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["BertVogelstein", "Kenneth W.Kinzler", "Sanford D.Markowitz"], "affiliation": "Case Western Reserve University", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 9.6666666667, "hindex_1": 10.6666666667, "hindex_2": 11.0, "hindex_3": 11.3333333333, "hindex_4": 12.0, "hindex_5": 12.6666666667, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 23.8286666667, "citationsperpaper_1": 25.349, "citationsperpaper_2": 26.465, "citationsperpaper_3": 27.2376666667, "citationsperpaper_4": 28.3616666667, "citationsperpaper_5": 28.3006666667, "citationsperyear_0": 41.3733333333, "citationsperyear_1": 41.8806666667, "citationsperyear_2": 41.898, "citationsperyear_3": 41.941, "citationsperyear_4": 41.786, "citationsperyear_5": 41.4886666667, "totalcitations_0": 890.3333333333, "totalcitations_1": 942.6666666667, "totalcitations_2": 985.0, "totalcitations_3": 1028.0, "totalcitations_4": 1065.3333333333, "totalcitations_5": 1099.3333333333, "totalpapers_0": 26.3333333333, "totalpapers_1": 27.0, "totalpapers_2": 27.3333333333, "totalpapers_3": 28.3333333333, "totalpapers_4": 29.3333333333, "totalpapers_5": 31.6666666667, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 66.0, "recentcoauthors_1": 33.0, "recentcoauthors_2": 11.6666666667, "recentcoauthors_3": 13.6666666667, "recentcoauthors_4": 15.6666666667, "recentcoauthors_5": 38.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.5042735043, "venuehindexmean_1": 129.0512820513, "venuehindexmean_2": 132.5555555556, "venuehindexmean_3": 134.4444444444, "venuehindexmean_4": 135.8888888889, "venuehindexmean_5": 139.1777777778, "totalvenues_0": 6.3333333333, "totalvenues_1": 6.3333333333, "totalvenues_2": 6.3333333333, "totalvenues_3": 6.6666666667, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 7.3673841272, "pagerank_1": 7.2553448717, "pagerank_2": 6.9135256558, "pagerank_3": 6.890448038, "pagerank_4": 6.7567539326, "pagerank_5": 7.175905285}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["YipingHe"], "affiliation": "Duke University", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 9.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 14.0, "hindex_4": 15.0, "hindex_5": 15.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 13.5, "citationsperpaper_1": 14.421, "citationsperpaper_2": 17.19, "citationsperpaper_3": 20.455, "citationsperpaper_4": 20.84, "citationsperpaper_5": 23.0, "citationsperyear_0": 24.0, "citationsperyear_1": 27.4, "citationsperyear_2": 32.818, "citationsperyear_3": 37.5, "citationsperyear_4": 40.077, "citationsperyear_5": 41.071, "totalcitations_0": 216.0, "totalcitations_1": 274.0, "totalcitations_2": 361.0, "totalcitations_3": 450.0, "totalcitations_4": 521.0, "totalcitations_5": 575.0, "totalpapers_0": 16.0, "totalpapers_1": 19.0, "totalpapers_2": 21.0, "totalpapers_3": 22.0, "totalpapers_4": 25.0, "totalpapers_5": 25.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 85.0, "recentcoauthors_1": 97.0, "recentcoauthors_2": 67.0, "recentcoauthors_3": 61.0, "recentcoauthors_4": 81.0, "recentcoauthors_5": 45.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 124.7777777778, "venuehindexmean_1": 124.1, "venuehindexmean_2": 128.1, "venuehindexmean_3": 132.2, "venuehindexmean_4": 132.9090909091, "venuehindexmean_5": 136.0909090909, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 4.7491388525, "pagerank_1": 5.4036712079, "pagerank_2": 5.6083759336, "pagerank_3": 6.020605781, "pagerank_4": 6.5026823419, "pagerank_5": 6.1904958422}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["YipingHe"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 9.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 14.0, "hindex_4": 15.0, "hindex_5": 15.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 13.5, "citationsperpaper_1": 14.421, "citationsperpaper_2": 17.19, "citationsperpaper_3": 20.455, "citationsperpaper_4": 20.84, "citationsperpaper_5": 23.0, "citationsperyear_0": 24.0, "citationsperyear_1": 27.4, "citationsperyear_2": 32.818, "citationsperyear_3": 37.5, "citationsperyear_4": 40.077, "citationsperyear_5": 41.071, "totalcitations_0": 216.0, "totalcitations_1": 274.0, "totalcitations_2": 361.0, "totalcitations_3": 450.0, "totalcitations_4": 521.0, "totalcitations_5": 575.0, "totalpapers_0": 16.0, "totalpapers_1": 19.0, "totalpapers_2": 21.0, "totalpapers_3": 22.0, "totalpapers_4": 25.0, "totalpapers_5": 25.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 85.0, "recentcoauthors_1": 97.0, "recentcoauthors_2": 67.0, "recentcoauthors_3": 61.0, "recentcoauthors_4": 81.0, "recentcoauthors_5": 45.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 124.7777777778, "venuehindexmean_1": 124.1, "venuehindexmean_2": 128.1, "venuehindexmean_3": 132.2, "venuehindexmean_4": 132.9090909091, "venuehindexmean_5": 136.0909090909, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 4.7491388525, "pagerank_1": 5.4036712079, "pagerank_2": 5.6083759336, "pagerank_3": 6.020605781, "pagerank_4": 6.5026823419, "pagerank_5": 6.1904958422}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["Sanford D.Markowitz", "Victor E.Velculescu"], "affiliation": "University Hospitals of Cleveland", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 24.5, "hindex_1": 26.0, "hindex_2": 27.5, "hindex_3": 29.0, "hindex_4": 30.5, "hindex_5": 32.5, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 42.0005, "citationsperpaper_1": 43.034, "citationsperpaper_2": 44.5065, "citationsperpaper_3": 45.4815, "citationsperpaper_4": 46.8505, "citationsperpaper_5": 45.703, "citationsperyear_0": 138.619, "citationsperyear_1": 145.753, "citationsperyear_2": 152.1835, "citationsperyear_3": 158.637, "citationsperyear_4": 162.8815, "citationsperyear_5": 167.0185, "totalcitations_0": 2723.5, "totalcitations_1": 3000.0, "totalcitations_2": 3274.5, "totalcitations_3": 3562.5, "totalcitations_4": 3813.0, "totalcitations_5": 4069.5, "totalpapers_0": 65.5, "totalpapers_1": 70.0, "totalpapers_2": 73.5, "totalpapers_3": 78.0, "totalpapers_4": 81.0, "totalpapers_5": 88.5, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 326.0, "recentcoauthors_1": 288.5, "recentcoauthors_2": 107.5, "recentcoauthors_3": 113.0, "recentcoauthors_4": 119.5, "recentcoauthors_5": 164.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 115.5897435897, "venuehindexmean_1": 114.5, "venuehindexmean_2": 118.6538461538, "venuehindexmean_3": 119.1153846154, "venuehindexmean_4": 119.1666666667, "venuehindexmean_5": 122.6512820513, "totalvenues_0": 12.5, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.5, "totalvenues_4": 14.0, "totalvenues_5": 14.0, "pagerank_0": 19.9508057431, "pagerank_1": 20.3919230836, "pagerank_2": 19.7716448454, "pagerank_3": 20.3510259609, "pagerank_4": 20.1785340552, "pagerank_5": 21.3109268351}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["JianWu"], "affiliation": "University of California, Davis", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 7.0, "hindex_4": 10.0, "hindex_5": 11.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 4.167, "citationsperpaper_1": 3.364, "citationsperpaper_2": 5.231, "citationsperpaper_3": 8.2, "citationsperpaper_4": 11.765, "citationsperpaper_5": 16.235, "citationsperyear_0": 2.273, "citationsperyear_1": 3.083, "citationsperyear_2": 5.231, "citationsperyear_3": 8.786, "citationsperyear_4": 13.333, "citationsperyear_5": 17.25, "totalcitations_0": 25.0, "totalcitations_1": 37.0, "totalcitations_2": 68.0, "totalcitations_3": 123.0, "totalcitations_4": 200.0, "totalcitations_5": 276.0, "totalpapers_0": 6.0, "totalpapers_1": 11.0, "totalpapers_2": 13.0, "totalpapers_3": 15.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 178.0, "recentcoauthors_2": 191.0, "recentcoauthors_3": 51.0, "recentcoauthors_4": 90.0, "recentcoauthors_5": 64.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.0, "venuehindexmean_1": 126.8333333333, "venuehindexmean_2": 130.6666666667, "venuehindexmean_3": 133.5, "venuehindexmean_4": 136.5, "venuehindexmean_5": 139.3333333333, "totalvenues_0": 4.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.4966227714, "pagerank_1": 4.9462073529, "pagerank_2": 5.2133161944, "pagerank_3": 5.8676958672, "pagerank_4": 6.8846745493, "pagerank_5": 6.665834585}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["JianWu"], "affiliation": "Fudan University Shanghai Medical College", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 7.0, "hindex_4": 10.0, "hindex_5": 11.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 4.167, "citationsperpaper_1": 3.364, "citationsperpaper_2": 5.231, "citationsperpaper_3": 8.2, "citationsperpaper_4": 11.765, "citationsperpaper_5": 16.235, "citationsperyear_0": 2.273, "citationsperyear_1": 3.083, "citationsperyear_2": 5.231, "citationsperyear_3": 8.786, "citationsperyear_4": 13.333, "citationsperyear_5": 17.25, "totalcitations_0": 25.0, "totalcitations_1": 37.0, "totalcitations_2": 68.0, "totalcitations_3": 123.0, "totalcitations_4": 200.0, "totalcitations_5": 276.0, "totalpapers_0": 6.0, "totalpapers_1": 11.0, "totalpapers_2": 13.0, "totalpapers_3": 15.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 178.0, "recentcoauthors_2": 191.0, "recentcoauthors_3": 51.0, "recentcoauthors_4": 90.0, "recentcoauthors_5": 64.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.0, "venuehindexmean_1": 126.8333333333, "venuehindexmean_2": 130.6666666667, "venuehindexmean_3": 133.5, "venuehindexmean_4": 136.5, "venuehindexmean_5": 139.3333333333, "totalvenues_0": 4.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.4966227714, "pagerank_1": 4.9462073529, "pagerank_2": 5.2133161944, "pagerank_3": 5.8676958672, "pagerank_4": 6.8846745493, "pagerank_5": 6.665834585}}, {"model": "papers.paper", "pk": 1003934, "fields": {"authors": ["JianWu"], "affiliation": "Fourth Military Medical University", "venue": "Nature", "doi": "10.1038/nature08802", "abstract": "With the help of massively parallel sequencing-by-synthesis of mitochondrial DNA (mtDNA) genomes, He et al. uncover widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells and homoplasmic and heteroplasmic mutations in cancer cells. The frequency of heteroplasmy is shown to vary among tissues of the same individual. Together, these findings provide new insights into the nature and variability of mtDNA sequences and have implications for cancer biomarker development and forensic analysis. Each human cell contains hundreds of copies of mitochondrial DNA (mtDNA), making it difficult to characterize mtDNA completely. Here, massively parallel sequencing-by-synthesis of mtDNA reveals widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells, and homoplasmic and heteroplasmic mutations in cancer cells. The findings provide new insight into the nature and variability of mtDNA sequences, with implications for forensic analysis and the development of biomarkers for cancer. The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies1. Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.", "year": 2010, "title": "Heteroplasmic mitochondrial DNA mutations in normal and tumour cells", "keywords": ["Mitochondrial DNA", "Genome", "Heteroplasmy", "Homoplasmy", "Mutation", "mtDNA control region", "Genetics", "Biology", "Genotype", "Genetic heterogeneity"], "citations_0": 2.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 4.0, "citations_4": 6.0, "citations_5": 3.0, "timescaledpagerank_0": 0.7431594538, "timescaledpagerank_1": 2.1504543942, "timescaledpagerank_2": 1.8153249978, "timescaledpagerank_3": 1.7053034306, "timescaledpagerank_4": 2.4958403681, "timescaledpagerank_5": 2.394453499, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 7.0, "hindex_4": 10.0, "hindex_5": 11.0, "adopters_0": 10.0, "adopters_1": 22.0, "adopters_2": 29.0, "adopters_3": 46.0, "adopters_4": 33.0, "adopters_5": 0.0, "citationsperpaper_0": 4.167, "citationsperpaper_1": 3.364, "citationsperpaper_2": 5.231, "citationsperpaper_3": 8.2, "citationsperpaper_4": 11.765, "citationsperpaper_5": 16.235, "citationsperyear_0": 2.273, "citationsperyear_1": 3.083, "citationsperyear_2": 5.231, "citationsperyear_3": 8.786, "citationsperyear_4": 13.333, "citationsperyear_5": 17.25, "totalcitations_0": 25.0, "totalcitations_1": 37.0, "totalcitations_2": 68.0, "totalcitations_3": 123.0, "totalcitations_4": 200.0, "totalcitations_5": 276.0, "totalpapers_0": 6.0, "totalpapers_1": 11.0, "totalpapers_2": 13.0, "totalpapers_3": 15.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 178.0, "recentcoauthors_2": 191.0, "recentcoauthors_3": 51.0, "recentcoauthors_4": 90.0, "recentcoauthors_5": 64.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.0, "venuehindexmean_1": 126.8333333333, "venuehindexmean_2": 130.6666666667, "venuehindexmean_3": 133.5, "venuehindexmean_4": 136.5, "venuehindexmean_5": 139.3333333333, "totalvenues_0": 4.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.4966227714, "pagerank_1": 4.9462073529, "pagerank_2": 5.2133161944, "pagerank_3": 5.8676958672, "pagerank_4": 6.8846745493, "pagerank_5": 6.665834585}}, {"model": "papers.paper", "pk": 1003080, "fields": {"authors": ["YoshinoriTokura", "NaoyaKanazawa", "NaotoNagaosa", "YoshinoriOnose"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/nature09124", "abstract": "Skyrmions are stable topological textures with particle-like properties, a mathematical concept originally developed to describe nuclear particles, but which in the past decade has found application at all scales from microscopic to cosmological. Skyrmions have proved particularly useful to describe novel spin configurations in magnets, and last year the presence of skyrmions in the magnetic compounds MnSi and Fe1xCoxSi was confirmed in neutron scattering experiments. Now Yu et al. present striking real-space images, using transmission electron microscopy, of a two-dimensional skyrmion lattice for the latter compound, in the form of a hexagonal arrangement of swirling spin structures. The lattice is shown to be stable for a wide range of temperatures and magnetic fields. The authors speculate that the observed nanometre-scale spin topology may lead to interesting new magnetoelectric effects.", "year": 2010, "title": "Real-space observation of a two-dimensional skyrmion crystal", "keywords": ["Skyrmion", "Magnetic skyrmion", "Neutron scattering", "Magnetic field", "Magnetic structure", "Condensed matter physics", "Chemistry", "Ferromagnetism", "Spin-\u00bd", "Spintronics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 3.0, "citations_3": 6.0, "citations_4": 0.0, "citations_5": 3.0, "timescaledpagerank_0": 0.8435728768, "timescaledpagerank_1": 0.5907885863, "timescaledpagerank_2": 1.3786332499, "timescaledpagerank_3": 2.4379544614, "timescaledpagerank_4": 1.9517435331, "timescaledpagerank_5": 2.0369756498, "hindex_0": 4.0, "hindex_1": 4.25, "hindex_2": 4.25, "hindex_3": 4.5, "hindex_4": 4.75, "hindex_5": 5.0, "adopters_0": 13.0, "adopters_1": 0.0, "adopters_2": 13.0, "adopters_3": 43.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.81675, "citationsperpaper_1": 3.97225, "citationsperpaper_2": 5.2375, "citationsperpaper_3": 7.30825, "citationsperpaper_4": 7.71825, "citationsperpaper_5": 8.75975, "citationsperyear_0": 4.21825, "citationsperyear_1": 4.0225, "citationsperyear_2": 4.84375, "citationsperyear_3": 5.51475, "citationsperyear_4": 5.613, "citationsperyear_5": 5.8145, "totalcitations_0": 67.5, "totalcitations_1": 74.0, "totalcitations_2": 90.75, "totalcitations_3": 103.75, "totalcitations_4": 115.25, "totalcitations_5": 124.75, "totalpapers_0": 12.75, "totalpapers_1": 13.0, "totalpapers_2": 14.25, "totalpapers_3": 15.0, "totalpapers_4": 15.0, "totalpapers_5": 15.75, "authorage_0": 9.5, "authorage_1": 10.5, "authorage_2": 11.5, "authorage_3": 12.5, "authorage_4": 13.5, "authorage_5": 14.5, "recentcoauthors_0": 12.75, "recentcoauthors_1": 13.5, "recentcoauthors_2": 6.5, "recentcoauthors_3": 10.25, "recentcoauthors_4": 4.5, "recentcoauthors_5": 5.25, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 229.0, "venuehindexmean_1": 233.5, "venuehindexmean_2": 232.6, "venuehindexmean_3": 238.2166666667, "venuehindexmean_4": 242.5833333333, "venuehindexmean_5": 246.975, "totalvenues_0": 2.25, "totalvenues_1": 2.25, "totalvenues_2": 2.75, "totalvenues_3": 2.75, "totalvenues_4": 2.75, "totalvenues_5": 2.75, "pagerank_0": 3.0417114208, "pagerank_1": 2.9700429618, "pagerank_2": 3.1608349326, "pagerank_3": 3.3165651665, "pagerank_4": 3.2686322747, "pagerank_5": 3.4591390014}}, {"model": "papers.paper", "pk": 1003080, "fields": {"authors": ["XiuzhenYu", "YoshioMatsui"], "affiliation": "National Institute for Materials Science", "venue": "Nature", "doi": "10.1038/nature09124", "abstract": "Skyrmions are stable topological textures with particle-like properties, a mathematical concept originally developed to describe nuclear particles, but which in the past decade has found application at all scales from microscopic to cosmological. Skyrmions have proved particularly useful to describe novel spin configurations in magnets, and last year the presence of skyrmions in the magnetic compounds MnSi and Fe1xCoxSi was confirmed in neutron scattering experiments. Now Yu et al. present striking real-space images, using transmission electron microscopy, of a two-dimensional skyrmion lattice for the latter compound, in the form of a hexagonal arrangement of swirling spin structures. The lattice is shown to be stable for a wide range of temperatures and magnetic fields. The authors speculate that the observed nanometre-scale spin topology may lead to interesting new magnetoelectric effects.", "year": 2010, "title": "Real-space observation of a two-dimensional skyrmion crystal", "keywords": ["Skyrmion", "Magnetic skyrmion", "Neutron scattering", "Magnetic field", "Magnetic structure", "Condensed matter physics", "Chemistry", "Ferromagnetism", "Spin-\u00bd", "Spintronics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 3.0, "citations_3": 6.0, "citations_4": 0.0, "citations_5": 3.0, "timescaledpagerank_0": 0.8435728768, "timescaledpagerank_1": 0.5907885863, "timescaledpagerank_2": 1.3786332499, "timescaledpagerank_3": 2.4379544614, "timescaledpagerank_4": 1.9517435331, "timescaledpagerank_5": 2.0369756498, "hindex_0": 2.5, "hindex_1": 2.5, "hindex_2": 3.0, "hindex_3": 3.5, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 13.0, "adopters_1": 0.0, "adopters_2": 13.0, "adopters_3": 43.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.55, "citationsperpaper_1": 3.0, "citationsperpaper_2": 3.8635, "citationsperpaper_3": 6.2725, "citationsperpaper_4": 6.4545, "citationsperpaper_5": 7.909, "citationsperyear_0": 4.1, "citationsperyear_1": 3.8335, "citationsperyear_2": 4.7145, "citationsperyear_3": 5.5625, "citationsperyear_4": 5.011, "citationsperyear_5": 5.25, "totalcitations_0": 16.5, "totalcitations_1": 21.0, "totalcitations_2": 29.0, "totalcitations_3": 37.5, "totalcitations_4": 39.5, "totalcitations_5": 46.5, "totalpapers_0": 5.5, "totalpapers_1": 5.5, "totalpapers_2": 6.5, "totalpapers_3": 6.5, "totalpapers_4": 6.5, "totalpapers_5": 6.5, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 18.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 212.0, "venuehindexmean_1": 216.6, "venuehindexmean_2": 198.2, "venuehindexmean_3": 203.1, "venuehindexmean_4": 207.5, "venuehindexmean_5": 211.7, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.5, "totalvenues_3": 3.5, "totalvenues_4": 3.5, "totalvenues_5": 3.5, "pagerank_0": 2.4085528007, "pagerank_1": 2.35375237, "pagerank_2": 2.6753772333, "pagerank_3": 2.5766308434, "pagerank_4": 2.5368124655, "pagerank_5": 2.485194105}}, {"model": "papers.paper", "pk": 1003080, "fields": {"authors": ["YoshinoriTokura", "NaotoNagaosa"], "affiliation": "National Institute of Advanced Industrial Science and Technology", "venue": "Nature", "doi": "10.1038/nature09124", "abstract": "Skyrmions are stable topological textures with particle-like properties, a mathematical concept originally developed to describe nuclear particles, but which in the past decade has found application at all scales from microscopic to cosmological. Skyrmions have proved particularly useful to describe novel spin configurations in magnets, and last year the presence of skyrmions in the magnetic compounds MnSi and Fe1xCoxSi was confirmed in neutron scattering experiments. Now Yu et al. present striking real-space images, using transmission electron microscopy, of a two-dimensional skyrmion lattice for the latter compound, in the form of a hexagonal arrangement of swirling spin structures. The lattice is shown to be stable for a wide range of temperatures and magnetic fields. The authors speculate that the observed nanometre-scale spin topology may lead to interesting new magnetoelectric effects.", "year": 2010, "title": "Real-space observation of a two-dimensional skyrmion crystal", "keywords": ["Skyrmion", "Magnetic skyrmion", "Neutron scattering", "Magnetic field", "Magnetic structure", "Condensed matter physics", "Chemistry", "Ferromagnetism", "Spin-\u00bd", "Spintronics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 3.0, "citations_3": 6.0, "citations_4": 0.0, "citations_5": 3.0, "timescaledpagerank_0": 0.8435728768, "timescaledpagerank_1": 0.5907885863, "timescaledpagerank_2": 1.3786332499, "timescaledpagerank_3": 2.4379544614, "timescaledpagerank_4": 1.9517435331, "timescaledpagerank_5": 2.0369756498, "hindex_0": 6.5, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.5, "hindex_4": 8.0, "hindex_5": 8.5, "adopters_0": 13.0, "adopters_1": 0.0, "adopters_2": 13.0, "adopters_3": 43.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.6335, "citationsperpaper_1": 5.9445, "citationsperpaper_2": 6.225, "citationsperpaper_3": 6.6165, "citationsperpaper_4": 7.3115, "citationsperpaper_5": 7.3945, "citationsperyear_0": 6.6365, "citationsperyear_1": 6.8785, "citationsperyear_2": 7.854, "citationsperyear_3": 8.4045, "citationsperyear_4": 8.9595, "citationsperyear_5": 9.2125, "totalcitations_0": 130.0, "totalcitations_1": 143.0, "totalcitations_2": 172.0, "totalcitations_3": 192.0, "totalcitations_4": 214.5, "totalcitations_5": 230.0, "totalpapers_0": 23.0, "totalpapers_1": 23.5, "totalpapers_2": 26.0, "totalpapers_3": 27.5, "totalpapers_4": 27.5, "totalpapers_5": 29.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 16.0, "recentcoauthors_1": 17.5, "recentcoauthors_2": 13.0, "recentcoauthors_3": 20.5, "recentcoauthors_4": 9.0, "recentcoauthors_5": 10.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 204.75, "venuehindexmean_1": 209.75, "venuehindexmean_2": 202.2, "venuehindexmean_3": 207.4333333333, "venuehindexmean_4": 211.6666666667, "venuehindexmean_5": 216.2, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 5.2176816114, "pagerank_1": 5.0905896501, "pagerank_2": 5.4997828757, "pagerank_3": 5.8230028117, "pagerank_4": 5.7346886184, "pagerank_5": 6.1238677805}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["LaurenceFlorens"], "affiliation": "J. Craig Venter Institute", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 11.0, "hindex_1": 14.0, "hindex_2": 16.0, "hindex_3": 18.0, "hindex_4": 19.0, "hindex_5": 19.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 14.579, "citationsperpaper_1": 14.625, "citationsperpaper_2": 15.691, "citationsperpaper_3": 17.627, "citationsperpaper_4": 17.615, "citationsperpaper_5": 18.261, "citationsperyear_0": 32.588, "citationsperyear_1": 39.0, "citationsperyear_2": 45.421, "citationsperyear_3": 52.0, "citationsperyear_4": 54.524, "citationsperyear_5": 57.273, "totalcitations_0": 554.0, "totalcitations_1": 702.0, "totalcitations_2": 863.0, "totalcitations_3": 1040.0, "totalcitations_4": 1145.0, "totalcitations_5": 1260.0, "totalpapers_0": 38.0, "totalpapers_1": 48.0, "totalpapers_2": 55.0, "totalpapers_3": 59.0, "totalpapers_4": 65.0, "totalpapers_5": 69.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 96.0, "recentcoauthors_1": 137.0, "recentcoauthors_2": 156.0, "recentcoauthors_3": 97.0, "recentcoauthors_4": 80.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.0, "venuehindexmean_1": 125.2857142857, "venuehindexmean_2": 128.6428571429, "venuehindexmean_3": 131.2857142857, "venuehindexmean_4": 128.4666666667, "venuehindexmean_5": 130.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 14.0, "totalvenues_2": 14.0, "totalvenues_3": 14.0, "totalvenues_4": 15.0, "totalvenues_5": 15.0, "pagerank_0": 10.6243938162, "pagerank_1": 13.0824681001, "pagerank_2": 14.4979175081, "pagerank_3": 15.0958256488, "pagerank_4": 15.9941032703, "pagerank_5": 16.4082972834}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["LaurenceFlorens", "AnitaSaraf"], "affiliation": "Scripps Research Institute", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 6.0, "hindex_1": 8.5, "hindex_2": 10.0, "hindex_3": 11.5, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 10.956, "citationsperpaper_1": 11.598, "citationsperpaper_2": 13.0955, "citationsperpaper_3": 14.3635, "citationsperpaper_4": 14.099, "citationsperpaper_5": 15.0535, "citationsperyear_0": 18.7385, "citationsperyear_1": 22.5, "citationsperyear_2": 26.5285, "citationsperyear_3": 30.625, "citationsperyear_4": 32.1465, "citationsperyear_5": 34.1365, "totalcitations_0": 299.0, "totalcitations_1": 381.0, "totalcitations_2": 473.5, "totalcitations_3": 575.5, "totalcitations_4": 636.0, "totalcitations_5": 707.0, "totalpapers_0": 22.0, "totalpapers_1": 27.5, "totalpapers_2": 31.5, "totalpapers_3": 34.5, "totalpapers_4": 38.5, "totalpapers_5": 41.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 61.5, "recentcoauthors_1": 81.5, "recentcoauthors_2": 86.0, "recentcoauthors_3": 60.5, "recentcoauthors_4": 54.0, "recentcoauthors_5": 49.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.9, "venuehindexmean_1": 146.2428571429, "venuehindexmean_2": 156.8214285714, "venuehindexmean_3": 152.2857142857, "venuehindexmean_4": 144.6083333333, "venuehindexmean_5": 146.6416666667, "totalvenues_0": 8.5, "totalvenues_1": 9.5, "totalvenues_2": 10.0, "totalvenues_3": 10.5, "totalvenues_4": 11.5, "totalvenues_5": 11.5, "pagerank_0": 6.1954849903, "pagerank_1": 7.5461596088, "pagerank_2": 8.3827556952, "pagerank_3": 8.8390345774, "pagerank_4": 9.45292466, "pagerank_5": 9.7222246393}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["LaurenceFlorens", "AnitaSaraf", "Michael P.Washburn"], "affiliation": "Stowers Institute for Medical Research", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 7.6666666667, "hindex_1": 10.0, "hindex_2": 11.6666666667, "hindex_3": 13.3333333333, "hindex_4": 14.0, "hindex_5": 14.3333333333, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 12.5263333333, "citationsperpaper_1": 12.7633333333, "citationsperpaper_2": 14.0253333333, "citationsperpaper_3": 15.4796666667, "citationsperpaper_4": 15.4946666667, "citationsperpaper_5": 16.465, "citationsperyear_0": 32.4316666667, "citationsperyear_1": 37.2223333333, "citationsperyear_2": 42.5316666667, "citationsperyear_3": 48.25, "citationsperyear_4": 49.8753333333, "citationsperyear_5": 52.091, "totalcitations_0": 418.6666666667, "totalcitations_1": 520.6666666667, "totalcitations_2": 638.6666666667, "totalcitations_3": 773.3333333333, "totalcitations_4": 850.6666666667, "totalcitations_5": 940.6666666667, "totalpapers_0": 28.6666666667, "totalpapers_1": 36.0, "totalpapers_2": 41.3333333333, "totalpapers_3": 45.0, "totalpapers_4": 49.0, "totalpapers_5": 51.6666666667, "authorage_0": 11.3333333333, "authorage_1": 12.3333333333, "authorage_2": 13.3333333333, "authorage_3": 14.3333333333, "authorage_4": 15.3333333333, "authorage_5": 16.3333333333, "recentcoauthors_0": 70.6666666667, "recentcoauthors_1": 98.0, "recentcoauthors_2": 111.6666666667, "recentcoauthors_3": 87.0, "recentcoauthors_4": 71.0, "recentcoauthors_5": 52.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 138.0761904762, "venuehindexmean_1": 136.0577380952, "venuehindexmean_2": 144.255952381, "venuehindexmean_3": 142.2529761905, "venuehindexmean_4": 138.0305555556, "venuehindexmean_5": 140.1777777778, "totalvenues_0": 10.3333333333, "totalvenues_1": 11.6666666667, "totalvenues_2": 12.0, "totalvenues_3": 12.3333333333, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 7.4925954536, "pagerank_1": 9.2229119468, "pagerank_2": 10.3952941668, "pagerank_3": 11.153058609, "pagerank_4": 11.7113020698, "pagerank_5": 11.9559903877}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Brian DavidDynlacht"], "affiliation": "University of North Carolina at Chapel Hill", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 20.0, "hindex_1": 20.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.0, "hindex_5": 21.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 47.121, "citationsperpaper_1": 44.722, "citationsperpaper_2": 43.395, "citationsperpaper_3": 43.538, "citationsperpaper_4": 40.465, "citationsperpaper_5": 41.512, "citationsperyear_0": 70.682, "citationsperyear_1": 70.0, "citationsperyear_2": 68.708, "citationsperyear_3": 67.92, "citationsperyear_4": 66.923, "citationsperyear_5": 66.111, "totalcitations_0": 1555.0, "totalcitations_1": 1610.0, "totalcitations_2": 1649.0, "totalcitations_3": 1698.0, "totalcitations_4": 1740.0, "totalcitations_5": 1785.0, "totalpapers_0": 33.0, "totalpapers_1": 36.0, "totalpapers_2": 38.0, "totalpapers_3": 39.0, "totalpapers_4": 43.0, "totalpapers_5": 43.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 20.0, "recentcoauthors_2": 26.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.625, "venuehindexmean_1": 159.625, "venuehindexmean_2": 154.3333333333, "venuehindexmean_3": 157.0, "venuehindexmean_4": 152.3, "venuehindexmean_5": 154.4, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 5.8838899143, "pagerank_1": 6.3234767031, "pagerank_2": 6.5379933007, "pagerank_3": 6.5238411977, "pagerank_4": 6.8435510307, "pagerank_5": 6.4581757049}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Brian DavidDynlacht"], "affiliation": "Rutgers University", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 20.0, "hindex_1": 20.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.0, "hindex_5": 21.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 47.121, "citationsperpaper_1": 44.722, "citationsperpaper_2": 43.395, "citationsperpaper_3": 43.538, "citationsperpaper_4": 40.465, "citationsperpaper_5": 41.512, "citationsperyear_0": 70.682, "citationsperyear_1": 70.0, "citationsperyear_2": 68.708, "citationsperyear_3": 67.92, "citationsperyear_4": 66.923, "citationsperyear_5": 66.111, "totalcitations_0": 1555.0, "totalcitations_1": 1610.0, "totalcitations_2": 1649.0, "totalcitations_3": 1698.0, "totalcitations_4": 1740.0, "totalcitations_5": 1785.0, "totalpapers_0": 33.0, "totalpapers_1": 36.0, "totalpapers_2": 38.0, "totalpapers_3": 39.0, "totalpapers_4": 43.0, "totalpapers_5": 43.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 20.0, "recentcoauthors_2": 26.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.625, "venuehindexmean_1": 159.625, "venuehindexmean_2": 154.3333333333, "venuehindexmean_3": 157.0, "venuehindexmean_4": 152.3, "venuehindexmean_5": 154.4, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 5.8838899143, "pagerank_1": 6.3234767031, "pagerank_2": 6.5379933007, "pagerank_3": 6.5238411977, "pagerank_4": 6.8435510307, "pagerank_5": 6.4581757049}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Brian DavidDynlacht"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 20.0, "hindex_1": 20.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.0, "hindex_5": 21.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 47.121, "citationsperpaper_1": 44.722, "citationsperpaper_2": 43.395, "citationsperpaper_3": 43.538, "citationsperpaper_4": 40.465, "citationsperpaper_5": 41.512, "citationsperyear_0": 70.682, "citationsperyear_1": 70.0, "citationsperyear_2": 68.708, "citationsperyear_3": 67.92, "citationsperyear_4": 66.923, "citationsperyear_5": 66.111, "totalcitations_0": 1555.0, "totalcitations_1": 1610.0, "totalcitations_2": 1649.0, "totalcitations_3": 1698.0, "totalcitations_4": 1740.0, "totalcitations_5": 1785.0, "totalpapers_0": 33.0, "totalpapers_1": 36.0, "totalpapers_2": 38.0, "totalpapers_3": 39.0, "totalpapers_4": 43.0, "totalpapers_5": 43.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 20.0, "recentcoauthors_2": 26.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.625, "venuehindexmean_1": 159.625, "venuehindexmean_2": 154.3333333333, "venuehindexmean_3": 157.0, "venuehindexmean_4": 152.3, "venuehindexmean_5": 154.4, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 5.8838899143, "pagerank_1": 6.3234767031, "pagerank_2": 6.5379933007, "pagerank_3": 6.5238411977, "pagerank_4": 6.8435510307, "pagerank_5": 6.4581757049}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Brian DavidDynlacht"], "affiliation": "University of California, Berkeley", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 20.0, "hindex_1": 20.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.0, "hindex_5": 21.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 47.121, "citationsperpaper_1": 44.722, "citationsperpaper_2": 43.395, "citationsperpaper_3": 43.538, "citationsperpaper_4": 40.465, "citationsperpaper_5": 41.512, "citationsperyear_0": 70.682, "citationsperyear_1": 70.0, "citationsperyear_2": 68.708, "citationsperyear_3": 67.92, "citationsperyear_4": 66.923, "citationsperyear_5": 66.111, "totalcitations_0": 1555.0, "totalcitations_1": 1610.0, "totalcitations_2": 1649.0, "totalcitations_3": 1698.0, "totalcitations_4": 1740.0, "totalcitations_5": 1785.0, "totalpapers_0": 33.0, "totalpapers_1": 36.0, "totalpapers_2": 38.0, "totalpapers_3": 39.0, "totalpapers_4": 43.0, "totalpapers_5": 43.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 20.0, "recentcoauthors_2": 26.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.625, "venuehindexmean_1": 159.625, "venuehindexmean_2": 154.3333333333, "venuehindexmean_3": 157.0, "venuehindexmean_4": 152.3, "venuehindexmean_5": 154.4, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 5.8838899143, "pagerank_1": 6.3234767031, "pagerank_2": 6.5379933007, "pagerank_3": 6.5238411977, "pagerank_4": 6.8435510307, "pagerank_5": 6.4581757049}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["SangeethaVijayakumar", "VincenzoD'Angiolella", "Brian DavidDynlacht", "ValerioDonato", "MichelePagano"], "affiliation": "New York University", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 9.8, "hindex_1": 10.0, "hindex_2": 10.6, "hindex_3": 11.2, "hindex_4": 11.6, "hindex_5": 11.6, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 17.842, "citationsperpaper_1": 19.897, "citationsperpaper_2": 19.6366, "citationsperpaper_3": 21.915, "citationsperpaper_4": 20.9086, "citationsperpaper_5": 22.2486, "citationsperyear_0": 42.1338, "citationsperyear_1": 42.9022, "citationsperyear_2": 42.9208, "citationsperyear_3": 43.4886, "citationsperyear_4": 43.2978, "citationsperyear_5": 42.9824, "totalcitations_0": 833.0, "totalcitations_1": 872.0, "totalcitations_2": 913.6, "totalcitations_3": 957.0, "totalcitations_4": 996.4, "totalcitations_5": 1027.6, "totalpapers_0": 22.2, "totalpapers_1": 23.4, "totalpapers_2": 26.0, "totalpapers_3": 27.2, "totalpapers_4": 29.0, "totalpapers_5": 29.2, "authorage_0": 9.2, "authorage_1": 10.2, "authorage_2": 11.2, "authorage_3": 12.2, "authorage_4": 13.2, "authorage_5": 14.2, "recentcoauthors_0": 13.8, "recentcoauthors_1": 13.8, "recentcoauthors_2": 24.0, "recentcoauthors_3": 29.4, "recentcoauthors_4": 16.8, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 189.4583333333, "venuehindexmean_1": 192.5916666667, "venuehindexmean_2": 199.4901960784, "venuehindexmean_3": 203.2862745098, "venuehindexmean_4": 185.7364705882, "venuehindexmean_5": 180.4849019608, "totalvenues_0": 5.6, "totalvenues_1": 5.6, "totalvenues_2": 6.6, "totalvenues_3": 6.6, "totalvenues_4": 7.0, "totalvenues_5": 7.2, "pagerank_0": 4.8501292148, "pagerank_1": 4.8520641367, "pagerank_2": 5.3208228341, "pagerank_3": 5.4144976942, "pagerank_4": 5.5365287708, "pagerank_5": 5.3662730215}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["VincenzoD'Angiolella"], "affiliation": "University of Oxford", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 5.0, "citationsperpaper_1": 9.5, "citationsperpaper_2": 9.333, "citationsperpaper_3": 11.25, "citationsperpaper_4": 13.75, "citationsperpaper_5": 14.0, "citationsperyear_0": 1.25, "citationsperyear_1": 2.111, "citationsperyear_2": 2.8, "citationsperyear_3": 4.091, "citationsperyear_4": 4.583, "citationsperyear_5": 5.385, "totalcitations_0": 10.0, "totalcitations_1": 19.0, "totalcitations_2": 28.0, "totalcitations_3": 45.0, "totalcitations_4": 55.0, "totalcitations_5": 70.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 5.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 17.0, "recentcoauthors_4": 8.0, "recentcoauthors_5": 17.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 196.0, "venuehindexmean_1": 199.5, "venuehindexmean_2": 221.6666666667, "venuehindexmean_3": 226.0, "venuehindexmean_4": 229.3333333333, "venuehindexmean_5": 193.75, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 4.0, "pagerank_0": 0.7215518496, "pagerank_1": 0.7110586614, "pagerank_2": 0.9925785036, "pagerank_3": 1.2727665219, "pagerank_4": 1.2509448109, "pagerank_5": 1.726006045}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["VincenzoD'Angiolella"], "affiliation": "Medical Research Council", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 5.0, "citationsperpaper_1": 9.5, "citationsperpaper_2": 9.333, "citationsperpaper_3": 11.25, "citationsperpaper_4": 13.75, "citationsperpaper_5": 14.0, "citationsperyear_0": 1.25, "citationsperyear_1": 2.111, "citationsperyear_2": 2.8, "citationsperyear_3": 4.091, "citationsperyear_4": 4.583, "citationsperyear_5": 5.385, "totalcitations_0": 10.0, "totalcitations_1": 19.0, "totalcitations_2": 28.0, "totalcitations_3": 45.0, "totalcitations_4": 55.0, "totalcitations_5": 70.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 5.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 17.0, "recentcoauthors_4": 8.0, "recentcoauthors_5": 17.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 196.0, "venuehindexmean_1": 199.5, "venuehindexmean_2": 221.6666666667, "venuehindexmean_3": 226.0, "venuehindexmean_4": 229.3333333333, "venuehindexmean_5": 193.75, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 4.0, "pagerank_0": 0.7215518496, "pagerank_1": 0.7110586614, "pagerank_2": 0.9925785036, "pagerank_3": 1.2727665219, "pagerank_4": 1.2509448109, "pagerank_5": 1.726006045}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Michael P.Washburn"], "affiliation": "Discovery Institute", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 11.0, "hindex_1": 13.0, "hindex_2": 15.0, "hindex_3": 17.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 15.667, "citationsperpaper_1": 15.094, "citationsperpaper_2": 15.885, "citationsperpaper_3": 17.712, "citationsperpaper_4": 18.286, "citationsperpaper_5": 19.288, "citationsperyear_0": 59.818, "citationsperyear_1": 66.667, "citationsperyear_2": 74.538, "citationsperyear_3": 83.5, "citationsperyear_4": 85.333, "citationsperyear_5": 88.0, "totalcitations_0": 658.0, "totalcitations_1": 800.0, "totalcitations_2": 969.0, "totalcitations_3": 1169.0, "totalcitations_4": 1280.0, "totalcitations_5": 1408.0, "totalpapers_0": 42.0, "totalpapers_1": 53.0, "totalpapers_2": 61.0, "totalpapers_3": 66.0, "totalpapers_4": 70.0, "totalpapers_5": 73.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 89.0, "recentcoauthors_1": 131.0, "recentcoauthors_2": 163.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 105.0, "recentcoauthors_5": 59.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.4285714286, "venuehindexmean_1": 115.6875, "venuehindexmean_2": 119.125, "venuehindexmean_3": 122.1875, "venuehindexmean_4": 124.875, "venuehindexmean_5": 127.25, "totalvenues_0": 14.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 10.0868163801, "pagerank_1": 12.5764166229, "pagerank_2": 14.4203711099, "pagerank_3": 15.7811066721, "pagerank_4": 16.2280568894, "pagerank_5": 16.4235218845}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Michael P.Washburn"], "affiliation": "Syngenta", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 11.0, "hindex_1": 13.0, "hindex_2": 15.0, "hindex_3": 17.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 15.667, "citationsperpaper_1": 15.094, "citationsperpaper_2": 15.885, "citationsperpaper_3": 17.712, "citationsperpaper_4": 18.286, "citationsperpaper_5": 19.288, "citationsperyear_0": 59.818, "citationsperyear_1": 66.667, "citationsperyear_2": 74.538, "citationsperyear_3": 83.5, "citationsperyear_4": 85.333, "citationsperyear_5": 88.0, "totalcitations_0": 658.0, "totalcitations_1": 800.0, "totalcitations_2": 969.0, "totalcitations_3": 1169.0, "totalcitations_4": 1280.0, "totalcitations_5": 1408.0, "totalpapers_0": 42.0, "totalpapers_1": 53.0, "totalpapers_2": 61.0, "totalpapers_3": 66.0, "totalpapers_4": 70.0, "totalpapers_5": 73.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 89.0, "recentcoauthors_1": 131.0, "recentcoauthors_2": 163.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 105.0, "recentcoauthors_5": 59.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.4285714286, "venuehindexmean_1": 115.6875, "venuehindexmean_2": 119.125, "venuehindexmean_3": 122.1875, "venuehindexmean_4": 124.875, "venuehindexmean_5": 127.25, "totalvenues_0": 14.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 10.0868163801, "pagerank_1": 12.5764166229, "pagerank_2": 14.4203711099, "pagerank_3": 15.7811066721, "pagerank_4": 16.2280568894, "pagerank_5": 16.4235218845}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Michael P.Washburn"], "affiliation": "University of Oklahoma Health Sciences Center", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 11.0, "hindex_1": 13.0, "hindex_2": 15.0, "hindex_3": 17.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 15.667, "citationsperpaper_1": 15.094, "citationsperpaper_2": 15.885, "citationsperpaper_3": 17.712, "citationsperpaper_4": 18.286, "citationsperpaper_5": 19.288, "citationsperyear_0": 59.818, "citationsperyear_1": 66.667, "citationsperyear_2": 74.538, "citationsperyear_3": 83.5, "citationsperyear_4": 85.333, "citationsperyear_5": 88.0, "totalcitations_0": 658.0, "totalcitations_1": 800.0, "totalcitations_2": 969.0, "totalcitations_3": 1169.0, "totalcitations_4": 1280.0, "totalcitations_5": 1408.0, "totalpapers_0": 42.0, "totalpapers_1": 53.0, "totalpapers_2": 61.0, "totalpapers_3": 66.0, "totalpapers_4": 70.0, "totalpapers_5": 73.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 89.0, "recentcoauthors_1": 131.0, "recentcoauthors_2": 163.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 105.0, "recentcoauthors_5": 59.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.4285714286, "venuehindexmean_1": 115.6875, "venuehindexmean_2": 119.125, "venuehindexmean_3": 122.1875, "venuehindexmean_4": 124.875, "venuehindexmean_5": 127.25, "totalvenues_0": 14.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 10.0868163801, "pagerank_1": 12.5764166229, "pagerank_2": 14.4203711099, "pagerank_3": 15.7811066721, "pagerank_4": 16.2280568894, "pagerank_5": 16.4235218845}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Michael P.Washburn"], "affiliation": "Michigan State University", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 11.0, "hindex_1": 13.0, "hindex_2": 15.0, "hindex_3": 17.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 15.667, "citationsperpaper_1": 15.094, "citationsperpaper_2": 15.885, "citationsperpaper_3": 17.712, "citationsperpaper_4": 18.286, "citationsperpaper_5": 19.288, "citationsperyear_0": 59.818, "citationsperyear_1": 66.667, "citationsperyear_2": 74.538, "citationsperyear_3": 83.5, "citationsperyear_4": 85.333, "citationsperyear_5": 88.0, "totalcitations_0": 658.0, "totalcitations_1": 800.0, "totalcitations_2": 969.0, "totalcitations_3": 1169.0, "totalcitations_4": 1280.0, "totalcitations_5": 1408.0, "totalpapers_0": 42.0, "totalpapers_1": 53.0, "totalpapers_2": 61.0, "totalpapers_3": 66.0, "totalpapers_4": 70.0, "totalpapers_5": 73.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 89.0, "recentcoauthors_1": 131.0, "recentcoauthors_2": 163.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 105.0, "recentcoauthors_5": 59.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.4285714286, "venuehindexmean_1": 115.6875, "venuehindexmean_2": 119.125, "venuehindexmean_3": 122.1875, "venuehindexmean_4": 124.875, "venuehindexmean_5": 127.25, "totalvenues_0": 14.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 10.0868163801, "pagerank_1": 12.5764166229, "pagerank_2": 14.4203711099, "pagerank_3": 15.7811066721, "pagerank_4": 16.2280568894, "pagerank_5": 16.4235218845}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["Michael P.Washburn"], "affiliation": "University of Kansas", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 11.0, "hindex_1": 13.0, "hindex_2": 15.0, "hindex_3": 17.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 15.667, "citationsperpaper_1": 15.094, "citationsperpaper_2": 15.885, "citationsperpaper_3": 17.712, "citationsperpaper_4": 18.286, "citationsperpaper_5": 19.288, "citationsperyear_0": 59.818, "citationsperyear_1": 66.667, "citationsperyear_2": 74.538, "citationsperyear_3": 83.5, "citationsperyear_4": 85.333, "citationsperyear_5": 88.0, "totalcitations_0": 658.0, "totalcitations_1": 800.0, "totalcitations_2": 969.0, "totalcitations_3": 1169.0, "totalcitations_4": 1280.0, "totalcitations_5": 1408.0, "totalpapers_0": 42.0, "totalpapers_1": 53.0, "totalpapers_2": 61.0, "totalpapers_3": 66.0, "totalpapers_4": 70.0, "totalpapers_5": 73.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 89.0, "recentcoauthors_1": 131.0, "recentcoauthors_2": 163.0, "recentcoauthors_3": 140.0, "recentcoauthors_4": 105.0, "recentcoauthors_5": 59.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 118.4285714286, "venuehindexmean_1": 115.6875, "venuehindexmean_2": 119.125, "venuehindexmean_3": 122.1875, "venuehindexmean_4": 124.875, "venuehindexmean_5": 127.25, "totalvenues_0": 14.0, "totalvenues_1": 16.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 10.0868163801, "pagerank_1": 12.5764166229, "pagerank_2": 14.4203711099, "pagerank_3": 15.7811066721, "pagerank_4": 16.2280568894, "pagerank_5": 16.4235218845}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["MichelePagano"], "affiliation": "Baylor College of Medicine", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 26.0, "hindex_1": 26.0, "hindex_2": 28.0, "hindex_3": 29.0, "hindex_4": 30.0, "hindex_5": 30.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 35.589, "citationsperpaper_1": 35.763, "citationsperpaper_2": 33.788, "citationsperpaper_3": 33.787, "citationsperpaper_4": 33.828, "citationsperpaper_5": 34.731, "citationsperyear_0": 136.737, "citationsperyear_1": 135.9, "citationsperyear_2": 136.762, "citationsperyear_3": 136.682, "citationsperyear_4": 136.783, "citationsperyear_5": 134.583, "totalcitations_0": 2598.0, "totalcitations_1": 2718.0, "totalcitations_2": 2872.0, "totalcitations_3": 3007.0, "totalcitations_4": 3146.0, "totalcitations_5": 3230.0, "totalpapers_0": 73.0, "totalpapers_1": 76.0, "totalpapers_2": 85.0, "totalpapers_3": 89.0, "totalpapers_4": 93.0, "totalpapers_5": 93.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 22.0, "recentcoauthors_2": 76.0, "recentcoauthors_3": 100.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.6666666667, "venuehindexmean_1": 138.3333333333, "venuehindexmean_2": 129.1176470588, "venuehindexmean_3": 131.7647058824, "venuehindexmean_4": 133.8823529412, "venuehindexmean_5": 135.9411764706, "totalvenues_0": 15.0, "totalvenues_1": 15.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 17.0, "pagerank_0": 16.6207954983, "pagerank_1": 16.2398264653, "pagerank_2": 17.8214123455, "pagerank_3": 18.0858818686, "pagerank_4": 18.0848572928, "pagerank_5": 17.1879010338}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["MichelePagano"], "affiliation": "Boston University", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 26.0, "hindex_1": 26.0, "hindex_2": 28.0, "hindex_3": 29.0, "hindex_4": 30.0, "hindex_5": 30.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 35.589, "citationsperpaper_1": 35.763, "citationsperpaper_2": 33.788, "citationsperpaper_3": 33.787, "citationsperpaper_4": 33.828, "citationsperpaper_5": 34.731, "citationsperyear_0": 136.737, "citationsperyear_1": 135.9, "citationsperyear_2": 136.762, "citationsperyear_3": 136.682, "citationsperyear_4": 136.783, "citationsperyear_5": 134.583, "totalcitations_0": 2598.0, "totalcitations_1": 2718.0, "totalcitations_2": 2872.0, "totalcitations_3": 3007.0, "totalcitations_4": 3146.0, "totalcitations_5": 3230.0, "totalpapers_0": 73.0, "totalpapers_1": 76.0, "totalpapers_2": 85.0, "totalpapers_3": 89.0, "totalpapers_4": 93.0, "totalpapers_5": 93.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 22.0, "recentcoauthors_2": 76.0, "recentcoauthors_3": 100.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.6666666667, "venuehindexmean_1": 138.3333333333, "venuehindexmean_2": 129.1176470588, "venuehindexmean_3": 131.7647058824, "venuehindexmean_4": 133.8823529412, "venuehindexmean_5": 135.9411764706, "totalvenues_0": 15.0, "totalvenues_1": 15.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 17.0, "pagerank_0": 16.6207954983, "pagerank_1": 16.2398264653, "pagerank_2": 17.8214123455, "pagerank_3": 18.0858818686, "pagerank_4": 18.0848572928, "pagerank_5": 17.1879010338}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["MichelePagano"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 26.0, "hindex_1": 26.0, "hindex_2": 28.0, "hindex_3": 29.0, "hindex_4": 30.0, "hindex_5": 30.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 35.589, "citationsperpaper_1": 35.763, "citationsperpaper_2": 33.788, "citationsperpaper_3": 33.787, "citationsperpaper_4": 33.828, "citationsperpaper_5": 34.731, "citationsperyear_0": 136.737, "citationsperyear_1": 135.9, "citationsperyear_2": 136.762, "citationsperyear_3": 136.682, "citationsperyear_4": 136.783, "citationsperyear_5": 134.583, "totalcitations_0": 2598.0, "totalcitations_1": 2718.0, "totalcitations_2": 2872.0, "totalcitations_3": 3007.0, "totalcitations_4": 3146.0, "totalcitations_5": 3230.0, "totalpapers_0": 73.0, "totalpapers_1": 76.0, "totalpapers_2": 85.0, "totalpapers_3": 89.0, "totalpapers_4": 93.0, "totalpapers_5": 93.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 22.0, "recentcoauthors_2": 76.0, "recentcoauthors_3": 100.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.6666666667, "venuehindexmean_1": 138.3333333333, "venuehindexmean_2": 129.1176470588, "venuehindexmean_3": 131.7647058824, "venuehindexmean_4": 133.8823529412, "venuehindexmean_5": 135.9411764706, "totalvenues_0": 15.0, "totalvenues_1": 15.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 17.0, "pagerank_0": 16.6207954983, "pagerank_1": 16.2398264653, "pagerank_2": 17.8214123455, "pagerank_3": 18.0858818686, "pagerank_4": 18.0848572928, "pagerank_5": 17.1879010338}}, {"model": "papers.paper", "pk": 1003121, "fields": {"authors": ["MichelePagano"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature09140", "abstract": "Cyclin F is the founding member of the F-box protein family but its functions are unknown. In contrast to most cyclins, it does not bind or activate cyclin-dependent kinases (CDKs). Here, a protein essential for centrosome duplication, CP110, is identified as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Cyclin F is the founding member of the F-box protein family but its functions are unknown; unlike most cyclins, it does not bind or activate cyclin-dependent kinases. Here the authors identify CP110, a protein essential for centrosome duplication, as a substrate of Cyclin F. CP110 and Cyclin F associate on centrioles during the cell cycle, and Cyclin F is proposed to limit centrosome duplication by targeting CP110 for degradation. Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1\u2013Cul1\u2013F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins1,2. Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions3,4. The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the \u223c40-amino-acid domain required for binding to Skp1) was first described5. Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)5,6,7. However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein\u2013substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.", "year": 2010, "title": "SCF Cyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation", "keywords": ["Cyclin A", "Cyclin-dependent kinase complex", "Cyclin D", "Cell biology", "Biology", "Centrosome duplication", "Cyclin D1", "Molecular biology", "Cyclin E", "Cyclin A2", "Cyclin-dependent kinase"], "citations_0": 1.0, "citations_1": 5.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 3.0, "timescaledpagerank_0": 0.1887117975, "timescaledpagerank_1": 0.342822054, "timescaledpagerank_2": 0.3554082333, "timescaledpagerank_3": 0.7143233255, "timescaledpagerank_4": 0.8318448696, "timescaledpagerank_5": 0.8331019166, "hindex_0": 26.0, "hindex_1": 26.0, "hindex_2": 28.0, "hindex_3": 29.0, "hindex_4": 30.0, "hindex_5": 30.0, "adopters_0": 4.0, "adopters_1": 31.0, "adopters_2": 19.0, "adopters_3": 40.0, "adopters_4": 22.0, "adopters_5": 0.0, "citationsperpaper_0": 35.589, "citationsperpaper_1": 35.763, "citationsperpaper_2": 33.788, "citationsperpaper_3": 33.787, "citationsperpaper_4": 33.828, "citationsperpaper_5": 34.731, "citationsperyear_0": 136.737, "citationsperyear_1": 135.9, "citationsperyear_2": 136.762, "citationsperyear_3": 136.682, "citationsperyear_4": 136.783, "citationsperyear_5": 134.583, "totalcitations_0": 2598.0, "totalcitations_1": 2718.0, "totalcitations_2": 2872.0, "totalcitations_3": 3007.0, "totalcitations_4": 3146.0, "totalcitations_5": 3230.0, "totalpapers_0": 73.0, "totalpapers_1": 76.0, "totalpapers_2": 85.0, "totalpapers_3": 89.0, "totalpapers_4": 93.0, "totalpapers_5": 93.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 22.0, "recentcoauthors_2": 76.0, "recentcoauthors_3": 100.0, "recentcoauthors_4": 56.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.6666666667, "venuehindexmean_1": 138.3333333333, "venuehindexmean_2": 129.1176470588, "venuehindexmean_3": 131.7647058824, "venuehindexmean_4": 133.8823529412, "venuehindexmean_5": 135.9411764706, "totalvenues_0": 15.0, "totalvenues_1": 15.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 17.0, "pagerank_0": 16.6207954983, "pagerank_1": 16.2398264653, "pagerank_2": 17.8214123455, "pagerank_3": 18.0858818686, "pagerank_4": 18.0848572928, "pagerank_5": 17.1879010338}}, {"model": "papers.paper", "pk": 1003672, "fields": {"authors": ["SadafShadan"], "affiliation": "Curtin University", "venue": "Nature", "doi": "10.1038/464043a", "abstract": "", "year": 2010, "title": "Time for teeth", "keywords": ["Developmental genetics", "Bioinformatics", "Developmental biology", "Anterior teeth", "Molecular interactions", "Biology", "Orthodontics", "Evolutionary biology", "Posterior teeth", "Medicine"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 13.0, "totalpapers_1": 16.0, "totalpapers_2": 17.0, "totalpapers_3": 18.0, "totalpapers_4": 19.0, "totalpapers_5": 19.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 3.0, "recentcoauthors_5": 3.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.2394367108, "pagerank_1": 0.3222190351, "pagerank_2": 0.3263122912, "pagerank_3": 0.323092902, "pagerank_4": 0.8099412353, "pagerank_5": 0.7448820879}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Laurence J.Zwiebel", "Allison F.Carey"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 4.5, "hindex_1": 4.5, "hindex_2": 5.0, "hindex_3": 5.5, "hindex_4": 6.5, "hindex_5": 6.5, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 9.0355, "citationsperpaper_1": 10.1, "citationsperpaper_2": 10.625, "citationsperpaper_3": 12.0195, "citationsperpaper_4": 14.075, "citationsperpaper_5": 15.1415, "citationsperyear_0": 8.6, "citationsperyear_1": 9.0475, "citationsperyear_2": 8.5455, "citationsperyear_3": 8.9295, "citationsperyear_4": 10.2125, "citationsperyear_5": 9.9635, "totalcitations_0": 105.5, "totalcitations_1": 123.5, "totalcitations_2": 131.0, "totalcitations_3": 146.0, "totalcitations_4": 171.0, "totalcitations_5": 181.0, "totalpapers_0": 8.0, "totalpapers_1": 9.0, "totalpapers_2": 9.5, "totalpapers_3": 10.0, "totalpapers_4": 11.5, "totalpapers_5": 11.5, "authorage_0": 9.5, "authorage_1": 10.5, "authorage_2": 11.5, "authorage_3": 12.5, "authorage_4": 13.5, "authorage_5": 14.5, "recentcoauthors_0": 9.5, "recentcoauthors_1": 11.5, "recentcoauthors_2": 5.5, "recentcoauthors_3": 6.0, "recentcoauthors_4": 67.0, "recentcoauthors_5": 64.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 185.8, "venuehindexmean_1": 189.1, "venuehindexmean_2": 181.9166666667, "venuehindexmean_3": 185.9166666667, "venuehindexmean_4": 188.9285714286, "venuehindexmean_5": 191.8571428571, "totalvenues_0": 3.5, "totalvenues_1": 3.5, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.5, "totalvenues_5": 4.5, "pagerank_0": 1.8599821892, "pagerank_1": 1.9801994063, "pagerank_2": 2.0789510793, "pagerank_3": 2.0965665527, "pagerank_4": 2.6914120657, "pagerank_5": 2.6709947667}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Chih-YingSu", "John R.Carlson", "Laurence J.Zwiebel", "Allison F.Carey"], "affiliation": "Yale University", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 6.25, "hindex_1": 6.5, "hindex_2": 7.0, "hindex_3": 7.5, "hindex_4": 8.75, "hindex_5": 8.75, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 10.001, "citationsperpaper_1": 11.198, "citationsperpaper_2": 11.7125, "citationsperpaper_3": 12.92075, "citationsperpaper_4": 14.768, "citationsperpaper_5": 15.58325, "citationsperyear_0": 10.82775, "citationsperyear_1": 12.04775, "citationsperyear_2": 12.23575, "citationsperyear_3": 13.2315, "citationsperyear_4": 14.59475, "citationsperyear_5": 14.54575, "totalcitations_0": 218.0, "totalcitations_1": 255.0, "totalcitations_2": 276.0, "totalcitations_3": 308.5, "totalcitations_4": 347.25, "totalcitations_5": 365.75, "totalpapers_0": 13.5, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.25, "totalpapers_4": 18.5, "totalpapers_5": 18.75, "authorage_0": 12.25, "authorage_1": 13.25, "authorage_2": 14.25, "authorage_3": 15.25, "authorage_4": 16.25, "authorage_5": 17.25, "recentcoauthors_0": 8.5, "recentcoauthors_1": 11.25, "recentcoauthors_2": 8.5, "recentcoauthors_3": 8.5, "recentcoauthors_4": 38.25, "recentcoauthors_5": 35.25, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 193.0979166667, "venuehindexmean_1": 191.55, "venuehindexmean_2": 186.9236111111, "venuehindexmean_3": 190.9305555556, "venuehindexmean_4": 191.2017857143, "venuehindexmean_5": 194.2910714286, "totalvenues_0": 4.5, "totalvenues_1": 4.75, "totalvenues_2": 5.25, "totalvenues_3": 5.25, "totalvenues_4": 5.75, "totalvenues_5": 5.75, "pagerank_0": 2.7629451328, "pagerank_1": 2.930969275, "pagerank_2": 3.0673456654, "pagerank_3": 3.1157641755, "pagerank_4": 3.377353667, "pagerank_5": 3.3703208595}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Laurence J.Zwiebel", "GuirongWang"], "affiliation": "Vanderbilt University Medical Center", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 5.0, "hindex_1": 5.5, "hindex_2": 6.0, "hindex_3": 6.5, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 8.7855, "citationsperpaper_1": 11.0165, "citationsperpaper_2": 11.125, "citationsperpaper_3": 12.853, "citationsperpaper_4": 14.2, "citationsperpaper_5": 15.1, "citationsperyear_0": 7.1, "citationsperyear_1": 8.7975, "citationsperyear_2": 8.3455, "citationsperyear_3": 9.138, "citationsperyear_4": 10.098, "citationsperyear_5": 9.9425, "totalcitations_0": 108.0, "totalcitations_1": 129.5, "totalcitations_2": 136.0, "totalcitations_3": 153.5, "totalcitations_4": 178.0, "totalcitations_5": 188.0, "totalpapers_0": 9.0, "totalpapers_1": 9.5, "totalpapers_2": 10.0, "totalpapers_3": 10.5, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 10.5, "authorage_1": 11.5, "authorage_2": 12.5, "authorage_3": 13.5, "authorage_4": 14.5, "authorage_5": 15.5, "recentcoauthors_0": 12.0, "recentcoauthors_1": 13.5, "recentcoauthors_2": 5.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 67.0, "recentcoauthors_5": 64.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.6333333333, "venuehindexmean_1": 160.4333333333, "venuehindexmean_2": 153.0833333333, "venuehindexmean_3": 157.25, "venuehindexmean_4": 160.0952380952, "venuehindexmean_5": 162.8571428571, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.5, "totalvenues_3": 4.5, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.1775903708, "pagerank_1": 2.2719675248, "pagerank_2": 2.3657308511, "pagerank_3": 2.3705098921, "pagerank_4": 2.8923219459, "pagerank_5": 2.8714716364}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Laurence J.Zwiebel", "GuirongWang"], "affiliation": "Vanderbilt University", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 5.0, "hindex_1": 5.5, "hindex_2": 6.0, "hindex_3": 6.5, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 8.7855, "citationsperpaper_1": 11.0165, "citationsperpaper_2": 11.125, "citationsperpaper_3": 12.853, "citationsperpaper_4": 14.2, "citationsperpaper_5": 15.1, "citationsperyear_0": 7.1, "citationsperyear_1": 8.7975, "citationsperyear_2": 8.3455, "citationsperyear_3": 9.138, "citationsperyear_4": 10.098, "citationsperyear_5": 9.9425, "totalcitations_0": 108.0, "totalcitations_1": 129.5, "totalcitations_2": 136.0, "totalcitations_3": 153.5, "totalcitations_4": 178.0, "totalcitations_5": 188.0, "totalpapers_0": 9.0, "totalpapers_1": 9.5, "totalpapers_2": 10.0, "totalpapers_3": 10.5, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 10.5, "authorage_1": 11.5, "authorage_2": 12.5, "authorage_3": 13.5, "authorage_4": 14.5, "authorage_5": 15.5, "recentcoauthors_0": 12.0, "recentcoauthors_1": 13.5, "recentcoauthors_2": 5.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 67.0, "recentcoauthors_5": 64.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.6333333333, "venuehindexmean_1": 160.4333333333, "venuehindexmean_2": 153.0833333333, "venuehindexmean_3": 157.25, "venuehindexmean_4": 160.0952380952, "venuehindexmean_5": 162.8571428571, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.5, "totalvenues_3": 4.5, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.1775903708, "pagerank_1": 2.2719675248, "pagerank_2": 2.3657308511, "pagerank_3": 2.3705098921, "pagerank_4": 2.8923219459, "pagerank_5": 2.8714716364}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Chih-YingSu"], "affiliation": "Johns Hopkins University School of Medicine", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 3.333, "citationsperpaper_1": 4.75, "citationsperpaper_2": 5.2, "citationsperpaper_3": 6.667, "citationsperpaper_4": 8.833, "citationsperpaper_5": 9.333, "citationsperyear_0": 2.0, "citationsperyear_1": 3.167, "citationsperyear_2": 3.714, "citationsperyear_3": 5.0, "citationsperyear_4": 5.889, "citationsperyear_5": 5.6, "totalcitations_0": 10.0, "totalcitations_1": 19.0, "totalcitations_2": 26.0, "totalcitations_3": 40.0, "totalcitations_4": 53.0, "totalcitations_5": 56.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 6.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 6.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 247.6666666667, "venuehindexmean_1": 231.5, "venuehindexmean_2": 236.75, "venuehindexmean_3": 241.0, "venuehindexmean_4": 244.75, "venuehindexmean_5": 248.25, "totalvenues_0": 3.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 0.7950156801, "pagerank_1": 0.970971082, "pagerank_2": 1.0814854314, "pagerank_3": 1.0597785479, "pagerank_4": 0.9882134429, "pagerank_5": 0.9658254519}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Chih-YingSu"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 3.333, "citationsperpaper_1": 4.75, "citationsperpaper_2": 5.2, "citationsperpaper_3": 6.667, "citationsperpaper_4": 8.833, "citationsperpaper_5": 9.333, "citationsperyear_0": 2.0, "citationsperyear_1": 3.167, "citationsperyear_2": 3.714, "citationsperyear_3": 5.0, "citationsperyear_4": 5.889, "citationsperyear_5": 5.6, "totalcitations_0": 10.0, "totalcitations_1": 19.0, "totalcitations_2": 26.0, "totalcitations_3": 40.0, "totalcitations_4": 53.0, "totalcitations_5": 56.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 6.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 6.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 247.6666666667, "venuehindexmean_1": 231.5, "venuehindexmean_2": 236.75, "venuehindexmean_3": 241.0, "venuehindexmean_4": 244.75, "venuehindexmean_5": 248.25, "totalvenues_0": 3.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 0.7950156801, "pagerank_1": 0.970971082, "pagerank_2": 1.0814854314, "pagerank_3": 1.0597785479, "pagerank_4": 0.9882134429, "pagerank_5": 0.9658254519}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Laurence J.Zwiebel"], "affiliation": "University of Illinois at Urbana\u2013Champaign", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 14.571, "citationsperpaper_1": 15.533, "citationsperpaper_2": 15.25, "citationsperpaper_3": 15.706, "citationsperpaper_4": 15.15, "citationsperpaper_5": 15.95, "citationsperyear_0": 10.2, "citationsperyear_1": 11.095, "citationsperyear_2": 11.091, "citationsperyear_3": 11.609, "citationsperyear_4": 12.625, "citationsperyear_5": 12.76, "totalcitations_0": 204.0, "totalcitations_1": 233.0, "totalcitations_2": 244.0, "totalcitations_3": 267.0, "totalcitations_4": 303.0, "totalcitations_5": 319.0, "totalpapers_0": 14.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 20.0, "totalpapers_5": 20.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 15.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 134.0, "recentcoauthors_5": 129.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 157.6, "venuehindexmean_1": 161.2, "venuehindexmean_2": 142.8333333333, "venuehindexmean_3": 146.8333333333, "venuehindexmean_4": 148.8571428571, "venuehindexmean_5": 151.7142857143, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.2219786424, "pagerank_1": 3.4188474522, "pagerank_2": 3.6304848775, "pagerank_3": 3.6830015959, "pagerank_4": 4.9469821425, "pagerank_5": 4.9095453909}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Laurence J.Zwiebel"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 14.571, "citationsperpaper_1": 15.533, "citationsperpaper_2": 15.25, "citationsperpaper_3": 15.706, "citationsperpaper_4": 15.15, "citationsperpaper_5": 15.95, "citationsperyear_0": 10.2, "citationsperyear_1": 11.095, "citationsperyear_2": 11.091, "citationsperyear_3": 11.609, "citationsperyear_4": 12.625, "citationsperyear_5": 12.76, "totalcitations_0": 204.0, "totalcitations_1": 233.0, "totalcitations_2": 244.0, "totalcitations_3": 267.0, "totalcitations_4": 303.0, "totalcitations_5": 319.0, "totalpapers_0": 14.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 20.0, "totalpapers_5": 20.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 15.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 134.0, "recentcoauthors_5": 129.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 157.6, "venuehindexmean_1": 161.2, "venuehindexmean_2": 142.8333333333, "venuehindexmean_3": 146.8333333333, "venuehindexmean_4": 148.8571428571, "venuehindexmean_5": 151.7142857143, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.2219786424, "pagerank_1": 3.4188474522, "pagerank_2": 3.6304848775, "pagerank_3": 3.6830015959, "pagerank_4": 4.9469821425, "pagerank_5": 4.9095453909}}, {"model": "papers.paper", "pk": 1003102, "fields": {"authors": ["Laurence J.Zwiebel"], "affiliation": "Brandeis University", "venue": "Nature", "doi": "10.1038/nature08834", "abstract": "The mosquito Anopheles gambiae is the major vector of malaria in sub-Saharan Africa. It locates its human hosts primarily through olfaction, but little is known about the molecular basis of this process. Here we functionally characterize the Anopheles gambiae odorant receptor (AgOr) repertoire. We identify receptors that respond strongly to components of human odour and that may act in the process of human recognition. Some of these receptors are narrowly tuned, and some salient odorants elicit strong responses from only one or a few receptors, suggesting a central role for specific transmission channels in human host-seeking behaviour. This analysis of the Anopheles gambiae receptors permits a comparison with the corresponding Drosophila melanogaster odorant receptor repertoire. We find that odorants are differentially encoded by the two species in ways consistent with their ecological needs. Our analysis of the Anopheles gambiae repertoire identifies receptors that may be useful targets for controlling the transmission of malaria.", "year": 2010, "title": "Odorant reception in the malaria mosquito Anopheles gambiae", "keywords": ["Olfaction", "Olfactory receptor", "Anopheles gambiae", "Vector (epidemiology)", "Biology", "Zoology", "Receptor", "Evolutionary biology", "Repertoire", "VUAA1", "Drosophila melanogaster"], "citations_0": 3.0, "citations_1": 4.0, "citations_2": 1.0, "citations_3": 5.0, "citations_4": 7.0, "citations_5": 1.0, "timescaledpagerank_0": 0.3710597441, "timescaledpagerank_1": 0.5748039738, "timescaledpagerank_2": 0.3786571555, "timescaledpagerank_3": 0.6534869429, "timescaledpagerank_4": 0.9107015507, "timescaledpagerank_5": 0.7671265116, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 10.0, "adopters_1": 11.0, "adopters_2": 3.0, "adopters_3": 32.0, "adopters_4": 31.0, "adopters_5": 0.0, "citationsperpaper_0": 14.571, "citationsperpaper_1": 15.533, "citationsperpaper_2": 15.25, "citationsperpaper_3": 15.706, "citationsperpaper_4": 15.15, "citationsperpaper_5": 15.95, "citationsperyear_0": 10.2, "citationsperyear_1": 11.095, "citationsperyear_2": 11.091, "citationsperyear_3": 11.609, "citationsperyear_4": 12.625, "citationsperyear_5": 12.76, "totalcitations_0": 204.0, "totalcitations_1": 233.0, "totalcitations_2": 244.0, "totalcitations_3": 267.0, "totalcitations_4": 303.0, "totalcitations_5": 319.0, "totalpapers_0": 14.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 20.0, "totalpapers_5": 20.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 15.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 134.0, "recentcoauthors_5": 129.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 157.6, "venuehindexmean_1": 161.2, "venuehindexmean_2": 142.8333333333, "venuehindexmean_3": 146.8333333333, "venuehindexmean_4": 148.8571428571, "venuehindexmean_5": 151.7142857143, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.2219786424, "pagerank_1": 3.4188474522, "pagerank_2": 3.6304848775, "pagerank_3": 3.6830015959, "pagerank_4": 4.9469821425, "pagerank_5": 4.9095453909}}, {"model": "papers.paper", "pk": 1003552, "fields": {"authors": ["HannaKokko"], "affiliation": "University of Helsinki", "venue": "Nature", "doi": "10.1038/464990b", "abstract": "To reduce parental care, just add water \u2014 that's the conclusion of an intriguing investigation into the extent of the motherly and fatherly devotion that different species of frog extend to their offspring.", "year": 2010, "title": "Ways to raise tadpoles", "keywords": ["Life history theory", "Biology", "Zoology", "Trade-off", "Environmental stress", "Paternal care", "Offspring", "Ecology", "Fecundity", "Behavioral ecology", "Larva"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.8, "citationsperpaper_1": 1.286, "citationsperpaper_2": 1.857, "citationsperpaper_3": 2.571, "citationsperpaper_4": 2.875, "citationsperpaper_5": 3.75, "citationsperyear_0": 0.8, "citationsperyear_1": 1.5, "citationsperyear_2": 1.857, "citationsperyear_3": 2.25, "citationsperyear_4": 2.556, "citationsperyear_5": 3.0, "totalcitations_0": 4.0, "totalcitations_1": 9.0, "totalcitations_2": 13.0, "totalcitations_3": 18.0, "totalcitations_4": 23.0, "totalcitations_5": 30.0, "totalpapers_0": 5.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 7.0, "totalpapers_4": 8.0, "totalpapers_5": 8.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 143.0, "recentcoauthors_2": 142.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 8.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 196.6666666667, "venuehindexmean_5": 200.3333333333, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.171356841, "pagerank_1": 3.8119171126, "pagerank_2": 3.7985572255, "pagerank_3": 3.8490281539, "pagerank_4": 4.1507064681, "pagerank_5": 4.0787768324}}, {"model": "papers.paper", "pk": 1003552, "fields": {"authors": ["HannaKokko", "Michael D.Jennions"], "affiliation": "Australian National University", "venue": "Nature", "doi": "10.1038/464990b", "abstract": "To reduce parental care, just add water \u2014 that's the conclusion of an intriguing investigation into the extent of the motherly and fatherly devotion that different species of frog extend to their offspring.", "year": 2010, "title": "Ways to raise tadpoles", "keywords": ["Life history theory", "Biology", "Zoology", "Trade-off", "Environmental stress", "Paternal care", "Offspring", "Ecology", "Fecundity", "Behavioral ecology", "Larva"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.5, "hindex_1": 2.5, "hindex_2": 2.5, "hindex_3": 2.5, "hindex_4": 2.5, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.025, "citationsperpaper_1": 1.3305, "citationsperpaper_2": 1.6785, "citationsperpaper_3": 2.0355, "citationsperpaper_4": 2.2555, "citationsperpaper_5": 2.7595, "citationsperyear_0": 0.7845, "citationsperyear_1": 1.143, "citationsperyear_2": 1.3285, "citationsperyear_3": 1.594, "citationsperyear_4": 1.8075, "citationsperyear_5": 2.139, "totalcitations_0": 7.0, "totalcitations_1": 10.0, "totalcitations_2": 12.5, "totalcitations_3": 16.5, "totalcitations_4": 20.5, "totalcitations_5": 26.5, "totalpapers_0": 6.5, "totalpapers_1": 7.5, "totalpapers_2": 7.5, "totalpapers_3": 8.5, "totalpapers_4": 9.5, "totalpapers_5": 10.5, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 72.0, "recentcoauthors_2": 71.0, "recentcoauthors_3": 2.5, "recentcoauthors_4": 10.5, "recentcoauthors_5": 11.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 211.9166666667, "venuehindexmean_1": 216.25, "venuehindexmean_2": 222.1666666667, "venuehindexmean_3": 225.75, "venuehindexmean_4": 194.3333333333, "venuehindexmean_5": 197.7916666667, "totalvenues_0": 2.5, "totalvenues_1": 2.5, "totalvenues_2": 2.5, "totalvenues_3": 3.0, "totalvenues_4": 3.5, "totalvenues_5": 3.5, "pagerank_0": 1.8243821243, "pagerank_1": 2.9034778586, "pagerank_2": 2.8950461005, "pagerank_3": 3.2774533116, "pagerank_4": 3.4551669738, "pagerank_5": 3.4847793445}}, {"model": "papers.paper", "pk": 1003552, "fields": {"authors": ["Michael D.Jennions"], "affiliation": "University of the Witwatersrand", "venue": "Nature", "doi": "10.1038/464990b", "abstract": "To reduce parental care, just add water \u2014 that's the conclusion of an intriguing investigation into the extent of the motherly and fatherly devotion that different species of frog extend to their offspring.", "year": 2010, "title": "Ways to raise tadpoles", "keywords": ["Life history theory", "Biology", "Zoology", "Trade-off", "Environmental stress", "Paternal care", "Offspring", "Ecology", "Fecundity", "Behavioral ecology", "Larva"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.25, "citationsperpaper_1": 1.375, "citationsperpaper_2": 1.5, "citationsperpaper_3": 1.5, "citationsperpaper_4": 1.636, "citationsperpaper_5": 1.769, "citationsperyear_0": 0.769, "citationsperyear_1": 0.786, "citationsperyear_2": 0.8, "citationsperyear_3": 0.938, "citationsperyear_4": 1.059, "citationsperyear_5": 1.278, "totalcitations_0": 10.0, "totalcitations_1": 11.0, "totalcitations_2": 12.0, "totalcitations_3": 15.0, "totalcitations_4": 18.0, "totalcitations_5": 23.0, "totalpapers_0": 8.0, "totalpapers_1": 8.0, "totalpapers_2": 8.0, "totalpapers_3": 10.0, "totalpapers_4": 11.0, "totalpapers_5": 13.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 5.0, "recentcoauthors_4": 13.0, "recentcoauthors_5": 15.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 177.3333333333, "venuehindexmean_1": 182.0, "venuehindexmean_2": 187.3333333333, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.4774074076, "pagerank_1": 1.9950386046, "pagerank_2": 1.9915349755, "pagerank_3": 2.7058784692, "pagerank_4": 2.7596274795, "pagerank_5": 2.8907818566}}, {"model": "papers.paper", "pk": 1003245, "fields": {"authors": ["Alan H.Handyside"], "affiliation": "Hammersmith Hospital", "venue": "Nature", "doi": "10.1038/464978a", "abstract": "Twenty years on from the first pregnancies after preimplantation genetic diagnosis, Alan Handyside argues that informed prospective parents are largely good guides to the use of the thriving technology.", "year": 2010, "title": "Let parents decide", "keywords": ["Preimplantation genetic diagnosis", "Family medicine", "Psychology", "Genetics", "Thriving"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 34.222, "citationsperpaper_1": 34.444, "citationsperpaper_2": 34.667, "citationsperpaper_3": 35.444, "citationsperpaper_4": 35.667, "citationsperpaper_5": 36.222, "citationsperyear_0": 12.833, "citationsperyear_1": 12.4, "citationsperyear_2": 12.0, "citationsperyear_3": 11.815, "citationsperyear_4": 11.464, "citationsperyear_5": 11.241, "totalcitations_0": 308.0, "totalcitations_1": 310.0, "totalcitations_2": 312.0, "totalcitations_3": 319.0, "totalcitations_4": 321.0, "totalcitations_5": 326.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 9.0, "totalpapers_4": 9.0, "totalpapers_5": 9.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 152.8, "venuehindexmean_1": 156.0, "venuehindexmean_2": 160.4, "venuehindexmean_3": 164.2, "venuehindexmean_4": 167.6, "venuehindexmean_5": 171.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.3415742325, "pagerank_1": 2.2975659, "pagerank_2": 2.2824665413, "pagerank_3": 2.2580932997, "pagerank_4": 2.232314285, "pagerank_5": 2.2136740106}}, {"model": "papers.paper", "pk": 1003217, "fields": {"authors": ["David B.Solit"], "affiliation": "Kettering University", "venue": "Nature", "doi": "10.1038/468902a", "abstract": "The promise of an exciting new drug that inhibits the mutant B-RAF protein in skin cancer is marred by the fact that most patients relapse within a year. Fresh data hint at how such resistance emerges. See Letters p.968 & p.973", "year": 2010, "title": "Drug discovery: How melanomas bypass new therapy", "keywords": ["Drug discovery", "Cancer research", "Pharmacology", "Skin cancer", "Drug", "Cancer", "Medicine"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2212669755, "timescaledpagerank_2": 0.1956443167, "timescaledpagerank_3": 0.1782231689, "timescaledpagerank_4": 0.1694004591, "timescaledpagerank_5": 0.1513895502, "hindex_0": 10.0, "hindex_1": 11.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 0.0, "adopters_1": 19.0, "adopters_2": 14.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 12.406, "citationsperpaper_1": 13.0, "citationsperpaper_2": 14.49, "citationsperpaper_3": 18.296, "citationsperpaper_4": 19.074, "citationsperpaper_5": 19.57, "citationsperyear_0": 44.111, "citationsperyear_1": 50.7, "citationsperyear_2": 64.545, "citationsperyear_3": 82.333, "citationsperyear_4": 99.769, "citationsperyear_5": 110.429, "totalcitations_0": 397.0, "totalcitations_1": 507.0, "totalcitations_2": 710.0, "totalcitations_3": 988.0, "totalcitations_4": 1297.0, "totalcitations_5": 1546.0, "totalpapers_0": 32.0, "totalpapers_1": 39.0, "totalpapers_2": 49.0, "totalpapers_3": 54.0, "totalpapers_4": 68.0, "totalpapers_5": 79.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 177.0, "recentcoauthors_1": 196.0, "recentcoauthors_2": 538.0, "recentcoauthors_3": 480.0, "recentcoauthors_4": 519.0, "recentcoauthors_5": 688.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 106.3333333333, "venuehindexmean_1": 93.9166666667, "venuehindexmean_2": 108.9230769231, "venuehindexmean_3": 111.2857142857, "venuehindexmean_4": 114.4285714286, "venuehindexmean_5": 117.2, "totalvenues_0": 9.0, "totalvenues_1": 12.0, "totalvenues_2": 13.0, "totalvenues_3": 14.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 7.8211700557, "pagerank_1": 9.1850576282, "pagerank_2": 12.8767397678, "pagerank_3": 12.554406, "pagerank_4": 16.0317226117, "pagerank_5": 17.8316041855}}, {"model": "papers.paper", "pk": 1003217, "fields": {"authors": ["David B.Solit"], "affiliation": "Cornell University", "venue": "Nature", "doi": "10.1038/468902a", "abstract": "The promise of an exciting new drug that inhibits the mutant B-RAF protein in skin cancer is marred by the fact that most patients relapse within a year. Fresh data hint at how such resistance emerges. See Letters p.968 & p.973", "year": 2010, "title": "Drug discovery: How melanomas bypass new therapy", "keywords": ["Drug discovery", "Cancer research", "Pharmacology", "Skin cancer", "Drug", "Cancer", "Medicine"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2212669755, "timescaledpagerank_2": 0.1956443167, "timescaledpagerank_3": 0.1782231689, "timescaledpagerank_4": 0.1694004591, "timescaledpagerank_5": 0.1513895502, "hindex_0": 10.0, "hindex_1": 11.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 0.0, "adopters_1": 19.0, "adopters_2": 14.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 12.406, "citationsperpaper_1": 13.0, "citationsperpaper_2": 14.49, "citationsperpaper_3": 18.296, "citationsperpaper_4": 19.074, "citationsperpaper_5": 19.57, "citationsperyear_0": 44.111, "citationsperyear_1": 50.7, "citationsperyear_2": 64.545, "citationsperyear_3": 82.333, "citationsperyear_4": 99.769, "citationsperyear_5": 110.429, "totalcitations_0": 397.0, "totalcitations_1": 507.0, "totalcitations_2": 710.0, "totalcitations_3": 988.0, "totalcitations_4": 1297.0, "totalcitations_5": 1546.0, "totalpapers_0": 32.0, "totalpapers_1": 39.0, "totalpapers_2": 49.0, "totalpapers_3": 54.0, "totalpapers_4": 68.0, "totalpapers_5": 79.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 177.0, "recentcoauthors_1": 196.0, "recentcoauthors_2": 538.0, "recentcoauthors_3": 480.0, "recentcoauthors_4": 519.0, "recentcoauthors_5": 688.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 106.3333333333, "venuehindexmean_1": 93.9166666667, "venuehindexmean_2": 108.9230769231, "venuehindexmean_3": 111.2857142857, "venuehindexmean_4": 114.4285714286, "venuehindexmean_5": 117.2, "totalvenues_0": 9.0, "totalvenues_1": 12.0, "totalvenues_2": 13.0, "totalvenues_3": 14.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 7.8211700557, "pagerank_1": 9.1850576282, "pagerank_2": 12.8767397678, "pagerank_3": 12.554406, "pagerank_4": 16.0317226117, "pagerank_5": 17.8316041855}}, {"model": "papers.paper", "pk": 1003217, "fields": {"authors": ["David B.Solit", "Charles L.Sawyers"], "affiliation": "Memorial Sloan Kettering Cancer Center", "venue": "Nature", "doi": "10.1038/468902a", "abstract": "The promise of an exciting new drug that inhibits the mutant B-RAF protein in skin cancer is marred by the fact that most patients relapse within a year. Fresh data hint at how such resistance emerges. See Letters p.968 & p.973", "year": 2010, "title": "Drug discovery: How melanomas bypass new therapy", "keywords": ["Drug discovery", "Cancer research", "Pharmacology", "Skin cancer", "Drug", "Cancer", "Medicine"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2212669755, "timescaledpagerank_2": 0.1956443167, "timescaledpagerank_3": 0.1782231689, "timescaledpagerank_4": 0.1694004591, "timescaledpagerank_5": 0.1513895502, "hindex_0": 14.5, "hindex_1": 15.5, "hindex_2": 17.5, "hindex_3": 18.5, "hindex_4": 21.0, "hindex_5": 22.0, "adopters_0": 0.0, "adopters_1": 19.0, "adopters_2": 14.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 19.834, "citationsperpaper_1": 20.6795, "citationsperpaper_2": 19.9695, "citationsperpaper_3": 22.3085, "citationsperpaper_4": 22.245, "citationsperpaper_5": 22.468, "citationsperyear_0": 61.6505, "citationsperyear_1": 66.6, "citationsperyear_2": 75.4245, "citationsperyear_3": 85.583, "citationsperyear_4": 95.1245, "citationsperyear_5": 100.58, "totalcitations_0": 1030.0, "totalcitations_1": 1161.0, "totalcitations_2": 1347.5, "totalcitations_3": 1560.0, "totalcitations_4": 1779.5, "totalcitations_5": 1952.5, "totalpapers_0": 46.5, "totalpapers_1": 51.5, "totalpapers_2": 63.5, "totalpapers_3": 67.5, "totalpapers_4": 78.5, "totalpapers_5": 86.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 115.5, "recentcoauthors_1": 134.0, "recentcoauthors_2": 357.5, "recentcoauthors_3": 313.5, "recentcoauthors_4": 334.5, "recentcoauthors_5": 462.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 120.8974358974, "venuehindexmean_1": 111.4583333333, "venuehindexmean_2": 119.7948717949, "venuehindexmean_3": 122.5428571429, "venuehindexmean_4": 125.4476190476, "venuehindexmean_5": 124.475, "totalvenues_0": 11.0, "totalvenues_1": 13.0, "totalvenues_2": 14.0, "totalvenues_3": 14.5, "totalvenues_4": 14.5, "totalvenues_5": 15.5, "pagerank_0": 9.4386657531, "pagerank_1": 10.4162233683, "pagerank_2": 13.6076476913, "pagerank_3": 13.2480280665, "pagerank_4": 15.9484168254, "pagerank_5": 17.0260207231}}, {"model": "papers.paper", "pk": 1003217, "fields": {"authors": ["Charles L.Sawyers"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/468902a", "abstract": "The promise of an exciting new drug that inhibits the mutant B-RAF protein in skin cancer is marred by the fact that most patients relapse within a year. Fresh data hint at how such resistance emerges. See Letters p.968 & p.973", "year": 2010, "title": "Drug discovery: How melanomas bypass new therapy", "keywords": ["Drug discovery", "Cancer research", "Pharmacology", "Skin cancer", "Drug", "Cancer", "Medicine"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2212669755, "timescaledpagerank_2": 0.1956443167, "timescaledpagerank_3": 0.1782231689, "timescaledpagerank_4": 0.1694004591, "timescaledpagerank_5": 0.1513895502, "hindex_0": 19.0, "hindex_1": 20.0, "hindex_2": 21.0, "hindex_3": 22.0, "hindex_4": 24.0, "hindex_5": 25.0, "adopters_0": 0.0, "adopters_1": 19.0, "adopters_2": 14.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 27.262, "citationsperpaper_1": 28.359, "citationsperpaper_2": 25.449, "citationsperpaper_3": 26.321, "citationsperpaper_4": 25.416, "citationsperpaper_5": 25.366, "citationsperyear_0": 79.19, "citationsperyear_1": 82.5, "citationsperyear_2": 86.304, "citationsperyear_3": 88.833, "citationsperyear_4": 90.48, "citationsperyear_5": 90.731, "totalcitations_0": 1663.0, "totalcitations_1": 1815.0, "totalcitations_2": 1985.0, "totalcitations_3": 2132.0, "totalcitations_4": 2262.0, "totalcitations_5": 2359.0, "totalpapers_0": 61.0, "totalpapers_1": 64.0, "totalpapers_2": 78.0, "totalpapers_3": 81.0, "totalpapers_4": 89.0, "totalpapers_5": 93.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 54.0, "recentcoauthors_1": 72.0, "recentcoauthors_2": 177.0, "recentcoauthors_3": 147.0, "recentcoauthors_4": 150.0, "recentcoauthors_5": 237.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.4615384615, "venuehindexmean_1": 129.0, "venuehindexmean_2": 130.6666666667, "venuehindexmean_3": 133.8, "venuehindexmean_4": 136.4666666667, "venuehindexmean_5": 131.75, "totalvenues_0": 13.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 15.0, "totalvenues_4": 15.0, "totalvenues_5": 16.0, "pagerank_0": 11.0561614504, "pagerank_1": 11.6473891083, "pagerank_2": 14.3385556148, "pagerank_3": 13.9416501331, "pagerank_4": 15.8651110391, "pagerank_5": 16.2204372608}}, {"model": "papers.paper", "pk": 1003307, "fields": {"authors": ["Friedhelmvon Blanckenburg"], "affiliation": "Free University of Berlin", "venue": "Nature", "doi": "10.1038/nature09044", "abstract": "Accelerated uplift and global cooling have been suggested as possible causes for a fourfold increase in global sedimentation rates, and by inference in erosion rates or weathering fluxes, during the past 5 million years. Here, proxy evidence is provided that indicates stable weathering fluxes in the late-Cenozoic era. It is proposed that processes different from an increase in denudation caused Cenozoic global cooling.", "year": 2010, "title": "Long-term stability of global erosion rates and weathering during late-Cenozoic cooling", "keywords": ["Geology", "Cenozoic", "Erosion", "Global warming", "Global cooling", "Sedimentation", "Weathering", "Climate change", "Earth science", "Denudation"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 2.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0396745044, "timescaledpagerank_1": 0.0502711716, "timescaledpagerank_2": 0.163551612, "timescaledpagerank_3": 0.1228381511, "timescaledpagerank_4": 0.4111678114, "timescaledpagerank_5": 0.3852524747, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 8.0, "adopters_4": 5.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 1.0, "citationsperpaper_2": 1.0, "citationsperpaper_3": 1.5, "citationsperpaper_4": 2.0, "citationsperpaper_5": 2.25, "citationsperyear_0": 0.333, "citationsperyear_1": 0.308, "citationsperyear_2": 0.286, "citationsperyear_3": 0.4, "citationsperyear_4": 0.5, "citationsperyear_5": 0.529, "totalcitations_0": 4.0, "totalcitations_1": 4.0, "totalcitations_2": 4.0, "totalcitations_3": 6.0, "totalcitations_4": 8.0, "totalcitations_5": 9.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 196.6666666667, "venuehindexmean_1": 200.0, "venuehindexmean_2": 205.3333333333, "venuehindexmean_3": 210.0, "venuehindexmean_4": 213.3333333333, "venuehindexmean_5": 216.6666666667, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.8689555535, "pagerank_1": 0.7166054761, "pagerank_2": 0.7107686128, "pagerank_3": 0.687153876, "pagerank_4": 0.685503312, "pagerank_5": 0.6834790419}}, {"model": "papers.paper", "pk": 1003307, "fields": {"authors": ["Jane K.Willenbring"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature09044", "abstract": "Accelerated uplift and global cooling have been suggested as possible causes for a fourfold increase in global sedimentation rates, and by inference in erosion rates or weathering fluxes, during the past 5 million years. Here, proxy evidence is provided that indicates stable weathering fluxes in the late-Cenozoic era. It is proposed that processes different from an increase in denudation caused Cenozoic global cooling.", "year": 2010, "title": "Long-term stability of global erosion rates and weathering during late-Cenozoic cooling", "keywords": ["Geology", "Cenozoic", "Erosion", "Global warming", "Global cooling", "Sedimentation", "Weathering", "Climate change", "Earth science", "Denudation"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 2.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0396745044, "timescaledpagerank_1": 0.0502711716, "timescaledpagerank_2": 0.163551612, "timescaledpagerank_3": 0.1228381511, "timescaledpagerank_4": 0.4111678114, "timescaledpagerank_5": 0.3852524747, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 8.0, "adopters_4": 5.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.5, "citationsperpaper_2": 3.0, "citationsperpaper_3": 4.0, "citationsperpaper_4": 5.0, "citationsperpaper_5": 5.0, "citationsperyear_0": 1.333, "citationsperyear_1": 1.25, "citationsperyear_2": 1.2, "citationsperyear_3": 1.333, "citationsperyear_4": 1.429, "citationsperyear_5": 1.25, "totalcitations_0": 4.0, "totalcitations_1": 5.0, "totalcitations_2": 6.0, "totalcitations_3": 8.0, "totalcitations_4": 10.0, "totalcitations_5": 10.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.9546505027, "pagerank_1": 0.9050816841, "pagerank_2": 0.8545111924, "pagerank_3": 0.8307274407, "pagerank_4": 0.8248961195, "pagerank_5": 0.818269667}}, {"model": "papers.paper", "pk": 1003187, "fields": {"authors": ["Claire L.Thompson"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nj7319-1", "abstract": "", "year": 2010, "title": "Reconnecting with family", "keywords": ["Biology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.25, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.167, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 1.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Fyodor A.Kondrashov"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.267, "citationsperpaper_1": 6.267, "citationsperpaper_2": 6.313, "citationsperpaper_3": 6.765, "citationsperpaper_4": 7.167, "citationsperpaper_5": 7.619, "citationsperyear_0": 6.583, "citationsperyear_1": 7.231, "citationsperyear_2": 7.214, "citationsperyear_3": 7.667, "citationsperyear_4": 8.063, "citationsperyear_5": 9.412, "totalcitations_0": 79.0, "totalcitations_1": 94.0, "totalcitations_2": 101.0, "totalcitations_3": 115.0, "totalcitations_4": 129.0, "totalcitations_5": 160.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 18.0, "totalpapers_5": 21.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 39.0, "recentcoauthors_5": 46.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6, "venuehindexmean_1": 120.4, "venuehindexmean_2": 124.6, "venuehindexmean_3": 128.4, "venuehindexmean_4": 131.8, "venuehindexmean_5": 134.8, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.6776842683, "pagerank_1": 1.6599296136, "pagerank_2": 1.8665719778, "pagerank_3": 1.8490934491, "pagerank_4": 2.2888884816, "pagerank_5": 2.4047299893}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Fyodor A.Kondrashov"], "affiliation": "Bard College at Simon's Rock", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.267, "citationsperpaper_1": 6.267, "citationsperpaper_2": 6.313, "citationsperpaper_3": 6.765, "citationsperpaper_4": 7.167, "citationsperpaper_5": 7.619, "citationsperyear_0": 6.583, "citationsperyear_1": 7.231, "citationsperyear_2": 7.214, "citationsperyear_3": 7.667, "citationsperyear_4": 8.063, "citationsperyear_5": 9.412, "totalcitations_0": 79.0, "totalcitations_1": 94.0, "totalcitations_2": 101.0, "totalcitations_3": 115.0, "totalcitations_4": 129.0, "totalcitations_5": 160.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 18.0, "totalpapers_5": 21.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 39.0, "recentcoauthors_5": 46.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6, "venuehindexmean_1": 120.4, "venuehindexmean_2": 124.6, "venuehindexmean_3": 128.4, "venuehindexmean_4": 131.8, "venuehindexmean_5": 134.8, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.6776842683, "pagerank_1": 1.6599296136, "pagerank_2": 1.8665719778, "pagerank_3": 1.8490934491, "pagerank_4": 2.2888884816, "pagerank_5": 2.4047299893}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Fyodor A.Kondrashov", "Inna S.Povolotskaya"], "affiliation": "Pompeu Fabra University", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 3.5, "hindex_1": 3.5, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.5, "hindex_5": 5.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.6335, "citationsperpaper_1": 5.6335, "citationsperpaper_2": 6.6565, "citationsperpaper_3": 8.3825, "citationsperpaper_4": 6.8335, "citationsperpaper_5": 10.3095, "citationsperyear_0": 4.2915, "citationsperyear_1": 4.8655, "citationsperyear_2": 4.7735, "citationsperyear_3": 5.0835, "citationsperyear_4": 5.3315, "citationsperyear_5": 6.8725, "totalcitations_0": 40.5, "totalcitations_1": 49.5, "totalcitations_2": 54.0, "totalcitations_3": 62.5, "totalcitations_4": 71.0, "totalcitations_5": 93.0, "totalpapers_0": 8.0, "totalpapers_1": 8.0, "totalpapers_2": 8.5, "totalpapers_3": 9.0, "totalpapers_4": 10.0, "totalpapers_5": 11.5, "authorage_0": 5.5, "authorage_1": 6.5, "authorage_2": 7.5, "authorage_3": 8.5, "authorage_4": 9.5, "authorage_5": 10.5, "recentcoauthors_0": 2.5, "recentcoauthors_1": 2.5, "recentcoauthors_2": 2.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 37.0, "recentcoauthors_5": 40.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 188.3, "venuehindexmean_1": 192.2, "venuehindexmean_2": 196.8, "venuehindexmean_3": 201.7, "venuehindexmean_4": 205.9, "venuehindexmean_5": 209.4, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.9277480563, "pagerank_1": 0.9187248999, "pagerank_2": 1.0226416276, "pagerank_3": 1.0128013985, "pagerank_4": 1.5489466266, "pagerank_5": 1.5986148742}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Fyodor A.Kondrashov", "Inna S.Povolotskaya"], "affiliation": "Barcelona Biomedical Research Park", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 3.5, "hindex_1": 3.5, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.5, "hindex_5": 5.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.6335, "citationsperpaper_1": 5.6335, "citationsperpaper_2": 6.6565, "citationsperpaper_3": 8.3825, "citationsperpaper_4": 6.8335, "citationsperpaper_5": 10.3095, "citationsperyear_0": 4.2915, "citationsperyear_1": 4.8655, "citationsperyear_2": 4.7735, "citationsperyear_3": 5.0835, "citationsperyear_4": 5.3315, "citationsperyear_5": 6.8725, "totalcitations_0": 40.5, "totalcitations_1": 49.5, "totalcitations_2": 54.0, "totalcitations_3": 62.5, "totalcitations_4": 71.0, "totalcitations_5": 93.0, "totalpapers_0": 8.0, "totalpapers_1": 8.0, "totalpapers_2": 8.5, "totalpapers_3": 9.0, "totalpapers_4": 10.0, "totalpapers_5": 11.5, "authorage_0": 5.5, "authorage_1": 6.5, "authorage_2": 7.5, "authorage_3": 8.5, "authorage_4": 9.5, "authorage_5": 10.5, "recentcoauthors_0": 2.5, "recentcoauthors_1": 2.5, "recentcoauthors_2": 2.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 37.0, "recentcoauthors_5": 40.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 188.3, "venuehindexmean_1": 192.2, "venuehindexmean_2": 196.8, "venuehindexmean_3": 201.7, "venuehindexmean_4": 205.9, "venuehindexmean_5": 209.4, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.9277480563, "pagerank_1": 0.9187248999, "pagerank_2": 1.0226416276, "pagerank_3": 1.0128013985, "pagerank_4": 1.5489466266, "pagerank_5": 1.5986148742}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Fyodor A.Kondrashov"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.267, "citationsperpaper_1": 6.267, "citationsperpaper_2": 6.313, "citationsperpaper_3": 6.765, "citationsperpaper_4": 7.167, "citationsperpaper_5": 7.619, "citationsperyear_0": 6.583, "citationsperyear_1": 7.231, "citationsperyear_2": 7.214, "citationsperyear_3": 7.667, "citationsperyear_4": 8.063, "citationsperyear_5": 9.412, "totalcitations_0": 79.0, "totalcitations_1": 94.0, "totalcitations_2": 101.0, "totalcitations_3": 115.0, "totalcitations_4": 129.0, "totalcitations_5": 160.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 18.0, "totalpapers_5": 21.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 39.0, "recentcoauthors_5": 46.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6, "venuehindexmean_1": 120.4, "venuehindexmean_2": 124.6, "venuehindexmean_3": 128.4, "venuehindexmean_4": 131.8, "venuehindexmean_5": 134.8, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.6776842683, "pagerank_1": 1.6599296136, "pagerank_2": 1.8665719778, "pagerank_3": 1.8490934491, "pagerank_4": 2.2888884816, "pagerank_5": 2.4047299893}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Fyodor A.Kondrashov"], "affiliation": "University of California, Davis", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.267, "citationsperpaper_1": 6.267, "citationsperpaper_2": 6.313, "citationsperpaper_3": 6.765, "citationsperpaper_4": 7.167, "citationsperpaper_5": 7.619, "citationsperyear_0": 6.583, "citationsperyear_1": 7.231, "citationsperyear_2": 7.214, "citationsperyear_3": 7.667, "citationsperyear_4": 8.063, "citationsperyear_5": 9.412, "totalcitations_0": 79.0, "totalcitations_1": 94.0, "totalcitations_2": 101.0, "totalcitations_3": 115.0, "totalcitations_4": 129.0, "totalcitations_5": 160.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 18.0, "totalpapers_5": 21.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 39.0, "recentcoauthors_5": 46.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.6, "venuehindexmean_1": 120.4, "venuehindexmean_2": 124.6, "venuehindexmean_3": 128.4, "venuehindexmean_4": 131.8, "venuehindexmean_5": 134.8, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.6776842683, "pagerank_1": 1.6599296136, "pagerank_2": 1.8665719778, "pagerank_3": 1.8490934491, "pagerank_4": 2.2888884816, "pagerank_5": 2.4047299893}}, {"model": "papers.paper", "pk": 1003614, "fields": {"authors": ["Inna S.Povolotskaya"], "affiliation": "Russian National Research Medical University", "venue": "Nature", "doi": "10.1038/nature09105", "abstract": "Protein evolution occurs only slowly, since most amino-acid substitutions are likely to be deleterious and selection will favour conservation of function. Inna Povolotskaya and Fyodor Kondrashov set out to find out just how slowly by asking the question, are ancient extant proteins \u2014 those that were present in the last universal common ancestor (LUCA) \u2014 continuing to diverge from the ancestral sequence? Their calculations, based on the approach used by Edwin Hubble in his study of the recession of galaxies in the physical Universe, suggests that extant protein sequences are still expanding from each other, and, therefore, from their common ancestor. Divergence is very slow: the 3.5 billion years or so since LUCA's time has not been long enough for the limit of sequence divergence to be reached. This tardiness is a consequence of the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: 98% of sites cannot accept an amino-acid substitution at a given moment, yet most sites may eventually be permitted to evolve when other, compensatory, changes occur. The need to maintain the structural and functional integrity of an evolving protein limits the range of acceptable amino-acid substitutions \u2014 but to what extent does this constrain how far homologous protein sequences can diverge? Here, sequence divergence data are used to explore the limits of protein evolution, and to conclude that ancient proteins are continuing to diverge from one another, indicating that the protein sequence universe is slowly expanding. The need to maintain the structural and functional integrity of an evolving protein severely restricts the repertoire of acceptable amino-acid substitutions1,2,3,4. However, it is not known whether these restrictions impose a global limit on how far homologous protein sequences can diverge from each other. Here we explore the limits of protein evolution using sequence divergence data. We formulate a computational approach to study the rate of divergence of distant protein sequences and measure this rate for ancient proteins, those that were present in the last universal common ancestor. We show that ancient proteins are still diverging from each other, indicating an ongoing expansion of the protein sequence universe. The slow rate of this divergence is imposed by the sparseness of functional protein sequences in sequence space and the ruggedness of the protein fitness landscape: \u223c98 per cent of sites cannot accept an amino-acid substitution at any given moment but a vast majority of all sites may eventually be permitted to evolve when other, compensatory, changes occur. Thus, \u223c3.5\u2009\u00d7\u2009109\u2009yr has not been enough to reach the limit of divergent evolution of proteins, and for most proteins the limit of sequence similarity imposed by common function may not exceed that of random sequences.", "year": 2010, "title": "Sequence space and the ongoing expansion of the protein universe", "keywords": ["Sequence space", "Fitness landscape", "Protein superfamily", "Molecular evolution", "Genetics", "Biology", "Divergent evolution", "Evolutionary biology", "Protein sequencing", "Divergence", "Last universal ancestor"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 6.0, "timescaledpagerank_0": 0.2556766667, "timescaledpagerank_1": 0.594015015, "timescaledpagerank_2": 0.6235440271, "timescaledpagerank_3": 0.9809562068, "timescaledpagerank_4": 0.7744040994, "timescaledpagerank_5": 0.9835419616, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 4.0, "adopters_1": 11.0, "adopters_2": 14.0, "adopters_3": 14.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 5.0, "citationsperpaper_2": 7.0, "citationsperpaper_3": 10.0, "citationsperpaper_4": 6.5, "citationsperpaper_5": 13.0, "citationsperyear_0": 2.0, "citationsperyear_1": 2.5, "citationsperyear_2": 2.333, "citationsperyear_3": 2.5, "citationsperyear_4": 2.6, "citationsperyear_5": 4.333, "totalcitations_0": 2.0, "totalcitations_1": 5.0, "totalcitations_2": 7.0, "totalcitations_3": 10.0, "totalcitations_4": 13.0, "totalcitations_5": 26.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 35.0, "recentcoauthors_5": 35.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.1778118443, "pagerank_1": 0.1775201861, "pagerank_2": 0.1787112773, "pagerank_3": 0.1765093479, "pagerank_4": 0.8090047717, "pagerank_5": 0.792499759}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["WahChiu"], "affiliation": "SLAC National Accelerator Laboratory", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 16.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.932, "citationsperpaper_1": 11.082, "citationsperpaper_2": 11.692, "citationsperpaper_3": 12.25, "citationsperpaper_4": 11.839, "citationsperpaper_5": 12.06, "citationsperyear_0": 20.913, "citationsperyear_1": 22.625, "citationsperyear_2": 24.32, "citationsperyear_3": 26.385, "citationsperyear_4": 27.185, "citationsperyear_5": 28.857, "totalcitations_0": 481.0, "totalcitations_1": 543.0, "totalcitations_2": 608.0, "totalcitations_3": 686.0, "totalcitations_4": 734.0, "totalcitations_5": 808.0, "totalpapers_0": 44.0, "totalpapers_1": 49.0, "totalpapers_2": 52.0, "totalpapers_3": 56.0, "totalpapers_4": 62.0, "totalpapers_5": 67.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 50.0, "recentcoauthors_1": 83.0, "recentcoauthors_2": 90.0, "recentcoauthors_3": 79.0, "recentcoauthors_4": 95.0, "recentcoauthors_5": 97.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 152.1, "venuehindexmean_1": 154.9, "venuehindexmean_2": 143.6666666667, "venuehindexmean_3": 146.75, "venuehindexmean_4": 142.4615384615, "venuehindexmean_5": 145.2307692308, "totalvenues_0": 10.0, "totalvenues_1": 10.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 11.2750664386, "pagerank_1": 12.4095451265, "pagerank_2": 13.0863627166, "pagerank_3": 13.9536627536, "pagerank_4": 15.7341796151, "pagerank_5": 16.2245015165}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["JoanitaJakana", "WahChiu"], "affiliation": "University of Southern California", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 9.5, "hindex_1": 10.5, "hindex_2": 10.5, "hindex_3": 11.5, "hindex_4": 12.0, "hindex_5": 12.5, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.466, "citationsperpaper_1": 9.8745, "citationsperpaper_2": 10.946, "citationsperpaper_3": 11.875, "citationsperpaper_4": 11.0775, "citationsperpaper_5": 11.767, "citationsperyear_0": 13.894, "citationsperyear_1": 15.136, "citationsperyear_2": 16.41, "citationsperyear_3": 18.0345, "citationsperyear_4": 18.4925, "citationsperyear_5": 19.619, "totalcitations_0": 295.5, "totalcitations_1": 336.5, "totalcitations_2": 380.5, "totalcitations_3": 435.0, "totalcitations_4": 465.0, "totalcitations_5": 513.0, "totalpapers_0": 27.5, "totalpapers_1": 32.0, "totalpapers_2": 33.5, "totalpapers_3": 36.0, "totalpapers_4": 40.5, "totalpapers_5": 43.0, "authorage_0": 18.5, "authorage_1": 19.5, "authorage_2": 20.5, "authorage_3": 21.5, "authorage_4": 22.5, "authorage_5": 23.5, "recentcoauthors_0": 36.5, "recentcoauthors_1": 72.0, "recentcoauthors_2": 64.0, "recentcoauthors_3": 44.5, "recentcoauthors_4": 64.5, "recentcoauthors_5": 60.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 161.25, "venuehindexmean_1": 166.45, "venuehindexmean_2": 162.8333333333, "venuehindexmean_3": 165.875, "venuehindexmean_4": 156.9182692308, "venuehindexmean_5": 159.5528846154, "totalvenues_0": 7.5, "totalvenues_1": 8.5, "totalvenues_2": 9.5, "totalvenues_3": 9.5, "totalvenues_4": 10.5, "totalvenues_5": 10.5, "pagerank_0": 7.3978650112, "pagerank_1": 8.5795314565, "pagerank_2": 8.7760127522, "pagerank_3": 9.2777295297, "pagerank_4": 10.5306133531, "pagerank_5": 10.6685431788}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["WahChiu"], "affiliation": "Johns Hopkins University School of Medicine", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 16.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.932, "citationsperpaper_1": 11.082, "citationsperpaper_2": 11.692, "citationsperpaper_3": 12.25, "citationsperpaper_4": 11.839, "citationsperpaper_5": 12.06, "citationsperyear_0": 20.913, "citationsperyear_1": 22.625, "citationsperyear_2": 24.32, "citationsperyear_3": 26.385, "citationsperyear_4": 27.185, "citationsperyear_5": 28.857, "totalcitations_0": 481.0, "totalcitations_1": 543.0, "totalcitations_2": 608.0, "totalcitations_3": 686.0, "totalcitations_4": 734.0, "totalcitations_5": 808.0, "totalpapers_0": 44.0, "totalpapers_1": 49.0, "totalpapers_2": 52.0, "totalpapers_3": 56.0, "totalpapers_4": 62.0, "totalpapers_5": 67.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 50.0, "recentcoauthors_1": 83.0, "recentcoauthors_2": 90.0, "recentcoauthors_3": 79.0, "recentcoauthors_4": 95.0, "recentcoauthors_5": 97.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 152.1, "venuehindexmean_1": 154.9, "venuehindexmean_2": 143.6666666667, "venuehindexmean_3": 146.75, "venuehindexmean_4": 142.4615384615, "venuehindexmean_5": 145.2307692308, "totalvenues_0": 10.0, "totalvenues_1": 10.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 11.2750664386, "pagerank_1": 12.4095451265, "pagerank_2": 13.0863627166, "pagerank_3": 13.9536627536, "pagerank_4": 15.7341796151, "pagerank_5": 16.2245015165}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["Gunnar F.Schr\u00f6der", "JudithFrydman", "S.Reissmann", "N.R.Douglas", "MichaelLevitt", "WahChiu"], "affiliation": "Stanford University", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 8.0, "hindex_1": 9.1666666667, "hindex_2": 9.8333333333, "hindex_3": 10.6666666667, "hindex_4": 11.0, "hindex_5": 11.6666666667, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.7973333333, "citationsperpaper_1": 10.1405, "citationsperpaper_2": 11.4036666667, "citationsperpaper_3": 12.4705, "citationsperpaper_4": 13.057, "citationsperpaper_5": 13.7496666667, "citationsperyear_0": 14.7311666667, "citationsperyear_1": 17.4763333333, "citationsperyear_2": 18.9821666667, "citationsperyear_3": 20.8081666667, "citationsperyear_4": 21.891, "citationsperyear_5": 22.6323333333, "totalcitations_0": 320.6666666667, "totalcitations_1": 368.1666666667, "totalcitations_2": 412.1666666667, "totalcitations_3": 464.1666666667, "totalcitations_4": 513.8333333333, "totalcitations_5": 555.0, "totalpapers_0": 27.1666666667, "totalpapers_1": 31.0, "totalpapers_2": 32.8333333333, "totalpapers_3": 34.8333333333, "totalpapers_4": 37.6666666667, "totalpapers_5": 39.1666666667, "authorage_0": 15.3333333333, "authorage_1": 16.3333333333, "authorage_2": 17.3333333333, "authorage_3": 18.3333333333, "authorage_4": 19.3333333333, "authorage_5": 20.3333333333, "recentcoauthors_0": 73.6666666667, "recentcoauthors_1": 97.5, "recentcoauthors_2": 42.3333333333, "recentcoauthors_3": 27.8333333333, "recentcoauthors_4": 32.8333333333, "recentcoauthors_5": 30.8333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 158.1027777778, "venuehindexmean_1": 156.8172979798, "venuehindexmean_2": 157.975, "venuehindexmean_3": 162.9845959596, "venuehindexmean_4": 163.498976949, "venuehindexmean_5": 164.8938746439, "totalvenues_0": 6.6666666667, "totalvenues_1": 8.3333333333, "totalvenues_2": 8.6666666667, "totalvenues_3": 8.8333333333, "totalvenues_4": 9.3333333333, "totalvenues_5": 9.5, "pagerank_0": 6.2938726182, "pagerank_1": 7.1858949847, "pagerank_2": 7.2669067688, "pagerank_3": 7.5911141294, "pagerank_4": 8.0071830176, "pagerank_5": 8.0423692404}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["Steven J.Ludtke", "MatthewDougherty", "JoanitaJakana", "JunjieZhang", "Caroline J.Fu", "WahChiu", "Matthew L.Baker"], "affiliation": "Baylor College of Medicine", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 5.1428571429, "hindex_1": 6.0, "hindex_2": 6.2857142857, "hindex_3": 6.8571428571, "hindex_4": 7.2857142857, "hindex_5": 7.7142857143, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.428, "citationsperpaper_1": 6.9878571429, "citationsperpaper_2": 8.3858571429, "citationsperpaper_3": 9.9261428571, "citationsperpaper_4": 10.2808571429, "citationsperpaper_5": 10.8592857143, "citationsperyear_0": 7.2247142857, "citationsperyear_1": 8.4512857143, "citationsperyear_2": 9.4268571429, "citationsperyear_3": 10.6648571429, "citationsperyear_4": 10.6821428571, "citationsperyear_5": 11.2255714286, "totalcitations_0": 109.4285714286, "totalcitations_1": 130.4285714286, "totalcitations_2": 153.1428571429, "totalcitations_3": 181.5714285714, "totalcitations_4": 195.8571428571, "totalcitations_5": 218.1428571429, "totalpapers_0": 12.2857142857, "totalpapers_1": 14.4285714286, "totalpapers_2": 15.1428571429, "totalpapers_3": 16.5714285714, "totalpapers_4": 17.8571428571, "totalpapers_5": 19.2857142857, "authorage_0": 9.5714285714, "authorage_1": 10.5714285714, "authorage_2": 11.5714285714, "authorage_3": 12.5714285714, "authorage_4": 13.5714285714, "authorage_5": 14.5714285714, "recentcoauthors_0": 28.4285714286, "recentcoauthors_1": 45.0, "recentcoauthors_2": 29.7142857143, "recentcoauthors_3": 22.2857142857, "recentcoauthors_4": 24.7142857143, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 168.5357142857, "venuehindexmean_1": 170.8404761905, "venuehindexmean_2": 168.3952380952, "venuehindexmean_3": 171.6666666667, "venuehindexmean_4": 171.659981685, "venuehindexmean_5": 173.8674908425, "totalvenues_0": 4.5714285714, "totalvenues_1": 5.4285714286, "totalvenues_2": 5.8571428571, "totalvenues_3": 5.8571428571, "totalvenues_4": 6.1428571429, "totalvenues_5": 6.2857142857, "pagerank_0": 3.6249979818, "pagerank_1": 4.1766322245, "pagerank_2": 4.2539133125, "pagerank_3": 4.5723680428, "pagerank_4": 4.8623220607, "pagerank_5": 4.9765310072}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["JudithFrydman"], "affiliation": "Memorial Sloan Kettering Cancer Center", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 14.0, "hindex_1": 15.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 18.345, "citationsperpaper_1": 18.529, "citationsperpaper_2": 18.973, "citationsperpaper_3": 19.95, "citationsperpaper_4": 19.717, "citationsperpaper_5": 19.837, "citationsperyear_0": 28.0, "citationsperyear_1": 31.5, "citationsperyear_2": 33.429, "citationsperyear_3": 36.273, "citationsperyear_4": 39.435, "citationsperyear_5": 40.5, "totalcitations_0": 532.0, "totalcitations_1": 630.0, "totalcitations_2": 702.0, "totalcitations_3": 798.0, "totalcitations_4": 907.0, "totalcitations_5": 972.0, "totalpapers_0": 29.0, "totalpapers_1": 34.0, "totalpapers_2": 37.0, "totalpapers_3": 40.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 41.0, "recentcoauthors_1": 70.0, "recentcoauthors_2": 56.0, "recentcoauthors_3": 36.0, "recentcoauthors_4": 55.0, "recentcoauthors_5": 67.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.3, "venuehindexmean_1": 148.5454545455, "venuehindexmean_2": 152.0, "venuehindexmean_3": 155.0909090909, "venuehindexmean_4": 152.5, "venuehindexmean_5": 147.0769230769, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 11.0, "totalvenues_4": 12.0, "totalvenues_5": 13.0, "pagerank_0": 6.5916674128, "pagerank_1": 7.8238047734, "pagerank_2": 7.8112793614, "pagerank_3": 8.2444960384, "pagerank_4": 9.1058510239, "pagerank_5": 9.4522060061}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["JudithFrydman"], "affiliation": "Oregon Health & Science University", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 14.0, "hindex_1": 15.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 18.345, "citationsperpaper_1": 18.529, "citationsperpaper_2": 18.973, "citationsperpaper_3": 19.95, "citationsperpaper_4": 19.717, "citationsperpaper_5": 19.837, "citationsperyear_0": 28.0, "citationsperyear_1": 31.5, "citationsperyear_2": 33.429, "citationsperyear_3": 36.273, "citationsperyear_4": 39.435, "citationsperyear_5": 40.5, "totalcitations_0": 532.0, "totalcitations_1": 630.0, "totalcitations_2": 702.0, "totalcitations_3": 798.0, "totalcitations_4": 907.0, "totalcitations_5": 972.0, "totalpapers_0": 29.0, "totalpapers_1": 34.0, "totalpapers_2": 37.0, "totalpapers_3": 40.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 41.0, "recentcoauthors_1": 70.0, "recentcoauthors_2": 56.0, "recentcoauthors_3": 36.0, "recentcoauthors_4": 55.0, "recentcoauthors_5": 67.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.3, "venuehindexmean_1": 148.5454545455, "venuehindexmean_2": 152.0, "venuehindexmean_3": 155.0909090909, "venuehindexmean_4": 152.5, "venuehindexmean_5": 147.0769230769, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 11.0, "totalvenues_4": 12.0, "totalvenues_5": 13.0, "pagerank_0": 6.5916674128, "pagerank_1": 7.8238047734, "pagerank_2": 7.8112793614, "pagerank_3": 8.2444960384, "pagerank_4": 9.1058510239, "pagerank_5": 9.4522060061}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["JudithFrydman"], "affiliation": "Kettering University", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 14.0, "hindex_1": 15.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 18.345, "citationsperpaper_1": 18.529, "citationsperpaper_2": 18.973, "citationsperpaper_3": 19.95, "citationsperpaper_4": 19.717, "citationsperpaper_5": 19.837, "citationsperyear_0": 28.0, "citationsperyear_1": 31.5, "citationsperyear_2": 33.429, "citationsperyear_3": 36.273, "citationsperyear_4": 39.435, "citationsperyear_5": 40.5, "totalcitations_0": 532.0, "totalcitations_1": 630.0, "totalcitations_2": 702.0, "totalcitations_3": 798.0, "totalcitations_4": 907.0, "totalcitations_5": 972.0, "totalpapers_0": 29.0, "totalpapers_1": 34.0, "totalpapers_2": 37.0, "totalpapers_3": 40.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 41.0, "recentcoauthors_1": 70.0, "recentcoauthors_2": 56.0, "recentcoauthors_3": 36.0, "recentcoauthors_4": 55.0, "recentcoauthors_5": 67.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.3, "venuehindexmean_1": 148.5454545455, "venuehindexmean_2": 152.0, "venuehindexmean_3": 155.0909090909, "venuehindexmean_4": 152.5, "venuehindexmean_5": 147.0769230769, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 11.0, "totalvenues_4": 12.0, "totalvenues_5": 13.0, "pagerank_0": 6.5916674128, "pagerank_1": 7.8238047734, "pagerank_2": 7.8112793614, "pagerank_3": 8.2444960384, "pagerank_4": 9.1058510239, "pagerank_5": 9.4522060061}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["MichaelLevitt"], "affiliation": "Weizmann Institute of Science", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 16.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.382, "citationsperpaper_1": 10.57, "citationsperpaper_2": 10.78, "citationsperpaper_3": 11.289, "citationsperpaper_4": 11.575, "citationsperpaper_5": 12.034, "citationsperyear_0": 18.349, "citationsperyear_1": 18.977, "citationsperyear_2": 19.644, "citationsperyear_3": 20.37, "citationsperyear_4": 21.426, "citationsperyear_5": 21.813, "totalcitations_0": 789.0, "totalcitations_1": 835.0, "totalcitations_2": 884.0, "totalcitations_3": 937.0, "totalcitations_4": 1007.0, "totalcitations_5": 1047.0, "totalpapers_0": 76.0, "totalpapers_1": 79.0, "totalpapers_2": 82.0, "totalpapers_3": 83.0, "totalpapers_4": 87.0, "totalpapers_5": 87.0, "authorage_0": 42.0, "authorage_1": 43.0, "authorage_2": 44.0, "authorage_3": 45.0, "authorage_4": 46.0, "authorage_5": 47.0, "recentcoauthors_0": 287.0, "recentcoauthors_1": 294.0, "recentcoauthors_2": 19.0, "recentcoauthors_3": 17.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 7.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.6666666667, "venuehindexmean_1": 134.5, "venuehindexmean_2": 138.2, "venuehindexmean_3": 141.4, "venuehindexmean_4": 142.4545454545, "venuehindexmean_5": 146.0, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 15.201182021, "pagerank_1": 15.3936816399, "pagerank_2": 15.1507809654, "pagerank_3": 15.1001692962, "pagerank_4": 14.9539813327, "pagerank_5": 14.4700103642}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["MichaelLevitt"], "affiliation": "University of Minnesota", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 16.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.382, "citationsperpaper_1": 10.57, "citationsperpaper_2": 10.78, "citationsperpaper_3": 11.289, "citationsperpaper_4": 11.575, "citationsperpaper_5": 12.034, "citationsperyear_0": 18.349, "citationsperyear_1": 18.977, "citationsperyear_2": 19.644, "citationsperyear_3": 20.37, "citationsperyear_4": 21.426, "citationsperyear_5": 21.813, "totalcitations_0": 789.0, "totalcitations_1": 835.0, "totalcitations_2": 884.0, "totalcitations_3": 937.0, "totalcitations_4": 1007.0, "totalcitations_5": 1047.0, "totalpapers_0": 76.0, "totalpapers_1": 79.0, "totalpapers_2": 82.0, "totalpapers_3": 83.0, "totalpapers_4": 87.0, "totalpapers_5": 87.0, "authorage_0": 42.0, "authorage_1": 43.0, "authorage_2": 44.0, "authorage_3": 45.0, "authorage_4": 46.0, "authorage_5": 47.0, "recentcoauthors_0": 287.0, "recentcoauthors_1": 294.0, "recentcoauthors_2": 19.0, "recentcoauthors_3": 17.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 7.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.6666666667, "venuehindexmean_1": 134.5, "venuehindexmean_2": 138.2, "venuehindexmean_3": 141.4, "venuehindexmean_4": 142.4545454545, "venuehindexmean_5": 146.0, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 15.201182021, "pagerank_1": 15.3936816399, "pagerank_2": 15.1507809654, "pagerank_3": 15.1001692962, "pagerank_4": 14.9539813327, "pagerank_5": 14.4700103642}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["MichaelLevitt"], "affiliation": "Laboratory of Molecular Biology", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 16.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.382, "citationsperpaper_1": 10.57, "citationsperpaper_2": 10.78, "citationsperpaper_3": 11.289, "citationsperpaper_4": 11.575, "citationsperpaper_5": 12.034, "citationsperyear_0": 18.349, "citationsperyear_1": 18.977, "citationsperyear_2": 19.644, "citationsperyear_3": 20.37, "citationsperyear_4": 21.426, "citationsperyear_5": 21.813, "totalcitations_0": 789.0, "totalcitations_1": 835.0, "totalcitations_2": 884.0, "totalcitations_3": 937.0, "totalcitations_4": 1007.0, "totalcitations_5": 1047.0, "totalpapers_0": 76.0, "totalpapers_1": 79.0, "totalpapers_2": 82.0, "totalpapers_3": 83.0, "totalpapers_4": 87.0, "totalpapers_5": 87.0, "authorage_0": 42.0, "authorage_1": 43.0, "authorage_2": 44.0, "authorage_3": 45.0, "authorage_4": 46.0, "authorage_5": 47.0, "recentcoauthors_0": 287.0, "recentcoauthors_1": 294.0, "recentcoauthors_2": 19.0, "recentcoauthors_3": 17.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 7.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.6666666667, "venuehindexmean_1": 134.5, "venuehindexmean_2": 138.2, "venuehindexmean_3": 141.4, "venuehindexmean_4": 142.4545454545, "venuehindexmean_5": 146.0, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 15.201182021, "pagerank_1": 15.3936816399, "pagerank_2": 15.1507809654, "pagerank_3": 15.1001692962, "pagerank_4": 14.9539813327, "pagerank_5": 14.4700103642}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["JunjieZhang"], "affiliation": "Texas A&M University", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 4.0, "citationsperpaper_1": 6.0, "citationsperpaper_2": 6.0, "citationsperpaper_3": 8.333, "citationsperpaper_4": 8.667, "citationsperpaper_5": 9.667, "citationsperyear_0": 4.0, "citationsperyear_1": 6.0, "citationsperyear_2": 6.0, "citationsperyear_3": 6.25, "citationsperyear_4": 5.2, "citationsperyear_5": 4.833, "totalcitations_0": 4.0, "totalcitations_1": 12.0, "totalcitations_2": 18.0, "totalcitations_3": 25.0, "totalcitations_4": 26.0, "totalcitations_5": 29.0, "totalpapers_0": 1.0, "totalpapers_1": 2.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 18.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 2.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 259.5, "venuehindexmean_2": 234.0, "venuehindexmean_3": 237.6666666667, "venuehindexmean_4": 241.6666666667, "venuehindexmean_5": 244.6666666667, "totalvenues_0": 1.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.5815353254, "pagerank_1": 0.8211528111, "pagerank_2": 0.8539672665, "pagerank_3": 0.8215823433, "pagerank_4": 0.7933746093, "pagerank_5": 0.7422545551}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["Gunnar F.Schr\u00f6der", "S.Reissmann"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 3.5, "hindex_1": 4.5, "hindex_2": 5.5, "hindex_3": 6.5, "hindex_4": 7.5, "hindex_5": 8.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.5625, "citationsperpaper_1": 8.731, "citationsperpaper_2": 11.655, "citationsperpaper_3": 12.917, "citationsperpaper_4": 14.772, "citationsperpaper_5": 16.2835, "citationsperyear_0": 8.5625, "citationsperyear_1": 11.878, "citationsperyear_2": 14.5835, "citationsperyear_3": 16.7855, "citationsperyear_4": 18.25, "citationsperyear_5": 19.312, "totalcitations_0": 59.0, "totalcitations_1": 92.5, "totalcitations_2": 128.5, "totalcitations_3": 165.5, "totalcitations_4": 200.5, "totalcitations_5": 233.5, "totalpapers_0": 6.0, "totalpapers_1": 9.5, "totalpapers_2": 10.0, "totalpapers_3": 12.0, "totalpapers_4": 12.5, "totalpapers_5": 13.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 22.5, "recentcoauthors_1": 49.0, "recentcoauthors_2": 29.5, "recentcoauthors_3": 13.0, "recentcoauthors_4": 14.5, "recentcoauthors_5": 7.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 154.275, "venuehindexmean_1": 155.9791666667, "venuehindexmean_2": 159.7916666667, "venuehindexmean_3": 168.8333333333, "venuehindexmean_4": 171.8888888889, "venuehindexmean_5": 174.5277777778, "totalvenues_0": 4.5, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.5, "totalvenues_4": 7.5, "totalvenues_5": 7.5, "pagerank_0": 1.8390488838, "pagerank_1": 2.8206038031, "pagerank_2": 2.8058458333, "pagerank_3": 3.2071563797, "pagerank_4": 3.2416252163, "pagerank_5": 3.2115592115}}, {"model": "papers.paper", "pk": 1003734, "fields": {"authors": ["Gunnar F.Schr\u00f6der"], "affiliation": "Forschungszentrum J\u00fclich", "venue": "Nature", "doi": "10.1038/nature08701", "abstract": "Chaperonins are large, cylindrical complexes that assist in the folding of cellular proteins in an ATP-dependent manner. Group II chaperonins are present in eukaryotes and archaea and consist of two back-to-back rings and a lid segment extending from an apical domain. In this study, Wah Chiu and colleagues determine the cryo-electron microscopy structure of an archael chaperonin called Mm-cpn in the nucleotide-free (open) and nucleotide-induced (closed) states. The structure provides details on conformational changes triggered by ATP hydrolysis leading to rearrangements in inter-ring subunits that differ from other classes of chaperonins. Group II chaperonins are present in eukaryotes and archaea and are essential mediators of cellular protein folding. This process is critically dependent on the closure of a built-in lid, which is triggered by ATP hydrolysis, but the structural rearrangements and molecular events leading to lid closure are unknown. Using cryo-electron microscopy, the structures of an archaeal group II chaperonin in the open and closed states are now reported, providing details of this mechanism. Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, \u223c1\u2009megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates1,2,3. Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid4,5, which is triggered by ATP hydrolysis6. The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group\u2009II chaperonin5,7, in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3\u2009A resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8\u2009A resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group\u2009II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.", "year": 2010, "title": "Mechanism of Folding Chamber Closure in a Group II Chaperonin", "keywords": ["Biophysics", "Protein folding", "Protein subunit", "Protein structure", "Chaperonin", "ATP hydrolysis", "Structural biology", "Cryo-electron microscopy", "Chemistry", "Chaperone (protein)"], "citations_0": 4.0, "citations_1": 5.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2445143084, "timescaledpagerank_1": 0.866508409, "timescaledpagerank_2": 1.1387910065, "timescaledpagerank_3": 1.4859885023, "timescaledpagerank_4": 1.3233602669, "timescaledpagerank_5": 1.4944093406, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 8.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 28.0, "adopters_1": 27.0, "adopters_2": 19.0, "adopters_3": 29.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 12.375, "citationsperpaper_1": 11.462, "citationsperpaper_2": 14.643, "citationsperpaper_3": 14.667, "citationsperpaper_4": 17.211, "citationsperpaper_5": 19.4, "citationsperyear_0": 12.375, "citationsperyear_1": 16.556, "citationsperyear_2": 20.5, "citationsperyear_3": 24.0, "citationsperyear_4": 27.25, "citationsperyear_5": 29.846, "totalcitations_0": 99.0, "totalcitations_1": 149.0, "totalcitations_2": 205.0, "totalcitations_3": 264.0, "totalcitations_4": 327.0, "totalcitations_5": 388.0, "totalpapers_0": 8.0, "totalpapers_1": 13.0, "totalpapers_2": 14.0, "totalpapers_3": 18.0, "totalpapers_4": 19.0, "totalpapers_5": 20.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 20.0, "recentcoauthors_1": 55.0, "recentcoauthors_2": 41.0, "recentcoauthors_3": 26.0, "recentcoauthors_4": 29.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.8, "venuehindexmean_1": 145.625, "venuehindexmean_2": 149.75, "venuehindexmean_3": 165.3333333333, "venuehindexmean_4": 168.4444444444, "venuehindexmean_5": 171.5555555556, "totalvenues_0": 5.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 2.3104995193, "pagerank_1": 3.6856282961, "pagerank_2": 3.7939129511, "pagerank_3": 4.6915481505, "pagerank_4": 4.8226851122, "pagerank_5": 4.8382319235}}, {"model": "papers.paper", "pk": 1003419, "fields": {"authors": ["NealHockley"], "affiliation": "Bangor University", "venue": "Nature", "doi": "10.1038/467271e", "abstract": "", "year": 2010, "title": "Low repopulation of poor districts in New Orleans proves little", "keywords": ["Socioeconomics", "Geography", "Repopulation", "Environmental ethics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.667, "citationsperpaper_1": 0.5, "citationsperpaper_2": 0.75, "citationsperpaper_3": 1.25, "citationsperpaper_4": 1.25, "citationsperpaper_5": 1.25, "citationsperyear_0": 0.286, "citationsperyear_1": 0.25, "citationsperyear_2": 0.333, "citationsperyear_3": 0.5, "citationsperyear_4": 0.455, "citationsperyear_5": 0.417, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 3.0, "totalcitations_3": 5.0, "totalcitations_4": 5.0, "totalcitations_5": 5.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.525622213, "pagerank_1": 0.5307297547, "pagerank_2": 0.5115413857, "pagerank_3": 0.5086595692, "pagerank_4": 0.4987194106, "pagerank_5": 0.4967399563}}, {"model": "papers.paper", "pk": 1002944, "fields": {"authors": ["James A.Screen"], "affiliation": "University of Exeter", "venue": "Nature", "doi": "10.1038/nature09051", "abstract": "Climate change does not occur symmetrically; instead, in a process called polar amplification, polar areas warm faster than the tropics. Recent work indicated that transport processes in the upper atmosphere account for much of the recent polar amplification, but this conclusion proved controversial. Here, updated reanalysis data have been used to show that reductions in sea ice are instead responsible.", "year": 2010, "title": "The central role of diminishing sea ice in recent Arctic temperature amplification", "keywords": ["Polar amplification", "Oceanography", "Climatology", "Arctic sea ice decline", "Sea ice", "Ice-albedo feedback", "Arctic dipole anomaly", "Environmental science", "Cryosphere", "Arctic ice pack", "Arctic geoengineering"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.002234131, "timescaledpagerank_1": 0.5252872956, "timescaledpagerank_2": 2.5730521873, "timescaledpagerank_3": 3.2114227424, "timescaledpagerank_4": 3.3372245403, "timescaledpagerank_5": 3.8987323981, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 2.0, "adopters_0": 2.0, "adopters_1": 9.0, "adopters_2": 6.0, "adopters_3": 8.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 4.0, "citationsperpaper_3": 4.0, "citationsperpaper_4": 5.5, "citationsperpaper_5": 7.0, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 1.333, "citationsperyear_3": 2.0, "citationsperyear_4": 2.2, "citationsperyear_5": 2.333, "totalcitations_0": 1.0, "totalcitations_1": 2.0, "totalcitations_2": 4.0, "totalcitations_3": 8.0, "totalcitations_4": 11.0, "totalcitations_5": 14.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 1.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.9670543998, "pagerank_1": 0.9670543998, "pagerank_2": 0.9670543998, "pagerank_3": 0.9670543998, "pagerank_4": 0.9670543998, "pagerank_5": 0.9670543998}}, {"model": "papers.paper", "pk": 1002944, "fields": {"authors": ["IanSimmonds", "James A.Screen"], "affiliation": "University of Melbourne", "venue": "Nature", "doi": "10.1038/nature09051", "abstract": "Climate change does not occur symmetrically; instead, in a process called polar amplification, polar areas warm faster than the tropics. Recent work indicated that transport processes in the upper atmosphere account for much of the recent polar amplification, but this conclusion proved controversial. Here, updated reanalysis data have been used to show that reductions in sea ice are instead responsible.", "year": 2010, "title": "The central role of diminishing sea ice in recent Arctic temperature amplification", "keywords": ["Polar amplification", "Oceanography", "Climatology", "Arctic sea ice decline", "Sea ice", "Ice-albedo feedback", "Arctic dipole anomaly", "Environmental science", "Cryosphere", "Arctic ice pack", "Arctic geoengineering"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.002234131, "timescaledpagerank_1": 0.5252872956, "timescaledpagerank_2": 2.5730521873, "timescaledpagerank_3": 3.2114227424, "timescaledpagerank_4": 3.3372245403, "timescaledpagerank_5": 3.8987323981, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 2.0, "adopters_0": 2.0, "adopters_1": 9.0, "adopters_2": 6.0, "adopters_3": 8.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 4.0, "citationsperpaper_3": 4.0, "citationsperpaper_4": 5.5, "citationsperpaper_5": 7.0, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 1.333, "citationsperyear_3": 2.0, "citationsperyear_4": 2.2, "citationsperyear_5": 2.333, "totalcitations_0": 1.0, "totalcitations_1": 2.0, "totalcitations_2": 4.0, "totalcitations_3": 8.0, "totalcitations_4": 11.0, "totalcitations_5": 14.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 1.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.9670543998, "pagerank_1": 0.9670543998, "pagerank_2": 0.9670543998, "pagerank_3": 0.9670543998, "pagerank_4": 0.9670543998, "pagerank_5": 0.9670543998}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Marcus A. M.de Aguiar", "Blake C.Stacey", "JustinWerfel", "YaneerBar-Yam"], "affiliation": "New England Complex Systems Institute", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.5, "hindex_1": 1.75, "hindex_2": 1.75, "hindex_3": 1.75, "hindex_4": 1.75, "hindex_5": 1.75, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.975, "citationsperpaper_1": 2.05, "citationsperpaper_2": 2.075, "citationsperpaper_3": 1.841, "citationsperpaper_4": 2.05675, "citationsperpaper_5": 2.5625, "citationsperyear_0": 1.35875, "citationsperyear_1": 0.86425, "citationsperyear_2": 0.684, "citationsperyear_3": 0.61, "citationsperyear_4": 0.67475, "citationsperyear_5": 0.7455, "totalcitations_0": 6.75, "totalcitations_1": 7.5, "totalcitations_2": 7.75, "totalcitations_3": 8.5, "totalcitations_4": 10.25, "totalcitations_5": 11.5, "totalpapers_0": 3.5, "totalpapers_1": 3.5, "totalpapers_2": 3.5, "totalpapers_3": 4.0, "totalpapers_4": 4.25, "totalpapers_5": 4.5, "authorage_0": 6.75, "authorage_1": 7.75, "authorage_2": 8.75, "authorage_3": 9.75, "authorage_4": 10.75, "authorage_5": 11.75, "recentcoauthors_0": 18.5, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 1.0, "recentcoauthors_4": 1.5, "recentcoauthors_5": 1.25, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 238.5833333333, "venuehindexmean_1": 242.1666666667, "venuehindexmean_2": 247.0, "venuehindexmean_3": 239.6666666667, "venuehindexmean_4": 245.9166666667, "venuehindexmean_5": 249.5, "totalvenues_0": 1.75, "totalvenues_1": 1.75, "totalvenues_2": 1.75, "totalvenues_3": 2.0, "totalvenues_4": 2.25, "totalvenues_5": 2.25, "pagerank_0": 1.443526038, "pagerank_1": 1.2693432391, "pagerank_2": 1.2087355768, "pagerank_3": 1.271404365, "pagerank_4": 1.3193320716, "pagerank_5": 1.355977262}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie", "DougTaylor", "Peter D.Fields"], "affiliation": "University of Virginia", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.3333333333, "hindex_3": 2.3333333333, "hindex_4": 2.3333333333, "hindex_5": 2.3333333333, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.4, "citationsperpaper_1": 2.4666666667, "citationsperpaper_2": 2.6876666667, "citationsperpaper_3": 2.6666666667, "citationsperpaper_4": 2.7253333333, "citationsperpaper_5": 3.4706666667, "citationsperyear_0": 1.7333333333, "citationsperyear_1": 1.0813333333, "citationsperyear_2": 0.9606666667, "citationsperyear_3": 0.8603333333, "citationsperyear_4": 0.8046666667, "citationsperyear_5": 0.889, "totalcitations_0": 17.3333333333, "totalcitations_1": 18.3333333333, "totalcitations_2": 23.0, "totalcitations_3": 24.0, "totalcitations_4": 25.0, "totalcitations_5": 27.0, "totalpapers_0": 5.6666666667, "totalpapers_1": 5.6666666667, "totalpapers_2": 6.0, "totalpapers_3": 6.3333333333, "totalpapers_4": 6.3333333333, "totalpapers_5": 6.3333333333, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 17.6666666667, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.6666666667, "recentcoauthors_3": 5.3333333333, "recentcoauthors_4": 4.6666666667, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 231.6666666667, "venuehindexmean_1": 235.6666666667, "venuehindexmean_2": 240.5833333333, "venuehindexmean_3": 246.1666666667, "venuehindexmean_4": 250.6666666667, "venuehindexmean_5": 254.4166666667, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.9702067887, "pagerank_1": 1.7021162599, "pagerank_2": 1.6655110177, "pagerank_3": 1.8377201661, "pagerank_4": 1.7570897959, "pagerank_5": 1.7268475153}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Guy A.Hoelzer"], "affiliation": "University of Nevada, Reno", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 1.0, "citationsperpaper_2": 1.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 1.0, "citationsperpaper_5": 1.5, "citationsperyear_0": 0.2, "citationsperyear_1": 0.182, "citationsperyear_2": 0.167, "citationsperyear_3": 0.154, "citationsperyear_4": 0.143, "citationsperyear_5": 0.2, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 2.0, "totalcitations_4": 2.0, "totalcitations_5": 3.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.1613821679, "pagerank_1": 1.0032906018, "pagerank_2": 0.9584437204, "pagerank_3": 0.9545768931, "pagerank_4": 0.9621350417, "pagerank_5": 0.9492040823}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie"], "affiliation": "Adelphi University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.2, "citationsperpaper_1": 3.4, "citationsperpaper_2": 4.063, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.176, "citationsperpaper_5": 4.412, "citationsperyear_0": 1.2, "citationsperyear_1": 1.244, "citationsperyear_2": 1.548, "citationsperyear_3": 1.581, "citationsperyear_4": 1.614, "citationsperyear_5": 1.667, "totalcitations_0": 48.0, "totalcitations_1": 51.0, "totalcitations_2": 65.0, "totalcitations_3": 68.0, "totalcitations_4": 71.0, "totalcitations_5": 75.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 39.0, "authorage_1": 40.0, "authorage_2": 41.0, "authorage_3": 42.0, "authorage_4": 43.0, "authorage_5": 44.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 2.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.8037796766, "pagerank_1": 3.3060341648, "pagerank_2": 3.283123067, "pagerank_3": 3.8070733541, "pagerank_4": 3.5504197978, "pagerank_5": 3.4846996331}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie"], "affiliation": "Utah State University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.2, "citationsperpaper_1": 3.4, "citationsperpaper_2": 4.063, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.176, "citationsperpaper_5": 4.412, "citationsperyear_0": 1.2, "citationsperyear_1": 1.244, "citationsperyear_2": 1.548, "citationsperyear_3": 1.581, "citationsperyear_4": 1.614, "citationsperyear_5": 1.667, "totalcitations_0": 48.0, "totalcitations_1": 51.0, "totalcitations_2": 65.0, "totalcitations_3": 68.0, "totalcitations_4": 71.0, "totalcitations_5": 75.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 39.0, "authorage_1": 40.0, "authorage_2": 41.0, "authorage_3": 42.0, "authorage_4": 43.0, "authorage_5": 44.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 2.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.8037796766, "pagerank_1": 3.3060341648, "pagerank_2": 3.283123067, "pagerank_3": 3.8070733541, "pagerank_4": 3.5504197978, "pagerank_5": 3.4846996331}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie"], "affiliation": "Indiana University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.2, "citationsperpaper_1": 3.4, "citationsperpaper_2": 4.063, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.176, "citationsperpaper_5": 4.412, "citationsperyear_0": 1.2, "citationsperyear_1": 1.244, "citationsperyear_2": 1.548, "citationsperyear_3": 1.581, "citationsperyear_4": 1.614, "citationsperyear_5": 1.667, "totalcitations_0": 48.0, "totalcitations_1": 51.0, "totalcitations_2": 65.0, "totalcitations_3": 68.0, "totalcitations_4": 71.0, "totalcitations_5": 75.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 39.0, "authorage_1": 40.0, "authorage_2": 41.0, "authorage_3": 42.0, "authorage_4": 43.0, "authorage_5": 44.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 2.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.8037796766, "pagerank_1": 3.3060341648, "pagerank_2": 3.283123067, "pagerank_3": 3.8070733541, "pagerank_4": 3.5504197978, "pagerank_5": 3.4846996331}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie", "Charles J.Goodnight", "Michael J.Wade"], "affiliation": "University of Chicago", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 3.6666666667, "hindex_1": 3.6666666667, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.3333333333, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.0033333333, "citationsperpaper_1": 3.1176666667, "citationsperpaper_2": 3.2656666667, "citationsperpaper_3": 3.289, "citationsperpaper_4": 3.231, "citationsperpaper_5": 3.5373333333, "citationsperyear_0": 0.9523333333, "citationsperyear_1": 0.9676666667, "citationsperyear_2": 1.0516666667, "citationsperyear_3": 1.064, "citationsperyear_4": 1.0816666667, "citationsperyear_5": 1.1673333333, "totalcitations_0": 33.3333333333, "totalcitations_1": 35.0, "totalcitations_2": 39.6666666667, "totalcitations_3": 41.3333333333, "totalcitations_4": 43.0, "totalcitations_5": 46.6666666667, "totalpapers_0": 10.6666666667, "totalpapers_1": 10.6666666667, "totalpapers_2": 11.3333333333, "totalpapers_3": 11.6666666667, "totalpapers_4": 12.0, "totalpapers_5": 12.3333333333, "authorage_0": 30.6666666667, "authorage_1": 31.6666666667, "authorage_2": 32.6666666667, "authorage_3": 33.6666666667, "authorage_4": 34.6666666667, "authorage_5": 35.6666666667, "recentcoauthors_0": 17.6666666667, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.6666666667, "recentcoauthors_3": 5.3333333333, "recentcoauthors_4": 5.0, "recentcoauthors_5": 0.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 205.2222222222, "venuehindexmean_1": 208.7777777778, "venuehindexmean_2": 213.9166666667, "venuehindexmean_3": 218.6111111111, "venuehindexmean_4": 222.2222222222, "venuehindexmean_5": 225.75, "totalvenues_0": 3.3333333333, "totalvenues_1": 3.3333333333, "totalvenues_2": 3.3333333333, "totalvenues_3": 3.3333333333, "totalvenues_4": 3.3333333333, "totalvenues_5": 3.3333333333, "pagerank_0": 2.3256979503, "pagerank_1": 1.9970943924, "pagerank_2": 1.9568777334, "pagerank_3": 2.0986910806, "pagerank_4": 2.0878054047, "pagerank_5": 2.0456966271}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie"], "affiliation": "Clemson University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.2, "citationsperpaper_1": 3.4, "citationsperpaper_2": 4.063, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.176, "citationsperpaper_5": 4.412, "citationsperyear_0": 1.2, "citationsperyear_1": 1.244, "citationsperyear_2": 1.548, "citationsperyear_3": 1.581, "citationsperyear_4": 1.614, "citationsperyear_5": 1.667, "totalcitations_0": 48.0, "totalcitations_1": 51.0, "totalcitations_2": 65.0, "totalcitations_3": 68.0, "totalcitations_4": 71.0, "totalcitations_5": 75.0, "totalpapers_0": 15.0, "totalpapers_1": 15.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 17.0, "totalpapers_5": 17.0, "authorage_0": 39.0, "authorage_1": 40.0, "authorage_2": 41.0, "authorage_3": 42.0, "authorage_4": 43.0, "authorage_5": 44.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 2.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.8037796766, "pagerank_1": 3.3060341648, "pagerank_2": 3.283123067, "pagerank_3": 3.8070733541, "pagerank_4": 3.5504197978, "pagerank_5": 3.4846996331}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Edmund D.Brodie", "Peter C.Zee", "James D.Bever", "J. DavidVan Dyken", "Michael J.Wade"], "affiliation": "Indiana University Bloomington", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.6, "hindex_1": 3.0, "hindex_2": 3.2, "hindex_3": 3.2, "hindex_4": 3.2, "hindex_5": 3.4, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.9686, "citationsperpaper_1": 2.8372, "citationsperpaper_2": 2.9594, "citationsperpaper_3": 3.0066, "citationsperpaper_4": 3.1552, "citationsperpaper_5": 3.2958, "citationsperyear_0": 1.4914, "citationsperyear_1": 1.8758, "citationsperyear_2": 1.6082, "citationsperyear_3": 1.4132, "citationsperyear_4": 1.334, "citationsperyear_5": 1.4822, "totalcitations_0": 20.4, "totalcitations_1": 23.0, "totalcitations_2": 26.6, "totalcitations_3": 27.8, "totalcitations_4": 29.2, "totalcitations_5": 32.2, "totalpapers_0": 7.4, "totalpapers_1": 7.4, "totalpapers_2": 8.2, "totalpapers_3": 8.4, "totalpapers_4": 8.4, "totalpapers_5": 8.8, "authorage_0": 15.6, "authorage_1": 16.6, "authorage_2": 17.6, "authorage_3": 18.6, "authorage_4": 19.6, "authorage_5": 20.6, "recentcoauthors_0": 19.4, "recentcoauthors_1": 19.0, "recentcoauthors_2": 1.6, "recentcoauthors_3": 4.4, "recentcoauthors_4": 2.8, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 226.9666666667, "venuehindexmean_1": 230.8333333333, "venuehindexmean_2": 236.75, "venuehindexmean_3": 242.2333333333, "venuehindexmean_4": 246.0666666667, "venuehindexmean_5": 237.95, "totalvenues_0": 2.6, "totalvenues_1": 2.6, "totalvenues_2": 2.6, "totalvenues_3": 2.6, "totalvenues_4": 2.6, "totalvenues_5": 3.0, "pagerank_0": 2.2875481677, "pagerank_1": 1.9915746178, "pagerank_2": 2.0426981041, "pagerank_3": 2.1340350266, "pagerank_4": 2.1009653734, "pagerank_5": 2.1657364843}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["FelixBreden"], "affiliation": "University of Missouri", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 2.25, "citationsperyear_0": 0.333, "citationsperyear_1": 0.32, "citationsperyear_2": 0.308, "citationsperyear_3": 0.296, "citationsperyear_4": 0.286, "citationsperyear_5": 0.31, "totalcitations_0": 8.0, "totalcitations_1": 8.0, "totalcitations_2": 8.0, "totalcitations_3": 8.0, "totalcitations_4": 8.0, "totalcitations_5": 9.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.2726304009, "pagerank_1": 1.1066697704, "pagerank_2": 1.059592338, "pagerank_3": 1.0556281509, "pagerank_4": 1.0636452614, "pagerank_5": 1.0501230743}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["FelixBreden"], "affiliation": "Simon Fraser University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 2.25, "citationsperyear_0": 0.333, "citationsperyear_1": 0.32, "citationsperyear_2": 0.308, "citationsperyear_3": 0.296, "citationsperyear_4": 0.286, "citationsperyear_5": 0.31, "totalcitations_0": 8.0, "totalcitations_1": 8.0, "totalcitations_2": 8.0, "totalcitations_3": 8.0, "totalcitations_4": 8.0, "totalcitations_5": 9.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.2726304009, "pagerank_1": 1.1066697704, "pagerank_2": 1.059592338, "pagerank_3": 1.0556281509, "pagerank_4": 1.0636452614, "pagerank_5": 1.0501230743}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Peter J.Richerson"], "affiliation": "University of California, Davis", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.8, "citationsperpaper_1": 10.333, "citationsperpaper_2": 9.714, "citationsperpaper_3": 10.429, "citationsperpaper_4": 10.375, "citationsperpaper_5": 11.375, "citationsperyear_0": 1.581, "citationsperyear_1": 1.938, "citationsperyear_2": 2.061, "citationsperyear_3": 2.147, "citationsperyear_4": 2.371, "citationsperyear_5": 2.528, "totalcitations_0": 49.0, "totalcitations_1": 62.0, "totalcitations_2": 68.0, "totalcitations_3": 73.0, "totalcitations_4": 83.0, "totalcitations_5": 91.0, "totalpapers_0": 5.0, "totalpapers_1": 6.0, "totalpapers_2": 7.0, "totalpapers_3": 7.0, "totalpapers_4": 8.0, "totalpapers_5": 8.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 21.0, "recentcoauthors_2": 24.0, "recentcoauthors_3": 22.0, "recentcoauthors_4": 21.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.4879878648, "pagerank_1": 1.4068347745, "pagerank_2": 1.7265633787, "pagerank_3": 1.7330740642, "pagerank_4": 2.122996821, "pagerank_5": 2.1015720185}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Jeffrey AlanFletcher"], "affiliation": "Portland State University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 3.0, "citationsperyear_0": 2.0, "citationsperyear_1": 1.0, "citationsperyear_2": 0.667, "citationsperyear_3": 0.5, "citationsperyear_4": 0.4, "citationsperyear_5": 0.5, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 2.0, "totalcitations_4": 2.0, "totalcitations_5": 3.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0534203453, "pagerank_1": 0.9001573125, "pagerank_2": 0.856704994, "pagerank_3": 0.8530435739, "pagerank_4": 0.8604247868, "pagerank_5": 0.8479214561}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Marcus A. M.de Aguiar"], "affiliation": "State University of Campinas", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 1.5, "citationsperpaper_5": 2.0, "citationsperyear_0": 2.0, "citationsperyear_1": 1.0, "citationsperyear_2": 0.667, "citationsperyear_3": 0.5, "citationsperyear_4": 0.6, "citationsperyear_5": 0.667, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 2.0, "totalcitations_4": 3.0, "totalcitations_5": 4.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 2.0, "recentcoauthors_4": 2.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.0534203455, "pagerank_1": 0.9001573024, "pagerank_2": 0.856704994, "pagerank_3": 1.0150145975, "pagerank_4": 1.022193303, "pagerank_5": 1.0088726819}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Peter C.Zee"], "affiliation": "California State University, Northridge", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 3.0, "citationsperpaper_2": 3.0, "citationsperpaper_3": 3.0, "citationsperpaper_4": 3.0, "citationsperpaper_5": 3.0, "citationsperyear_0": 2.0, "citationsperyear_1": 3.0, "citationsperyear_2": 2.0, "citationsperyear_3": 1.5, "citationsperyear_4": 1.2, "citationsperyear_5": 1.5, "totalcitations_0": 2.0, "totalcitations_1": 6.0, "totalcitations_2": 6.0, "totalcitations_3": 6.0, "totalcitations_4": 6.0, "totalcitations_5": 9.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 3.0, "pagerank_0": 1.2154366526, "pagerank_1": 0.9609631733, "pagerank_2": 0.9152872036, "pagerank_3": 0.9115715183, "pagerank_4": 0.9192054469, "pagerank_5": 1.1079006542}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["David SloanWilson"], "affiliation": "Binghamton University", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.0, "citationsperpaper_1": 6.545, "citationsperpaper_2": 6.909, "citationsperpaper_3": 7.182, "citationsperpaper_4": 7.455, "citationsperpaper_5": 7.818, "citationsperyear_0": 1.833, "citationsperyear_1": 1.946, "citationsperyear_2": 2.0, "citationsperyear_3": 2.026, "citationsperyear_4": 2.05, "citationsperyear_5": 2.098, "totalcitations_0": 66.0, "totalcitations_1": 72.0, "totalcitations_2": 76.0, "totalcitations_3": 79.0, "totalcitations_4": 82.0, "totalcitations_5": 86.0, "totalpapers_0": 11.0, "totalpapers_1": 11.0, "totalpapers_2": 11.0, "totalpapers_3": 11.0, "totalpapers_4": 11.0, "totalpapers_5": 11.0, "authorage_0": 35.0, "authorage_1": 36.0, "authorage_2": 37.0, "authorage_3": 38.0, "authorage_4": 39.0, "authorage_5": 40.0, "recentcoauthors_0": 20.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.4596240142, "pagerank_1": 2.2603195397, "pagerank_2": 2.2029571942, "pagerank_3": 2.1916233537, "pagerank_4": 2.196187404, "pagerank_5": 2.1767228305}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Peter D.Fields"], "affiliation": "University of Basel", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 3.0, "citationsperyear_0": 2.0, "citationsperyear_1": 1.0, "citationsperyear_2": 0.667, "citationsperyear_3": 0.5, "citationsperyear_4": 0.4, "citationsperyear_5": 0.5, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 2.0, "totalcitations_4": 2.0, "totalcitations_5": 3.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0534203455, "pagerank_1": 0.9001573125, "pagerank_2": 0.8567049926, "pagerank_3": 0.8530435723, "pagerank_4": 0.8604247971, "pagerank_5": 0.8479214561}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Timothy A.Linksvayer"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 3.5, "citationsperpaper_2": 4.0, "citationsperpaper_3": 6.0, "citationsperpaper_4": 5.0, "citationsperpaper_5": 7.0, "citationsperyear_0": 2.0, "citationsperyear_1": 3.5, "citationsperyear_2": 2.667, "citationsperyear_3": 3.0, "citationsperyear_4": 3.0, "citationsperyear_5": 3.5, "totalcitations_0": 2.0, "totalcitations_1": 7.0, "totalcitations_2": 8.0, "totalcitations_3": 12.0, "totalcitations_4": 15.0, "totalcitations_5": 21.0, "totalpapers_0": 1.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 153.0, "recentcoauthors_2": 136.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0534203521, "pagerank_1": 3.3086773607, "pagerank_2": 3.2577228687, "pagerank_3": 3.2745271126, "pagerank_4": 3.2612166255, "pagerank_5": 3.2243212634}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Timothy A.Linksvayer"], "affiliation": "University of Copenhagen", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 3.5, "citationsperpaper_2": 4.0, "citationsperpaper_3": 6.0, "citationsperpaper_4": 5.0, "citationsperpaper_5": 7.0, "citationsperyear_0": 2.0, "citationsperyear_1": 3.5, "citationsperyear_2": 2.667, "citationsperyear_3": 3.0, "citationsperyear_4": 3.0, "citationsperyear_5": 3.5, "totalcitations_0": 2.0, "totalcitations_1": 7.0, "totalcitations_2": 8.0, "totalcitations_3": 12.0, "totalcitations_4": 15.0, "totalcitations_5": 21.0, "totalpapers_0": 1.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 153.0, "recentcoauthors_2": 136.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0534203521, "pagerank_1": 3.3086773607, "pagerank_2": 3.2577228687, "pagerank_3": 3.2745271126, "pagerank_4": 3.2612166255, "pagerank_5": 3.2243212634}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["JustinWerfel"], "affiliation": "Massachusetts Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 2.667, "citationsperyear_0": 0.571, "citationsperyear_1": 0.5, "citationsperyear_2": 0.444, "citationsperyear_3": 0.4, "citationsperyear_4": 0.545, "citationsperyear_5": 0.667, "totalcitations_0": 4.0, "totalcitations_1": 4.0, "totalcitations_2": 4.0, "totalcitations_3": 4.0, "totalcitations_4": 6.0, "totalcitations_5": 8.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 2.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.120583077, "pagerank_1": 0.9611012984, "pagerank_2": 0.9147697433, "pagerank_3": 0.9102098664, "pagerank_4": 1.0987095151, "pagerank_5": 1.0857307079}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["J. DavidVan Dyken"], "affiliation": "University of Miami", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 3.0, "citationsperpaper_2": 3.0, "citationsperpaper_3": 3.0, "citationsperpaper_4": 3.0, "citationsperpaper_5": 2.667, "citationsperyear_0": 2.0, "citationsperyear_1": 3.0, "citationsperyear_2": 2.0, "citationsperyear_3": 1.5, "citationsperyear_4": 1.2, "citationsperyear_5": 1.333, "totalcitations_0": 2.0, "totalcitations_1": 6.0, "totalcitations_2": 6.0, "totalcitations_3": 6.0, "totalcitations_4": 6.0, "totalcitations_5": 8.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 3.0, "pagerank_0": 1.2154366495, "pagerank_1": 0.9609631733, "pagerank_2": 0.915287203, "pagerank_3": 0.9115715167, "pagerank_4": 0.9192054766, "pagerank_5": 1.177038847}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["YaneerBar-Yam"], "affiliation": "Weizmann Institute of Science", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.9, "citationsperpaper_1": 2.2, "citationsperpaper_2": 2.3, "citationsperpaper_3": 2.364, "citationsperpaper_4": 2.727, "citationsperpaper_5": 2.583, "citationsperyear_0": 0.864, "citationsperyear_1": 0.957, "citationsperyear_2": 0.958, "citationsperyear_3": 1.04, "citationsperyear_4": 1.154, "citationsperyear_5": 1.148, "totalcitations_0": 19.0, "totalcitations_1": 22.0, "totalcitations_2": 23.0, "totalcitations_3": 26.0, "totalcitations_4": 30.0, "totalcitations_5": 31.0, "totalpapers_0": 10.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 11.0, "totalpapers_4": 11.0, "totalpapers_5": 12.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 2.0, "recentcoauthors_4": 2.0, "recentcoauthors_5": 3.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.5466803755, "pagerank_1": 2.3159570478, "pagerank_2": 2.2067625757, "pagerank_3": 2.3073494223, "pagerank_4": 2.2960006814, "pagerank_5": 2.4813842022}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Charles J.Goodnight"], "affiliation": "University of Pittsburgh", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.667, "citationsperpaper_1": 2.667, "citationsperpaper_2": 2.667, "citationsperpaper_3": 2.667, "citationsperpaper_4": 2.25, "citationsperpaper_5": 2.8, "citationsperyear_0": 0.4, "citationsperyear_1": 0.381, "citationsperyear_2": 0.364, "citationsperyear_3": 0.348, "citationsperyear_4": 0.375, "citationsperyear_5": 0.56, "totalcitations_0": 8.0, "totalcitations_1": 8.0, "totalcitations_2": 8.0, "totalcitations_3": 8.0, "totalcitations_4": 9.0, "totalcitations_5": 14.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 4.0, "totalpapers_5": 5.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.1252616137, "pagerank_1": 0.9606995903, "pagerank_2": 0.9153654681, "pagerank_3": 0.9085946938, "pagerank_4": 1.1142801612, "pagerank_5": 1.0728246433}}, {"model": "papers.paper", "pk": 1003316, "fields": {"authors": ["Charles J.Goodnight"], "affiliation": "University of Vermont", "venue": "Nature", "doi": "10.1038/nature08809", "abstract": "Arising from: G. Wild, A. Gardner & S. A. West , 983\u2013986 (2009)10.1038/nature08071\n ; Wild, Gardner & West reply\n Wild et al.1 argue that the evolution of reduced virulence can be understood from the perspective of inclusive fitness, obviating the need to evoke group selection as a contributing causal factor. Although they acknowledge the mathematical equivalence of the inclusive fitness and multilevel selection approaches, they conclude that reduced virulence can be viewed entirely as an individual-level adaptation by the parasite1. Here we show that their model is a well-known special case of the more general theory of multilevel selection, and that the cause of reduced virulence resides in the opposition of two processes: within-group and among-group selection. This distinction is important in light of the current controversy among evolutionary biologists in which some continue to affirm that natural selection centres only and always at the level of the individual organism or gene, despite mathematical demonstrations that evolutionary dynamics must be described by selection at various levels in the hierarchy of biological organization.", "year": 2010, "title": "Multilevel and Kin Selection in a Connected World", "keywords": ["Genetic Fitness", "Cognitive science", "Special case", "Genetics", "Natural selection", "Inclusive fitness", "Biology", "Hierarchy", "Kin selection", "Group selection", "Evolutionary dynamics"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 0.8384819194, "timescaledpagerank_1": 0.8972840945, "timescaledpagerank_2": 0.6407490664, "timescaledpagerank_3": 0.4365224459, "timescaledpagerank_4": 0.308451512, "timescaledpagerank_5": 0.2518171332, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 6.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.667, "citationsperpaper_1": 2.667, "citationsperpaper_2": 2.667, "citationsperpaper_3": 2.667, "citationsperpaper_4": 2.25, "citationsperpaper_5": 2.8, "citationsperyear_0": 0.4, "citationsperyear_1": 0.381, "citationsperyear_2": 0.364, "citationsperyear_3": 0.348, "citationsperyear_4": 0.375, "citationsperyear_5": 0.56, "totalcitations_0": 8.0, "totalcitations_1": 8.0, "totalcitations_2": 8.0, "totalcitations_3": 8.0, "totalcitations_4": 9.0, "totalcitations_5": 14.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 4.0, "totalpapers_5": 5.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.1252616137, "pagerank_1": 0.9606995903, "pagerank_2": 0.9153654681, "pagerank_3": 0.9085946938, "pagerank_4": 1.1142801612, "pagerank_5": 1.0728246433}}, {"model": "papers.paper", "pk": 1003414, "fields": {"authors": ["Lauren A.Rogers", "RayHilborn", "Thomas P.Quinn", "Christopher P.Boatright", "Daniel E.Schindler", "Brandon E.Chasco"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/nature09060", "abstract": "The value of having a diversity of species within an ecosystem is well appreciated: species-rich communities are thought to produce more stable ecosystem services. But population diversity within a species is important too. Here, the effects of diversity in population and life history in a heavily exploited Alaskan salmon species are quantified. The results show that population diversity increases the resilience of this ecosystem, and hence the value of salmon fisheries.", "year": 2010, "title": "Population diversity and the portfolio effect in an exploited species", "keywords": ["Species diversity", "Ecosystem services", "Ecosystem diversity", "Biology", "Extinction", "Ecosystem", "Biodiversity", "Psychological resilience", "Ecology", "Population"], "citations_0": 1.0, "citations_1": 4.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 4.0, "timescaledpagerank_0": 0.6012801381, "timescaledpagerank_1": 1.7999194394, "timescaledpagerank_2": 2.1858596719, "timescaledpagerank_3": 2.7299804351, "timescaledpagerank_4": 2.173961512, "timescaledpagerank_5": 2.6882075984, "hindex_0": 2.1666666667, "hindex_1": 2.6666666667, "hindex_2": 2.8333333333, "hindex_3": 3.0, "hindex_4": 3.3333333333, "hindex_5": 3.5, "adopters_0": 1.0, "adopters_1": 17.0, "adopters_2": 5.0, "adopters_3": 18.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.7023333333, "citationsperpaper_1": 4.3705, "citationsperpaper_2": 5.4543333333, "citationsperpaper_3": 6.6736666667, "citationsperpaper_4": 6.9, "citationsperpaper_5": 8.6535, "citationsperyear_0": 1.6573333333, "citationsperyear_1": 2.6441666667, "citationsperyear_2": 2.7066666667, "citationsperyear_3": 3.2191666667, "citationsperyear_4": 3.0108333333, "citationsperyear_5": 3.3998333333, "totalcitations_0": 23.0, "totalcitations_1": 29.8333333333, "totalcitations_2": 35.0, "totalcitations_3": 46.1666666667, "totalcitations_4": 49.5, "totalcitations_5": 59.3333333333, "totalpapers_0": 5.5, "totalpapers_1": 6.5, "totalpapers_2": 6.6666666667, "totalpapers_3": 8.3333333333, "totalpapers_4": 8.3333333333, "totalpapers_5": 9.1666666667, "authorage_0": 11.5, "authorage_1": 12.5, "authorage_2": 13.5, "authorage_3": 14.5, "authorage_4": 15.5, "authorage_5": 16.5, "recentcoauthors_0": 19.8333333333, "recentcoauthors_1": 20.5, "recentcoauthors_2": 9.0, "recentcoauthors_3": 10.5, "recentcoauthors_4": 9.6666666667, "recentcoauthors_5": 1.1666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 234.6527777778, "venuehindexmean_1": 231.5416666667, "venuehindexmean_2": 236.625, "venuehindexmean_3": 241.625, "venuehindexmean_4": 245.6666666667, "venuehindexmean_5": 249.4166666667, "totalvenues_0": 2.1666666667, "totalvenues_1": 2.5, "totalvenues_2": 2.5, "totalvenues_3": 2.5, "totalvenues_4": 2.5, "totalvenues_5": 2.5, "pagerank_0": 1.8219350276, "pagerank_1": 2.1244604824, "pagerank_2": 2.103778123, "pagerank_3": 2.4581653874, "pagerank_4": 2.3645250862, "pagerank_5": 2.4286670911}}, {"model": "papers.paper", "pk": 1003414, "fields": {"authors": ["Lauren A.Rogers"], "affiliation": "University of Oslo", "venue": "Nature", "doi": "10.1038/nature09060", "abstract": "The value of having a diversity of species within an ecosystem is well appreciated: species-rich communities are thought to produce more stable ecosystem services. But population diversity within a species is important too. Here, the effects of diversity in population and life history in a heavily exploited Alaskan salmon species are quantified. The results show that population diversity increases the resilience of this ecosystem, and hence the value of salmon fisheries.", "year": 2010, "title": "Population diversity and the portfolio effect in an exploited species", "keywords": ["Species diversity", "Ecosystem services", "Ecosystem diversity", "Biology", "Extinction", "Ecosystem", "Biodiversity", "Psychological resilience", "Ecology", "Population"], "citations_0": 1.0, "citations_1": 4.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 4.0, "timescaledpagerank_0": 0.6012801381, "timescaledpagerank_1": 1.7999194394, "timescaledpagerank_2": 2.1858596719, "timescaledpagerank_3": 2.7299804351, "timescaledpagerank_4": 2.173961512, "timescaledpagerank_5": 2.6882075984, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 17.0, "adopters_2": 5.0, "adopters_3": 18.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 3.0, "citationsperpaper_3": 3.75, "citationsperpaper_4": 4.0, "citationsperpaper_5": 5.25, "citationsperyear_0": 1.0, "citationsperyear_1": 3.0, "citationsperyear_2": 3.0, "citationsperyear_3": 3.75, "citationsperyear_4": 3.2, "citationsperyear_5": 3.5, "totalcitations_0": 1.0, "totalcitations_1": 6.0, "totalcitations_2": 9.0, "totalcitations_3": 15.0, "totalcitations_4": 16.0, "totalcitations_5": 21.0, "totalpapers_0": 1.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 6.0, "recentcoauthors_1": 29.0, "recentcoauthors_2": 23.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 1.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 0.4843552046, "pagerank_1": 1.5290908957, "pagerank_2": 1.4972274549, "pagerank_3": 1.7858846457, "pagerank_4": 1.7497635051, "pagerank_5": 1.7726589625}}, {"model": "papers.paper", "pk": 1003414, "fields": {"authors": ["Daniel E.Schindler"], "affiliation": "University of Wisconsin-Madison", "venue": "Nature", "doi": "10.1038/nature09060", "abstract": "The value of having a diversity of species within an ecosystem is well appreciated: species-rich communities are thought to produce more stable ecosystem services. But population diversity within a species is important too. Here, the effects of diversity in population and life history in a heavily exploited Alaskan salmon species are quantified. The results show that population diversity increases the resilience of this ecosystem, and hence the value of salmon fisheries.", "year": 2010, "title": "Population diversity and the portfolio effect in an exploited species", "keywords": ["Species diversity", "Ecosystem services", "Ecosystem diversity", "Biology", "Extinction", "Ecosystem", "Biodiversity", "Psychological resilience", "Ecology", "Population"], "citations_0": 1.0, "citations_1": 4.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 4.0, "timescaledpagerank_0": 0.6012801381, "timescaledpagerank_1": 1.7999194394, "timescaledpagerank_2": 2.1858596719, "timescaledpagerank_3": 2.7299804351, "timescaledpagerank_4": 2.173961512, "timescaledpagerank_5": 2.6882075984, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 1.0, "adopters_1": 17.0, "adopters_2": 5.0, "adopters_3": 18.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.778, "citationsperpaper_1": 3.0, "citationsperpaper_2": 3.455, "citationsperpaper_3": 4.083, "citationsperpaper_4": 4.5, "citationsperpaper_5": 4.571, "citationsperyear_0": 0.676, "citationsperyear_1": 0.868, "citationsperyear_2": 0.974, "citationsperyear_3": 1.225, "citationsperyear_4": 1.317, "citationsperyear_5": 1.524, "totalcitations_0": 25.0, "totalcitations_1": 33.0, "totalcitations_2": 38.0, "totalcitations_3": 49.0, "totalcitations_4": 54.0, "totalcitations_5": 64.0, "totalpapers_0": 9.0, "totalpapers_1": 11.0, "totalpapers_2": 11.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 14.0, "authorage_0": 36.0, "authorage_1": 37.0, "authorage_2": 38.0, "authorage_3": 39.0, "authorage_4": 40.0, "authorage_5": 41.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 26.0, "recentcoauthors_2": 19.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.0987827732, "pagerank_1": 2.9861742985, "pagerank_2": 2.9278611151, "pagerank_3": 3.1908461189, "pagerank_4": 3.0425949023, "pagerank_5": 3.3274625483}}, {"model": "papers.paper", "pk": 1003414, "fields": {"authors": ["Michael S.Webster"], "affiliation": "Gordon and Betty Moore Foundation", "venue": "Nature", "doi": "10.1038/nature09060", "abstract": "The value of having a diversity of species within an ecosystem is well appreciated: species-rich communities are thought to produce more stable ecosystem services. But population diversity within a species is important too. Here, the effects of diversity in population and life history in a heavily exploited Alaskan salmon species are quantified. The results show that population diversity increases the resilience of this ecosystem, and hence the value of salmon fisheries.", "year": 2010, "title": "Population diversity and the portfolio effect in an exploited species", "keywords": ["Species diversity", "Ecosystem services", "Ecosystem diversity", "Biology", "Extinction", "Ecosystem", "Biodiversity", "Psychological resilience", "Ecology", "Population"], "citations_0": 1.0, "citations_1": 4.0, "citations_2": 2.0, "citations_3": 3.0, "citations_4": 0.0, "citations_5": 4.0, "timescaledpagerank_0": 0.6012801381, "timescaledpagerank_1": 1.7999194394, "timescaledpagerank_2": 2.1858596719, "timescaledpagerank_3": 2.7299804351, "timescaledpagerank_4": 2.173961512, "timescaledpagerank_5": 2.6882075984, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 17.0, "adopters_2": 5.0, "adopters_3": 18.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.5, "citationsperpaper_1": 5.5, "citationsperpaper_2": 6.5, "citationsperpaper_3": 8.0, "citationsperpaper_4": 8.0, "citationsperpaper_5": 10.0, "citationsperyear_0": 0.875, "citationsperyear_1": 1.222, "citationsperyear_2": 1.3, "citationsperyear_3": 1.455, "citationsperyear_4": 1.333, "citationsperyear_5": 1.538, "totalcitations_0": 7.0, "totalcitations_1": 11.0, "totalcitations_2": 13.0, "totalcitations_3": 16.0, "totalcitations_4": 16.0, "totalcitations_5": 20.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 6.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.0554135846, "pagerank_1": 0.9939421144, "pagerank_2": 0.9657055873, "pagerank_3": 0.9435881856, "pagerank_4": 0.9151884182, "pagerank_5": 0.9082305332}}, {"model": "papers.paper", "pk": 1003521, "fields": {"authors": ["JonathanSilvertown"], "affiliation": "Open University", "venue": "Nature", "doi": "10.1038/467788b", "abstract": "", "year": 2010, "title": "Taxonomy: include social networking", "keywords": ["Sociology of the Internet", "Sociology", "Taxonomy (biology)", "World Wide Web", "The Internet", "Social network"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 1.0505646853, "timescaledpagerank_1": 0.7558518868, "timescaledpagerank_2": 0.4275889742, "timescaledpagerank_3": 0.2380608308, "timescaledpagerank_4": 0.1189462427, "timescaledpagerank_5": 0.042716847, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.5, "citationsperpaper_1": 2.5, "citationsperpaper_2": 2.5, "citationsperpaper_3": 2.5, "citationsperpaper_4": 2.5, "citationsperpaper_5": 2.5, "citationsperyear_0": 0.37, "citationsperyear_1": 0.357, "citationsperyear_2": 0.345, "citationsperyear_3": 0.333, "citationsperyear_4": 0.323, "citationsperyear_5": 0.313, "totalcitations_0": 10.0, "totalcitations_1": 10.0, "totalcitations_2": 10.0, "totalcitations_3": 10.0, "totalcitations_4": 10.0, "totalcitations_5": 10.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.6256510745, "pagerank_1": 0.5054207095, "pagerank_2": 0.4511977682, "pagerank_3": 0.4475438643, "pagerank_4": 0.4404670694, "pagerank_5": 0.4398899873}}, {"model": "papers.paper", "pk": 1003656, "fields": {"authors": ["Abdallah S.Daar"], "affiliation": "Sultan Qaboos University", "venue": "Nature", "doi": "10.1038/463298a", "abstract": "The director of the US National Institutes of Health, Francis Collins, calls for a revolution in personalized medicine. Such advances should be shared beyond the developed world, says Abdallah S. Daar.", "year": 2010, "title": "Vision of a personal genomics future", "keywords": ["Personalized medicine", "Library science", "Molecular interactions", "Science policy", "Biology", "Computational biology", "Personal genomics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.885, "citationsperpaper_1": 2.964, "citationsperpaper_2": 3.333, "citationsperpaper_3": 3.9, "citationsperpaper_4": 4.1, "citationsperpaper_5": 4.129, "citationsperyear_0": 5.769, "citationsperyear_1": 5.929, "citationsperyear_2": 6.667, "citationsperyear_3": 7.313, "citationsperyear_4": 7.235, "citationsperyear_5": 7.111, "totalcitations_0": 75.0, "totalcitations_1": 83.0, "totalcitations_2": 100.0, "totalcitations_3": 117.0, "totalcitations_4": 123.0, "totalcitations_5": 128.0, "totalpapers_0": 26.0, "totalpapers_1": 28.0, "totalpapers_2": 30.0, "totalpapers_3": 30.0, "totalpapers_4": 30.0, "totalpapers_5": 31.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 70.0, "recentcoauthors_1": 86.0, "recentcoauthors_2": 43.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.3333333333, "venuehindexmean_1": 129.5, "venuehindexmean_2": 134.0, "venuehindexmean_3": 138.5, "venuehindexmean_4": 142.8333333333, "venuehindexmean_5": 146.8333333333, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 6.7686509786, "pagerank_1": 7.8146073919, "pagerank_2": 8.1786613454, "pagerank_3": 8.0085526343, "pagerank_4": 7.8729055015, "pagerank_5": 7.9860770343}}, {"model": "papers.paper", "pk": 1003656, "fields": {"authors": ["Abdallah S.Daar"], "affiliation": "University of Toronto", "venue": "Nature", "doi": "10.1038/463298a", "abstract": "The director of the US National Institutes of Health, Francis Collins, calls for a revolution in personalized medicine. Such advances should be shared beyond the developed world, says Abdallah S. Daar.", "year": 2010, "title": "Vision of a personal genomics future", "keywords": ["Personalized medicine", "Library science", "Molecular interactions", "Science policy", "Biology", "Computational biology", "Personal genomics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.885, "citationsperpaper_1": 2.964, "citationsperpaper_2": 3.333, "citationsperpaper_3": 3.9, "citationsperpaper_4": 4.1, "citationsperpaper_5": 4.129, "citationsperyear_0": 5.769, "citationsperyear_1": 5.929, "citationsperyear_2": 6.667, "citationsperyear_3": 7.313, "citationsperyear_4": 7.235, "citationsperyear_5": 7.111, "totalcitations_0": 75.0, "totalcitations_1": 83.0, "totalcitations_2": 100.0, "totalcitations_3": 117.0, "totalcitations_4": 123.0, "totalcitations_5": 128.0, "totalpapers_0": 26.0, "totalpapers_1": 28.0, "totalpapers_2": 30.0, "totalpapers_3": 30.0, "totalpapers_4": 30.0, "totalpapers_5": 31.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 70.0, "recentcoauthors_1": 86.0, "recentcoauthors_2": 43.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.3333333333, "venuehindexmean_1": 129.5, "venuehindexmean_2": 134.0, "venuehindexmean_3": 138.5, "venuehindexmean_4": 142.8333333333, "venuehindexmean_5": 146.8333333333, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 6.7686509786, "pagerank_1": 7.8146073919, "pagerank_2": 8.1786613454, "pagerank_3": 8.0085526343, "pagerank_4": 7.8729055015, "pagerank_5": 7.9860770343}}, {"model": "papers.paper", "pk": 1003656, "fields": {"authors": ["Abdallah S.Daar"], "affiliation": "Wellcome Trust", "venue": "Nature", "doi": "10.1038/463298a", "abstract": "The director of the US National Institutes of Health, Francis Collins, calls for a revolution in personalized medicine. Such advances should be shared beyond the developed world, says Abdallah S. Daar.", "year": 2010, "title": "Vision of a personal genomics future", "keywords": ["Personalized medicine", "Library science", "Molecular interactions", "Science policy", "Biology", "Computational biology", "Personal genomics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.885, "citationsperpaper_1": 2.964, "citationsperpaper_2": 3.333, "citationsperpaper_3": 3.9, "citationsperpaper_4": 4.1, "citationsperpaper_5": 4.129, "citationsperyear_0": 5.769, "citationsperyear_1": 5.929, "citationsperyear_2": 6.667, "citationsperyear_3": 7.313, "citationsperyear_4": 7.235, "citationsperyear_5": 7.111, "totalcitations_0": 75.0, "totalcitations_1": 83.0, "totalcitations_2": 100.0, "totalcitations_3": 117.0, "totalcitations_4": 123.0, "totalcitations_5": 128.0, "totalpapers_0": 26.0, "totalpapers_1": 28.0, "totalpapers_2": 30.0, "totalpapers_3": 30.0, "totalpapers_4": 30.0, "totalpapers_5": 31.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 70.0, "recentcoauthors_1": 86.0, "recentcoauthors_2": 43.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.3333333333, "venuehindexmean_1": 129.5, "venuehindexmean_2": 134.0, "venuehindexmean_3": 138.5, "venuehindexmean_4": 142.8333333333, "venuehindexmean_5": 146.8333333333, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 6.7686509786, "pagerank_1": 7.8146073919, "pagerank_2": 8.1786613454, "pagerank_3": 8.0085526343, "pagerank_4": 7.8729055015, "pagerank_5": 7.9860770343}}, {"model": "papers.paper", "pk": 1003656, "fields": {"authors": ["Abdallah S.Daar"], "affiliation": "University Health Network", "venue": "Nature", "doi": "10.1038/463298a", "abstract": "The director of the US National Institutes of Health, Francis Collins, calls for a revolution in personalized medicine. Such advances should be shared beyond the developed world, says Abdallah S. Daar.", "year": 2010, "title": "Vision of a personal genomics future", "keywords": ["Personalized medicine", "Library science", "Molecular interactions", "Science policy", "Biology", "Computational biology", "Personal genomics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.885, "citationsperpaper_1": 2.964, "citationsperpaper_2": 3.333, "citationsperpaper_3": 3.9, "citationsperpaper_4": 4.1, "citationsperpaper_5": 4.129, "citationsperyear_0": 5.769, "citationsperyear_1": 5.929, "citationsperyear_2": 6.667, "citationsperyear_3": 7.313, "citationsperyear_4": 7.235, "citationsperyear_5": 7.111, "totalcitations_0": 75.0, "totalcitations_1": 83.0, "totalcitations_2": 100.0, "totalcitations_3": 117.0, "totalcitations_4": 123.0, "totalcitations_5": 128.0, "totalpapers_0": 26.0, "totalpapers_1": 28.0, "totalpapers_2": 30.0, "totalpapers_3": 30.0, "totalpapers_4": 30.0, "totalpapers_5": 31.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 70.0, "recentcoauthors_1": 86.0, "recentcoauthors_2": 43.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.3333333333, "venuehindexmean_1": 129.5, "venuehindexmean_2": 134.0, "venuehindexmean_3": 138.5, "venuehindexmean_4": 142.8333333333, "venuehindexmean_5": 146.8333333333, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 6.7686509786, "pagerank_1": 7.8146073919, "pagerank_2": 8.1786613454, "pagerank_3": 8.0085526343, "pagerank_4": 7.8729055015, "pagerank_5": 7.9860770343}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Jun-LiLuo"], "affiliation": "Scripps Research Institute", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 22.941, "citationsperpaper_1": 27.0, "citationsperpaper_2": 30.722, "citationsperpaper_3": 33.167, "citationsperpaper_4": 36.444, "citationsperpaper_5": 36.316, "citationsperyear_0": 39.0, "citationsperyear_1": 44.182, "citationsperyear_2": 46.083, "citationsperyear_3": 45.923, "citationsperyear_4": 46.857, "citationsperyear_5": 46.0, "totalcitations_0": 390.0, "totalcitations_1": 486.0, "totalcitations_2": 553.0, "totalcitations_3": 597.0, "totalcitations_4": 656.0, "totalcitations_5": 690.0, "totalpapers_0": 17.0, "totalpapers_1": 18.0, "totalpapers_2": 18.0, "totalpapers_3": 18.0, "totalpapers_4": 18.0, "totalpapers_5": 19.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 3.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 15.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.0, "venuehindexmean_1": 138.4, "venuehindexmean_2": 142.6, "venuehindexmean_3": 146.0, "venuehindexmean_4": 148.7, "venuehindexmean_5": 141.7272727273, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 3.9807762486, "pagerank_1": 3.8765438182, "pagerank_2": 3.6818636976, "pagerank_3": 3.5101649072, "pagerank_4": 3.3656703368, "pagerank_5": 3.7547896002}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["MassimoAmmirante", "Jun-LiLuo", "Sergei I.Grivennikov", "MichaelKarin"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 20.5, "hindex_1": 22.5, "hindex_2": 23.0, "hindex_3": 23.75, "hindex_4": 24.0, "hindex_5": 24.75, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 27.285, "citationsperpaper_1": 32.82925, "citationsperpaper_2": 35.9925, "citationsperpaper_3": 34.541, "citationsperpaper_4": 33.91275, "citationsperpaper_5": 34.8555, "citationsperyear_0": 149.09025, "citationsperyear_1": 158.392, "citationsperyear_2": 161.8885, "citationsperyear_3": 164.25275, "citationsperyear_4": 165.90625, "citationsperyear_5": 166.175, "totalcitations_0": 4242.75, "totalcitations_1": 4513.25, "totalcitations_2": 4730.75, "totalcitations_3": 4925.25, "totalcitations_4": 5106.5, "totalcitations_5": 5243.75, "totalpapers_0": 66.75, "totalpapers_1": 71.5, "totalpapers_2": 74.25, "totalpapers_3": 78.75, "totalpapers_4": 85.25, "totalpapers_5": 88.5, "authorage_0": 10.75, "authorage_1": 11.75, "authorage_2": 12.75, "authorage_3": 13.75, "authorage_4": 14.75, "authorage_5": 15.75, "recentcoauthors_0": 73.0, "recentcoauthors_1": 74.5, "recentcoauthors_2": 63.0, "recentcoauthors_3": 71.0, "recentcoauthors_4": 111.5, "recentcoauthors_5": 116.25, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 166.775, "venuehindexmean_1": 164.7818181818, "venuehindexmean_2": 168.0956521739, "venuehindexmean_3": 145.21875, "venuehindexmean_4": 148.5291666667, "venuehindexmean_5": 146.6609848485, "totalvenues_0": 8.75, "totalvenues_1": 9.75, "totalvenues_2": 10.0, "totalvenues_3": 11.25, "totalvenues_4": 11.5, "totalvenues_5": 12.0, "pagerank_0": 13.8323550799, "pagerank_1": 14.1699652158, "pagerank_2": 14.437537449, "pagerank_3": 14.9896139704, "pagerank_4": 16.0481591538, "pagerank_5": 16.5936051362}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "Engelhardt Institute of Molecular Biology", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "Science Applications International Corporation", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "Moscow State University", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "Leibniz Association", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "Russian Academy of Sciences", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["Sergei A.Nedospasov"], "affiliation": "Ludwig Institute for Cancer Research", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 14.222, "citationsperpaper_1": 14.333, "citationsperpaper_2": 15.467, "citationsperpaper_3": 16.29, "citationsperpaper_4": 17.516, "citationsperpaper_5": 17.324, "citationsperyear_0": 15.36, "citationsperyear_1": 16.538, "citationsperyear_2": 17.185, "citationsperyear_3": 18.036, "citationsperyear_4": 18.724, "citationsperyear_5": 19.633, "totalcitations_0": 384.0, "totalcitations_1": 430.0, "totalcitations_2": 464.0, "totalcitations_3": 505.0, "totalcitations_4": 543.0, "totalcitations_5": 589.0, "totalpapers_0": 27.0, "totalpapers_1": 30.0, "totalpapers_2": 30.0, "totalpapers_3": 31.0, "totalpapers_4": 31.0, "totalpapers_5": 34.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 53.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.0, "venuehindexmean_1": 116.0, "venuehindexmean_2": 118.9090909091, "venuehindexmean_3": 132.5833333333, "venuehindexmean_4": 134.8333333333, "venuehindexmean_5": 131.8666666667, "totalvenues_0": 10.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 7.940388081, "pagerank_1": 8.3048784019, "pagerank_2": 7.9671036465, "pagerank_3": 7.9260314693, "pagerank_4": 7.598834803, "pagerank_5": 8.7973707031}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["MichaelKarin"], "affiliation": "University of Massachusetts Medical School", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 66.0, "hindex_1": 70.0, "hindex_2": 72.0, "hindex_3": 73.0, "hindex_4": 73.0, "hindex_5": 73.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 68.324, "citationsperpaper_1": 67.59, "citationsperpaper_2": 67.665, "citationsperpaper_3": 66.731, "citationsperpaper_4": 64.107, "citationsperpaper_5": 63.506, "citationsperyear_0": 531.161, "citationsperyear_1": 540.719, "citationsperyear_2": 545.424, "citationsperyear_3": 547.588, "citationsperyear_4": 547.657, "citationsperyear_5": 543.333, "totalcitations_0": 16466.0, "totalcitations_1": 17303.0, "totalcitations_2": 17999.0, "totalcitations_3": 18618.0, "totalcitations_4": 19168.0, "totalcitations_5": 19560.0, "totalpapers_0": 241.0, "totalpapers_1": 256.0, "totalpapers_2": 266.0, "totalpapers_3": 279.0, "totalpapers_4": 299.0, "totalpapers_5": 308.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 230.0, "recentcoauthors_1": 262.0, "recentcoauthors_2": 219.0, "recentcoauthors_3": 232.0, "recentcoauthors_4": 348.0, "recentcoauthors_5": 346.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.3, "venuehindexmean_1": 110.2272727273, "venuehindexmean_2": 109.7826086957, "venuehindexmean_3": 111.3333333333, "venuehindexmean_4": 113.9166666667, "venuehindexmean_5": 116.4166666667, "totalvenues_0": 20.0, "totalvenues_1": 22.0, "totalvenues_2": 23.0, "totalvenues_3": 24.0, "totalvenues_4": 24.0, "totalvenues_5": 24.0, "pagerank_0": 49.247717776, "pagerank_1": 50.4477148721, "pagerank_2": 51.3163781347, "pagerank_3": 52.9700445708, "pagerank_4": 55.9545942643, "pagerank_5": 56.9159349034}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["MichaelKarin"], "affiliation": "University of California, Berkeley", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 66.0, "hindex_1": 70.0, "hindex_2": 72.0, "hindex_3": 73.0, "hindex_4": 73.0, "hindex_5": 73.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 68.324, "citationsperpaper_1": 67.59, "citationsperpaper_2": 67.665, "citationsperpaper_3": 66.731, "citationsperpaper_4": 64.107, "citationsperpaper_5": 63.506, "citationsperyear_0": 531.161, "citationsperyear_1": 540.719, "citationsperyear_2": 545.424, "citationsperyear_3": 547.588, "citationsperyear_4": 547.657, "citationsperyear_5": 543.333, "totalcitations_0": 16466.0, "totalcitations_1": 17303.0, "totalcitations_2": 17999.0, "totalcitations_3": 18618.0, "totalcitations_4": 19168.0, "totalcitations_5": 19560.0, "totalpapers_0": 241.0, "totalpapers_1": 256.0, "totalpapers_2": 266.0, "totalpapers_3": 279.0, "totalpapers_4": 299.0, "totalpapers_5": 308.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 230.0, "recentcoauthors_1": 262.0, "recentcoauthors_2": 219.0, "recentcoauthors_3": 232.0, "recentcoauthors_4": 348.0, "recentcoauthors_5": 346.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.3, "venuehindexmean_1": 110.2272727273, "venuehindexmean_2": 109.7826086957, "venuehindexmean_3": 111.3333333333, "venuehindexmean_4": 113.9166666667, "venuehindexmean_5": 116.4166666667, "totalvenues_0": 20.0, "totalvenues_1": 22.0, "totalvenues_2": 23.0, "totalvenues_3": 24.0, "totalvenues_4": 24.0, "totalvenues_5": 24.0, "pagerank_0": 49.247717776, "pagerank_1": 50.4477148721, "pagerank_2": 51.3163781347, "pagerank_3": 52.9700445708, "pagerank_4": 55.9545942643, "pagerank_5": 56.9159349034}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["MichaelKarin"], "affiliation": "University of California, Los Angeles", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 66.0, "hindex_1": 70.0, "hindex_2": 72.0, "hindex_3": 73.0, "hindex_4": 73.0, "hindex_5": 73.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 68.324, "citationsperpaper_1": 67.59, "citationsperpaper_2": 67.665, "citationsperpaper_3": 66.731, "citationsperpaper_4": 64.107, "citationsperpaper_5": 63.506, "citationsperyear_0": 531.161, "citationsperyear_1": 540.719, "citationsperyear_2": 545.424, "citationsperyear_3": 547.588, "citationsperyear_4": 547.657, "citationsperyear_5": 543.333, "totalcitations_0": 16466.0, "totalcitations_1": 17303.0, "totalcitations_2": 17999.0, "totalcitations_3": 18618.0, "totalcitations_4": 19168.0, "totalcitations_5": 19560.0, "totalpapers_0": 241.0, "totalpapers_1": 256.0, "totalpapers_2": 266.0, "totalpapers_3": 279.0, "totalpapers_4": 299.0, "totalpapers_5": 308.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 230.0, "recentcoauthors_1": 262.0, "recentcoauthors_2": 219.0, "recentcoauthors_3": 232.0, "recentcoauthors_4": 348.0, "recentcoauthors_5": 346.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.3, "venuehindexmean_1": 110.2272727273, "venuehindexmean_2": 109.7826086957, "venuehindexmean_3": 111.3333333333, "venuehindexmean_4": 113.9166666667, "venuehindexmean_5": 116.4166666667, "totalvenues_0": 20.0, "totalvenues_1": 22.0, "totalvenues_2": 23.0, "totalvenues_3": 24.0, "totalvenues_4": 24.0, "totalvenues_5": 24.0, "pagerank_0": 49.247717776, "pagerank_1": 50.4477148721, "pagerank_2": 51.3163781347, "pagerank_3": 52.9700445708, "pagerank_4": 55.9545942643, "pagerank_5": 56.9159349034}}, {"model": "papers.paper", "pk": 1003258, "fields": {"authors": ["MichaelKarin"], "affiliation": "Spanish National Research Council", "venue": "Nature", "doi": "10.1038/nature08782", "abstract": "In a mouse model of prostate cancer it is shown that infiltrating B cells promote tumorigenesis by secreting lymphotoxin. Lymphotoxin accelerates the emergence of castration-resistant prostate tumours in this model. Interfering with this pathway may offer therapeutic strategies for androgen-independent prostate cancer.", "year": 2010, "title": "B cell\u2013derived lymphotoxin promotes castration-resistant prostate cancer", "keywords": ["Prostate", "Lymphotoxin alpha", "Biology", "Lymphotoxin", "Carcinogenesis", "Cancer research", "Androgen deprivation therapy", "B cell", "Immunology", "Cancer", "Prostate cancer"], "citations_0": 4.0, "citations_1": 10.0, "citations_2": 2.0, "citations_3": 6.0, "citations_4": 3.0, "citations_5": 8.0, "timescaledpagerank_0": 4.0601674897, "timescaledpagerank_1": 4.1862905314, "timescaledpagerank_2": 3.2397702337, "timescaledpagerank_3": 2.7789788176, "timescaledpagerank_4": 2.4536706781, "timescaledpagerank_5": 2.4122697552, "hindex_0": 66.0, "hindex_1": 70.0, "hindex_2": 72.0, "hindex_3": 73.0, "hindex_4": 73.0, "hindex_5": 73.0, "adopters_0": 18.0, "adopters_1": 63.0, "adopters_2": 14.0, "adopters_3": 39.0, "adopters_4": 32.0, "adopters_5": 0.0, "citationsperpaper_0": 68.324, "citationsperpaper_1": 67.59, "citationsperpaper_2": 67.665, "citationsperpaper_3": 66.731, "citationsperpaper_4": 64.107, "citationsperpaper_5": 63.506, "citationsperyear_0": 531.161, "citationsperyear_1": 540.719, "citationsperyear_2": 545.424, "citationsperyear_3": 547.588, "citationsperyear_4": 547.657, "citationsperyear_5": 543.333, "totalcitations_0": 16466.0, "totalcitations_1": 17303.0, "totalcitations_2": 17999.0, "totalcitations_3": 18618.0, "totalcitations_4": 19168.0, "totalcitations_5": 19560.0, "totalpapers_0": 241.0, "totalpapers_1": 256.0, "totalpapers_2": 266.0, "totalpapers_3": 279.0, "totalpapers_4": 299.0, "totalpapers_5": 308.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 230.0, "recentcoauthors_1": 262.0, "recentcoauthors_2": 219.0, "recentcoauthors_3": 232.0, "recentcoauthors_4": 348.0, "recentcoauthors_5": 346.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 116.3, "venuehindexmean_1": 110.2272727273, "venuehindexmean_2": 109.7826086957, "venuehindexmean_3": 111.3333333333, "venuehindexmean_4": 113.9166666667, "venuehindexmean_5": 116.4166666667, "totalvenues_0": 20.0, "totalvenues_1": 22.0, "totalvenues_2": 23.0, "totalvenues_3": 24.0, "totalvenues_4": 24.0, "totalvenues_5": 24.0, "pagerank_0": 49.247717776, "pagerank_1": 50.4477148721, "pagerank_2": 51.3163781347, "pagerank_3": 52.9700445708, "pagerank_4": 55.9545942643, "pagerank_5": 56.9159349034}}, {"model": "papers.paper", "pk": 1003216, "fields": {"authors": ["RogerBuick"], "affiliation": "University of Sydney", "venue": "Nature", "doi": "10.1038/463885a", "abstract": "Big and beautiful microfossils have been extracted from rocks that are more than 3 billion years old. They offer tantalizing hints about the antiquity of the eukaryote lineage of organisms that includes ourselves.", "year": 2010, "title": "Early life: Ancient acritarchs.", "keywords": ["Paleontology", "Biology", "Acritarch", "Billion years"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2294096312, "timescaledpagerank_2": 0.283797157, "timescaledpagerank_3": 0.2911385501, "timescaledpagerank_4": 0.2988004684, "timescaledpagerank_5": 0.2905235962, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 4.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.333, "citationsperpaper_1": 12.167, "citationsperpaper_2": 11.692, "citationsperpaper_3": 12.0, "citationsperpaper_4": 13.0, "citationsperpaper_5": 12.125, "citationsperyear_0": 4.387, "citationsperyear_1": 4.563, "citationsperyear_2": 4.606, "citationsperyear_3": 4.941, "citationsperyear_4": 5.2, "citationsperyear_5": 5.389, "totalcitations_0": 136.0, "totalcitations_1": 146.0, "totalcitations_2": 152.0, "totalcitations_3": 168.0, "totalcitations_4": 182.0, "totalcitations_5": 194.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 16.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8633090756, "pagerank_1": 2.6600976843, "pagerank_2": 2.8891180143, "pagerank_3": 3.0251966359, "pagerank_4": 3.0044092926, "pagerank_5": 3.6870636872}}, {"model": "papers.paper", "pk": 1003216, "fields": {"authors": ["RogerBuick"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/463885a", "abstract": "Big and beautiful microfossils have been extracted from rocks that are more than 3 billion years old. They offer tantalizing hints about the antiquity of the eukaryote lineage of organisms that includes ourselves.", "year": 2010, "title": "Early life: Ancient acritarchs.", "keywords": ["Paleontology", "Biology", "Acritarch", "Billion years"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2294096312, "timescaledpagerank_2": 0.283797157, "timescaledpagerank_3": 0.2911385501, "timescaledpagerank_4": 0.2988004684, "timescaledpagerank_5": 0.2905235962, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 4.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.333, "citationsperpaper_1": 12.167, "citationsperpaper_2": 11.692, "citationsperpaper_3": 12.0, "citationsperpaper_4": 13.0, "citationsperpaper_5": 12.125, "citationsperyear_0": 4.387, "citationsperyear_1": 4.563, "citationsperyear_2": 4.606, "citationsperyear_3": 4.941, "citationsperyear_4": 5.2, "citationsperyear_5": 5.389, "totalcitations_0": 136.0, "totalcitations_1": 146.0, "totalcitations_2": 152.0, "totalcitations_3": 168.0, "totalcitations_4": 182.0, "totalcitations_5": 194.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 16.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8633090756, "pagerank_1": 2.6600976843, "pagerank_2": 2.8891180143, "pagerank_3": 3.0251966359, "pagerank_4": 3.0044092926, "pagerank_5": 3.6870636872}}, {"model": "papers.paper", "pk": 1003216, "fields": {"authors": ["RogerBuick"], "affiliation": "NASA Astrobiology Institute", "venue": "Nature", "doi": "10.1038/463885a", "abstract": "Big and beautiful microfossils have been extracted from rocks that are more than 3 billion years old. They offer tantalizing hints about the antiquity of the eukaryote lineage of organisms that includes ourselves.", "year": 2010, "title": "Early life: Ancient acritarchs.", "keywords": ["Paleontology", "Biology", "Acritarch", "Billion years"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2294096312, "timescaledpagerank_2": 0.283797157, "timescaledpagerank_3": 0.2911385501, "timescaledpagerank_4": 0.2988004684, "timescaledpagerank_5": 0.2905235962, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 4.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.333, "citationsperpaper_1": 12.167, "citationsperpaper_2": 11.692, "citationsperpaper_3": 12.0, "citationsperpaper_4": 13.0, "citationsperpaper_5": 12.125, "citationsperyear_0": 4.387, "citationsperyear_1": 4.563, "citationsperyear_2": 4.606, "citationsperyear_3": 4.941, "citationsperyear_4": 5.2, "citationsperyear_5": 5.389, "totalcitations_0": 136.0, "totalcitations_1": 146.0, "totalcitations_2": 152.0, "totalcitations_3": 168.0, "totalcitations_4": 182.0, "totalcitations_5": 194.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 16.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8633090756, "pagerank_1": 2.6600976843, "pagerank_2": 2.8891180143, "pagerank_3": 3.0251966359, "pagerank_4": 3.0044092926, "pagerank_5": 3.6870636872}}, {"model": "papers.paper", "pk": 1003216, "fields": {"authors": ["RogerBuick"], "affiliation": "University of Western Australia", "venue": "Nature", "doi": "10.1038/463885a", "abstract": "Big and beautiful microfossils have been extracted from rocks that are more than 3 billion years old. They offer tantalizing hints about the antiquity of the eukaryote lineage of organisms that includes ourselves.", "year": 2010, "title": "Early life: Ancient acritarchs.", "keywords": ["Paleontology", "Biology", "Acritarch", "Billion years"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.2294096312, "timescaledpagerank_2": 0.283797157, "timescaledpagerank_3": 0.2911385501, "timescaledpagerank_4": 0.2988004684, "timescaledpagerank_5": 0.2905235962, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 4.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.333, "citationsperpaper_1": 12.167, "citationsperpaper_2": 11.692, "citationsperpaper_3": 12.0, "citationsperpaper_4": 13.0, "citationsperpaper_5": 12.125, "citationsperyear_0": 4.387, "citationsperyear_1": 4.563, "citationsperyear_2": 4.606, "citationsperyear_3": 4.941, "citationsperyear_4": 5.2, "citationsperyear_5": 5.389, "totalcitations_0": 136.0, "totalcitations_1": 146.0, "totalcitations_2": 152.0, "totalcitations_3": 168.0, "totalcitations_4": 182.0, "totalcitations_5": 194.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 16.0, "authorage_0": 30.0, "authorage_1": 31.0, "authorage_2": 32.0, "authorage_3": 33.0, "authorage_4": 34.0, "authorage_5": 35.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8633090756, "pagerank_1": 2.6600976843, "pagerank_2": 2.8891180143, "pagerank_3": 3.0251966359, "pagerank_4": 3.0044092926, "pagerank_5": 3.6870636872}}, {"model": "papers.paper", "pk": 1003123, "fields": {"authors": ["MichaelHeinrich"], "affiliation": "United States Department of Veterans Affairs", "venue": "Nature", "doi": "10.1038/467796a", "abstract": "In certain types of gastrointestinal cell, mutations in the protein KIT give rise to gastrointestinal stromal tumours. Why are other cell types that express KIT not affected? The answer lies with a second protein. See Letter p.849\n Gastroinestinal stromal tumours (GISTs) arise in the interstitial cells of Cajal, cells embedded in the musculature of the gastrointestinal tract where they generate electrical rhythmicity. Chi et al. now show that the transcription factor ETV1 is required for the development of these cells, and also promotes tumour development. The KIT gene, often activated by mutations in GIST, cooperates with ETV1 in the transformation of interstitial cells of Cajal, in part by promoting ETV1 stabilization. ETV1 seems to be present in high levels in all GISTs, making it a candidate diagnostic biomarker, and ETV1 blockers may prove useful against drug-resistant GIST.", "year": 2010, "title": "Cancer: Oncogenes in context", "keywords": ["Cell type", "ETV1", "Interstitial cell of Cajal", "Mutation", "Biology", "Cancer research", "Gastrointestinal tract", "GiST", "Immunology", "Cancer", "Proto-Oncogene Proteins c-kit"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 18.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.907, "citationsperpaper_1": 12.645, "citationsperpaper_2": 13.39, "citationsperpaper_3": 13.7, "citationsperpaper_4": 13.939, "citationsperpaper_5": 13.779, "citationsperyear_0": 47.0, "citationsperyear_1": 48.05, "citationsperyear_2": 49.095, "citationsperyear_3": 49.818, "citationsperyear_4": 49.696, "citationsperyear_5": 49.375, "totalcitations_0": 893.0, "totalcitations_1": 961.0, "totalcitations_2": 1031.0, "totalcitations_3": 1096.0, "totalcitations_4": 1143.0, "totalcitations_5": 1185.0, "totalpapers_0": 75.0, "totalpapers_1": 76.0, "totalpapers_2": 77.0, "totalpapers_3": 80.0, "totalpapers_4": 82.0, "totalpapers_5": 86.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 64.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 38.0, "recentcoauthors_5": 75.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.9166666667, "venuehindexmean_1": 128.5833333333, "venuehindexmean_2": 132.0, "venuehindexmean_3": 132.5384615385, "venuehindexmean_4": 134.9230769231, "venuehindexmean_5": 137.5384615385, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 18.4322129606, "pagerank_1": 17.8854155751, "pagerank_2": 17.0675207467, "pagerank_3": 16.5989399079, "pagerank_4": 16.3764381435, "pagerank_5": 16.664387805}}, {"model": "papers.paper", "pk": 1003123, "fields": {"authors": ["MichaelHeinrich"], "affiliation": "University of Mainz", "venue": "Nature", "doi": "10.1038/467796a", "abstract": "In certain types of gastrointestinal cell, mutations in the protein KIT give rise to gastrointestinal stromal tumours. Why are other cell types that express KIT not affected? The answer lies with a second protein. See Letter p.849\n Gastroinestinal stromal tumours (GISTs) arise in the interstitial cells of Cajal, cells embedded in the musculature of the gastrointestinal tract where they generate electrical rhythmicity. Chi et al. now show that the transcription factor ETV1 is required for the development of these cells, and also promotes tumour development. The KIT gene, often activated by mutations in GIST, cooperates with ETV1 in the transformation of interstitial cells of Cajal, in part by promoting ETV1 stabilization. ETV1 seems to be present in high levels in all GISTs, making it a candidate diagnostic biomarker, and ETV1 blockers may prove useful against drug-resistant GIST.", "year": 2010, "title": "Cancer: Oncogenes in context", "keywords": ["Cell type", "ETV1", "Interstitial cell of Cajal", "Mutation", "Biology", "Cancer research", "Gastrointestinal tract", "GiST", "Immunology", "Cancer", "Proto-Oncogene Proteins c-kit"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 18.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.907, "citationsperpaper_1": 12.645, "citationsperpaper_2": 13.39, "citationsperpaper_3": 13.7, "citationsperpaper_4": 13.939, "citationsperpaper_5": 13.779, "citationsperyear_0": 47.0, "citationsperyear_1": 48.05, "citationsperyear_2": 49.095, "citationsperyear_3": 49.818, "citationsperyear_4": 49.696, "citationsperyear_5": 49.375, "totalcitations_0": 893.0, "totalcitations_1": 961.0, "totalcitations_2": 1031.0, "totalcitations_3": 1096.0, "totalcitations_4": 1143.0, "totalcitations_5": 1185.0, "totalpapers_0": 75.0, "totalpapers_1": 76.0, "totalpapers_2": 77.0, "totalpapers_3": 80.0, "totalpapers_4": 82.0, "totalpapers_5": 86.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 64.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 38.0, "recentcoauthors_5": 75.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.9166666667, "venuehindexmean_1": 128.5833333333, "venuehindexmean_2": 132.0, "venuehindexmean_3": 132.5384615385, "venuehindexmean_4": 134.9230769231, "venuehindexmean_5": 137.5384615385, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 18.4322129606, "pagerank_1": 17.8854155751, "pagerank_2": 17.0675207467, "pagerank_3": 16.5989399079, "pagerank_4": 16.3764381435, "pagerank_5": 16.664387805}}, {"model": "papers.paper", "pk": 1003123, "fields": {"authors": ["MichaelHeinrich"], "affiliation": "University of Kiel", "venue": "Nature", "doi": "10.1038/467796a", "abstract": "In certain types of gastrointestinal cell, mutations in the protein KIT give rise to gastrointestinal stromal tumours. Why are other cell types that express KIT not affected? The answer lies with a second protein. See Letter p.849\n Gastroinestinal stromal tumours (GISTs) arise in the interstitial cells of Cajal, cells embedded in the musculature of the gastrointestinal tract where they generate electrical rhythmicity. Chi et al. now show that the transcription factor ETV1 is required for the development of these cells, and also promotes tumour development. The KIT gene, often activated by mutations in GIST, cooperates with ETV1 in the transformation of interstitial cells of Cajal, in part by promoting ETV1 stabilization. ETV1 seems to be present in high levels in all GISTs, making it a candidate diagnostic biomarker, and ETV1 blockers may prove useful against drug-resistant GIST.", "year": 2010, "title": "Cancer: Oncogenes in context", "keywords": ["Cell type", "ETV1", "Interstitial cell of Cajal", "Mutation", "Biology", "Cancer research", "Gastrointestinal tract", "GiST", "Immunology", "Cancer", "Proto-Oncogene Proteins c-kit"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 18.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.907, "citationsperpaper_1": 12.645, "citationsperpaper_2": 13.39, "citationsperpaper_3": 13.7, "citationsperpaper_4": 13.939, "citationsperpaper_5": 13.779, "citationsperyear_0": 47.0, "citationsperyear_1": 48.05, "citationsperyear_2": 49.095, "citationsperyear_3": 49.818, "citationsperyear_4": 49.696, "citationsperyear_5": 49.375, "totalcitations_0": 893.0, "totalcitations_1": 961.0, "totalcitations_2": 1031.0, "totalcitations_3": 1096.0, "totalcitations_4": 1143.0, "totalcitations_5": 1185.0, "totalpapers_0": 75.0, "totalpapers_1": 76.0, "totalpapers_2": 77.0, "totalpapers_3": 80.0, "totalpapers_4": 82.0, "totalpapers_5": 86.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 64.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 38.0, "recentcoauthors_5": 75.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.9166666667, "venuehindexmean_1": 128.5833333333, "venuehindexmean_2": 132.0, "venuehindexmean_3": 132.5384615385, "venuehindexmean_4": 134.9230769231, "venuehindexmean_5": 137.5384615385, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 18.4322129606, "pagerank_1": 17.8854155751, "pagerank_2": 17.0675207467, "pagerank_3": 16.5989399079, "pagerank_4": 16.3764381435, "pagerank_5": 16.664387805}}, {"model": "papers.paper", "pk": 1003123, "fields": {"authors": ["MichaelHeinrich"], "affiliation": "Oregon Health & Science University", "venue": "Nature", "doi": "10.1038/467796a", "abstract": "In certain types of gastrointestinal cell, mutations in the protein KIT give rise to gastrointestinal stromal tumours. Why are other cell types that express KIT not affected? The answer lies with a second protein. See Letter p.849\n Gastroinestinal stromal tumours (GISTs) arise in the interstitial cells of Cajal, cells embedded in the musculature of the gastrointestinal tract where they generate electrical rhythmicity. Chi et al. now show that the transcription factor ETV1 is required for the development of these cells, and also promotes tumour development. The KIT gene, often activated by mutations in GIST, cooperates with ETV1 in the transformation of interstitial cells of Cajal, in part by promoting ETV1 stabilization. ETV1 seems to be present in high levels in all GISTs, making it a candidate diagnostic biomarker, and ETV1 blockers may prove useful against drug-resistant GIST.", "year": 2010, "title": "Cancer: Oncogenes in context", "keywords": ["Cell type", "ETV1", "Interstitial cell of Cajal", "Mutation", "Biology", "Cancer research", "Gastrointestinal tract", "GiST", "Immunology", "Cancer", "Proto-Oncogene Proteins c-kit"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 18.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 19.0, "hindex_4": 20.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.907, "citationsperpaper_1": 12.645, "citationsperpaper_2": 13.39, "citationsperpaper_3": 13.7, "citationsperpaper_4": 13.939, "citationsperpaper_5": 13.779, "citationsperyear_0": 47.0, "citationsperyear_1": 48.05, "citationsperyear_2": 49.095, "citationsperyear_3": 49.818, "citationsperyear_4": 49.696, "citationsperyear_5": 49.375, "totalcitations_0": 893.0, "totalcitations_1": 961.0, "totalcitations_2": 1031.0, "totalcitations_3": 1096.0, "totalcitations_4": 1143.0, "totalcitations_5": 1185.0, "totalpapers_0": 75.0, "totalpapers_1": 76.0, "totalpapers_2": 77.0, "totalpapers_3": 80.0, "totalpapers_4": 82.0, "totalpapers_5": 86.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 64.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 10.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 38.0, "recentcoauthors_5": 75.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.9166666667, "venuehindexmean_1": 128.5833333333, "venuehindexmean_2": 132.0, "venuehindexmean_3": 132.5384615385, "venuehindexmean_4": 134.9230769231, "venuehindexmean_5": 137.5384615385, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 18.4322129606, "pagerank_1": 17.8854155751, "pagerank_2": 17.0675207467, "pagerank_3": 16.5989399079, "pagerank_4": 16.3764381435, "pagerank_5": 16.664387805}}, {"model": "papers.paper", "pk": 1003123, "fields": {"authors": ["C. L.Corless", "MichaelHeinrich"], "affiliation": "Portland VA Medical Center", "venue": "Nature", "doi": "10.1038/467796a", "abstract": "In certain types of gastrointestinal cell, mutations in the protein KIT give rise to gastrointestinal stromal tumours. Why are other cell types that express KIT not affected? The answer lies with a second protein. See Letter p.849\n Gastroinestinal stromal tumours (GISTs) arise in the interstitial cells of Cajal, cells embedded in the musculature of the gastrointestinal tract where they generate electrical rhythmicity. Chi et al. now show that the transcription factor ETV1 is required for the development of these cells, and also promotes tumour development. The KIT gene, often activated by mutations in GIST, cooperates with ETV1 in the transformation of interstitial cells of Cajal, in part by promoting ETV1 stabilization. ETV1 seems to be present in high levels in all GISTs, making it a candidate diagnostic biomarker, and ETV1 blockers may prove useful against drug-resistant GIST.", "year": 2010, "title": "Cancer: Oncogenes in context", "keywords": ["Cell type", "ETV1", "Interstitial cell of Cajal", "Mutation", "Biology", "Cancer research", "Gastrointestinal tract", "GiST", "Immunology", "Cancer", "Proto-Oncogene Proteins c-kit"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 9.5, "hindex_3": 9.5, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.9535, "citationsperpaper_1": 6.3225, "citationsperpaper_2": 6.695, "citationsperpaper_3": 6.85, "citationsperpaper_4": 6.9695, "citationsperpaper_5": 6.8895, "citationsperyear_0": 23.5, "citationsperyear_1": 24.025, "citationsperyear_2": 24.5475, "citationsperyear_3": 24.909, "citationsperyear_4": 24.848, "citationsperyear_5": 24.6875, "totalcitations_0": 446.5, "totalcitations_1": 480.5, "totalcitations_2": 515.5, "totalcitations_3": 548.0, "totalcitations_4": 571.5, "totalcitations_5": 592.5, "totalpapers_0": 38.0, "totalpapers_1": 38.5, "totalpapers_2": 39.0, "totalpapers_3": 40.5, "totalpapers_4": 41.5, "totalpapers_5": 43.5, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 32.5, "recentcoauthors_1": 23.5, "recentcoauthors_2": 5.0, "recentcoauthors_3": 11.5, "recentcoauthors_4": 19.0, "recentcoauthors_5": 37.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 192.9583333333, "venuehindexmean_1": 196.2916666667, "venuehindexmean_2": 200.5, "venuehindexmean_3": 203.7692307692, "venuehindexmean_4": 207.4615384615, "venuehindexmean_5": 210.7692307692, "totalvenues_0": 6.5, "totalvenues_1": 6.5, "totalvenues_2": 6.5, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 9.302134846, "pagerank_1": 9.028336288, "pagerank_2": 8.6188338943, "pagerank_3": 8.3840279464, "pagerank_4": 8.2723996316, "pagerank_5": 8.4158997132}}, {"model": "papers.paper", "pk": 1003386, "fields": {"authors": ["SharonWeinberger"], "affiliation": "Northwestern University", "venue": "Nature", "doi": "10.1038/466542b", "abstract": "", "year": 2010, "title": "US charges scientist with economic espionage", "keywords": ["Law and economics", "Molecular interactions", "Computational biology", "Environmental science", "Industrial espionage"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1912348624, "timescaledpagerank_2": 0.2549039785, "timescaledpagerank_3": 0.2271388018, "timescaledpagerank_4": 0.2282650103, "timescaledpagerank_5": 0.2310833188, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 11.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.091, "citationsperpaper_1": 0.15, "citationsperpaper_2": 0.143, "citationsperpaper_3": 0.143, "citationsperpaper_4": 0.138, "citationsperpaper_5": 0.138, "citationsperyear_0": 0.333, "citationsperyear_1": 0.75, "citationsperyear_2": 0.8, "citationsperyear_3": 0.667, "citationsperyear_4": 0.571, "citationsperyear_5": 0.5, "totalcitations_0": 1.0, "totalcitations_1": 3.0, "totalcitations_2": 4.0, "totalcitations_3": 4.0, "totalcitations_4": 4.0, "totalcitations_5": 4.0, "totalpapers_0": 11.0, "totalpapers_1": 20.0, "totalpapers_2": 28.0, "totalpapers_3": 28.0, "totalpapers_4": 29.0, "totalpapers_5": 29.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["Peter J.Baker", "Matthew J.Rosseinsky"], "affiliation": "University of Oxford", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 7.5, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.5, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.6195, "citationsperpaper_1": 6.355, "citationsperpaper_2": 6.4435, "citationsperpaper_3": 6.7985, "citationsperpaper_4": 7.067, "citationsperpaper_5": 7.463, "citationsperyear_0": 16.8585, "citationsperyear_1": 18.1965, "citationsperyear_2": 19.1865, "citationsperyear_3": 19.8185, "citationsperyear_4": 20.4675, "citationsperyear_5": 21.04, "totalcitations_0": 314.5, "totalcitations_1": 354.5, "totalcitations_2": 391.5, "totalcitations_3": 427.5, "totalcitations_4": 464.5, "totalcitations_5": 500.5, "totalpapers_0": 34.5, "totalpapers_1": 35.5, "totalpapers_2": 39.5, "totalpapers_3": 41.0, "totalpapers_4": 43.0, "totalpapers_5": 44.0, "authorage_0": 10.5, "authorage_1": 11.5, "authorage_2": 12.5, "authorage_3": 13.5, "authorage_4": 14.5, "authorage_5": 15.5, "recentcoauthors_0": 104.0, "recentcoauthors_1": 47.5, "recentcoauthors_2": 44.5, "recentcoauthors_3": 54.0, "recentcoauthors_4": 37.0, "recentcoauthors_5": 27.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 123.6666666667, "venuehindexmean_1": 129.8666666667, "venuehindexmean_2": 136.2666666667, "venuehindexmean_3": 142.5666666667, "venuehindexmean_4": 148.9, "venuehindexmean_5": 154.8333333333, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 10.7435934501, "pagerank_1": 10.8276554184, "pagerank_2": 11.8723523582, "pagerank_3": 12.1947241309, "pagerank_4": 12.5986758097, "pagerank_5": 12.708660905}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["Alexey Y.Ganin", "George R.Darling", "AlecMcLennan", "Matthew J.Rosseinsky"], "affiliation": "University of Liverpool", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 5.0, "hindex_1": 5.5, "hindex_2": 5.75, "hindex_3": 6.25, "hindex_4": 6.75, "hindex_5": 6.75, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.86725, "citationsperpaper_1": 7.16925, "citationsperpaper_2": 7.77175, "citationsperpaper_3": 8.83375, "citationsperpaper_4": 10.01675, "citationsperpaper_5": 11.3065, "citationsperyear_0": 11.52925, "citationsperyear_1": 12.381, "citationsperyear_2": 13.41925, "citationsperyear_3": 14.05875, "citationsperyear_4": 14.698, "citationsperyear_5": 15.43125, "totalcitations_0": 171.75, "totalcitations_1": 197.5, "totalcitations_2": 224.25, "totalcitations_3": 248.5, "totalcitations_4": 273.75, "totalcitations_5": 301.25, "totalpapers_0": 18.5, "totalpapers_1": 19.5, "totalpapers_2": 22.25, "totalpapers_3": 23.5, "totalpapers_4": 24.75, "totalpapers_5": 25.25, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 49.25, "recentcoauthors_1": 34.75, "recentcoauthors_2": 31.5, "recentcoauthors_3": 39.5, "recentcoauthors_4": 26.5, "recentcoauthors_5": 16.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 179.75, "venuehindexmean_1": 185.35, "venuehindexmean_2": 168.55, "venuehindexmean_3": 175.075, "venuehindexmean_4": 173.275, "venuehindexmean_5": 179.3125, "totalvenues_0": 3.5, "totalvenues_1": 3.5, "totalvenues_2": 3.75, "totalvenues_3": 3.75, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 5.6083382391, "pagerank_1": 5.7362977843, "pagerank_2": 6.4979639113, "pagerank_3": 6.8424884568, "pagerank_4": 7.0882102253, "pagerank_5": 7.1312776689}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["Alexey Y.Ganin"], "affiliation": "University of Glasgow", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 7.833, "citationsperpaper_1": 10.667, "citationsperpaper_2": 14.667, "citationsperpaper_3": 17.167, "citationsperpaper_4": 19.5, "citationsperpaper_5": 22.667, "citationsperyear_0": 9.4, "citationsperyear_1": 10.667, "citationsperyear_2": 12.571, "citationsperyear_3": 12.875, "citationsperyear_4": 13.0, "citationsperyear_5": 13.6, "totalcitations_0": 47.0, "totalcitations_1": 64.0, "totalcitations_2": 88.0, "totalcitations_3": 103.0, "totalcitations_4": 117.0, "totalcitations_5": 136.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 48.0, "recentcoauthors_1": 25.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 163.0, "venuehindexmean_1": 169.0, "venuehindexmean_2": 176.0, "venuehindexmean_3": 182.75, "venuehindexmean_4": 188.0, "venuehindexmean_5": 194.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.7461949492, "pagerank_1": 2.6778255121, "pagerank_2": 2.5438048056, "pagerank_3": 2.4850980993, "pagerank_4": 2.4170408854, "pagerank_5": 2.3859203321}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["Manolis D.Tzirakis", "Martin T.McDonald", "YasuhiroTakabayashi", "KosnnasPrassides"], "affiliation": "Durham University", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 1.5, "hindex_1": 1.5, "hindex_2": 1.5, "hindex_3": 1.5, "hindex_4": 1.75, "hindex_5": 1.75, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.4525, "citationsperpaper_1": 3.10725, "citationsperpaper_2": 3.21425, "citationsperpaper_3": 3.28575, "citationsperpaper_4": 3.35725, "citationsperpaper_5": 3.5475, "citationsperyear_0": 2.16675, "citationsperyear_1": 1.64075, "citationsperyear_2": 1.2605, "citationsperyear_3": 1.0555, "citationsperyear_4": 0.93, "citationsperyear_5": 0.88975, "totalcitations_0": 6.5, "totalcitations_1": 7.75, "totalcitations_2": 8.5, "totalcitations_3": 9.0, "totalcitations_4": 9.5, "totalcitations_5": 10.5, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 22.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 218.1666666667, "venuehindexmean_1": 222.5833333333, "venuehindexmean_2": 228.25, "venuehindexmean_3": 234.25, "venuehindexmean_4": 239.2916666667, "venuehindexmean_5": 244.0, "totalvenues_0": 1.75, "totalvenues_1": 1.75, "totalvenues_2": 1.75, "totalvenues_3": 1.75, "totalvenues_4": 1.75, "totalvenues_5": 1.75, "pagerank_0": 1.4610470442, "pagerank_1": 1.4314195474, "pagerank_2": 1.3783910499, "pagerank_3": 1.356548531, "pagerank_4": 1.3281904812, "pagerank_5": 1.3118925706}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["YasuhiroTakabayashi"], "affiliation": "Okayama University", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.143, "citationsperpaper_1": 2.429, "citationsperpaper_2": 2.857, "citationsperpaper_3": 3.143, "citationsperpaper_4": 3.429, "citationsperpaper_5": 3.857, "citationsperyear_0": 1.0, "citationsperyear_1": 1.063, "citationsperyear_2": 1.176, "citationsperyear_3": 1.222, "citationsperyear_4": 1.263, "citationsperyear_5": 1.35, "totalcitations_0": 15.0, "totalcitations_1": 17.0, "totalcitations_2": 20.0, "totalcitations_3": 22.0, "totalcitations_4": 24.0, "totalcitations_5": 27.0, "totalpapers_0": 7.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 7.0, "totalpapers_4": 7.0, "totalpapers_5": 7.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 36.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.6666666667, "venuehindexmean_1": 192.3333333333, "venuehindexmean_2": 199.0, "venuehindexmean_3": 205.0, "venuehindexmean_4": 209.6666666667, "venuehindexmean_5": 215.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.9165542241, "pagerank_1": 2.8653180344, "pagerank_2": 2.7667515993, "pagerank_3": 2.722672621, "pagerank_4": 2.6691881536, "pagerank_5": 2.63556737}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["YasuhiroTakabayashi", "MasakiTakata"], "affiliation": "Tohoku University", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 5.5, "hindex_1": 6.5, "hindex_2": 7.5, "hindex_3": 8.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 4.933, "citationsperpaper_1": 5.409, "citationsperpaper_2": 5.827, "citationsperpaper_3": 6.0435, "citationsperpaper_4": 6.708, "citationsperpaper_5": 7.1755, "citationsperyear_0": 11.844, "citationsperyear_1": 13.855, "citationsperyear_2": 16.227, "citationsperyear_3": 17.3215, "citationsperyear_4": 19.3565, "citationsperyear_5": 20.913, "totalcitations_0": 189.0, "totalcitations_1": 235.0, "totalcitations_2": 291.5, "totalcitations_3": 328.5, "totalcitations_4": 386.5, "totalcitations_5": 438.5, "totalpapers_0": 27.0, "totalpapers_1": 30.5, "totalpapers_2": 35.5, "totalpapers_3": 39.0, "totalpapers_4": 41.0, "totalpapers_5": 44.0, "authorage_0": 14.5, "authorage_1": 15.5, "authorage_2": 16.5, "authorage_3": 17.5, "authorage_4": 18.5, "authorage_5": 19.5, "recentcoauthors_0": 100.0, "recentcoauthors_1": 76.0, "recentcoauthors_2": 73.0, "recentcoauthors_3": 71.5, "recentcoauthors_4": 45.0, "recentcoauthors_5": 38.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 160.3333333333, "venuehindexmean_1": 165.8666666667, "venuehindexmean_2": 172.6, "venuehindexmean_3": 178.9, "venuehindexmean_4": 184.2333333333, "venuehindexmean_5": 190.0, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 9.1800456608, "pagerank_1": 10.1787368948, "pagerank_2": 11.3798534318, "pagerank_3": 12.2866535783, "pagerank_4": 12.6126451883, "pagerank_5": 13.258421034}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["MasakiTakata"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 9.0, "hindex_1": 11.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 15.0, "hindex_5": 17.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 7.723, "citationsperpaper_1": 8.389, "citationsperpaper_2": 8.797, "citationsperpaper_3": 8.944, "citationsperpaper_4": 9.987, "citationsperpaper_5": 10.494, "citationsperyear_0": 22.688, "citationsperyear_1": 26.647, "citationsperyear_2": 31.278, "citationsperyear_3": 33.421, "citationsperyear_4": 37.45, "citationsperyear_5": 40.476, "totalcitations_0": 363.0, "totalcitations_1": 453.0, "totalcitations_2": 563.0, "totalcitations_3": 635.0, "totalcitations_4": 749.0, "totalcitations_5": 850.0, "totalpapers_0": 47.0, "totalpapers_1": 54.0, "totalpapers_2": 64.0, "totalpapers_3": 71.0, "totalpapers_4": 75.0, "totalpapers_5": 81.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 164.0, "recentcoauthors_1": 139.0, "recentcoauthors_2": 146.0, "recentcoauthors_3": 143.0, "recentcoauthors_4": 90.0, "recentcoauthors_5": 77.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.0, "venuehindexmean_1": 139.4, "venuehindexmean_2": 146.2, "venuehindexmean_3": 152.8, "venuehindexmean_4": 158.8, "venuehindexmean_5": 165.0, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.4435370974, "pagerank_1": 17.4921557553, "pagerank_2": 19.9929552642, "pagerank_3": 21.8506345356, "pagerank_4": 22.5561022231, "pagerank_5": 23.881274698}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["MasakiTakata"], "affiliation": "Nagoya University", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 9.0, "hindex_1": 11.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 15.0, "hindex_5": 17.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 7.723, "citationsperpaper_1": 8.389, "citationsperpaper_2": 8.797, "citationsperpaper_3": 8.944, "citationsperpaper_4": 9.987, "citationsperpaper_5": 10.494, "citationsperyear_0": 22.688, "citationsperyear_1": 26.647, "citationsperyear_2": 31.278, "citationsperyear_3": 33.421, "citationsperyear_4": 37.45, "citationsperyear_5": 40.476, "totalcitations_0": 363.0, "totalcitations_1": 453.0, "totalcitations_2": 563.0, "totalcitations_3": 635.0, "totalcitations_4": 749.0, "totalcitations_5": 850.0, "totalpapers_0": 47.0, "totalpapers_1": 54.0, "totalpapers_2": 64.0, "totalpapers_3": 71.0, "totalpapers_4": 75.0, "totalpapers_5": 81.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 164.0, "recentcoauthors_1": 139.0, "recentcoauthors_2": 146.0, "recentcoauthors_3": 143.0, "recentcoauthors_4": 90.0, "recentcoauthors_5": 77.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.0, "venuehindexmean_1": 139.4, "venuehindexmean_2": 146.2, "venuehindexmean_3": 152.8, "venuehindexmean_4": 158.8, "venuehindexmean_5": 165.0, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.4435370974, "pagerank_1": 17.4921557553, "pagerank_2": 19.9929552642, "pagerank_3": 21.8506345356, "pagerank_4": 22.5561022231, "pagerank_5": 23.881274698}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["DenisAr\u010don"], "affiliation": "University of Ljubljana", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.2, "citationsperpaper_1": 3.6, "citationsperpaper_2": 4.4, "citationsperpaper_3": 4.4, "citationsperpaper_4": 4.6, "citationsperpaper_5": 4.6, "citationsperyear_0": 1.0, "citationsperyear_1": 1.059, "citationsperyear_2": 1.222, "citationsperyear_3": 1.158, "citationsperyear_4": 1.15, "citationsperyear_5": 1.095, "totalcitations_0": 16.0, "totalcitations_1": 18.0, "totalcitations_2": 22.0, "totalcitations_3": 22.0, "totalcitations_4": 23.0, "totalcitations_5": 23.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 5.0, "totalpapers_4": 5.0, "totalpapers_5": 5.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.6666666667, "venuehindexmean_1": 192.3333333333, "venuehindexmean_2": 199.0, "venuehindexmean_3": 205.0, "venuehindexmean_4": 209.6666666667, "venuehindexmean_5": 215.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.1179902495, "pagerank_1": 2.0787797307, "pagerank_2": 2.0175874604, "pagerank_3": 1.986026828, "pagerank_4": 1.9500942416, "pagerank_5": 1.926227481}}, {"model": "papers.paper", "pk": 1003544, "fields": {"authors": ["Peter J.Baker"], "affiliation": "Rutherford Appleton Laboratory", "venue": "Nature", "doi": "10.1038/nature09120", "abstract": "The crystal structure of a solid controls the interactions between the electronically active units and thus its electronic properties. In the high-temperature superconducting copper oxides, only one spatial arrangement of the electronically active Cu2+ units\u2014a two-dimensional square lattice\u2014is available to study the competition between the cooperative electronic states of magnetic order and superconductivity1. Crystals of the spherical molecular C603- anion support both superconductivity and magnetism but can consist of fundamentally distinct three-dimensional arrangements of the anions. Superconductivity in the A3C60 (A = alkali metal) fullerides has been exclusively associated with face-centred cubic (f.c.c.) packing of C603- (refs 2, 3), but recently the most expanded (and thus having the highest superconducting transition temperature, Tc; ref. 4) composition Cs3C60 has been isolated as a body-centred cubic (b.c.c.) packing, which supports both superconductivity and magnetic order5, 6. Here we isolate the f.c.c. polymorph of Cs3C60 to show how the spatial arrangement of the electronically active units controls the competing superconducting and magnetic electronic ground states. Unlike all the other f.c.c. A3C60 fullerides, f.c.c. Cs3C60 is not a superconductor but a magnetic insulator at ambient pressure, and becomes superconducting under pressure. The magnetic ordering occurs at an order of magnitude lower temperature in the geometrically frustrated f.c.c. polymorph (Neel temperature TN = 2.2\u2009K) than in the b.c.c.-based packing (TN = 46\u2009K). The different lattice packings of C603- change Tc from 38\u2009K in b.c.c. Cs3C60 to 35\u2009K in f.c.c. Cs3C60 (the highest found in the f.c.c. A3C60 family). The existence of two superconducting packings of the same electronically active unit reveals that Tc scales universally in a structure-independent dome-like relationship with proximity to the Mott metal\u2013insulator transition, which is governed by the role of electron correlations characteristic of high-temperature superconducting materials other than fullerides.", "year": 2010, "title": "Polymorphism control of superconductivity and magnetism in Cs3C60 close to the Mott transition", "keywords": ["N\u00e9el temperature", "Metal\u2013insulator transition", "Mott transition", "Superconductivity", "Magnetism", "Transition temperature", "Electronic structure", "Condensed matter physics", "Chemistry", "Crystal structure"], "citations_0": 3.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 3.8361287171, "timescaledpagerank_1": 3.1921348364, "timescaledpagerank_2": 2.227227296, "timescaledpagerank_3": 1.6399590628, "timescaledpagerank_4": 1.2508002291, "timescaledpagerank_5": 0.9922760267, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 2.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.889, "citationsperpaper_1": 1.3, "citationsperpaper_2": 1.8, "citationsperpaper_3": 2.0, "citationsperpaper_4": 2.2, "citationsperpaper_5": 2.4, "citationsperyear_0": 2.667, "citationsperyear_1": 3.25, "citationsperyear_2": 3.6, "citationsperyear_3": 3.333, "citationsperyear_4": 3.143, "citationsperyear_5": 3.0, "totalcitations_0": 8.0, "totalcitations_1": 13.0, "totalcitations_2": 18.0, "totalcitations_3": 20.0, "totalcitations_4": 22.0, "totalcitations_5": 24.0, "totalpapers_0": 9.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 10.0, "totalpapers_4": 10.0, "totalpapers_5": 10.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 104.0, "recentcoauthors_1": 37.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.3333333333, "venuehindexmean_1": 120.3333333333, "venuehindexmean_2": 126.3333333333, "venuehindexmean_3": 132.3333333333, "venuehindexmean_4": 139.0, "venuehindexmean_5": 144.6666666667, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 4.7631508546, "pagerank_1": 4.9100831456, "pagerank_2": 4.7403052075, "pagerank_3": 4.6469498049, "pagerank_4": 4.560653532, "pagerank_5": 4.4894253966}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["IngolfBach"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 14.538, "citationsperpaper_1": 14.786, "citationsperpaper_2": 15.067, "citationsperpaper_3": 15.667, "citationsperpaper_4": 15.563, "citationsperpaper_5": 15.938, "citationsperyear_0": 10.5, "citationsperyear_1": 10.895, "citationsperyear_2": 11.3, "citationsperyear_3": 11.19, "citationsperyear_4": 11.318, "citationsperyear_5": 11.087, "totalcitations_0": 189.0, "totalcitations_1": 207.0, "totalcitations_2": 226.0, "totalcitations_3": 235.0, "totalcitations_4": 249.0, "totalcitations_5": 255.0, "totalpapers_0": 13.0, "totalpapers_1": 14.0, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 16.0, "totalpapers_5": 16.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 23.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.3333333333, "venuehindexmean_1": 146.0, "venuehindexmean_2": 164.8571428571, "venuehindexmean_3": 167.7142857143, "venuehindexmean_4": 170.5714285714, "venuehindexmean_5": 172.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.8764932209, "pagerank_1": 4.1209075243, "pagerank_2": 4.3332291641, "pagerank_3": 4.1593551999, "pagerank_4": 4.2680321648, "pagerank_5": 4.1244021188}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["IngolfBach", "Stephen N.Jones", "Lisa L.Hall", "Jeanne B.Lawrence", "Michael R.Green", "BaoweiJiao", "MegByron", "NaokoTaniguchi-Ishigaki", "JongDaeShin", "XiaochunZhu", "HongMa"], "affiliation": "University of Massachusetts Medical School", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 10.4545454545, "hindex_1": 11.0, "hindex_2": 11.2727272727, "hindex_3": 11.6363636364, "hindex_4": 12.0, "hindex_5": 12.1818181818, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 15.1245454545, "citationsperpaper_1": 16.388, "citationsperpaper_2": 16.5872727273, "citationsperpaper_3": 16.8327272727, "citationsperpaper_4": 16.7345454545, "citationsperpaper_5": 17.1085454545, "citationsperyear_0": 28.7959090909, "citationsperyear_1": 29.3663636364, "citationsperyear_2": 29.4665454545, "citationsperyear_3": 29.5832727273, "citationsperyear_4": 29.6788181818, "citationsperyear_5": 29.468, "totalcitations_0": 850.6363636364, "totalcitations_1": 879.4545454545, "totalcitations_2": 904.5454545455, "totalcitations_3": 933.0909090909, "totalcitations_4": 960.4545454545, "totalcitations_5": 982.8181818182, "totalpapers_0": 26.7272727273, "totalpapers_1": 27.7272727273, "totalpapers_2": 29.1818181818, "totalpapers_3": 30.8181818182, "totalpapers_4": 32.5454545455, "totalpapers_5": 33.4545454545, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 32.2727272727, "recentcoauthors_1": 33.2727272727, "recentcoauthors_2": 23.0, "recentcoauthors_3": 34.0909090909, "recentcoauthors_4": 36.2727272727, "recentcoauthors_5": 23.9090909091, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.5478042457, "venuehindexmean_1": 178.4927118781, "venuehindexmean_2": 181.9298504526, "venuehindexmean_3": 187.3889708776, "venuehindexmean_4": 190.6223829201, "venuehindexmean_5": 192.9439090225, "totalvenues_0": 6.2727272727, "totalvenues_1": 6.2727272727, "totalvenues_2": 6.8181818182, "totalvenues_3": 7.0909090909, "totalvenues_4": 7.3636363636, "totalvenues_5": 7.5454545455, "pagerank_0": 5.2594847339, "pagerank_1": 5.2731436551, "pagerank_2": 5.5276876104, "pagerank_3": 5.8400092363, "pagerank_4": 6.0093717526, "pagerank_5": 5.9953122937}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["IngolfBach", "MichaelBossenz", "IrmHermans-Borgmeyer"], "affiliation": "University of Hamburg", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 6.3333333333, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.6666666667, "hindex_4": 7.6666666667, "hindex_5": 7.6666666667, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 18.046, "citationsperpaper_1": 18.9286666667, "citationsperpaper_2": 18.974, "citationsperpaper_3": 18.9166666667, "citationsperpaper_4": 18.9376666667, "citationsperpaper_5": 17.9873333333, "citationsperyear_0": 9.971, "citationsperyear_1": 10.1226666667, "citationsperyear_2": 10.3566666667, "citationsperyear_3": 10.2716666667, "citationsperyear_4": 10.31, "citationsperyear_5": 10.1296666667, "totalcitations_0": 183.3333333333, "totalcitations_1": 195.0, "totalcitations_2": 208.0, "totalcitations_3": 217.0, "totalcitations_4": 227.6666666667, "totalcitations_5": 234.0, "totalpapers_0": 9.3333333333, "totalpapers_1": 9.6666666667, "totalpapers_2": 10.3333333333, "totalpapers_3": 10.6666666667, "totalpapers_4": 11.3333333333, "totalpapers_5": 12.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 17.3333333333, "recentcoauthors_1": 16.3333333333, "recentcoauthors_2": 11.0, "recentcoauthors_3": 9.3333333333, "recentcoauthors_4": 8.3333333333, "recentcoauthors_5": 13.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 158.8888888889, "venuehindexmean_1": 161.6666666667, "venuehindexmean_2": 168.6031746032, "venuehindexmean_3": 166.9186507937, "venuehindexmean_4": 169.6626984127, "venuehindexmean_5": 172.0357142857, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.6666666667, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.929258688, "pagerank_1": 2.952210386, "pagerank_2": 3.0792295019, "pagerank_3": 3.05079668, "pagerank_4": 3.1206777504, "pagerank_5": 3.2058299846}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["IngolfBach"], "affiliation": "Pasteur Institute", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 14.538, "citationsperpaper_1": 14.786, "citationsperpaper_2": 15.067, "citationsperpaper_3": 15.667, "citationsperpaper_4": 15.563, "citationsperpaper_5": 15.938, "citationsperyear_0": 10.5, "citationsperyear_1": 10.895, "citationsperyear_2": 11.3, "citationsperyear_3": 11.19, "citationsperyear_4": 11.318, "citationsperyear_5": 11.087, "totalcitations_0": 189.0, "totalcitations_1": 207.0, "totalcitations_2": 226.0, "totalcitations_3": 235.0, "totalcitations_4": 249.0, "totalcitations_5": 255.0, "totalpapers_0": 13.0, "totalpapers_1": 14.0, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 16.0, "totalpapers_5": 16.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 23.0, "recentcoauthors_2": 22.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.3333333333, "venuehindexmean_1": 146.0, "venuehindexmean_2": 164.8571428571, "venuehindexmean_3": 167.7142857143, "venuehindexmean_4": 170.5714285714, "venuehindexmean_5": 172.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.8764932209, "pagerank_1": 4.1209075243, "pagerank_2": 4.3332291641, "pagerank_3": 4.1593551999, "pagerank_4": 4.2680321648, "pagerank_5": 4.1244021188}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Stephen N.Jones", "Lisa L.Hall", "Jeanne B.Lawrence", "Michael R.Green", "MegByron", "XiaochunZhu"], "affiliation": "University of Massachusetts Amherst", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 16.1666666667, "hindex_1": 16.5, "hindex_2": 17.0, "hindex_3": 17.3333333333, "hindex_4": 17.8333333333, "hindex_5": 18.1666666667, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 22.642, "citationsperpaper_1": 23.3431666667, "citationsperpaper_2": 23.7135, "citationsperpaper_3": 23.2703333333, "citationsperpaper_4": 23.1131666667, "citationsperpaper_5": 23.7031666667, "citationsperyear_0": 47.9195, "citationsperyear_1": 48.115, "citationsperyear_2": 47.9758333333, "citationsperyear_3": 48.0931666667, "citationsperyear_4": 48.2248333333, "citationsperyear_5": 48.0178333333, "totalcitations_0": 1466.6666666667, "totalcitations_1": 1512.0, "totalcitations_2": 1548.5, "totalcitations_3": 1594.0, "totalcitations_4": 1637.6666666667, "totalcitations_5": 1673.8333333333, "totalpapers_0": 41.6666666667, "totalpapers_1": 43.1666666667, "totalpapers_2": 44.8333333333, "totalpapers_3": 47.8333333333, "totalpapers_4": 50.5, "totalpapers_5": 51.8333333333, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 39.0, "recentcoauthors_1": 42.8333333333, "recentcoauthors_2": 26.3333333333, "recentcoauthors_3": 51.0, "recentcoauthors_4": 61.5, "recentcoauthors_5": 36.8333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 151.8598633393, "venuehindexmean_1": 154.5366384433, "venuehindexmean_2": 160.9785353535, "venuehindexmean_3": 167.9829545455, "venuehindexmean_4": 170.8791305916, "venuehindexmean_5": 172.8098649539, "totalvenues_0": 8.8333333333, "totalvenues_1": 8.8333333333, "totalvenues_2": 9.1666666667, "totalvenues_3": 9.6666666667, "totalvenues_4": 10.1666666667, "totalvenues_5": 10.5, "pagerank_0": 7.5426422888, "pagerank_1": 7.5493582604, "pagerank_2": 7.6692285539, "pagerank_3": 8.3479607867, "pagerank_4": 8.6299226529, "pagerank_5": 8.5991713082}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Stephen N.Jones"], "affiliation": "Baylor College of Medicine", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 15.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 37.206, "citationsperpaper_1": 36.216, "citationsperpaper_2": 35.872, "citationsperpaper_3": 35.512, "citationsperpaper_4": 35.905, "citationsperpaper_5": 35.045, "citationsperyear_0": 60.238, "citationsperyear_1": 60.909, "citationsperyear_2": 60.826, "citationsperyear_3": 60.667, "citationsperyear_4": 60.32, "citationsperyear_5": 59.308, "totalcitations_0": 1265.0, "totalcitations_1": 1340.0, "totalcitations_2": 1399.0, "totalcitations_3": 1456.0, "totalcitations_4": 1508.0, "totalcitations_5": 1542.0, "totalpapers_0": 34.0, "totalpapers_1": 37.0, "totalpapers_2": 39.0, "totalpapers_3": 41.0, "totalpapers_4": 42.0, "totalpapers_5": 44.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 58.0, "recentcoauthors_1": 65.0, "recentcoauthors_2": 37.0, "recentcoauthors_3": 39.0, "recentcoauthors_4": 41.0, "recentcoauthors_5": 19.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.5454545455, "venuehindexmean_1": 142.0909090909, "venuehindexmean_2": 145.4545454545, "venuehindexmean_3": 148.2727272727, "venuehindexmean_4": 150.4545454545, "venuehindexmean_5": 152.6363636364, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 11.0, "totalvenues_3": 11.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 8.5336236491, "pagerank_1": 9.0149840213, "pagerank_2": 8.8577075929, "pagerank_3": 9.3512112636, "pagerank_4": 9.3453595883, "pagerank_5": 9.5228166891}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["XiaochunZhu", "Michael R.Green"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 28.0, "hindex_1": 28.0, "hindex_2": 29.0, "hindex_3": 29.5, "hindex_4": 30.0, "hindex_5": 30.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 24.3575, "citationsperpaper_1": 24.9365, "citationsperpaper_2": 25.3585, "citationsperpaper_3": 25.952, "citationsperpaper_4": 24.8615, "citationsperpaper_5": 25.173, "citationsperyear_0": 84.347, "citationsperyear_1": 84.2785, "citationsperyear_2": 83.705, "citationsperyear_3": 83.849, "citationsperyear_4": 83.45, "citationsperyear_5": 82.9145, "totalcitations_0": 2931.5, "totalcitations_1": 3002.0, "totalcitations_2": 3056.5, "totalcitations_3": 3132.5, "totalcitations_4": 3197.0, "totalcitations_5": 3255.5, "totalpapers_0": 79.0, "totalpapers_1": 82.0, "totalpapers_2": 85.0, "totalpapers_3": 89.5, "totalpapers_4": 94.5, "totalpapers_5": 97.5, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 52.5, "recentcoauthors_1": 65.0, "recentcoauthors_2": 48.5, "recentcoauthors_3": 75.0, "recentcoauthors_4": 97.0, "recentcoauthors_5": 80.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 142.9485294118, "venuehindexmean_1": 145.7977941176, "venuehindexmean_2": 147.7083333333, "venuehindexmean_3": 149.9375, "venuehindexmean_4": 147.5267857143, "venuehindexmean_5": 148.1114130435, "totalvenues_0": 12.5, "totalvenues_1": 12.5, "totalvenues_2": 13.0, "totalvenues_3": 13.5, "totalvenues_4": 14.5, "totalvenues_5": 15.5, "pagerank_0": 13.2469160137, "pagerank_1": 13.3751555756, "pagerank_2": 13.5694487854, "pagerank_3": 14.1986941726, "pagerank_4": 14.5761852229, "pagerank_5": 14.6654922242}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Michael R.Green"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 50.0, "hindex_1": 50.0, "hindex_2": 51.0, "hindex_3": 52.0, "hindex_4": 52.0, "hindex_5": 52.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 39.17, "citationsperpaper_1": 38.418, "citationsperpaper_2": 37.535, "citationsperpaper_3": 36.268, "citationsperpaper_4": 35.261, "citationsperpaper_5": 34.654, "citationsperyear_0": 159.944, "citationsperyear_1": 158.865, "citationsperyear_2": 157.053, "citationsperyear_3": 156.231, "citationsperyear_4": 155.15, "citationsperyear_5": 153.829, "totalcitations_0": 5758.0, "totalcitations_1": 5878.0, "totalcitations_2": 5968.0, "totalcitations_3": 6093.0, "totalcitations_4": 6206.0, "totalcitations_5": 6307.0, "totalpapers_0": 147.0, "totalpapers_1": 153.0, "totalpapers_2": 159.0, "totalpapers_3": 168.0, "totalpapers_4": 176.0, "totalpapers_5": 182.0, "authorage_0": 35.0, "authorage_1": 36.0, "authorage_2": 37.0, "authorage_3": 38.0, "authorage_4": 39.0, "authorage_5": 40.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 107.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 150.0, "recentcoauthors_4": 177.0, "recentcoauthors_5": 144.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.6470588235, "venuehindexmean_1": 120.4705882353, "venuehindexmean_2": 120.6666666667, "venuehindexmean_3": 122.0, "venuehindexmean_4": 114.4285714286, "venuehindexmean_5": 113.347826087, "totalvenues_0": 17.0, "totalvenues_1": 17.0, "totalvenues_2": 18.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 23.0, "pagerank_0": 23.3792663195, "pagerank_1": 23.7626315926, "pagerank_2": 24.351013005, "pagerank_3": 25.7297160848, "pagerank_4": 26.2593821362, "pagerank_5": 26.6091903064}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Michael R.Green"], "affiliation": "University of Texas MD Anderson Cancer Center", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 50.0, "hindex_1": 50.0, "hindex_2": 51.0, "hindex_3": 52.0, "hindex_4": 52.0, "hindex_5": 52.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 39.17, "citationsperpaper_1": 38.418, "citationsperpaper_2": 37.535, "citationsperpaper_3": 36.268, "citationsperpaper_4": 35.261, "citationsperpaper_5": 34.654, "citationsperyear_0": 159.944, "citationsperyear_1": 158.865, "citationsperyear_2": 157.053, "citationsperyear_3": 156.231, "citationsperyear_4": 155.15, "citationsperyear_5": 153.829, "totalcitations_0": 5758.0, "totalcitations_1": 5878.0, "totalcitations_2": 5968.0, "totalcitations_3": 6093.0, "totalcitations_4": 6206.0, "totalcitations_5": 6307.0, "totalpapers_0": 147.0, "totalpapers_1": 153.0, "totalpapers_2": 159.0, "totalpapers_3": 168.0, "totalpapers_4": 176.0, "totalpapers_5": 182.0, "authorage_0": 35.0, "authorage_1": 36.0, "authorage_2": 37.0, "authorage_3": 38.0, "authorage_4": 39.0, "authorage_5": 40.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 107.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 150.0, "recentcoauthors_4": 177.0, "recentcoauthors_5": 144.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.6470588235, "venuehindexmean_1": 120.4705882353, "venuehindexmean_2": 120.6666666667, "venuehindexmean_3": 122.0, "venuehindexmean_4": 114.4285714286, "venuehindexmean_5": 113.347826087, "totalvenues_0": 17.0, "totalvenues_1": 17.0, "totalvenues_2": 18.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 23.0, "pagerank_0": 23.3792663195, "pagerank_1": 23.7626315926, "pagerank_2": 24.351013005, "pagerank_3": 25.7297160848, "pagerank_4": 26.2593821362, "pagerank_5": 26.6091903064}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Michael R.Green"], "affiliation": "University of Nebraska Medical Center", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 50.0, "hindex_1": 50.0, "hindex_2": 51.0, "hindex_3": 52.0, "hindex_4": 52.0, "hindex_5": 52.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 39.17, "citationsperpaper_1": 38.418, "citationsperpaper_2": 37.535, "citationsperpaper_3": 36.268, "citationsperpaper_4": 35.261, "citationsperpaper_5": 34.654, "citationsperyear_0": 159.944, "citationsperyear_1": 158.865, "citationsperyear_2": 157.053, "citationsperyear_3": 156.231, "citationsperyear_4": 155.15, "citationsperyear_5": 153.829, "totalcitations_0": 5758.0, "totalcitations_1": 5878.0, "totalcitations_2": 5968.0, "totalcitations_3": 6093.0, "totalcitations_4": 6206.0, "totalcitations_5": 6307.0, "totalpapers_0": 147.0, "totalpapers_1": 153.0, "totalpapers_2": 159.0, "totalpapers_3": 168.0, "totalpapers_4": 176.0, "totalpapers_5": 182.0, "authorage_0": 35.0, "authorage_1": 36.0, "authorage_2": 37.0, "authorage_3": 38.0, "authorage_4": 39.0, "authorage_5": 40.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 107.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 150.0, "recentcoauthors_4": 177.0, "recentcoauthors_5": 144.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.6470588235, "venuehindexmean_1": 120.4705882353, "venuehindexmean_2": 120.6666666667, "venuehindexmean_3": 122.0, "venuehindexmean_4": 114.4285714286, "venuehindexmean_5": 113.347826087, "totalvenues_0": 17.0, "totalvenues_1": 17.0, "totalvenues_2": 18.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 23.0, "pagerank_0": 23.3792663195, "pagerank_1": 23.7626315926, "pagerank_2": 24.351013005, "pagerank_3": 25.7297160848, "pagerank_4": 26.2593821362, "pagerank_5": 26.6091903064}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Michael R.Green"], "affiliation": "Stanford University", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 50.0, "hindex_1": 50.0, "hindex_2": 51.0, "hindex_3": 52.0, "hindex_4": 52.0, "hindex_5": 52.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 39.17, "citationsperpaper_1": 38.418, "citationsperpaper_2": 37.535, "citationsperpaper_3": 36.268, "citationsperpaper_4": 35.261, "citationsperpaper_5": 34.654, "citationsperyear_0": 159.944, "citationsperyear_1": 158.865, "citationsperyear_2": 157.053, "citationsperyear_3": 156.231, "citationsperyear_4": 155.15, "citationsperyear_5": 153.829, "totalcitations_0": 5758.0, "totalcitations_1": 5878.0, "totalcitations_2": 5968.0, "totalcitations_3": 6093.0, "totalcitations_4": 6206.0, "totalcitations_5": 6307.0, "totalpapers_0": 147.0, "totalpapers_1": 153.0, "totalpapers_2": 159.0, "totalpapers_3": 168.0, "totalpapers_4": 176.0, "totalpapers_5": 182.0, "authorage_0": 35.0, "authorage_1": 36.0, "authorage_2": 37.0, "authorage_3": 38.0, "authorage_4": 39.0, "authorage_5": 40.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 107.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 150.0, "recentcoauthors_4": 177.0, "recentcoauthors_5": 144.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.6470588235, "venuehindexmean_1": 120.4705882353, "venuehindexmean_2": 120.6666666667, "venuehindexmean_3": 122.0, "venuehindexmean_4": 114.4285714286, "venuehindexmean_5": 113.347826087, "totalvenues_0": 17.0, "totalvenues_1": 17.0, "totalvenues_2": 18.0, "totalvenues_3": 19.0, "totalvenues_4": 21.0, "totalvenues_5": 23.0, "pagerank_0": 23.3792663195, "pagerank_1": 23.7626315926, "pagerank_2": 24.351013005, "pagerank_3": 25.7297160848, "pagerank_4": 26.2593821362, "pagerank_5": 26.6091903064}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["IrmHermans-Borgmeyer"], "affiliation": "Salk Institute for Biological Studies", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 32.6, "citationsperpaper_1": 33.6, "citationsperpaper_2": 31.455, "citationsperpaper_3": 30.083, "citationsperpaper_4": 31.083, "citationsperpaper_5": 27.357, "citationsperyear_0": 15.524, "citationsperyear_1": 15.273, "citationsperyear_2": 15.043, "citationsperyear_3": 15.042, "citationsperyear_4": 14.92, "citationsperyear_5": 14.731, "totalcitations_0": 326.0, "totalcitations_1": 336.0, "totalcitations_2": 346.0, "totalcitations_3": 361.0, "totalcitations_4": 373.0, "totalcitations_5": 383.0, "totalpapers_0": 10.0, "totalpapers_1": 10.0, "totalpapers_2": 11.0, "totalpapers_3": 12.0, "totalpapers_4": 12.0, "totalpapers_5": 14.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 5.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 146.6666666667, "venuehindexmean_1": 149.3333333333, "venuehindexmean_2": 148.2857142857, "venuehindexmean_3": 136.375, "venuehindexmean_4": 138.75, "venuehindexmean_5": 141.25, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 3.0762451121, "pagerank_1": 2.9793792795, "pagerank_2": 3.2185583666, "pagerank_3": 3.3600475152, "pagerank_4": 3.2569245988, "pagerank_5": 3.7105193956}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["HongMa"], "affiliation": "Fudan University", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 14.48, "citationsperpaper_1": 14.423, "citationsperpaper_2": 13.862, "citationsperpaper_3": 14.621, "citationsperpaper_4": 15.172, "citationsperpaper_5": 14.871, "citationsperyear_0": 17.238, "citationsperyear_1": 17.045, "citationsperyear_2": 17.478, "citationsperyear_3": 17.667, "citationsperyear_4": 17.6, "citationsperyear_5": 17.731, "totalcitations_0": 362.0, "totalcitations_1": 375.0, "totalcitations_2": 402.0, "totalcitations_3": 424.0, "totalcitations_4": 440.0, "totalcitations_5": 461.0, "totalpapers_0": 25.0, "totalpapers_1": 26.0, "totalpapers_2": 29.0, "totalpapers_3": 29.0, "totalpapers_4": 29.0, "totalpapers_5": 31.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 43.0, "recentcoauthors_1": 47.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 33.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.2, "venuehindexmean_1": 190.2, "venuehindexmean_2": 166.1666666667, "venuehindexmean_3": 169.3333333333, "venuehindexmean_4": 172.3333333333, "venuehindexmean_5": 174.6666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8721848993, "pagerank_1": 5.8718397418, "pagerank_2": 7.0521431762, "pagerank_3": 6.7231596607, "pagerank_4": 6.3548732385, "pagerank_5": 6.6553307118}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["HongMa"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 14.48, "citationsperpaper_1": 14.423, "citationsperpaper_2": 13.862, "citationsperpaper_3": 14.621, "citationsperpaper_4": 15.172, "citationsperpaper_5": 14.871, "citationsperyear_0": 17.238, "citationsperyear_1": 17.045, "citationsperyear_2": 17.478, "citationsperyear_3": 17.667, "citationsperyear_4": 17.6, "citationsperyear_5": 17.731, "totalcitations_0": 362.0, "totalcitations_1": 375.0, "totalcitations_2": 402.0, "totalcitations_3": 424.0, "totalcitations_4": 440.0, "totalcitations_5": 461.0, "totalpapers_0": 25.0, "totalpapers_1": 26.0, "totalpapers_2": 29.0, "totalpapers_3": 29.0, "totalpapers_4": 29.0, "totalpapers_5": 31.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 43.0, "recentcoauthors_1": 47.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 33.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.2, "venuehindexmean_1": 190.2, "venuehindexmean_2": 166.1666666667, "venuehindexmean_3": 169.3333333333, "venuehindexmean_4": 172.3333333333, "venuehindexmean_5": 174.6666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8721848993, "pagerank_1": 5.8718397418, "pagerank_2": 7.0521431762, "pagerank_3": 6.7231596607, "pagerank_4": 6.3548732385, "pagerank_5": 6.6553307118}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["HongMa"], "affiliation": "Pennsylvania State University", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 14.48, "citationsperpaper_1": 14.423, "citationsperpaper_2": 13.862, "citationsperpaper_3": 14.621, "citationsperpaper_4": 15.172, "citationsperpaper_5": 14.871, "citationsperyear_0": 17.238, "citationsperyear_1": 17.045, "citationsperyear_2": 17.478, "citationsperyear_3": 17.667, "citationsperyear_4": 17.6, "citationsperyear_5": 17.731, "totalcitations_0": 362.0, "totalcitations_1": 375.0, "totalcitations_2": 402.0, "totalcitations_3": 424.0, "totalcitations_4": 440.0, "totalcitations_5": 461.0, "totalpapers_0": 25.0, "totalpapers_1": 26.0, "totalpapers_2": 29.0, "totalpapers_3": 29.0, "totalpapers_4": 29.0, "totalpapers_5": 31.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 43.0, "recentcoauthors_1": 47.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 33.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.2, "venuehindexmean_1": 190.2, "venuehindexmean_2": 166.1666666667, "venuehindexmean_3": 169.3333333333, "venuehindexmean_4": 172.3333333333, "venuehindexmean_5": 174.6666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8721848993, "pagerank_1": 5.8718397418, "pagerank_2": 7.0521431762, "pagerank_3": 6.7231596607, "pagerank_4": 6.3548732385, "pagerank_5": 6.6553307118}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["HongMa"], "affiliation": "Cold Spring Harbor Laboratory", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 14.48, "citationsperpaper_1": 14.423, "citationsperpaper_2": 13.862, "citationsperpaper_3": 14.621, "citationsperpaper_4": 15.172, "citationsperpaper_5": 14.871, "citationsperyear_0": 17.238, "citationsperyear_1": 17.045, "citationsperyear_2": 17.478, "citationsperyear_3": 17.667, "citationsperyear_4": 17.6, "citationsperyear_5": 17.731, "totalcitations_0": 362.0, "totalcitations_1": 375.0, "totalcitations_2": 402.0, "totalcitations_3": 424.0, "totalcitations_4": 440.0, "totalcitations_5": 461.0, "totalpapers_0": 25.0, "totalpapers_1": 26.0, "totalpapers_2": 29.0, "totalpapers_3": 29.0, "totalpapers_4": 29.0, "totalpapers_5": 31.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 43.0, "recentcoauthors_1": 47.0, "recentcoauthors_2": 49.0, "recentcoauthors_3": 33.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.2, "venuehindexmean_1": 190.2, "venuehindexmean_2": 166.1666666667, "venuehindexmean_3": 169.3333333333, "venuehindexmean_4": 172.3333333333, "venuehindexmean_5": 174.6666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8721848993, "pagerank_1": 5.8718397418, "pagerank_2": 7.0521431762, "pagerank_3": 6.7231596607, "pagerank_4": 6.3548732385, "pagerank_5": 6.6553307118}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["Young GieChung"], "affiliation": "Advanced Cell Technology", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 9.333, "citationsperpaper_1": 10.167, "citationsperpaper_2": 11.5, "citationsperpaper_3": 12.333, "citationsperpaper_4": 12.143, "citationsperpaper_5": 11.5, "citationsperyear_0": 7.0, "citationsperyear_1": 6.778, "citationsperyear_2": 6.9, "citationsperyear_3": 6.727, "citationsperyear_4": 7.083, "citationsperyear_5": 7.077, "totalcitations_0": 56.0, "totalcitations_1": 61.0, "totalcitations_2": 69.0, "totalcitations_3": 74.0, "totalcitations_4": 85.0, "totalcitations_5": 92.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 7.0, "totalpapers_5": 8.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 12.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.25, "venuehindexmean_1": 151.75, "venuehindexmean_2": 157.0, "venuehindexmean_3": 161.5, "venuehindexmean_4": 165.75, "venuehindexmean_5": 169.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.7483952222, "pagerank_1": 1.6957862129, "pagerank_2": 1.6620064692, "pagerank_3": 1.6109328008, "pagerank_4": 2.0579564912, "pagerank_5": 2.2642849632}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["BaoweiJiao"], "affiliation": "Kunming Institute of Zoology", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 0.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 4.0, "citationsperpaper_2": 3.5, "citationsperpaper_3": 5.0, "citationsperpaper_4": 4.333, "citationsperpaper_5": 4.333, "citationsperyear_0": 0.0, "citationsperyear_1": 2.0, "citationsperyear_2": 2.333, "citationsperyear_3": 2.5, "citationsperyear_4": 2.6, "citationsperyear_5": 2.167, "totalcitations_0": 0.0, "totalcitations_1": 4.0, "totalcitations_2": 7.0, "totalcitations_3": 10.0, "totalcitations_4": 13.0, "totalcitations_5": 13.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 12.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 264.5, "venuehindexmean_3": 269.0, "venuehindexmean_4": 273.5, "venuehindexmean_5": 277.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.6059971879, "pagerank_1": 0.5797835346, "pagerank_2": 0.95645888, "pagerank_3": 0.9187607975, "pagerank_4": 1.1827420473, "pagerank_5": 1.1447874258}}, {"model": "papers.paper", "pk": 1004065, "fields": {"authors": ["BaoweiJiao"], "affiliation": "Chinese Academy of Sciences", "venue": "Nature", "doi": "10.1038/nature09457", "abstract": "To ensure that female mammals do not have an excess of X-chromosome gene products, one of the two X chromosomes present in each cell is silenced. During embryogenesis, the imprinted form of this X-chromosome inactivation (XCI) process selectively silences the paternal X following the detection of Xist RNA expression on the paternal X chromosome (Xp) at about the four-cell stage of embryonic development. Later, an embryonic form of XCI occurs in the developing blastocyst of the embryo proper, inactivating either the paternal or maternal X chromosome at random. Using mouse genetics, Shin et al. show that maternal deposits of Rnf12/RLIM ubiquitin ligase are crucial in the initiation of the initial process, but not in the later random X inactivation. Two forms of X-chromosome inactivation ensure the selective silencing of female sex chromosomes in mouse embryos. Imprinted silencing begins with the detection of Xist RNA expression on the paternal X chromosome at about the four-cell stage of development. Later, a random form of inactivation silences either the paternal or the maternal X chromosome. Here it is shown that maternal deposits of the ubiquitin ligase Rnf12/RLIM are required for the imprinted form of X-chromosome inactivation. Two forms of X-chromosome inactivation (XCI) ensure the selective silencing of female sex chromosomes during mouse embryogenesis. Imprinted XCI begins with the detection of Xist RNA expression on the paternal X\u2009chromosome (Xp) at about the four-cell stage of embryonic development. In the embryonic tissues of the inner cell mass, a random form of XCI occurs in blastocysts that inactivates either Xp or the maternal X\u2009chromosome (Xm)1,2. Both forms of XCI require the non-coding Xist RNA that coats the inactive X\u2009chromosome from which it is expressed. Xist has crucial functions in the silencing of X-linked genes, including Rnf12 (refs 3, 4) encoding the ubiquitin ligase RLIM (RING finger LIM-domain-interacting protein). Here we show, by targeting a conditional knockout of Rnf12 to oocytes where RLIM accumulates to high levels, that the maternal transmission of the mutant X\u2009chromosome (\u0394m) leads to lethality in female embryos as a result of defective imprinted XCI. We provide evidence that in \u0394m female embryos the initial formation of Xist clouds and Xp silencing are inhibited. In contrast, embryonic stem cells lacking RLIM are able to form Xist clouds and silence at least some X-linked genes during random XCI. These results assign crucial functions to the maternal deposit of Rnf12/RLIM for the initiation of imprinted XCI.", "year": 2010, "title": "Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice", "keywords": ["XIST", "Gene silencing", "Genetics", "Biology", "X-inactivation", "X chromosome", "Conditional gene knockout", "Inner cell mass", "Ubiquitin ligase", "RNA"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0808247148, "timescaledpagerank_2": 0.2385942356, "timescaledpagerank_3": 0.2397963797, "timescaledpagerank_4": 0.2766845876, "timescaledpagerank_5": 0.1930410533, "hindex_0": 0.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 33.0, "adopters_3": 15.0, "adopters_4": 19.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 4.0, "citationsperpaper_2": 3.5, "citationsperpaper_3": 5.0, "citationsperpaper_4": 4.333, "citationsperpaper_5": 4.333, "citationsperyear_0": 0.0, "citationsperyear_1": 2.0, "citationsperyear_2": 2.333, "citationsperyear_3": 2.5, "citationsperyear_4": 2.6, "citationsperyear_5": 2.167, "totalcitations_0": 0.0, "totalcitations_1": 4.0, "totalcitations_2": 7.0, "totalcitations_3": 10.0, "totalcitations_4": 13.0, "totalcitations_5": 13.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 12.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 264.5, "venuehindexmean_3": 269.0, "venuehindexmean_4": 273.5, "venuehindexmean_5": 277.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.6059971879, "pagerank_1": 0.5797835346, "pagerank_2": 0.95645888, "pagerank_3": 0.9187607975, "pagerank_4": 1.1827420473, "pagerank_5": 1.1447874258}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["John R.Christy"], "affiliation": "University of Alabama in Huntsville", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 4.857, "citationsperpaper_1": 4.857, "citationsperpaper_2": 4.857, "citationsperpaper_3": 4.857, "citationsperpaper_4": 4.857, "citationsperpaper_5": 5.0, "citationsperyear_0": 1.619, "citationsperyear_1": 1.545, "citationsperyear_2": 1.478, "citationsperyear_3": 1.417, "citationsperyear_4": 1.36, "citationsperyear_5": 1.346, "totalcitations_0": 34.0, "totalcitations_1": 34.0, "totalcitations_2": 34.0, "totalcitations_3": 34.0, "totalcitations_4": 34.0, "totalcitations_5": 35.0, "totalpapers_0": 7.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 7.0, "totalpapers_4": 7.0, "totalpapers_5": 7.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 4.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.8226275477, "pagerank_1": 1.8096520762, "pagerank_2": 1.7921907165, "pagerank_3": 1.7667877315, "pagerank_4": 1.7631912041, "pagerank_5": 1.7488677717}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["Thomas F.Stocker"], "affiliation": "Intergovernmental Panel on Climate Change", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 15.0, "hindex_1": 16.0, "hindex_2": 16.0, "hindex_3": 17.0, "hindex_4": 17.0, "hindex_5": 17.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 12.821, "citationsperpaper_1": 14.103, "citationsperpaper_2": 14.833, "citationsperpaper_3": 15.295, "citationsperpaper_4": 15.717, "citationsperpaper_5": 16.574, "citationsperyear_0": 25.0, "citationsperyear_1": 26.19, "citationsperyear_2": 28.318, "citationsperyear_3": 29.261, "citationsperyear_4": 30.125, "citationsperyear_5": 31.16, "totalcitations_0": 500.0, "totalcitations_1": 550.0, "totalcitations_2": 623.0, "totalcitations_3": 673.0, "totalcitations_4": 723.0, "totalcitations_5": 779.0, "totalpapers_0": 39.0, "totalpapers_1": 39.0, "totalpapers_2": 42.0, "totalpapers_3": 44.0, "totalpapers_4": 46.0, "totalpapers_5": 47.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 149.0, "recentcoauthors_4": 146.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 8.9267706529, "pagerank_1": 8.8590390783, "pagerank_2": 9.0961249319, "pagerank_3": 9.4523146048, "pagerank_4": 9.6728425922, "pagerank_5": 9.4374037328}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["Thomas F.Stocker"], "affiliation": "University of Bern", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 15.0, "hindex_1": 16.0, "hindex_2": 16.0, "hindex_3": 17.0, "hindex_4": 17.0, "hindex_5": 17.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 12.821, "citationsperpaper_1": 14.103, "citationsperpaper_2": 14.833, "citationsperpaper_3": 15.295, "citationsperpaper_4": 15.717, "citationsperpaper_5": 16.574, "citationsperyear_0": 25.0, "citationsperyear_1": 26.19, "citationsperyear_2": 28.318, "citationsperyear_3": 29.261, "citationsperyear_4": 30.125, "citationsperyear_5": 31.16, "totalcitations_0": 500.0, "totalcitations_1": 550.0, "totalcitations_2": 623.0, "totalcitations_3": 673.0, "totalcitations_4": 723.0, "totalcitations_5": 779.0, "totalpapers_0": 39.0, "totalpapers_1": 39.0, "totalpapers_2": 42.0, "totalpapers_3": 44.0, "totalpapers_4": 46.0, "totalpapers_5": 47.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 149.0, "recentcoauthors_4": 146.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 8.9267706529, "pagerank_1": 8.8590390783, "pagerank_2": 9.0961249319, "pagerank_3": 9.4523146048, "pagerank_4": 9.6728425922, "pagerank_5": 9.4374037328}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["Thomas F.Stocker"], "affiliation": "McGill University", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 15.0, "hindex_1": 16.0, "hindex_2": 16.0, "hindex_3": 17.0, "hindex_4": 17.0, "hindex_5": 17.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 12.821, "citationsperpaper_1": 14.103, "citationsperpaper_2": 14.833, "citationsperpaper_3": 15.295, "citationsperpaper_4": 15.717, "citationsperpaper_5": 16.574, "citationsperyear_0": 25.0, "citationsperyear_1": 26.19, "citationsperyear_2": 28.318, "citationsperyear_3": 29.261, "citationsperyear_4": 30.125, "citationsperyear_5": 31.16, "totalcitations_0": 500.0, "totalcitations_1": 550.0, "totalcitations_2": 623.0, "totalcitations_3": 673.0, "totalcitations_4": 723.0, "totalcitations_5": 779.0, "totalpapers_0": 39.0, "totalpapers_1": 39.0, "totalpapers_2": 42.0, "totalpapers_3": 44.0, "totalpapers_4": 46.0, "totalpapers_5": 47.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 12.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 149.0, "recentcoauthors_4": 146.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 8.9267706529, "pagerank_1": 8.8590390783, "pagerank_2": 9.0961249319, "pagerank_3": 9.4523146048, "pagerank_4": 9.6728425922, "pagerank_5": 9.4374037328}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["MikeHulme"], "affiliation": "University of East Anglia", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.538, "citationsperpaper_1": 1.176, "citationsperpaper_2": 1.167, "citationsperpaper_3": 1.105, "citationsperpaper_4": 1.211, "citationsperpaper_5": 1.368, "citationsperyear_0": 0.769, "citationsperyear_1": 0.741, "citationsperyear_2": 0.75, "citationsperyear_3": 0.724, "citationsperyear_4": 0.767, "citationsperyear_5": 0.839, "totalcitations_0": 20.0, "totalcitations_1": 20.0, "totalcitations_2": 21.0, "totalcitations_3": 21.0, "totalcitations_4": 23.0, "totalcitations_5": 26.0, "totalpapers_0": 13.0, "totalpapers_1": 17.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 19.0, "totalpapers_5": 19.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 14.0, "recentcoauthors_1": 34.0, "recentcoauthors_2": 34.0, "recentcoauthors_3": 5.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 2.8956636692, "pagerank_1": 3.9731799212, "pagerank_2": 4.3239660455, "pagerank_3": 3.9063009795, "pagerank_4": 3.8205744895, "pagerank_5": 3.7418466017}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["MikeHulme"], "affiliation": "King's College London", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.538, "citationsperpaper_1": 1.176, "citationsperpaper_2": 1.167, "citationsperpaper_3": 1.105, "citationsperpaper_4": 1.211, "citationsperpaper_5": 1.368, "citationsperyear_0": 0.769, "citationsperyear_1": 0.741, "citationsperyear_2": 0.75, "citationsperyear_3": 0.724, "citationsperyear_4": 0.767, "citationsperyear_5": 0.839, "totalcitations_0": 20.0, "totalcitations_1": 20.0, "totalcitations_2": 21.0, "totalcitations_3": 21.0, "totalcitations_4": 23.0, "totalcitations_5": 26.0, "totalpapers_0": 13.0, "totalpapers_1": 17.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 19.0, "totalpapers_5": 19.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 14.0, "recentcoauthors_1": 34.0, "recentcoauthors_2": 34.0, "recentcoauthors_3": 5.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 2.8956636692, "pagerank_1": 3.9731799212, "pagerank_2": 4.3239660455, "pagerank_3": 3.9063009795, "pagerank_4": 3.8205744895, "pagerank_5": 3.7418466017}}, {"model": "papers.paper", "pk": 1003922, "fields": {"authors": ["MikeHulme"], "affiliation": "University of Salford", "venue": "Nature", "doi": "10.1038/463730a", "abstract": "As calls for reform intensify following recent furores about e-mails, conflicts of interest, glaciers and extreme weather, five climatologists propose ways forward for the Intergovernmental Panel on Climate Change. Their suggestions range from reaffirming the panel' governing principles to increasing the number and speed of its publications to replacing the volunteer organization with a permanently staffed structure.", "year": 2010, "title": "IPCC: cherish it, tweak it or scrap it?", "keywords": ["Political science", "Volunteer Organization", "Extreme weather", "Environmental resource management", "Climate change", "Scrap"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 1.8306826313, "timescaledpagerank_2": 1.2157764224, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 1.2709603724, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.538, "citationsperpaper_1": 1.176, "citationsperpaper_2": 1.167, "citationsperpaper_3": 1.105, "citationsperpaper_4": 1.211, "citationsperpaper_5": 1.368, "citationsperyear_0": 0.769, "citationsperyear_1": 0.741, "citationsperyear_2": 0.75, "citationsperyear_3": 0.724, "citationsperyear_4": 0.767, "citationsperyear_5": 0.839, "totalcitations_0": 20.0, "totalcitations_1": 20.0, "totalcitations_2": 21.0, "totalcitations_3": 21.0, "totalcitations_4": 23.0, "totalcitations_5": 26.0, "totalpapers_0": 13.0, "totalpapers_1": 17.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 19.0, "totalpapers_5": 19.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 14.0, "recentcoauthors_1": 34.0, "recentcoauthors_2": 34.0, "recentcoauthors_3": 5.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 2.8956636692, "pagerank_1": 3.9731799212, "pagerank_2": 4.3239660455, "pagerank_3": 3.9063009795, "pagerank_4": 3.8205744895, "pagerank_5": 3.7418466017}}, {"model": "papers.paper", "pk": 1003273, "fields": {"authors": ["Stephen J.Del Grosso"], "affiliation": "United States Department of Agriculture", "venue": "Nature", "doi": "10.1038/464843a", "abstract": "Most emissions of nitrous oxide from semi-arid, temperate grasslands usually occur during the spring thaw. The effects that grazing has on plant litter and snow cover dramatically reduce these seasonal emissions.", "year": 2010, "title": "Climate change: Grazing and nitrous oxide", "keywords": ["Grassland", "Agriculture", "Atmospheric sciences", "Steppe", "Grazing", "Climate change", "Temperate grassland", "Plant litter", "Nitrous oxide", "Ecology", "Environmental science", "Livestock grazing", "Agronomy", "Greenhouse gas", "Snow cover"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Ho-kwangMao"], "affiliation": "Argonne National Laboratory", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.559, "citationsperpaper_1": 5.531, "citationsperpaper_2": 5.571, "citationsperpaper_3": 5.685, "citationsperpaper_4": 5.83, "citationsperpaper_5": 5.904, "citationsperyear_0": 12.31, "citationsperyear_1": 12.605, "citationsperyear_2": 13.295, "citationsperyear_3": 13.644, "citationsperyear_4": 14.196, "citationsperyear_5": 14.319, "totalcitations_0": 517.0, "totalcitations_1": 542.0, "totalcitations_2": 585.0, "totalcitations_3": 614.0, "totalcitations_4": 653.0, "totalcitations_5": 673.0, "totalpapers_0": 93.0, "totalpapers_1": 98.0, "totalpapers_2": 105.0, "totalpapers_3": 108.0, "totalpapers_4": 112.0, "totalpapers_5": 114.0, "authorage_0": 41.0, "authorage_1": 42.0, "authorage_2": 43.0, "authorage_3": 44.0, "authorage_4": 45.0, "authorage_5": 46.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 101.0, "recentcoauthors_2": 96.0, "recentcoauthors_3": 72.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 45.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 184.8, "venuehindexmean_1": 170.5, "venuehindexmean_2": 176.1666666667, "venuehindexmean_3": 181.0, "venuehindexmean_4": 186.0, "venuehindexmean_5": 190.5, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 23.834956274, "pagerank_1": 24.8341637036, "pagerank_2": 26.5897891265, "pagerank_3": 26.6515682728, "pagerank_4": 27.3498239758, "pagerank_5": 27.6035207717}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Ho-kwangMao"], "affiliation": "Jilin University", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.559, "citationsperpaper_1": 5.531, "citationsperpaper_2": 5.571, "citationsperpaper_3": 5.685, "citationsperpaper_4": 5.83, "citationsperpaper_5": 5.904, "citationsperyear_0": 12.31, "citationsperyear_1": 12.605, "citationsperyear_2": 13.295, "citationsperyear_3": 13.644, "citationsperyear_4": 14.196, "citationsperyear_5": 14.319, "totalcitations_0": 517.0, "totalcitations_1": 542.0, "totalcitations_2": 585.0, "totalcitations_3": 614.0, "totalcitations_4": 653.0, "totalcitations_5": 673.0, "totalpapers_0": 93.0, "totalpapers_1": 98.0, "totalpapers_2": 105.0, "totalpapers_3": 108.0, "totalpapers_4": 112.0, "totalpapers_5": 114.0, "authorage_0": 41.0, "authorage_1": 42.0, "authorage_2": 43.0, "authorage_3": 44.0, "authorage_4": 45.0, "authorage_5": 46.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 101.0, "recentcoauthors_2": 96.0, "recentcoauthors_3": 72.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 45.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 184.8, "venuehindexmean_1": 170.5, "venuehindexmean_2": 176.1666666667, "venuehindexmean_3": 181.0, "venuehindexmean_4": 186.0, "venuehindexmean_5": 190.5, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 23.834956274, "pagerank_1": 24.8341637036, "pagerank_2": 26.5897891265, "pagerank_3": 26.6515682728, "pagerank_4": 27.3498239758, "pagerank_5": 27.6035207717}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Ho-kwangMao"], "affiliation": "Zhejiang University", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.559, "citationsperpaper_1": 5.531, "citationsperpaper_2": 5.571, "citationsperpaper_3": 5.685, "citationsperpaper_4": 5.83, "citationsperpaper_5": 5.904, "citationsperyear_0": 12.31, "citationsperyear_1": 12.605, "citationsperyear_2": 13.295, "citationsperyear_3": 13.644, "citationsperyear_4": 14.196, "citationsperyear_5": 14.319, "totalcitations_0": 517.0, "totalcitations_1": 542.0, "totalcitations_2": 585.0, "totalcitations_3": 614.0, "totalcitations_4": 653.0, "totalcitations_5": 673.0, "totalpapers_0": 93.0, "totalpapers_1": 98.0, "totalpapers_2": 105.0, "totalpapers_3": 108.0, "totalpapers_4": 112.0, "totalpapers_5": 114.0, "authorage_0": 41.0, "authorage_1": 42.0, "authorage_2": 43.0, "authorage_3": 44.0, "authorage_4": 45.0, "authorage_5": 46.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 101.0, "recentcoauthors_2": 96.0, "recentcoauthors_3": 72.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 45.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 184.8, "venuehindexmean_1": 170.5, "venuehindexmean_2": 176.1666666667, "venuehindexmean_3": 181.0, "venuehindexmean_4": 186.0, "venuehindexmean_5": 190.5, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 23.834956274, "pagerank_1": 24.8341637036, "pagerank_2": 26.5897891265, "pagerank_3": 26.6515682728, "pagerank_4": 27.3498239758, "pagerank_5": 27.6035207717}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Ho-kwangMao"], "affiliation": "University of Chicago", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.559, "citationsperpaper_1": 5.531, "citationsperpaper_2": 5.571, "citationsperpaper_3": 5.685, "citationsperpaper_4": 5.83, "citationsperpaper_5": 5.904, "citationsperyear_0": 12.31, "citationsperyear_1": 12.605, "citationsperyear_2": 13.295, "citationsperyear_3": 13.644, "citationsperyear_4": 14.196, "citationsperyear_5": 14.319, "totalcitations_0": 517.0, "totalcitations_1": 542.0, "totalcitations_2": 585.0, "totalcitations_3": 614.0, "totalcitations_4": 653.0, "totalcitations_5": 673.0, "totalpapers_0": 93.0, "totalpapers_1": 98.0, "totalpapers_2": 105.0, "totalpapers_3": 108.0, "totalpapers_4": 112.0, "totalpapers_5": 114.0, "authorage_0": 41.0, "authorage_1": 42.0, "authorage_2": 43.0, "authorage_3": 44.0, "authorage_4": 45.0, "authorage_5": 46.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 101.0, "recentcoauthors_2": 96.0, "recentcoauthors_3": 72.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 45.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 184.8, "venuehindexmean_1": 170.5, "venuehindexmean_2": 176.1666666667, "venuehindexmean_3": 181.0, "venuehindexmean_4": 186.0, "venuehindexmean_5": 190.5, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 23.834956274, "pagerank_1": 24.8341637036, "pagerank_2": 26.5897891265, "pagerank_3": 26.6515682728, "pagerank_4": 27.3498239758, "pagerank_5": 27.6035207717}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Viktor V.Struzhkin", "Xiao-JiaChen", "Russell J.Hemley", "Ho-kwangMao", "YongYu", "Alexander F.Goncharov"], "affiliation": "Carnegie Institution for Science", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 6.1666666667, "hindex_1": 6.3333333333, "hindex_2": 6.8333333333, "hindex_3": 7.1666666667, "hindex_4": 7.3333333333, "hindex_5": 7.6666666667, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 4.7313333333, "citationsperpaper_1": 4.7885, "citationsperpaper_2": 5.4968333333, "citationsperpaper_3": 5.5103333333, "citationsperpaper_4": 5.8093333333, "citationsperpaper_5": 5.8576666667, "citationsperyear_0": 7.4591666667, "citationsperyear_1": 7.531, "citationsperyear_2": 7.9778333333, "citationsperyear_3": 8.051, "citationsperyear_4": 8.214, "citationsperyear_5": 8.2076666667, "totalcitations_0": 194.3333333333, "totalcitations_1": 204.8333333333, "totalcitations_2": 221.8333333333, "totalcitations_3": 233.3333333333, "totalcitations_4": 247.8333333333, "totalcitations_5": 256.8333333333, "totalpapers_0": 33.3333333333, "totalpapers_1": 34.6666666667, "totalpapers_2": 36.1666666667, "totalpapers_3": 37.5, "totalpapers_4": 38.3333333333, "totalpapers_5": 39.0, "authorage_0": 16.5, "authorage_1": 17.5, "authorage_2": 18.5, "authorage_3": 19.5, "authorage_4": 20.5, "authorage_5": 21.5, "recentcoauthors_0": 29.1666666667, "recentcoauthors_1": 26.1666666667, "recentcoauthors_2": 22.1666666667, "recentcoauthors_3": 22.5, "recentcoauthors_4": 14.5, "recentcoauthors_5": 9.8333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 199.4055555556, "venuehindexmean_1": 200.2944444444, "venuehindexmean_2": 205.5111111111, "venuehindexmean_3": 210.4611111111, "venuehindexmean_4": 215.1055555556, "venuehindexmean_5": 219.1416666667, "totalvenues_0": 3.3333333333, "totalvenues_1": 3.5, "totalvenues_2": 3.5, "totalvenues_3": 3.5, "totalvenues_4": 3.5, "totalvenues_5": 3.5, "pagerank_0": 8.5869672591, "pagerank_1": 8.6844555346, "pagerank_2": 8.998729501, "pagerank_3": 9.1385225789, "pagerank_4": 9.1839790142, "pagerank_5": 9.2259183598}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Alexander F.Goncharov"], "affiliation": "Chinese Academy of Sciences", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.357, "citationsperpaper_1": 6.4, "citationsperpaper_2": 7.133, "citationsperpaper_3": 7.25, "citationsperpaper_4": 7.813, "citationsperpaper_5": 8.0, "citationsperyear_0": 5.933, "citationsperyear_1": 6.0, "citationsperyear_2": 6.294, "citationsperyear_3": 6.444, "citationsperyear_4": 6.579, "citationsperyear_5": 6.8, "totalcitations_0": 89.0, "totalcitations_1": 96.0, "totalcitations_2": 107.0, "totalcitations_3": 116.0, "totalcitations_4": 125.0, "totalcitations_5": 136.0, "totalpapers_0": 14.0, "totalpapers_1": 15.0, "totalpapers_2": 15.0, "totalpapers_3": 16.0, "totalpapers_4": 16.0, "totalpapers_5": 17.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 14.0, "recentcoauthors_1": 10.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 9.0, "recentcoauthors_4": 9.0, "recentcoauthors_5": 4.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 168.5, "venuehindexmean_1": 173.0, "venuehindexmean_2": 178.5, "venuehindexmean_3": 183.5, "venuehindexmean_4": 188.5, "venuehindexmean_5": 192.75, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.6994848612, "pagerank_1": 3.6951739644, "pagerank_2": 3.5839664391, "pagerank_3": 3.8603516316, "pagerank_4": 3.7990836201, "pagerank_5": 3.9431117066}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Russell J.Hemley"], "affiliation": "\u00c9cole normale sup\u00e9rieure de Lyon", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 11.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.722, "citationsperpaper_1": 5.918, "citationsperpaper_2": 6.23, "citationsperpaper_3": 6.316, "citationsperpaper_4": 6.571, "citationsperpaper_5": 6.792, "citationsperyear_0": 15.846, "citationsperyear_1": 16.0, "citationsperyear_2": 16.464, "citationsperyear_3": 16.552, "citationsperyear_4": 16.867, "citationsperyear_5": 16.871, "totalcitations_0": 412.0, "totalcitations_1": 432.0, "totalcitations_2": 461.0, "totalcitations_3": 480.0, "totalcitations_4": 506.0, "totalcitations_5": 523.0, "totalpapers_0": 72.0, "totalpapers_1": 73.0, "totalpapers_2": 74.0, "totalpapers_3": 76.0, "totalpapers_4": 77.0, "totalpapers_5": 77.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 36.0, "recentcoauthors_1": 24.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 19.0, "recentcoauthors_4": 15.0, "recentcoauthors_5": 3.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 148.8, "venuehindexmean_1": 153.6, "venuehindexmean_2": 159.4, "venuehindexmean_3": 164.6, "venuehindexmean_4": 169.8, "venuehindexmean_5": 174.6, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 17.0417724056, "pagerank_1": 16.6878785793, "pagerank_2": 16.4774926006, "pagerank_3": 16.365124141, "pagerank_4": 16.1545541211, "pagerank_5": 15.8694501842}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["Xiao-JiaChen"], "affiliation": "South China University of Technology", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.4, "citationsperpaper_3": 2.6, "citationsperpaper_4": 2.8, "citationsperpaper_5": 2.8, "citationsperyear_0": 1.333, "citationsperyear_1": 1.143, "citationsperyear_2": 1.5, "citationsperyear_3": 1.444, "citationsperyear_4": 1.4, "citationsperyear_5": 1.273, "totalcitations_0": 8.0, "totalcitations_1": 8.0, "totalcitations_2": 12.0, "totalcitations_3": 13.0, "totalcitations_4": 14.0, "totalcitations_5": 14.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 5.0, "totalpapers_4": 5.0, "totalpapers_5": 5.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 6.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 18.0, "recentcoauthors_3": 18.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.453042777, "pagerank_1": 1.3998458025, "pagerank_2": 1.9998281578, "pagerank_3": 1.9422116699, "pagerank_4": 1.9056536265, "pagerank_5": 1.8629064172}}, {"model": "papers.paper", "pk": 1003136, "fields": {"authors": ["C. T.Lin"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature09293", "abstract": "Superconductivity often occurs in competition with other types of electronic order, such as antiferromagnetism. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Xiao-Jia Chen et al. have now identified a related effect in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. This points to a way of making higher transition temperatures through the suppression of the antiferromagnetic phase in the inner CuO2 plane, and the optimization of two competing energy scales (pairing and phase ordering) of different CuO2 planes. The superconducting phase of a superconductor is often one of several competing types of electronic order, including antiferromagnetism and charge density waves. For some superconductors, the superconducting transition temperature can be maximized by forcing the critical temperature of the competing order down to zero. Now, a related effect has been identified in a high-temperature superconductor, with the application of pressure yielding a striking two-step increase in the transition temperature. Finding ways to achieve higher values of the transition temperature, Tc, in superconductors remains a great challenge. The superconducting phase is often one of several competing types of electronic order, including antiferromagnetism and charge density waves1,2,3,4,5. An emerging trend documented in heavy-fermion1 and organic2 conductors is that the maximum Tc for superconductivity occurs under external conditions that cause the critical temperature for a competing order to go to zero. Recently, such competition has been found in multilayer copper oxide high-temperature superconductors (HTSCs3,4,5) that possess two crystallographically inequivalent CuO2 planes in the unit cell. However, whether the competing electronic state can be suppressed to enhance Tc in HTSCs remains an open question. Here we show that pressure-driven phase competition leads to an unusual two-step enhancement of Tc in optimally doped trilayer Bi2Sr2Ca2Cu3O10+\u03b4 (Bi2223). We find that Tc first increases with pressure and then decreases after passing through a maximum. Unexpectedly, Tc increases again when the pressure is further raised above a critical value of around 24\u2009GPa, surpassing the first maximum. The presence of this critical pressure is a manifestation of the crossover from the competing order to superconductivity in the inner of the three CuO2 planes. We suggest that the increase at higher pressures occurs as a result of competition between pairing and phase ordering in different CuO2 planes.", "year": 2010, "title": "Enhancement of superconductivity by pressure-driven competition in electronic order", "keywords": ["Pairing", "Critical value", "Superconductivity", "Transition temperature", "Charge density", "Condensed matter physics", "Chemistry", "Antiferromagnetism", "Critical point (thermodynamics)", "Phonon"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.1542255612, "timescaledpagerank_3": 0.0423813297, "timescaledpagerank_4": 0.0205599154, "timescaledpagerank_5": 0.0738838781, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 23.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.667, "citationsperpaper_2": 3.667, "citationsperpaper_3": 4.0, "citationsperpaper_4": 3.571, "citationsperpaper_5": 4.286, "citationsperyear_0": 1.5, "citationsperyear_1": 1.778, "citationsperyear_2": 2.2, "citationsperyear_3": 2.182, "citationsperyear_4": 2.083, "citationsperyear_5": 2.308, "totalcitations_0": 12.0, "totalcitations_1": 16.0, "totalcitations_2": 22.0, "totalcitations_3": 24.0, "totalcitations_4": 25.0, "totalcitations_5": 30.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 7.0, "totalpapers_5": 7.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 22.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 3.0372586506, "pagerank_1": 2.8820252134, "pagerank_2": 2.8161149867, "pagerank_3": 2.7532874544, "pagerank_4": 3.1817600473, "pagerank_5": 3.1379756878}}, {"model": "papers.paper", "pk": 1004150, "fields": {"authors": ["MingWu", "Jos\u00e9 CarlosPastor-Pareja", "TianXu"], "affiliation": "Yale University", "venue": "Nature", "doi": "10.1038/nature08702", "abstract": "In a genetically well-defined model system in Drosophila, Tian Xu and colleagues show that cell clones carrying distinct oncogenic mutations can cooperate to produce invasive tumours. This cooperation involves JNK and JAK/STAT signalling pathways. Similar cooperative mechanism might be at play in the communication between genetically heterogeneous human cancer cells or between tumour cells and their microenvironment.", "year": 2010, "title": "Interaction between Ras V12 and scribbled clones induces tumour growth and invasion", "keywords": ["Cell signaling", "Janus kinase", "Signal transduction", "Cell", "Genetics", "Biology", "Tumor suppressor gene", "Carcinogenesis", "Cell cycle", "Cancer research", "stat"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 7.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 9.0, "timescaledpagerank_0": 0.0582606736, "timescaledpagerank_1": 0.1213613388, "timescaledpagerank_2": 0.2605514939, "timescaledpagerank_3": 0.2884989608, "timescaledpagerank_4": 0.3242794171, "timescaledpagerank_5": 0.6272346944, "hindex_0": 5.3333333333, "hindex_1": 5.6666666667, "hindex_2": 6.0, "hindex_3": 6.6666666667, "hindex_4": 7.0, "hindex_5": 7.3333333333, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 46.0, "adopters_3": 15.0, "adopters_4": 10.0, "adopters_5": 0.0, "citationsperpaper_0": 14.4146666667, "citationsperpaper_1": 14.3396666667, "citationsperpaper_2": 17.5953333333, "citationsperpaper_3": 19.454, "citationsperpaper_4": 20.6333333333, "citationsperpaper_5": 25.07, "citationsperyear_0": 12.3136666667, "citationsperyear_1": 12.3396666667, "citationsperyear_2": 13.3453333333, "citationsperyear_3": 13.716, "citationsperyear_4": 13.8443333333, "citationsperyear_5": 14.556, "totalcitations_0": 291.6666666667, "totalcitations_1": 312.3333333333, "totalcitations_2": 333.6666666667, "totalcitations_3": 356.3333333333, "totalcitations_4": 375.3333333333, "totalcitations_5": 398.6666666667, "totalpapers_0": 10.0, "totalpapers_1": 10.6666666667, "totalpapers_2": 11.0, "totalpapers_3": 11.3333333333, "totalpapers_4": 11.6666666667, "totalpapers_5": 12.0, "authorage_0": 11.6666666667, "authorage_1": 12.6666666667, "authorage_2": 13.6666666667, "authorage_3": 14.6666666667, "authorage_4": 15.6666666667, "authorage_5": 16.6666666667, "recentcoauthors_0": 14.6666666667, "recentcoauthors_1": 9.3333333333, "recentcoauthors_2": 9.0, "recentcoauthors_3": 4.6666666667, "recentcoauthors_4": 14.3333333333, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 208.0303030303, "venuehindexmean_1": 207.75, "venuehindexmean_2": 211.9444444444, "venuehindexmean_3": 216.2777777778, "venuehindexmean_4": 220.0833333333, "venuehindexmean_5": 223.25, "totalvenues_0": 4.6666666667, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.4961274921, "pagerank_1": 2.4857172352, "pagerank_2": 2.5845432049, "pagerank_3": 2.5230611381, "pagerank_4": 2.5566207077, "pagerank_5": 2.6215185812}}, {"model": "papers.paper", "pk": 1004150, "fields": {"authors": ["Jos\u00e9 CarlosPastor-Pareja"], "affiliation": "Tsinghua University", "venue": "Nature", "doi": "10.1038/nature08702", "abstract": "In a genetically well-defined model system in Drosophila, Tian Xu and colleagues show that cell clones carrying distinct oncogenic mutations can cooperate to produce invasive tumours. This cooperation involves JNK and JAK/STAT signalling pathways. Similar cooperative mechanism might be at play in the communication between genetically heterogeneous human cancer cells or between tumour cells and their microenvironment.", "year": 2010, "title": "Interaction between Ras V12 and scribbled clones induces tumour growth and invasion", "keywords": ["Cell signaling", "Janus kinase", "Signal transduction", "Cell", "Genetics", "Biology", "Tumor suppressor gene", "Carcinogenesis", "Cell cycle", "Cancer research", "stat"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 7.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 9.0, "timescaledpagerank_0": 0.0582606736, "timescaledpagerank_1": 0.1213613388, "timescaledpagerank_2": 0.2605514939, "timescaledpagerank_3": 0.2884989608, "timescaledpagerank_4": 0.3242794171, "timescaledpagerank_5": 0.6272346944, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 46.0, "adopters_3": 15.0, "adopters_4": 10.0, "adopters_5": 0.0, "citationsperpaper_0": 8.667, "citationsperpaper_1": 7.5, "citationsperpaper_2": 9.75, "citationsperpaper_3": 11.5, "citationsperpaper_4": 12.5, "citationsperpaper_5": 16.5, "citationsperyear_0": 2.364, "citationsperyear_1": 2.5, "citationsperyear_2": 3.0, "citationsperyear_3": 3.286, "citationsperyear_4": 3.333, "citationsperyear_5": 4.125, "totalcitations_0": 26.0, "totalcitations_1": 30.0, "totalcitations_2": 39.0, "totalcitations_3": 46.0, "totalcitations_4": 50.0, "totalcitations_5": 66.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 18.0, "recentcoauthors_2": 16.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 217.0, "venuehindexmean_2": 221.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 232.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.7006501229, "pagerank_1": 1.0870272729, "pagerank_2": 1.0570032491, "pagerank_3": 1.0286068242, "pagerank_4": 0.9758102539, "pagerank_5": 0.9280343944}}, {"model": "papers.paper", "pk": 1004150, "fields": {"authors": ["TianXu"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08702", "abstract": "In a genetically well-defined model system in Drosophila, Tian Xu and colleagues show that cell clones carrying distinct oncogenic mutations can cooperate to produce invasive tumours. This cooperation involves JNK and JAK/STAT signalling pathways. Similar cooperative mechanism might be at play in the communication between genetically heterogeneous human cancer cells or between tumour cells and their microenvironment.", "year": 2010, "title": "Interaction between Ras V12 and scribbled clones induces tumour growth and invasion", "keywords": ["Cell signaling", "Janus kinase", "Signal transduction", "Cell", "Genetics", "Biology", "Tumor suppressor gene", "Carcinogenesis", "Cell cycle", "Cancer research", "stat"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 7.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 9.0, "timescaledpagerank_0": 0.0582606736, "timescaledpagerank_1": 0.1213613388, "timescaledpagerank_2": 0.2605514939, "timescaledpagerank_3": 0.2884989608, "timescaledpagerank_4": 0.3242794171, "timescaledpagerank_5": 0.6272346944, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 17.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 46.0, "adopters_3": 15.0, "adopters_4": 10.0, "adopters_5": 0.0, "citationsperpaper_0": 32.577, "citationsperpaper_1": 33.519, "citationsperpaper_2": 34.036, "citationsperpaper_3": 34.862, "citationsperpaper_4": 35.4, "citationsperpaper_5": 35.71, "citationsperyear_0": 32.577, "citationsperyear_1": 33.519, "citationsperyear_2": 34.036, "citationsperyear_3": 34.862, "citationsperyear_4": 35.4, "citationsperyear_5": 35.71, "totalcitations_0": 847.0, "totalcitations_1": 905.0, "totalcitations_2": 953.0, "totalcitations_3": 1011.0, "totalcitations_4": 1062.0, "totalcitations_5": 1107.0, "totalpapers_0": 26.0, "totalpapers_1": 27.0, "totalpapers_2": 28.0, "totalpapers_3": 29.0, "totalpapers_4": 30.0, "totalpapers_5": 31.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 40.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 14.0, "recentcoauthors_4": 43.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 150.0909090909, "venuehindexmean_1": 142.25, "venuehindexmean_2": 145.8333333333, "venuehindexmean_3": 148.8333333333, "venuehindexmean_4": 151.25, "venuehindexmean_5": 153.75, "totalvenues_0": 11.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 6.5204392737, "pagerank_1": 6.1415632965, "pagerank_2": 6.4700073345, "pagerank_3": 6.3169542057, "pagerank_4": 6.4795543915, "pagerank_5": 6.7280745927}}, {"model": "papers.paper", "pk": 1004150, "fields": {"authors": ["TianXu"], "affiliation": "Fudan University", "venue": "Nature", "doi": "10.1038/nature08702", "abstract": "In a genetically well-defined model system in Drosophila, Tian Xu and colleagues show that cell clones carrying distinct oncogenic mutations can cooperate to produce invasive tumours. This cooperation involves JNK and JAK/STAT signalling pathways. Similar cooperative mechanism might be at play in the communication between genetically heterogeneous human cancer cells or between tumour cells and their microenvironment.", "year": 2010, "title": "Interaction between Ras V12 and scribbled clones induces tumour growth and invasion", "keywords": ["Cell signaling", "Janus kinase", "Signal transduction", "Cell", "Genetics", "Biology", "Tumor suppressor gene", "Carcinogenesis", "Cell cycle", "Cancer research", "stat"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 7.0, "citations_3": 3.0, "citations_4": 2.0, "citations_5": 9.0, "timescaledpagerank_0": 0.0582606736, "timescaledpagerank_1": 0.1213613388, "timescaledpagerank_2": 0.2605514939, "timescaledpagerank_3": 0.2884989608, "timescaledpagerank_4": 0.3242794171, "timescaledpagerank_5": 0.6272346944, "hindex_0": 13.0, "hindex_1": 14.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 17.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 46.0, "adopters_3": 15.0, "adopters_4": 10.0, "adopters_5": 0.0, "citationsperpaper_0": 32.577, "citationsperpaper_1": 33.519, "citationsperpaper_2": 34.036, "citationsperpaper_3": 34.862, "citationsperpaper_4": 35.4, "citationsperpaper_5": 35.71, "citationsperyear_0": 32.577, "citationsperyear_1": 33.519, "citationsperyear_2": 34.036, "citationsperyear_3": 34.862, "citationsperyear_4": 35.4, "citationsperyear_5": 35.71, "totalcitations_0": 847.0, "totalcitations_1": 905.0, "totalcitations_2": 953.0, "totalcitations_3": 1011.0, "totalcitations_4": 1062.0, "totalcitations_5": 1107.0, "totalpapers_0": 26.0, "totalpapers_1": 27.0, "totalpapers_2": 28.0, "totalpapers_3": 29.0, "totalpapers_4": 30.0, "totalpapers_5": 31.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 40.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 14.0, "recentcoauthors_4": 43.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 150.0909090909, "venuehindexmean_1": 142.25, "venuehindexmean_2": 145.8333333333, "venuehindexmean_3": 148.8333333333, "venuehindexmean_4": 151.25, "venuehindexmean_5": 153.75, "totalvenues_0": 11.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 6.5204392737, "pagerank_1": 6.1415632965, "pagerank_2": 6.4700073345, "pagerank_3": 6.3169542057, "pagerank_4": 6.4795543915, "pagerank_5": 6.7280745927}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 16.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 20.0, "hindex_4": 22.0, "hindex_5": 23.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.667, "citationsperpaper_1": 11.474, "citationsperpaper_2": 13.036, "citationsperpaper_3": 14.248, "citationsperpaper_4": 15.275, "citationsperpaper_5": 16.289, "citationsperyear_0": 50.0, "citationsperyear_1": 65.471, "citationsperyear_2": 79.667, "citationsperyear_3": 90.737, "citationsperyear_4": 100.05, "citationsperyear_5": 104.714, "totalcitations_0": 800.0, "totalcitations_1": 1113.0, "totalcitations_2": 1434.0, "totalcitations_3": 1724.0, "totalcitations_4": 2001.0, "totalcitations_5": 2199.0, "totalpapers_0": 75.0, "totalpapers_1": 97.0, "totalpapers_2": 110.0, "totalpapers_3": 121.0, "totalpapers_4": 131.0, "totalpapers_5": 135.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 188.0, "recentcoauthors_2": 169.0, "recentcoauthors_3": 105.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 169.2, "venuehindexmean_2": 175.4, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.1928371158, "pagerank_1": 18.646897497, "pagerank_2": 21.4179293106, "pagerank_3": 23.4720752489, "pagerank_4": 24.3509200968, "pagerank_5": 24.5953331265}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia"], "affiliation": "Yonsei University", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 16.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 20.0, "hindex_4": 22.0, "hindex_5": 23.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.667, "citationsperpaper_1": 11.474, "citationsperpaper_2": 13.036, "citationsperpaper_3": 14.248, "citationsperpaper_4": 15.275, "citationsperpaper_5": 16.289, "citationsperyear_0": 50.0, "citationsperyear_1": 65.471, "citationsperyear_2": 79.667, "citationsperyear_3": 90.737, "citationsperyear_4": 100.05, "citationsperyear_5": 104.714, "totalcitations_0": 800.0, "totalcitations_1": 1113.0, "totalcitations_2": 1434.0, "totalcitations_3": 1724.0, "totalcitations_4": 2001.0, "totalcitations_5": 2199.0, "totalpapers_0": 75.0, "totalpapers_1": 97.0, "totalpapers_2": 110.0, "totalpapers_3": 121.0, "totalpapers_4": 131.0, "totalpapers_5": 135.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 188.0, "recentcoauthors_2": 169.0, "recentcoauthors_3": 105.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 169.2, "venuehindexmean_2": 175.4, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.1928371158, "pagerank_1": 18.646897497, "pagerank_2": 21.4179293106, "pagerank_3": 23.4720752489, "pagerank_4": 24.3509200968, "pagerank_5": 24.5953331265}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia"], "affiliation": "Emory University", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 16.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 20.0, "hindex_4": 22.0, "hindex_5": 23.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.667, "citationsperpaper_1": 11.474, "citationsperpaper_2": 13.036, "citationsperpaper_3": 14.248, "citationsperpaper_4": 15.275, "citationsperpaper_5": 16.289, "citationsperyear_0": 50.0, "citationsperyear_1": 65.471, "citationsperyear_2": 79.667, "citationsperyear_3": 90.737, "citationsperyear_4": 100.05, "citationsperyear_5": 104.714, "totalcitations_0": 800.0, "totalcitations_1": 1113.0, "totalcitations_2": 1434.0, "totalcitations_3": 1724.0, "totalcitations_4": 2001.0, "totalcitations_5": 2199.0, "totalpapers_0": 75.0, "totalpapers_1": 97.0, "totalpapers_2": 110.0, "totalpapers_3": 121.0, "totalpapers_4": 131.0, "totalpapers_5": 135.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 188.0, "recentcoauthors_2": 169.0, "recentcoauthors_3": 105.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 169.2, "venuehindexmean_2": 175.4, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.1928371158, "pagerank_1": 18.646897497, "pagerank_2": 21.4179293106, "pagerank_3": 23.4720752489, "pagerank_4": 24.3509200968, "pagerank_5": 24.5953331265}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia"], "affiliation": "The Wallace H. Coulter Department of Biomedical Engineering", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 16.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 20.0, "hindex_4": 22.0, "hindex_5": 23.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.667, "citationsperpaper_1": 11.474, "citationsperpaper_2": 13.036, "citationsperpaper_3": 14.248, "citationsperpaper_4": 15.275, "citationsperpaper_5": 16.289, "citationsperyear_0": 50.0, "citationsperyear_1": 65.471, "citationsperyear_2": 79.667, "citationsperyear_3": 90.737, "citationsperyear_4": 100.05, "citationsperyear_5": 104.714, "totalcitations_0": 800.0, "totalcitations_1": 1113.0, "totalcitations_2": 1434.0, "totalcitations_3": 1724.0, "totalcitations_4": 2001.0, "totalcitations_5": 2199.0, "totalpapers_0": 75.0, "totalpapers_1": 97.0, "totalpapers_2": 110.0, "totalpapers_3": 121.0, "totalpapers_4": 131.0, "totalpapers_5": 135.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 188.0, "recentcoauthors_2": 169.0, "recentcoauthors_3": 105.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 169.2, "venuehindexmean_2": 175.4, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.1928371158, "pagerank_1": 18.646897497, "pagerank_2": 21.4179293106, "pagerank_3": 23.4720752489, "pagerank_4": 24.3509200968, "pagerank_5": 24.5953331265}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia"], "affiliation": "Georgia Institute of Technology", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 16.0, "hindex_1": 18.0, "hindex_2": 19.0, "hindex_3": 20.0, "hindex_4": 22.0, "hindex_5": 23.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.667, "citationsperpaper_1": 11.474, "citationsperpaper_2": 13.036, "citationsperpaper_3": 14.248, "citationsperpaper_4": 15.275, "citationsperpaper_5": 16.289, "citationsperyear_0": 50.0, "citationsperyear_1": 65.471, "citationsperyear_2": 79.667, "citationsperyear_3": 90.737, "citationsperyear_4": 100.05, "citationsperyear_5": 104.714, "totalcitations_0": 800.0, "totalcitations_1": 1113.0, "totalcitations_2": 1434.0, "totalcitations_3": 1724.0, "totalcitations_4": 2001.0, "totalcitations_5": 2199.0, "totalpapers_0": 75.0, "totalpapers_1": 97.0, "totalpapers_2": 110.0, "totalpapers_3": 121.0, "totalpapers_4": 131.0, "totalpapers_5": 135.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 188.0, "recentcoauthors_2": 169.0, "recentcoauthors_3": 105.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 54.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 169.2, "venuehindexmean_2": 175.4, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 15.1928371158, "pagerank_1": 18.646897497, "pagerank_2": 21.4179293106, "pagerank_3": 23.4720752489, "pagerank_4": 24.3509200968, "pagerank_5": 24.5953331265}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia", "ByungkwonLim"], "affiliation": "Washington University in St. Louis", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 14.0, "hindex_3": 14.5, "hindex_4": 16.0, "hindex_5": 16.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.9405, "citationsperpaper_1": 16.331, "citationsperpaper_2": 20.8415, "citationsperpaper_3": 23.9295, "citationsperpaper_4": 27.2485, "citationsperpaper_5": 30.1725, "citationsperyear_0": 48.125, "citationsperyear_1": 66.6355, "citationsperyear_2": 80.417, "citationsperyear_3": 88.583, "citationsperyear_4": 94.15, "citationsperyear_5": 96.4125, "totalcitations_0": 492.5, "totalcitations_1": 726.0, "totalcitations_2": 960.5, "totalcitations_3": 1164.5, "totalcitations_4": 1353.5, "totalcitations_5": 1496.0, "totalpapers_0": 44.5, "totalpapers_1": 56.5, "totalpapers_2": 63.5, "totalpapers_3": 69.5, "totalpapers_4": 74.5, "totalpapers_5": 76.5, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 73.5, "recentcoauthors_1": 109.0, "recentcoauthors_2": 90.0, "recentcoauthors_3": 62.0, "recentcoauthors_4": 44.5, "recentcoauthors_5": 27.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 163.5, "venuehindexmean_1": 169.1, "venuehindexmean_2": 175.7, "venuehindexmean_3": 181.975, "venuehindexmean_4": 187.0, "venuehindexmean_5": 192.825, "totalvenues_0": 4.5, "totalvenues_1": 4.5, "totalvenues_2": 4.5, "totalvenues_3": 4.5, "totalvenues_4": 4.5, "totalvenues_5": 4.5, "pagerank_0": 8.9285444375, "pagerank_1": 10.6000682795, "pagerank_2": 12.1463137199, "pagerank_3": 13.4043401696, "pagerank_4": 13.8090499686, "pagerank_5": 13.8757214635}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["YounanXia", "ByungkwonLim"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 14.0, "hindex_3": 14.5, "hindex_4": 16.0, "hindex_5": 16.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.9405, "citationsperpaper_1": 16.331, "citationsperpaper_2": 20.8415, "citationsperpaper_3": 23.9295, "citationsperpaper_4": 27.2485, "citationsperpaper_5": 30.1725, "citationsperyear_0": 48.125, "citationsperyear_1": 66.6355, "citationsperyear_2": 80.417, "citationsperyear_3": 88.583, "citationsperyear_4": 94.15, "citationsperyear_5": 96.4125, "totalcitations_0": 492.5, "totalcitations_1": 726.0, "totalcitations_2": 960.5, "totalcitations_3": 1164.5, "totalcitations_4": 1353.5, "totalcitations_5": 1496.0, "totalpapers_0": 44.5, "totalpapers_1": 56.5, "totalpapers_2": 63.5, "totalpapers_3": 69.5, "totalpapers_4": 74.5, "totalpapers_5": 76.5, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 73.5, "recentcoauthors_1": 109.0, "recentcoauthors_2": 90.0, "recentcoauthors_3": 62.0, "recentcoauthors_4": 44.5, "recentcoauthors_5": 27.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 163.5, "venuehindexmean_1": 169.1, "venuehindexmean_2": 175.7, "venuehindexmean_3": 181.975, "venuehindexmean_4": 187.0, "venuehindexmean_5": 192.825, "totalvenues_0": 4.5, "totalvenues_1": 4.5, "totalvenues_2": 4.5, "totalvenues_3": 4.5, "totalvenues_4": 4.5, "totalvenues_5": 4.5, "pagerank_0": 8.9285444375, "pagerank_1": 10.6000682795, "pagerank_2": 12.1463137199, "pagerank_3": 13.4043401696, "pagerank_4": 13.8090499686, "pagerank_5": 13.8757214635}}, {"model": "papers.paper", "pk": 1003585, "fields": {"authors": ["ByungkwonLim"], "affiliation": "Sungkyunkwan University", "venue": "Nature", "doi": "10.1038/467923a", "abstract": "The use of templates to control the morphology of nanostructures is a powerful but inflexible technique. A template that is remodelled during synthesis suggests fresh opportunities for fabricating new nanostructures.", "year": 2010, "title": "Nanotechnology: Beyond the confines of templates", "keywords": ["Template", "Materials science", "Nanotechnology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 2.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.2271487508, "timescaledpagerank_3": 0.2676937917, "timescaledpagerank_4": 0.2874560926, "timescaledpagerank_5": 0.2968597784, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 6.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 13.214, "citationsperpaper_1": 21.188, "citationsperpaper_2": 28.647, "citationsperpaper_3": 33.611, "citationsperpaper_4": 39.222, "citationsperpaper_5": 44.056, "citationsperyear_0": 46.25, "citationsperyear_1": 67.8, "citationsperyear_2": 81.167, "citationsperyear_3": 86.429, "citationsperyear_4": 88.25, "citationsperyear_5": 88.111, "totalcitations_0": 185.0, "totalcitations_1": 339.0, "totalcitations_2": 487.0, "totalcitations_3": 605.0, "totalcitations_4": 706.0, "totalcitations_5": 793.0, "totalpapers_0": 14.0, "totalpapers_1": 16.0, "totalpapers_2": 17.0, "totalpapers_3": 18.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 37.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 19.0, "recentcoauthors_4": 13.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 163.0, "venuehindexmean_1": 169.0, "venuehindexmean_2": 176.0, "venuehindexmean_3": 182.75, "venuehindexmean_4": 188.0, "venuehindexmean_5": 194.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.6642517592, "pagerank_1": 2.553239062, "pagerank_2": 2.8746981292, "pagerank_3": 3.3366050904, "pagerank_4": 3.2671798405, "pagerank_5": 3.1561098005}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["Kang L.Wang"], "affiliation": "University of California, Berkeley", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 1.667, "citationsperpaper_1": 1.667, "citationsperpaper_2": 2.4, "citationsperpaper_3": 3.7, "citationsperpaper_4": 5.7, "citationsperpaper_5": 5.5, "citationsperyear_0": 0.435, "citationsperyear_1": 0.625, "citationsperyear_2": 0.96, "citationsperyear_3": 1.423, "citationsperyear_4": 2.111, "citationsperyear_5": 2.357, "totalcitations_0": 10.0, "totalcitations_1": 15.0, "totalcitations_2": 24.0, "totalcitations_3": 37.0, "totalcitations_4": 57.0, "totalcitations_5": 66.0, "totalpapers_0": 6.0, "totalpapers_1": 9.0, "totalpapers_2": 10.0, "totalpapers_3": 10.0, "totalpapers_4": 10.0, "totalpapers_5": 12.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 36.0, "recentcoauthors_1": 60.0, "recentcoauthors_2": 42.0, "recentcoauthors_3": 18.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 165.0, "venuehindexmean_1": 170.0, "venuehindexmean_2": 175.0, "venuehindexmean_3": 179.6666666667, "venuehindexmean_4": 184.3333333333, "venuehindexmean_5": 188.6666666667, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.3925174558, "pagerank_1": 3.1892279884, "pagerank_2": 3.580654422, "pagerank_3": 3.4614976012, "pagerank_4": 3.3864764999, "pagerank_5": 4.1944783865}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["Kang L.Wang"], "affiliation": "King Abdulaziz City for Science and Technology", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 1.667, "citationsperpaper_1": 1.667, "citationsperpaper_2": 2.4, "citationsperpaper_3": 3.7, "citationsperpaper_4": 5.7, "citationsperpaper_5": 5.5, "citationsperyear_0": 0.435, "citationsperyear_1": 0.625, "citationsperyear_2": 0.96, "citationsperyear_3": 1.423, "citationsperyear_4": 2.111, "citationsperyear_5": 2.357, "totalcitations_0": 10.0, "totalcitations_1": 15.0, "totalcitations_2": 24.0, "totalcitations_3": 37.0, "totalcitations_4": 57.0, "totalcitations_5": 66.0, "totalpapers_0": 6.0, "totalpapers_1": 9.0, "totalpapers_2": 10.0, "totalpapers_3": 10.0, "totalpapers_4": 10.0, "totalpapers_5": 12.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 36.0, "recentcoauthors_1": 60.0, "recentcoauthors_2": 42.0, "recentcoauthors_3": 18.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 165.0, "venuehindexmean_1": 170.0, "venuehindexmean_2": 175.0, "venuehindexmean_3": 179.6666666667, "venuehindexmean_4": 184.3333333333, "venuehindexmean_5": 188.6666666667, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.3925174558, "pagerank_1": 3.1892279884, "pagerank_2": 3.580654422, "pagerank_3": 3.4614976012, "pagerank_4": 3.3864764999, "pagerank_5": 4.1944783865}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["MingqiangBao", "LeiLiao", "YuanLiu", "YongquanQu", "Kang L.Wang", "YuHuang", "RuiCheng", "JingweiBai", "Yung-ChenLin", "XiangfengDuan"], "affiliation": "University of California, Los Angeles", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 2.3, "hindex_1": 3.1, "hindex_2": 3.9, "hindex_3": 4.3, "hindex_4": 4.4, "hindex_5": 4.4, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 5.7955, "citationsperpaper_1": 7.2924, "citationsperpaper_2": 7.7479, "citationsperpaper_3": 7.9271, "citationsperpaper_4": 8.6156, "citationsperpaper_5": 8.9686, "citationsperyear_0": 4.9731, "citationsperyear_1": 6.7298, "citationsperyear_2": 8.2576, "citationsperyear_3": 8.17, "citationsperyear_4": 8.0014, "citationsperyear_5": 8.1892, "totalcitations_0": 58.7, "totalcitations_1": 73.2, "totalcitations_2": 89.2, "totalcitations_3": 99.6, "totalcitations_4": 109.1, "totalcitations_5": 121.8, "totalpapers_0": 5.4, "totalpapers_1": 6.7, "totalpapers_2": 9.2, "totalpapers_3": 10.3, "totalpapers_4": 10.5, "totalpapers_5": 11.8, "authorage_0": 6.7, "authorage_1": 7.7, "authorage_2": 8.7, "authorage_3": 9.7, "authorage_4": 10.7, "authorage_5": 11.7, "recentcoauthors_0": 19.7, "recentcoauthors_1": 25.3, "recentcoauthors_2": 30.9, "recentcoauthors_3": 29.6, "recentcoauthors_4": 8.1, "recentcoauthors_5": 13.7, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 191.8166666667, "venuehindexmean_1": 180.5902380952, "venuehindexmean_2": 184.0066666667, "venuehindexmean_3": 189.12, "venuehindexmean_4": 193.7904761905, "venuehindexmean_5": 197.6525, "totalvenues_0": 3.1, "totalvenues_1": 3.6, "totalvenues_2": 3.8, "totalvenues_3": 3.8, "totalvenues_4": 3.8, "totalvenues_5": 3.9, "pagerank_0": 1.8465429809, "pagerank_1": 2.093706558, "pagerank_2": 2.7880171977, "pagerank_3": 2.938005954, "pagerank_4": 2.917278251, "pagerank_5": 3.2628214335}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["XiangfengDuan", "YuHuang"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 8.5, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 19.6025, "citationsperpaper_1": 19.27, "citationsperpaper_2": 15.6125, "citationsperpaper_3": 13.4565, "citationsperpaper_4": 14.261, "citationsperpaper_5": 13.9295, "citationsperyear_0": 15.642, "citationsperyear_1": 16.9865, "citationsperyear_2": 17.893, "citationsperyear_3": 18.7255, "citationsperyear_4": 19.057, "citationsperyear_5": 20.15, "totalcitations_0": 213.5, "totalcitations_1": 248.5, "totalcitations_2": 280.5, "totalcitations_3": 309.5, "totalcitations_4": 334.5, "totalcitations_5": 375.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 18.0, "totalpapers_3": 23.0, "totalpapers_4": 23.5, "totalpapers_5": 27.0, "authorage_0": 13.5, "authorage_1": 14.5, "authorage_2": 15.5, "authorage_3": 16.5, "authorage_4": 17.5, "authorage_5": 18.5, "recentcoauthors_0": 23.0, "recentcoauthors_1": 33.5, "recentcoauthors_2": 54.0, "recentcoauthors_3": 72.0, "recentcoauthors_4": 37.0, "recentcoauthors_5": 40.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 156.85, "venuehindexmean_2": 163.0333333333, "venuehindexmean_3": 168.85, "venuehindexmean_4": 174.0, "venuehindexmean_5": 179.45, "totalvenues_0": 5.0, "totalvenues_1": 5.5, "totalvenues_2": 5.5, "totalvenues_3": 5.5, "totalvenues_4": 5.5, "totalvenues_5": 5.5, "pagerank_0": 3.1463587337, "pagerank_1": 3.5548189285, "pagerank_2": 5.0328630141, "pagerank_3": 6.1065501418, "pagerank_4": 6.2238643344, "pagerank_5": 7.1288344839}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["YuanLiu"], "affiliation": "Emory University", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 8.0, "hindex_4": 8.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 11.0, "citationsperpaper_1": 10.8, "citationsperpaper_2": 9.737, "citationsperpaper_3": 9.85, "citationsperpaper_4": 10.35, "citationsperpaper_5": 9.522, "citationsperyear_0": 9.429, "citationsperyear_1": 10.8, "citationsperyear_2": 11.563, "citationsperyear_3": 11.588, "citationsperyear_4": 11.5, "citationsperyear_5": 11.526, "totalcitations_0": 132.0, "totalcitations_1": 162.0, "totalcitations_2": 185.0, "totalcitations_3": 197.0, "totalcitations_4": 207.0, "totalcitations_5": 219.0, "totalpapers_0": 12.0, "totalpapers_1": 15.0, "totalpapers_2": 19.0, "totalpapers_3": 20.0, "totalpapers_4": 20.0, "totalpapers_5": 23.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 28.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 57.0, "recentcoauthors_3": 44.0, "recentcoauthors_4": 5.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 180.5, "venuehindexmean_1": 171.2857142857, "venuehindexmean_2": 175.0, "venuehindexmean_3": 178.0, "venuehindexmean_4": 180.5714285714, "venuehindexmean_5": 176.625, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 8.0, "pagerank_0": 3.6185229913, "pagerank_1": 4.2178176988, "pagerank_2": 5.0504649922, "pagerank_3": 5.0000961521, "pagerank_4": 4.795052319, "pagerank_5": 5.4167176769}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["XiangfengDuan", "LeiLiao", "YuanLiu"], "affiliation": "Hunan University", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 4.6666666667, "hindex_1": 5.3333333333, "hindex_2": 6.3333333333, "hindex_3": 6.3333333333, "hindex_4": 6.3333333333, "hindex_5": 6.3333333333, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 9.9293333333, "citationsperpaper_1": 10.2723333333, "citationsperpaper_2": 9.429, "citationsperpaper_3": 8.9693333333, "citationsperpaper_4": 9.119, "citationsperpaper_5": 8.967, "citationsperyear_0": 7.4543333333, "citationsperyear_1": 8.6333333333, "citationsperyear_2": 9.6163333333, "citationsperyear_3": 9.6136666667, "citationsperyear_4": 9.6393333333, "citationsperyear_5": 10.12, "totalcitations_0": 124.6666666667, "totalcitations_1": 147.6666666667, "totalcitations_2": 169.3333333333, "totalcitations_3": 179.3333333333, "totalcitations_4": 190.6666666667, "totalcitations_5": 210.3333333333, "totalpapers_0": 9.6666666667, "totalpapers_1": 11.3333333333, "totalpapers_2": 14.6666666667, "totalpapers_3": 16.3333333333, "totalpapers_4": 17.0, "totalpapers_5": 19.3333333333, "authorage_0": 11.3333333333, "authorage_1": 12.3333333333, "authorage_2": 13.3333333333, "authorage_3": 14.3333333333, "authorage_4": 15.3333333333, "authorage_5": 16.3333333333, "recentcoauthors_0": 23.6666666667, "recentcoauthors_1": 26.3333333333, "recentcoauthors_2": 39.3333333333, "recentcoauthors_3": 38.3333333333, "recentcoauthors_4": 13.6666666667, "recentcoauthors_5": 25.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 170.1666666667, "venuehindexmean_1": 170.1619047619, "venuehindexmean_2": 175.1333333333, "venuehindexmean_3": 179.6222222222, "venuehindexmean_4": 183.6349206349, "venuehindexmean_5": 185.5638888889, "totalvenues_0": 4.6666666667, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.3333333333, "pagerank_0": 2.9990008817, "pagerank_1": 3.2564088382, "pagerank_2": 4.0966182144, "pagerank_3": 4.2920966893, "pagerank_4": 4.3615126286, "pagerank_5": 4.8889811067}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["YuanLiu"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 8.0, "hindex_4": 8.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 11.0, "citationsperpaper_1": 10.8, "citationsperpaper_2": 9.737, "citationsperpaper_3": 9.85, "citationsperpaper_4": 10.35, "citationsperpaper_5": 9.522, "citationsperyear_0": 9.429, "citationsperyear_1": 10.8, "citationsperyear_2": 11.563, "citationsperyear_3": 11.588, "citationsperyear_4": 11.5, "citationsperyear_5": 11.526, "totalcitations_0": 132.0, "totalcitations_1": 162.0, "totalcitations_2": 185.0, "totalcitations_3": 197.0, "totalcitations_4": 207.0, "totalcitations_5": 219.0, "totalpapers_0": 12.0, "totalpapers_1": 15.0, "totalpapers_2": 19.0, "totalpapers_3": 20.0, "totalpapers_4": 20.0, "totalpapers_5": 23.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 28.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 57.0, "recentcoauthors_3": 44.0, "recentcoauthors_4": 5.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 180.5, "venuehindexmean_1": 171.2857142857, "venuehindexmean_2": 175.0, "venuehindexmean_3": 178.0, "venuehindexmean_4": 180.5714285714, "venuehindexmean_5": 176.625, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 8.0, "pagerank_0": 3.6185229913, "pagerank_1": 4.2178176988, "pagerank_2": 5.0504649922, "pagerank_3": 5.0000961521, "pagerank_4": 4.795052319, "pagerank_5": 5.4167176769}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["YuanLiu"], "affiliation": "University of Science and Technology of China", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 8.0, "hindex_4": 8.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 11.0, "citationsperpaper_1": 10.8, "citationsperpaper_2": 9.737, "citationsperpaper_3": 9.85, "citationsperpaper_4": 10.35, "citationsperpaper_5": 9.522, "citationsperyear_0": 9.429, "citationsperyear_1": 10.8, "citationsperyear_2": 11.563, "citationsperyear_3": 11.588, "citationsperyear_4": 11.5, "citationsperyear_5": 11.526, "totalcitations_0": 132.0, "totalcitations_1": 162.0, "totalcitations_2": 185.0, "totalcitations_3": 197.0, "totalcitations_4": 207.0, "totalcitations_5": 219.0, "totalpapers_0": 12.0, "totalpapers_1": 15.0, "totalpapers_2": 19.0, "totalpapers_3": 20.0, "totalpapers_4": 20.0, "totalpapers_5": 23.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 28.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 57.0, "recentcoauthors_3": 44.0, "recentcoauthors_4": 5.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 180.5, "venuehindexmean_1": 171.2857142857, "venuehindexmean_2": 175.0, "venuehindexmean_3": 178.0, "venuehindexmean_4": 180.5714285714, "venuehindexmean_5": 176.625, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 8.0, "pagerank_0": 3.6185229913, "pagerank_1": 4.2178176988, "pagerank_2": 5.0504649922, "pagerank_3": 5.0000961521, "pagerank_4": 4.795052319, "pagerank_5": 5.4167176769}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["YuanLiu"], "affiliation": "Georgia State University", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 8.0, "hindex_4": 8.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 11.0, "citationsperpaper_1": 10.8, "citationsperpaper_2": 9.737, "citationsperpaper_3": 9.85, "citationsperpaper_4": 10.35, "citationsperpaper_5": 9.522, "citationsperyear_0": 9.429, "citationsperyear_1": 10.8, "citationsperyear_2": 11.563, "citationsperyear_3": 11.588, "citationsperyear_4": 11.5, "citationsperyear_5": 11.526, "totalcitations_0": 132.0, "totalcitations_1": 162.0, "totalcitations_2": 185.0, "totalcitations_3": 197.0, "totalcitations_4": 207.0, "totalcitations_5": 219.0, "totalpapers_0": 12.0, "totalpapers_1": 15.0, "totalpapers_2": 19.0, "totalpapers_3": 20.0, "totalpapers_4": 20.0, "totalpapers_5": 23.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 28.0, "recentcoauthors_1": 27.0, "recentcoauthors_2": 57.0, "recentcoauthors_3": 44.0, "recentcoauthors_4": 5.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 180.5, "venuehindexmean_1": 171.2857142857, "venuehindexmean_2": 175.0, "venuehindexmean_3": 178.0, "venuehindexmean_4": 180.5714285714, "venuehindexmean_5": 176.625, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 8.0, "pagerank_0": 3.6185229913, "pagerank_1": 4.2178176988, "pagerank_2": 5.0504649922, "pagerank_3": 5.0000961521, "pagerank_4": 4.795052319, "pagerank_5": 5.4167176769}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["YongquanQu"], "affiliation": "Xi'an Jiaotong University", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 3.0, "citationsperpaper_2": 4.25, "citationsperpaper_3": 5.125, "citationsperpaper_4": 6.0, "citationsperpaper_5": 6.222, "citationsperyear_0": 3.0, "citationsperyear_1": 7.5, "citationsperyear_2": 11.333, "citationsperyear_3": 10.25, "citationsperyear_4": 9.6, "citationsperyear_5": 9.333, "totalcitations_0": 3.0, "totalcitations_1": 15.0, "totalcitations_2": 34.0, "totalcitations_3": 41.0, "totalcitations_4": 48.0, "totalcitations_5": 56.0, "totalpapers_0": 3.0, "totalpapers_1": 5.0, "totalpapers_2": 8.0, "totalpapers_3": 8.0, "totalpapers_4": 8.0, "totalpapers_5": 9.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 20.0, "recentcoauthors_1": 29.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 27.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 172.3333333333, "venuehindexmean_1": 152.25, "venuehindexmean_2": 158.0, "venuehindexmean_3": 163.75, "venuehindexmean_4": 169.0, "venuehindexmean_5": 174.5, "totalvenues_0": 3.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.2585008381, "pagerank_1": 1.6596588046, "pagerank_2": 2.4813299271, "pagerank_3": 2.3465459757, "pagerank_4": 2.2833738387, "pagerank_5": 2.7515401889}}, {"model": "papers.paper", "pk": 1003053, "fields": {"authors": ["XiangfengDuan"], "affiliation": "University of California", "venue": "Nature", "doi": "10.1038/nature09405", "abstract": "There is much interest in graphene for applications in ultrahigh-speed radio-frequency electronics, but conventional device fabrication processes lead to significant defects in graphene. Here a new way of fabricating high-speed graphene transistors is described. A nanowire with a metallic core and insulating shell is placed as the gate electrode on top of graphene, and source and drain electrodes are deposited through a self-alignment process, causing no appreciable damage to the graphene lattice.", "year": 2010, "title": "High-speed graphene transistors with a self-aligned nanowire gate", "keywords": ["Transconductance", "Transistor", "Fabrication", "Graphene", "Nanotechnology", "Materials science", "Nanowire", "Graphene nanoribbons", "Electrode", "High-electron-mobility transistor"], "citations_0": 0.0, "citations_1": 5.0, "citations_2": 7.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 1.2583195412, "timescaledpagerank_2": 2.3555204886, "timescaledpagerank_3": 2.4820622976, "timescaledpagerank_4": 2.426870039, "timescaledpagerank_5": 2.6554568512, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 28.0, "adopters_2": 67.0, "adopters_3": 8.0, "adopters_4": 3.0, "adopters_5": 0.0, "citationsperpaper_0": 18.538, "citationsperpaper_1": 18.267, "citationsperpaper_2": 15.35, "citationsperpaper_3": 13.458, "citationsperpaper_4": 13.84, "citationsperpaper_5": 13.379, "citationsperyear_0": 12.684, "citationsperyear_1": 13.7, "citationsperyear_2": 14.619, "citationsperyear_3": 14.682, "citationsperyear_4": 15.043, "citationsperyear_5": 16.167, "totalcitations_0": 241.0, "totalcitations_1": 274.0, "totalcitations_2": 307.0, "totalcitations_3": 323.0, "totalcitations_4": 346.0, "totalcitations_5": 388.0, "totalpapers_0": 13.0, "totalpapers_1": 15.0, "totalpapers_2": 20.0, "totalpapers_3": 24.0, "totalpapers_4": 25.0, "totalpapers_5": 29.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 24.0, "recentcoauthors_1": 33.0, "recentcoauthors_2": 52.0, "recentcoauthors_3": 62.0, "recentcoauthors_4": 34.0, "recentcoauthors_5": 53.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 164.0, "venuehindexmean_1": 169.2, "venuehindexmean_2": 175.4, "venuehindexmean_3": 181.2, "venuehindexmean_4": 186.0, "venuehindexmean_5": 191.4, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 3.7847825767, "pagerank_1": 4.0604542567, "pagerank_2": 5.5571952263, "pagerank_3": 6.2727246762, "pagerank_4": 6.6652946029, "pagerank_5": 7.6892875468}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["SolSchulman"], "affiliation": "Brigham and Women's Hospital", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 1.5, "citationsperpaper_1": 3.0, "citationsperpaper_2": 5.0, "citationsperpaper_3": 8.0, "citationsperpaper_4": 8.75, "citationsperpaper_5": 9.75, "citationsperyear_0": 3.0, "citationsperyear_1": 4.5, "citationsperyear_2": 5.0, "citationsperyear_3": 6.0, "citationsperyear_4": 7.0, "citationsperyear_5": 6.5, "totalcitations_0": 3.0, "totalcitations_1": 9.0, "totalcitations_2": 15.0, "totalcitations_3": 24.0, "totalcitations_4": 35.0, "totalcitations_5": 39.0, "totalpapers_0": 2.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 187.3333333333, "venuehindexmean_2": 191.0, "venuehindexmean_3": 194.0, "venuehindexmean_4": 174.25, "venuehindexmean_5": 176.25, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 0.5488179122, "pagerank_1": 0.9527891664, "pagerank_2": 0.9297705049, "pagerank_3": 0.9112581096, "pagerank_4": 0.9083634504, "pagerank_5": 0.8777343498}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["SolSchulman", "WeikaiLi", "Tom A.Rapoport"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 13.3333333333, "hindex_1": 14.3333333333, "hindex_2": 15.0, "hindex_3": 15.3333333333, "hindex_4": 15.6666666667, "hindex_5": 16.3333333333, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 14.3623333333, "citationsperpaper_1": 15.7456666667, "citationsperpaper_2": 17.0453333333, "citationsperpaper_3": 18.598, "citationsperpaper_4": 19.4706666667, "citationsperpaper_5": 20.2123333333, "citationsperyear_0": 47.4876666667, "citationsperyear_1": 50.3213333333, "citationsperyear_2": 51.2643333333, "citationsperyear_3": 52.8186666667, "citationsperyear_4": 54.5043333333, "citationsperyear_5": 54.2586666667, "totalcitations_0": 1248.0, "totalcitations_1": 1355.0, "totalcitations_2": 1422.3333333333, "totalcitations_3": 1507.6666666667, "totalcitations_4": 1594.6666666667, "totalcitations_5": 1643.6666666667, "totalpapers_0": 33.6666666667, "totalpapers_1": 35.3333333333, "totalpapers_2": 36.3333333333, "totalpapers_3": 37.6666666667, "totalpapers_4": 39.6666666667, "totalpapers_5": 40.3333333333, "authorage_0": 10.3333333333, "authorage_1": 11.3333333333, "authorage_2": 12.3333333333, "authorage_3": 13.3333333333, "authorage_4": 14.3333333333, "authorage_5": 15.3333333333, "recentcoauthors_0": 14.0, "recentcoauthors_1": 20.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 15.0, "recentcoauthors_4": 16.6666666667, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 193.75, "venuehindexmean_1": 186.8194444444, "venuehindexmean_2": 190.8333333333, "venuehindexmean_3": 194.125, "venuehindexmean_4": 182.1666666667, "venuehindexmean_5": 184.4916666667, "totalvenues_0": 4.6666666667, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.6666666667, "totalvenues_5": 5.6666666667, "pagerank_0": 6.2508035728, "pagerank_1": 6.4916330728, "pagerank_2": 6.499378793, "pagerank_3": 6.7184999662, "pagerank_4": 6.8390146977, "pagerank_5": 6.7075606949}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["JonBeckwith", "DanaBoyd", "Rachel J.Dutton", "WeikaiLi", "Tom A.Rapoport", "SolSchulman"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 13.5, "hindex_1": 14.1666666667, "hindex_2": 14.5, "hindex_3": 14.8333333333, "hindex_4": 15.1666666667, "hindex_5": 15.6666666667, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 14.0391666667, "citationsperpaper_1": 14.78, "citationsperpaper_2": 15.7298333333, "citationsperpaper_3": 16.5891666667, "citationsperpaper_4": 17.8688333333, "citationsperpaper_5": 18.4518333333, "citationsperyear_0": 35.2968333333, "citationsperyear_1": 36.6896666667, "citationsperyear_2": 37.2741666667, "citationsperyear_3": 38.0631666667, "citationsperyear_4": 39.5033333333, "citationsperyear_5": 39.8313333333, "totalcitations_0": 1050.1666666667, "totalcitations_1": 1115.8333333333, "totalcitations_2": 1163.1666666667, "totalcitations_3": 1217.1666666667, "totalcitations_4": 1276.6666666667, "totalcitations_5": 1318.0, "totalpapers_0": 38.1666666667, "totalpapers_1": 39.5, "totalpapers_2": 40.3333333333, "totalpapers_3": 41.5, "totalpapers_4": 42.6666666667, "totalpapers_5": 43.8333333333, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 17.3333333333, "recentcoauthors_1": 15.8333333333, "recentcoauthors_2": 11.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 10.8333333333, "recentcoauthors_5": 14.8333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 176.5555555556, "venuehindexmean_1": 174.5763888889, "venuehindexmean_2": 180.8313492063, "venuehindexmean_3": 183.1069139194, "venuehindexmean_4": 180.4188644689, "venuehindexmean_5": 177.9857600733, "totalvenues_0": 6.0, "totalvenues_1": 6.1666666667, "totalvenues_2": 6.3333333333, "totalvenues_3": 6.5, "totalvenues_4": 7.0, "totalvenues_5": 7.1666666667, "pagerank_0": 7.3351042998, "pagerank_1": 7.4344710284, "pagerank_2": 7.4039096051, "pagerank_3": 7.4534289748, "pagerank_4": 7.4328065977, "pagerank_5": 7.5645515805}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["SolSchulman"], "affiliation": "Beth Israel Deaconess Medical Center", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 1.5, "citationsperpaper_1": 3.0, "citationsperpaper_2": 5.0, "citationsperpaper_3": 8.0, "citationsperpaper_4": 8.75, "citationsperpaper_5": 9.75, "citationsperyear_0": 3.0, "citationsperyear_1": 4.5, "citationsperyear_2": 5.0, "citationsperyear_3": 6.0, "citationsperyear_4": 7.0, "citationsperyear_5": 6.5, "totalcitations_0": 3.0, "totalcitations_1": 9.0, "totalcitations_2": 15.0, "totalcitations_3": 24.0, "totalcitations_4": 35.0, "totalcitations_5": 39.0, "totalpapers_0": 2.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 17.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 1.0, "recentcoauthors_5": 1.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 214.0, "venuehindexmean_1": 187.3333333333, "venuehindexmean_2": 191.0, "venuehindexmean_3": 194.0, "venuehindexmean_4": 174.25, "venuehindexmean_5": 176.25, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 0.5488179122, "pagerank_1": 0.9527891664, "pagerank_2": 0.9297705049, "pagerank_3": 0.9112581096, "pagerank_4": 0.9083634504, "pagerank_5": 0.8777343498}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["JonBeckwith"], "affiliation": "American Cancer Society", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 28.0, "hindex_1": 28.0, "hindex_2": 28.0, "hindex_3": 29.0, "hindex_4": 29.0, "hindex_5": 29.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 22.04, "citationsperpaper_1": 22.576, "citationsperpaper_2": 23.091, "citationsperpaper_3": 23.069, "citationsperpaper_4": 23.475, "citationsperpaper_5": 23.647, "citationsperyear_0": 50.744, "citationsperyear_1": 50.795, "citationsperyear_2": 50.8, "citationsperyear_3": 50.652, "citationsperyear_4": 50.447, "citationsperyear_5": 50.25, "totalcitations_0": 2182.0, "totalcitations_1": 2235.0, "totalcitations_2": 2286.0, "totalcitations_3": 2330.0, "totalcitations_4": 2371.0, "totalcitations_5": 2412.0, "totalpapers_0": 99.0, "totalpapers_1": 99.0, "totalpapers_2": 99.0, "totalpapers_3": 101.0, "totalpapers_4": 101.0, "totalpapers_5": 102.0, "authorage_0": 42.0, "authorage_1": 43.0, "authorage_2": 44.0, "authorage_3": 45.0, "authorage_4": 46.0, "authorage_5": 47.0, "recentcoauthors_0": 38.0, "recentcoauthors_1": 9.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 15.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.3333333333, "venuehindexmean_1": 138.3333333333, "venuehindexmean_2": 141.9166666667, "venuehindexmean_3": 138.2307692308, "venuehindexmean_4": 141.3846153846, "venuehindexmean_5": 144.1538461538, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 13.0, "totalvenues_4": 13.0, "totalvenues_5": 13.0, "pagerank_0": 18.8594404315, "pagerank_1": 18.2456799846, "pagerank_2": 17.7994084438, "pagerank_3": 17.2651252166, "pagerank_4": 16.8289312433, "pagerank_5": 16.8748994631}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["Tom A.Rapoport"], "affiliation": "Berlin-Brandenburg Academy of Sciences and Humanities", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 37.0, "hindex_1": 38.0, "hindex_2": 39.0, "hindex_3": 39.0, "hindex_4": 40.0, "hindex_5": 41.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 40.587, "citationsperpaper_1": 42.094, "citationsperpaper_2": 42.707, "citationsperpaper_3": 43.794, "citationsperpaper_4": 44.762, "citationsperpaper_5": 45.187, "citationsperyear_0": 138.296, "citationsperyear_1": 144.321, "citationsperyear_2": 145.793, "citationsperyear_3": 148.9, "citationsperyear_4": 151.613, "citationsperyear_5": 151.094, "totalcitations_0": 3734.0, "totalcitations_1": 4041.0, "totalcitations_2": 4228.0, "totalcitations_3": 4467.0, "totalcitations_4": 4700.0, "totalcitations_5": 4835.0, "totalpapers_0": 92.0, "totalpapers_1": 96.0, "totalpapers_2": 99.0, "totalpapers_3": 102.0, "totalpapers_4": 105.0, "totalpapers_5": 107.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 38.0, "recentcoauthors_4": 36.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 167.5, "venuehindexmean_1": 170.625, "venuehindexmean_2": 174.5, "venuehindexmean_3": 177.625, "venuehindexmean_4": 180.25, "venuehindexmean_5": 182.625, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 16.2740419452, "pagerank_1": 16.7167531355, "pagerank_2": 16.8488905475, "pagerank_3": 17.2759639498, "pagerank_4": 17.3956928493, "pagerank_5": 17.1072506544}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["Tom A.Rapoport"], "affiliation": "Boston Children's Hospital", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 37.0, "hindex_1": 38.0, "hindex_2": 39.0, "hindex_3": 39.0, "hindex_4": 40.0, "hindex_5": 41.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 40.587, "citationsperpaper_1": 42.094, "citationsperpaper_2": 42.707, "citationsperpaper_3": 43.794, "citationsperpaper_4": 44.762, "citationsperpaper_5": 45.187, "citationsperyear_0": 138.296, "citationsperyear_1": 144.321, "citationsperyear_2": 145.793, "citationsperyear_3": 148.9, "citationsperyear_4": 151.613, "citationsperyear_5": 151.094, "totalcitations_0": 3734.0, "totalcitations_1": 4041.0, "totalcitations_2": 4228.0, "totalcitations_3": 4467.0, "totalcitations_4": 4700.0, "totalcitations_5": 4835.0, "totalpapers_0": 92.0, "totalpapers_1": 96.0, "totalpapers_2": 99.0, "totalpapers_3": 102.0, "totalpapers_4": 105.0, "totalpapers_5": 107.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 38.0, "recentcoauthors_4": 36.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 167.5, "venuehindexmean_1": 170.625, "venuehindexmean_2": 174.5, "venuehindexmean_3": 177.625, "venuehindexmean_4": 180.25, "venuehindexmean_5": 182.625, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 16.2740419452, "pagerank_1": 16.7167531355, "pagerank_2": 16.8488905475, "pagerank_3": 17.2759639498, "pagerank_4": 17.3956928493, "pagerank_5": 17.1072506544}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["Tom A.Rapoport"], "affiliation": "Massachusetts Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 37.0, "hindex_1": 38.0, "hindex_2": 39.0, "hindex_3": 39.0, "hindex_4": 40.0, "hindex_5": 41.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 40.587, "citationsperpaper_1": 42.094, "citationsperpaper_2": 42.707, "citationsperpaper_3": 43.794, "citationsperpaper_4": 44.762, "citationsperpaper_5": 45.187, "citationsperyear_0": 138.296, "citationsperyear_1": 144.321, "citationsperyear_2": 145.793, "citationsperyear_3": 148.9, "citationsperyear_4": 151.613, "citationsperyear_5": 151.094, "totalcitations_0": 3734.0, "totalcitations_1": 4041.0, "totalcitations_2": 4228.0, "totalcitations_3": 4467.0, "totalcitations_4": 4700.0, "totalcitations_5": 4835.0, "totalpapers_0": 92.0, "totalpapers_1": 96.0, "totalpapers_2": 99.0, "totalpapers_3": 102.0, "totalpapers_4": 105.0, "totalpapers_5": 107.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 38.0, "recentcoauthors_4": 36.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 167.5, "venuehindexmean_1": 170.625, "venuehindexmean_2": 174.5, "venuehindexmean_3": 177.625, "venuehindexmean_4": 180.25, "venuehindexmean_5": 182.625, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 16.2740419452, "pagerank_1": 16.7167531355, "pagerank_2": 16.8488905475, "pagerank_3": 17.2759639498, "pagerank_4": 17.3956928493, "pagerank_5": 17.1072506544}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["Tom A.Rapoport"], "affiliation": "Heidelberg University", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 37.0, "hindex_1": 38.0, "hindex_2": 39.0, "hindex_3": 39.0, "hindex_4": 40.0, "hindex_5": 41.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 40.587, "citationsperpaper_1": 42.094, "citationsperpaper_2": 42.707, "citationsperpaper_3": 43.794, "citationsperpaper_4": 44.762, "citationsperpaper_5": 45.187, "citationsperyear_0": 138.296, "citationsperyear_1": 144.321, "citationsperyear_2": 145.793, "citationsperyear_3": 148.9, "citationsperyear_4": 151.613, "citationsperyear_5": 151.094, "totalcitations_0": 3734.0, "totalcitations_1": 4041.0, "totalcitations_2": 4228.0, "totalcitations_3": 4467.0, "totalcitations_4": 4700.0, "totalcitations_5": 4835.0, "totalpapers_0": 92.0, "totalpapers_1": 96.0, "totalpapers_2": 99.0, "totalpapers_3": 102.0, "totalpapers_4": 105.0, "totalpapers_5": 107.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 38.0, "recentcoauthors_4": 36.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 167.5, "venuehindexmean_1": 170.625, "venuehindexmean_2": 174.5, "venuehindexmean_3": 177.625, "venuehindexmean_4": 180.25, "venuehindexmean_5": 182.625, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 16.2740419452, "pagerank_1": 16.7167531355, "pagerank_2": 16.8488905475, "pagerank_3": 17.2759639498, "pagerank_4": 17.3956928493, "pagerank_5": 17.1072506544}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["Tom A.Rapoport"], "affiliation": "Max Delbr\u00fcck Center for Molecular Medicine", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 37.0, "hindex_1": 38.0, "hindex_2": 39.0, "hindex_3": 39.0, "hindex_4": 40.0, "hindex_5": 41.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 40.587, "citationsperpaper_1": 42.094, "citationsperpaper_2": 42.707, "citationsperpaper_3": 43.794, "citationsperpaper_4": 44.762, "citationsperpaper_5": 45.187, "citationsperyear_0": 138.296, "citationsperyear_1": 144.321, "citationsperyear_2": 145.793, "citationsperyear_3": 148.9, "citationsperyear_4": 151.613, "citationsperyear_5": 151.094, "totalcitations_0": 3734.0, "totalcitations_1": 4041.0, "totalcitations_2": 4228.0, "totalcitations_3": 4467.0, "totalcitations_4": 4700.0, "totalcitations_5": 4835.0, "totalpapers_0": 92.0, "totalpapers_1": 96.0, "totalpapers_2": 99.0, "totalpapers_3": 102.0, "totalpapers_4": 105.0, "totalpapers_5": 107.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 23.0, "recentcoauthors_1": 35.0, "recentcoauthors_2": 36.0, "recentcoauthors_3": 38.0, "recentcoauthors_4": 36.0, "recentcoauthors_5": 26.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 167.5, "venuehindexmean_1": 170.625, "venuehindexmean_2": 174.5, "venuehindexmean_3": 177.625, "venuehindexmean_4": 180.25, "venuehindexmean_5": 182.625, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 16.2740419452, "pagerank_1": 16.7167531355, "pagerank_2": 16.8488905475, "pagerank_3": 17.2759639498, "pagerank_4": 17.3956928493, "pagerank_5": 17.1072506544}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["Rachel J.Dutton"], "affiliation": "Oregon State University", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 4.4, "citationsperpaper_1": 5.2, "citationsperpaper_2": 6.6, "citationsperpaper_3": 6.5, "citationsperpaper_4": 10.429, "citationsperpaper_5": 11.556, "citationsperyear_0": 5.5, "citationsperyear_1": 5.2, "citationsperyear_2": 5.5, "citationsperyear_3": 5.571, "citationsperyear_4": 9.125, "citationsperyear_5": 11.556, "totalcitations_0": 22.0, "totalcitations_1": 26.0, "totalcitations_2": 33.0, "totalcitations_3": 39.0, "totalcitations_4": 73.0, "totalcitations_5": 104.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 7.0, "totalpapers_5": 9.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 10.0, "recentcoauthors_1": 5.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 15.0, "recentcoauthors_5": 19.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 199.75, "venuehindexmean_1": 202.5, "venuehindexmean_2": 207.0, "venuehindexmean_3": 210.75, "venuehindexmean_4": 224.2, "venuehindexmean_5": 197.0, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 5.0, "totalvenues_5": 6.0, "pagerank_0": 1.4951349167, "pagerank_1": 1.4341998623, "pagerank_2": 1.3900316362, "pagerank_3": 1.7564482018, "pagerank_4": 1.8555674809, "pagerank_5": 2.3510221981}}, {"model": "papers.paper", "pk": 1003148, "fields": {"authors": ["WeikaiLi"], "affiliation": "Washington University in St. Louis", "venue": "Nature", "doi": "10.1038/nature08720", "abstract": "Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain \u03b3-carboxylation of many blood coagulation factors. Here, we report the 3.6\u2009A crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant. Mammalian vitamin K epoxide reductase (VKOR) catalyses the generation of vitamin K hydroquinone, a decisive step in the vitamin K cycle that is required to sustain blood coagulation. The X-ray crystal structure of a bacterial homologue of VKOR has now been determined. It shows VKOR in a complex with its redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. This points to a possible mechanism by which VKOR uses electrons from newly synthesized proteins to reduce the quinone. This work may help explain how mutations to VKOR cause resistance to warfarin, the ubiquitous anticoagulant that acts by inhibiting VKOR. The \u03b3-carboxylation of many blood coagulation factors relies on the generation of vitamin K hydroquinone by the enzyme vitamin K epoxide reductase (VKOR), of which the anticoagulant warfarin is an inhibitor. Here, the X-ray crystal structure of a bacterial homologue of VKOR is presented; the results have implications for the mechanism of action of mammalian VKOR and explain how mutations can cause warfarin resistance.", "year": 2010, "title": "Structure of a bacterial homologue of vitamin K epoxide reductase", "keywords": ["Enzyme", "Transmembrane domain", "Oxidoreductase", "Biochemistry", "Quinone", "Vitamin K epoxide reductase", "Warfarin resistance", "Cysteine", "Periplasmic space", "Chemistry"], "citations_0": 2.0, "citations_1": 2.0, "citations_2": 1.0, "citations_3": 2.0, "citations_4": 4.0, "citations_5": 2.0, "timescaledpagerank_0": 0.0429716611, "timescaledpagerank_1": 0.1638539975, "timescaledpagerank_2": 0.0916322824, "timescaledpagerank_3": 0.1922642953, "timescaledpagerank_4": 0.3670713646, "timescaledpagerank_5": 0.3683910615, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 5.0, "adopters_0": 8.0, "adopters_1": 14.0, "adopters_2": 3.0, "adopters_3": 13.0, "adopters_4": 14.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.143, "citationsperpaper_2": 3.429, "citationsperpaper_3": 4.0, "citationsperpaper_4": 4.9, "citationsperpaper_5": 5.7, "citationsperyear_0": 1.167, "citationsperyear_1": 2.143, "citationsperyear_2": 3.0, "citationsperyear_3": 3.556, "citationsperyear_4": 4.9, "citationsperyear_5": 5.182, "totalcitations_0": 7.0, "totalcitations_1": 15.0, "totalcitations_2": 24.0, "totalcitations_3": 32.0, "totalcitations_4": 49.0, "totalcitations_5": 57.0, "totalpapers_0": 7.0, "totalpapers_1": 7.0, "totalpapers_2": 7.0, "totalpapers_3": 8.0, "totalpapers_4": 10.0, "totalpapers_5": 10.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 7.0, "recentcoauthors_4": 13.0, "recentcoauthors_5": 6.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 199.75, "venuehindexmean_1": 202.5, "venuehindexmean_2": 207.0, "venuehindexmean_3": 210.75, "venuehindexmean_4": 192.0, "venuehindexmean_5": 194.6, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.9295508609, "pagerank_1": 1.8053569164, "pagerank_2": 1.7194753268, "pagerank_3": 1.9682778392, "pagerank_4": 2.2129877932, "pagerank_5": 2.1376970805}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Laura A.Johnson", "David E.Hill"], "affiliation": "University of Michigan", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 13.5, "hindex_1": 15.5, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 27.3565, "citationsperpaper_1": 29.0065, "citationsperpaper_2": 32.2235, "citationsperpaper_3": 34.7785, "citationsperpaper_4": 37.3255, "citationsperpaper_5": 37.6715, "citationsperyear_0": 36.8245, "citationsperyear_1": 41.393, "citationsperyear_2": 45.261, "citationsperyear_3": 48.7975, "citationsperyear_4": 51.5725, "citationsperyear_5": 52.853, "totalcitations_0": 858.0, "totalcitations_1": 1007.5, "totalcitations_2": 1147.5, "totalcitations_3": 1285.0, "totalcitations_4": 1410.0, "totalcitations_5": 1499.0, "totalpapers_0": 31.0, "totalpapers_1": 34.5, "totalpapers_2": 36.0, "totalpapers_3": 37.0, "totalpapers_4": 38.5, "totalpapers_5": 42.0, "authorage_0": 20.5, "authorage_1": 21.5, "authorage_2": 22.5, "authorage_3": 23.5, "authorage_4": 24.5, "authorage_5": 25.5, "recentcoauthors_0": 110.0, "recentcoauthors_1": 132.5, "recentcoauthors_2": 123.0, "recentcoauthors_3": 65.5, "recentcoauthors_4": 59.0, "recentcoauthors_5": 98.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 129.1666666667, "venuehindexmean_1": 128.8717948718, "venuehindexmean_2": 130.5833333333, "venuehindexmean_3": 134.5357142857, "venuehindexmean_4": 138.9, "venuehindexmean_5": 138.9362745098, "totalvenues_0": 9.0, "totalvenues_1": 9.5, "totalvenues_2": 10.0, "totalvenues_3": 10.0, "totalvenues_4": 10.5, "totalvenues_5": 11.5, "pagerank_0": 11.8217437936, "pagerank_1": 12.6188130179, "pagerank_2": 12.9595850958, "pagerank_3": 12.7893071908, "pagerank_4": 12.8405632881, "pagerank_5": 13.2513991809}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Laura A.Johnson"], "affiliation": "Johns Hopkins University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 6.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 10.0, "hindex_5": 11.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 26.833, "citationsperpaper_1": 28.692, "citationsperpaper_2": 32.769, "citationsperpaper_3": 34.857, "citationsperpaper_4": 38.429, "citationsperpaper_5": 40.643, "citationsperyear_0": 17.889, "citationsperyear_1": 19.632, "citationsperyear_2": 21.3, "citationsperyear_3": 23.238, "citationsperyear_4": 24.455, "citationsperyear_5": 24.739, "totalcitations_0": 322.0, "totalcitations_1": 373.0, "totalcitations_2": 426.0, "totalcitations_3": 488.0, "totalcitations_4": 538.0, "totalcitations_5": 569.0, "totalpapers_0": 12.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 14.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 96.0, "recentcoauthors_2": 21.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 148.0, "venuehindexmean_1": 151.6666666667, "venuehindexmean_2": 156.6666666667, "venuehindexmean_3": 160.5, "venuehindexmean_4": 163.6666666667, "venuehindexmean_5": 167.1666666667, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 4.6138017029, "pagerank_1": 4.8134649975, "pagerank_2": 4.4213306425, "pagerank_3": 4.3321428492, "pagerank_4": 4.0355651254, "pagerank_5": 3.8284305852}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Todd R.Golub", "Sapana R.Thomas", "Levi A.Garraway", "Cory M.Johannessen", "William R.Sellers", "So YoungKim", "Jesse S.Boehm", "William C.Hahn", "NicolasStransky", "David E.Root", "HaleyHieronymus", "JordiBarretina", "Laura A.Johnson", "Jean J.Zhao"], "affiliation": "Broad Institute", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 11.7857142857, "hindex_1": 13.3571428571, "hindex_2": 15.2857142857, "hindex_3": 17.3571428571, "hindex_4": 19.0, "hindex_5": 20.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 18.2878571429, "citationsperpaper_1": 20.7262857143, "citationsperpaper_2": 24.5242857143, "citationsperpaper_3": 28.5546428571, "citationsperpaper_4": 31.6512857143, "citationsperpaper_5": 34.0043571429, "citationsperyear_0": 57.8982142857, "citationsperyear_1": 70.7609285714, "citationsperyear_2": 85.9453571429, "citationsperyear_3": 102.6319285714, "citationsperyear_4": 115.0764285714, "citationsperyear_5": 124.1004285714, "totalcitations_0": 886.0714285714, "totalcitations_1": 1110.0, "totalcitations_2": 1396.2142857143, "totalcitations_3": 1743.5, "totalcitations_4": 2056.1428571429, "totalcitations_5": 2339.8571428571, "totalpapers_0": 35.5714285714, "totalpapers_1": 42.9285714286, "totalpapers_2": 49.7857142857, "totalpapers_3": 56.7142857143, "totalpapers_4": 63.7142857143, "totalpapers_5": 68.5, "authorage_0": 10.4285714286, "authorage_1": 11.4285714286, "authorage_2": 12.4285714286, "authorage_3": 13.4285714286, "authorage_4": 14.4285714286, "authorage_5": 15.4285714286, "recentcoauthors_0": 278.5714285714, "recentcoauthors_1": 338.0, "recentcoauthors_2": 302.1428571429, "recentcoauthors_3": 274.2142857143, "recentcoauthors_4": 281.4285714286, "recentcoauthors_5": 246.2857142857, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.7387810602, "venuehindexmean_1": 128.3582155939, "venuehindexmean_2": 127.8101669153, "venuehindexmean_3": 128.657067145, "venuehindexmean_4": 131.9838937848, "venuehindexmean_5": 132.1141646052, "totalvenues_0": 9.3571428571, "totalvenues_1": 10.5, "totalvenues_2": 11.4285714286, "totalvenues_3": 11.8571428571, "totalvenues_4": 12.4285714286, "totalvenues_5": 12.8571428571, "pagerank_0": 12.2769245559, "pagerank_1": 14.1691128163, "pagerank_2": 15.1094552352, "pagerank_3": 16.0493250548, "pagerank_4": 17.0474739616, "pagerank_5": 17.494753389}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Laura A.Johnson", "Thomas M.Roberts"], "affiliation": "Tufts University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 18.5, "hindex_1": 21.0, "hindex_2": 22.0, "hindex_3": 22.5, "hindex_4": 22.5, "hindex_5": 23.5, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 31.7975, "citationsperpaper_1": 33.28, "citationsperpaper_2": 35.069, "citationsperpaper_3": 36.4065, "citationsperpaper_4": 38.24, "citationsperpaper_5": 39.8, "citationsperyear_0": 61.1065, "citationsperyear_1": 62.632, "citationsperyear_2": 63.8295, "citationsperyear_3": 65.2315, "citationsperyear_4": 66.52, "citationsperyear_5": 66.6315, "totalcitations_0": 2091.0, "totalcitations_1": 2193.5, "totalcitations_2": 2287.0, "totalcitations_3": 2388.5, "totalcitations_4": 2495.0, "totalcitations_5": 2563.5, "totalpapers_0": 58.5, "totalpapers_1": 59.5, "totalpapers_2": 62.0, "totalpapers_3": 63.5, "totalpapers_4": 65.5, "totalpapers_5": 65.5, "authorage_0": 26.5, "authorage_1": 27.5, "authorage_2": 28.5, "authorage_3": 29.5, "authorage_4": 30.5, "authorage_5": 31.5, "recentcoauthors_0": 70.0, "recentcoauthors_1": 78.5, "recentcoauthors_2": 49.5, "recentcoauthors_3": 53.5, "recentcoauthors_4": 36.0, "recentcoauthors_5": 20.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.0588235294, "venuehindexmean_1": 134.3333333333, "venuehindexmean_2": 135.4444444444, "venuehindexmean_3": 138.8333333333, "venuehindexmean_4": 141.7222222222, "venuehindexmean_5": 144.8055555556, "totalvenues_0": 11.5, "totalvenues_1": 11.5, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 13.7732881708, "pagerank_1": 13.5263962392, "pagerank_2": 13.4590811567, "pagerank_3": 13.1862163151, "pagerank_4": 13.1074507149, "pagerank_5": 12.6274470435}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Laura A.Johnson"], "affiliation": "Johns Hopkins University School of Medicine", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 6.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 10.0, "hindex_5": 11.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 26.833, "citationsperpaper_1": 28.692, "citationsperpaper_2": 32.769, "citationsperpaper_3": 34.857, "citationsperpaper_4": 38.429, "citationsperpaper_5": 40.643, "citationsperyear_0": 17.889, "citationsperyear_1": 19.632, "citationsperyear_2": 21.3, "citationsperyear_3": 23.238, "citationsperyear_4": 24.455, "citationsperyear_5": 24.739, "totalcitations_0": 322.0, "totalcitations_1": 373.0, "totalcitations_2": 426.0, "totalcitations_3": 488.0, "totalcitations_4": 538.0, "totalcitations_5": 569.0, "totalpapers_0": 12.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 14.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 75.0, "recentcoauthors_1": 96.0, "recentcoauthors_2": 21.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 148.0, "venuehindexmean_1": 151.6666666667, "venuehindexmean_2": 156.6666666667, "venuehindexmean_3": 160.5, "venuehindexmean_4": 163.6666666667, "venuehindexmean_5": 167.1666666667, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 4.6138017029, "pagerank_1": 4.8134649975, "pagerank_2": 4.4213306425, "pagerank_3": 4.3321428492, "pagerank_4": 4.0355651254, "pagerank_5": 3.8284305852}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Todd R.Golub", "Sapana R.Thomas", "Levi A.Garraway", "Cory M.Johannessen", "William R.Sellers", "XiaopingYang", "Jesse S.Boehm", "William C.Hahn", "NicolasStransky", "David E.Root", "OzanAlkan", "HaleyHieronymus", "Christopher J.Wilson", "JordiBarretina", "Laura A.Johnson"], "affiliation": "Massachusetts Institute of Technology", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 10.4, "hindex_1": 11.7333333333, "hindex_2": 13.6, "hindex_3": 15.4, "hindex_4": 16.8666666667, "hindex_5": 17.8666666667, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 16.0534, "citationsperpaper_1": 19.2005333333, "citationsperpaper_2": 24.4682666667, "citationsperpaper_3": 30.9376, "citationsperpaper_4": 36.4670666667, "citationsperpaper_5": 41.0856666667, "citationsperyear_0": 50.5666, "citationsperyear_1": 63.1206, "citationsperyear_2": 77.604, "citationsperyear_3": 93.328, "citationsperyear_4": 105.1234666667, "citationsperyear_5": 113.7792666667, "totalcitations_0": 793.7333333333, "totalcitations_1": 992.8666666667, "totalcitations_2": 1255.2, "totalcitations_3": 1577.1333333333, "totalcitations_4": 1867.8, "totalcitations_5": 2136.8666666667, "totalpapers_0": 31.4, "totalpapers_1": 38.2666666667, "totalpapers_2": 44.6, "totalpapers_3": 50.4666666667, "totalpapers_4": 56.6666666667, "totalpapers_5": 60.8, "authorage_0": 9.7333333333, "authorage_1": 10.7333333333, "authorage_2": 11.7333333333, "authorage_3": 12.7333333333, "authorage_4": 13.7333333333, "authorage_5": 14.7333333333, "recentcoauthors_0": 252.9333333333, "recentcoauthors_1": 322.7333333333, "recentcoauthors_2": 291.7333333333, "recentcoauthors_3": 255.0, "recentcoauthors_4": 253.0666666667, "recentcoauthors_5": 224.8666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.0293438043, "venuehindexmean_1": 136.5965567766, "venuehindexmean_2": 133.5150446765, "venuehindexmean_3": 134.3753838808, "venuehindexmean_4": 137.7983874459, "venuehindexmean_5": 138.8432202982, "totalvenues_0": 7.9333333333, "totalvenues_1": 9.0, "totalvenues_2": 9.8, "totalvenues_3": 10.2, "totalvenues_4": 10.6666666667, "totalvenues_5": 10.9333333333, "pagerank_0": 10.9947316418, "pagerank_1": 12.8280322803, "pagerank_2": 13.7738115287, "pagerank_3": 14.5333879379, "pagerank_4": 15.4306647634, "pagerank_5": 15.8031382568}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Cory M.Johannessen", "HaleyHieronymus", "Keith T.Flaherty", "Sapana R.Thomas", "Levi A.Garraway", "Ryan R.Murray", "So YoungKim", "Jesse S.Boehm", "Thomas M.Roberts", "Alexandria P.Cogdill", "NicolasStransky", "LeslieWardwell", "JordiBarretina", "KouroshSalehi-Ashtiani", "Todd R.Golub", "MarcVidal", "CarolineEmery", "William R.Sellers", "William C.Hahn", "David E.Hill", "Laura A.Johnson", "Jean J.Zhao"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 11.4090909091, "hindex_1": 12.9090909091, "hindex_2": 14.4090909091, "hindex_3": 16.0, "hindex_4": 17.0454545455, "hindex_5": 17.8636363636, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 16.4829545455, "citationsperpaper_1": 20.0321363636, "citationsperpaper_2": 24.3591818182, "citationsperpaper_3": 29.2693636364, "citationsperpaper_4": 32.9131818182, "citationsperpaper_5": 34.7201363636, "citationsperyear_0": 47.8000454545, "citationsperyear_1": 58.0755454545, "citationsperyear_2": 69.591, "citationsperyear_3": 81.7432272727, "citationsperyear_4": 90.5597272727, "citationsperyear_5": 96.2953181818, "totalcitations_0": 864.1818181818, "totalcitations_1": 1043.7727272727, "totalcitations_2": 1267.8636363636, "totalcitations_3": 1531.0909090909, "totalcitations_4": 1770.5, "totalcitations_5": 1976.8636363636, "totalpapers_0": 33.8181818182, "totalpapers_1": 39.0909090909, "totalpapers_2": 44.3181818182, "totalpapers_3": 49.0454545455, "totalpapers_4": 54.3181818182, "totalpapers_5": 58.4545454545, "authorage_0": 11.7272727273, "authorage_1": 12.7272727273, "authorage_2": 13.7272727273, "authorage_3": 14.7272727273, "authorage_4": 15.7272727273, "authorage_5": 16.7272727273, "recentcoauthors_0": 206.5, "recentcoauthors_1": 249.0909090909, "recentcoauthors_2": 227.5, "recentcoauthors_3": 198.6363636364, "recentcoauthors_4": 200.7272727273, "recentcoauthors_5": 196.8181818182, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.2979605993, "venuehindexmean_1": 131.9908101702, "venuehindexmean_2": 130.4676446281, "venuehindexmean_3": 131.5478658337, "venuehindexmean_4": 136.0916777567, "venuehindexmean_5": 137.2580130431, "totalvenues_0": 8.4545454545, "totalvenues_1": 9.2727272727, "totalvenues_2": 10.0, "totalvenues_3": 10.3636363636, "totalvenues_4": 10.7272727273, "totalvenues_5": 11.3181818182, "pagerank_0": 11.0909818189, "pagerank_1": 12.3631948437, "pagerank_2": 13.1873240584, "pagerank_3": 13.7394591595, "pagerank_4": 14.5253738428, "pagerank_5": 15.0479136088}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Todd R.Golub", "Levi A.Garraway", "Cory M.Johannessen", "William R.Sellers", "So YoungKim", "Jesse S.Boehm", "William C.Hahn", "Laura A.Johnson"], "affiliation": "Brigham and Women's Hospital", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 15.875, "hindex_1": 17.625, "hindex_2": 19.5, "hindex_3": 21.75, "hindex_4": 23.75, "hindex_5": 25.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 21.72025, "citationsperpaper_1": 24.5755, "citationsperpaper_2": 27.934125, "citationsperpaper_3": 30.52975, "citationsperpaper_4": 33.037, "citationsperpaper_5": 34.3275, "citationsperyear_0": 80.9865, "citationsperyear_1": 95.533375, "citationsperyear_2": 111.396, "citationsperyear_3": 128.822, "citationsperyear_4": 142.254875, "citationsperyear_5": 152.2905, "totalcitations_0": 1390.5, "totalcitations_1": 1696.375, "totalcitations_2": 2069.0, "totalcitations_3": 2516.5, "totalcitations_4": 2918.875, "totalcitations_5": 3284.5, "totalpapers_0": 51.25, "totalpapers_1": 60.0, "totalpapers_2": 68.25, "totalpapers_3": 77.75, "totalpapers_4": 87.125, "totalpapers_5": 93.625, "authorage_0": 13.75, "authorage_1": 14.75, "authorage_2": 15.75, "authorage_3": 16.75, "authorage_4": 17.75, "authorage_5": 18.75, "recentcoauthors_0": 362.5, "recentcoauthors_1": 415.875, "recentcoauthors_2": 351.375, "recentcoauthors_3": 344.625, "recentcoauthors_4": 398.5, "recentcoauthors_5": 358.125, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 130.0225677101, "venuehindexmean_1": 124.931043956, "venuehindexmean_2": 122.5113203463, "venuehindexmean_3": 121.531540855, "venuehindexmean_4": 124.6147524351, "venuehindexmean_5": 126.801366342, "totalvenues_0": 11.0, "totalvenues_1": 12.0, "totalvenues_2": 12.75, "totalvenues_3": 13.25, "totalvenues_4": 13.375, "totalvenues_5": 13.5, "pagerank_0": 16.9037853716, "pagerank_1": 18.9292671833, "pagerank_2": 19.8133008161, "pagerank_3": 21.085736581, "pagerank_4": 22.449390029, "pagerank_5": 23.1606773663}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Thomas M.Roberts", "William R.Sellers"], "affiliation": "Beth Israel Deaconess Medical Center", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 29.0, "hindex_1": 31.0, "hindex_2": 32.5, "hindex_3": 33.0, "hindex_4": 34.5, "hindex_5": 35.5, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 32.57, "citationsperpaper_1": 34.2465, "citationsperpaper_2": 34.6845, "citationsperpaper_3": 35.665, "citationsperpaper_4": 36.615, "citationsperpaper_5": 37.538, "citationsperyear_0": 113.399, "citationsperyear_1": 120.191, "citationsperyear_2": 127.0845, "citationsperyear_3": 134.7715, "citationsperyear_4": 139.9445, "citationsperyear_5": 143.0535, "totalcitations_0": 3093.5, "totalcitations_1": 3354.5, "totalcitations_2": 3626.0, "totalcitations_3": 3930.0, "totalcitations_4": 4196.0, "totalcitations_5": 4410.0, "totalpapers_0": 93.5, "totalpapers_1": 97.0, "totalpapers_2": 104.0, "totalpapers_3": 110.0, "totalpapers_4": 114.5, "totalpapers_5": 117.5, "authorage_0": 27.0, "authorage_1": 28.0, "authorage_2": 29.0, "authorage_3": 30.0, "authorage_4": 31.0, "authorage_5": 32.0, "recentcoauthors_0": 317.5, "recentcoauthors_1": 303.0, "recentcoauthors_2": 190.0, "recentcoauthors_3": 233.5, "recentcoauthors_4": 178.0, "recentcoauthors_5": 164.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 120.9516806723, "venuehindexmean_1": 123.8928571429, "venuehindexmean_2": 120.1777777778, "venuehindexmean_3": 123.3166666667, "venuehindexmean_4": 126.0555555556, "venuehindexmean_5": 128.8888888889, "totalvenues_0": 15.5, "totalvenues_1": 15.5, "totalvenues_2": 16.5, "totalvenues_3": 16.5, "totalvenues_4": 16.5, "totalvenues_5": 16.5, "pagerank_0": 25.1432021267, "pagerank_1": 25.0078343729, "pagerank_2": 25.5788145287, "pagerank_3": 26.0620107485, "pagerank_4": 26.1017043579, "pagerank_5": 26.2867575291}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Thomas M.Roberts", "So YoungKim"], "affiliation": "Stony Brook University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 19.5, "hindex_1": 22.0, "hindex_2": 23.0, "hindex_3": 23.5, "hindex_4": 23.5, "hindex_5": 24.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 31.1145, "citationsperpaper_1": 36.028, "citationsperpaper_2": 38.601, "citationsperpaper_3": 40.121, "citationsperpaper_4": 42.3665, "citationsperpaper_5": 40.8055, "citationsperyear_0": 68.0785, "citationsperyear_1": 73.8545, "citationsperyear_2": 78.7865, "citationsperyear_3": 83.2125, "citationsperyear_4": 86.3865, "citationsperyear_5": 86.8795, "totalcitations_0": 2121.0, "totalcitations_1": 2280.5, "totalcitations_2": 2432.5, "totalcitations_3": 2588.5, "totalcitations_4": 2739.5, "totalcitations_5": 2833.5, "totalpapers_0": 60.0, "totalpapers_1": 61.0, "totalpapers_2": 64.5, "totalpapers_3": 67.0, "totalpapers_4": 69.5, "totalpapers_5": 71.5, "authorage_0": 23.5, "authorage_1": 24.5, "authorage_2": 25.5, "authorage_3": 26.5, "authorage_4": 27.5, "authorage_5": 28.5, "recentcoauthors_0": 143.0, "recentcoauthors_1": 75.0, "recentcoauthors_2": 58.5, "recentcoauthors_3": 75.5, "recentcoauthors_4": 60.0, "recentcoauthors_5": 44.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 121.2810457516, "venuehindexmean_1": 122.2, "venuehindexmean_2": 122.7111111111, "venuehindexmean_3": 119.9924242424, "venuehindexmean_4": 122.7525252525, "venuehindexmean_5": 121.7638888889, "totalvenues_0": 13.0, "totalvenues_1": 13.5, "totalvenues_2": 14.0, "totalvenues_3": 14.5, "totalvenues_4": 14.5, "totalvenues_5": 15.0, "pagerank_0": 14.8274581109, "pagerank_1": 14.5229785187, "pagerank_2": 14.6249220104, "pagerank_3": 14.6033246134, "pagerank_4": 14.6048354638, "pagerank_5": 14.4405994188}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Thomas M.Roberts"], "affiliation": "Florida State University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 31.0, "hindex_1": 34.0, "hindex_2": 35.0, "hindex_3": 35.0, "hindex_4": 35.0, "hindex_5": 36.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 36.762, "citationsperpaper_1": 37.868, "citationsperpaper_2": 37.369, "citationsperpaper_3": 37.956, "citationsperpaper_4": 38.051, "citationsperpaper_5": 38.957, "citationsperyear_0": 104.324, "citationsperyear_1": 105.632, "citationsperyear_2": 106.359, "citationsperyear_3": 107.225, "citationsperyear_4": 108.585, "citationsperyear_5": 108.524, "totalcitations_0": 3860.0, "totalcitations_1": 4014.0, "totalcitations_2": 4148.0, "totalcitations_3": 4289.0, "totalcitations_4": 4452.0, "totalcitations_5": 4558.0, "totalpapers_0": 105.0, "totalpapers_1": 106.0, "totalpapers_2": 111.0, "totalpapers_3": 113.0, "totalpapers_4": 117.0, "totalpapers_5": 117.0, "authorage_0": 36.0, "authorage_1": 37.0, "authorage_2": 38.0, "authorage_3": 39.0, "authorage_4": 40.0, "authorage_5": 41.0, "recentcoauthors_0": 65.0, "recentcoauthors_1": 61.0, "recentcoauthors_2": 78.0, "recentcoauthors_3": 97.0, "recentcoauthors_4": 62.0, "recentcoauthors_5": 40.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.1176470588, "venuehindexmean_1": 117.0, "venuehindexmean_2": 114.2222222222, "venuehindexmean_3": 117.1666666667, "venuehindexmean_4": 119.7777777778, "venuehindexmean_5": 122.4444444444, "totalvenues_0": 17.0, "totalvenues_1": 17.0, "totalvenues_2": 18.0, "totalvenues_3": 18.0, "totalvenues_4": 18.0, "totalvenues_5": 18.0, "pagerank_0": 22.9327746387, "pagerank_1": 22.239327481, "pagerank_2": 22.4968316708, "pagerank_3": 22.040289781, "pagerank_4": 22.1793363045, "pagerank_5": 21.4264635019}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["CarolineEmery", "Vic E.Myer", "Cory M.Johannessen", "GiordanoCaponigro", "William R.Sellers", "So YoungKim", "RobertSchlegel", "Jennifer L.Harris", "Christopher J.Wilson", "JordiBarretina", "PeterFinan", "SungjoonKim", "ReinhardDummer", "Barbara L.Weber"], "affiliation": "Novartis", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 5.7142857143, "hindex_1": 6.7142857143, "hindex_2": 7.9285714286, "hindex_3": 8.4285714286, "hindex_4": 9.4285714286, "hindex_5": 9.8571428571, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 12.7305, "citationsperpaper_1": 16.9115714286, "citationsperpaper_2": 23.8064285714, "citationsperpaper_3": 31.9577142857, "citationsperpaper_4": 31.5908571429, "citationsperpaper_5": 35.8247142857, "citationsperyear_0": 18.9385, "citationsperyear_1": 25.6145, "citationsperyear_2": 34.9597142857, "citationsperyear_3": 43.7115, "citationsperyear_4": 49.5468571429, "citationsperyear_5": 54.1577857143, "totalcitations_0": 282.6428571429, "totalcitations_1": 363.8571428571, "totalcitations_2": 492.7857142857, "totalcitations_3": 642.5714285714, "totalcitations_4": 773.5714285714, "totalcitations_5": 897.8571428571, "totalpapers_0": 15.0714285714, "totalpapers_1": 17.9285714286, "totalpapers_2": 20.9285714286, "totalpapers_3": 23.6428571429, "totalpapers_4": 25.7857142857, "totalpapers_5": 28.2142857143, "authorage_0": 10.7857142857, "authorage_1": 11.7857142857, "authorage_2": 12.7857142857, "authorage_3": 13.7857142857, "authorage_4": 14.7857142857, "authorage_5": 15.7857142857, "recentcoauthors_0": 157.8571428571, "recentcoauthors_1": 192.5714285714, "recentcoauthors_2": 153.0714285714, "recentcoauthors_3": 124.5714285714, "recentcoauthors_4": 94.2142857143, "recentcoauthors_5": 93.6428571429, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 161.8928829107, "venuehindexmean_1": 154.4154839208, "venuehindexmean_2": 148.8162698413, "venuehindexmean_3": 145.5489125953, "venuehindexmean_4": 131.1154710369, "venuehindexmean_5": 131.9602143888, "totalvenues_0": 5.4285714286, "totalvenues_1": 5.9285714286, "totalvenues_2": 6.4285714286, "totalvenues_3": 7.0, "totalvenues_4": 7.4285714286, "totalvenues_5": 7.7857142857, "pagerank_0": 6.0583516961, "pagerank_1": 6.8733176113, "pagerank_2": 7.5102448235, "pagerank_3": 7.8993615848, "pagerank_4": 8.2506876207, "pagerank_5": 8.6370007751}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["NicolasStransky"], "affiliation": "Centre national de la recherche scientifique", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 3.0, "hindex_1": 5.0, "hindex_2": 9.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 15.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 19.75, "citationsperpaper_1": 15.706, "citationsperpaper_2": 21.76, "citationsperpaper_3": 36.222, "citationsperpaper_4": 46.172, "citationsperpaper_5": 51.0, "citationsperyear_0": 26.333, "citationsperyear_1": 38.143, "citationsperyear_2": 68.0, "citationsperyear_3": 108.667, "citationsperyear_4": 133.9, "citationsperyear_5": 153.0, "totalcitations_0": 158.0, "totalcitations_1": 267.0, "totalcitations_2": 544.0, "totalcitations_3": 978.0, "totalcitations_4": 1339.0, "totalcitations_5": 1683.0, "totalpapers_0": 8.0, "totalpapers_1": 17.0, "totalpapers_2": 25.0, "totalpapers_3": 27.0, "totalpapers_4": 29.0, "totalpapers_5": 33.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 120.0, "recentcoauthors_1": 367.0, "recentcoauthors_2": 575.0, "recentcoauthors_3": 420.0, "recentcoauthors_4": 116.0, "recentcoauthors_5": 74.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 144.6666666667, "venuehindexmean_1": 164.3333333333, "venuehindexmean_2": 181.4285714286, "venuehindexmean_3": 185.0, "venuehindexmean_4": 188.0, "venuehindexmean_5": 160.8888888889, "totalvenues_0": 3.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 9.0, "pagerank_0": 6.3323962776, "pagerank_1": 9.771049069, "pagerank_2": 12.5102635296, "pagerank_3": 12.5445816276, "pagerank_4": 12.2446041426, "pagerank_5": 12.3331475076}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Levi A.Garraway"], "affiliation": "Eli Lilly and Company", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 13.0, "hindex_1": 15.0, "hindex_2": 19.0, "hindex_3": 25.0, "hindex_4": 30.0, "hindex_5": 33.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 15.951, "citationsperpaper_1": 16.279, "citationsperpaper_2": 20.092, "citationsperpaper_3": 22.5, "citationsperpaper_4": 24.101, "citationsperpaper_5": 26.658, "citationsperyear_0": 36.333, "citationsperyear_1": 52.263, "citationsperyear_2": 76.35, "citationsperyear_3": 111.429, "citationsperyear_4": 141.318, "citationsperyear_5": 169.217, "totalcitations_0": 654.0, "totalcitations_1": 993.0, "totalcitations_2": 1527.0, "totalcitations_3": 2340.0, "totalcitations_4": 3109.0, "totalcitations_5": 3892.0, "totalpapers_0": 41.0, "totalpapers_1": 61.0, "totalpapers_2": 76.0, "totalpapers_3": 104.0, "totalpapers_4": 129.0, "totalpapers_5": 146.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 502.0, "recentcoauthors_1": 803.0, "recentcoauthors_2": 859.0, "recentcoauthors_3": 959.0, "recentcoauthors_4": 1257.0, "recentcoauthors_5": 1128.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.2727272727, "venuehindexmean_1": 122.0769230769, "venuehindexmean_2": 119.2857142857, "venuehindexmean_3": 119.2666666667, "venuehindexmean_4": 122.0, "venuehindexmean_5": 125.1875, "totalvenues_0": 11.0, "totalvenues_1": 13.0, "totalvenues_2": 14.0, "totalvenues_3": 15.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 18.9693848304, "pagerank_1": 25.0746785684, "pagerank_2": 27.3751700283, "pagerank_3": 32.7498172563, "pagerank_4": 37.205055933, "pagerank_5": 40.4472377569}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["GiordanoCaponigro"], "affiliation": "University of Arizona", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 5.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 28.5, "citationsperpaper_1": 20.143, "citationsperpaper_2": 21.3, "citationsperpaper_3": 20.733, "citationsperpaper_4": 20.1, "citationsperpaper_5": 19.88, "citationsperyear_0": 7.125, "citationsperyear_1": 8.294, "citationsperyear_2": 11.833, "citationsperyear_3": 16.368, "citationsperyear_4": 20.1, "citationsperyear_5": 23.667, "totalcitations_0": 114.0, "totalcitations_1": 141.0, "totalcitations_2": 213.0, "totalcitations_3": 311.0, "totalcitations_4": 402.0, "totalcitations_5": 497.0, "totalpapers_0": 4.0, "totalpapers_1": 7.0, "totalpapers_2": 10.0, "totalpapers_3": 15.0, "totalpapers_4": 20.0, "totalpapers_5": 25.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 83.0, "recentcoauthors_1": 165.0, "recentcoauthors_2": 177.0, "recentcoauthors_3": 178.0, "recentcoauthors_4": 153.0, "recentcoauthors_5": 139.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 157.3333333333, "venuehindexmean_1": 160.3333333333, "venuehindexmean_2": 163.0, "venuehindexmean_3": 142.0, "venuehindexmean_4": 144.6, "venuehindexmean_5": 146.8, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 1.9833186546, "pagerank_1": 2.9802717474, "pagerank_2": 4.1499078881, "pagerank_3": 5.5131396122, "pagerank_4": 6.3350064661, "pagerank_5": 6.8972657843}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Ryan R.Murray"], "affiliation": "University of Helsinki", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 8.857, "citationsperpaper_1": 16.125, "citationsperpaper_2": 23.875, "citationsperpaper_3": 31.875, "citationsperpaper_4": 36.111, "citationsperpaper_5": 41.222, "citationsperyear_0": 20.667, "citationsperyear_1": 32.25, "citationsperyear_2": 38.2, "citationsperyear_3": 42.5, "citationsperyear_4": 46.429, "citationsperyear_5": 46.375, "totalcitations_0": 62.0, "totalcitations_1": 129.0, "totalcitations_2": 191.0, "totalcitations_3": 255.0, "totalcitations_4": 325.0, "totalcitations_5": 371.0, "totalpapers_0": 7.0, "totalpapers_1": 8.0, "totalpapers_2": 8.0, "totalpapers_3": 8.0, "totalpapers_4": 9.0, "totalpapers_5": 9.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 51.0, "recentcoauthors_1": 57.0, "recentcoauthors_2": 23.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 69.0, "recentcoauthors_5": 69.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 174.0, "venuehindexmean_1": 178.6666666667, "venuehindexmean_2": 184.6666666667, "venuehindexmean_3": 190.6666666667, "venuehindexmean_4": 213.0, "venuehindexmean_5": 217.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.3973355471, "pagerank_1": 3.493729105, "pagerank_2": 3.3286081489, "pagerank_3": 3.1962837237, "pagerank_4": 4.0004045967, "pagerank_5": 3.8509722554}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Keith T.Flaherty"], "affiliation": "Partners HealthCare", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 6.0, "hindex_1": 8.0, "hindex_2": 11.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 17.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 6.5, "citationsperpaper_1": 14.118, "citationsperpaper_2": 16.903, "citationsperpaper_3": 21.75, "citationsperpaper_4": 23.056, "citationsperpaper_5": 22.294, "citationsperyear_0": 5.056, "citationsperyear_1": 12.632, "citationsperyear_2": 26.2, "citationsperyear_3": 41.429, "citationsperyear_4": 56.591, "citationsperyear_5": 65.913, "totalcitations_0": 91.0, "totalcitations_1": 240.0, "totalcitations_2": 524.0, "totalcitations_3": 870.0, "totalcitations_4": 1245.0, "totalcitations_5": 1516.0, "totalpapers_0": 14.0, "totalpapers_1": 17.0, "totalpapers_2": 31.0, "totalpapers_3": 40.0, "totalpapers_4": 54.0, "totalpapers_5": 68.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 112.0, "recentcoauthors_1": 163.0, "recentcoauthors_2": 326.0, "recentcoauthors_3": 407.0, "recentcoauthors_4": 373.0, "recentcoauthors_5": 541.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.0, "venuehindexmean_1": 128.0, "venuehindexmean_2": 108.2857142857, "venuehindexmean_3": 92.4444444444, "venuehindexmean_4": 95.7777777778, "venuehindexmean_5": 111.1538461538, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 7.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 13.0, "pagerank_0": 4.8845954755, "pagerank_1": 6.0160443875, "pagerank_2": 10.8182028537, "pagerank_3": 12.7884637553, "pagerank_4": 16.4888392939, "pagerank_5": 20.2951829924}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Keith T.Flaherty"], "affiliation": "GlaxoSmithKline", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 6.0, "hindex_1": 8.0, "hindex_2": 11.0, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 17.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 6.5, "citationsperpaper_1": 14.118, "citationsperpaper_2": 16.903, "citationsperpaper_3": 21.75, "citationsperpaper_4": 23.056, "citationsperpaper_5": 22.294, "citationsperyear_0": 5.056, "citationsperyear_1": 12.632, "citationsperyear_2": 26.2, "citationsperyear_3": 41.429, "citationsperyear_4": 56.591, "citationsperyear_5": 65.913, "totalcitations_0": 91.0, "totalcitations_1": 240.0, "totalcitations_2": 524.0, "totalcitations_3": 870.0, "totalcitations_4": 1245.0, "totalcitations_5": 1516.0, "totalpapers_0": 14.0, "totalpapers_1": 17.0, "totalpapers_2": 31.0, "totalpapers_3": 40.0, "totalpapers_4": 54.0, "totalpapers_5": 68.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 112.0, "recentcoauthors_1": 163.0, "recentcoauthors_2": 326.0, "recentcoauthors_3": 407.0, "recentcoauthors_4": 373.0, "recentcoauthors_5": 541.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.0, "venuehindexmean_1": 128.0, "venuehindexmean_2": 108.2857142857, "venuehindexmean_3": 92.4444444444, "venuehindexmean_4": 95.7777777778, "venuehindexmean_5": 111.1538461538, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 7.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 13.0, "pagerank_0": 4.8845954755, "pagerank_1": 6.0160443875, "pagerank_2": 10.8182028537, "pagerank_3": 12.7884637553, "pagerank_4": 16.4888392939, "pagerank_5": 20.2951829924}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Keith T.Flaherty", "Alexandria P.Cogdill", "William C.Hahn"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 11.0, "hindex_1": 13.0, "hindex_2": 15.3333333333, "hindex_3": 17.3333333333, "hindex_4": 17.6666666667, "hindex_5": 19.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 11.0553333333, "citationsperpaper_1": 16.503, "citationsperpaper_2": 20.0026666667, "citationsperpaper_3": 25.7106666667, "citationsperpaper_4": 28.6966666667, "citationsperpaper_5": 26.8566666667, "citationsperyear_0": 33.4076666667, "citationsperyear_1": 43.593, "citationsperyear_2": 55.945, "citationsperyear_3": 68.7996666667, "citationsperyear_4": 78.82, "citationsperyear_5": 84.7903333333, "totalcitations_0": 707.3333333333, "totalcitations_1": 913.0, "totalcitations_2": 1184.0, "totalcitations_3": 1499.0, "totalcitations_4": 1801.6666666667, "totalcitations_5": 2039.0, "totalpapers_0": 36.6666666667, "totalpapers_1": 42.6666666667, "totalpapers_2": 54.0, "totalpapers_3": 63.0, "totalpapers_4": 76.3333333333, "totalpapers_5": 85.6666666667, "authorage_0": 13.6666666667, "authorage_1": 14.6666666667, "authorage_2": 15.6666666667, "authorage_3": 16.6666666667, "authorage_4": 17.6666666667, "authorage_5": 18.6666666667, "recentcoauthors_0": 249.3333333333, "recentcoauthors_1": 247.3333333333, "recentcoauthors_2": 286.3333333333, "recentcoauthors_3": 305.3333333333, "recentcoauthors_4": 363.6666666667, "recentcoauthors_5": 419.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.0277777778, "venuehindexmean_1": 126.5777777778, "venuehindexmean_2": 110.1519047619, "venuehindexmean_3": 107.0481481481, "venuehindexmean_4": 110.2592592593, "venuehindexmean_5": 110.7846153846, "totalvenues_0": 10.6666666667, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 12.6666666667, "totalvenues_4": 12.6666666667, "totalvenues_5": 14.3333333333, "pagerank_0": 11.1109499535, "pagerank_1": 12.4602236622, "pagerank_2": 14.8972892405, "pagerank_3": 16.2364724729, "pagerank_4": 19.0663560093, "pagerank_5": 20.9458941921}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["JordiBarretina"], "affiliation": "Autonomous University of Barcelona", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 8.0, "hindex_1": 9.0, "hindex_2": 12.0, "hindex_3": 14.0, "hindex_4": 16.0, "hindex_5": 17.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 11.235, "citationsperpaper_1": 13.16, "citationsperpaper_2": 20.448, "citationsperpaper_3": 28.968, "citationsperpaper_4": 35.094, "citationsperpaper_5": 40.636, "citationsperyear_0": 19.1, "citationsperyear_1": 29.909, "citationsperyear_2": 49.417, "citationsperyear_3": 69.077, "citationsperyear_4": 80.214, "citationsperyear_5": 89.4, "totalcitations_0": 191.0, "totalcitations_1": 329.0, "totalcitations_2": 593.0, "totalcitations_3": 898.0, "totalcitations_4": 1123.0, "totalcitations_5": 1341.0, "totalpapers_0": 17.0, "totalpapers_1": 25.0, "totalpapers_2": 29.0, "totalpapers_3": 31.0, "totalpapers_4": 32.0, "totalpapers_5": 33.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 325.0, "recentcoauthors_1": 429.0, "recentcoauthors_2": 353.0, "recentcoauthors_3": 209.0, "recentcoauthors_4": 90.0, "recentcoauthors_5": 58.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.1111111111, "venuehindexmean_1": 128.4, "venuehindexmean_2": 131.4, "venuehindexmean_3": 145.8181818182, "venuehindexmean_4": 148.0909090909, "venuehindexmean_5": 150.3636363636, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 11.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 10.0049172531, "pagerank_1": 12.5939267925, "pagerank_2": 13.1433869583, "pagerank_3": 13.0936865645, "pagerank_4": 12.7250735796, "pagerank_5": 12.3976662121}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Todd R.Golub"], "affiliation": "University of Chicago", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 38.0, "hindex_1": 40.0, "hindex_2": 42.0, "hindex_3": 48.0, "hindex_4": 51.0, "hindex_5": 53.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 35.692, "citationsperpaper_1": 36.729, "citationsperpaper_2": 39.404, "citationsperpaper_3": 43.636, "citationsperpaper_4": 46.466, "citationsperpaper_5": 49.59, "citationsperyear_0": 306.529, "citationsperyear_1": 338.722, "citationsperyear_2": 379.526, "citationsperyear_3": 425.45, "citationsperyear_4": 460.238, "citationsperyear_5": 489.136, "totalcitations_0": 5211.0, "totalcitations_1": 6097.0, "totalcitations_2": 7211.0, "totalcitations_3": 8509.0, "totalcitations_4": 9665.0, "totalcitations_5": 10761.0, "totalpapers_0": 146.0, "totalpapers_1": 166.0, "totalpapers_2": 183.0, "totalpapers_3": 195.0, "totalpapers_4": 208.0, "totalpapers_5": 217.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 534.0, "recentcoauthors_1": 891.0, "recentcoauthors_2": 910.0, "recentcoauthors_3": 740.0, "recentcoauthors_4": 638.0, "recentcoauthors_5": 513.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.1538461538, "venuehindexmean_1": 127.7857142857, "venuehindexmean_2": 128.7333333333, "venuehindexmean_3": 126.3125, "venuehindexmean_4": 129.4375, "venuehindexmean_5": 132.4375, "totalvenues_0": 13.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 40.6048562759, "pagerank_1": 45.975057079, "pagerank_2": 47.8359605976, "pagerank_3": 48.3709488291, "pagerank_4": 49.5275833067, "pagerank_5": 49.3854189844}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Todd R.Golub"], "affiliation": "Boston Children's Hospital", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 38.0, "hindex_1": 40.0, "hindex_2": 42.0, "hindex_3": 48.0, "hindex_4": 51.0, "hindex_5": 53.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 35.692, "citationsperpaper_1": 36.729, "citationsperpaper_2": 39.404, "citationsperpaper_3": 43.636, "citationsperpaper_4": 46.466, "citationsperpaper_5": 49.59, "citationsperyear_0": 306.529, "citationsperyear_1": 338.722, "citationsperyear_2": 379.526, "citationsperyear_3": 425.45, "citationsperyear_4": 460.238, "citationsperyear_5": 489.136, "totalcitations_0": 5211.0, "totalcitations_1": 6097.0, "totalcitations_2": 7211.0, "totalcitations_3": 8509.0, "totalcitations_4": 9665.0, "totalcitations_5": 10761.0, "totalpapers_0": 146.0, "totalpapers_1": 166.0, "totalpapers_2": 183.0, "totalpapers_3": 195.0, "totalpapers_4": 208.0, "totalpapers_5": 217.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 534.0, "recentcoauthors_1": 891.0, "recentcoauthors_2": 910.0, "recentcoauthors_3": 740.0, "recentcoauthors_4": 638.0, "recentcoauthors_5": 513.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.1538461538, "venuehindexmean_1": 127.7857142857, "venuehindexmean_2": 128.7333333333, "venuehindexmean_3": 126.3125, "venuehindexmean_4": 129.4375, "venuehindexmean_5": 132.4375, "totalvenues_0": 13.0, "totalvenues_1": 14.0, "totalvenues_2": 15.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 40.6048562759, "pagerank_1": 45.975057079, "pagerank_2": 47.8359605976, "pagerank_3": 48.3709488291, "pagerank_4": 49.5275833067, "pagerank_5": 49.3854189844}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Todd R.Golub", "KouroshSalehi-Ashtiani"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 21.0, "hindex_1": 22.5, "hindex_2": 23.5, "hindex_3": 27.5, "hindex_4": 29.0, "hindex_5": 30.5, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 19.5545, "citationsperpaper_1": 21.0645, "citationsperpaper_2": 23.9685, "citationsperpaper_3": 27.6845, "citationsperpaper_4": 30.9665, "citationsperpaper_5": 33.3575, "citationsperyear_0": 154.4035, "citationsperyear_1": 171.4925, "citationsperyear_2": 192.963, "citationsperyear_3": 216.9155, "citationsperyear_4": 235.3915, "citationsperyear_5": 250.5245, "totalcitations_0": 2626.0, "totalcitations_1": 3089.0, "totalcitations_2": 3669.5, "totalcitations_3": 4342.5, "totalcitations_4": 4948.5, "totalcitations_5": 5517.5, "totalpapers_0": 79.0, "totalpapers_1": 90.5, "totalpapers_2": 99.0, "totalpapers_3": 105.0, "totalpapers_4": 111.5, "totalpapers_5": 116.5, "authorage_0": 16.5, "authorage_1": 17.5, "authorage_2": 18.5, "authorage_3": 19.5, "authorage_4": 20.5, "authorage_5": 21.5, "recentcoauthors_0": 320.5, "recentcoauthors_1": 506.0, "recentcoauthors_2": 481.0, "recentcoauthors_3": 370.0, "recentcoauthors_4": 319.0, "recentcoauthors_5": 280.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.0769230769, "venuehindexmean_1": 135.8928571429, "venuehindexmean_2": 138.8666666667, "venuehindexmean_3": 139.90625, "venuehindexmean_4": 143.46875, "venuehindexmean_5": 154.6473214286, "totalvenues_0": 9.5, "totalvenues_1": 10.0, "totalvenues_2": 10.5, "totalvenues_3": 11.0, "totalvenues_4": 11.0, "totalvenues_5": 11.5, "pagerank_0": 21.9582817641, "pagerank_1": 24.9639653241, "pagerank_2": 25.8167056579, "pagerank_3": 25.9932880049, "pagerank_4": 26.4769116744, "pagerank_5": 26.7125261455}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["David E.Hill"], "affiliation": "Scripps Research Institute", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 21.0, "hindex_1": 23.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 26.0, "hindex_5": 27.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 27.88, "citationsperpaper_1": 29.321, "citationsperpaper_2": 31.678, "citationsperpaper_3": 34.7, "citationsperpaper_4": 36.222, "citationsperpaper_5": 34.7, "citationsperyear_0": 55.76, "citationsperyear_1": 63.154, "citationsperyear_2": 69.222, "citationsperyear_3": 74.357, "citationsperyear_4": 78.69, "citationsperyear_5": 80.967, "totalcitations_0": 1394.0, "totalcitations_1": 1642.0, "totalcitations_2": 1869.0, "totalcitations_3": 2082.0, "totalcitations_4": 2282.0, "totalcitations_5": 2429.0, "totalpapers_0": 50.0, "totalpapers_1": 56.0, "totalpapers_2": 59.0, "totalpapers_3": 60.0, "totalpapers_4": 63.0, "totalpapers_5": 70.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 145.0, "recentcoauthors_1": 169.0, "recentcoauthors_2": 225.0, "recentcoauthors_3": 121.0, "recentcoauthors_4": 108.0, "recentcoauthors_5": 197.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 110.3333333333, "venuehindexmean_1": 106.0769230769, "venuehindexmean_2": 104.5, "venuehindexmean_3": 108.5714285714, "venuehindexmean_4": 114.1333333333, "venuehindexmean_5": 110.7058823529, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 14.0, "totalvenues_3": 14.0, "totalvenues_4": 15.0, "totalvenues_5": 17.0, "pagerank_0": 19.0296858843, "pagerank_1": 20.4241610384, "pagerank_2": 21.4978395491, "pagerank_3": 21.2464715325, "pagerank_4": 21.6455614508, "pagerank_5": 22.6743677765}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Alexandria P.Cogdill", "Jennifer A.Wargo"], "affiliation": "University of Texas MD Anderson Cancer Center", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 1.5, "hindex_1": 2.0, "hindex_2": 4.5, "hindex_3": 4.5, "hindex_4": 6.5, "hindex_5": 7.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 3.3, "citationsperpaper_1": 10.5335, "citationsperpaper_2": 14.6665, "citationsperpaper_3": 23.083, "citationsperpaper_4": 27.8975, "citationsperpaper_5": 24.9445, "citationsperyear_0": 6.75, "citationsperyear_1": 16.8335, "citationsperyear_2": 33.875, "citationsperyear_3": 52.175, "citationsperyear_4": 61.4165, "citationsperyear_5": 64.893, "totalcitations_0": 12.5, "totalcitations_1": 44.0, "totalcitations_2": 116.5, "totalcitations_3": 227.5, "totalcitations_4": 327.0, "totalcitations_5": 409.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 9.0, "totalpapers_3": 12.0, "totalpapers_4": 16.0, "totalpapers_5": 21.5, "authorage_0": 0.5, "authorage_1": 1.5, "authorage_2": 2.5, "authorage_3": 3.5, "authorage_4": 4.5, "authorage_5": 5.5, "recentcoauthors_0": 60.5, "recentcoauthors_1": 66.0, "recentcoauthors_2": 107.5, "recentcoauthors_3": 144.0, "recentcoauthors_4": 109.0, "recentcoauthors_5": 163.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 202.8333333333, "venuehindexmean_1": 160.6666666667, "venuehindexmean_2": 114.125, "venuehindexmean_3": 114.25, "venuehindexmean_4": 112.1428571429, "venuehindexmean_5": 105.0333333333, "totalvenues_0": 2.0, "totalvenues_1": 2.5, "totalvenues_2": 4.0, "totalvenues_3": 5.0, "totalvenues_4": 5.5, "totalvenues_5": 7.0, "pagerank_0": 1.4754659773, "pagerank_1": 1.8072532347, "pagerank_2": 3.2097794801, "pagerank_3": 3.9586229359, "pagerank_4": 4.825572544, "pagerank_5": 6.121170718}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Alexandria P.Cogdill", "Barbara L.Weber"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.5, "hindex_5": 4.5, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 7.4, "citationsperpaper_1": 10.825, "citationsperpaper_2": 17.972, "citationsperpaper_3": 29.1665, "citationsperpaper_4": 38.3055, "citationsperpaper_5": 40.743, "citationsperyear_0": 6.9645, "citationsperyear_1": 12.0155, "citationsperyear_2": 18.027, "citationsperyear_3": 23.8625, "citationsperyear_4": 26.5365, "citationsperyear_5": 27.797, "totalcitations_0": 37.0, "totalcitations_1": 68.0, "totalcitations_2": 132.0, "totalcitations_3": 215.5, "totalcitations_4": 285.0, "totalcitations_5": 349.5, "totalpapers_0": 5.0, "totalpapers_1": 6.5, "totalpapers_2": 7.5, "totalpapers_3": 7.5, "totalpapers_4": 7.5, "totalpapers_5": 8.5, "authorage_0": 10.5, "authorage_1": 11.5, "authorage_2": 12.5, "authorage_3": 13.5, "authorage_4": 14.5, "authorage_5": 15.5, "recentcoauthors_0": 85.0, "recentcoauthors_1": 183.5, "recentcoauthors_2": 148.0, "recentcoauthors_3": 37.5, "recentcoauthors_4": 0.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.3333333333, "venuehindexmean_1": 127.5, "venuehindexmean_2": 112.375, "venuehindexmean_3": 115.5, "venuehindexmean_4": 118.4166666667, "venuehindexmean_5": 111.2833333333, "totalvenues_0": 4.0, "totalvenues_1": 4.5, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.5, "pagerank_0": 2.407090362, "pagerank_1": 3.4721016532, "pagerank_2": 3.6943991687, "pagerank_3": 3.2933182255, "pagerank_4": 3.1438954666, "pagerank_5": 3.4578281239}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["William C.Hahn"], "affiliation": "University of Washington", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 25.0, "hindex_1": 28.0, "hindex_2": 31.0, "hindex_3": 33.0, "hindex_4": 34.0, "hindex_5": 36.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 22.066, "citationsperpaper_1": 22.991, "citationsperpaper_2": 23.272, "citationsperpaper_3": 24.049, "citationsperpaper_4": 23.201, "citationsperpaper_5": 23.901, "citationsperyear_0": 83.667, "citationsperyear_1": 97.48, "citationsperyear_2": 111.885, "citationsperyear_3": 127.37, "citationsperyear_4": 140.036, "citationsperyear_5": 149.172, "totalcitations_0": 2008.0, "totalcitations_1": 2437.0, "totalcitations_2": 2909.0, "totalcitations_3": 3439.0, "totalcitations_4": 3921.0, "totalcitations_5": 4326.0, "totalpapers_0": 91.0, "totalpapers_1": 106.0, "totalpapers_2": 125.0, "totalpapers_3": 143.0, "totalpapers_4": 169.0, "totalpapers_5": 181.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 549.0, "recentcoauthors_1": 516.0, "recentcoauthors_2": 518.0, "recentcoauthors_3": 494.0, "recentcoauthors_4": 718.0, "recentcoauthors_5": 675.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.4166666667, "venuehindexmean_1": 103.4, "venuehindexmean_2": 106.92, "venuehindexmean_3": 110.2, "venuehindexmean_4": 113.0, "venuehindexmean_5": 115.8, "totalvenues_0": 24.0, "totalvenues_1": 25.0, "totalvenues_2": 25.0, "totalvenues_3": 25.0, "totalvenues_4": 25.0, "totalvenues_5": 25.0, "pagerank_0": 26.274340218, "pagerank_1": 29.3466004079, "pagerank_2": 31.7381180445, "pagerank_3": 33.9076792433, "pagerank_4": 38.7937949048, "pagerank_5": 39.8331306206}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Christopher J.Wilson"], "affiliation": "Purdue University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 7.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 18.0, "citationsperpaper_1": 19.778, "citationsperpaper_2": 18.25, "citationsperpaper_3": 25.882, "citationsperpaper_4": 30.105, "citationsperpaper_5": 36.1, "citationsperyear_0": 6.632, "citationsperyear_1": 8.9, "citationsperyear_2": 13.905, "citationsperyear_3": 20.0, "citationsperyear_4": 24.87, "citationsperyear_5": 30.083, "totalcitations_0": 126.0, "totalcitations_1": 178.0, "totalcitations_2": 292.0, "totalcitations_3": 440.0, "totalcitations_4": 572.0, "totalcitations_5": 722.0, "totalpapers_0": 7.0, "totalpapers_1": 9.0, "totalpapers_2": 16.0, "totalpapers_3": 17.0, "totalpapers_4": 19.0, "totalpapers_5": 20.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 171.0, "recentcoauthors_1": 185.0, "recentcoauthors_2": 227.0, "recentcoauthors_3": 185.0, "recentcoauthors_4": 78.0, "recentcoauthors_5": 80.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 196.6666666667, "venuehindexmean_1": 200.3333333333, "venuehindexmean_2": 152.0, "venuehindexmean_3": 135.8333333333, "venuehindexmean_4": 131.5714285714, "venuehindexmean_5": 134.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 5.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 4.124605728, "pagerank_1": 4.8404035574, "pagerank_2": 7.0721659281, "pagerank_3": 7.2055642074, "pagerank_4": 7.8657189706, "pagerank_5": 7.9756368332}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["KouroshSalehi-Ashtiani"], "affiliation": "Cornell University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 3.417, "citationsperpaper_1": 5.4, "citationsperpaper_2": 8.533, "citationsperpaper_3": 11.733, "citationsperpaper_4": 15.467, "citationsperpaper_5": 17.125, "citationsperyear_0": 2.278, "citationsperyear_1": 4.263, "citationsperyear_2": 6.4, "citationsperyear_3": 8.381, "citationsperyear_4": 10.545, "citationsperyear_5": 11.913, "totalcitations_0": 41.0, "totalcitations_1": 81.0, "totalcitations_2": 128.0, "totalcitations_3": 176.0, "totalcitations_4": 232.0, "totalcitations_5": 274.0, "totalpapers_0": 12.0, "totalpapers_1": 15.0, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 15.0, "totalpapers_5": 16.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 121.0, "recentcoauthors_2": 52.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 47.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 140.0, "venuehindexmean_1": 144.0, "venuehindexmean_2": 149.0, "venuehindexmean_3": 153.5, "venuehindexmean_4": 157.5, "venuehindexmean_5": 176.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 7.0, "pagerank_0": 3.3117072523, "pagerank_1": 3.9528735693, "pagerank_2": 3.7974507182, "pagerank_3": 3.6156271807, "pagerank_4": 3.4262400422, "pagerank_5": 4.0396333066}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["MarcVidal", "KouroshSalehi-Ashtiani"], "affiliation": "Northwestern University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 14.5, "hindex_1": 16.0, "hindex_2": 16.0, "hindex_3": 18.0, "hindex_4": 18.5, "hindex_5": 19.5, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 11.891, "citationsperpaper_1": 13.601, "citationsperpaper_2": 16.202, "citationsperpaper_3": 18.8265, "citationsperpaper_4": 20.909, "citationsperpaper_5": 21.543, "citationsperyear_0": 40.797, "citationsperyear_1": 46.2815, "citationsperyear_2": 51.5095, "citationsperyear_3": 55.4405, "citationsperyear_4": 59.1205, "citationsperyear_5": 61.123, "totalcitations_0": 774.0, "totalcitations_1": 923.5, "totalcitations_2": 1078.5, "totalcitations_3": 1215.5, "totalcitations_4": 1354.5, "totalcitations_5": 1461.0, "totalpapers_0": 43.0, "totalpapers_1": 48.0, "totalpapers_2": 50.0, "totalpapers_3": 51.0, "totalpapers_4": 54.5, "totalpapers_5": 59.0, "authorage_0": 17.5, "authorage_1": 18.5, "authorage_2": 19.5, "authorage_3": 20.5, "authorage_4": 21.5, "authorage_5": 22.5, "recentcoauthors_0": 168.0, "recentcoauthors_1": 231.5, "recentcoauthors_2": 209.0, "recentcoauthors_3": 74.5, "recentcoauthors_4": 78.5, "recentcoauthors_5": 143.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 121.90625, "venuehindexmean_1": 124.3529411765, "venuehindexmean_2": 126.4444444444, "venuehindexmean_3": 130.6666666667, "venuehindexmean_4": 134.1184210526, "venuehindexmean_5": 142.9785714286, "totalvenues_0": 11.0, "totalvenues_1": 11.5, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.5, "totalvenues_5": 13.5, "pagerank_0": 12.5068717421, "pagerank_1": 13.9590280092, "pagerank_2": 14.4340909203, "pagerank_3": 14.1432897698, "pagerank_4": 14.4920737373, "pagerank_5": 15.2957581091}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["KouroshSalehi-Ashtiani"], "affiliation": "New York University Abu Dhabi", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 4.0, "hindex_1": 5.0, "hindex_2": 5.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 3.417, "citationsperpaper_1": 5.4, "citationsperpaper_2": 8.533, "citationsperpaper_3": 11.733, "citationsperpaper_4": 15.467, "citationsperpaper_5": 17.125, "citationsperyear_0": 2.278, "citationsperyear_1": 4.263, "citationsperyear_2": 6.4, "citationsperyear_3": 8.381, "citationsperyear_4": 10.545, "citationsperyear_5": 11.913, "totalcitations_0": 41.0, "totalcitations_1": 81.0, "totalcitations_2": 128.0, "totalcitations_3": 176.0, "totalcitations_4": 232.0, "totalcitations_5": 274.0, "totalpapers_0": 12.0, "totalpapers_1": 15.0, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 15.0, "totalpapers_5": 16.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 107.0, "recentcoauthors_1": 121.0, "recentcoauthors_2": 52.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 47.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 140.0, "venuehindexmean_1": 144.0, "venuehindexmean_2": 149.0, "venuehindexmean_3": 153.5, "venuehindexmean_4": 157.5, "venuehindexmean_5": 176.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 7.0, "pagerank_0": 3.3117072523, "pagerank_1": 3.9528735693, "pagerank_2": 3.7974507182, "pagerank_3": 3.6156271807, "pagerank_4": 3.4262400422, "pagerank_5": 4.0396333066}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["HaleyHieronymus"], "affiliation": "Memorial Sloan Kettering Cancer Center", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 8.0, "hindex_1": 10.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 23.818, "citationsperpaper_1": 27.286, "citationsperpaper_2": 30.176, "citationsperpaper_3": 36.944, "citationsperpaper_4": 38.95, "citationsperpaper_5": 44.35, "citationsperyear_0": 32.75, "citationsperyear_1": 42.444, "citationsperyear_2": 51.3, "citationsperyear_3": 60.455, "citationsperyear_4": 64.917, "citationsperyear_5": 68.231, "totalcitations_0": 262.0, "totalcitations_1": 382.0, "totalcitations_2": 513.0, "totalcitations_3": 665.0, "totalcitations_4": 779.0, "totalcitations_5": 887.0, "totalpapers_0": 11.0, "totalpapers_1": 14.0, "totalpapers_2": 17.0, "totalpapers_3": 18.0, "totalpapers_4": 20.0, "totalpapers_5": 20.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 83.0, "recentcoauthors_1": 118.0, "recentcoauthors_2": 57.0, "recentcoauthors_3": 35.0, "recentcoauthors_4": 59.0, "recentcoauthors_5": 35.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 144.875, "venuehindexmean_1": 136.3333333333, "venuehindexmean_2": 140.8888888889, "venuehindexmean_3": 131.8, "venuehindexmean_4": 139.2727272727, "venuehindexmean_5": 142.8181818182, "totalvenues_0": 8.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 11.0, "totalvenues_5": 11.0, "pagerank_0": 3.2370687665, "pagerank_1": 3.9728921346, "pagerank_2": 3.9746777366, "pagerank_3": 4.2172908212, "pagerank_4": 4.4829302381, "pagerank_5": 4.1358864083}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["Barbara L.Weber"], "affiliation": "University of Utah", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 10.2, "citationsperpaper_1": 9.25, "citationsperpaper_2": 16.111, "citationsperpaper_3": 27.0, "citationsperpaper_4": 36.778, "citationsperpaper_5": 47.111, "citationsperyear_0": 2.429, "citationsperyear_1": 3.364, "citationsperyear_2": 6.304, "citationsperyear_3": 10.125, "citationsperyear_4": 13.24, "citationsperyear_5": 16.308, "totalcitations_0": 51.0, "totalcitations_1": 74.0, "totalcitations_2": 145.0, "totalcitations_3": 243.0, "totalcitations_4": 331.0, "totalcitations_5": 424.0, "totalpapers_0": 5.0, "totalpapers_1": 8.0, "totalpapers_2": 9.0, "totalpapers_3": 9.0, "totalpapers_4": 9.0, "totalpapers_5": 9.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 83.0, "recentcoauthors_1": 304.0, "recentcoauthors_2": 281.0, "recentcoauthors_3": 60.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.0, "venuehindexmean_1": 106.6666666667, "venuehindexmean_2": 109.5, "venuehindexmean_3": 112.5, "venuehindexmean_4": 114.8333333333, "venuehindexmean_5": 117.1666666667, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.6402665569, "pagerank_1": 4.9261771151, "pagerank_2": 5.2532515139, "pagerank_3": 4.573362031, "pagerank_4": 4.3713571041, "pagerank_5": 4.2062872845}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["SungjoonKim"], "affiliation": "Genomics Institute of the Novartis Research Foundation", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 0.667, "citationsperpaper_1": 6.25, "citationsperpaper_2": 18.8, "citationsperpaper_3": 38.0, "citationsperpaper_4": 39.857, "citationsperpaper_5": 54.429, "citationsperyear_0": 2.0, "citationsperyear_1": 12.5, "citationsperyear_2": 31.333, "citationsperyear_3": 47.5, "citationsperyear_4": 55.8, "citationsperyear_5": 63.5, "totalcitations_0": 2.0, "totalcitations_1": 25.0, "totalcitations_2": 94.0, "totalcitations_3": 190.0, "totalcitations_4": 279.0, "totalcitations_5": 381.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 5.0, "totalpapers_4": 7.0, "totalpapers_5": 7.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 120.0, "recentcoauthors_1": 169.0, "recentcoauthors_2": 109.0, "recentcoauthors_3": 60.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 46.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 170.0, "venuehindexmean_1": 173.0, "venuehindexmean_2": 176.5, "venuehindexmean_3": 180.0, "venuehindexmean_4": 127.3333333333, "venuehindexmean_5": 130.6666666667, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.0826042041, "pagerank_1": 2.5245981444, "pagerank_2": 2.9883170663, "pagerank_3": 2.7981114431, "pagerank_4": 3.4931210799, "pagerank_5": 3.325916574}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["So YoungKim"], "affiliation": "Duke University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 8.0, "hindex_1": 10.0, "hindex_2": 11.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 25.467, "citationsperpaper_1": 34.188, "citationsperpaper_2": 39.833, "citationsperpaper_3": 42.286, "citationsperpaper_4": 46.682, "citationsperpaper_5": 42.654, "citationsperyear_0": 31.833, "citationsperyear_1": 42.077, "citationsperyear_2": 51.214, "citationsperyear_3": 59.2, "citationsperyear_4": 64.188, "citationsperyear_5": 65.235, "totalcitations_0": 382.0, "totalcitations_1": 547.0, "totalcitations_2": 717.0, "totalcitations_3": 888.0, "totalcitations_4": 1027.0, "totalcitations_5": 1109.0, "totalpapers_0": 15.0, "totalpapers_1": 16.0, "totalpapers_2": 18.0, "totalpapers_3": 21.0, "totalpapers_4": 22.0, "totalpapers_5": 26.0, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 221.0, "recentcoauthors_1": 89.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 54.0, "recentcoauthors_4": 58.0, "recentcoauthors_5": 49.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.4444444444, "venuehindexmean_1": 127.4, "venuehindexmean_2": 131.2, "venuehindexmean_3": 122.8181818182, "venuehindexmean_4": 125.7272727273, "venuehindexmean_5": 121.0833333333, "totalvenues_0": 9.0, "totalvenues_1": 10.0, "totalvenues_2": 10.0, "totalvenues_3": 11.0, "totalvenues_4": 11.0, "totalvenues_5": 12.0, "pagerank_0": 6.7221415831, "pagerank_1": 6.8066295564, "pagerank_2": 6.75301235, "pagerank_3": 7.1663594457, "pagerank_4": 7.0303346231, "pagerank_5": 7.4547353357}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["ReinhardDummer"], "affiliation": "Prairie View A&M University", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 17.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 10.818, "citationsperpaper_1": 11.286, "citationsperpaper_2": 13.642, "citationsperpaper_3": 14.639, "citationsperpaper_4": 17.194, "citationsperpaper_5": 17.042, "citationsperyear_0": 23.8, "citationsperyear_1": 26.333, "citationsperyear_2": 32.864, "citationsperyear_3": 38.826, "citationsperyear_4": 44.417, "citationsperyear_5": 48.4, "totalcitations_0": 476.0, "totalcitations_1": 553.0, "totalcitations_2": 723.0, "totalcitations_3": 893.0, "totalcitations_4": 1066.0, "totalcitations_5": 1210.0, "totalpapers_0": 44.0, "totalpapers_1": 49.0, "totalpapers_2": 53.0, "totalpapers_3": 61.0, "totalpapers_4": 62.0, "totalpapers_5": 71.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 80.0, "recentcoauthors_1": 139.0, "recentcoauthors_2": 137.0, "recentcoauthors_3": 163.0, "recentcoauthors_4": 139.0, "recentcoauthors_5": 193.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.9090909091, "venuehindexmean_1": 117.2727272727, "venuehindexmean_2": 131.8333333333, "venuehindexmean_3": 134.4166666667, "venuehindexmean_4": 137.0, "venuehindexmean_5": 138.5333333333, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 13.1111744023, "pagerank_1": 14.5943907693, "pagerank_2": 15.11065759, "pagerank_3": 16.4785454532, "pagerank_4": 16.1679473498, "pagerank_5": 18.5561738724}}, {"model": "papers.paper", "pk": 1003542, "fields": {"authors": ["ReinhardDummer"], "affiliation": "University of Zurich", "venue": "Nature", "doi": "10.1038/nature09627", "abstract": "Recent data from early clinical trials in melanoma patients carrying mutations in the B-RAF gene have shown promising results with the B-RAF kinase inhibitor PLX4032; however, many patients eventually develop resistance to this treatment. Two papers now uncover possible mechanisms of resistance to PLX4032. One paper shows that upregulation of MAP3K8 (which encodes COT) can confer resistance of melanoma cells to B-RAF inhibitors, whereas another paper found that melanomas can acquire resistance due to mutations of N-RAS or increased expression of PDGFR\u03b2. Each of these resistance mechanisms seems to apply to at least some patients on recent PLX4032 trial, whereas, surprisingly, so far no secondary B-RAF mutations have been observed.", "year": 2010, "title": "COT drives resistance to RAF inhibition through MAP kinase pathway reactivation", "keywords": ["Proto-Oncogene Proteins c-raf", "Biology", "Melanoma", "Vemurafenib", "Cancer research", "Proto-Oncogene Proteins B-raf", "MAP kinase kinase kinase", "Mitogen-activated protein kinase", "Mitogen-activated protein kinase kinase", "MAP3K8"], "citations_0": 2.0, "citations_1": 23.0, "citations_2": 29.0, "citations_3": 31.0, "citations_4": 25.0, "citations_5": 13.0, "timescaledpagerank_0": 0.5839999658, "timescaledpagerank_1": 4.8988203522, "timescaledpagerank_2": 7.6322762578, "timescaledpagerank_3": 9.7345190015, "timescaledpagerank_4": 10.8650300883, "timescaledpagerank_5": 11.16243488, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 14.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 17.0, "adopters_0": 3.0, "adopters_1": 186.0, "adopters_2": 335.0, "adopters_3": 356.0, "adopters_4": 319.0, "adopters_5": 0.0, "citationsperpaper_0": 10.818, "citationsperpaper_1": 11.286, "citationsperpaper_2": 13.642, "citationsperpaper_3": 14.639, "citationsperpaper_4": 17.194, "citationsperpaper_5": 17.042, "citationsperyear_0": 23.8, "citationsperyear_1": 26.333, "citationsperyear_2": 32.864, "citationsperyear_3": 38.826, "citationsperyear_4": 44.417, "citationsperyear_5": 48.4, "totalcitations_0": 476.0, "totalcitations_1": 553.0, "totalcitations_2": 723.0, "totalcitations_3": 893.0, "totalcitations_4": 1066.0, "totalcitations_5": 1210.0, "totalpapers_0": 44.0, "totalpapers_1": 49.0, "totalpapers_2": 53.0, "totalpapers_3": 61.0, "totalpapers_4": 62.0, "totalpapers_5": 71.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 80.0, "recentcoauthors_1": 139.0, "recentcoauthors_2": 137.0, "recentcoauthors_3": 163.0, "recentcoauthors_4": 139.0, "recentcoauthors_5": 193.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 114.9090909091, "venuehindexmean_1": 117.2727272727, "venuehindexmean_2": 131.8333333333, "venuehindexmean_3": 134.4166666667, "venuehindexmean_4": 137.0, "venuehindexmean_5": 138.5333333333, "totalvenues_0": 11.0, "totalvenues_1": 11.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 15.0, "pagerank_0": 13.1111744023, "pagerank_1": 14.5943907693, "pagerank_2": 15.11065759, "pagerank_3": 16.4785454532, "pagerank_4": 16.1679473498, "pagerank_5": 18.5561738724}}, {"model": "papers.paper", "pk": 1003510, "fields": {"authors": ["Gregory J.Quirk"], "affiliation": "University of Puerto Rico", "venue": "Nature", "doi": "10.1038/463036a", "abstract": "Retrieving a memory initiates a window of vulnerability for that memory. Simple behavioural methods can modify distressing memories during this window, eliminating fear reactions to traumatic reminders.", "year": 2010, "title": "Neuroscience: Editing out fear", "keywords": ["Bioinformatics", "Vulnerability", "Cognitive science", "Molecular interactions", "Biology", "Distressing"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.25, "citationsperpaper_1": 12.875, "citationsperpaper_2": 11.7, "citationsperpaper_3": 14.0, "citationsperpaper_4": 15.8, "citationsperpaper_5": 16.455, "citationsperyear_0": 5.625, "citationsperyear_1": 6.059, "citationsperyear_2": 6.5, "citationsperyear_3": 7.368, "citationsperyear_4": 7.9, "citationsperyear_5": 8.619, "totalcitations_0": 90.0, "totalcitations_1": 103.0, "totalcitations_2": 117.0, "totalcitations_3": 140.0, "totalcitations_4": 158.0, "totalcitations_5": 181.0, "totalpapers_0": 8.0, "totalpapers_1": 8.0, "totalpapers_2": 10.0, "totalpapers_3": 10.0, "totalpapers_4": 10.0, "totalpapers_5": 11.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 5.0, "recentcoauthors_3": 5.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 157.5, "venuehindexmean_1": 160.75, "venuehindexmean_2": 167.0, "venuehindexmean_3": 170.8, "venuehindexmean_4": 174.0, "venuehindexmean_5": 177.4, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.5616164176, "pagerank_1": 2.532221895, "pagerank_2": 3.4486129892, "pagerank_3": 3.4357236941, "pagerank_4": 3.4189654011, "pagerank_5": 3.9360738799}}, {"model": "papers.paper", "pk": 1003510, "fields": {"authors": ["Gregory J.Quirk"], "affiliation": "Ponce Health Sciences University", "venue": "Nature", "doi": "10.1038/463036a", "abstract": "Retrieving a memory initiates a window of vulnerability for that memory. Simple behavioural methods can modify distressing memories during this window, eliminating fear reactions to traumatic reminders.", "year": 2010, "title": "Neuroscience: Editing out fear", "keywords": ["Bioinformatics", "Vulnerability", "Cognitive science", "Molecular interactions", "Biology", "Distressing"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.25, "citationsperpaper_1": 12.875, "citationsperpaper_2": 11.7, "citationsperpaper_3": 14.0, "citationsperpaper_4": 15.8, "citationsperpaper_5": 16.455, "citationsperyear_0": 5.625, "citationsperyear_1": 6.059, "citationsperyear_2": 6.5, "citationsperyear_3": 7.368, "citationsperyear_4": 7.9, "citationsperyear_5": 8.619, "totalcitations_0": 90.0, "totalcitations_1": 103.0, "totalcitations_2": 117.0, "totalcitations_3": 140.0, "totalcitations_4": 158.0, "totalcitations_5": 181.0, "totalpapers_0": 8.0, "totalpapers_1": 8.0, "totalpapers_2": 10.0, "totalpapers_3": 10.0, "totalpapers_4": 10.0, "totalpapers_5": 11.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 5.0, "recentcoauthors_3": 5.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 157.5, "venuehindexmean_1": 160.75, "venuehindexmean_2": 167.0, "venuehindexmean_3": 170.8, "venuehindexmean_4": 174.0, "venuehindexmean_5": 177.4, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 2.5616164176, "pagerank_1": 2.532221895, "pagerank_2": 3.4486129892, "pagerank_3": 3.4357236941, "pagerank_4": 3.4189654011, "pagerank_5": 3.9360738799}}, {"model": "papers.paper", "pk": 1003510, "fields": {"authors": ["Mohammed R.Milad"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/463036a", "abstract": "Retrieving a memory initiates a window of vulnerability for that memory. Simple behavioural methods can modify distressing memories during this window, eliminating fear reactions to traumatic reminders.", "year": 2010, "title": "Neuroscience: Editing out fear", "keywords": ["Bioinformatics", "Vulnerability", "Cognitive science", "Molecular interactions", "Biology", "Distressing"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.3050386198, "pagerank_1": 0.303257042, "pagerank_2": 0.3037013587, "pagerank_3": 0.3031361544, "pagerank_4": 0.3024001747, "pagerank_5": 0.3087235211}}, {"model": "papers.paper", "pk": 1003321, "fields": {"authors": ["AnnaleeYassi"], "affiliation": "University of Manitoba", "venue": "Nature", "doi": "10.1038/464486a", "abstract": "", "year": 2010, "title": "Industry in academia: ethical frameworks would clarify links.", "keywords": ["Political science", "Engineering ethics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 2.333, "citationsperpaper_4": 2.333, "citationsperpaper_5": 2.333, "citationsperyear_0": 0.429, "citationsperyear_1": 0.4, "citationsperyear_2": 0.375, "citationsperyear_3": 0.412, "citationsperyear_4": 0.389, "citationsperyear_5": 0.368, "totalcitations_0": 6.0, "totalcitations_1": 6.0, "totalcitations_2": 6.0, "totalcitations_3": 7.0, "totalcitations_4": 7.0, "totalcitations_5": 7.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 2.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 165.5, "venuehindexmean_1": 168.5, "venuehindexmean_2": 171.5, "venuehindexmean_3": 175.0, "venuehindexmean_4": 178.5, "venuehindexmean_5": 181.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.1158494319, "pagerank_1": 1.1157315807, "pagerank_2": 1.1155727702, "pagerank_3": 0.9440901666, "pagerank_4": 0.9422906002, "pagerank_5": 0.9411849696}}, {"model": "papers.paper", "pk": 1003321, "fields": {"authors": ["AnnaleeYassi", "JerrySpiegel", "ShafikDharamsi"], "affiliation": "University of British Columbia", "venue": "Nature", "doi": "10.1038/464486a", "abstract": "", "year": 2010, "title": "Industry in academia: ethical frameworks would clarify links.", "keywords": ["Political science", "Engineering ethics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.3333333333, "hindex_1": 0.3333333333, "hindex_2": 0.3333333333, "hindex_3": 0.6666666667, "hindex_4": 0.6666666667, "hindex_5": 0.6666666667, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.6666666667, "citationsperpaper_1": 0.6666666667, "citationsperpaper_2": 0.6666666667, "citationsperpaper_3": 0.8886666667, "citationsperpaper_4": 0.8886666667, "citationsperpaper_5": 0.8886666667, "citationsperyear_0": 0.143, "citationsperyear_1": 0.1333333333, "citationsperyear_2": 0.125, "citationsperyear_3": 0.1676666667, "citationsperyear_4": 0.1573333333, "citationsperyear_5": 0.1483333333, "totalcitations_0": 2.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 2.6666666667, "totalcitations_4": 2.6666666667, "totalcitations_5": 2.6666666667, "totalpapers_0": 2.3333333333, "totalpapers_1": 2.3333333333, "totalpapers_2": 2.3333333333, "totalpapers_3": 2.6666666667, "totalpapers_4": 2.6666666667, "totalpapers_5": 2.6666666667, "authorage_0": 6.6666666667, "authorage_1": 7.6666666667, "authorage_2": 8.6666666667, "authorage_3": 9.6666666667, "authorage_4": 10.6666666667, "authorage_5": 11.6666666667, "recentcoauthors_0": 2.0, "recentcoauthors_1": 2.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.6666666667, "recentcoauthors_4": 0.6666666667, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 197.0, "venuehindexmean_1": 200.3333333333, "venuehindexmean_2": 204.0, "venuehindexmean_3": 170.0, "venuehindexmean_4": 174.3333333333, "venuehindexmean_5": 177.3333333333, "totalvenues_0": 1.6666666667, "totalvenues_1": 1.6666666667, "totalvenues_2": 1.6666666667, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.1424303577, "pagerank_1": 1.1422564746, "pagerank_2": 1.1420132835, "pagerank_3": 1.0269277237, "pagerank_4": 1.0239331431, "pagerank_5": 1.0221013189}}, {"model": "papers.paper", "pk": 1003061, "fields": {"authors": ["Helle F.J\u00f8rgensen"], "affiliation": "University of Cambridge", "venue": "Nature", "doi": "10.1038/nature09305", "abstract": "Arising from: S. K. Singh et al. , 223\u2013227 (2008)10.1038/nature06863\n ; Singh et al. reply\n The contribution of REST to embryonic stem (ES) cell pluripotency has been uncertain. Two years ago, Singh et al.1 claimed that Rest+/\u2212 and REST knock-down ES cells expressed reduced levels of pluripotency markers1, in contrast to a prior2 and subsequent reports3,4,5,6. To understand the basis of this difference, we analysed the YHC334 (YHC) and RRC160 (RRC) gene-trap ES cell lines used by Singh et al.1, obtained directly from BayGenomics. Both REST mutant lines generated REST\u2013\u03b2Geo fusion proteins, but expressed pluripotency genes at levels similar to appropriately matched parental wild ES cells, consistent with expression being REST\u2013independent.", "year": 2010, "title": "Can controversies be put to REST", "keywords": ["Gene", "Cell", "Cell biology", "Biology", "Cell culture", "Embryonic stem cell", "Stem cell", "Fusion protein", "Mutant"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0522246121, "timescaledpagerank_1": 0.1235550933, "timescaledpagerank_2": 0.2172916706, "timescaledpagerank_3": 0.2625043594, "timescaledpagerank_4": 0.2842328503, "timescaledpagerank_5": 0.2942645109, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 13.583, "citationsperpaper_1": 17.417, "citationsperpaper_2": 20.333, "citationsperpaper_3": 21.0, "citationsperpaper_4": 22.462, "citationsperpaper_5": 22.286, "citationsperyear_0": 8.15, "citationsperyear_1": 9.952, "citationsperyear_2": 11.091, "citationsperyear_3": 11.87, "citationsperyear_4": 12.167, "citationsperyear_5": 12.48, "totalcitations_0": 163.0, "totalcitations_1": 209.0, "totalcitations_2": 244.0, "totalcitations_3": 273.0, "totalcitations_4": 292.0, "totalcitations_5": 312.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 12.0, "totalpapers_3": 13.0, "totalpapers_4": 13.0, "totalpapers_5": 14.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 48.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 103.125, "venuehindexmean_1": 107.125, "venuehindexmean_2": 110.5, "venuehindexmean_3": 110.1111111111, "venuehindexmean_4": 113.2222222222, "venuehindexmean_5": 115.5555555556, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 3.1732912902, "pagerank_1": 3.0657274261, "pagerank_2": 2.9302030196, "pagerank_3": 3.0575775545, "pagerank_4": 2.963896105, "pagerank_5": 3.1107303062}}, {"model": "papers.paper", "pk": 1003061, "fields": {"authors": ["Helle F.J\u00f8rgensen"], "affiliation": "National Institute for Medical Research", "venue": "Nature", "doi": "10.1038/nature09305", "abstract": "Arising from: S. K. Singh et al. , 223\u2013227 (2008)10.1038/nature06863\n ; Singh et al. reply\n The contribution of REST to embryonic stem (ES) cell pluripotency has been uncertain. Two years ago, Singh et al.1 claimed that Rest+/\u2212 and REST knock-down ES cells expressed reduced levels of pluripotency markers1, in contrast to a prior2 and subsequent reports3,4,5,6. To understand the basis of this difference, we analysed the YHC334 (YHC) and RRC160 (RRC) gene-trap ES cell lines used by Singh et al.1, obtained directly from BayGenomics. Both REST mutant lines generated REST\u2013\u03b2Geo fusion proteins, but expressed pluripotency genes at levels similar to appropriately matched parental wild ES cells, consistent with expression being REST\u2013independent.", "year": 2010, "title": "Can controversies be put to REST", "keywords": ["Gene", "Cell", "Cell biology", "Biology", "Cell culture", "Embryonic stem cell", "Stem cell", "Fusion protein", "Mutant"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0522246121, "timescaledpagerank_1": 0.1235550933, "timescaledpagerank_2": 0.2172916706, "timescaledpagerank_3": 0.2625043594, "timescaledpagerank_4": 0.2842328503, "timescaledpagerank_5": 0.2942645109, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 13.583, "citationsperpaper_1": 17.417, "citationsperpaper_2": 20.333, "citationsperpaper_3": 21.0, "citationsperpaper_4": 22.462, "citationsperpaper_5": 22.286, "citationsperyear_0": 8.15, "citationsperyear_1": 9.952, "citationsperyear_2": 11.091, "citationsperyear_3": 11.87, "citationsperyear_4": 12.167, "citationsperyear_5": 12.48, "totalcitations_0": 163.0, "totalcitations_1": 209.0, "totalcitations_2": 244.0, "totalcitations_3": 273.0, "totalcitations_4": 292.0, "totalcitations_5": 312.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 12.0, "totalpapers_3": 13.0, "totalpapers_4": 13.0, "totalpapers_5": 14.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 48.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 103.125, "venuehindexmean_1": 107.125, "venuehindexmean_2": 110.5, "venuehindexmean_3": 110.1111111111, "venuehindexmean_4": 113.2222222222, "venuehindexmean_5": 115.5555555556, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 3.1732912902, "pagerank_1": 3.0657274261, "pagerank_2": 2.9302030196, "pagerank_3": 3.0575775545, "pagerank_4": 2.963896105, "pagerank_5": 3.1107303062}}, {"model": "papers.paper", "pk": 1003061, "fields": {"authors": ["Helle F.J\u00f8rgensen"], "affiliation": "Aarhus University", "venue": "Nature", "doi": "10.1038/nature09305", "abstract": "Arising from: S. K. Singh et al. , 223\u2013227 (2008)10.1038/nature06863\n ; Singh et al. reply\n The contribution of REST to embryonic stem (ES) cell pluripotency has been uncertain. Two years ago, Singh et al.1 claimed that Rest+/\u2212 and REST knock-down ES cells expressed reduced levels of pluripotency markers1, in contrast to a prior2 and subsequent reports3,4,5,6. To understand the basis of this difference, we analysed the YHC334 (YHC) and RRC160 (RRC) gene-trap ES cell lines used by Singh et al.1, obtained directly from BayGenomics. Both REST mutant lines generated REST\u2013\u03b2Geo fusion proteins, but expressed pluripotency genes at levels similar to appropriately matched parental wild ES cells, consistent with expression being REST\u2013independent.", "year": 2010, "title": "Can controversies be put to REST", "keywords": ["Gene", "Cell", "Cell biology", "Biology", "Cell culture", "Embryonic stem cell", "Stem cell", "Fusion protein", "Mutant"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0522246121, "timescaledpagerank_1": 0.1235550933, "timescaledpagerank_2": 0.2172916706, "timescaledpagerank_3": 0.2625043594, "timescaledpagerank_4": 0.2842328503, "timescaledpagerank_5": 0.2942645109, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 13.583, "citationsperpaper_1": 17.417, "citationsperpaper_2": 20.333, "citationsperpaper_3": 21.0, "citationsperpaper_4": 22.462, "citationsperpaper_5": 22.286, "citationsperyear_0": 8.15, "citationsperyear_1": 9.952, "citationsperyear_2": 11.091, "citationsperyear_3": 11.87, "citationsperyear_4": 12.167, "citationsperyear_5": 12.48, "totalcitations_0": 163.0, "totalcitations_1": 209.0, "totalcitations_2": 244.0, "totalcitations_3": 273.0, "totalcitations_4": 292.0, "totalcitations_5": 312.0, "totalpapers_0": 12.0, "totalpapers_1": 12.0, "totalpapers_2": 12.0, "totalpapers_3": 13.0, "totalpapers_4": 13.0, "totalpapers_5": 14.0, "authorage_0": 19.0, "authorage_1": 20.0, "authorage_2": 21.0, "authorage_3": 22.0, "authorage_4": 23.0, "authorage_5": 24.0, "recentcoauthors_0": 48.0, "recentcoauthors_1": 31.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 103.125, "venuehindexmean_1": 107.125, "venuehindexmean_2": 110.5, "venuehindexmean_3": 110.1111111111, "venuehindexmean_4": 113.2222222222, "venuehindexmean_5": 115.5555555556, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 3.1732912902, "pagerank_1": 3.0657274261, "pagerank_2": 2.9302030196, "pagerank_3": 3.0575775545, "pagerank_4": 2.963896105, "pagerank_5": 3.1107303062}}, {"model": "papers.paper", "pk": 1003061, "fields": {"authors": ["Amanda G.Fisher", "Helle F.J\u00f8rgensen"], "affiliation": "Medical Research Council", "venue": "Nature", "doi": "10.1038/nature09305", "abstract": "Arising from: S. K. Singh et al. , 223\u2013227 (2008)10.1038/nature06863\n ; Singh et al. reply\n The contribution of REST to embryonic stem (ES) cell pluripotency has been uncertain. Two years ago, Singh et al.1 claimed that Rest+/\u2212 and REST knock-down ES cells expressed reduced levels of pluripotency markers1, in contrast to a prior2 and subsequent reports3,4,5,6. To understand the basis of this difference, we analysed the YHC334 (YHC) and RRC160 (RRC) gene-trap ES cell lines used by Singh et al.1, obtained directly from BayGenomics. Both REST mutant lines generated REST\u2013\u03b2Geo fusion proteins, but expressed pluripotency genes at levels similar to appropriately matched parental wild ES cells, consistent with expression being REST\u2013independent.", "year": 2010, "title": "Can controversies be put to REST", "keywords": ["Gene", "Cell", "Cell biology", "Biology", "Cell culture", "Embryonic stem cell", "Stem cell", "Fusion protein", "Mutant"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0522246121, "timescaledpagerank_1": 0.1235550933, "timescaledpagerank_2": 0.2172916706, "timescaledpagerank_3": 0.2625043594, "timescaledpagerank_4": 0.2842328503, "timescaledpagerank_5": 0.2942645109, "hindex_0": 12.0, "hindex_1": 13.0, "hindex_2": 13.5, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 19.572, "citationsperpaper_1": 22.5455, "citationsperpaper_2": 25.4225, "citationsperpaper_3": 26.0745, "citationsperpaper_4": 27.408, "citationsperpaper_5": 27.583, "citationsperyear_0": 24.229, "citationsperyear_1": 27.013, "citationsperyear_2": 28.974, "citationsperyear_3": 31.1765, "citationsperyear_4": 31.967, "citationsperyear_5": 32.756, "totalcitations_0": 605.5, "totalcitations_1": 699.5, "totalcitations_2": 778.0, "totalcitations_3": 868.5, "totalcitations_4": 922.5, "totalcitations_5": 978.0, "totalpapers_0": 26.5, "totalpapers_1": 27.5, "totalpapers_2": 27.5, "totalpapers_3": 30.0, "totalpapers_4": 30.5, "totalpapers_5": 32.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 79.0, "recentcoauthors_1": 56.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 14.5, "recentcoauthors_4": 21.5, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 115.2958333333, "venuehindexmean_1": 118.9291666667, "venuehindexmean_2": 122.55, "venuehindexmean_3": 121.4618055556, "venuehindexmean_4": 124.5173611111, "venuehindexmean_5": 126.9652777778, "totalvenues_0": 11.5, "totalvenues_1": 11.5, "totalvenues_2": 11.5, "totalvenues_3": 12.5, "totalvenues_4": 12.5, "totalvenues_5": 12.5, "pagerank_0": 6.9752248584, "pagerank_1": 7.0035649118, "pagerank_2": 6.6493006222, "pagerank_3": 6.8313337689, "pagerank_4": 6.7902098664, "pagerank_5": 6.8814922083}}, {"model": "papers.paper", "pk": 1003061, "fields": {"authors": ["Amanda G.Fisher", "Helle F.J\u00f8rgensen"], "affiliation": "Imperial College London", "venue": "Nature", "doi": "10.1038/nature09305", "abstract": "Arising from: S. K. Singh et al. , 223\u2013227 (2008)10.1038/nature06863\n ; Singh et al. reply\n The contribution of REST to embryonic stem (ES) cell pluripotency has been uncertain. Two years ago, Singh et al.1 claimed that Rest+/\u2212 and REST knock-down ES cells expressed reduced levels of pluripotency markers1, in contrast to a prior2 and subsequent reports3,4,5,6. To understand the basis of this difference, we analysed the YHC334 (YHC) and RRC160 (RRC) gene-trap ES cell lines used by Singh et al.1, obtained directly from BayGenomics. Both REST mutant lines generated REST\u2013\u03b2Geo fusion proteins, but expressed pluripotency genes at levels similar to appropriately matched parental wild ES cells, consistent with expression being REST\u2013independent.", "year": 2010, "title": "Can controversies be put to REST", "keywords": ["Gene", "Cell", "Cell biology", "Biology", "Cell culture", "Embryonic stem cell", "Stem cell", "Fusion protein", "Mutant"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0522246121, "timescaledpagerank_1": 0.1235550933, "timescaledpagerank_2": 0.2172916706, "timescaledpagerank_3": 0.2625043594, "timescaledpagerank_4": 0.2842328503, "timescaledpagerank_5": 0.2942645109, "hindex_0": 12.0, "hindex_1": 13.0, "hindex_2": 13.5, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 19.572, "citationsperpaper_1": 22.5455, "citationsperpaper_2": 25.4225, "citationsperpaper_3": 26.0745, "citationsperpaper_4": 27.408, "citationsperpaper_5": 27.583, "citationsperyear_0": 24.229, "citationsperyear_1": 27.013, "citationsperyear_2": 28.974, "citationsperyear_3": 31.1765, "citationsperyear_4": 31.967, "citationsperyear_5": 32.756, "totalcitations_0": 605.5, "totalcitations_1": 699.5, "totalcitations_2": 778.0, "totalcitations_3": 868.5, "totalcitations_4": 922.5, "totalcitations_5": 978.0, "totalpapers_0": 26.5, "totalpapers_1": 27.5, "totalpapers_2": 27.5, "totalpapers_3": 30.0, "totalpapers_4": 30.5, "totalpapers_5": 32.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 79.0, "recentcoauthors_1": 56.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 14.5, "recentcoauthors_4": 21.5, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 115.2958333333, "venuehindexmean_1": 118.9291666667, "venuehindexmean_2": 122.55, "venuehindexmean_3": 121.4618055556, "venuehindexmean_4": 124.5173611111, "venuehindexmean_5": 126.9652777778, "totalvenues_0": 11.5, "totalvenues_1": 11.5, "totalvenues_2": 11.5, "totalvenues_3": 12.5, "totalvenues_4": 12.5, "totalvenues_5": 12.5, "pagerank_0": 6.9752248584, "pagerank_1": 7.0035649118, "pagerank_2": 6.6493006222, "pagerank_3": 6.8313337689, "pagerank_4": 6.7902098664, "pagerank_5": 6.8814922083}}, {"model": "papers.paper", "pk": 1003061, "fields": {"authors": ["Amanda G.Fisher"], "affiliation": "Hammersmith Hospital", "venue": "Nature", "doi": "10.1038/nature09305", "abstract": "Arising from: S. K. Singh et al. , 223\u2013227 (2008)10.1038/nature06863\n ; Singh et al. reply\n The contribution of REST to embryonic stem (ES) cell pluripotency has been uncertain. Two years ago, Singh et al.1 claimed that Rest+/\u2212 and REST knock-down ES cells expressed reduced levels of pluripotency markers1, in contrast to a prior2 and subsequent reports3,4,5,6. To understand the basis of this difference, we analysed the YHC334 (YHC) and RRC160 (RRC) gene-trap ES cell lines used by Singh et al.1, obtained directly from BayGenomics. Both REST mutant lines generated REST\u2013\u03b2Geo fusion proteins, but expressed pluripotency genes at levels similar to appropriately matched parental wild ES cells, consistent with expression being REST\u2013independent.", "year": 2010, "title": "Can controversies be put to REST", "keywords": ["Gene", "Cell", "Cell biology", "Biology", "Cell culture", "Embryonic stem cell", "Stem cell", "Fusion protein", "Mutant"], "citations_0": 1.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.0522246121, "timescaledpagerank_1": 0.1235550933, "timescaledpagerank_2": 0.2172916706, "timescaledpagerank_3": 0.2625043594, "timescaledpagerank_4": 0.2842328503, "timescaledpagerank_5": 0.2942645109, "hindex_0": 19.0, "hindex_1": 20.0, "hindex_2": 21.0, "hindex_3": 22.0, "hindex_4": 22.0, "hindex_5": 22.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 25.561, "citationsperpaper_1": 27.674, "citationsperpaper_2": 30.512, "citationsperpaper_3": 31.149, "citationsperpaper_4": 32.354, "citationsperpaper_5": 32.88, "citationsperyear_0": 40.308, "citationsperyear_1": 44.074, "citationsperyear_2": 46.857, "citationsperyear_3": 50.483, "citationsperyear_4": 51.767, "citationsperyear_5": 53.032, "totalcitations_0": 1048.0, "totalcitations_1": 1190.0, "totalcitations_2": 1312.0, "totalcitations_3": 1464.0, "totalcitations_4": 1553.0, "totalcitations_5": 1644.0, "totalpapers_0": 41.0, "totalpapers_1": 43.0, "totalpapers_2": 43.0, "totalpapers_3": 47.0, "totalpapers_4": 48.0, "totalpapers_5": 50.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 110.0, "recentcoauthors_1": 81.0, "recentcoauthors_2": 18.0, "recentcoauthors_3": 25.0, "recentcoauthors_4": 39.0, "recentcoauthors_5": 33.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 127.4666666667, "venuehindexmean_1": 130.7333333333, "venuehindexmean_2": 134.6, "venuehindexmean_3": 132.8125, "venuehindexmean_4": 135.8125, "venuehindexmean_5": 138.375, "totalvenues_0": 15.0, "totalvenues_1": 15.0, "totalvenues_2": 15.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 10.7771584267, "pagerank_1": 10.9414023975, "pagerank_2": 10.3683982248, "pagerank_3": 10.6050899834, "pagerank_4": 10.6165236278, "pagerank_5": 10.6522541104}}, {"model": "papers.paper", "pk": 1003616, "fields": {"authors": ["Felicia A.Huppert"], "affiliation": "University of Cambridge", "venue": "Nature", "doi": "10.1038/4641275a", "abstract": "", "year": 2010, "title": "Happiness breeds prosperity", "keywords": ["Development economics", "Economics", "Happiness", "Prosperity"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.667, "citationsperpaper_1": 2.167, "citationsperpaper_2": 2.333, "citationsperpaper_3": 2.5, "citationsperpaper_4": 2.5, "citationsperpaper_5": 2.667, "citationsperyear_0": 0.233, "citationsperyear_1": 0.295, "citationsperyear_2": 0.311, "citationsperyear_3": 0.326, "citationsperyear_4": 0.319, "citationsperyear_5": 0.333, "totalcitations_0": 10.0, "totalcitations_1": 13.0, "totalcitations_2": 14.0, "totalcitations_3": 15.0, "totalcitations_4": 15.0, "totalcitations_5": 16.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 42.0, "authorage_1": 43.0, "authorage_2": 44.0, "authorage_3": 45.0, "authorage_4": 46.0, "authorage_5": 47.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 195.6666666667, "venuehindexmean_1": 199.6666666667, "venuehindexmean_2": 205.6666666667, "venuehindexmean_3": 210.6666666667, "venuehindexmean_4": 214.3333333333, "venuehindexmean_5": 218.6666666667, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.7118181703, "pagerank_1": 1.6342428811, "pagerank_2": 1.5798380107, "pagerank_3": 1.5229080065, "pagerank_4": 1.5119340372, "pagerank_5": 1.4918439849}}, {"model": "papers.paper", "pk": 1004260, "fields": {"authors": ["KatherineSixt"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nj7305-519b", "abstract": "'Alternative' careers may be commonplace, but that doesn't mitigate a sense of failure, says Katherine Sixt.", "year": 2010, "title": "Finding a 'real' job", "keywords": ["Marketing", "Job analysis", "Psychology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "Armed Forces Institute of Pathology", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "Fudan University", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "University of Colorado Boulder", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "Chinese Center for Disease Control and Prevention", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "University of Edinburgh", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "John E. Fogarty International Center", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "University of Sydney", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "Pennsylvania State University", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003315, "fields": {"authors": ["Edward C.Holmes"], "affiliation": "University of Oxford", "venue": "Nature", "doi": "10.1038/467404a", "abstract": "Plasmodium falciparum is the agent of the deadliest form of human malaria. A survey of Plasmodium diversity in African apes reveals that western gorillas are the reservoir species for this parasite. See Article p. 420", "year": 2010, "title": "Malaria: The gorilla connection", "keywords": ["Virology", "Biology", "Malaria", "Gorilla", "Parasite hosting", "Parasitology", "Plasmodium falciparum"], "citations_0": 0.0, "citations_1": 2.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1193527462, "timescaledpagerank_2": 0.0087316618, "timescaledpagerank_3": 0.0861624587, "timescaledpagerank_4": 0.1417535832, "timescaledpagerank_5": 0.1705422217, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.907, "citationsperpaper_1": 6.885, "citationsperpaper_2": 7.415, "citationsperpaper_3": 7.493, "citationsperpaper_4": 7.886, "citationsperpaper_5": 8.034, "citationsperyear_0": 20.722, "citationsperyear_1": 22.105, "citationsperyear_2": 24.1, "citationsperyear_3": 26.048, "citationsperyear_4": 28.318, "citationsperyear_5": 30.391, "totalcitations_0": 373.0, "totalcitations_1": 420.0, "totalcitations_2": 482.0, "totalcitations_3": 547.0, "totalcitations_4": 623.0, "totalcitations_5": 699.0, "totalpapers_0": 54.0, "totalpapers_1": 61.0, "totalpapers_2": 65.0, "totalpapers_3": 73.0, "totalpapers_4": 79.0, "totalpapers_5": 87.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 29.0, "recentcoauthors_1": 63.0, "recentcoauthors_2": 97.0, "recentcoauthors_3": 164.0, "recentcoauthors_4": 156.0, "recentcoauthors_5": 228.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 104.5, "venuehindexmean_1": 100.4615384615, "venuehindexmean_2": 103.8461538462, "venuehindexmean_3": 107.1538461538, "venuehindexmean_4": 110.2857142857, "venuehindexmean_5": 123.5333333333, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 13.0, "totalvenues_4": 14.0, "totalvenues_5": 15.0, "pagerank_0": 11.5056483137, "pagerank_1": 12.2004805742, "pagerank_2": 12.915290807, "pagerank_3": 15.6531435911, "pagerank_4": 16.4741345049, "pagerank_5": 19.0537083358}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["SvenFindei\u00df"], "affiliation": "Arizona State University", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 35.0, "citationsperpaper_1": 47.0, "citationsperpaper_2": 57.0, "citationsperpaper_3": 67.0, "citationsperpaper_4": 77.0, "citationsperpaper_5": 85.5, "citationsperyear_0": 17.5, "citationsperyear_1": 18.8, "citationsperyear_2": 19.0, "citationsperyear_3": 19.143, "citationsperyear_4": 19.25, "citationsperyear_5": 19.0, "totalcitations_0": 70.0, "totalcitations_1": 94.0, "totalcitations_2": 114.0, "totalcitations_3": 134.0, "totalcitations_4": 154.0, "totalcitations_5": 171.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 2.9539383934, "pagerank_1": 2.993715385, "pagerank_2": 2.9485654309, "pagerank_3": 2.951677379, "pagerank_4": 2.9569490566, "pagerank_5": 2.9271046452}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["SvenFindei\u00df", "Peter F.Stadler", "SteveHoffmann"], "affiliation": "Leipzig University", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 3.3333333333, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.6666666667, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 21.9443333333, "citationsperpaper_1": 30.3973333333, "citationsperpaper_2": 34.6, "citationsperpaper_3": 34.3313333333, "citationsperpaper_4": 39.8493333333, "citationsperpaper_5": 41.295, "citationsperyear_0": 10.406, "citationsperyear_1": 13.1916666667, "citationsperyear_2": 14.2246666667, "citationsperyear_3": 15.5676666667, "citationsperyear_4": 16.8633333333, "citationsperyear_5": 17.2073333333, "totalcitations_0": 138.3333333333, "totalcitations_1": 188.0, "totalcitations_2": 230.6666666667, "totalcitations_3": 269.0, "totalcitations_4": 308.0, "totalcitations_5": 337.0, "totalpapers_0": 5.3333333333, "totalpapers_1": 5.6666666667, "totalpapers_2": 6.6666666667, "totalpapers_3": 10.3333333333, "totalpapers_4": 10.3333333333, "totalpapers_5": 12.6666666667, "authorage_0": 13.6666666667, "authorage_1": 14.6666666667, "authorage_2": 15.6666666667, "authorage_3": 16.6666666667, "authorage_4": 17.6666666667, "authorage_5": 18.6666666667, "recentcoauthors_0": 61.0, "recentcoauthors_1": 66.3333333333, "recentcoauthors_2": 86.3333333333, "recentcoauthors_3": 198.6666666667, "recentcoauthors_4": 117.6666666667, "recentcoauthors_5": 89.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 181.5416666667, "venuehindexmean_1": 185.9583333333, "venuehindexmean_2": 182.7407407407, "venuehindexmean_3": 173.9333333333, "venuehindexmean_4": 177.8, "venuehindexmean_5": 184.5888888889, "totalvenues_0": 3.6666666667, "totalvenues_1": 3.6666666667, "totalvenues_2": 4.3333333333, "totalvenues_3": 5.3333333333, "totalvenues_4": 5.3333333333, "totalvenues_5": 5.6666666667, "pagerank_0": 3.2273370286, "pagerank_1": 3.2367496688, "pagerank_2": 4.1051349357, "pagerank_3": 5.6741465521, "pagerank_4": 5.517755712, "pagerank_5": 6.5708719091}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["Cynthia M.Sharma", "Peter F.Stadler", "AlexandraSittka", "RichardReinhardt", "J\u00f6rgVogel"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 5.6, "hindex_1": 6.6, "hindex_2": 7.4, "hindex_3": 8.6, "hindex_4": 9.8, "hindex_5": 10.2, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 17.0338, "citationsperpaper_1": 20.0352, "citationsperpaper_2": 21.8314, "citationsperpaper_3": 23.1028, "citationsperpaper_4": 25.2482, "citationsperpaper_5": 26.4376, "citationsperyear_0": 17.017, "citationsperyear_1": 20.292, "citationsperyear_2": 24.2996, "citationsperyear_3": 28.181, "citationsperyear_4": 29.7896, "citationsperyear_5": 31.3372, "totalcitations_0": 362.4, "totalcitations_1": 423.4, "totalcitations_2": 495.8, "totalcitations_3": 574.4, "totalcitations_4": 634.2, "totalcitations_5": 689.8, "totalpapers_0": 13.6, "totalpapers_1": 16.0, "totalpapers_2": 18.8, "totalpapers_3": 21.8, "totalpapers_4": 22.6, "totalpapers_5": 24.2, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 69.8, "recentcoauthors_1": 87.0, "recentcoauthors_2": 101.6, "recentcoauthors_3": 124.2, "recentcoauthors_4": 53.2, "recentcoauthors_5": 36.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 121.9734848485, "venuehindexmean_1": 125.3204545455, "venuehindexmean_2": 130.553989899, "venuehindexmean_3": 135.2975757576, "venuehindexmean_4": 140.5081818182, "venuehindexmean_5": 143.3972727273, "totalvenues_0": 6.8, "totalvenues_1": 6.8, "totalvenues_2": 7.4, "totalvenues_3": 7.8, "totalvenues_4": 8.2, "totalvenues_5": 8.2, "pagerank_0": 6.1657809147, "pagerank_1": 6.8742849403, "pagerank_2": 7.7327118966, "pagerank_3": 8.427817174, "pagerank_4": 8.4078946939, "pagerank_5": 8.7066520286}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["FabienDarfeuille", "J\u00e9r\u00e9myReignier", "SandrineChabas"], "affiliation": "University of Bordeaux", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 1.6666666667, "hindex_1": 1.6666666667, "hindex_2": 1.6666666667, "hindex_3": 1.6666666667, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 6.25, "citationsperpaper_1": 14.6666666667, "citationsperpaper_2": 21.3333333333, "citationsperpaper_3": 28.0, "citationsperpaper_4": 33.8333333333, "citationsperpaper_5": 39.5, "citationsperyear_0": 4.6296666667, "citationsperyear_1": 6.9333333333, "citationsperyear_2": 7.2726666667, "citationsperyear_3": 7.5556666667, "citationsperyear_4": 7.6103333333, "citationsperyear_5": 7.635, "totalcitations_0": 15.0, "totalcitations_1": 26.6666666667, "totalcitations_2": 37.3333333333, "totalcitations_3": 48.0, "totalcitations_4": 57.3333333333, "totalcitations_5": 66.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 2.6666666667, "authorage_1": 3.6666666667, "authorage_2": 4.6666666667, "authorage_3": 5.6666666667, "authorage_4": 6.6666666667, "authorage_5": 7.6666666667, "recentcoauthors_0": 11.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 235.5555555556, "venuehindexmean_1": 239.2222222222, "venuehindexmean_2": 243.5555555556, "venuehindexmean_3": 248.8888888889, "venuehindexmean_4": 253.2222222222, "venuehindexmean_5": 256.6666666667, "totalvenues_0": 1.6666666667, "totalvenues_1": 1.6666666667, "totalvenues_2": 1.6666666667, "totalvenues_3": 1.6666666667, "totalvenues_4": 1.6666666667, "totalvenues_5": 1.6666666667, "pagerank_0": 0.6330549495, "pagerank_1": 0.6297979454, "pagerank_2": 0.5926893386, "pagerank_3": 0.5771958198, "pagerank_4": 0.5754974934, "pagerank_5": 0.5642038079}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["FabienDarfeuille", "J\u00e9r\u00e9myReignier", "SandrineChabas"], "affiliation": "French Institute of Health and Medical Research", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 1.6666666667, "hindex_1": 1.6666666667, "hindex_2": 1.6666666667, "hindex_3": 1.6666666667, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 6.25, "citationsperpaper_1": 14.6666666667, "citationsperpaper_2": 21.3333333333, "citationsperpaper_3": 28.0, "citationsperpaper_4": 33.8333333333, "citationsperpaper_5": 39.5, "citationsperyear_0": 4.6296666667, "citationsperyear_1": 6.9333333333, "citationsperyear_2": 7.2726666667, "citationsperyear_3": 7.5556666667, "citationsperyear_4": 7.6103333333, "citationsperyear_5": 7.635, "totalcitations_0": 15.0, "totalcitations_1": 26.6666666667, "totalcitations_2": 37.3333333333, "totalcitations_3": 48.0, "totalcitations_4": 57.3333333333, "totalcitations_5": 66.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 2.6666666667, "authorage_1": 3.6666666667, "authorage_2": 4.6666666667, "authorage_3": 5.6666666667, "authorage_4": 6.6666666667, "authorage_5": 7.6666666667, "recentcoauthors_0": 11.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 235.5555555556, "venuehindexmean_1": 239.2222222222, "venuehindexmean_2": 243.5555555556, "venuehindexmean_3": 248.8888888889, "venuehindexmean_4": 253.2222222222, "venuehindexmean_5": 256.6666666667, "totalvenues_0": 1.6666666667, "totalvenues_1": 1.6666666667, "totalvenues_2": 1.6666666667, "totalvenues_3": 1.6666666667, "totalvenues_4": 1.6666666667, "totalvenues_5": 1.6666666667, "pagerank_0": 0.6330549495, "pagerank_1": 0.6297979454, "pagerank_2": 0.5926893386, "pagerank_3": 0.5771958198, "pagerank_4": 0.5754974934, "pagerank_5": 0.5642038079}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["Peter F.Stadler"], "affiliation": "Santa Fe Institute", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 28.333, "citationsperpaper_1": 34.692, "citationsperpaper_2": 36.467, "citationsperpaper_3": 29.619, "citationsperpaper_4": 33.048, "citationsperpaper_5": 29.84, "citationsperyear_0": 8.718, "citationsperyear_1": 11.275, "citationsperyear_2": 13.341, "citationsperyear_3": 14.81, "citationsperyear_4": 16.14, "citationsperyear_5": 16.955, "totalcitations_0": 340.0, "totalcitations_1": 451.0, "totalcitations_2": 547.0, "totalcitations_3": 622.0, "totalcitations_4": 694.0, "totalcitations_5": 746.0, "totalpapers_0": 12.0, "totalpapers_1": 13.0, "totalpapers_2": 15.0, "totalpapers_3": 21.0, "totalpapers_4": 21.0, "totalpapers_5": 25.0, "authorage_0": 38.0, "authorage_1": 39.0, "authorage_2": 40.0, "authorage_3": 41.0, "authorage_4": 42.0, "authorage_5": 43.0, "recentcoauthors_0": 91.0, "recentcoauthors_1": 107.0, "recentcoauthors_2": 205.0, "recentcoauthors_3": 392.0, "recentcoauthors_4": 203.0, "recentcoauthors_5": 148.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.125, "venuehindexmean_1": 139.375, "venuehindexmean_2": 139.2222222222, "venuehindexmean_3": 132.6, "venuehindexmean_4": 136.0, "venuehindexmean_5": 139.6, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 5.4817375442, "pagerank_1": 5.4950648103, "pagerank_2": 7.4298414209, "pagerank_3": 10.0609386971, "pagerank_4": 9.7631057506, "pagerank_5": 11.7272825616}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["Peter F.Stadler"], "affiliation": "University of Vienna", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 28.333, "citationsperpaper_1": 34.692, "citationsperpaper_2": 36.467, "citationsperpaper_3": 29.619, "citationsperpaper_4": 33.048, "citationsperpaper_5": 29.84, "citationsperyear_0": 8.718, "citationsperyear_1": 11.275, "citationsperyear_2": 13.341, "citationsperyear_3": 14.81, "citationsperyear_4": 16.14, "citationsperyear_5": 16.955, "totalcitations_0": 340.0, "totalcitations_1": 451.0, "totalcitations_2": 547.0, "totalcitations_3": 622.0, "totalcitations_4": 694.0, "totalcitations_5": 746.0, "totalpapers_0": 12.0, "totalpapers_1": 13.0, "totalpapers_2": 15.0, "totalpapers_3": 21.0, "totalpapers_4": 21.0, "totalpapers_5": 25.0, "authorage_0": 38.0, "authorage_1": 39.0, "authorage_2": 40.0, "authorage_3": 41.0, "authorage_4": 42.0, "authorage_5": 43.0, "recentcoauthors_0": 91.0, "recentcoauthors_1": 107.0, "recentcoauthors_2": 205.0, "recentcoauthors_3": 392.0, "recentcoauthors_4": 203.0, "recentcoauthors_5": 148.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.125, "venuehindexmean_1": 139.375, "venuehindexmean_2": 139.2222222222, "venuehindexmean_3": 132.6, "venuehindexmean_4": 136.0, "venuehindexmean_5": 139.6, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 5.4817375442, "pagerank_1": 5.4950648103, "pagerank_2": 7.4298414209, "pagerank_3": 10.0609386971, "pagerank_4": 9.7631057506, "pagerank_5": 11.7272825616}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["J\u00f6rgHackerm\u00fcller", "KristinReiche", "Peter F.Stadler"], "affiliation": "Fraunhofer Society", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 4.0, "hindex_1": 4.3333333333, "hindex_2": 4.3333333333, "hindex_3": 4.6666666667, "hindex_4": 5.6666666667, "hindex_5": 5.6666666667, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 34.2776666667, "citationsperpaper_1": 48.314, "citationsperpaper_2": 58.239, "citationsperpaper_3": 62.4563333333, "citationsperpaper_4": 68.5993333333, "citationsperpaper_5": 71.8633333333, "citationsperyear_0": 27.7393333333, "citationsperyear_1": 31.5583333333, "citationsperyear_2": 32.5026666667, "citationsperyear_3": 31.5556666667, "citationsperyear_4": 30.2716666667, "citationsperyear_5": 28.911, "totalcitations_0": 207.6666666667, "totalcitations_1": 281.3333333333, "totalcitations_2": 342.6666666667, "totalcitations_3": 385.6666666667, "totalcitations_4": 422.6666666667, "totalcitations_5": 450.3333333333, "totalpapers_0": 5.6666666667, "totalpapers_1": 6.0, "totalpapers_2": 6.6666666667, "totalpapers_3": 8.6666666667, "totalpapers_4": 8.6666666667, "totalpapers_5": 10.0, "authorage_0": 13.6666666667, "authorage_1": 14.6666666667, "authorage_2": 15.6666666667, "authorage_3": 16.6666666667, "authorage_4": 17.6666666667, "authorage_5": 18.6666666667, "recentcoauthors_0": 37.6666666667, "recentcoauthors_1": 43.0, "recentcoauthors_2": 68.3333333333, "recentcoauthors_3": 130.6666666667, "recentcoauthors_4": 67.6666666667, "recentcoauthors_5": 49.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 197.2638888889, "venuehindexmean_1": 201.125, "venuehindexmean_2": 204.5185185185, "venuehindexmean_3": 205.8666666667, "venuehindexmean_4": 209.7777777778, "venuehindexmean_5": 213.4222222222, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.3333333333, "totalvenues_3": 4.6666666667, "totalvenues_4": 4.6666666667, "totalvenues_5": 4.6666666667, "pagerank_0": 3.1657897914, "pagerank_1": 3.1113410647, "pagerank_2": 3.7198757394, "pagerank_3": 4.5868770972, "pagerank_4": 4.470697133, "pagerank_5": 5.0981963252}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["Cynthia M.Sharma", "J\u00f6rgVogel"], "affiliation": "University of W\u00fcrzburg", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 4.0, "hindex_1": 5.5, "hindex_2": 7.0, "hindex_3": 8.5, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 6.023, "citationsperpaper_1": 8.0755, "citationsperpaper_2": 11.561, "citationsperpaper_3": 15.2465, "citationsperpaper_4": 16.4025, "citationsperpaper_5": 18.403, "citationsperyear_0": 8.097, "citationsperyear_1": 12.4, "citationsperyear_2": 19.7045, "citationsperyear_3": 26.9345, "citationsperyear_4": 29.404, "citationsperyear_5": 32.282, "totalcitations_0": 53.5, "totalcitations_1": 93.0, "totalcitations_2": 165.5, "totalcitations_3": 255.0, "totalcitations_4": 308.5, "totalcitations_5": 372.5, "totalpapers_0": 9.0, "totalpapers_1": 12.0, "totalpapers_2": 15.5, "totalpapers_3": 19.0, "totalpapers_4": 20.5, "totalpapers_5": 22.0, "authorage_0": 5.5, "authorage_1": 6.5, "authorage_2": 7.5, "authorage_3": 8.5, "authorage_4": 9.5, "authorage_5": 10.5, "recentcoauthors_0": 22.5, "recentcoauthors_1": 37.5, "recentcoauthors_2": 46.5, "recentcoauthors_3": 37.5, "recentcoauthors_4": 17.5, "recentcoauthors_5": 9.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 123.75, "venuehindexmean_1": 126.75, "venuehindexmean_2": 127.7625, "venuehindexmean_3": 139.4666666667, "venuehindexmean_4": 147.6, "venuehindexmean_5": 150.0, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.5, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 2.3682975439, "pagerank_1": 3.4057345715, "pagerank_2": 3.8404562991, "pagerank_3": 4.3831552014, "pagerank_4": 4.645924274, "pagerank_5": 4.6544395684}}, {"model": "papers.paper", "pk": 1003146, "fields": {"authors": ["J\u00f6rgVogel"], "affiliation": "Uppsala University", "venue": "Nature", "doi": "10.1038/nature08756", "abstract": "The transcriptome of Helicobacter pylori, an important human pathogen involved in gastric ulcers and cancer, is presented. The approach establishes a model for mapping and annotating the primary transcriptomes of many living species.", "year": 2010, "title": "The primary transcriptome of the major human pathogen Helicobacter pylori", "keywords": ["Helicobacter pylori", "Genome", "Genetics", "Gene expression profiling", "Biology", "Bacterial genetics", "Transcriptome", "Genomics", "Human pathogen", "Cancer"], "citations_0": 5.0, "citations_1": 11.0, "citations_2": 8.0, "citations_3": 8.0, "citations_4": 7.0, "citations_5": 7.0, "timescaledpagerank_0": 0.4869332499, "timescaledpagerank_1": 2.1492997679, "timescaledpagerank_2": 2.6114341667, "timescaledpagerank_3": 2.9465476667, "timescaledpagerank_4": 3.2729211286, "timescaledpagerank_5": 3.3413264838, "hindex_0": 5.0, "hindex_1": 7.0, "hindex_2": 8.0, "hindex_3": 10.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 13.0, "adopters_1": 74.0, "adopters_2": 120.0, "adopters_3": 65.0, "adopters_4": 50.0, "adopters_5": 0.0, "citationsperpaper_0": 5.846, "citationsperpaper_1": 7.294, "citationsperpaper_2": 9.455, "citationsperpaper_3": 11.393, "citationsperpaper_4": 13.138, "citationsperpaper_5": 14.806, "citationsperyear_0": 8.444, "citationsperyear_1": 12.4, "citationsperyear_2": 18.909, "citationsperyear_3": 26.583, "citationsperyear_4": 29.308, "citationsperyear_5": 32.786, "totalcitations_0": 76.0, "totalcitations_1": 124.0, "totalcitations_2": 208.0, "totalcitations_3": 319.0, "totalcitations_4": 381.0, "totalcitations_5": 459.0, "totalpapers_0": 13.0, "totalpapers_1": 17.0, "totalpapers_2": 22.0, "totalpapers_3": 28.0, "totalpapers_4": 29.0, "totalpapers_5": 31.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 25.0, "recentcoauthors_1": 42.0, "recentcoauthors_2": 64.0, "recentcoauthors_3": 58.0, "recentcoauthors_4": 20.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 102.0, "venuehindexmean_1": 105.0, "venuehindexmean_2": 108.125, "venuehindexmean_3": 128.3333333333, "venuehindexmean_4": 143.7, "venuehindexmean_5": 146.5, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 10.0, "pagerank_0": 3.2816016603, "pagerank_1": 4.4964746366, "pagerank_2": 5.3244266143, "pagerank_3": 6.244767206, "pagerank_4": 6.1414071391, "pagerank_5": 6.1097207553}}, {"model": "papers.paper", "pk": 1003654, "fields": {"authors": ["DanielSarewitz"], "affiliation": "Arizona State University", "venue": "Nature", "doi": "10.1038/466027a", "abstract": "Efforts by the US National Academy of Sciences to popularize science through movies will sanitize it as well, says Daniel Sarewitz.", "year": 2010, "title": "World view: Entertaining science", "keywords": ["Science policy", "Molecular interactions", "Media studies", "Computational biology", "World view", "Environmental science"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.167, "citationsperpaper_1": 0.238, "citationsperpaper_2": 0.417, "citationsperpaper_3": 0.407, "citationsperpaper_4": 0.448, "citationsperpaper_5": 0.469, "citationsperyear_0": 0.3, "citationsperyear_1": 0.455, "citationsperyear_2": 0.833, "citationsperyear_3": 0.846, "citationsperyear_4": 0.929, "citationsperyear_5": 1.0, "totalcitations_0": 3.0, "totalcitations_1": 5.0, "totalcitations_2": 10.0, "totalcitations_3": 11.0, "totalcitations_4": 13.0, "totalcitations_5": 15.0, "totalpapers_0": 18.0, "totalpapers_1": 21.0, "totalpapers_2": 24.0, "totalpapers_3": 27.0, "totalpapers_4": 29.0, "totalpapers_5": 32.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.4193204893, "pagerank_1": 1.3607199429, "pagerank_2": 1.351293932, "pagerank_3": 1.2382853017, "pagerank_4": 1.2364233718, "pagerank_5": 2.0414378688}}, {"model": "papers.paper", "pk": 1003654, "fields": {"authors": ["DanielSarewitz"], "affiliation": "Columbia University", "venue": "Nature", "doi": "10.1038/466027a", "abstract": "Efforts by the US National Academy of Sciences to popularize science through movies will sanitize it as well, says Daniel Sarewitz.", "year": 2010, "title": "World view: Entertaining science", "keywords": ["Science policy", "Molecular interactions", "Media studies", "Computational biology", "World view", "Environmental science"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.167, "citationsperpaper_1": 0.238, "citationsperpaper_2": 0.417, "citationsperpaper_3": 0.407, "citationsperpaper_4": 0.448, "citationsperpaper_5": 0.469, "citationsperyear_0": 0.3, "citationsperyear_1": 0.455, "citationsperyear_2": 0.833, "citationsperyear_3": 0.846, "citationsperyear_4": 0.929, "citationsperyear_5": 1.0, "totalcitations_0": 3.0, "totalcitations_1": 5.0, "totalcitations_2": 10.0, "totalcitations_3": 11.0, "totalcitations_4": 13.0, "totalcitations_5": 15.0, "totalpapers_0": 18.0, "totalpapers_1": 21.0, "totalpapers_2": 24.0, "totalpapers_3": 27.0, "totalpapers_4": 29.0, "totalpapers_5": 32.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 5.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 14.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.4193204893, "pagerank_1": 1.3607199429, "pagerank_2": 1.351293932, "pagerank_3": 1.2382853017, "pagerank_4": 1.2364233718, "pagerank_5": 2.0414378688}}, {"model": "papers.paper", "pk": 1003954, "fields": {"authors": ["Jacob M.Taylor", "Mikhail D.Lukin"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/467278a", "abstract": "Jumps resulting from the measurement of discrete state changes in single quantum systems have fascinated scientists from the early days of quantum theory. They have now been observed in solid-state quantum bits.", "year": 2010, "title": "Quantum physics: Quantum leaps in the solid state", "keywords": ["Quantum technology", "Quantum simulator", "Quantum nanoscience", "LEAPS", "Quantum", "Quantum dynamics", "Open quantum system", "Physics", "Quantum mechanics", "Quantum optics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.5, "hindex_1": 7.5, "hindex_2": 8.0, "hindex_3": 8.5, "hindex_4": 9.0, "hindex_5": 9.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.431, "citationsperpaper_1": 12.379, "citationsperpaper_2": 11.1075, "citationsperpaper_3": 11.593, "citationsperpaper_4": 11.963, "citationsperpaper_5": 11.726, "citationsperyear_0": 15.593, "citationsperyear_1": 16.585, "citationsperyear_2": 17.3195, "citationsperyear_3": 18.619, "citationsperyear_4": 19.237, "citationsperyear_5": 19.7415, "totalcitations_0": 136.0, "totalcitations_1": 162.0, "totalcitations_2": 187.5, "totalcitations_3": 221.5, "totalcitations_4": 249.0, "totalcitations_5": 275.5, "totalpapers_0": 13.0, "totalpapers_1": 13.0, "totalpapers_2": 16.5, "totalpapers_3": 19.0, "totalpapers_4": 20.5, "totalpapers_5": 23.0, "authorage_0": 7.5, "authorage_1": 8.5, "authorage_2": 9.5, "authorage_3": 10.5, "authorage_4": 11.5, "authorage_5": 12.5, "recentcoauthors_0": 16.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 22.5, "recentcoauthors_3": 40.0, "recentcoauthors_4": 25.5, "recentcoauthors_5": 25.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 217.75, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.5, "pagerank_0": 3.9513769494, "pagerank_1": 3.8424606841, "pagerank_2": 5.050701409, "pagerank_3": 5.6664892465, "pagerank_4": 5.9380486953, "pagerank_5": 6.676748929}}, {"model": "papers.paper", "pk": 1003954, "fields": {"authors": ["Mikhail D.Lukin"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/467278a", "abstract": "Jumps resulting from the measurement of discrete state changes in single quantum systems have fascinated scientists from the early days of quantum theory. They have now been observed in solid-state quantum bits.", "year": 2010, "title": "Quantum physics: Quantum leaps in the solid state", "keywords": ["Quantum technology", "Quantum simulator", "Quantum nanoscience", "LEAPS", "Quantum", "Quantum dynamics", "Open quantum system", "Physics", "Quantum mechanics", "Quantum optics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 9.0, "hindex_1": 9.0, "hindex_2": 10.0, "hindex_3": 11.0, "hindex_4": 12.0, "hindex_5": 13.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.529, "citationsperpaper_1": 12.647, "citationsperpaper_2": 12.048, "citationsperpaper_3": 11.769, "citationsperpaper_4": 12.464, "citationsperpaper_5": 12.452, "citationsperyear_0": 17.9, "citationsperyear_1": 19.545, "citationsperyear_2": 21.083, "citationsperyear_3": 23.538, "citationsperyear_4": 24.929, "citationsperyear_5": 25.733, "totalcitations_0": 179.0, "totalcitations_1": 215.0, "totalcitations_2": 253.0, "totalcitations_3": 306.0, "totalcitations_4": 349.0, "totalcitations_5": 386.0, "totalpapers_0": 17.0, "totalpapers_1": 17.0, "totalpapers_2": 21.0, "totalpapers_3": 26.0, "totalpapers_4": 28.0, "totalpapers_5": 31.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 21.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 29.0, "recentcoauthors_3": 64.0, "recentcoauthors_4": 41.0, "recentcoauthors_5": 32.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 194.5, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 4.0, "pagerank_0": 5.0333384495, "pagerank_1": 4.9020926861, "pagerank_2": 6.5311051187, "pagerank_3": 7.8636098063, "pagerank_4": 7.9025123674, "pagerank_5": 8.8694186997}}, {"model": "papers.paper", "pk": 1003954, "fields": {"authors": ["Jacob M.Taylor"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/467278a", "abstract": "Jumps resulting from the measurement of discrete state changes in single quantum systems have fascinated scientists from the early days of quantum theory. They have now been observed in solid-state quantum bits.", "year": 2010, "title": "Quantum physics: Quantum leaps in the solid state", "keywords": ["Quantum technology", "Quantum simulator", "Quantum nanoscience", "LEAPS", "Quantum", "Quantum dynamics", "Open quantum system", "Physics", "Quantum mechanics", "Quantum optics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.333, "citationsperpaper_1": 12.111, "citationsperpaper_2": 10.167, "citationsperpaper_3": 11.417, "citationsperpaper_4": 11.462, "citationsperpaper_5": 11.0, "citationsperyear_0": 13.286, "citationsperyear_1": 13.625, "citationsperyear_2": 13.556, "citationsperyear_3": 13.7, "citationsperyear_4": 13.545, "citationsperyear_5": 13.75, "totalcitations_0": 93.0, "totalcitations_1": 109.0, "totalcitations_2": 122.0, "totalcitations_3": 137.0, "totalcitations_4": 149.0, "totalcitations_5": 165.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 12.0, "totalpapers_3": 12.0, "totalpapers_4": 13.0, "totalpapers_5": 15.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 16.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 19.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8694154494, "pagerank_1": 2.782828682, "pagerank_2": 3.5702976992, "pagerank_3": 3.4693686867, "pagerank_4": 3.9735850232, "pagerank_5": 4.4840791583}}, {"model": "papers.paper", "pk": 1003954, "fields": {"authors": ["Jacob M.Taylor"], "affiliation": "Massachusetts Institute of Technology", "venue": "Nature", "doi": "10.1038/467278a", "abstract": "Jumps resulting from the measurement of discrete state changes in single quantum systems have fascinated scientists from the early days of quantum theory. They have now been observed in solid-state quantum bits.", "year": 2010, "title": "Quantum physics: Quantum leaps in the solid state", "keywords": ["Quantum technology", "Quantum simulator", "Quantum nanoscience", "LEAPS", "Quantum", "Quantum dynamics", "Open quantum system", "Physics", "Quantum mechanics", "Quantum optics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.333, "citationsperpaper_1": 12.111, "citationsperpaper_2": 10.167, "citationsperpaper_3": 11.417, "citationsperpaper_4": 11.462, "citationsperpaper_5": 11.0, "citationsperyear_0": 13.286, "citationsperyear_1": 13.625, "citationsperyear_2": 13.556, "citationsperyear_3": 13.7, "citationsperyear_4": 13.545, "citationsperyear_5": 13.75, "totalcitations_0": 93.0, "totalcitations_1": 109.0, "totalcitations_2": 122.0, "totalcitations_3": 137.0, "totalcitations_4": 149.0, "totalcitations_5": 165.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 12.0, "totalpapers_3": 12.0, "totalpapers_4": 13.0, "totalpapers_5": 15.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 16.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 19.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8694154494, "pagerank_1": 2.782828682, "pagerank_2": 3.5702976992, "pagerank_3": 3.4693686867, "pagerank_4": 3.9735850232, "pagerank_5": 4.4840791583}}, {"model": "papers.paper", "pk": 1003954, "fields": {"authors": ["Jacob M.Taylor"], "affiliation": "National Institute of Standards and Technology", "venue": "Nature", "doi": "10.1038/467278a", "abstract": "Jumps resulting from the measurement of discrete state changes in single quantum systems have fascinated scientists from the early days of quantum theory. They have now been observed in solid-state quantum bits.", "year": 2010, "title": "Quantum physics: Quantum leaps in the solid state", "keywords": ["Quantum technology", "Quantum simulator", "Quantum nanoscience", "LEAPS", "Quantum", "Quantum dynamics", "Open quantum system", "Physics", "Quantum mechanics", "Quantum optics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 10.333, "citationsperpaper_1": 12.111, "citationsperpaper_2": 10.167, "citationsperpaper_3": 11.417, "citationsperpaper_4": 11.462, "citationsperpaper_5": 11.0, "citationsperyear_0": 13.286, "citationsperyear_1": 13.625, "citationsperyear_2": 13.556, "citationsperyear_3": 13.7, "citationsperyear_4": 13.545, "citationsperyear_5": 13.75, "totalcitations_0": 93.0, "totalcitations_1": 109.0, "totalcitations_2": 122.0, "totalcitations_3": 137.0, "totalcitations_4": 149.0, "totalcitations_5": 165.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 12.0, "totalpapers_3": 12.0, "totalpapers_4": 13.0, "totalpapers_5": 15.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 1.0, "recentcoauthors_2": 16.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 19.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 2.8694154494, "pagerank_1": 2.782828682, "pagerank_2": 3.5702976992, "pagerank_3": 3.4693686867, "pagerank_4": 3.9735850232, "pagerank_5": 4.4840791583}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["Yujiao J.Sun", "Guangying K.Wu", "Bao-huaLiu", "Li I.Zhang", "PingyangLi", "MuZhou", "Huizhong W.Tao"], "affiliation": "University of Southern California", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 3.5714285714, "hindex_1": 4.5714285714, "hindex_2": 4.5714285714, "hindex_3": 5.1428571429, "hindex_4": 5.7142857143, "hindex_5": 6.4285714286, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 6.1857142857, "citationsperpaper_1": 8.1362857143, "citationsperpaper_2": 9.115, "citationsperpaper_3": 10.5884285714, "citationsperpaper_4": 11.372, "citationsperpaper_5": 12.9532857143, "citationsperyear_0": 7.0121428571, "citationsperyear_1": 8.3504285714, "citationsperyear_2": 8.4434285714, "citationsperyear_3": 9.5248571429, "citationsperyear_4": 9.6831428571, "citationsperyear_5": 10.2407142857, "totalcitations_0": 72.8571428571, "totalcitations_1": 88.7142857143, "totalcitations_2": 100.0, "totalcitations_3": 117.7142857143, "totalcitations_4": 129.4285714286, "totalcitations_5": 146.2857142857, "totalpapers_0": 6.7142857143, "totalpapers_1": 7.5714285714, "totalpapers_2": 7.7142857143, "totalpapers_3": 8.8571428571, "totalpapers_4": 9.2857142857, "totalpapers_5": 9.5714285714, "authorage_0": 5.1428571429, "authorage_1": 6.1428571429, "authorage_2": 7.1428571429, "authorage_3": 8.1428571429, "authorage_4": 9.1428571429, "authorage_5": 10.1428571429, "recentcoauthors_0": 14.1428571429, "recentcoauthors_1": 16.1428571429, "recentcoauthors_2": 5.8571428571, "recentcoauthors_3": 5.8571428571, "recentcoauthors_4": 8.7142857143, "recentcoauthors_5": 4.4285714286, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 158.9071428571, "venuehindexmean_1": 160.1428571429, "venuehindexmean_2": 164.3, "venuehindexmean_3": 153.0285714286, "venuehindexmean_4": 156.6, "venuehindexmean_5": 160.0571428571, "totalvenues_0": 3.0, "totalvenues_1": 3.1428571429, "totalvenues_2": 3.1428571429, "totalvenues_3": 3.2857142857, "totalvenues_4": 3.2857142857, "totalvenues_5": 3.2857142857, "pagerank_0": 1.6712331079, "pagerank_1": 1.8770042084, "pagerank_2": 1.8916773496, "pagerank_3": 2.13363192, "pagerank_4": 2.1072004546, "pagerank_5": 2.1143495679}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["Li I.Zhang", "Huizhong W.Tao"], "affiliation": "University of California, Berkeley", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 7.5, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 10.0, "hindex_4": 10.5, "hindex_5": 12.5, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 14.7835, "citationsperpaper_1": 14.444, "citationsperpaper_2": 16.069, "citationsperpaper_3": 15.333, "citationsperpaper_4": 15.921, "citationsperpaper_5": 16.92, "citationsperyear_0": 17.6925, "citationsperyear_1": 18.643, "citationsperyear_2": 19.367, "citationsperyear_3": 20.219, "citationsperyear_4": 20.706, "citationsperyear_5": 21.7225, "totalcitations_0": 230.0, "totalcitations_1": 261.0, "totalcitations_2": 290.5, "totalcitations_3": 323.5, "totalcitations_4": 352.0, "totalcitations_5": 391.0, "totalpapers_0": 15.5, "totalpapers_1": 18.0, "totalpapers_2": 18.0, "totalpapers_3": 21.0, "totalpapers_4": 22.0, "totalpapers_5": 23.0, "authorage_0": 12.0, "authorage_1": 13.0, "authorage_2": 14.0, "authorage_3": 15.0, "authorage_4": 16.0, "authorage_5": 17.0, "recentcoauthors_0": 18.5, "recentcoauthors_1": 30.5, "recentcoauthors_2": 17.5, "recentcoauthors_3": 16.0, "recentcoauthors_4": 23.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 150.425, "venuehindexmean_1": 146.5, "venuehindexmean_2": 150.8, "venuehindexmean_3": 154.6, "venuehindexmean_4": 158.1, "venuehindexmean_5": 161.7, "totalvenues_0": 4.5, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 3.1624563066, "pagerank_1": 3.8799877051, "pagerank_2": 3.8284551543, "pagerank_3": 4.5788857214, "pagerank_4": 4.5151567109, "pagerank_5": 4.6003595054}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["Guangying K.Wu"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 3.8, "citationsperpaper_1": 6.4, "citationsperpaper_2": 6.333, "citationsperpaper_3": 8.5, "citationsperpaper_4": 9.333, "citationsperpaper_5": 10.5, "citationsperyear_0": 3.8, "citationsperyear_1": 5.333, "citationsperyear_2": 5.429, "citationsperyear_3": 6.375, "citationsperyear_4": 6.222, "citationsperyear_5": 6.3, "totalcitations_0": 19.0, "totalcitations_1": 32.0, "totalcitations_2": 38.0, "totalcitations_3": 51.0, "totalcitations_4": 56.0, "totalcitations_5": 63.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 6.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 1.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.3333333333, "venuehindexmean_1": 135.3333333333, "venuehindexmean_2": 139.0, "venuehindexmean_3": 142.6666666667, "venuehindexmean_4": 146.0, "venuehindexmean_5": 149.3333333333, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.4686377382, "pagerank_1": 1.3947414876, "pagerank_2": 1.5689925644, "pagerank_3": 1.5114256573, "pagerank_4": 1.4107466441, "pagerank_5": 1.3836526122}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["Bao-huaLiu", "Li I.Zhang"], "affiliation": "University of California, San Diego", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 5.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 8.0, "hindex_4": 8.5, "hindex_5": 10.0, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 10.05, "citationsperpaper_1": 10.3915, "citationsperpaper_2": 11.9335, "citationsperpaper_3": 12.6865, "citationsperpaper_4": 13.6105, "citationsperpaper_5": 15.42, "citationsperyear_0": 12.404, "citationsperyear_1": 14.1785, "citationsperyear_2": 14.717, "citationsperyear_3": 16.2055, "citationsperyear_4": 16.4155, "citationsperyear_5": 17.4445, "totalcitations_0": 141.0, "totalcitations_1": 167.0, "totalcitations_2": 188.5, "totalcitations_3": 217.5, "totalcitations_4": 238.0, "totalcitations_5": 268.5, "totalpapers_0": 10.5, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 15.0, "totalpapers_4": 15.5, "totalpapers_5": 16.0, "authorage_0": 7.5, "authorage_1": 8.5, "authorage_2": 9.5, "authorage_3": 10.5, "authorage_4": 11.5, "authorage_5": 12.5, "recentcoauthors_0": 18.0, "recentcoauthors_1": 30.5, "recentcoauthors_2": 17.5, "recentcoauthors_3": 10.0, "recentcoauthors_4": 13.5, "recentcoauthors_5": 6.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 136.7916666667, "venuehindexmean_1": 132.8666666667, "venuehindexmean_2": 136.8, "venuehindexmean_3": 140.5333333333, "venuehindexmean_4": 144.1, "venuehindexmean_5": 147.6666666667, "totalvenues_0": 3.5, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.4177963187, "pagerank_1": 3.1661034221, "pagerank_2": 3.1274584908, "pagerank_3": 3.5686388771, "pagerank_4": 3.4666254748, "pagerank_5": 3.469591268}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["ZhongjuXiao"], "affiliation": "Southern Medical University", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.6, "citationsperpaper_2": 2.8, "citationsperpaper_3": 3.333, "citationsperpaper_4": 3.857, "citationsperpaper_5": 5.571, "citationsperyear_0": 1.111, "citationsperyear_1": 1.3, "citationsperyear_2": 1.273, "citationsperyear_3": 1.667, "citationsperyear_4": 2.077, "citationsperyear_5": 2.786, "totalcitations_0": 10.0, "totalcitations_1": 13.0, "totalcitations_2": 14.0, "totalcitations_3": 20.0, "totalcitations_4": 27.0, "totalcitations_5": 39.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 7.0, "totalpapers_5": 7.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 15.0, "recentcoauthors_5": 7.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 172.0, "venuehindexmean_1": 174.6666666667, "venuehindexmean_2": 178.0, "venuehindexmean_3": 181.3333333333, "venuehindexmean_4": 154.0, "venuehindexmean_5": 157.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.2459190469, "pagerank_1": 1.2019017777, "pagerank_2": 1.2101077172, "pagerank_3": 1.6237487046, "pagerank_4": 1.8390510799, "pagerank_5": 1.7936471515}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["Yujiao J.Sun", "Li I.Zhang"], "affiliation": "University of California, San Francisco", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.5, "hindex_4": 6.5, "hindex_5": 7.5, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 9.25, "citationsperpaper_1": 10.225, "citationsperpaper_2": 11.6, "citationsperpaper_3": 13.2935, "citationsperpaper_4": 13.896, "citationsperpaper_5": 14.92, "citationsperyear_0": 11.154, "citationsperyear_1": 12.512, "citationsperyear_2": 12.7585, "citationsperyear_3": 13.6625, "citationsperyear_4": 13.6865, "citationsperyear_5": 14.1035, "totalcitations_0": 134.0, "totalcitations_1": 155.0, "totalcitations_2": 173.5, "totalcitations_3": 195.5, "totalcitations_4": 212.5, "totalcitations_5": 235.0, "totalpapers_0": 9.0, "totalpapers_1": 11.0, "totalpapers_2": 11.0, "totalpapers_3": 12.5, "totalpapers_4": 13.0, "totalpapers_5": 13.5, "authorage_0": 6.5, "authorage_1": 7.5, "authorage_2": 8.5, "authorage_3": 9.5, "authorage_4": 10.5, "authorage_5": 11.5, "recentcoauthors_0": 15.0, "recentcoauthors_1": 25.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 11.5, "recentcoauthors_5": 6.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.875, "venuehindexmean_1": 144.2, "venuehindexmean_2": 148.55, "venuehindexmean_3": 152.7, "venuehindexmean_4": 156.6, "venuehindexmean_5": 160.25, "totalvenues_0": 3.0, "totalvenues_1": 3.5, "totalvenues_2": 3.5, "totalvenues_3": 3.5, "totalvenues_4": 3.5, "totalvenues_5": 3.5, "pagerank_0": 2.026237194, "pagerank_1": 2.6502020403, "pagerank_2": 2.6063228639, "pagerank_3": 2.9620277514, "pagerank_4": 2.9028428436, "pagerank_5": 2.9181829558}}, {"model": "papers.paper", "pk": 1003018, "fields": {"authors": ["MuZhou"], "affiliation": "Stanford University", "venue": "Nature", "doi": "10.1038/nature09079", "abstract": "In order to build a proper and stable representation of the auditory world, neonatal rodents exhibit a significant degree of circuit plasticity, allowing for sensitivity to the pattern of sensory inputs. During this time, neurons construct a receptive field, one that relies upon a particular balance of excitatory and inhibitory inputs, yet it is unknown as to how this balance is formed. Two studies published in this issue of Nature reveal contrasting views as to how the mature system develops. Excitation and inhibition were found to be equally strong upon hearing onset in each study. But whereas Dorrn et al. find evidence for an experience-dependent refinement of inhibition as the receptive fields develop, Sun et al. observed a fine adjustment in the excitatory input strength to produce a shifted balance. Nevertheless, taken together, both studies point towards a fine adjustment of synaptic inputs as the force behind the production of mature receptive fields, as opposed to more radical changes such as input pruning. To build a representation of the auditory world, neuronal circuits in neonatal rodents exhibit plasticity, allowing sensitivity to the pattern of sensory inputs. At this time, neurons construct a receptive field, which relies on a balance of excitatory and inhibitory inputs. Here, excitation and inhibition were found to be co-tuned upon hearing onset, but later an adjustment in the excitatory input strength occurred. Thus a fine adjustment in synaptic inputs, rather than more radical changes such as input pruning, may refine mature receptive fields. Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development1,2,3,4. Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency\u2013intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation\u2013inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.", "year": 2010, "title": "Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development", "keywords": ["Neuroscience", "Electrophysiology", "Receptive field", "Central nervous system", "Biology", "Sensory system", "Anatomy", "Excitatory postsynaptic potential", "Inhibitory postsynaptic potential", "Sensory neuron", "Auditory cortex"], "citations_0": 2.0, "citations_1": 3.0, "citations_2": 0.0, "citations_3": 4.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.0778007309, "timescaledpagerank_1": 0.3684029608, "timescaledpagerank_2": 0.2020574971, "timescaledpagerank_3": 0.3126874015, "timescaledpagerank_4": 0.2648206089, "timescaledpagerank_5": 0.2504080096, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 2.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 5.0, "adopters_1": 7.0, "adopters_2": 0.0, "adopters_3": 26.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 5.0, "citationsperpaper_2": 5.0, "citationsperpaper_3": 5.5, "citationsperpaper_4": 6.333, "citationsperpaper_5": 10.0, "citationsperyear_0": 2.0, "citationsperyear_1": 2.5, "citationsperyear_2": 1.667, "citationsperyear_3": 2.75, "citationsperyear_4": 3.8, "citationsperyear_5": 5.0, "totalcitations_0": 2.0, "totalcitations_1": 5.0, "totalcitations_2": 5.0, "totalcitations_3": 11.0, "totalcitations_4": 19.0, "totalcitations_5": 30.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 11.0, "recentcoauthors_5": 7.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 167.0, "venuehindexmean_4": 171.0, "venuehindexmean_5": 174.5, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.5300295469, "pagerank_1": 0.5087706388, "pagerank_2": 0.513347145, "pagerank_3": 0.7074152285, "pagerank_4": 0.9988802989, "pagerank_5": 0.9727041525}}, {"model": "papers.paper", "pk": 1003160, "fields": {"authors": ["William D.Solecki"], "affiliation": "City University of New York", "venue": "Nature", "doi": "10.1038/467909a", "abstract": "Scientists should do the research to help mayors prepare for a warming world, say Cynthia Rosenzweig, William Solecki, Stephen A. Hammer and Shagun Mehrotra.", "year": 2010, "title": "Cities lead the way in climate\u2013change action", "keywords": ["Political science", "Meteorology", "Natural resource economics", "Global warming", "Hammer", "Climate change", "Greenhouse gas"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.0678401163, "timescaledpagerank_4": 0.0368171648, "timescaledpagerank_5": 0.3965472661, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 2.0, "citationsperpaper_5": 3.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.25, "citationsperyear_4": 0.4, "citationsperyear_5": 0.5, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 1.0, "totalcitations_4": 2.0, "totalcitations_5": 3.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 3.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.4568264662, "pagerank_1": 0.4551717807, "pagerank_2": 0.4546683128, "pagerank_3": 0.4242125565, "pagerank_4": 0.4227466751, "pagerank_5": 0.4192444032}}, {"model": "papers.paper", "pk": 1003160, "fields": {"authors": ["CynthiaRosenzweig"], "affiliation": "Goddard Institute for Space Studies", "venue": "Nature", "doi": "10.1038/467909a", "abstract": "Scientists should do the research to help mayors prepare for a warming world, say Cynthia Rosenzweig, William Solecki, Stephen A. Hammer and Shagun Mehrotra.", "year": 2010, "title": "Cities lead the way in climate\u2013change action", "keywords": ["Political science", "Meteorology", "Natural resource economics", "Global warming", "Hammer", "Climate change", "Greenhouse gas"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.0678401163, "timescaledpagerank_4": 0.0368171648, "timescaledpagerank_5": 0.3965472661, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 7.0, "citationsperpaper_1": 7.571, "citationsperpaper_2": 8.286, "citationsperpaper_3": 8.375, "citationsperpaper_4": 8.813, "citationsperpaper_5": 9.375, "citationsperyear_0": 4.261, "citationsperyear_1": 4.417, "citationsperyear_2": 4.64, "citationsperyear_3": 5.154, "citationsperyear_4": 5.222, "citationsperyear_5": 5.357, "totalcitations_0": 98.0, "totalcitations_1": 106.0, "totalcitations_2": 116.0, "totalcitations_3": 134.0, "totalcitations_4": 141.0, "totalcitations_5": 150.0, "totalpapers_0": 14.0, "totalpapers_1": 14.0, "totalpapers_2": 14.0, "totalpapers_3": 16.0, "totalpapers_4": 16.0, "totalpapers_5": 16.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 42.0, "recentcoauthors_4": 42.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 188.0, "venuehindexmean_1": 191.3333333333, "venuehindexmean_2": 196.0, "venuehindexmean_3": 194.0, "venuehindexmean_4": 197.25, "venuehindexmean_5": 200.25, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 4.188059292, "pagerank_1": 4.1237249907, "pagerank_2": 4.1015542604, "pagerank_3": 4.6615395807, "pagerank_4": 4.5721757879, "pagerank_5": 4.3604961798}}, {"model": "papers.paper", "pk": 1003160, "fields": {"authors": ["CynthiaRosenzweig", "ShagunMehrotra"], "affiliation": "Columbia University", "venue": "Nature", "doi": "10.1038/467909a", "abstract": "Scientists should do the research to help mayors prepare for a warming world, say Cynthia Rosenzweig, William Solecki, Stephen A. Hammer and Shagun Mehrotra.", "year": 2010, "title": "Cities lead the way in climate\u2013change action", "keywords": ["Political science", "Meteorology", "Natural resource economics", "Global warming", "Hammer", "Climate change", "Greenhouse gas"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.0678401163, "timescaledpagerank_4": 0.0368171648, "timescaledpagerank_5": 0.3965472661, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.5, "hindex_4": 3.0, "hindex_5": 3.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 3.5, "citationsperpaper_1": 3.7855, "citationsperpaper_2": 4.143, "citationsperpaper_3": 4.6875, "citationsperpaper_4": 5.4065, "citationsperpaper_5": 6.1875, "citationsperyear_0": 2.1305, "citationsperyear_1": 2.2085, "citationsperyear_2": 2.32, "citationsperyear_3": 2.702, "citationsperyear_4": 2.811, "citationsperyear_5": 2.9285, "totalcitations_0": 49.0, "totalcitations_1": 53.0, "totalcitations_2": 58.0, "totalcitations_3": 67.5, "totalcitations_4": 71.5, "totalcitations_5": 76.5, "totalpapers_0": 7.5, "totalpapers_1": 7.5, "totalpapers_2": 7.5, "totalpapers_3": 8.5, "totalpapers_4": 8.5, "totalpapers_5": 8.5, "authorage_0": 11.0, "authorage_1": 12.0, "authorage_2": 13.0, "authorage_3": 14.0, "authorage_4": 15.0, "authorage_5": 16.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 21.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 224.0, "venuehindexmean_1": 227.6666666667, "venuehindexmean_2": 232.5, "venuehindexmean_3": 234.5, "venuehindexmean_4": 238.625, "venuehindexmean_5": 242.125, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.5, "totalvenues_4": 2.5, "totalvenues_5": 2.5, "pagerank_0": 2.3224428791, "pagerank_1": 2.2894483857, "pagerank_2": 2.2781112866, "pagerank_3": 2.5428760686, "pagerank_4": 2.4974612315, "pagerank_5": 2.3898702915}}, {"model": "papers.paper", "pk": 1003160, "fields": {"authors": ["CynthiaRosenzweig"], "affiliation": "Goddard Space Flight Center", "venue": "Nature", "doi": "10.1038/467909a", "abstract": "Scientists should do the research to help mayors prepare for a warming world, say Cynthia Rosenzweig, William Solecki, Stephen A. Hammer and Shagun Mehrotra.", "year": 2010, "title": "Cities lead the way in climate\u2013change action", "keywords": ["Political science", "Meteorology", "Natural resource economics", "Global warming", "Hammer", "Climate change", "Greenhouse gas"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.0678401163, "timescaledpagerank_4": 0.0368171648, "timescaledpagerank_5": 0.3965472661, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 2.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 7.0, "citationsperpaper_1": 7.571, "citationsperpaper_2": 8.286, "citationsperpaper_3": 8.375, "citationsperpaper_4": 8.813, "citationsperpaper_5": 9.375, "citationsperyear_0": 4.261, "citationsperyear_1": 4.417, "citationsperyear_2": 4.64, "citationsperyear_3": 5.154, "citationsperyear_4": 5.222, "citationsperyear_5": 5.357, "totalcitations_0": 98.0, "totalcitations_1": 106.0, "totalcitations_2": 116.0, "totalcitations_3": 134.0, "totalcitations_4": 141.0, "totalcitations_5": 150.0, "totalpapers_0": 14.0, "totalpapers_1": 14.0, "totalpapers_2": 14.0, "totalpapers_3": 16.0, "totalpapers_4": 16.0, "totalpapers_5": 16.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 13.0, "recentcoauthors_1": 13.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 42.0, "recentcoauthors_4": 42.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 188.0, "venuehindexmean_1": 191.3333333333, "venuehindexmean_2": 196.0, "venuehindexmean_3": 194.0, "venuehindexmean_4": 197.25, "venuehindexmean_5": 200.25, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 4.188059292, "pagerank_1": 4.1237249907, "pagerank_2": 4.1015542604, "pagerank_3": 4.6615395807, "pagerank_4": 4.5721757879, "pagerank_5": 4.3604961798}}, {"model": "papers.paper", "pk": 1003323, "fields": {"authors": ["YoshihiroIwasa"], "affiliation": "Tohoku University", "venue": "Nature", "doi": "10.1038/466191a", "abstract": "The discovery that the face-centred cubic form of the fullerene Cs3C60 is a superconductor, just as its body-centred cubic counterpart is, sheds light on the origin of superconductivity in organic materials.", "year": 2010, "title": "Superconductivity: Revelations of the fullerenes", "keywords": ["Biophysics", "Molecular interactions", "Superconductivity", "Fullerene", "Cubic form", "Condensed matter physics", "Physics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.5, "citationsperpaper_1": 2.75, "citationsperpaper_2": 3.133, "citationsperpaper_3": 3.867, "citationsperpaper_4": 4.375, "citationsperpaper_5": 4.941, "citationsperyear_0": 1.471, "citationsperyear_1": 1.833, "citationsperyear_2": 2.474, "citationsperyear_3": 2.9, "citationsperyear_4": 3.333, "citationsperyear_5": 3.818, "totalcitations_0": 25.0, "totalcitations_1": 33.0, "totalcitations_2": 47.0, "totalcitations_3": 58.0, "totalcitations_4": 70.0, "totalcitations_5": 84.0, "totalpapers_0": 10.0, "totalpapers_1": 12.0, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 16.0, "totalpapers_5": 17.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 22.0, "recentcoauthors_1": 29.0, "recentcoauthors_2": 30.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.6666666667, "venuehindexmean_1": 186.75, "venuehindexmean_2": 192.5, "venuehindexmean_3": 197.5, "venuehindexmean_4": 201.75, "venuehindexmean_5": 206.25, "totalvenues_0": 3.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.5921551388, "pagerank_1": 4.4249358397, "pagerank_2": 4.9693682713, "pagerank_3": 4.8215056119, "pagerank_4": 5.1830614621, "pagerank_5": 5.3848211003}}, {"model": "papers.paper", "pk": 1003323, "fields": {"authors": ["YoshihiroIwasa"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/466191a", "abstract": "The discovery that the face-centred cubic form of the fullerene Cs3C60 is a superconductor, just as its body-centred cubic counterpart is, sheds light on the origin of superconductivity in organic materials.", "year": 2010, "title": "Superconductivity: Revelations of the fullerenes", "keywords": ["Biophysics", "Molecular interactions", "Superconductivity", "Fullerene", "Cubic form", "Condensed matter physics", "Physics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 6.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.5, "citationsperpaper_1": 2.75, "citationsperpaper_2": 3.133, "citationsperpaper_3": 3.867, "citationsperpaper_4": 4.375, "citationsperpaper_5": 4.941, "citationsperyear_0": 1.471, "citationsperyear_1": 1.833, "citationsperyear_2": 2.474, "citationsperyear_3": 2.9, "citationsperyear_4": 3.333, "citationsperyear_5": 3.818, "totalcitations_0": 25.0, "totalcitations_1": 33.0, "totalcitations_2": 47.0, "totalcitations_3": 58.0, "totalcitations_4": 70.0, "totalcitations_5": 84.0, "totalpapers_0": 10.0, "totalpapers_1": 12.0, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 16.0, "totalpapers_5": 17.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 22.0, "recentcoauthors_1": 29.0, "recentcoauthors_2": 30.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.6666666667, "venuehindexmean_1": 186.75, "venuehindexmean_2": 192.5, "venuehindexmean_3": 197.5, "venuehindexmean_4": 201.75, "venuehindexmean_5": 206.25, "totalvenues_0": 3.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.5921551388, "pagerank_1": 4.4249358397, "pagerank_2": 4.9693682713, "pagerank_3": 4.8215056119, "pagerank_4": 5.1830614621, "pagerank_5": 5.3848211003}}, {"model": "papers.paper", "pk": 1002968, "fields": {"authors": ["SantiagoTorres", "Leandro G.Althaus", "PabloLor\u00e9n-Aguilar", "EnriqueGarc\u00eda-Berro", "I.Renedo"], "affiliation": "Polytechnic University of Catalonia", "venue": "Nature", "doi": "10.1038/nature09045", "abstract": "Fil: Garcia Berro, Enrique. Instituto de Estudios Espaciales de Cataluna; . Universidad Politecnica de Catalunya; Espana", "year": 2010, "title": "A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes", "keywords": ["Astrophysics", "Stellar evolution", "Black dwarf", "White dwarf", "Blue dwarf", "Astronomy", "Physics", "Physical separation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 0.4545829477, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 12.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.9, "citationsperpaper_4": 1.0, "citationsperpaper_5": 1.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.25, "citationsperyear_4": 0.24, "citationsperyear_5": 0.2002, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 1.0, "totalcitations_4": 1.2, "totalcitations_5": 1.2, "totalpapers_0": 1.0, "totalpapers_1": 1.2, "totalpapers_2": 1.2, "totalpapers_3": 1.2, "totalpapers_4": 1.2, "totalpapers_5": 1.2, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.8, "recentcoauthors_2": 0.8, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0273595182, "pagerank_1": 1.1832740309, "pagerank_2": 1.1832740485, "pagerank_3": 1.1832740406, "pagerank_4": 0.9843658692, "pagerank_5": 0.9837038502}}, {"model": "papers.paper", "pk": 1002968, "fields": {"authors": ["Alejandro HugoC\u00f3rsico", "Leandro G.Althaus"], "affiliation": "National University of La Plata", "venue": "Nature", "doi": "10.1038/nature09045", "abstract": "Fil: Garcia Berro, Enrique. Instituto de Estudios Espaciales de Cataluna; . Universidad Politecnica de Catalunya; Espana", "year": 2010, "title": "A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes", "keywords": ["Astrophysics", "Stellar evolution", "Black dwarf", "White dwarf", "Blue dwarf", "Astronomy", "Physics", "Physical separation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 0.4545829477, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 12.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 1.0, "citationsperpaper_5": 1.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.25, "citationsperyear_4": 0.2, "citationsperyear_5": 0.167, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0273595193, "pagerank_1": 1.0605351792, "pagerank_2": 1.0605351955, "pagerank_3": 1.0605351911, "pagerank_4": 0.8692272234, "pagerank_5": 0.8685898285}}, {"model": "papers.paper", "pk": 1002968, "fields": {"authors": ["R. D.Rohrmann", "Alejandro HugoC\u00f3rsico", "Leandro G.Althaus"], "affiliation": "National Scientific and Technical Research Council", "venue": "Nature", "doi": "10.1038/nature09045", "abstract": "Fil: Garcia Berro, Enrique. Instituto de Estudios Espaciales de Cataluna; . Universidad Politecnica de Catalunya; Espana", "year": 2010, "title": "A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes", "keywords": ["Astrophysics", "Stellar evolution", "Black dwarf", "White dwarf", "Blue dwarf", "Astronomy", "Physics", "Physical separation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 0.4545829477, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 12.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 1.0, "citationsperpaper_5": 1.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.25, "citationsperyear_4": 0.2, "citationsperyear_5": 0.167, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0273595201, "pagerank_1": 1.0605351792, "pagerank_2": 1.060535195, "pagerank_3": 1.0605351911, "pagerank_4": 0.8692272234, "pagerank_5": 0.8685898288}}, {"model": "papers.paper", "pk": 1002968, "fields": {"authors": ["JordiIsern"], "affiliation": "Spanish National Research Council", "venue": "Nature", "doi": "10.1038/nature09045", "abstract": "Fil: Garcia Berro, Enrique. Instituto de Estudios Espaciales de Cataluna; . Universidad Politecnica de Catalunya; Espana", "year": 2010, "title": "A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes", "keywords": ["Astrophysics", "Stellar evolution", "Black dwarf", "White dwarf", "Blue dwarf", "Astronomy", "Physics", "Physical separation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 0.4545829477, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 12.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.5, "citationsperpaper_1": 2.5, "citationsperpaper_2": 2.5, "citationsperpaper_3": 3.0, "citationsperpaper_4": 2.333, "citationsperpaper_5": 2.333, "citationsperyear_0": 0.278, "citationsperyear_1": 0.263, "citationsperyear_2": 0.25, "citationsperyear_3": 0.286, "citationsperyear_4": 0.318, "citationsperyear_5": 0.304, "totalcitations_0": 5.0, "totalcitations_1": 5.0, "totalcitations_2": 5.0, "totalcitations_3": 6.0, "totalcitations_4": 7.0, "totalcitations_5": 7.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.5387978081, "pagerank_1": 1.5779399419, "pagerank_2": 1.5779399657, "pagerank_3": 1.5779399528, "pagerank_4": 1.6203145025, "pagerank_5": 1.6156341373}}, {"model": "papers.paper", "pk": 1002968, "fields": {"authors": ["JordiIsern"], "affiliation": "Institut d'Estudis Catalans", "venue": "Nature", "doi": "10.1038/nature09045", "abstract": "Fil: Garcia Berro, Enrique. Instituto de Estudios Espaciales de Cataluna; . Universidad Politecnica de Catalunya; Espana", "year": 2010, "title": "A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes", "keywords": ["Astrophysics", "Stellar evolution", "Black dwarf", "White dwarf", "Blue dwarf", "Astronomy", "Physics", "Physical separation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 0.4545829477, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 12.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.5, "citationsperpaper_1": 2.5, "citationsperpaper_2": 2.5, "citationsperpaper_3": 3.0, "citationsperpaper_4": 2.333, "citationsperpaper_5": 2.333, "citationsperyear_0": 0.278, "citationsperyear_1": 0.263, "citationsperyear_2": 0.25, "citationsperyear_3": 0.286, "citationsperyear_4": 0.318, "citationsperyear_5": 0.304, "totalcitations_0": 5.0, "totalcitations_1": 5.0, "totalcitations_2": 5.0, "totalcitations_3": 6.0, "totalcitations_4": 7.0, "totalcitations_5": 7.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.5387978081, "pagerank_1": 1.5779399419, "pagerank_2": 1.5779399657, "pagerank_3": 1.5779399528, "pagerank_4": 1.6203145025, "pagerank_5": 1.6156341373}}, {"model": "papers.paper", "pk": 1002968, "fields": {"authors": ["MaurizioSalaris"], "affiliation": "Liverpool John Moores University", "venue": "Nature", "doi": "10.1038/nature09045", "abstract": "Fil: Garcia Berro, Enrique. Instituto de Estudios Espaciales de Cataluna; . Universidad Politecnica de Catalunya; Espana", "year": 2010, "title": "A white dwarf cooling age of 8 Gyr for NGC 6791 from physical separation processes", "keywords": ["Astrophysics", "Stellar evolution", "Black dwarf", "White dwarf", "Blue dwarf", "Astronomy", "Physics", "Physical separation"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.8498627248, "timescaledpagerank_4": 0.6117206858, "timescaledpagerank_5": 0.4545829477, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 12.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 1.0, "citationsperpaper_4": 1.0, "citationsperpaper_5": 1.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.25, "citationsperyear_4": 0.2, "citationsperyear_5": 0.167, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 8.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0273595217, "pagerank_1": 1.0605351792, "pagerank_2": 1.0605351971, "pagerank_3": 1.0605351911, "pagerank_4": 0.8692272234, "pagerank_5": 0.8685898275}}, {"model": "papers.paper", "pk": 1003306, "fields": {"authors": ["RobertCraigie"], "affiliation": "Laboratory of Molecular Biology", "venue": "Nature", "doi": "10.1038/464167a", "abstract": "Every machine is made of parts. But, as the new structure of the HIV integrase enzyme in complex with viral DNA shows, one could not have predicted from the individual parts just how this machine works.", "year": 2010, "title": "Structural biology: When four become one", "keywords": ["Systems biology", "Molecular interactions", "Biology", "Integrase", "Computational biology", "Structural biology", "Protein stability", "Genomics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 23.0, "hindex_1": 23.0, "hindex_2": 24.0, "hindex_3": 25.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 26.212, "citationsperpaper_1": 26.827, "citationsperpaper_2": 27.577, "citationsperpaper_3": 27.83, "citationsperpaper_4": 28.453, "citationsperpaper_5": 28.642, "citationsperyear_0": 50.481, "citationsperyear_1": 49.821, "citationsperyear_2": 49.448, "citationsperyear_3": 49.167, "citationsperyear_4": 48.645, "citationsperyear_5": 47.438, "totalcitations_0": 1363.0, "totalcitations_1": 1395.0, "totalcitations_2": 1434.0, "totalcitations_3": 1475.0, "totalcitations_4": 1508.0, "totalcitations_5": 1518.0, "totalpapers_0": 52.0, "totalpapers_1": 52.0, "totalpapers_2": 52.0, "totalpapers_3": 53.0, "totalpapers_4": 53.0, "totalpapers_5": 53.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 10.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 3.0, "recentcoauthors_4": 3.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 159.0, "venuehindexmean_1": 161.5555555556, "venuehindexmean_2": 165.3333333333, "venuehindexmean_3": 168.1111111111, "venuehindexmean_4": 170.7777777778, "venuehindexmean_5": 173.1111111111, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 7.86461553, "pagerank_1": 7.581898381, "pagerank_2": 7.3098375824, "pagerank_3": 7.2052354685, "pagerank_4": 7.0218104403, "pagerank_5": 6.8519017568}}, {"model": "papers.paper", "pk": 1003306, "fields": {"authors": ["RobertCraigie"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/464167a", "abstract": "Every machine is made of parts. But, as the new structure of the HIV integrase enzyme in complex with viral DNA shows, one could not have predicted from the individual parts just how this machine works.", "year": 2010, "title": "Structural biology: When four become one", "keywords": ["Systems biology", "Molecular interactions", "Biology", "Integrase", "Computational biology", "Structural biology", "Protein stability", "Genomics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 23.0, "hindex_1": 23.0, "hindex_2": 24.0, "hindex_3": 25.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 26.212, "citationsperpaper_1": 26.827, "citationsperpaper_2": 27.577, "citationsperpaper_3": 27.83, "citationsperpaper_4": 28.453, "citationsperpaper_5": 28.642, "citationsperyear_0": 50.481, "citationsperyear_1": 49.821, "citationsperyear_2": 49.448, "citationsperyear_3": 49.167, "citationsperyear_4": 48.645, "citationsperyear_5": 47.438, "totalcitations_0": 1363.0, "totalcitations_1": 1395.0, "totalcitations_2": 1434.0, "totalcitations_3": 1475.0, "totalcitations_4": 1508.0, "totalcitations_5": 1518.0, "totalpapers_0": 52.0, "totalpapers_1": 52.0, "totalpapers_2": 52.0, "totalpapers_3": 53.0, "totalpapers_4": 53.0, "totalpapers_5": 53.0, "authorage_0": 26.0, "authorage_1": 27.0, "authorage_2": 28.0, "authorage_3": 29.0, "authorage_4": 30.0, "authorage_5": 31.0, "recentcoauthors_0": 10.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 3.0, "recentcoauthors_4": 3.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 159.0, "venuehindexmean_1": 161.5555555556, "venuehindexmean_2": 165.3333333333, "venuehindexmean_3": 168.1111111111, "venuehindexmean_4": 170.7777777778, "venuehindexmean_5": 173.1111111111, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 7.86461553, "pagerank_1": 7.581898381, "pagerank_2": 7.3098375824, "pagerank_3": 7.2052354685, "pagerank_4": 7.0218104403, "pagerank_5": 6.8519017568}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Zhi-HengLoh"], "affiliation": "Nanyang Technological University", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 6.0, "citationsperpaper_1": 10.5, "citationsperpaper_2": 15.5, "citationsperpaper_3": 19.0, "citationsperpaper_4": 22.5, "citationsperpaper_5": 25.0, "citationsperyear_0": 1.714, "citationsperyear_1": 2.625, "citationsperyear_2": 3.444, "citationsperyear_3": 3.8, "citationsperyear_4": 4.091, "citationsperyear_5": 4.167, "totalcitations_0": 12.0, "totalcitations_1": 21.0, "totalcitations_2": 31.0, "totalcitations_3": 38.0, "totalcitations_4": 45.0, "totalcitations_5": 50.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 165.0, "venuehindexmean_1": 170.0, "venuehindexmean_2": 176.0, "venuehindexmean_3": 182.0, "venuehindexmean_4": 187.5, "venuehindexmean_5": 193.0, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.7342587238, "pagerank_1": 0.7002047614, "pagerank_2": 0.6891449551, "pagerank_3": 0.6935176991, "pagerank_4": 0.6545382654, "pagerank_5": 0.6503263764}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Matthias F.Kling", "Zhi-HengLoh", "Stephen R.Leone", "ThomasPfeifer"], "affiliation": "University of California, Berkeley", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.25, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.5, "hindex_5": 2.75, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 2.35, "citationsperpaper_1": 4.459, "citationsperpaper_2": 7.303, "citationsperpaper_3": 7.55075, "citationsperpaper_4": 8.59, "citationsperpaper_5": 9.28275, "citationsperyear_0": 1.4045, "citationsperyear_1": 2.0265, "citationsperyear_2": 2.711, "citationsperyear_3": 2.80975, "citationsperyear_4": 3.131, "citationsperyear_5": 3.236, "totalcitations_0": 9.75, "totalcitations_1": 15.25, "totalcitations_2": 23.25, "totalcitations_3": 27.5, "totalcitations_4": 35.0, "totalcitations_5": 41.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.5, "totalpapers_3": 7.0, "totalpapers_4": 7.75, "totalpapers_5": 8.75, "authorage_0": 9.5, "authorage_1": 10.5, "authorage_2": 11.5, "authorage_3": 12.5, "authorage_4": 13.5, "authorage_5": 14.5, "recentcoauthors_0": 17.5, "recentcoauthors_1": 15.75, "recentcoauthors_2": 2.25, "recentcoauthors_3": 5.75, "recentcoauthors_4": 20.25, "recentcoauthors_5": 22.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 193.9166666667, "venuehindexmean_1": 198.8333333333, "venuehindexmean_2": 194.25, "venuehindexmean_3": 197.4375, "venuehindexmean_4": 202.5625, "venuehindexmean_5": 200.375, "totalvenues_0": 2.5, "totalvenues_1": 2.5, "totalvenues_2": 2.75, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.25, "pagerank_0": 1.9796482435, "pagerank_1": 1.9292235035, "pagerank_2": 2.029430261, "pagerank_3": 2.2241517782, "pagerank_4": 2.4908901056, "pagerank_5": 2.7244108786}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Matthias F.Kling", "Zhi-HengLoh", "Stephen R.Leone", "ThomasPfeifer"], "affiliation": "Lawrence Berkeley National Laboratory", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.25, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.5, "hindex_5": 2.75, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 2.35, "citationsperpaper_1": 4.459, "citationsperpaper_2": 7.303, "citationsperpaper_3": 7.55075, "citationsperpaper_4": 8.59, "citationsperpaper_5": 9.28275, "citationsperyear_0": 1.4045, "citationsperyear_1": 2.0265, "citationsperyear_2": 2.711, "citationsperyear_3": 2.80975, "citationsperyear_4": 3.131, "citationsperyear_5": 3.236, "totalcitations_0": 9.75, "totalcitations_1": 15.25, "totalcitations_2": 23.25, "totalcitations_3": 27.5, "totalcitations_4": 35.0, "totalcitations_5": 41.0, "totalpapers_0": 6.0, "totalpapers_1": 6.0, "totalpapers_2": 6.5, "totalpapers_3": 7.0, "totalpapers_4": 7.75, "totalpapers_5": 8.75, "authorage_0": 9.5, "authorage_1": 10.5, "authorage_2": 11.5, "authorage_3": 12.5, "authorage_4": 13.5, "authorage_5": 14.5, "recentcoauthors_0": 17.5, "recentcoauthors_1": 15.75, "recentcoauthors_2": 2.25, "recentcoauthors_3": 5.75, "recentcoauthors_4": 20.25, "recentcoauthors_5": 22.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 193.9166666667, "venuehindexmean_1": 198.8333333333, "venuehindexmean_2": 194.25, "venuehindexmean_3": 197.4375, "venuehindexmean_4": 202.5625, "venuehindexmean_5": 200.375, "totalvenues_0": 2.5, "totalvenues_1": 2.5, "totalvenues_2": 2.75, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.25, "pagerank_0": 1.9796482435, "pagerank_1": 1.9292235035, "pagerank_2": 2.029430261, "pagerank_3": 2.2241517782, "pagerank_4": 2.4908901056, "pagerank_5": 2.7244108786}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["EleftheriosGoulielmakis", "NinaRohringer", "SergeyZherebtsov", "Vladislav S.Yakovlev", "AdrianWirth", "Matthias F.Kling", "ThomasPfeifer", "FerencKrausz"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 2.875, "hindex_1": 3.375, "hindex_2": 3.75, "hindex_3": 3.875, "hindex_4": 4.375, "hindex_5": 4.875, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 3.640125, "citationsperpaper_1": 5.12875, "citationsperpaper_2": 6.864875, "citationsperpaper_3": 7.184625, "citationsperpaper_4": 8.22425, "citationsperpaper_5": 8.839375, "citationsperyear_0": 4.50125, "citationsperyear_1": 5.466625, "citationsperyear_2": 6.438375, "citationsperyear_3": 6.202625, "citationsperyear_4": 6.48125, "citationsperyear_5": 6.5345, "totalcitations_0": 39.125, "totalcitations_1": 48.5, "totalcitations_2": 58.5, "totalcitations_3": 62.875, "totalcitations_4": 73.0, "totalcitations_5": 81.0, "totalpapers_0": 6.875, "totalpapers_1": 7.375, "totalpapers_2": 8.125, "totalpapers_3": 8.25, "totalpapers_4": 8.625, "totalpapers_5": 9.0, "authorage_0": 4.375, "authorage_1": 5.375, "authorage_2": 6.375, "authorage_3": 7.375, "authorage_4": 8.375, "authorage_5": 9.375, "recentcoauthors_0": 26.75, "recentcoauthors_1": 33.25, "recentcoauthors_2": 14.375, "recentcoauthors_3": 8.875, "recentcoauthors_4": 6.375, "recentcoauthors_5": 8.75, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 239.5416666667, "venuehindexmean_1": 242.0208333333, "venuehindexmean_2": 247.875, "venuehindexmean_3": 252.3020833333, "venuehindexmean_4": 256.6666666667, "venuehindexmean_5": 257.34375, "totalvenues_0": 1.875, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.125, "totalvenues_4": 2.125, "totalvenues_5": 2.25, "pagerank_0": 2.6533617467, "pagerank_1": 2.7710764795, "pagerank_2": 2.9852243683, "pagerank_3": 3.0573234744, "pagerank_4": 3.1088279279, "pagerank_5": 3.2458311567}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Vladislav S.Yakovlev", "EleftheriosGoulielmakis", "FerencKrausz"], "affiliation": "Vienna University of Technology", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 5.6666666667, "hindex_1": 6.3333333333, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 7.6666666667, "hindex_5": 8.6666666667, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 7.707, "citationsperpaper_1": 8.4646666667, "citationsperpaper_2": 8.7913333333, "citationsperpaper_3": 9.2196666667, "citationsperpaper_4": 10.078, "citationsperpaper_5": 10.5186666667, "citationsperyear_0": 9.0866666667, "citationsperyear_1": 9.837, "citationsperyear_2": 10.0913333333, "citationsperyear_3": 9.7676666667, "citationsperyear_4": 10.3056666667, "citationsperyear_5": 10.6516666667, "totalcitations_0": 95.0, "totalcitations_1": 112.3333333333, "totalcitations_2": 125.6666666667, "totalcitations_3": 131.6666666667, "totalcitations_4": 149.6666666667, "totalcitations_5": 165.6666666667, "totalpapers_0": 12.6666666667, "totalpapers_1": 13.6666666667, "totalpapers_2": 15.0, "totalpapers_3": 15.0, "totalpapers_4": 15.6666666667, "totalpapers_5": 16.3333333333, "authorage_0": 9.3333333333, "authorage_1": 10.3333333333, "authorage_2": 11.3333333333, "authorage_3": 12.3333333333, "authorage_4": 13.3333333333, "authorage_5": 14.3333333333, "recentcoauthors_0": 33.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 30.3333333333, "recentcoauthors_3": 17.3333333333, "recentcoauthors_4": 10.0, "recentcoauthors_5": 16.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 237.7777777778, "venuehindexmean_1": 241.5555555556, "venuehindexmean_2": 247.6666666667, "venuehindexmean_3": 253.2222222222, "venuehindexmean_4": 257.1111111111, "venuehindexmean_5": 261.3333333333, "totalvenues_0": 2.3333333333, "totalvenues_1": 2.3333333333, "totalvenues_2": 2.3333333333, "totalvenues_3": 2.3333333333, "totalvenues_4": 2.3333333333, "totalvenues_5": 2.3333333333, "pagerank_0": 4.6541867336, "pagerank_1": 4.9359159294, "pagerank_2": 5.4388330312, "pagerank_3": 5.4459834332, "pagerank_4": 5.5416426039, "pagerank_5": 5.7996900511}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["A. M.Azzeer"], "affiliation": "King Saud University", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.333, "citationsperpaper_2": 4.333, "citationsperpaper_3": 5.667, "citationsperpaper_4": 7.0, "citationsperpaper_5": 8.333, "citationsperyear_0": 2.0, "citationsperyear_1": 3.5, "citationsperyear_2": 4.333, "citationsperyear_3": 4.25, "citationsperyear_4": 4.2, "citationsperyear_5": 4.167, "totalcitations_0": 2.0, "totalcitations_1": 7.0, "totalcitations_2": 13.0, "totalcitations_3": 17.0, "totalcitations_4": 21.0, "totalcitations_5": 25.0, "totalpapers_0": 2.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 32.0, "recentcoauthors_1": 45.0, "recentcoauthors_2": 13.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 257.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.1710535421, "pagerank_1": 1.5595543026, "pagerank_2": 1.5332267776, "pagerank_3": 1.5592007882, "pagerank_4": 1.4870756841, "pagerank_5": 1.5054903261}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["RobinSantra"], "affiliation": "Argonne National Laboratory", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 1.667, "citationsperpaper_1": 2.75, "citationsperpaper_2": 4.4, "citationsperpaper_3": 4.5, "citationsperpaper_4": 5.333, "citationsperpaper_5": 6.0, "citationsperyear_0": 1.667, "citationsperyear_1": 2.75, "citationsperyear_2": 4.4, "citationsperyear_3": 4.5, "citationsperyear_4": 4.571, "citationsperyear_5": 4.5, "totalcitations_0": 5.0, "totalcitations_1": 11.0, "totalcitations_2": 22.0, "totalcitations_3": 27.0, "totalcitations_4": 32.0, "totalcitations_5": 36.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 33.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 2.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 229.0, "venuehindexmean_3": 204.25, "venuehindexmean_4": 208.75, "venuehindexmean_5": 213.75, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.6055143336, "pagerank_1": 1.8440744069, "pagerank_2": 1.9731439978, "pagerank_3": 2.1622547374, "pagerank_4": 2.0758132117, "pagerank_5": 2.0839669531}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["RobinSantra"], "affiliation": "University of Chicago", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 1.667, "citationsperpaper_1": 2.75, "citationsperpaper_2": 4.4, "citationsperpaper_3": 4.5, "citationsperpaper_4": 5.333, "citationsperpaper_5": 6.0, "citationsperyear_0": 1.667, "citationsperyear_1": 2.75, "citationsperyear_2": 4.4, "citationsperyear_3": 4.5, "citationsperyear_4": 4.571, "citationsperyear_5": 4.5, "totalcitations_0": 5.0, "totalcitations_1": 11.0, "totalcitations_2": 22.0, "totalcitations_3": 27.0, "totalcitations_4": 32.0, "totalcitations_5": 36.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 33.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 2.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 229.0, "venuehindexmean_3": 204.25, "venuehindexmean_4": 208.75, "venuehindexmean_5": 213.75, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.6055143336, "pagerank_1": 1.8440744069, "pagerank_2": 1.9731439978, "pagerank_3": 2.1622547374, "pagerank_4": 2.0758132117, "pagerank_5": 2.0839669531}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["RobinSantra"], "affiliation": "University of Hamburg", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 1.667, "citationsperpaper_1": 2.75, "citationsperpaper_2": 4.4, "citationsperpaper_3": 4.5, "citationsperpaper_4": 5.333, "citationsperpaper_5": 6.0, "citationsperyear_0": 1.667, "citationsperyear_1": 2.75, "citationsperyear_2": 4.4, "citationsperyear_3": 4.5, "citationsperyear_4": 4.571, "citationsperyear_5": 4.5, "totalcitations_0": 5.0, "totalcitations_1": 11.0, "totalcitations_2": 22.0, "totalcitations_3": 27.0, "totalcitations_4": 32.0, "totalcitations_5": 36.0, "totalpapers_0": 3.0, "totalpapers_1": 4.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 33.0, "recentcoauthors_1": 46.0, "recentcoauthors_2": 15.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 2.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 250.5, "venuehindexmean_2": 229.0, "venuehindexmean_3": 204.25, "venuehindexmean_4": 208.75, "venuehindexmean_5": 213.75, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.6055143336, "pagerank_1": 1.8440744069, "pagerank_2": 1.9731439978, "pagerank_3": 2.1622547374, "pagerank_4": 2.0758132117, "pagerank_5": 2.0839669531}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Vladislav S.Yakovlev", "FerencKrausz"], "affiliation": "Ludwig Maximilian University of Munich", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 7.0, "hindex_1": 7.0, "hindex_2": 7.5, "hindex_3": 7.5, "hindex_4": 8.5, "hindex_5": 9.5, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 7.489, "citationsperpaper_1": 8.1345, "citationsperpaper_2": 8.062, "citationsperpaper_3": 8.4545, "citationsperpaper_4": 9.1795, "citationsperpaper_5": 10.0, "citationsperyear_0": 10.0675, "citationsperyear_1": 10.7, "citationsperyear_2": 11.037, "citationsperyear_3": 10.7425, "citationsperyear_4": 11.5, "citationsperyear_5": 11.9775, "totalcitations_0": 114.0, "totalcitations_1": 132.0, "totalcitations_2": 147.5, "totalcitations_3": 154.5, "totalcitations_4": 177.0, "totalcitations_5": 196.5, "totalpapers_0": 15.5, "totalpapers_1": 16.5, "totalpapers_2": 18.5, "totalpapers_3": 18.5, "totalpapers_4": 19.5, "totalpapers_5": 20.0, "authorage_0": 10.5, "authorage_1": 11.5, "authorage_2": 12.5, "authorage_3": 13.5, "authorage_4": 14.5, "authorage_5": 15.5, "recentcoauthors_0": 33.5, "recentcoauthors_1": 46.5, "recentcoauthors_2": 39.0, "recentcoauthors_3": 26.0, "recentcoauthors_4": 15.0, "recentcoauthors_5": 22.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 233.4166666667, "venuehindexmean_1": 237.0833333333, "venuehindexmean_2": 243.0, "venuehindexmean_3": 248.3333333333, "venuehindexmean_4": 252.1666666667, "venuehindexmean_5": 256.25, "totalvenues_0": 2.5, "totalvenues_1": 2.5, "totalvenues_2": 2.5, "totalvenues_3": 2.5, "totalvenues_4": 2.5, "totalvenues_5": 2.5, "pagerank_0": 5.6457325021, "pagerank_1": 5.905368011, "pagerank_2": 6.67755276, "pagerank_3": 6.6800875226, "pagerank_4": 6.8797623493, "pagerank_5": 7.1217466556}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["NinaRohringer"], "affiliation": "Lawrence Livermore National Laboratory", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 1.5, "citationsperpaper_1": 4.5, "citationsperpaper_2": 5.5, "citationsperpaper_3": 7.0, "citationsperpaper_4": 8.0, "citationsperpaper_5": 9.25, "citationsperyear_0": 3.0, "citationsperyear_1": 4.5, "citationsperyear_2": 7.333, "citationsperyear_3": 7.0, "citationsperyear_4": 6.4, "citationsperyear_5": 6.167, "totalcitations_0": 3.0, "totalcitations_1": 9.0, "totalcitations_2": 22.0, "totalcitations_3": 28.0, "totalcitations_4": 32.0, "totalcitations_5": 37.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 4.0, "totalpapers_3": 4.0, "totalpapers_4": 4.0, "totalpapers_5": 4.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 33.0, "recentcoauthors_1": 33.0, "recentcoauthors_2": 11.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.2601372612, "pagerank_1": 1.0774833523, "pagerank_2": 1.3217298304, "pagerank_3": 1.3370124909, "pagerank_4": 1.2755717184, "pagerank_5": 1.2781804525}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["ThomasPfeifer"], "affiliation": "Heidelberg University", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 4.0, "citationsperpaper_2": 9.0, "citationsperpaper_3": 6.0, "citationsperpaper_4": 5.333, "citationsperpaper_5": 5.0, "citationsperyear_0": 1.0, "citationsperyear_1": 2.0, "citationsperyear_2": 3.0, "citationsperyear_3": 3.0, "citationsperyear_4": 3.2, "citationsperyear_5": 3.333, "totalcitations_0": 1.0, "totalcitations_1": 4.0, "totalcitations_2": 9.0, "totalcitations_3": 12.0, "totalcitations_4": 16.0, "totalcitations_5": 20.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 3.0, "totalpapers_5": 4.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 11.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 21.0, "recentcoauthors_5": 20.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 263.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 241.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 3.0, "pagerank_0": 0.5310203013, "pagerank_1": 0.5058966939, "pagerank_2": 0.5013974814, "pagerank_3": 1.0350847619, "pagerank_4": 1.4235054529, "pagerank_5": 1.7509548249}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Matthias F.Kling"], "affiliation": "University of G\u00f6ttingen", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 2.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 2.0, "citationsperpaper_1": 2.636, "citationsperpaper_2": 3.545, "citationsperpaper_3": 3.818, "citationsperpaper_4": 4.727, "citationsperpaper_5": 4.909, "citationsperyear_0": 2.75, "citationsperyear_1": 3.222, "citationsperyear_2": 3.9, "citationsperyear_3": 3.818, "citationsperyear_4": 4.333, "citationsperyear_5": 4.154, "totalcitations_0": 22.0, "totalcitations_1": 29.0, "totalcitations_2": 39.0, "totalcitations_3": 42.0, "totalcitations_4": 52.0, "totalcitations_5": 54.0, "totalpapers_0": 11.0, "totalpapers_1": 11.0, "totalpapers_2": 11.0, "totalpapers_3": 11.0, "totalpapers_4": 11.0, "totalpapers_5": 11.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 30.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 163.0, "venuehindexmean_1": 169.0, "venuehindexmean_2": 176.0, "venuehindexmean_3": 182.75, "venuehindexmean_4": 188.0, "venuehindexmean_5": 194.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 3.6677945991, "pagerank_1": 3.5959198467, "pagerank_2": 3.5730011173, "pagerank_3": 3.5565341359, "pagerank_4": 3.4529594036, "pagerank_5": 3.4310452826}}, {"model": "papers.paper", "pk": 1003260, "fields": {"authors": ["Stephen R.Leone"], "affiliation": "University of Colorado Boulder", "venue": "Nature", "doi": "10.1038/nature09212", "abstract": "Attosecond technology (1 as = 10\u221218 S) promises the tools needed to directly probe electron motion in real time. These authors report attosecond pump\u2013probe measurements that track the movement of valence electrons in krypton ions. This first proof-of-principle demonstration uses a simple system, but the expectation is that attosecond transient absorption spectroscopy will ultimately also reveal the elementary electron motions that underlie the properties of molecules and solid-state materials.", "year": 2010, "title": "Real-time observation of valence electron motion", "keywords": ["Attophysics", "Atom", "Atomic physics", "Valence (chemistry)", "Electron", "Core electron", "Chemistry", "Krypton", "Attosecond", "Valence electron"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 5.0, "citations_3": 2.0, "citations_4": 3.0, "citations_5": 1.0, "timescaledpagerank_0": 2.3984182599, "timescaledpagerank_1": 2.6863672923, "timescaledpagerank_2": 3.4260037867, "timescaledpagerank_3": 3.0009261374, "timescaledpagerank_4": 3.2159074099, "timescaledpagerank_5": 2.9457699775, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 1.0, "adopters_1": 30.0, "adopters_2": 30.0, "adopters_3": 8.0, "adopters_4": 28.0, "adopters_5": 0.0, "citationsperpaper_0": 0.4, "citationsperpaper_1": 0.7, "citationsperpaper_2": 1.167, "citationsperpaper_3": 1.385, "citationsperpaper_4": 1.8, "citationsperpaper_5": 2.222, "citationsperyear_0": 0.154, "citationsperyear_1": 0.259, "citationsperyear_2": 0.5, "citationsperyear_3": 0.621, "citationsperyear_4": 0.9, "citationsperyear_5": 1.29, "totalcitations_0": 4.0, "totalcitations_1": 7.0, "totalcitations_2": 14.0, "totalcitations_3": 18.0, "totalcitations_4": 27.0, "totalcitations_5": 40.0, "totalpapers_0": 10.0, "totalpapers_1": 10.0, "totalpapers_2": 12.0, "totalpapers_3": 13.0, "totalpapers_4": 15.0, "totalpapers_5": 18.0, "authorage_0": 25.0, "authorage_1": 26.0, "authorage_2": 27.0, "authorage_3": 28.0, "authorage_4": 29.0, "authorage_5": 30.0, "recentcoauthors_0": 18.0, "recentcoauthors_1": 11.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 15.0, "recentcoauthors_4": 60.0, "recentcoauthors_5": 70.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 187.6666666667, "venuehindexmean_1": 192.3333333333, "venuehindexmean_2": 156.0, "venuehindexmean_3": 162.0, "venuehindexmean_4": 167.75, "venuehindexmean_5": 173.25, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.9855193497, "pagerank_1": 2.9148727118, "pagerank_2": 3.35417749, "pagerank_3": 3.6114705159, "pagerank_4": 4.4325573005, "pagerank_5": 5.0653170303}}, {"model": "papers.paper", "pk": 1003086, "fields": {"authors": ["John E.Chambers"], "affiliation": "Carnegie Institution for Science", "venue": "Nature", "doi": "10.1038/467405a", "abstract": "A fresh analysis of data from gravitational microlensing surveys for planets orbiting stars other than the Sun finds that gas-giant planets similar to Jupiter are more common than previously thought.", "year": 2010, "title": "Extrasolar planets: More giants in focus", "keywords": ["Planetary mass", "Exomoon", "Astrobiology", "Planetary migration", "Exoplanet", "Planetary mnemonic", "Planetary system", "Astronomy", "Jupiter mass", "Physics", "Planet"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.2, "citationsperpaper_5": 0.2, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.077, "citationsperyear_5": 0.071, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 5.0, "totalpapers_5": 5.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003086, "fields": {"authors": ["John E.Chambers"], "affiliation": "Ames Research Center", "venue": "Nature", "doi": "10.1038/467405a", "abstract": "A fresh analysis of data from gravitational microlensing surveys for planets orbiting stars other than the Sun finds that gas-giant planets similar to Jupiter are more common than previously thought.", "year": 2010, "title": "Extrasolar planets: More giants in focus", "keywords": ["Planetary mass", "Exomoon", "Astrobiology", "Planetary migration", "Exoplanet", "Planetary mnemonic", "Planetary system", "Astronomy", "Jupiter mass", "Physics", "Planet"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.2, "citationsperpaper_5": 0.2, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.077, "citationsperyear_5": 0.071, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 5.0, "totalpapers_5": 5.0, "authorage_0": 8.0, "authorage_1": 9.0, "authorage_2": 10.0, "authorage_3": 11.0, "authorage_4": 12.0, "authorage_5": 13.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 267.0, "venuehindexmean_5": 271.5, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["KyeongJinKang", "Leslie C.Griffith", "Paul A.Garrity", "Stefan R.Pulver", "Vincent C.Panzano", "Elaine C.Chang", "Douglas L.Theobald"], "affiliation": "Brandeis University", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 4.1428571429, "hindex_1": 4.4285714286, "hindex_2": 4.4285714286, "hindex_3": 5.1428571429, "hindex_4": 5.8571428571, "hindex_5": 6.1428571429, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 7.607, "citationsperpaper_1": 9.2132857143, "citationsperpaper_2": 11.2351428571, "citationsperpaper_3": 12.1181428571, "citationsperpaper_4": 14.2798571429, "citationsperpaper_5": 17.1044285714, "citationsperyear_0": 8.737, "citationsperyear_1": 9.7484285714, "citationsperyear_2": 10.2614285714, "citationsperyear_3": 11.1474285714, "citationsperyear_4": 13.5275714286, "citationsperyear_5": 15.4471428571, "totalcitations_0": 95.8571428571, "totalcitations_1": 115.2857142857, "totalcitations_2": 132.7142857143, "totalcitations_3": 152.4285714286, "totalcitations_4": 186.8571428571, "totalcitations_5": 220.8571428571, "totalpapers_0": 8.7142857143, "totalpapers_1": 9.4285714286, "totalpapers_2": 9.4285714286, "totalpapers_3": 10.5714285714, "totalpapers_4": 11.4285714286, "totalpapers_5": 12.0, "authorage_0": 7.1428571429, "authorage_1": 8.1428571429, "authorage_2": 9.1428571429, "authorage_3": 10.1428571429, "authorage_4": 11.1428571429, "authorage_5": 12.1428571429, "recentcoauthors_0": 14.4285714286, "recentcoauthors_1": 19.8571428571, "recentcoauthors_2": 5.7142857143, "recentcoauthors_3": 8.4285714286, "recentcoauthors_4": 19.5714285714, "recentcoauthors_5": 15.5714285714, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 161.5241496599, "venuehindexmean_1": 164.5302721088, "venuehindexmean_2": 168.1734693878, "venuehindexmean_3": 171.8085034014, "venuehindexmean_4": 171.6091836735, "venuehindexmean_5": 174.7295918367, "totalvenues_0": 4.1428571429, "totalvenues_1": 4.1428571429, "totalvenues_2": 4.1428571429, "totalvenues_3": 4.1428571429, "totalvenues_4": 4.2857142857, "totalvenues_5": 4.7142857143, "pagerank_0": 2.0331582258, "pagerank_1": 2.1945376347, "pagerank_2": 2.1313976661, "pagerank_3": 2.4180587356, "pagerank_4": 2.5016240409, "pagerank_5": 2.6146345339}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["Douglas L.Theobald"], "affiliation": "University of Colorado Boulder", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 2.4, "citationsperpaper_1": 3.8, "citationsperpaper_2": 4.0, "citationsperpaper_3": 3.429, "citationsperpaper_4": 4.571, "citationsperpaper_5": 5.375, "citationsperyear_0": 1.5, "citationsperyear_1": 2.111, "citationsperyear_2": 2.0, "citationsperyear_3": 2.182, "citationsperyear_4": 2.667, "citationsperyear_5": 3.308, "totalcitations_0": 12.0, "totalcitations_1": 19.0, "totalcitations_2": 20.0, "totalcitations_3": 24.0, "totalcitations_4": 32.0, "totalcitations_5": 43.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 7.0, "totalpapers_4": 7.0, "totalpapers_5": 8.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 151.75, "venuehindexmean_1": 153.75, "venuehindexmean_2": 157.0, "venuehindexmean_3": 159.75, "venuehindexmean_4": 163.0, "venuehindexmean_5": 184.0, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 5.0, "pagerank_0": 0.7533170271, "pagerank_1": 0.702771757, "pagerank_2": 0.6915961079, "pagerank_3": 1.2063112031, "pagerank_4": 1.1310149668, "pagerank_5": 1.5326510905}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["Paul A.Garrity"], "affiliation": "Massachusetts Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 8.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 15.412, "citationsperpaper_1": 16.833, "citationsperpaper_2": 18.889, "citationsperpaper_3": 19.842, "citationsperpaper_4": 21.3, "citationsperpaper_5": 22.381, "citationsperyear_0": 13.789, "citationsperyear_1": 15.15, "citationsperyear_2": 16.19, "citationsperyear_3": 17.136, "citationsperyear_4": 18.522, "citationsperyear_5": 19.583, "totalcitations_0": 262.0, "totalcitations_1": 303.0, "totalcitations_2": 340.0, "totalcitations_3": 377.0, "totalcitations_4": 426.0, "totalcitations_5": 470.0, "totalpapers_0": 17.0, "totalpapers_1": 18.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 20.0, "totalpapers_5": 21.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 60.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 16.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 138.8571428571, "venuehindexmean_1": 142.0, "venuehindexmean_2": 145.1428571429, "venuehindexmean_3": 148.2857142857, "venuehindexmean_4": 151.0, "venuehindexmean_5": 153.5714285714, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.8967451501, "pagerank_1": 4.0426764753, "pagerank_2": 3.8084149145, "pagerank_3": 4.0008881651, "pagerank_4": 4.203450692, "pagerank_5": 4.186994151}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["Stefan R.Pulver", "Paul A.Garrity"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 5.5, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.5, "hindex_4": 7.5, "hindex_5": 8.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 11.106, "citationsperpaper_1": 14.5165, "citationsperpaper_2": 18.3445, "citationsperpaper_3": 20.2545, "citationsperpaper_4": 22.9835, "citationsperpaper_5": 29.4125, "citationsperyear_0": 11.1445, "citationsperyear_1": 13.675, "citationsperyear_2": 15.5115, "citationsperyear_3": 17.425, "citationsperyear_4": 23.136, "citationsperyear_5": 28.0135, "totalcitations_0": 148.0, "totalcitations_1": 182.0, "totalcitations_2": 214.5, "totalcitations_3": 250.5, "totalcitations_4": 324.0, "totalcitations_5": 399.0, "totalpapers_0": 11.0, "totalpapers_1": 11.5, "totalpapers_2": 11.5, "totalpapers_3": 12.5, "totalpapers_4": 14.5, "totalpapers_5": 15.0, "authorage_0": 10.5, "authorage_1": 11.5, "authorage_2": 12.5, "authorage_3": 13.5, "authorage_4": 14.5, "authorage_5": 15.5, "recentcoauthors_0": 29.5, "recentcoauthors_1": 33.0, "recentcoauthors_2": 4.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 47.0, "recentcoauthors_5": 38.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.5952380952, "venuehindexmean_1": 138.6666666667, "venuehindexmean_2": 142.0714285714, "venuehindexmean_3": 145.4761904762, "venuehindexmean_4": 136.625, "venuehindexmean_5": 139.6607142857, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.5, "totalvenues_5": 5.5, "pagerank_0": 2.6376609074, "pagerank_1": 2.6670664582, "pagerank_2": 2.5372529996, "pagerank_3": 2.8214006018, "pagerank_4": 3.4249510058, "pagerank_5": 3.374124988}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["Paul A.Garrity"], "affiliation": "University of California, Los Angeles", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 8.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 15.412, "citationsperpaper_1": 16.833, "citationsperpaper_2": 18.889, "citationsperpaper_3": 19.842, "citationsperpaper_4": 21.3, "citationsperpaper_5": 22.381, "citationsperyear_0": 13.789, "citationsperyear_1": 15.15, "citationsperyear_2": 16.19, "citationsperyear_3": 17.136, "citationsperyear_4": 18.522, "citationsperyear_5": 19.583, "totalcitations_0": 262.0, "totalcitations_1": 303.0, "totalcitations_2": 340.0, "totalcitations_3": 377.0, "totalcitations_4": 426.0, "totalcitations_5": 470.0, "totalpapers_0": 17.0, "totalpapers_1": 18.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 20.0, "totalpapers_5": 21.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 60.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 16.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 138.8571428571, "venuehindexmean_1": 142.0, "venuehindexmean_2": 145.1428571429, "venuehindexmean_3": 148.2857142857, "venuehindexmean_4": 151.0, "venuehindexmean_5": 153.5714285714, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.8967451501, "pagerank_1": 4.0426764753, "pagerank_2": 3.8084149145, "pagerank_3": 4.0008881651, "pagerank_4": 4.203450692, "pagerank_5": 4.186994151}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["Paul A.Garrity"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 8.0, "hindex_1": 9.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 10.0, "hindex_5": 10.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 15.412, "citationsperpaper_1": 16.833, "citationsperpaper_2": 18.889, "citationsperpaper_3": 19.842, "citationsperpaper_4": 21.3, "citationsperpaper_5": 22.381, "citationsperyear_0": 13.789, "citationsperyear_1": 15.15, "citationsperyear_2": 16.19, "citationsperyear_3": 17.136, "citationsperyear_4": 18.522, "citationsperyear_5": 19.583, "totalcitations_0": 262.0, "totalcitations_1": 303.0, "totalcitations_2": 340.0, "totalcitations_3": 377.0, "totalcitations_4": 426.0, "totalcitations_5": 470.0, "totalpapers_0": 17.0, "totalpapers_1": 18.0, "totalpapers_2": 18.0, "totalpapers_3": 19.0, "totalpapers_4": 20.0, "totalpapers_5": 21.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 60.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 8.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 16.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 138.8571428571, "venuehindexmean_1": 142.0, "venuehindexmean_2": 145.1428571429, "venuehindexmean_3": 148.2857142857, "venuehindexmean_4": 151.0, "venuehindexmean_5": 153.5714285714, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.8967451501, "pagerank_1": 4.0426764753, "pagerank_2": 3.8084149145, "pagerank_3": 4.0008881651, "pagerank_4": 4.203450692, "pagerank_5": 4.186994151}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["KyeongJinKang"], "affiliation": "University of Calgary", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 6.429, "citationsperpaper_1": 9.0, "citationsperpaper_2": 12.75, "citationsperpaper_3": 16.25, "citationsperpaper_4": 18.778, "citationsperpaper_5": 18.091, "citationsperyear_0": 6.429, "citationsperyear_1": 9.0, "citationsperyear_2": 11.333, "citationsperyear_3": 13.0, "citationsperyear_4": 15.364, "citationsperyear_5": 16.583, "totalcitations_0": 45.0, "totalcitations_1": 72.0, "totalcitations_2": 102.0, "totalcitations_3": 130.0, "totalcitations_4": 169.0, "totalcitations_5": 199.0, "totalpapers_0": 7.0, "totalpapers_1": 8.0, "totalpapers_2": 8.0, "totalpapers_3": 8.0, "totalpapers_4": 9.0, "totalpapers_5": 11.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 16.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 23.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.8, "venuehindexmean_1": 138.2, "venuehindexmean_2": 141.0, "venuehindexmean_3": 143.6, "venuehindexmean_4": 145.8, "venuehindexmean_5": 130.5714285714, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 7.0, "pagerank_0": 1.8331261721, "pagerank_1": 2.0924692801, "pagerank_2": 2.0535921364, "pagerank_3": 1.9537298809, "pagerank_4": 1.992679082, "pagerank_5": 2.7209185692}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["KyeongJinKang"], "affiliation": "Samsung", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 6.429, "citationsperpaper_1": 9.0, "citationsperpaper_2": 12.75, "citationsperpaper_3": 16.25, "citationsperpaper_4": 18.778, "citationsperpaper_5": 18.091, "citationsperyear_0": 6.429, "citationsperyear_1": 9.0, "citationsperyear_2": 11.333, "citationsperyear_3": 13.0, "citationsperyear_4": 15.364, "citationsperyear_5": 16.583, "totalcitations_0": 45.0, "totalcitations_1": 72.0, "totalcitations_2": 102.0, "totalcitations_3": 130.0, "totalcitations_4": 169.0, "totalcitations_5": 199.0, "totalpapers_0": 7.0, "totalpapers_1": 8.0, "totalpapers_2": 8.0, "totalpapers_3": 8.0, "totalpapers_4": 9.0, "totalpapers_5": 11.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 16.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 23.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.8, "venuehindexmean_1": 138.2, "venuehindexmean_2": 141.0, "venuehindexmean_3": 143.6, "venuehindexmean_4": 145.8, "venuehindexmean_5": 130.5714285714, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 7.0, "pagerank_0": 1.8331261721, "pagerank_1": 2.0924692801, "pagerank_2": 2.0535921364, "pagerank_3": 1.9537298809, "pagerank_4": 1.992679082, "pagerank_5": 2.7209185692}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["KyeongJinKang"], "affiliation": "Sungkyunkwan University", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 5.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 6.429, "citationsperpaper_1": 9.0, "citationsperpaper_2": 12.75, "citationsperpaper_3": 16.25, "citationsperpaper_4": 18.778, "citationsperpaper_5": 18.091, "citationsperyear_0": 6.429, "citationsperyear_1": 9.0, "citationsperyear_2": 11.333, "citationsperyear_3": 13.0, "citationsperyear_4": 15.364, "citationsperyear_5": 16.583, "totalcitations_0": 45.0, "totalcitations_1": 72.0, "totalcitations_2": 102.0, "totalcitations_3": 130.0, "totalcitations_4": 169.0, "totalcitations_5": 199.0, "totalpapers_0": 7.0, "totalpapers_1": 8.0, "totalpapers_2": 8.0, "totalpapers_3": 8.0, "totalpapers_4": 9.0, "totalpapers_5": 11.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 8.0, "recentcoauthors_1": 16.0, "recentcoauthors_2": 8.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 4.0, "recentcoauthors_5": 23.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 135.8, "venuehindexmean_1": 138.2, "venuehindexmean_2": 141.0, "venuehindexmean_3": 143.6, "venuehindexmean_4": 145.8, "venuehindexmean_5": 130.5714285714, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 7.0, "pagerank_0": 1.8331261721, "pagerank_1": 2.0924692801, "pagerank_2": 2.0535921364, "pagerank_3": 1.9537298809, "pagerank_4": 1.992679082, "pagerank_5": 2.7209185692}}, {"model": "papers.paper", "pk": 1003025, "fields": {"authors": ["Stefan R.Pulver"], "affiliation": "University of Cambridge", "venue": "Nature", "doi": "10.1038/nature08848", "abstract": "Reactive electrophiles are noxious chemicals, such as acrolein in cigarette smoke, and are detected by the ion channel TRPA1 in humans. Here it is shown that TRPA1 channels sense these chemicals in the gustatory chemosensory neurons of fruitflies and mosquitoes, too. Further findings show that, unlike with other chemical senses such as smell or taste, the detection of reactive electrophiles relies on an ancient sensor that has been conserved in molecular detail through some 500 million years of evolution.", "year": 2010, "title": "Analysis of Drosophila TRPA1 reveals an ancient origin for human chemical nociception", "keywords": ["Acrolein", "TRPA1 Cation Channel", "Conserved sequence", "Biochemistry", "Cell biology", "Sensory Receptor Cells", "Biology", "Drosophila Protein", "Drosophilidae", "Drosophila melanogaster", "Taste"], "citations_0": 6.0, "citations_1": 5.0, "citations_2": 1.0, "citations_3": 3.0, "citations_4": 3.0, "citations_5": 2.0, "timescaledpagerank_0": 0.965974453, "timescaledpagerank_1": 1.2298281022, "timescaledpagerank_2": 0.8896933649, "timescaledpagerank_3": 0.9011410765, "timescaledpagerank_4": 0.8775827795, "timescaledpagerank_5": 0.8134603895, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 4.0, "hindex_4": 5.0, "hindex_5": 6.0, "adopters_0": 25.0, "adopters_1": 21.0, "adopters_2": 7.0, "adopters_3": 15.0, "adopters_4": 21.0, "adopters_5": 0.0, "citationsperpaper_0": 6.8, "citationsperpaper_1": 12.2, "citationsperpaper_2": 17.8, "citationsperpaper_3": 20.667, "citationsperpaper_4": 24.667, "citationsperpaper_5": 36.444, "citationsperyear_0": 8.5, "citationsperyear_1": 12.2, "citationsperyear_2": 14.833, "citationsperyear_3": 17.714, "citationsperyear_4": 27.75, "citationsperyear_5": 36.444, "totalcitations_0": 34.0, "totalcitations_1": 61.0, "totalcitations_2": 89.0, "totalcitations_3": 124.0, "totalcitations_4": 222.0, "totalcitations_5": 328.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 9.0, "totalpapers_5": 9.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 7.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 12.0, "recentcoauthors_4": 72.0, "recentcoauthors_5": 60.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.3333333333, "venuehindexmean_1": 135.3333333333, "venuehindexmean_2": 139.0, "venuehindexmean_3": 142.6666666667, "venuehindexmean_4": 122.25, "venuehindexmean_5": 125.75, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.3785766646, "pagerank_1": 1.2914564411, "pagerank_2": 1.2660910846, "pagerank_3": 1.6419130386, "pagerank_4": 2.6464513195, "pagerank_5": 2.5612558251}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["Wei-GuoZhu"], "affiliation": "Shenzhen University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.636, "citationsperpaper_1": 4.154, "citationsperpaper_2": 5.615, "citationsperpaper_3": 6.5, "citationsperpaper_4": 5.944, "citationsperpaper_5": 6.389, "citationsperyear_0": 2.5, "citationsperyear_1": 3.176, "citationsperyear_2": 4.056, "citationsperyear_3": 4.789, "citationsperyear_4": 5.35, "citationsperyear_5": 5.476, "totalcitations_0": 40.0, "totalcitations_1": 54.0, "totalcitations_2": 73.0, "totalcitations_3": 91.0, "totalcitations_4": 107.0, "totalcitations_5": 115.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 53.0, "recentcoauthors_5": 37.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.5, "venuehindexmean_1": 136.0, "venuehindexmean_2": 138.8571428571, "venuehindexmean_3": 141.4285714286, "venuehindexmean_4": 133.75, "venuehindexmean_5": 135.75, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 4.0530274316, "pagerank_1": 5.1721699049, "pagerank_2": 4.9723782461, "pagerank_3": 5.3119304177, "pagerank_4": 6.3373295165, "pagerank_5": 6.1971078158}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["Wei-GuoZhu"], "affiliation": "Peking University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.636, "citationsperpaper_1": 4.154, "citationsperpaper_2": 5.615, "citationsperpaper_3": 6.5, "citationsperpaper_4": 5.944, "citationsperpaper_5": 6.389, "citationsperyear_0": 2.5, "citationsperyear_1": 3.176, "citationsperyear_2": 4.056, "citationsperyear_3": 4.789, "citationsperyear_4": 5.35, "citationsperyear_5": 5.476, "totalcitations_0": 40.0, "totalcitations_1": 54.0, "totalcitations_2": 73.0, "totalcitations_3": 91.0, "totalcitations_4": 107.0, "totalcitations_5": 115.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 53.0, "recentcoauthors_5": 37.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.5, "venuehindexmean_1": 136.0, "venuehindexmean_2": 138.8571428571, "venuehindexmean_3": 141.4285714286, "venuehindexmean_4": 133.75, "venuehindexmean_5": 135.75, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 4.0530274316, "pagerank_1": 5.1721699049, "pagerank_2": 4.9723782461, "pagerank_3": 5.3119304177, "pagerank_4": 6.3373295165, "pagerank_5": 6.1971078158}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["Wei-GuoZhu"], "affiliation": "Ohio State University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.636, "citationsperpaper_1": 4.154, "citationsperpaper_2": 5.615, "citationsperpaper_3": 6.5, "citationsperpaper_4": 5.944, "citationsperpaper_5": 6.389, "citationsperyear_0": 2.5, "citationsperyear_1": 3.176, "citationsperyear_2": 4.056, "citationsperyear_3": 4.789, "citationsperyear_4": 5.35, "citationsperyear_5": 5.476, "totalcitations_0": 40.0, "totalcitations_1": 54.0, "totalcitations_2": 73.0, "totalcitations_3": 91.0, "totalcitations_4": 107.0, "totalcitations_5": 115.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 53.0, "recentcoauthors_5": 37.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.5, "venuehindexmean_1": 136.0, "venuehindexmean_2": 138.8571428571, "venuehindexmean_3": 141.4285714286, "venuehindexmean_4": 133.75, "venuehindexmean_5": 135.75, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 4.0530274316, "pagerank_1": 5.1721699049, "pagerank_2": 4.9723782461, "pagerank_3": 5.3119304177, "pagerank_4": 6.3373295165, "pagerank_5": 6.1971078158}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["Wei-GuoZhu"], "affiliation": "Tsinghua University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.636, "citationsperpaper_1": 4.154, "citationsperpaper_2": 5.615, "citationsperpaper_3": 6.5, "citationsperpaper_4": 5.944, "citationsperpaper_5": 6.389, "citationsperyear_0": 2.5, "citationsperyear_1": 3.176, "citationsperyear_2": 4.056, "citationsperyear_3": 4.789, "citationsperyear_4": 5.35, "citationsperyear_5": 5.476, "totalcitations_0": 40.0, "totalcitations_1": 54.0, "totalcitations_2": 73.0, "totalcitations_3": 91.0, "totalcitations_4": 107.0, "totalcitations_5": 115.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 53.0, "recentcoauthors_5": 37.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.5, "venuehindexmean_1": 136.0, "venuehindexmean_2": 138.8571428571, "venuehindexmean_3": 141.4285714286, "venuehindexmean_4": 133.75, "venuehindexmean_5": 135.75, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 4.0530274316, "pagerank_1": 5.1721699049, "pagerank_2": 4.9723782461, "pagerank_3": 5.3119304177, "pagerank_4": 6.3373295165, "pagerank_5": 6.1971078158}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["Wei-GuoZhu"], "affiliation": "Indiana University \u2013 Purdue University Indianapolis", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.636, "citationsperpaper_1": 4.154, "citationsperpaper_2": 5.615, "citationsperpaper_3": 6.5, "citationsperpaper_4": 5.944, "citationsperpaper_5": 6.389, "citationsperyear_0": 2.5, "citationsperyear_1": 3.176, "citationsperyear_2": 4.056, "citationsperyear_3": 4.789, "citationsperyear_4": 5.35, "citationsperyear_5": 5.476, "totalcitations_0": 40.0, "totalcitations_1": 54.0, "totalcitations_2": 73.0, "totalcitations_3": 91.0, "totalcitations_4": 107.0, "totalcitations_5": 115.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 53.0, "recentcoauthors_5": 37.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.5, "venuehindexmean_1": 136.0, "venuehindexmean_2": 138.8571428571, "venuehindexmean_3": 141.4285714286, "venuehindexmean_4": 133.75, "venuehindexmean_5": 135.75, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 4.0530274316, "pagerank_1": 5.1721699049, "pagerank_2": 4.9723782461, "pagerank_3": 5.3119304177, "pagerank_4": 6.3373295165, "pagerank_5": 6.1971078158}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["Wei-GuoZhu"], "affiliation": "Indiana University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.636, "citationsperpaper_1": 4.154, "citationsperpaper_2": 5.615, "citationsperpaper_3": 6.5, "citationsperpaper_4": 5.944, "citationsperpaper_5": 6.389, "citationsperyear_0": 2.5, "citationsperyear_1": 3.176, "citationsperyear_2": 4.056, "citationsperyear_3": 4.789, "citationsperyear_4": 5.35, "citationsperyear_5": 5.476, "totalcitations_0": 40.0, "totalcitations_1": 54.0, "totalcitations_2": 73.0, "totalcitations_3": 91.0, "totalcitations_4": 107.0, "totalcitations_5": 115.0, "totalpapers_0": 11.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 26.0, "recentcoauthors_1": 53.0, "recentcoauthors_2": 40.0, "recentcoauthors_3": 16.0, "recentcoauthors_4": 53.0, "recentcoauthors_5": 37.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.5, "venuehindexmean_1": 136.0, "venuehindexmean_2": 138.8571428571, "venuehindexmean_3": 141.4285714286, "venuehindexmean_4": 133.75, "venuehindexmean_5": 135.75, "totalvenues_0": 6.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 8.0, "totalvenues_5": 8.0, "pagerank_0": 4.0530274316, "pagerank_1": 5.1721699049, "pagerank_2": 4.9723782461, "pagerank_3": 5.3119304177, "pagerank_4": 6.3373295165, "pagerank_5": 6.1971078158}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["DelinChen", "JingShan", "WeiGu"], "affiliation": "Columbia University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 10.0, "hindex_1": 10.3333333333, "hindex_2": 11.0, "hindex_3": 11.3333333333, "hindex_4": 11.3333333333, "hindex_5": 11.3333333333, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 43.668, "citationsperpaper_1": 45.9316666667, "citationsperpaper_2": 49.2193333333, "citationsperpaper_3": 50.5413333333, "citationsperpaper_4": 52.496, "citationsperpaper_5": 53.452, "citationsperyear_0": 52.8823333333, "citationsperyear_1": 54.339, "citationsperyear_2": 55.3303333333, "citationsperyear_3": 55.222, "citationsperyear_4": 55.0213333333, "citationsperyear_5": 53.7316666667, "totalcitations_0": 821.3333333333, "totalcitations_1": 907.0, "totalcitations_2": 976.0, "totalcitations_3": 1035.0, "totalcitations_4": 1089.0, "totalcitations_5": 1120.0, "totalpapers_0": 15.6666666667, "totalpapers_1": 17.3333333333, "totalpapers_2": 18.6666666667, "totalpapers_3": 20.0, "totalpapers_4": 21.0, "totalpapers_5": 21.6666666667, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 8.3333333333, "recentcoauthors_1": 18.3333333333, "recentcoauthors_2": 21.3333333333, "recentcoauthors_3": 21.0, "recentcoauthors_4": 15.3333333333, "recentcoauthors_5": 9.3333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 203.0277777778, "venuehindexmean_1": 206.75, "venuehindexmean_2": 208.4404761905, "venuehindexmean_3": 212.8214285714, "venuehindexmean_4": 216.3452380952, "venuehindexmean_5": 219.6428571429, "totalvenues_0": 5.6666666667, "totalvenues_1": 5.6666666667, "totalvenues_2": 6.3333333333, "totalvenues_3": 6.3333333333, "totalvenues_4": 6.3333333333, "totalvenues_5": 6.3333333333, "pagerank_0": 3.2764701806, "pagerank_1": 3.5037167034, "pagerank_2": 3.7524707701, "pagerank_3": 3.9319363633, "pagerank_4": 4.0803183242, "pagerank_5": 4.0631344679}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["WeiGu"], "affiliation": "Rockefeller University", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 23.0, "hindex_1": 24.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 26.0, "hindex_5": 26.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 48.718, "citationsperpaper_1": 47.795, "citationsperpaper_2": 47.229, "citationsperpaper_3": 46.481, "citationsperpaper_4": 46.345, "citationsperpaper_5": 46.07, "citationsperyear_0": 105.556, "citationsperyear_1": 110.684, "citationsperyear_2": 113.35, "citationsperyear_3": 115.095, "citationsperyear_4": 115.864, "citationsperyear_5": 114.174, "totalcitations_0": 1900.0, "totalcitations_1": 2103.0, "totalcitations_2": 2267.0, "totalcitations_3": 2417.0, "totalcitations_4": 2549.0, "totalcitations_5": 2626.0, "totalpapers_0": 39.0, "totalpapers_1": 44.0, "totalpapers_2": 48.0, "totalpapers_3": 52.0, "totalpapers_4": 55.0, "totalpapers_5": 57.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 47.0, "recentcoauthors_2": 64.0, "recentcoauthors_3": 63.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 28.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.8333333333, "venuehindexmean_1": 132.5, "venuehindexmean_2": 127.5714285714, "venuehindexmean_3": 130.7142857143, "venuehindexmean_4": 133.2857142857, "venuehindexmean_5": 135.9285714286, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 14.0, "totalvenues_3": 14.0, "totalvenues_4": 14.0, "totalvenues_5": 14.0, "pagerank_0": 7.9328574835, "pagerank_1": 8.7154758128, "pagerank_2": 9.5309542996, "pagerank_3": 10.1390936165, "pagerank_4": 10.6148534848, "pagerank_5": 10.6039733777}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["WeiGu"], "affiliation": "Columbia University Medical Center", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 23.0, "hindex_1": 24.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 26.0, "hindex_5": 26.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 48.718, "citationsperpaper_1": 47.795, "citationsperpaper_2": 47.229, "citationsperpaper_3": 46.481, "citationsperpaper_4": 46.345, "citationsperpaper_5": 46.07, "citationsperyear_0": 105.556, "citationsperyear_1": 110.684, "citationsperyear_2": 113.35, "citationsperyear_3": 115.095, "citationsperyear_4": 115.864, "citationsperyear_5": 114.174, "totalcitations_0": 1900.0, "totalcitations_1": 2103.0, "totalcitations_2": 2267.0, "totalcitations_3": 2417.0, "totalcitations_4": 2549.0, "totalcitations_5": 2626.0, "totalpapers_0": 39.0, "totalpapers_1": 44.0, "totalpapers_2": 48.0, "totalpapers_3": 52.0, "totalpapers_4": 55.0, "totalpapers_5": 57.0, "authorage_0": 17.0, "authorage_1": 18.0, "authorage_2": 19.0, "authorage_3": 20.0, "authorage_4": 21.0, "authorage_5": 22.0, "recentcoauthors_0": 17.0, "recentcoauthors_1": 47.0, "recentcoauthors_2": 64.0, "recentcoauthors_3": 63.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 28.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.8333333333, "venuehindexmean_1": 132.5, "venuehindexmean_2": 127.5714285714, "venuehindexmean_3": 130.7142857143, "venuehindexmean_4": 133.2857142857, "venuehindexmean_5": 135.9285714286, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 14.0, "totalvenues_3": 14.0, "totalvenues_4": 14.0, "totalvenues_5": 14.0, "pagerank_0": 7.9328574835, "pagerank_1": 8.7154758128, "pagerank_2": 9.5309542996, "pagerank_3": 10.1390936165, "pagerank_4": 10.6148534848, "pagerank_5": 10.6039733777}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["JunQin"], "affiliation": "National Institutes of Health", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 23.0, "hindex_1": 25.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 27.0, "hindex_5": 28.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 29.067, "citationsperpaper_1": 29.877, "citationsperpaper_2": 31.397, "citationsperpaper_3": 32.493, "citationsperpaper_4": 34.718, "citationsperpaper_5": 35.233, "citationsperyear_0": 124.571, "citationsperyear_1": 129.467, "citationsperyear_2": 133.438, "citationsperyear_3": 135.706, "citationsperyear_4": 136.944, "citationsperyear_5": 135.368, "totalcitations_0": 1744.0, "totalcitations_1": 1942.0, "totalcitations_2": 2135.0, "totalcitations_3": 2307.0, "totalcitations_4": 2465.0, "totalcitations_5": 2572.0, "totalpapers_0": 60.0, "totalpapers_1": 65.0, "totalpapers_2": 68.0, "totalpapers_3": 71.0, "totalpapers_4": 71.0, "totalpapers_5": 73.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 122.0, "recentcoauthors_1": 84.0, "recentcoauthors_2": 64.0, "recentcoauthors_3": 54.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 31.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.25, "venuehindexmean_1": 126.5333333333, "venuehindexmean_2": 127.4375, "venuehindexmean_3": 130.1875, "venuehindexmean_4": 132.5, "venuehindexmean_5": 134.625, "totalvenues_0": 12.0, "totalvenues_1": 15.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 16.0069320249, "pagerank_1": 16.6332808757, "pagerank_2": 16.6080509808, "pagerank_3": 16.9094012672, "pagerank_4": 16.3214493293, "pagerank_5": 16.5090827771}}, {"model": "papers.paper", "pk": 1003302, "fields": {"authors": ["JunQin"], "affiliation": "Baylor College of Medicine", "venue": "Nature", "doi": "10.1038/nature08820", "abstract": "Of the known tumour suppressors, ARF and p53 are among the most relevant clinically, with p53 loss or inactivation found in more than half of human cancers and ARF known to activate p53 during oncogenic stress. A study of the mechanism of ARF-mediated p53 activation now shows that ARF is unstable in normal human cells but stable in cancer cells. In normal cells ARF ubiquitination and degradation is promoted by a ligase termed ULF (ubiquitin ligase for ARF), and this activity is abrogated in cancer cells. In response to oncogenic stress, the tumour suppressor ARF activates the p53 protein. ARF protein is highly stable in most human cell lines, so it has been thought that ARF activation occurs mainly at the level of transcription. Here, however, ARF is shown to be unstable in normal human cells but stable in cancer cells, through a transcription-independent mechanism. A ubiquitin ligase for ARF is identified and shown to promote ARF degradation in normal cells. This activity is prevented in cancer cells, stabilizing ARF. The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress1,2,3,4,5,6. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings7,8, suggesting that the ARF\u2013p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF\u2013p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF\u2013p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.", "year": 2010, "title": "Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses", "keywords": ["Cell signaling", "Cell biology", "Biology", "Tumor suppressor gene", "Ubiquitin", "Carcinogenesis", "Cell cycle", "Cancer cell", "ADP ribosylation factor", "Ubiquitin ligase"], "citations_0": 2.0, "citations_1": 0.0, "citations_2": 5.0, "citations_3": 1.0, "citations_4": 2.0, "citations_5": 1.0, "timescaledpagerank_0": 0.1776690266, "timescaledpagerank_1": 0.0601318248, "timescaledpagerank_2": 0.3167586545, "timescaledpagerank_3": 0.2294926292, "timescaledpagerank_4": 0.3434789452, "timescaledpagerank_5": 0.3103958976, "hindex_0": 23.0, "hindex_1": 25.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 27.0, "hindex_5": 28.0, "adopters_0": 8.0, "adopters_1": 0.0, "adopters_2": 57.0, "adopters_3": 23.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 29.067, "citationsperpaper_1": 29.877, "citationsperpaper_2": 31.397, "citationsperpaper_3": 32.493, "citationsperpaper_4": 34.718, "citationsperpaper_5": 35.233, "citationsperyear_0": 124.571, "citationsperyear_1": 129.467, "citationsperyear_2": 133.438, "citationsperyear_3": 135.706, "citationsperyear_4": 136.944, "citationsperyear_5": 135.368, "totalcitations_0": 1744.0, "totalcitations_1": 1942.0, "totalcitations_2": 2135.0, "totalcitations_3": 2307.0, "totalcitations_4": 2465.0, "totalcitations_5": 2572.0, "totalpapers_0": 60.0, "totalpapers_1": 65.0, "totalpapers_2": 68.0, "totalpapers_3": 71.0, "totalpapers_4": 71.0, "totalpapers_5": 73.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 122.0, "recentcoauthors_1": 84.0, "recentcoauthors_2": 64.0, "recentcoauthors_3": 54.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 31.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.25, "venuehindexmean_1": 126.5333333333, "venuehindexmean_2": 127.4375, "venuehindexmean_3": 130.1875, "venuehindexmean_4": 132.5, "venuehindexmean_5": 134.625, "totalvenues_0": 12.0, "totalvenues_1": 15.0, "totalvenues_2": 16.0, "totalvenues_3": 16.0, "totalvenues_4": 16.0, "totalvenues_5": 16.0, "pagerank_0": 16.0069320249, "pagerank_1": 16.6332808757, "pagerank_2": 16.6080509808, "pagerank_3": 16.9094012672, "pagerank_4": 16.3214493293, "pagerank_5": 16.5090827771}}, {"model": "papers.paper", "pk": 1003555, "fields": {"authors": ["LeeSmolin"], "affiliation": "Perimeter Institute for Theoretical Physics", "venue": "Nature", "doi": "10.1038/4671034a", "abstract": "Lee Smolin marvels at Roger Penrose's masterly and imaginative argument that our Universe is one of a succession.", "year": 2010, "title": "Cosmology: Space[hyphen]time turn around", "keywords": ["Cosmology", "Universe", "Hyphen", "Theoretical physics", "Astronomy", "Physics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.5, "citationsperpaper_1": 0.5, "citationsperpaper_2": 0.5, "citationsperpaper_3": 0.5, "citationsperpaper_4": 0.5, "citationsperpaper_5": 0.5, "citationsperyear_0": 0.167, "citationsperyear_1": 0.143, "citationsperyear_2": 0.125, "citationsperyear_3": 0.111, "citationsperyear_4": 0.1, "citationsperyear_5": 0.091, "totalcitations_0": 1.0, "totalcitations_1": 1.0, "totalcitations_2": 1.0, "totalcitations_3": 1.0, "totalcitations_4": 1.0, "totalcitations_5": 1.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.2351991388, "pagerank_1": 1.2350604096, "pagerank_2": 1.2631035714, "pagerank_3": 1.1425313374, "pagerank_4": 1.1308121197, "pagerank_5": 1.1463579511}}, {"model": "papers.paper", "pk": 1003182, "fields": {"authors": ["R. JohnEllis"], "affiliation": "University of Warwick", "venue": "Nature", "doi": "10.1038/465685b", "abstract": "", "year": 2010, "title": "On the occurrence of similar traits in related organisms", "keywords": ["Physiology", "Molecular interactions", "Biology", "Zoology"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 8.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 8.0, "hindex_4": 8.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 19.294, "citationsperpaper_1": 19.824, "citationsperpaper_2": 20.412, "citationsperpaper_3": 20.824, "citationsperpaper_4": 19.889, "citationsperpaper_5": 20.222, "citationsperyear_0": 9.939, "citationsperyear_1": 9.912, "citationsperyear_2": 9.914, "citationsperyear_3": 9.833, "citationsperyear_4": 9.676, "citationsperyear_5": 9.579, "totalcitations_0": 328.0, "totalcitations_1": 337.0, "totalcitations_2": 347.0, "totalcitations_3": 354.0, "totalcitations_4": 358.0, "totalcitations_5": 364.0, "totalpapers_0": 17.0, "totalpapers_1": 17.0, "totalpapers_2": 17.0, "totalpapers_3": 17.0, "totalpapers_4": 18.0, "totalpapers_5": 18.0, "authorage_0": 32.0, "authorage_1": 33.0, "authorage_2": 34.0, "authorage_3": 35.0, "authorage_4": 36.0, "authorage_5": 37.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 193.0, "venuehindexmean_1": 195.5, "venuehindexmean_2": 199.0, "venuehindexmean_3": 202.5, "venuehindexmean_4": 206.0, "venuehindexmean_5": 208.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 1.4725738754, "pagerank_1": 1.4208516169, "pagerank_2": 1.3800414512, "pagerank_3": 1.3523491635, "pagerank_4": 1.3325305574, "pagerank_5": 1.3169581819}}, {"model": "papers.paper", "pk": 1003382, "fields": {"authors": ["ZeeyaMerali"], "affiliation": "Foundational Questions Institute", "venue": "Nature", "doi": "10.1038/news.2010.113", "abstract": "", "year": 2010, "title": "Einstein passes cosmic test", "keywords": ["COSMIC cancer database", "Einstein", "Theoretical physics", "Classical mechanics", "Physics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.128, "citationsperpaper_1": 0.103, "citationsperpaper_2": 0.136, "citationsperpaper_3": 0.138, "citationsperpaper_4": 0.14, "citationsperpaper_5": 0.154, "citationsperyear_0": 0.857, "citationsperyear_1": 0.75, "citationsperyear_2": 1.0, "citationsperyear_3": 1.1, "citationsperyear_4": 1.091, "citationsperyear_5": 1.167, "totalcitations_0": 6.0, "totalcitations_1": 6.0, "totalcitations_2": 9.0, "totalcitations_3": 11.0, "totalcitations_4": 12.0, "totalcitations_5": 14.0, "totalpapers_0": 47.0, "totalpapers_1": 58.0, "totalpapers_2": 66.0, "totalpapers_3": 80.0, "totalpapers_4": 86.0, "totalpapers_5": 91.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.2708333126, "pagerank_1": 0.2657805316, "pagerank_2": 0.2635133507, "pagerank_3": 0.2435711377, "pagerank_4": 0.2416813936, "pagerank_5": 0.2402028969}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "Conservation International", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "NatureServe", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "University of Tennessee", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "University of Tasmania", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "International Union for Conservation of Nature and Natural Resources", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "University of the Philippines Los Ba\u00f1os", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "University of Arkansas", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "University of the Philippines", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Thomas M.Brooks"], "affiliation": "University of Virginia", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 9.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.273, "citationsperpaper_1": 8.87, "citationsperpaper_2": 9.783, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.222, "citationsperpaper_5": 11.37, "citationsperyear_0": 11.375, "citationsperyear_1": 12.0, "citationsperyear_2": 12.5, "citationsperyear_3": 12.632, "citationsperyear_4": 13.8, "citationsperyear_5": 14.619, "totalcitations_0": 182.0, "totalcitations_1": 204.0, "totalcitations_2": 225.0, "totalcitations_3": 240.0, "totalcitations_4": 276.0, "totalcitations_5": 307.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 23.0, "totalpapers_3": 24.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 174.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 32.0, "recentcoauthors_5": 22.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 175.0, "venuehindexmean_1": 179.0, "venuehindexmean_2": 183.75, "venuehindexmean_3": 188.5, "venuehindexmean_4": 192.0, "venuehindexmean_5": 195.25, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 6.4950487638, "pagerank_1": 6.4282769761, "pagerank_2": 6.2668076692, "pagerank_3": 6.5060884287, "pagerank_4": 7.0834400698, "pagerank_5": 7.020276995}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Kristofer M.Helgen"], "affiliation": "Australian Museum", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.333, "citationsperpaper_1": 2.25, "citationsperpaper_2": 3.556, "citationsperpaper_3": 3.7, "citationsperpaper_4": 3.917, "citationsperpaper_5": 4.583, "citationsperyear_0": 2.0, "citationsperyear_1": 2.25, "citationsperyear_2": 3.556, "citationsperyear_3": 3.7, "citationsperyear_4": 4.273, "citationsperyear_5": 4.583, "totalcitations_0": 14.0, "totalcitations_1": 18.0, "totalcitations_2": 32.0, "totalcitations_3": 37.0, "totalcitations_4": 47.0, "totalcitations_5": 55.0, "totalpapers_0": 6.0, "totalpapers_1": 8.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 58.0, "recentcoauthors_3": 30.0, "recentcoauthors_4": 131.0, "recentcoauthors_5": 130.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.8774314243, "pagerank_1": 2.2326536548, "pagerank_2": 2.4457425306, "pagerank_3": 2.5809706715, "pagerank_4": 4.3545876303, "pagerank_5": 4.303382448}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Kristofer M.Helgen"], "affiliation": "National Museum of Natural History", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.333, "citationsperpaper_1": 2.25, "citationsperpaper_2": 3.556, "citationsperpaper_3": 3.7, "citationsperpaper_4": 3.917, "citationsperpaper_5": 4.583, "citationsperyear_0": 2.0, "citationsperyear_1": 2.25, "citationsperyear_2": 3.556, "citationsperyear_3": 3.7, "citationsperyear_4": 4.273, "citationsperyear_5": 4.583, "totalcitations_0": 14.0, "totalcitations_1": 18.0, "totalcitations_2": 32.0, "totalcitations_3": 37.0, "totalcitations_4": 47.0, "totalcitations_5": 55.0, "totalpapers_0": 6.0, "totalpapers_1": 8.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 58.0, "recentcoauthors_3": 30.0, "recentcoauthors_4": 131.0, "recentcoauthors_5": 130.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.8774314243, "pagerank_1": 2.2326536548, "pagerank_2": 2.4457425306, "pagerank_3": 2.5809706715, "pagerank_4": 4.3545876303, "pagerank_5": 4.303382448}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Kristofer M.Helgen"], "affiliation": "Smithsonian Institution", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.333, "citationsperpaper_1": 2.25, "citationsperpaper_2": 3.556, "citationsperpaper_3": 3.7, "citationsperpaper_4": 3.917, "citationsperpaper_5": 4.583, "citationsperyear_0": 2.0, "citationsperyear_1": 2.25, "citationsperyear_2": 3.556, "citationsperyear_3": 3.7, "citationsperyear_4": 4.273, "citationsperyear_5": 4.583, "totalcitations_0": 14.0, "totalcitations_1": 18.0, "totalcitations_2": 32.0, "totalcitations_3": 37.0, "totalcitations_4": 47.0, "totalcitations_5": 55.0, "totalpapers_0": 6.0, "totalpapers_1": 8.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 58.0, "recentcoauthors_3": 30.0, "recentcoauthors_4": 131.0, "recentcoauthors_5": 130.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.8774314243, "pagerank_1": 2.2326536548, "pagerank_2": 2.4457425306, "pagerank_3": 2.5809706715, "pagerank_4": 4.3545876303, "pagerank_5": 4.303382448}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Kristofer M.Helgen"], "affiliation": "South Australian Museum", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.333, "citationsperpaper_1": 2.25, "citationsperpaper_2": 3.556, "citationsperpaper_3": 3.7, "citationsperpaper_4": 3.917, "citationsperpaper_5": 4.583, "citationsperyear_0": 2.0, "citationsperyear_1": 2.25, "citationsperyear_2": 3.556, "citationsperyear_3": 3.7, "citationsperyear_4": 4.273, "citationsperyear_5": 4.583, "totalcitations_0": 14.0, "totalcitations_1": 18.0, "totalcitations_2": 32.0, "totalcitations_3": 37.0, "totalcitations_4": 47.0, "totalcitations_5": 55.0, "totalpapers_0": 6.0, "totalpapers_1": 8.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 58.0, "recentcoauthors_3": 30.0, "recentcoauthors_4": 131.0, "recentcoauthors_5": 130.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.8774314243, "pagerank_1": 2.2326536548, "pagerank_2": 2.4457425306, "pagerank_3": 2.5809706715, "pagerank_4": 4.3545876303, "pagerank_5": 4.303382448}}, {"model": "papers.paper", "pk": 1003271, "fields": {"authors": ["Kristofer M.Helgen"], "affiliation": "University of Adelaide", "venue": "Nature", "doi": "10.1038/467540a", "abstract": "Delimitation of species is especially taxing when populations of similar organisms occupy non-overlapping geographical ranges. A new quantitative framework offers a consistent approach for tackling the problem.", "year": 2010, "title": "Biodiversity: A standard for species.", "keywords": ["Specific identification", "Geographic distribution", "Taxonomy (biology)", "Biology", "Biodiversity", "Evolutionary biology", "Phylogenetics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 2.0, "hindex_1": 2.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.333, "citationsperpaper_1": 2.25, "citationsperpaper_2": 3.556, "citationsperpaper_3": 3.7, "citationsperpaper_4": 3.917, "citationsperpaper_5": 4.583, "citationsperyear_0": 2.0, "citationsperyear_1": 2.25, "citationsperyear_2": 3.556, "citationsperyear_3": 3.7, "citationsperyear_4": 4.273, "citationsperyear_5": 4.583, "totalcitations_0": 14.0, "totalcitations_1": 18.0, "totalcitations_2": 32.0, "totalcitations_3": 37.0, "totalcitations_4": 47.0, "totalcitations_5": 55.0, "totalpapers_0": 6.0, "totalpapers_1": 8.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 12.0, "totalpapers_5": 12.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 30.0, "recentcoauthors_2": 58.0, "recentcoauthors_3": 30.0, "recentcoauthors_4": 131.0, "recentcoauthors_5": 130.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 246.5, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 2.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.8774314243, "pagerank_1": 2.2326536548, "pagerank_2": 2.4457425306, "pagerank_3": 2.5809706715, "pagerank_4": 4.3545876303, "pagerank_5": 4.303382448}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["YukoTsuya", "MasakazuYamazaki", "ShinsukeChida", "YasuoHorie", "SatoshiKofuji", "JunkoSasaki", "KouichiMiura", "HarukaMurakami", "SatoshiEguchi", "ReietsuItoh", "KenAsanuma", "KiyohikoTakayama", "HirokazuHirai", "TakehikoSasaki", "AkiraSuzuki", "ShunsukeTakasuga"], "affiliation": "Akita University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 4.125, "hindex_1": 4.3125, "hindex_2": 4.4375, "hindex_3": 4.625, "hindex_4": 4.875, "hindex_5": 5.375, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.11225, "citationsperpaper_1": 10.033375, "citationsperpaper_2": 10.3148125, "citationsperpaper_3": 10.1555, "citationsperpaper_4": 10.6510625, "citationsperpaper_5": 11.2659375, "citationsperyear_0": 10.021, "citationsperyear_1": 10.2153125, "citationsperyear_2": 10.1753125, "citationsperyear_3": 10.2386875, "citationsperyear_4": 10.240375, "citationsperyear_5": 10.6736875, "totalcitations_0": 198.75, "totalcitations_1": 213.5, "totalcitations_2": 226.0, "totalcitations_3": 239.0, "totalcitations_4": 250.8125, "totalcitations_5": 266.1875, "totalpapers_0": 8.5625, "totalpapers_1": 9.1875, "totalpapers_2": 9.8125, "totalpapers_3": 10.625, "totalpapers_4": 10.875, "totalpapers_5": 11.75, "authorage_0": 6.9375, "authorage_1": 7.9375, "authorage_2": 8.9375, "authorage_3": 9.9375, "authorage_4": 10.9375, "authorage_5": 11.9375, "recentcoauthors_0": 22.5, "recentcoauthors_1": 29.9375, "recentcoauthors_2": 21.4375, "recentcoauthors_3": 24.5, "recentcoauthors_4": 17.4375, "recentcoauthors_5": 19.1875, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 197.8964460784, "venuehindexmean_1": 200.7961309524, "venuehindexmean_2": 196.975070028, "venuehindexmean_3": 195.0504187092, "venuehindexmean_4": 199.181921025, "venuehindexmean_5": 183.6504464286, "totalvenues_0": 4.1875, "totalvenues_1": 4.4375, "totalvenues_2": 4.75, "totalvenues_3": 5.125, "totalvenues_4": 5.25, "totalvenues_5": 5.8125, "pagerank_0": 3.5033561649, "pagerank_1": 3.6251606522, "pagerank_2": 3.7610844875, "pagerank_3": 3.9665001271, "pagerank_4": 3.9463812562, "pagerank_5": 4.1695700549}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["HirokazuHirai"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 16.556, "citationsperpaper_1": 17.889, "citationsperpaper_2": 18.667, "citationsperpaper_3": 17.3, "citationsperpaper_4": 16.364, "citationsperpaper_5": 17.273, "citationsperyear_0": 9.933, "citationsperyear_1": 10.063, "citationsperyear_2": 9.882, "citationsperyear_3": 9.611, "citationsperyear_4": 9.474, "citationsperyear_5": 9.5, "totalcitations_0": 149.0, "totalcitations_1": 161.0, "totalcitations_2": 168.0, "totalcitations_3": 173.0, "totalcitations_4": 180.0, "totalcitations_5": 190.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 11.0, "totalpapers_5": 11.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 136.1666666667, "venuehindexmean_1": 138.5, "venuehindexmean_2": 141.6666666667, "venuehindexmean_3": 144.1666666667, "venuehindexmean_4": 162.1428571429, "venuehindexmean_5": 164.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.3180845121, "pagerank_1": 3.2245812007, "pagerank_2": 3.123013673, "pagerank_3": 3.2144117161, "pagerank_4": 3.3437456581, "pagerank_5": 3.2667957623}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TadaomiTakenawa", "AkiraSuzuki", "HirokazuHirai"], "affiliation": "Kobe University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 15.3333333333, "hindex_1": 15.6666666667, "hindex_2": 16.0, "hindex_3": 16.3333333333, "hindex_4": 16.3333333333, "hindex_5": 16.6666666667, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 22.7186666667, "citationsperpaper_1": 22.5393333333, "citationsperpaper_2": 23.165, "citationsperpaper_3": 23.141, "citationsperpaper_4": 22.7636666667, "citationsperpaper_5": 22.9803333333, "citationsperyear_0": 41.8676666667, "citationsperyear_1": 42.436, "citationsperyear_2": 42.4476666667, "citationsperyear_3": 42.183, "citationsperyear_4": 42.0046666667, "citationsperyear_5": 41.8393333333, "totalcitations_0": 1157.6666666667, "totalcitations_1": 1220.6666666667, "totalcitations_2": 1269.0, "totalcitations_3": 1311.3333333333, "totalcitations_4": 1353.3333333333, "totalcitations_5": 1394.0, "totalpapers_0": 48.3333333333, "totalpapers_1": 51.0, "totalpapers_2": 52.0, "totalpapers_3": 53.0, "totalpapers_4": 54.6666666667, "totalpapers_5": 56.0, "authorage_0": 27.0, "authorage_1": 28.0, "authorage_2": 29.0, "authorage_3": 30.0, "authorage_4": 31.0, "authorage_5": 32.0, "recentcoauthors_0": 32.0, "recentcoauthors_1": 54.6666666667, "recentcoauthors_2": 41.6666666667, "recentcoauthors_3": 20.6666666667, "recentcoauthors_4": 35.3333333333, "recentcoauthors_5": 43.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 133.3921568627, "venuehindexmean_1": 134.7222222222, "venuehindexmean_2": 137.9722222222, "venuehindexmean_3": 140.6759259259, "venuehindexmean_4": 146.5900167084, "venuehindexmean_5": 147.219047619, "totalvenues_0": 11.6666666667, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.6666666667, "totalvenues_5": 13.0, "pagerank_0": 13.2724976605, "pagerank_1": 13.8122859942, "pagerank_2": 13.5320238923, "pagerank_3": 13.5099884908, "pagerank_4": 13.74813402, "pagerank_5": 13.8949302257}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["HirokazuHirai"], "affiliation": "RIKEN Brain Science Institute", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 16.556, "citationsperpaper_1": 17.889, "citationsperpaper_2": 18.667, "citationsperpaper_3": 17.3, "citationsperpaper_4": 16.364, "citationsperpaper_5": 17.273, "citationsperyear_0": 9.933, "citationsperyear_1": 10.063, "citationsperyear_2": 9.882, "citationsperyear_3": 9.611, "citationsperyear_4": 9.474, "citationsperyear_5": 9.5, "totalcitations_0": 149.0, "totalcitations_1": 161.0, "totalcitations_2": 168.0, "totalcitations_3": 173.0, "totalcitations_4": 180.0, "totalcitations_5": 190.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 11.0, "totalpapers_5": 11.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 136.1666666667, "venuehindexmean_1": 138.5, "venuehindexmean_2": 141.6666666667, "venuehindexmean_3": 144.1666666667, "venuehindexmean_4": 162.1428571429, "venuehindexmean_5": 164.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.3180845121, "pagerank_1": 3.2245812007, "pagerank_2": 3.123013673, "pagerank_3": 3.2144117161, "pagerank_4": 3.3437456581, "pagerank_5": 3.2667957623}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["HirokazuHirai"], "affiliation": "St. Jude Children's Research Hospital", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 16.556, "citationsperpaper_1": 17.889, "citationsperpaper_2": 18.667, "citationsperpaper_3": 17.3, "citationsperpaper_4": 16.364, "citationsperpaper_5": 17.273, "citationsperyear_0": 9.933, "citationsperyear_1": 10.063, "citationsperyear_2": 9.882, "citationsperyear_3": 9.611, "citationsperyear_4": 9.474, "citationsperyear_5": 9.5, "totalcitations_0": 149.0, "totalcitations_1": 161.0, "totalcitations_2": 168.0, "totalcitations_3": 173.0, "totalcitations_4": 180.0, "totalcitations_5": 190.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 11.0, "totalpapers_5": 11.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 136.1666666667, "venuehindexmean_1": 138.5, "venuehindexmean_2": 141.6666666667, "venuehindexmean_3": 144.1666666667, "venuehindexmean_4": 162.1428571429, "venuehindexmean_5": 164.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.3180845121, "pagerank_1": 3.2245812007, "pagerank_2": 3.123013673, "pagerank_3": 3.2144117161, "pagerank_4": 3.3437456581, "pagerank_5": 3.2667957623}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["KiyohikoTakayama", "HirokazuHirai"], "affiliation": "Gunma University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 3.5, "hindex_1": 3.5, "hindex_2": 3.5, "hindex_3": 3.5, "hindex_4": 3.5, "hindex_5": 3.5, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 8.778, "citationsperpaper_1": 9.9445, "citationsperpaper_2": 10.3335, "citationsperpaper_3": 10.15, "citationsperpaper_4": 9.682, "citationsperpaper_5": 11.1365, "citationsperyear_0": 5.4665, "citationsperyear_1": 5.5315, "citationsperyear_2": 5.2745, "citationsperyear_3": 5.1805, "citationsperyear_4": 5.037, "citationsperyear_5": 5.1665, "totalcitations_0": 75.0, "totalcitations_1": 81.5, "totalcitations_2": 85.0, "totalcitations_3": 88.0, "totalcitations_4": 91.5, "totalcitations_5": 97.5, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 5.5, "totalpapers_4": 6.0, "totalpapers_5": 6.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 3.0, "recentcoauthors_4": 7.0, "recentcoauthors_5": 4.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 198.0833333333, "venuehindexmean_1": 201.25, "venuehindexmean_2": 205.3333333333, "venuehindexmean_3": 209.5833333333, "venuehindexmean_4": 221.0714285714, "venuehindexmean_5": 224.4285714286, "totalvenues_0": 3.5, "totalvenues_1": 3.5, "totalvenues_2": 3.5, "totalvenues_3": 3.5, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 2.0111058774, "pagerank_1": 1.9506184922, "pagerank_2": 1.8891900812, "pagerank_3": 1.9196083115, "pagerank_4": 1.9777614024, "pagerank_5": 1.927821211}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["HirokazuHirai"], "affiliation": "Kanazawa University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 16.556, "citationsperpaper_1": 17.889, "citationsperpaper_2": 18.667, "citationsperpaper_3": 17.3, "citationsperpaper_4": 16.364, "citationsperpaper_5": 17.273, "citationsperyear_0": 9.933, "citationsperyear_1": 10.063, "citationsperyear_2": 9.882, "citationsperyear_3": 9.611, "citationsperyear_4": 9.474, "citationsperyear_5": 9.5, "totalcitations_0": 149.0, "totalcitations_1": 161.0, "totalcitations_2": 168.0, "totalcitations_3": 173.0, "totalcitations_4": 180.0, "totalcitations_5": 190.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 10.0, "totalpapers_4": 11.0, "totalpapers_5": 11.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 14.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 136.1666666667, "venuehindexmean_1": 138.5, "venuehindexmean_2": 141.6666666667, "venuehindexmean_3": 144.1666666667, "venuehindexmean_4": 162.1428571429, "venuehindexmean_5": 164.8571428571, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.3180845121, "pagerank_1": 3.2245812007, "pagerank_2": 3.123013673, "pagerank_3": 3.2144117161, "pagerank_4": 3.3437456581, "pagerank_5": 3.2667957623}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TakehikoSasaki", "AkiraSuzuki"], "affiliation": "Amgen", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 18.5, "hindex_1": 19.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.5, "hindex_5": 22.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 29.0035, "citationsperpaper_1": 28.081, "citationsperpaper_2": 27.991, "citationsperpaper_3": 28.706, "citationsperpaper_4": 28.9965, "citationsperpaper_5": 28.621, "citationsperyear_0": 50.807, "citationsperyear_1": 51.7155, "citationsperyear_2": 52.221, "citationsperyear_3": 52.8085, "citationsperyear_4": 53.0705, "citationsperyear_5": 53.3295, "totalcitations_0": 1368.0, "totalcitations_1": 1451.5, "totalcitations_2": 1524.0, "totalcitations_3": 1602.0, "totalcitations_4": 1669.5, "totalcitations_5": 1736.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 54.0, "totalpapers_3": 55.5, "totalpapers_4": 57.0, "totalpapers_5": 60.0, "authorage_0": 32.0, "authorage_1": 33.0, "authorage_2": 34.0, "authorage_3": 35.0, "authorage_4": 36.0, "authorage_5": 37.0, "recentcoauthors_0": 35.5, "recentcoauthors_1": 85.0, "recentcoauthors_2": 118.0, "recentcoauthors_3": 80.5, "recentcoauthors_4": 52.0, "recentcoauthors_5": 82.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 129.8215686275, "venuehindexmean_1": 129.1666666667, "venuehindexmean_2": 129.1862745098, "venuehindexmean_3": 132.1241830065, "venuehindexmean_4": 132.0464396285, "venuehindexmean_5": 128.2888888889, "totalvenues_0": 16.0, "totalvenues_1": 17.0, "totalvenues_2": 17.5, "totalvenues_3": 17.5, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 16.8806744285, "pagerank_1": 17.8198925819, "pagerank_2": 18.4617698748, "pagerank_3": 18.4294930724, "pagerank_4": 18.5348048098, "pagerank_5": 19.2385881976}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["AkiraSuzuki"], "affiliation": "Osaka University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 16.0, "hindex_1": 16.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 28.6, "citationsperpaper_1": 26.146, "citationsperpaper_2": 26.952, "citationsperpaper_3": 28.0, "citationsperpaper_4": 27.478, "citationsperpaper_5": 26.918, "citationsperyear_0": 22.75, "citationsperyear_1": 23.822, "citationsperyear_2": 24.609, "citationsperyear_3": 25.617, "citationsperyear_4": 26.333, "citationsperyear_5": 26.918, "totalcitations_0": 1001.0, "totalcitations_1": 1072.0, "totalcitations_2": 1132.0, "totalcitations_3": 1204.0, "totalcitations_4": 1264.0, "totalcitations_5": 1319.0, "totalpapers_0": 35.0, "totalpapers_1": 41.0, "totalpapers_2": 42.0, "totalpapers_3": 43.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 43.0, "authorage_1": 44.0, "authorage_2": 45.0, "authorage_3": 46.0, "authorage_4": 47.0, "authorage_5": 48.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 100.0, "recentcoauthors_2": 105.0, "recentcoauthors_3": 45.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 112.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 122.1764705882, "venuehindexmean_1": 121.3333333333, "venuehindexmean_2": 124.6666666667, "venuehindexmean_3": 127.7777777778, "venuehindexmean_4": 125.2105263158, "venuehindexmean_5": 122.3, "totalvenues_0": 17.0, "totalvenues_1": 18.0, "totalvenues_2": 18.0, "totalvenues_3": 18.0, "totalvenues_4": 19.0, "totalvenues_5": 20.0, "pagerank_0": 13.7810354456, "pagerank_1": 15.5307036828, "pagerank_2": 15.3413925157, "pagerank_3": 15.3116431524, "pagerank_4": 16.2260596398, "pagerank_5": 17.0723127604}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["AkiraSuzuki"], "affiliation": "Tohoku University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 16.0, "hindex_1": 16.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 28.6, "citationsperpaper_1": 26.146, "citationsperpaper_2": 26.952, "citationsperpaper_3": 28.0, "citationsperpaper_4": 27.478, "citationsperpaper_5": 26.918, "citationsperyear_0": 22.75, "citationsperyear_1": 23.822, "citationsperyear_2": 24.609, "citationsperyear_3": 25.617, "citationsperyear_4": 26.333, "citationsperyear_5": 26.918, "totalcitations_0": 1001.0, "totalcitations_1": 1072.0, "totalcitations_2": 1132.0, "totalcitations_3": 1204.0, "totalcitations_4": 1264.0, "totalcitations_5": 1319.0, "totalpapers_0": 35.0, "totalpapers_1": 41.0, "totalpapers_2": 42.0, "totalpapers_3": 43.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 43.0, "authorage_1": 44.0, "authorage_2": 45.0, "authorage_3": 46.0, "authorage_4": 47.0, "authorage_5": 48.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 100.0, "recentcoauthors_2": 105.0, "recentcoauthors_3": 45.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 112.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 122.1764705882, "venuehindexmean_1": 121.3333333333, "venuehindexmean_2": 124.6666666667, "venuehindexmean_3": 127.7777777778, "venuehindexmean_4": 125.2105263158, "venuehindexmean_5": 122.3, "totalvenues_0": 17.0, "totalvenues_1": 18.0, "totalvenues_2": 18.0, "totalvenues_3": 18.0, "totalvenues_4": 19.0, "totalvenues_5": 20.0, "pagerank_0": 13.7810354456, "pagerank_1": 15.5307036828, "pagerank_2": 15.3413925157, "pagerank_3": 15.3116431524, "pagerank_4": 16.2260596398, "pagerank_5": 17.0723127604}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["AkiraSuzuki"], "affiliation": "Kyushu University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 16.0, "hindex_1": 16.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 28.6, "citationsperpaper_1": 26.146, "citationsperpaper_2": 26.952, "citationsperpaper_3": 28.0, "citationsperpaper_4": 27.478, "citationsperpaper_5": 26.918, "citationsperyear_0": 22.75, "citationsperyear_1": 23.822, "citationsperyear_2": 24.609, "citationsperyear_3": 25.617, "citationsperyear_4": 26.333, "citationsperyear_5": 26.918, "totalcitations_0": 1001.0, "totalcitations_1": 1072.0, "totalcitations_2": 1132.0, "totalcitations_3": 1204.0, "totalcitations_4": 1264.0, "totalcitations_5": 1319.0, "totalpapers_0": 35.0, "totalpapers_1": 41.0, "totalpapers_2": 42.0, "totalpapers_3": 43.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 43.0, "authorage_1": 44.0, "authorage_2": 45.0, "authorage_3": 46.0, "authorage_4": 47.0, "authorage_5": 48.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 100.0, "recentcoauthors_2": 105.0, "recentcoauthors_3": 45.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 112.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 122.1764705882, "venuehindexmean_1": 121.3333333333, "venuehindexmean_2": 124.6666666667, "venuehindexmean_3": 127.7777777778, "venuehindexmean_4": 125.2105263158, "venuehindexmean_5": 122.3, "totalvenues_0": 17.0, "totalvenues_1": 18.0, "totalvenues_2": 18.0, "totalvenues_3": 18.0, "totalvenues_4": 19.0, "totalvenues_5": 20.0, "pagerank_0": 13.7810354456, "pagerank_1": 15.5307036828, "pagerank_2": 15.3413925157, "pagerank_3": 15.3116431524, "pagerank_4": 16.2260596398, "pagerank_5": 17.0723127604}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["AkiraSuzuki"], "affiliation": "Kyoto University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 16.0, "hindex_1": 16.0, "hindex_2": 17.0, "hindex_3": 18.0, "hindex_4": 18.0, "hindex_5": 19.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 28.6, "citationsperpaper_1": 26.146, "citationsperpaper_2": 26.952, "citationsperpaper_3": 28.0, "citationsperpaper_4": 27.478, "citationsperpaper_5": 26.918, "citationsperyear_0": 22.75, "citationsperyear_1": 23.822, "citationsperyear_2": 24.609, "citationsperyear_3": 25.617, "citationsperyear_4": 26.333, "citationsperyear_5": 26.918, "totalcitations_0": 1001.0, "totalcitations_1": 1072.0, "totalcitations_2": 1132.0, "totalcitations_3": 1204.0, "totalcitations_4": 1264.0, "totalcitations_5": 1319.0, "totalpapers_0": 35.0, "totalpapers_1": 41.0, "totalpapers_2": 42.0, "totalpapers_3": 43.0, "totalpapers_4": 46.0, "totalpapers_5": 49.0, "authorage_0": 43.0, "authorage_1": 44.0, "authorage_2": 45.0, "authorage_3": 46.0, "authorage_4": 47.0, "authorage_5": 48.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 100.0, "recentcoauthors_2": 105.0, "recentcoauthors_3": 45.0, "recentcoauthors_4": 76.0, "recentcoauthors_5": 112.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 122.1764705882, "venuehindexmean_1": 121.3333333333, "venuehindexmean_2": 124.6666666667, "venuehindexmean_3": 127.7777777778, "venuehindexmean_4": 125.2105263158, "venuehindexmean_5": 122.3, "totalvenues_0": 17.0, "totalvenues_1": 18.0, "totalvenues_2": 18.0, "totalvenues_3": 18.0, "totalvenues_4": 19.0, "totalvenues_5": 20.0, "pagerank_0": 13.7810354456, "pagerank_1": 15.5307036828, "pagerank_2": 15.3413925157, "pagerank_3": 15.3116431524, "pagerank_4": 16.2260596398, "pagerank_5": 17.0723127604}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TakehikoSasaki", "AkiraSuzuki"], "affiliation": "University of Toronto", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 18.5, "hindex_1": 19.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.5, "hindex_5": 22.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 29.0035, "citationsperpaper_1": 28.081, "citationsperpaper_2": 27.991, "citationsperpaper_3": 28.706, "citationsperpaper_4": 28.9965, "citationsperpaper_5": 28.621, "citationsperyear_0": 50.807, "citationsperyear_1": 51.7155, "citationsperyear_2": 52.221, "citationsperyear_3": 52.8085, "citationsperyear_4": 53.0705, "citationsperyear_5": 53.3295, "totalcitations_0": 1368.0, "totalcitations_1": 1451.5, "totalcitations_2": 1524.0, "totalcitations_3": 1602.0, "totalcitations_4": 1669.5, "totalcitations_5": 1736.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 54.0, "totalpapers_3": 55.5, "totalpapers_4": 57.0, "totalpapers_5": 60.0, "authorage_0": 32.0, "authorage_1": 33.0, "authorage_2": 34.0, "authorage_3": 35.0, "authorage_4": 36.0, "authorage_5": 37.0, "recentcoauthors_0": 35.5, "recentcoauthors_1": 85.0, "recentcoauthors_2": 118.0, "recentcoauthors_3": 80.5, "recentcoauthors_4": 52.0, "recentcoauthors_5": 82.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 129.8215686275, "venuehindexmean_1": 129.1666666667, "venuehindexmean_2": 129.1862745098, "venuehindexmean_3": 132.1241830065, "venuehindexmean_4": 132.0464396285, "venuehindexmean_5": 128.2888888889, "totalvenues_0": 16.0, "totalvenues_1": 17.0, "totalvenues_2": 17.5, "totalvenues_3": 17.5, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 16.8806744285, "pagerank_1": 17.8198925819, "pagerank_2": 18.4617698748, "pagerank_3": 18.4294930724, "pagerank_4": 18.5348048098, "pagerank_5": 19.2385881976}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TakehikoSasaki", "AkiraSuzuki"], "affiliation": "Ontario Institute for Cancer Research", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 18.5, "hindex_1": 19.0, "hindex_2": 20.0, "hindex_3": 21.0, "hindex_4": 21.5, "hindex_5": 22.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 29.0035, "citationsperpaper_1": 28.081, "citationsperpaper_2": 27.991, "citationsperpaper_3": 28.706, "citationsperpaper_4": 28.9965, "citationsperpaper_5": 28.621, "citationsperyear_0": 50.807, "citationsperyear_1": 51.7155, "citationsperyear_2": 52.221, "citationsperyear_3": 52.8085, "citationsperyear_4": 53.0705, "citationsperyear_5": 53.3295, "totalcitations_0": 1368.0, "totalcitations_1": 1451.5, "totalcitations_2": 1524.0, "totalcitations_3": 1602.0, "totalcitations_4": 1669.5, "totalcitations_5": 1736.0, "totalpapers_0": 47.0, "totalpapers_1": 51.0, "totalpapers_2": 54.0, "totalpapers_3": 55.5, "totalpapers_4": 57.0, "totalpapers_5": 60.0, "authorage_0": 32.0, "authorage_1": 33.0, "authorage_2": 34.0, "authorage_3": 35.0, "authorage_4": 36.0, "authorage_5": 37.0, "recentcoauthors_0": 35.5, "recentcoauthors_1": 85.0, "recentcoauthors_2": 118.0, "recentcoauthors_3": 80.5, "recentcoauthors_4": 52.0, "recentcoauthors_5": 82.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 129.8215686275, "venuehindexmean_1": 129.1666666667, "venuehindexmean_2": 129.1862745098, "venuehindexmean_3": 132.1241830065, "venuehindexmean_4": 132.0464396285, "venuehindexmean_5": 128.2888888889, "totalvenues_0": 16.0, "totalvenues_1": 17.0, "totalvenues_2": 17.5, "totalvenues_3": 17.5, "totalvenues_4": 18.0, "totalvenues_5": 19.0, "pagerank_0": 16.8806744285, "pagerank_1": 17.8198925819, "pagerank_2": 18.4617698748, "pagerank_3": 18.4294930724, "pagerank_4": 18.5348048098, "pagerank_5": 19.2385881976}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TadaomiTakenawa"], "affiliation": "Hokkaido University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 24.0, "hindex_1": 25.0, "hindex_2": 25.0, "hindex_3": 25.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 23.0, "citationsperpaper_1": 23.583, "citationsperpaper_2": 23.876, "citationsperpaper_3": 24.123, "citationsperpaper_4": 24.449, "citationsperpaper_5": 24.75, "citationsperyear_0": 92.92, "citationsperyear_1": 93.423, "citationsperyear_2": 92.852, "citationsperyear_3": 91.321, "citationsperyear_4": 90.207, "citationsperyear_5": 89.1, "totalcitations_0": 2323.0, "totalcitations_1": 2429.0, "totalcitations_2": 2507.0, "totalcitations_3": 2557.0, "totalcitations_4": 2616.0, "totalcitations_5": 2673.0, "totalpapers_0": 101.0, "totalpapers_1": 103.0, "totalpapers_2": 105.0, "totalpapers_3": 106.0, "totalpapers_4": 107.0, "totalpapers_5": 108.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 58.0, "recentcoauthors_1": 45.0, "recentcoauthors_2": 20.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 16.0, "recentcoauthors_5": 9.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.8333333333, "venuehindexmean_1": 144.3333333333, "venuehindexmean_2": 147.5833333333, "venuehindexmean_3": 150.0833333333, "venuehindexmean_4": 152.4166666667, "venuehindexmean_5": 154.5, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 22.718373024, "pagerank_1": 22.6815730991, "pagerank_2": 22.1316654883, "pagerank_3": 22.0039106038, "pagerank_4": 21.6745967623, "pagerank_5": 21.3456821544}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TadaomiTakenawa"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 24.0, "hindex_1": 25.0, "hindex_2": 25.0, "hindex_3": 25.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 23.0, "citationsperpaper_1": 23.583, "citationsperpaper_2": 23.876, "citationsperpaper_3": 24.123, "citationsperpaper_4": 24.449, "citationsperpaper_5": 24.75, "citationsperyear_0": 92.92, "citationsperyear_1": 93.423, "citationsperyear_2": 92.852, "citationsperyear_3": 91.321, "citationsperyear_4": 90.207, "citationsperyear_5": 89.1, "totalcitations_0": 2323.0, "totalcitations_1": 2429.0, "totalcitations_2": 2507.0, "totalcitations_3": 2557.0, "totalcitations_4": 2616.0, "totalcitations_5": 2673.0, "totalpapers_0": 101.0, "totalpapers_1": 103.0, "totalpapers_2": 105.0, "totalpapers_3": 106.0, "totalpapers_4": 107.0, "totalpapers_5": 108.0, "authorage_0": 24.0, "authorage_1": 25.0, "authorage_2": 26.0, "authorage_3": 27.0, "authorage_4": 28.0, "authorage_5": 29.0, "recentcoauthors_0": 58.0, "recentcoauthors_1": 45.0, "recentcoauthors_2": 20.0, "recentcoauthors_3": 11.0, "recentcoauthors_4": 16.0, "recentcoauthors_5": 9.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 141.8333333333, "venuehindexmean_1": 144.3333333333, "venuehindexmean_2": 147.5833333333, "venuehindexmean_3": 150.0833333333, "venuehindexmean_4": 152.4166666667, "venuehindexmean_5": 154.5, "totalvenues_0": 12.0, "totalvenues_1": 12.0, "totalvenues_2": 12.0, "totalvenues_3": 12.0, "totalvenues_4": 12.0, "totalvenues_5": 12.0, "pagerank_0": 22.718373024, "pagerank_1": 22.6815730991, "pagerank_2": 22.1316654883, "pagerank_3": 22.0039106038, "pagerank_4": 21.6745967623, "pagerank_5": 21.3456821544}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["MasakazuYamazaki"], "affiliation": "Austrian Academy of Sciences", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 4.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 11.5, "citationsperpaper_1": 14.25, "citationsperpaper_2": 16.25, "citationsperpaper_3": 14.6, "citationsperpaper_4": 16.2, "citationsperpaper_5": 15.833, "citationsperyear_0": 7.667, "citationsperyear_1": 8.143, "citationsperyear_2": 8.125, "citationsperyear_3": 8.111, "citationsperyear_4": 8.1, "citationsperyear_5": 8.636, "totalcitations_0": 46.0, "totalcitations_1": 57.0, "totalcitations_2": 65.0, "totalcitations_3": 73.0, "totalcitations_4": 81.0, "totalcitations_5": 95.0, "totalpapers_0": 4.0, "totalpapers_1": 4.0, "totalpapers_2": 4.0, "totalpapers_3": 5.0, "totalpapers_4": 5.0, "totalpapers_5": 6.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 27.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 21.0, "recentcoauthors_5": 17.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 153.0, "venuehindexmean_1": 155.6666666667, "venuehindexmean_2": 158.6666666667, "venuehindexmean_3": 165.5, "venuehindexmean_4": 168.75, "venuehindexmean_5": 141.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 5.0, "pagerank_0": 2.2232091201, "pagerank_1": 2.1324803721, "pagerank_2": 2.0432108942, "pagerank_3": 2.4796401451, "pagerank_4": 2.4133971245, "pagerank_5": 2.7114577038}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TakehikoSasaki"], "affiliation": "University Health Network", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 21.0, "hindex_1": 22.0, "hindex_2": 23.0, "hindex_3": 24.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 29.407, "citationsperpaper_1": 30.016, "citationsperpaper_2": 29.03, "citationsperpaper_3": 29.412, "citationsperpaper_4": 30.515, "citationsperpaper_5": 30.324, "citationsperyear_0": 78.864, "citationsperyear_1": 79.609, "citationsperyear_2": 79.833, "citationsperyear_3": 80.0, "citationsperyear_4": 79.808, "citationsperyear_5": 79.741, "totalcitations_0": 1735.0, "totalcitations_1": 1831.0, "totalcitations_2": 1916.0, "totalcitations_3": 2000.0, "totalcitations_4": 2075.0, "totalcitations_5": 2153.0, "totalpapers_0": 59.0, "totalpapers_1": 61.0, "totalpapers_2": 66.0, "totalpapers_3": 68.0, "totalpapers_4": 68.0, "totalpapers_5": 71.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 70.0, "recentcoauthors_2": 131.0, "recentcoauthors_3": 116.0, "recentcoauthors_4": 28.0, "recentcoauthors_5": 53.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.4666666667, "venuehindexmean_1": 137.0, "venuehindexmean_2": 133.7058823529, "venuehindexmean_3": 136.4705882353, "venuehindexmean_4": 138.8823529412, "venuehindexmean_5": 134.2777777778, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 18.0, "pagerank_0": 19.9803134115, "pagerank_1": 20.1090814809, "pagerank_2": 21.5821472339, "pagerank_3": 21.5473429923, "pagerank_4": 20.8435499798, "pagerank_5": 21.4048636349}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TakehikoSasaki"], "affiliation": "State University of New York System", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 21.0, "hindex_1": 22.0, "hindex_2": 23.0, "hindex_3": 24.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 29.407, "citationsperpaper_1": 30.016, "citationsperpaper_2": 29.03, "citationsperpaper_3": 29.412, "citationsperpaper_4": 30.515, "citationsperpaper_5": 30.324, "citationsperyear_0": 78.864, "citationsperyear_1": 79.609, "citationsperyear_2": 79.833, "citationsperyear_3": 80.0, "citationsperyear_4": 79.808, "citationsperyear_5": 79.741, "totalcitations_0": 1735.0, "totalcitations_1": 1831.0, "totalcitations_2": 1916.0, "totalcitations_3": 2000.0, "totalcitations_4": 2075.0, "totalcitations_5": 2153.0, "totalpapers_0": 59.0, "totalpapers_1": 61.0, "totalpapers_2": 66.0, "totalpapers_3": 68.0, "totalpapers_4": 68.0, "totalpapers_5": 71.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 70.0, "recentcoauthors_2": 131.0, "recentcoauthors_3": 116.0, "recentcoauthors_4": 28.0, "recentcoauthors_5": 53.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.4666666667, "venuehindexmean_1": 137.0, "venuehindexmean_2": 133.7058823529, "venuehindexmean_3": 136.4705882353, "venuehindexmean_4": 138.8823529412, "venuehindexmean_5": 134.2777777778, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 18.0, "pagerank_0": 19.9803134115, "pagerank_1": 20.1090814809, "pagerank_2": 21.5821472339, "pagerank_3": 21.5473429923, "pagerank_4": 20.8435499798, "pagerank_5": 21.4048636349}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["TakehikoSasaki"], "affiliation": "Tokyo Medical and Dental University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 21.0, "hindex_1": 22.0, "hindex_2": 23.0, "hindex_3": 24.0, "hindex_4": 25.0, "hindex_5": 25.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 29.407, "citationsperpaper_1": 30.016, "citationsperpaper_2": 29.03, "citationsperpaper_3": 29.412, "citationsperpaper_4": 30.515, "citationsperpaper_5": 30.324, "citationsperyear_0": 78.864, "citationsperyear_1": 79.609, "citationsperyear_2": 79.833, "citationsperyear_3": 80.0, "citationsperyear_4": 79.808, "citationsperyear_5": 79.741, "totalcitations_0": 1735.0, "totalcitations_1": 1831.0, "totalcitations_2": 1916.0, "totalcitations_3": 2000.0, "totalcitations_4": 2075.0, "totalcitations_5": 2153.0, "totalpapers_0": 59.0, "totalpapers_1": 61.0, "totalpapers_2": 66.0, "totalpapers_3": 68.0, "totalpapers_4": 68.0, "totalpapers_5": 71.0, "authorage_0": 21.0, "authorage_1": 22.0, "authorage_2": 23.0, "authorage_3": 24.0, "authorage_4": 25.0, "authorage_5": 26.0, "recentcoauthors_0": 52.0, "recentcoauthors_1": 70.0, "recentcoauthors_2": 131.0, "recentcoauthors_3": 116.0, "recentcoauthors_4": 28.0, "recentcoauthors_5": 53.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 137.4666666667, "venuehindexmean_1": 137.0, "venuehindexmean_2": 133.7058823529, "venuehindexmean_3": 136.4705882353, "venuehindexmean_4": 138.8823529412, "venuehindexmean_5": 134.2777777778, "totalvenues_0": 15.0, "totalvenues_1": 16.0, "totalvenues_2": 17.0, "totalvenues_3": 17.0, "totalvenues_4": 17.0, "totalvenues_5": 18.0, "pagerank_0": 19.9803134115, "pagerank_1": 20.1090814809, "pagerank_2": 21.5821472339, "pagerank_3": 21.5473429923, "pagerank_4": 20.8435499798, "pagerank_5": 21.4048636349}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell", "TakehikoSasaki"], "affiliation": "Discovery Institute", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 16.0, "hindex_1": 16.5, "hindex_2": 17.5, "hindex_3": 18.5, "hindex_4": 19.0, "hindex_5": 19.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 19.4815, "citationsperpaper_1": 19.5795, "citationsperpaper_2": 19.2905, "citationsperpaper_3": 19.506, "citationsperpaper_4": 19.9305, "citationsperpaper_5": 19.762, "citationsperyear_0": 48.3905, "citationsperyear_1": 48.7645, "citationsperyear_2": 48.9165, "citationsperyear_3": 48.889, "citationsperyear_4": 48.5825, "citationsperyear_5": 48.5945, "totalcitations_0": 1082.5, "totalcitations_1": 1139.5, "totalcitations_2": 1192.0, "totalcitations_3": 1240.0, "totalcitations_4": 1280.5, "totalcitations_5": 1329.5, "totalpapers_0": 52.0, "totalpapers_1": 55.0, "totalpapers_2": 57.5, "totalpapers_3": 59.0, "totalpapers_4": 60.0, "totalpapers_5": 63.0, "authorage_0": 22.0, "authorage_1": 23.0, "authorage_2": 24.0, "authorage_3": 25.0, "authorage_4": 26.0, "authorage_5": 27.0, "recentcoauthors_0": 59.0, "recentcoauthors_1": 73.5, "recentcoauthors_2": 85.0, "recentcoauthors_3": 64.5, "recentcoauthors_4": 28.5, "recentcoauthors_5": 52.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 131.7333333333, "venuehindexmean_1": 132.6666666667, "venuehindexmean_2": 132.5196078431, "venuehindexmean_3": 132.6852941176, "venuehindexmean_4": 134.9911764706, "venuehindexmean_5": 131.2752525253, "totalvenues_0": 12.0, "totalvenues_1": 12.5, "totalvenues_2": 13.0, "totalvenues_3": 13.5, "totalvenues_4": 13.5, "totalvenues_5": 14.5, "pagerank_0": 15.1652728667, "pagerank_1": 15.5260788701, "pagerank_2": 16.0541255847, "pagerank_3": 16.0227846783, "pagerank_4": 15.6941780002, "pagerank_5": 16.1302740493}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["ToshihikoMomiyama"], "affiliation": "Jikei University School of Medicine", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 3.0, "citationsperpaper_4": 3.0, "citationsperpaper_5": 5.0, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 0.667, "citationsperyear_3": 0.75, "citationsperyear_4": 0.6, "citationsperyear_5": 0.833, "totalcitations_0": 1.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 3.0, "totalcitations_4": 3.0, "totalcitations_5": 5.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.7041272428, "pagerank_1": 0.6766557836, "pagerank_2": 0.6553664894, "pagerank_3": 0.6248049008, "pagerank_4": 0.6117771467, "pagerank_5": 0.5888466581}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["SatoshiKofuji"], "affiliation": "University of Cincinnati", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 1.5, "citationsperpaper_4": 2.5, "citationsperpaper_5": 3.667, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 0.667, "citationsperyear_3": 0.75, "citationsperyear_4": 1.0, "citationsperyear_5": 1.833, "totalcitations_0": 1.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 3.0, "totalcitations_4": 5.0, "totalcitations_5": 11.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 21.0, "recentcoauthors_5": 17.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 161.3333333333, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 3.0, "pagerank_0": 0.7041272404, "pagerank_1": 0.6766557749, "pagerank_2": 0.6553664853, "pagerank_3": 1.1527446244, "pagerank_4": 1.1233165101, "pagerank_5": 1.4721634679}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["SatoshiKofuji"], "affiliation": "Hiroshima University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 2.0, "hindex_5": 3.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 2.0, "citationsperpaper_2": 2.0, "citationsperpaper_3": 1.5, "citationsperpaper_4": 2.5, "citationsperpaper_5": 3.667, "citationsperyear_0": 1.0, "citationsperyear_1": 1.0, "citationsperyear_2": 0.667, "citationsperyear_3": 0.75, "citationsperyear_4": 1.0, "citationsperyear_5": 1.833, "totalcitations_0": 1.0, "totalcitations_1": 2.0, "totalcitations_2": 2.0, "totalcitations_3": 3.0, "totalcitations_4": 5.0, "totalcitations_5": 11.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 3.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 19.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 21.0, "recentcoauthors_4": 21.0, "recentcoauthors_5": 17.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 225.0, "venuehindexmean_4": 229.0, "venuehindexmean_5": 161.3333333333, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 3.0, "pagerank_0": 0.7041272404, "pagerank_1": 0.6766557749, "pagerank_2": 0.6553664853, "pagerank_3": 1.1527446244, "pagerank_4": 1.1233165101, "pagerank_5": 1.4721634679}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell", "Elizabeth MDavies"], "affiliation": "Monash University", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 7.5, "hindex_4": 7.5, "hindex_5": 7.5, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 5.278, "citationsperpaper_1": 5.3215, "citationsperpaper_2": 5.7755, "citationsperpaper_3": 6.05, "citationsperpaper_4": 5.923, "citationsperpaper_5": 5.9335, "citationsperyear_0": 9.4585, "citationsperyear_1": 9.71, "citationsperyear_2": 9.6665, "citationsperyear_3": 9.514, "citationsperyear_4": 9.1785, "citationsperyear_5": 9.3905, "totalcitations_0": 215.5, "totalcitations_1": 225.5, "totalcitations_2": 236.0, "totalcitations_3": 242.5, "totalcitations_4": 245.5, "totalcitations_5": 257.0, "totalpapers_0": 23.0, "totalpapers_1": 25.5, "totalpapers_2": 25.5, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 29.0, "authorage_0": 11.5, "authorage_1": 12.5, "authorage_2": 13.5, "authorage_3": 14.5, "authorage_4": 15.5, "authorage_5": 16.5, "recentcoauthors_0": 42.5, "recentcoauthors_1": 53.5, "recentcoauthors_2": 25.0, "recentcoauthors_3": 6.5, "recentcoauthors_4": 14.5, "recentcoauthors_5": 33.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 193.0, "venuehindexmean_1": 154.9166666667, "venuehindexmean_2": 158.4166666667, "venuehindexmean_3": 159.2, "venuehindexmean_4": 162.05, "venuehindexmean_5": 142.4696969697, "totalvenues_0": 5.0, "totalvenues_1": 5.5, "totalvenues_2": 5.5, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 7.0, "pagerank_0": 5.5271797824, "pagerank_1": 5.9474045215, "pagerank_2": 5.7205659042, "pagerank_3": 5.68453225, "pagerank_4": 5.6944813152, "pagerank_5": 6.0064111759}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell"], "affiliation": "Peter MacCallum Cancer Centre", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 11.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.556, "citationsperpaper_1": 9.143, "citationsperpaper_2": 9.551, "citationsperpaper_3": 9.6, "citationsperpaper_4": 9.346, "citationsperpaper_5": 9.2, "citationsperyear_0": 17.917, "citationsperyear_1": 17.92, "citationsperyear_2": 18.0, "citationsperyear_3": 17.778, "citationsperyear_4": 17.357, "citationsperyear_5": 17.448, "totalcitations_0": 430.0, "totalcitations_1": 448.0, "totalcitations_2": 468.0, "totalcitations_3": 480.0, "totalcitations_4": 486.0, "totalcitations_5": 506.0, "totalpapers_0": 45.0, "totalpapers_1": 49.0, "totalpapers_2": 49.0, "totalpapers_3": 50.0, "totalpapers_4": 52.0, "totalpapers_5": 55.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 66.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 29.0, "recentcoauthors_5": 51.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 126.0, "venuehindexmean_1": 128.3333333333, "venuehindexmean_2": 131.3333333333, "venuehindexmean_3": 128.9, "venuehindexmean_4": 131.1, "venuehindexmean_5": 128.2727272727, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 10.3502323219, "pagerank_1": 10.9430762592, "pagerank_2": 10.5261039356, "pagerank_3": 10.4982263642, "pagerank_4": 10.5448060207, "pagerank_5": 10.8556844636}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell"], "affiliation": "Alfred Hospital", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 11.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.556, "citationsperpaper_1": 9.143, "citationsperpaper_2": 9.551, "citationsperpaper_3": 9.6, "citationsperpaper_4": 9.346, "citationsperpaper_5": 9.2, "citationsperyear_0": 17.917, "citationsperyear_1": 17.92, "citationsperyear_2": 18.0, "citationsperyear_3": 17.778, "citationsperyear_4": 17.357, "citationsperyear_5": 17.448, "totalcitations_0": 430.0, "totalcitations_1": 448.0, "totalcitations_2": 468.0, "totalcitations_3": 480.0, "totalcitations_4": 486.0, "totalcitations_5": 506.0, "totalpapers_0": 45.0, "totalpapers_1": 49.0, "totalpapers_2": 49.0, "totalpapers_3": 50.0, "totalpapers_4": 52.0, "totalpapers_5": 55.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 66.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 29.0, "recentcoauthors_5": 51.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 126.0, "venuehindexmean_1": 128.3333333333, "venuehindexmean_2": 131.3333333333, "venuehindexmean_3": 128.9, "venuehindexmean_4": 131.1, "venuehindexmean_5": 128.2727272727, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 10.3502323219, "pagerank_1": 10.9430762592, "pagerank_2": 10.5261039356, "pagerank_3": 10.4982263642, "pagerank_4": 10.5448060207, "pagerank_5": 10.8556844636}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell"], "affiliation": "Walter and Eliza Hall Institute of Medical Research", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 11.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.556, "citationsperpaper_1": 9.143, "citationsperpaper_2": 9.551, "citationsperpaper_3": 9.6, "citationsperpaper_4": 9.346, "citationsperpaper_5": 9.2, "citationsperyear_0": 17.917, "citationsperyear_1": 17.92, "citationsperyear_2": 18.0, "citationsperyear_3": 17.778, "citationsperyear_4": 17.357, "citationsperyear_5": 17.448, "totalcitations_0": 430.0, "totalcitations_1": 448.0, "totalcitations_2": 468.0, "totalcitations_3": 480.0, "totalcitations_4": 486.0, "totalcitations_5": 506.0, "totalpapers_0": 45.0, "totalpapers_1": 49.0, "totalpapers_2": 49.0, "totalpapers_3": 50.0, "totalpapers_4": 52.0, "totalpapers_5": 55.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 66.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 29.0, "recentcoauthors_5": 51.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 126.0, "venuehindexmean_1": 128.3333333333, "venuehindexmean_2": 131.3333333333, "venuehindexmean_3": 128.9, "venuehindexmean_4": 131.1, "venuehindexmean_5": 128.2727272727, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 10.3502323219, "pagerank_1": 10.9430762592, "pagerank_2": 10.5261039356, "pagerank_3": 10.4982263642, "pagerank_4": 10.5448060207, "pagerank_5": 10.8556844636}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell"], "affiliation": "Box Hill Hospital", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 11.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.556, "citationsperpaper_1": 9.143, "citationsperpaper_2": 9.551, "citationsperpaper_3": 9.6, "citationsperpaper_4": 9.346, "citationsperpaper_5": 9.2, "citationsperyear_0": 17.917, "citationsperyear_1": 17.92, "citationsperyear_2": 18.0, "citationsperyear_3": 17.778, "citationsperyear_4": 17.357, "citationsperyear_5": 17.448, "totalcitations_0": 430.0, "totalcitations_1": 448.0, "totalcitations_2": 468.0, "totalcitations_3": 480.0, "totalcitations_4": 486.0, "totalcitations_5": 506.0, "totalpapers_0": 45.0, "totalpapers_1": 49.0, "totalpapers_2": 49.0, "totalpapers_3": 50.0, "totalpapers_4": 52.0, "totalpapers_5": 55.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 66.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 29.0, "recentcoauthors_5": 51.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 126.0, "venuehindexmean_1": 128.3333333333, "venuehindexmean_2": 131.3333333333, "venuehindexmean_3": 128.9, "venuehindexmean_4": 131.1, "venuehindexmean_5": 128.2727272727, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 10.3502323219, "pagerank_1": 10.9430762592, "pagerank_2": 10.5261039356, "pagerank_3": 10.4982263642, "pagerank_4": 10.5448060207, "pagerank_5": 10.8556844636}}, {"model": "papers.paper", "pk": 1003462, "fields": {"authors": ["Christina AnneMitchell"], "affiliation": "Washington University in St. Louis", "venue": "Nature", "doi": "10.1038/nature09023", "abstract": "The enzyme inositol polyphosphate phosphatase 4A (INPP4A) removes phosphate groups from phosphatidylinositol-3,4-bisphosphate, a key cellular lipid. Here, a crucial role for INPP4A in maintaining the integrity of the brain is described. Mice that lack this enzyme suffer from neurodegeneration in the striatum of the brain, as well as severe involuntary movements. When present, INPP4A protects neurons from a particular type of cell death.", "year": 2010, "title": "The PtdIns(3,4)P 2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death", "keywords": ["Neurodegeneration", "Excitotoxicity", "Phosphatase", "Biochemistry", "Cell biology", "Biology", "Programmed cell death", "Inositol", "Neuron", "Central nervous system", "Striatum"], "citations_0": 1.0, "citations_1": 1.0, "citations_2": 0.0, "citations_3": 1.0, "citations_4": 0.0, "citations_5": 2.0, "timescaledpagerank_0": 0.1554095736, "timescaledpagerank_1": 0.0841073032, "timescaledpagerank_2": 0.1798824714, "timescaledpagerank_3": 0.1558738344, "timescaledpagerank_4": 0.1836686752, "timescaledpagerank_5": 0.0814792529, "hindex_0": 11.0, "hindex_1": 11.0, "hindex_2": 12.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 13.0, "adopters_0": 20.0, "adopters_1": 8.0, "adopters_2": 0.0, "adopters_3": 22.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 9.556, "citationsperpaper_1": 9.143, "citationsperpaper_2": 9.551, "citationsperpaper_3": 9.6, "citationsperpaper_4": 9.346, "citationsperpaper_5": 9.2, "citationsperyear_0": 17.917, "citationsperyear_1": 17.92, "citationsperyear_2": 18.0, "citationsperyear_3": 17.778, "citationsperyear_4": 17.357, "citationsperyear_5": 17.448, "totalcitations_0": 430.0, "totalcitations_1": 448.0, "totalcitations_2": 468.0, "totalcitations_3": 480.0, "totalcitations_4": 486.0, "totalcitations_5": 506.0, "totalpapers_0": 45.0, "totalpapers_1": 49.0, "totalpapers_2": 49.0, "totalpapers_3": 50.0, "totalpapers_4": 52.0, "totalpapers_5": 55.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 66.0, "recentcoauthors_1": 77.0, "recentcoauthors_2": 39.0, "recentcoauthors_3": 13.0, "recentcoauthors_4": 29.0, "recentcoauthors_5": 51.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 126.0, "venuehindexmean_1": 128.3333333333, "venuehindexmean_2": 131.3333333333, "venuehindexmean_3": 128.9, "venuehindexmean_4": 131.1, "venuehindexmean_5": 128.2727272727, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 10.3502323219, "pagerank_1": 10.9430762592, "pagerank_2": 10.5261039356, "pagerank_3": 10.4982263642, "pagerank_4": 10.5448060207, "pagerank_5": 10.8556844636}}, {"model": "papers.paper", "pk": 1003407, "fields": {"authors": ["PeterTurchin"], "affiliation": "University of Connecticut", "venue": "Nature", "doi": "10.1038/463608a", "abstract": "", "year": 2010, "title": "Political instability may be a contributor in the coming decade", "keywords": ["Political economy", "Political science", "Political instability"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 3.6, "citationsperpaper_1": 3.7, "citationsperpaper_2": 3.8, "citationsperpaper_3": 3.636, "citationsperpaper_4": 3.583, "citationsperpaper_5": 3.462, "citationsperyear_0": 1.714, "citationsperyear_1": 1.682, "citationsperyear_2": 1.652, "citationsperyear_3": 1.667, "citationsperyear_4": 1.72, "citationsperyear_5": 1.731, "totalcitations_0": 36.0, "totalcitations_1": 37.0, "totalcitations_2": 38.0, "totalcitations_3": 40.0, "totalcitations_4": 43.0, "totalcitations_5": 45.0, "totalpapers_0": 10.0, "totalpapers_1": 10.0, "totalpapers_2": 10.0, "totalpapers_3": 11.0, "totalpapers_4": 12.0, "totalpapers_5": 13.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 1.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 3.0, "recentcoauthors_4": 6.0, "recentcoauthors_5": 3.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 220.3333333333, "venuehindexmean_1": 223.6666666667, "venuehindexmean_2": 229.0, "venuehindexmean_3": 233.6666666667, "venuehindexmean_4": 237.3333333333, "venuehindexmean_5": 241.0, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.9414073996, "pagerank_1": 1.6843638565, "pagerank_2": 1.539653524, "pagerank_3": 1.7762959356, "pagerank_4": 1.8773575567, "pagerank_5": 1.8613049713}}, {"model": "papers.paper", "pk": 1004003, "fields": {"authors": ["Luciano A.Marraffini", "Erik J.Sontheimer"], "affiliation": "University of Chicago", "venue": "Nature", "doi": "10.1038/468045a", "abstract": "Many bacteria and archaea protect themselves from viruses and other invasive genomes through a genetic interference pathway. The small RNAs that guide this defence specify the direct cleavage of foreign DNA.", "year": 2010, "title": "Microbiology: Slicer for DNA", "keywords": ["Genome", "Bacteria", "Genetics", "Biology", "Rolling circle replication", "Cas9", "DNA", "Human genome", "Plasmid", "Microbiology", "RNA"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.5, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 14.009, "citationsperpaper_1": 16.1775, "citationsperpaper_2": 17.3245, "citationsperpaper_3": 20.4805, "citationsperpaper_4": 27.015, "citationsperpaper_5": 31.4745, "citationsperyear_0": 15.215, "citationsperyear_1": 17.3105, "citationsperyear_2": 18.479, "citationsperyear_3": 26.2855, "citationsperyear_4": 36.289, "citationsperyear_5": 45.305, "totalcitations_0": 255.5, "totalcitations_1": 297.0, "totalcitations_2": 332.0, "totalcitations_3": 429.5, "totalcitations_4": 561.0, "totalcitations_5": 698.5, "totalpapers_0": 13.5, "totalpapers_1": 14.5, "totalpapers_2": 15.5, "totalpapers_3": 19.5, "totalpapers_4": 21.0, "totalpapers_5": 23.0, "authorage_0": 11.5, "authorage_1": 12.5, "authorage_2": 13.5, "authorage_3": 14.5, "authorage_4": 15.5, "authorage_5": 16.5, "recentcoauthors_0": 16.5, "recentcoauthors_1": 5.5, "recentcoauthors_2": 5.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 27.0, "recentcoauthors_5": 11.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 179.7083333333, "venuehindexmean_1": 182.4166666667, "venuehindexmean_2": 168.0444444444, "venuehindexmean_3": 147.0625, "venuehindexmean_4": 149.9583333333, "venuehindexmean_5": 155.85, "totalvenues_0": 6.5, "totalvenues_1": 6.5, "totalvenues_2": 7.0, "totalvenues_3": 8.5, "totalvenues_4": 8.5, "totalvenues_5": 9.5, "pagerank_0": 1.8788089117, "pagerank_1": 2.0759093508, "pagerank_2": 2.0389560578, "pagerank_3": 2.6522673944, "pagerank_4": 2.8699784898, "pagerank_5": 2.9795656822}}, {"model": "papers.paper", "pk": 1004003, "fields": {"authors": ["Luciano A.Marraffini", "Erik J.Sontheimer"], "affiliation": "Northwestern University", "venue": "Nature", "doi": "10.1038/468045a", "abstract": "Many bacteria and archaea protect themselves from viruses and other invasive genomes through a genetic interference pathway. The small RNAs that guide this defence specify the direct cleavage of foreign DNA.", "year": 2010, "title": "Microbiology: Slicer for DNA", "keywords": ["Genome", "Bacteria", "Genetics", "Biology", "Rolling circle replication", "Cas9", "DNA", "Human genome", "Plasmid", "Microbiology", "RNA"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.5, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 14.009, "citationsperpaper_1": 16.1775, "citationsperpaper_2": 17.3245, "citationsperpaper_3": 20.4805, "citationsperpaper_4": 27.015, "citationsperpaper_5": 31.4745, "citationsperyear_0": 15.215, "citationsperyear_1": 17.3105, "citationsperyear_2": 18.479, "citationsperyear_3": 26.2855, "citationsperyear_4": 36.289, "citationsperyear_5": 45.305, "totalcitations_0": 255.5, "totalcitations_1": 297.0, "totalcitations_2": 332.0, "totalcitations_3": 429.5, "totalcitations_4": 561.0, "totalcitations_5": 698.5, "totalpapers_0": 13.5, "totalpapers_1": 14.5, "totalpapers_2": 15.5, "totalpapers_3": 19.5, "totalpapers_4": 21.0, "totalpapers_5": 23.0, "authorage_0": 11.5, "authorage_1": 12.5, "authorage_2": 13.5, "authorage_3": 14.5, "authorage_4": 15.5, "authorage_5": 16.5, "recentcoauthors_0": 16.5, "recentcoauthors_1": 5.5, "recentcoauthors_2": 5.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 27.0, "recentcoauthors_5": 11.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 179.7083333333, "venuehindexmean_1": 182.4166666667, "venuehindexmean_2": 168.0444444444, "venuehindexmean_3": 147.0625, "venuehindexmean_4": 149.9583333333, "venuehindexmean_5": 155.85, "totalvenues_0": 6.5, "totalvenues_1": 6.5, "totalvenues_2": 7.0, "totalvenues_3": 8.5, "totalvenues_4": 8.5, "totalvenues_5": 9.5, "pagerank_0": 1.8788089117, "pagerank_1": 2.0759093508, "pagerank_2": 2.0389560578, "pagerank_3": 2.6522673944, "pagerank_4": 2.8699784898, "pagerank_5": 2.9795656822}}, {"model": "papers.paper", "pk": 1004003, "fields": {"authors": ["Luciano A.Marraffini", "Erik J.Sontheimer"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/468045a", "abstract": "Many bacteria and archaea protect themselves from viruses and other invasive genomes through a genetic interference pathway. The small RNAs that guide this defence specify the direct cleavage of foreign DNA.", "year": 2010, "title": "Microbiology: Slicer for DNA", "keywords": ["Genome", "Bacteria", "Genetics", "Biology", "Rolling circle replication", "Cas9", "DNA", "Human genome", "Plasmid", "Microbiology", "RNA"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 7.0, "hindex_1": 8.0, "hindex_2": 8.5, "hindex_3": 10.0, "hindex_4": 11.0, "hindex_5": 11.5, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 14.009, "citationsperpaper_1": 16.1775, "citationsperpaper_2": 17.3245, "citationsperpaper_3": 20.4805, "citationsperpaper_4": 27.015, "citationsperpaper_5": 31.4745, "citationsperyear_0": 15.215, "citationsperyear_1": 17.3105, "citationsperyear_2": 18.479, "citationsperyear_3": 26.2855, "citationsperyear_4": 36.289, "citationsperyear_5": 45.305, "totalcitations_0": 255.5, "totalcitations_1": 297.0, "totalcitations_2": 332.0, "totalcitations_3": 429.5, "totalcitations_4": 561.0, "totalcitations_5": 698.5, "totalpapers_0": 13.5, "totalpapers_1": 14.5, "totalpapers_2": 15.5, "totalpapers_3": 19.5, "totalpapers_4": 21.0, "totalpapers_5": 23.0, "authorage_0": 11.5, "authorage_1": 12.5, "authorage_2": 13.5, "authorage_3": 14.5, "authorage_4": 15.5, "authorage_5": 16.5, "recentcoauthors_0": 16.5, "recentcoauthors_1": 5.5, "recentcoauthors_2": 5.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 27.0, "recentcoauthors_5": 11.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 179.7083333333, "venuehindexmean_1": 182.4166666667, "venuehindexmean_2": 168.0444444444, "venuehindexmean_3": 147.0625, "venuehindexmean_4": 149.9583333333, "venuehindexmean_5": 155.85, "totalvenues_0": 6.5, "totalvenues_1": 6.5, "totalvenues_2": 7.0, "totalvenues_3": 8.5, "totalvenues_4": 8.5, "totalvenues_5": 9.5, "pagerank_0": 1.8788089117, "pagerank_1": 2.0759093508, "pagerank_2": 2.0389560578, "pagerank_3": 2.6522673944, "pagerank_4": 2.8699784898, "pagerank_5": 2.9795656822}}, {"model": "papers.paper", "pk": 1004003, "fields": {"authors": ["Luciano A.Marraffini"], "affiliation": "Rockefeller University", "venue": "Nature", "doi": "10.1038/468045a", "abstract": "Many bacteria and archaea protect themselves from viruses and other invasive genomes through a genetic interference pathway. The small RNAs that guide this defence specify the direct cleavage of foreign DNA.", "year": 2010, "title": "Microbiology: Slicer for DNA", "keywords": ["Genome", "Bacteria", "Genetics", "Biology", "Rolling circle replication", "Cas9", "DNA", "Human genome", "Plasmid", "Microbiology", "RNA"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 7.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 6.2, "citationsperpaper_1": 8.833, "citationsperpaper_2": 9.857, "citationsperpaper_3": 15.846, "citationsperpaper_4": 28.067, "citationsperpaper_5": 36.556, "citationsperyear_0": 5.167, "citationsperyear_1": 7.571, "citationsperyear_2": 8.625, "citationsperyear_3": 22.889, "citationsperyear_4": 42.1, "citationsperyear_5": 59.818, "totalcitations_0": 31.0, "totalcitations_1": 53.0, "totalcitations_2": 69.0, "totalcitations_3": 206.0, "totalcitations_4": 421.0, "totalcitations_5": 658.0, "totalpapers_0": 5.0, "totalpapers_1": 6.0, "totalpapers_2": 7.0, "totalpapers_3": 13.0, "totalpapers_4": 15.0, "totalpapers_5": 18.0, "authorage_0": 5.0, "authorage_1": 6.0, "authorage_2": 7.0, "authorage_3": 8.0, "authorage_4": 9.0, "authorage_5": 10.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 4.0, "recentcoauthors_2": 5.0, "recentcoauthors_3": 39.0, "recentcoauthors_4": 46.0, "recentcoauthors_5": 21.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 199.75, "venuehindexmean_1": 202.5, "venuehindexmean_2": 170.2, "venuehindexmean_3": 125.125, "venuehindexmean_4": 128.25, "venuehindexmean_5": 147.0, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 5.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 9.0, "pagerank_0": 0.498476621, "pagerank_1": 0.7962979314, "pagerank_2": 0.8219191559, "pagerank_3": 1.9875045378, "pagerank_4": 2.3507846467, "pagerank_5": 2.5940916671}}, {"model": "papers.paper", "pk": 1004003, "fields": {"authors": ["Erik J.Sontheimer"], "affiliation": "Yale University", "venue": "Nature", "doi": "10.1038/468045a", "abstract": "Many bacteria and archaea protect themselves from viruses and other invasive genomes through a genetic interference pathway. The small RNAs that guide this defence specify the direct cleavage of foreign DNA.", "year": 2010, "title": "Microbiology: Slicer for DNA", "keywords": ["Genome", "Bacteria", "Genetics", "Biology", "Rolling circle replication", "Cas9", "DNA", "Human genome", "Plasmid", "Microbiology", "RNA"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 21.818, "citationsperpaper_1": 23.522, "citationsperpaper_2": 24.792, "citationsperpaper_3": 25.115, "citationsperpaper_4": 25.963, "citationsperpaper_5": 26.393, "citationsperyear_0": 25.263, "citationsperyear_1": 27.05, "citationsperyear_2": 28.333, "citationsperyear_3": 29.682, "citationsperyear_4": 30.478, "citationsperyear_5": 30.792, "totalcitations_0": 480.0, "totalcitations_1": 541.0, "totalcitations_2": 595.0, "totalcitations_3": 653.0, "totalcitations_4": 701.0, "totalcitations_5": 739.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 24.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 28.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 5.0, "recentcoauthors_3": 7.0, "recentcoauthors_4": 8.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 159.6666666667, "venuehindexmean_1": 162.3333333333, "venuehindexmean_2": 165.8888888889, "venuehindexmean_3": 169.0, "venuehindexmean_4": 171.6666666667, "venuehindexmean_5": 164.7, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 10.0, "pagerank_0": 3.2591412024, "pagerank_1": 3.3555207703, "pagerank_2": 3.2559929597, "pagerank_3": 3.3170302511, "pagerank_4": 3.3891723329, "pagerank_5": 3.3650396972}}, {"model": "papers.paper", "pk": 1004003, "fields": {"authors": ["Erik J.Sontheimer"], "affiliation": "University of Massachusetts Medical School", "venue": "Nature", "doi": "10.1038/468045a", "abstract": "Many bacteria and archaea protect themselves from viruses and other invasive genomes through a genetic interference pathway. The small RNAs that guide this defence specify the direct cleavage of foreign DNA.", "year": 2010, "title": "Microbiology: Slicer for DNA", "keywords": ["Genome", "Bacteria", "Genetics", "Biology", "Rolling circle replication", "Cas9", "DNA", "Human genome", "Plasmid", "Microbiology", "RNA"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 11.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 13.0, "hindex_4": 13.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 21.818, "citationsperpaper_1": 23.522, "citationsperpaper_2": 24.792, "citationsperpaper_3": 25.115, "citationsperpaper_4": 25.963, "citationsperpaper_5": 26.393, "citationsperyear_0": 25.263, "citationsperyear_1": 27.05, "citationsperyear_2": 28.333, "citationsperyear_3": 29.682, "citationsperyear_4": 30.478, "citationsperyear_5": 30.792, "totalcitations_0": 480.0, "totalcitations_1": 541.0, "totalcitations_2": 595.0, "totalcitations_3": 653.0, "totalcitations_4": 701.0, "totalcitations_5": 739.0, "totalpapers_0": 22.0, "totalpapers_1": 23.0, "totalpapers_2": 24.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 28.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 31.0, "recentcoauthors_1": 7.0, "recentcoauthors_2": 5.0, "recentcoauthors_3": 7.0, "recentcoauthors_4": 8.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 159.6666666667, "venuehindexmean_1": 162.3333333333, "venuehindexmean_2": 165.8888888889, "venuehindexmean_3": 169.0, "venuehindexmean_4": 171.6666666667, "venuehindexmean_5": 164.7, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 10.0, "pagerank_0": 3.2591412024, "pagerank_1": 3.3555207703, "pagerank_2": 3.2559929597, "pagerank_3": 3.3170302511, "pagerank_4": 3.3891723329, "pagerank_5": 3.3650396972}}, {"model": "papers.paper", "pk": 1003125, "fields": {"authors": ["PedroCintas"], "affiliation": "University of Extremadura", "venue": "Nature", "doi": "10.1038/466179d", "abstract": "", "year": 2010, "title": "Metrics: include refereeing as part of performance rating", "keywords": ["Reliability engineering", "Performance rating", "Computer science"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 5.0, "hindex_4": 5.0, "hindex_5": 5.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 2.565, "citationsperpaper_1": 2.826, "citationsperpaper_2": 2.852, "citationsperpaper_3": 2.75, "citationsperpaper_4": 2.964, "citationsperpaper_5": 2.9, "citationsperyear_0": 5.364, "citationsperyear_1": 5.417, "citationsperyear_2": 5.923, "citationsperyear_3": 5.5, "citationsperyear_4": 5.533, "citationsperyear_5": 5.438, "totalcitations_0": 59.0, "totalcitations_1": 65.0, "totalcitations_2": 77.0, "totalcitations_3": 77.0, "totalcitations_4": 83.0, "totalcitations_5": 87.0, "totalpapers_0": 23.0, "totalpapers_1": 23.0, "totalpapers_2": 27.0, "totalpapers_3": 28.0, "totalpapers_4": 28.0, "totalpapers_5": 30.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 2.0, "recentcoauthors_1": 2.0, "recentcoauthors_2": 1.0, "recentcoauthors_3": 4.0, "recentcoauthors_4": 3.0, "recentcoauthors_5": 2.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 174.5, "venuehindexmean_1": 181.5, "venuehindexmean_2": 134.3333333333, "venuehindexmean_3": 141.3333333333, "venuehindexmean_4": 148.3333333333, "venuehindexmean_5": 154.6666666667, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 3.0, "totalvenues_3": 3.0, "totalvenues_4": 3.0, "totalvenues_5": 3.0, "pagerank_0": 1.4641813208, "pagerank_1": 1.4517666319, "pagerank_2": 1.4964977092, "pagerank_3": 1.6233944416, "pagerank_4": 1.6107228236, "pagerank_5": 1.7189953632}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["Sean B.Carroll", "Thomas M.Williams"], "affiliation": "Laboratory of Molecular Biology", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 13.0, "hindex_1": 13.5, "hindex_2": 14.5, "hindex_3": 15.0, "hindex_4": 15.0, "hindex_5": 15.5, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 15.4355, "citationsperpaper_1": 17.4695, "citationsperpaper_2": 19.6395, "citationsperpaper_3": 20.1225, "citationsperpaper_4": 21.152, "citationsperpaper_5": 20.9375, "citationsperyear_0": 31.876, "citationsperyear_1": 33.7165, "citationsperyear_2": 34.9445, "citationsperyear_3": 35.8595, "citationsperyear_4": 35.9545, "citationsperyear_5": 37.2295, "totalcitations_0": 814.0, "totalcitations_1": 887.5, "totalcitations_2": 953.0, "totalcitations_3": 1011.0, "totalcitations_4": 1050.5, "totalcitations_5": 1117.0, "totalpapers_0": 39.0, "totalpapers_1": 40.5, "totalpapers_2": 40.5, "totalpapers_3": 41.5, "totalpapers_4": 42.5, "totalpapers_5": 44.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 15.5, "recentcoauthors_1": 6.0, "recentcoauthors_2": 3.0, "recentcoauthors_3": 3.5, "recentcoauthors_4": 6.5, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 167.6666666667, "venuehindexmean_1": 172.0555555556, "venuehindexmean_2": 176.1666666667, "venuehindexmean_3": 160.0, "venuehindexmean_4": 163.375, "venuehindexmean_5": 166.375, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.5, "totalvenues_4": 6.5, "totalvenues_5": 6.5, "pagerank_0": 5.7776717322, "pagerank_1": 5.7960375627, "pagerank_2": 5.6440317961, "pagerank_3": 5.7949121024, "pagerank_4": 5.8400944774, "pagerank_5": 6.2418415544}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["Sean B.Carroll", "ShigeyukiKoshikawa"], "affiliation": "University of Wisconsin-Madison", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 12.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 13.5, "hindex_4": 13.5, "hindex_5": 14.0, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 11.3355, "citationsperpaper_1": 13.2695, "citationsperpaper_2": 16.0395, "citationsperpaper_3": 17.039, "citationsperpaper_4": 18.652, "citationsperpaper_5": 17.1875, "citationsperyear_0": 27.776, "citationsperyear_1": 29.55, "citationsperyear_2": 30.8495, "citationsperyear_3": 31.297, "citationsperyear_4": 31.488, "citationsperyear_5": 32.363, "totalcitations_0": 791.5, "totalcitations_1": 858.5, "totalcitations_2": 919.0, "totalcitations_3": 970.0, "totalcitations_4": 1005.5, "totalcitations_5": 1063.0, "totalpapers_0": 37.0, "totalpapers_1": 38.5, "totalpapers_2": 38.5, "totalpapers_3": 39.0, "totalpapers_4": 40.0, "totalpapers_5": 41.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 12.5, "recentcoauthors_1": 6.0, "recentcoauthors_2": 3.0, "recentcoauthors_3": 0.5, "recentcoauthors_4": 3.5, "recentcoauthors_5": 9.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 206.1666666667, "venuehindexmean_1": 210.0555555556, "venuehindexmean_2": 214.5, "venuehindexmean_3": 219.5, "venuehindexmean_4": 223.5, "venuehindexmean_5": 201.0, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.5, "pagerank_0": 5.3389323502, "pagerank_1": 5.3778315477, "pagerank_2": 5.2425604037, "pagerank_3": 5.1780604789, "pagerank_4": 5.2350712581, "pagerank_5": 5.4580710649}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["Sean B.Carroll"], "affiliation": "University of Colorado Boulder", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 23.0, "hindex_1": 23.0, "hindex_2": 25.0, "hindex_3": 26.0, "hindex_4": 26.0, "hindex_5": 27.0, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 21.671, "citationsperpaper_1": 22.539, "citationsperpaper_2": 24.079, "citationsperpaper_3": 25.078, "citationsperpaper_4": 25.304, "citationsperpaper_5": 26.375, "citationsperyear_0": 54.552, "citationsperyear_1": 57.1, "citationsperyear_2": 59.032, "citationsperyear_3": 60.344, "citationsperyear_4": 60.576, "citationsperyear_5": 62.059, "totalcitations_0": 1582.0, "totalcitations_1": 1713.0, "totalcitations_2": 1830.0, "totalcitations_3": 1931.0, "totalcitations_4": 1999.0, "totalcitations_5": 2110.0, "totalpapers_0": 73.0, "totalpapers_1": 76.0, "totalpapers_2": 76.0, "totalpapers_3": 77.0, "totalpapers_4": 79.0, "totalpapers_5": 80.0, "authorage_0": 28.0, "authorage_1": 29.0, "authorage_2": 30.0, "authorage_3": 31.0, "authorage_4": 32.0, "authorage_5": 33.0, "recentcoauthors_0": 22.0, "recentcoauthors_1": 9.0, "recentcoauthors_2": 6.0, "recentcoauthors_3": 1.0, "recentcoauthors_4": 7.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 152.3333333333, "venuehindexmean_1": 156.1111111111, "venuehindexmean_2": 160.0, "venuehindexmean_3": 164.0, "venuehindexmean_4": 167.0, "venuehindexmean_5": 170.0, "totalvenues_0": 9.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 9.0, "totalvenues_4": 9.0, "totalvenues_5": 9.0, "pagerank_0": 10.3990403276, "pagerank_1": 10.480447986, "pagerank_2": 10.2139404575, "pagerank_3": 10.082443461, "pagerank_4": 10.1990959543, "pagerank_5": 10.3315588917}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["ThomasWerner", "Sean B.Carroll", "ShigeyukiKoshikawa", "Thomas M.Williams"], "affiliation": "Howard Hughes Medical Institute", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 8.0, "hindex_1": 8.25, "hindex_2": 9.0, "hindex_3": 9.25, "hindex_4": 9.25, "hindex_5": 9.5, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 13.02325, "citationsperpaper_1": 15.42925, "citationsperpaper_2": 18.042, "citationsperpaper_3": 19.00575, "citationsperpaper_4": 20.465, "citationsperpaper_5": 19.09375, "citationsperyear_0": 18.35475, "citationsperyear_1": 19.68775, "citationsperyear_2": 20.57375, "citationsperyear_3": 21.00275, "citationsperyear_4": 21.05725, "citationsperyear_5": 21.8295, "totalcitations_0": 452.75, "totalcitations_1": 496.0, "totalcitations_2": 534.5, "totalcitations_3": 568.0, "totalcitations_4": 590.25, "totalcitations_5": 628.75, "totalpapers_0": 22.0, "totalpapers_1": 22.75, "totalpapers_2": 22.75, "totalpapers_3": 23.25, "totalpapers_4": 23.75, "totalpapers_5": 25.0, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 13.25, "recentcoauthors_1": 4.5, "recentcoauthors_2": 1.5, "recentcoauthors_3": 1.75, "recentcoauthors_4": 3.25, "recentcoauthors_5": 8.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 195.875, "venuehindexmean_1": 199.8194444444, "venuehindexmean_2": 204.1666666667, "venuehindexmean_3": 198.375, "venuehindexmean_4": 202.0208333333, "venuehindexmean_5": 192.1875, "totalvenues_0": 4.75, "totalvenues_1": 4.75, "totalvenues_2": 4.75, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.25, "pagerank_0": 3.5105012931, "pagerank_1": 3.5058857943, "pagerank_2": 3.4081082614, "pagerank_3": 3.473275329, "pagerank_4": 3.4789010796, "pagerank_5": 3.8348552423}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["Thomas M.Williams"], "affiliation": "University of Dayton", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 3.0, "hindex_1": 4.0, "hindex_2": 4.0, "hindex_3": 4.0, "hindex_4": 4.0, "hindex_5": 4.0, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 9.2, "citationsperpaper_1": 12.4, "citationsperpaper_2": 15.2, "citationsperpaper_3": 15.167, "citationsperpaper_4": 17.0, "citationsperpaper_5": 15.5, "citationsperyear_0": 9.2, "citationsperyear_1": 10.333, "citationsperyear_2": 10.857, "citationsperyear_3": 11.375, "citationsperyear_4": 11.333, "citationsperyear_5": 12.4, "totalcitations_0": 46.0, "totalcitations_1": 62.0, "totalcitations_2": 76.0, "totalcitations_3": 91.0, "totalcitations_4": 102.0, "totalcitations_5": 124.0, "totalpapers_0": 5.0, "totalpapers_1": 5.0, "totalpapers_2": 5.0, "totalpapers_3": 6.0, "totalpapers_4": 6.0, "totalpapers_5": 8.0, "authorage_0": 4.0, "authorage_1": 5.0, "authorage_2": 6.0, "authorage_3": 7.0, "authorage_4": 8.0, "authorage_5": 9.0, "recentcoauthors_0": 9.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 6.0, "recentcoauthors_4": 6.0, "recentcoauthors_5": 10.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 183.0, "venuehindexmean_1": 188.0, "venuehindexmean_2": 192.3333333333, "venuehindexmean_3": 156.0, "venuehindexmean_4": 159.75, "venuehindexmean_5": 162.75, "totalvenues_0": 3.0, "totalvenues_1": 3.0, "totalvenues_2": 3.0, "totalvenues_3": 4.0, "totalvenues_4": 4.0, "totalvenues_5": 4.0, "pagerank_0": 1.1563031368, "pagerank_1": 1.1116271395, "pagerank_2": 1.0741231348, "pagerank_3": 1.5073807438, "pagerank_4": 1.4810930005, "pagerank_5": 2.152124217}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["ThomasWerner"], "affiliation": "Michigan Technological University", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 5.0, "hindex_1": 5.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 20.222, "citationsperpaper_1": 22.778, "citationsperpaper_2": 24.889, "citationsperpaper_3": 26.778, "citationsperpaper_4": 27.556, "citationsperpaper_5": 26.5, "citationsperyear_0": 8.667, "citationsperyear_1": 9.318, "citationsperyear_2": 9.739, "citationsperyear_3": 10.042, "citationsperyear_4": 9.92, "citationsperyear_5": 10.192, "totalcitations_0": 182.0, "totalcitations_1": 205.0, "totalcitations_2": 224.0, "totalcitations_3": 241.0, "totalcitations_4": 248.0, "totalcitations_5": 265.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 9.0, "totalpapers_4": 9.0, "totalpapers_5": 10.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 6.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 188.1666666667, "venuehindexmean_1": 191.1666666667, "venuehindexmean_2": 195.3333333333, "venuehindexmean_3": 198.5, "venuehindexmean_4": 201.3333333333, "venuehindexmean_5": 204.0, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.2078373354, "pagerank_1": 2.1562529424, "pagerank_2": 2.0731891033, "pagerank_3": 2.0295996145, "pagerank_4": 1.9643688017, "pagerank_5": 2.2711546224}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["ThomasWerner"], "affiliation": "Ume\u00e5 University", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 5.0, "hindex_1": 5.0, "hindex_2": 6.0, "hindex_3": 6.0, "hindex_4": 6.0, "hindex_5": 6.0, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 20.222, "citationsperpaper_1": 22.778, "citationsperpaper_2": 24.889, "citationsperpaper_3": 26.778, "citationsperpaper_4": 27.556, "citationsperpaper_5": 26.5, "citationsperyear_0": 8.667, "citationsperyear_1": 9.318, "citationsperyear_2": 9.739, "citationsperyear_3": 10.042, "citationsperyear_4": 9.92, "citationsperyear_5": 10.192, "totalcitations_0": 182.0, "totalcitations_1": 205.0, "totalcitations_2": 224.0, "totalcitations_3": 241.0, "totalcitations_4": 248.0, "totalcitations_5": 265.0, "totalpapers_0": 9.0, "totalpapers_1": 9.0, "totalpapers_2": 9.0, "totalpapers_3": 9.0, "totalpapers_4": 9.0, "totalpapers_5": 10.0, "authorage_0": 20.0, "authorage_1": 21.0, "authorage_2": 22.0, "authorage_3": 23.0, "authorage_4": 24.0, "authorage_5": 25.0, "recentcoauthors_0": 19.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 6.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 188.1666666667, "venuehindexmean_1": 191.1666666667, "venuehindexmean_2": 195.3333333333, "venuehindexmean_3": 198.5, "venuehindexmean_4": 201.3333333333, "venuehindexmean_5": 204.0, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 2.2078373354, "pagerank_1": 2.1562529424, "pagerank_2": 2.0731891033, "pagerank_3": 2.0295996145, "pagerank_4": 1.9643688017, "pagerank_5": 2.2711546224}}, {"model": "papers.paper", "pk": 1003178, "fields": {"authors": ["ShigeyukiKoshikawa"], "affiliation": "Kyoto University", "venue": "Nature", "doi": "10.1038/nature08896", "abstract": "Here, the generation and evolution of the complex spotted wing pattern of Drosophila guttifera are investigated. The findings show that wing spots are induced by the Wingless morphogen, and that the elaborate spot pattern evolved from simpler schemes by co-option of Wingless expression at new sites. This type of process is likely to occur in other animals, too.", "year": 2010, "title": "Generation of a novel wing colour pattern by the Wingless morphogen", "keywords": ["Drosophila guttifera", "Morphogen", "Biology", "Zoology", "Evolutionary biology", "Wing", "Drosophilidae", "Drosophila melanogaster", "Biological evolution"], "citations_0": 1.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 3.0, "citations_5": 4.0, "timescaledpagerank_0": 0.104738381, "timescaledpagerank_1": 0.7712358405, "timescaledpagerank_2": 1.0034277631, "timescaledpagerank_3": 0.7482731276, "timescaledpagerank_4": 0.8774452095, "timescaledpagerank_5": 0.9587199214, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 1.0, "hindex_3": 1.0, "hindex_4": 1.0, "hindex_5": 1.0, "adopters_0": 2.0, "adopters_1": 21.0, "adopters_2": 18.0, "adopters_3": 7.0, "adopters_4": 17.0, "adopters_5": 0.0, "citationsperpaper_0": 1.0, "citationsperpaper_1": 4.0, "citationsperpaper_2": 8.0, "citationsperpaper_3": 9.0, "citationsperpaper_4": 12.0, "citationsperpaper_5": 8.0, "citationsperyear_0": 1.0, "citationsperyear_1": 2.0, "citationsperyear_2": 2.667, "citationsperyear_3": 2.25, "citationsperyear_4": 2.4, "citationsperyear_5": 2.667, "totalcitations_0": 1.0, "totalcitations_1": 4.0, "totalcitations_2": 8.0, "totalcitations_3": 9.0, "totalcitations_4": 12.0, "totalcitations_5": 16.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 2.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 3.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 6.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 232.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 2.0, "pagerank_0": 0.2788243727, "pagerank_1": 0.2752151094, "pagerank_2": 0.27118035, "pagerank_3": 0.2736774968, "pagerank_4": 0.2710465619, "pagerank_5": 0.5845832381}}, {"model": "papers.paper", "pk": 1003606, "fields": {"authors": ["James W.Vaupel"], "affiliation": "Max Planck Society", "venue": "Nature", "doi": "10.1038/nature08984", "abstract": "Human senescence has been delayed by a decade. This finding, documented in 1994 and bolstered since, is a fundamental discovery about the biology of human ageing, and one with profound implications for individuals, society and the economy. Remarkably, the rate of deterioration with age seems to be constant across individuals and over time: it seems that death is being delayed because people are reaching old age in better health. Research by demographers, epidemiologists and other biomedical researchers suggests that further progress is likely to be made in advancing the frontier of survival \u2014 and healthy survival \u2014 to even greater ages.", "year": 2010, "title": "Biodemography of human ageing", "keywords": ["Epidemiology", "Ageing", "Gerontology", "Physiology", "Molecular interactions", "Biology", "Senescence", "Biodemography", "Public health", "Longevity"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 4.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0081948919, "timescaledpagerank_2": 0.6318433289, "timescaledpagerank_3": 0.7546321467, "timescaledpagerank_4": 1.289279772, "timescaledpagerank_5": 1.2377563076, "hindex_0": 8.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 1.0, "adopters_2": 3.0, "adopters_3": 14.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 8.095, "citationsperpaper_1": 8.952, "citationsperpaper_2": 8.696, "citationsperpaper_3": 8.92, "citationsperpaper_4": 9.68, "citationsperpaper_5": 9.846, "citationsperyear_0": 8.947, "citationsperyear_1": 9.4, "citationsperyear_2": 9.524, "citationsperyear_3": 10.136, "citationsperyear_4": 10.522, "citationsperyear_5": 10.667, "totalcitations_0": 170.0, "totalcitations_1": 188.0, "totalcitations_2": 200.0, "totalcitations_3": 223.0, "totalcitations_4": 242.0, "totalcitations_5": 256.0, "totalpapers_0": 21.0, "totalpapers_1": 21.0, "totalpapers_2": 23.0, "totalpapers_3": 25.0, "totalpapers_4": 25.0, "totalpapers_5": 26.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 9.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 3.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 20.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.0, "venuehindexmean_1": 149.8571428571, "venuehindexmean_2": 153.8571428571, "venuehindexmean_3": 157.1428571429, "venuehindexmean_4": 160.2857142857, "venuehindexmean_5": 163.4285714286, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.9863040278, "pagerank_1": 3.8444709123, "pagerank_2": 4.0256273913, "pagerank_3": 4.7338539511, "pagerank_4": 4.5172085125, "pagerank_5": 4.7134119304}}, {"model": "papers.paper", "pk": 1003606, "fields": {"authors": ["James W.Vaupel"], "affiliation": "University of Southern Denmark", "venue": "Nature", "doi": "10.1038/nature08984", "abstract": "Human senescence has been delayed by a decade. This finding, documented in 1994 and bolstered since, is a fundamental discovery about the biology of human ageing, and one with profound implications for individuals, society and the economy. Remarkably, the rate of deterioration with age seems to be constant across individuals and over time: it seems that death is being delayed because people are reaching old age in better health. Research by demographers, epidemiologists and other biomedical researchers suggests that further progress is likely to be made in advancing the frontier of survival \u2014 and healthy survival \u2014 to even greater ages.", "year": 2010, "title": "Biodemography of human ageing", "keywords": ["Epidemiology", "Ageing", "Gerontology", "Physiology", "Molecular interactions", "Biology", "Senescence", "Biodemography", "Public health", "Longevity"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 4.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0081948919, "timescaledpagerank_2": 0.6318433289, "timescaledpagerank_3": 0.7546321467, "timescaledpagerank_4": 1.289279772, "timescaledpagerank_5": 1.2377563076, "hindex_0": 8.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 1.0, "adopters_2": 3.0, "adopters_3": 14.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 8.095, "citationsperpaper_1": 8.952, "citationsperpaper_2": 8.696, "citationsperpaper_3": 8.92, "citationsperpaper_4": 9.68, "citationsperpaper_5": 9.846, "citationsperyear_0": 8.947, "citationsperyear_1": 9.4, "citationsperyear_2": 9.524, "citationsperyear_3": 10.136, "citationsperyear_4": 10.522, "citationsperyear_5": 10.667, "totalcitations_0": 170.0, "totalcitations_1": 188.0, "totalcitations_2": 200.0, "totalcitations_3": 223.0, "totalcitations_4": 242.0, "totalcitations_5": 256.0, "totalpapers_0": 21.0, "totalpapers_1": 21.0, "totalpapers_2": 23.0, "totalpapers_3": 25.0, "totalpapers_4": 25.0, "totalpapers_5": 26.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 9.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 3.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 20.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.0, "venuehindexmean_1": 149.8571428571, "venuehindexmean_2": 153.8571428571, "venuehindexmean_3": 157.1428571429, "venuehindexmean_4": 160.2857142857, "venuehindexmean_5": 163.4285714286, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.9863040278, "pagerank_1": 3.8444709123, "pagerank_2": 4.0256273913, "pagerank_3": 4.7338539511, "pagerank_4": 4.5172085125, "pagerank_5": 4.7134119304}}, {"model": "papers.paper", "pk": 1003606, "fields": {"authors": ["James W.Vaupel"], "affiliation": "Duke University", "venue": "Nature", "doi": "10.1038/nature08984", "abstract": "Human senescence has been delayed by a decade. This finding, documented in 1994 and bolstered since, is a fundamental discovery about the biology of human ageing, and one with profound implications for individuals, society and the economy. Remarkably, the rate of deterioration with age seems to be constant across individuals and over time: it seems that death is being delayed because people are reaching old age in better health. Research by demographers, epidemiologists and other biomedical researchers suggests that further progress is likely to be made in advancing the frontier of survival \u2014 and healthy survival \u2014 to even greater ages.", "year": 2010, "title": "Biodemography of human ageing", "keywords": ["Epidemiology", "Ageing", "Gerontology", "Physiology", "Molecular interactions", "Biology", "Senescence", "Biodemography", "Public health", "Longevity"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 2.0, "citations_3": 1.0, "citations_4": 4.0, "citations_5": 1.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0081948919, "timescaledpagerank_2": 0.6318433289, "timescaledpagerank_3": 0.7546321467, "timescaledpagerank_4": 1.289279772, "timescaledpagerank_5": 1.2377563076, "hindex_0": 8.0, "hindex_1": 8.0, "hindex_2": 8.0, "hindex_3": 9.0, "hindex_4": 9.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 1.0, "adopters_2": 3.0, "adopters_3": 14.0, "adopters_4": 8.0, "adopters_5": 0.0, "citationsperpaper_0": 8.095, "citationsperpaper_1": 8.952, "citationsperpaper_2": 8.696, "citationsperpaper_3": 8.92, "citationsperpaper_4": 9.68, "citationsperpaper_5": 9.846, "citationsperyear_0": 8.947, "citationsperyear_1": 9.4, "citationsperyear_2": 9.524, "citationsperyear_3": 10.136, "citationsperyear_4": 10.522, "citationsperyear_5": 10.667, "totalcitations_0": 170.0, "totalcitations_1": 188.0, "totalcitations_2": 200.0, "totalcitations_3": 223.0, "totalcitations_4": 242.0, "totalcitations_5": 256.0, "totalpapers_0": 21.0, "totalpapers_1": 21.0, "totalpapers_2": 23.0, "totalpapers_3": 25.0, "totalpapers_4": 25.0, "totalpapers_5": 26.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 9.0, "recentcoauthors_1": 6.0, "recentcoauthors_2": 3.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 20.0, "recentcoauthors_5": 5.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.0, "venuehindexmean_1": 149.8571428571, "venuehindexmean_2": 153.8571428571, "venuehindexmean_3": 157.1428571429, "venuehindexmean_4": 160.2857142857, "venuehindexmean_5": 163.4285714286, "totalvenues_0": 7.0, "totalvenues_1": 7.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 3.9863040278, "pagerank_1": 3.8444709123, "pagerank_2": 4.0256273913, "pagerank_3": 4.7338539511, "pagerank_4": 4.5172085125, "pagerank_5": 4.7134119304}}, {"model": "papers.paper", "pk": 1002973, "fields": {"authors": ["GregorBetz"], "affiliation": "University of Stuttgart", "venue": "Nature", "doi": "10.1038/4641125b", "abstract": "", "year": 2010, "title": "Climate policy: dissent over moral as well as factual issues", "keywords": ["Political science", "Environmental resource management", "Dissent", "Climate policy", "Environmental ethics"], "citations_0": 0.0, "citations_1": 0.0, "citations_2": 0.0, "citations_3": 0.0, "citations_4": 0.0, "citations_5": 0.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.3189788577, "timescaledpagerank_2": 0.360598474, "timescaledpagerank_3": 0.3737410633, "timescaledpagerank_4": 0.3738282003, "timescaledpagerank_5": 0.3691492536, "hindex_0": 0.0, "hindex_1": 0.0, "hindex_2": 0.0, "hindex_3": 0.0, "hindex_4": 0.0, "hindex_5": 0.0, "adopters_0": 0.0, "adopters_1": 0.0, "adopters_2": 0.0, "adopters_3": 0.0, "adopters_4": 0.0, "adopters_5": 0.0, "citationsperpaper_0": 0.0, "citationsperpaper_1": 0.0, "citationsperpaper_2": 0.0, "citationsperpaper_3": 0.0, "citationsperpaper_4": 0.0, "citationsperpaper_5": 0.0, "citationsperyear_0": 0.0, "citationsperyear_1": 0.0, "citationsperyear_2": 0.0, "citationsperyear_3": 0.0, "citationsperyear_4": 0.0, "citationsperyear_5": 0.0, "totalcitations_0": 0.0, "totalcitations_1": 0.0, "totalcitations_2": 0.0, "totalcitations_3": 0.0, "totalcitations_4": 0.0, "totalcitations_5": 0.0, "totalpapers_0": 1.0, "totalpapers_1": 1.0, "totalpapers_2": 1.0, "totalpapers_3": 1.0, "totalpapers_4": 1.0, "totalpapers_5": 1.0, "authorage_0": 0.0, "authorage_1": 1.0, "authorage_2": 2.0, "authorage_3": 3.0, "authorage_4": 4.0, "authorage_5": 5.0, "recentcoauthors_0": 0.0, "recentcoauthors_1": 0.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 0.15, "pagerank_1": 0.15, "pagerank_2": 0.15, "pagerank_3": 0.15, "pagerank_4": 0.15, "pagerank_5": 0.15}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Patrick A.Mayes", "MariaGarris", "Joseph T.Glessner", "MauraDiamond", "WendyGlaberson", "Edward F.Attiyeh", "Kristopher R.Bosse", "MarioCapasso", "Edward C.Frackelton", "HakonHakonarson", "Rosetta M.Chiavacci", "CynthiaWinter", "CeciliaKim", "MarcellaDevoto", "Yael P.Mosse", "CuipingHou", "Sharon J.Diskin", "LeNguyen", "HongzheLi", "JayantiJagannathan", "HaitaoZhang", "Kristina A.Cole", "John M.Maris", "Robert W.Schnepp", "Struan F.A.Grant"], "affiliation": "University of Pennsylvania", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 4.6, "hindex_1": 5.24, "hindex_2": 6.32, "hindex_3": 6.84, "hindex_4": 7.56, "hindex_5": 8.48, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 5.3918, "citationsperpaper_1": 6.99652, "citationsperpaper_2": 8.92052, "citationsperpaper_3": 10.01812, "citationsperpaper_4": 11.46872, "citationsperpaper_5": 13.24144, "citationsperyear_0": 10.95732, "citationsperyear_1": 14.69748, "citationsperyear_2": 18.15432, "citationsperyear_3": 19.511, "citationsperyear_4": 20.76904, "citationsperyear_5": 22.84208, "totalcitations_0": 83.96, "totalcitations_1": 123.4, "totalcitations_2": 172.0, "totalcitations_3": 208.36, "totalcitations_4": 247.6, "totalcitations_5": 298.88, "totalpapers_0": 13.4, "totalpapers_1": 16.68, "totalpapers_2": 19.48, "totalpapers_3": 22.2, "totalpapers_4": 23.84, "totalpapers_5": 26.8, "authorage_0": 6.56, "authorage_1": 7.56, "authorage_2": 8.56, "authorage_3": 9.56, "authorage_4": 10.56, "authorage_5": 11.56, "recentcoauthors_0": 234.32, "recentcoauthors_1": 289.2, "recentcoauthors_2": 270.4, "recentcoauthors_3": 207.04, "recentcoauthors_4": 124.76, "recentcoauthors_5": 132.64, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.0508888889, "venuehindexmean_1": 136.9811365301, "venuehindexmean_2": 139.0936486846, "venuehindexmean_3": 140.561, "venuehindexmean_4": 143.4753333333, "venuehindexmean_5": 141.8974471607, "totalvenues_0": 4.68, "totalvenues_1": 5.6, "totalvenues_2": 5.8, "totalvenues_3": 6.12, "totalvenues_4": 6.2, "totalvenues_5": 6.8, "pagerank_0": 5.2205929406, "pagerank_1": 6.696152219, "pagerank_2": 7.233241416, "pagerank_3": 7.6295450357, "pagerank_4": 7.8522127806, "pagerank_5": 8.3588260352}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Patrick A.Mayes", "MariaGarris", "Joseph T.Glessner", "MauraDiamond", "WendyGlaberson", "Edward F.Attiyeh", "Kristopher R.Bosse", "MarioCapasso", "Edward C.Frackelton", "HakonHakonarson", "Rosetta M.Chiavacci", "CynthiaWinter", "CeciliaKim", "MarcellaDevoto", "Yael P.Mosse", "CuipingHou", "Sharon J.Diskin", "QunWang", "LeNguyen", "Wendy B.London", "JayantiJagannathan", "KaiWang", "HaitaoZhang", "Kristina A.Cole", "John M.Maris", "Robert W.Schnepp", "Struan F.A.Grant"], "affiliation": "Children's Hospital of Philadelphia", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 4.4814814815, "hindex_1": 5.1111111111, "hindex_2": 6.1111111111, "hindex_3": 6.5555555556, "hindex_4": 7.2592592593, "hindex_5": 8.1481481481, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 5.3590740741, "citationsperpaper_1": 6.933037037, "citationsperpaper_2": 8.7915555556, "citationsperpaper_3": 9.8165925926, "citationsperpaper_4": 11.1234444444, "citationsperpaper_5": 12.9098148148, "citationsperyear_0": 10.582962963, "citationsperyear_1": 14.083037037, "citationsperyear_2": 17.3538518519, "citationsperyear_3": 18.5633333333, "citationsperyear_4": 19.696, "citationsperyear_5": 21.6860740741, "totalcitations_0": 80.9259259259, "totalcitations_1": 118.3703703704, "totalcitations_2": 164.4074074074, "totalcitations_3": 198.0740740741, "totalcitations_4": 234.5925925926, "totalcitations_5": 283.5185185185, "totalpapers_0": 13.0740740741, "totalpapers_1": 16.1481481481, "totalpapers_2": 18.8888888889, "totalpapers_3": 21.4814814815, "totalpapers_4": 23.1851851852, "totalpapers_5": 26.0, "authorage_0": 6.3703703704, "authorage_1": 7.3703703704, "authorage_2": 8.3703703704, "authorage_3": 9.3703703704, "authorage_4": 10.3703703704, "authorage_5": 11.3703703704, "recentcoauthors_0": 222.8148148148, "recentcoauthors_1": 272.7777777778, "recentcoauthors_2": 252.9259259259, "recentcoauthors_3": 196.5555555556, "recentcoauthors_4": 121.3703703704, "recentcoauthors_5": 126.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.6644032922, "venuehindexmean_1": 142.3266696267, "venuehindexmean_2": 144.5681932265, "venuehindexmean_3": 146.4391975309, "venuehindexmean_4": 149.3277777778, "venuehindexmean_5": 148.4726242349, "totalvenues_0": 4.4814814815, "totalvenues_1": 5.2592592593, "totalvenues_2": 5.4444444444, "totalvenues_3": 5.7037037037, "totalvenues_4": 5.7777777778, "totalvenues_5": 6.2962962963, "pagerank_0": 5.1117608765, "pagerank_1": 6.4796885214, "pagerank_2": 6.998299257, "pagerank_3": 7.3883842652, "pagerank_4": 7.6387322606, "pagerank_5": 8.1129071453}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Struan F.A.Grant"], "affiliation": "University of Aberdeen", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 8.0, "hindex_1": 10.0, "hindex_2": 12.0, "hindex_3": 12.0, "hindex_4": 13.0, "hindex_5": 15.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 11.0, "citationsperpaper_1": 12.115, "citationsperpaper_2": 13.333, "citationsperpaper_3": 14.333, "citationsperpaper_4": 16.273, "citationsperpaper_5": 17.686, "citationsperyear_0": 16.133, "citationsperyear_1": 19.688, "citationsperyear_2": 23.529, "citationsperyear_3": 26.278, "citationsperyear_4": 28.263, "citationsperyear_5": 30.95, "totalcitations_0": 242.0, "totalcitations_1": 315.0, "totalcitations_2": 400.0, "totalcitations_3": 473.0, "totalcitations_4": 537.0, "totalcitations_5": 619.0, "totalpapers_0": 22.0, "totalpapers_1": 26.0, "totalpapers_2": 30.0, "totalpapers_3": 33.0, "totalpapers_4": 33.0, "totalpapers_5": 35.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 366.0, "recentcoauthors_1": 474.0, "recentcoauthors_2": 880.0, "recentcoauthors_3": 893.0, "recentcoauthors_4": 383.0, "recentcoauthors_5": 423.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 128.0, "venuehindexmean_1": 131.5, "venuehindexmean_2": 135.375, "venuehindexmean_3": 138.75, "venuehindexmean_4": 141.875, "venuehindexmean_5": 140.1111111111, "totalvenues_0": 8.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 8.0, "totalvenues_4": 8.0, "totalvenues_5": 9.0, "pagerank_0": 8.6681622433, "pagerank_1": 11.8171778339, "pagerank_2": 13.7604863464, "pagerank_3": 15.1272728373, "pagerank_4": 14.6254434593, "pagerank_5": 15.728676789}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Struan F.A.Grant", "HakonHakonarson"], "affiliation": "deCODE genetics", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 9.0, "hindex_1": 11.0, "hindex_2": 14.0, "hindex_3": 14.0, "hindex_4": 15.5, "hindex_5": 17.5, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 8.7, "citationsperpaper_1": 10.6615, "citationsperpaper_2": 12.227, "citationsperpaper_3": 13.222, "citationsperpaper_4": 15.076, "citationsperpaper_5": 17.0235, "citationsperyear_0": 16.6, "citationsperyear_1": 25.094, "citationsperyear_2": 33.3525, "citationsperyear_3": 40.389, "citationsperyear_4": 47.3685, "citationsperyear_5": 55.15, "totalcitations_0": 249.0, "totalcitations_1": 401.5, "totalcitations_2": 567.0, "totalcitations_3": 727.0, "totalcitations_4": 900.0, "totalcitations_5": 1103.0, "totalpapers_0": 31.0, "totalpapers_1": 39.5, "totalpapers_2": 48.0, "totalpapers_3": 57.0, "totalpapers_4": 62.0, "totalpapers_5": 66.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 801.5, "recentcoauthors_1": 1318.5, "recentcoauthors_2": 1696.0, "recentcoauthors_3": 1613.0, "recentcoauthors_4": 935.0, "recentcoauthors_5": 850.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 117.0416666667, "venuehindexmean_1": 118.8269230769, "venuehindexmean_2": 122.3798076923, "venuehindexmean_3": 124.675, "venuehindexmean_4": 124.4375, "venuehindexmean_5": 123.3496732026, "totalvenues_0": 10.0, "totalvenues_1": 10.5, "totalvenues_2": 10.5, "totalvenues_3": 11.5, "totalvenues_4": 12.0, "totalvenues_5": 13.0, "pagerank_0": 14.1014211235, "pagerank_1": 21.5128302346, "pagerank_2": 25.5099695696, "pagerank_3": 29.99850658, "pagerank_4": 31.1001050376, "pagerank_5": 32.9092770151}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["AchilleIolascon", "HakonHakonarson"], "affiliation": "Pasteur Institute", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 7.5, "hindex_1": 8.5, "hindex_2": 11.0, "hindex_3": 11.5, "hindex_4": 12.5, "hindex_5": 14.5, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 4.717, "citationsperpaper_1": 6.1845, "citationsperpaper_2": 7.275, "citationsperpaper_3": 8.1095, "citationsperpaper_4": 9.2395, "citationsperpaper_5": 10.5555, "citationsperyear_0": 11.1215, "citationsperyear_1": 17.972, "citationsperyear_2": 24.746, "citationsperyear_3": 31.05, "citationsperyear_4": 37.618, "citationsperyear_5": 44.425, "totalcitations_0": 172.0, "totalcitations_1": 293.0, "totalcitations_2": 427.0, "totalcitations_3": 566.5, "totalcitations_4": 723.5, "totalcitations_5": 898.0, "totalpapers_0": 34.5, "totalpapers_1": 42.0, "totalpapers_2": 50.5, "totalpapers_3": 59.0, "totalpapers_4": 65.5, "totalpapers_5": 70.5, "authorage_0": 15.0, "authorage_1": 16.0, "authorage_2": 17.0, "authorage_3": 18.0, "authorage_4": 19.0, "authorage_5": 20.0, "recentcoauthors_0": 659.0, "recentcoauthors_1": 1117.5, "recentcoauthors_2": 1353.0, "recentcoauthors_3": 1266.0, "recentcoauthors_4": 766.0, "recentcoauthors_5": 677.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 119.4166666667, "venuehindexmean_1": 109.8769230769, "venuehindexmean_2": 113.4923076923, "venuehindexmean_3": 115.6, "venuehindexmean_4": 115.3, "venuehindexmean_5": 116.3941176471, "totalvenues_0": 8.0, "totalvenues_1": 9.0, "totalvenues_2": 9.0, "totalvenues_3": 10.0, "totalvenues_4": 10.5, "totalvenues_5": 11.0, "pagerank_0": 14.6230595119, "pagerank_1": 20.331996559, "pagerank_2": 24.4140460529, "pagerank_3": 28.2181436579, "pagerank_4": 29.5685083585, "pagerank_5": 31.1286613971}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["AchilleIolascon", "MarioCapasso"], "affiliation": "University of Naples Federico II", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 3.5, "hindex_1": 3.5, "hindex_2": 4.5, "hindex_3": 5.5, "hindex_4": 6.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.517, "citationsperpaper_1": 3.7055, "citationsperpaper_2": 4.0, "citationsperpaper_3": 4.2205, "citationsperpaper_4": 4.5725, "citationsperpaper_5": 5.2085, "citationsperyear_0": 4.588, "citationsperyear_1": 4.847, "citationsperyear_2": 6.358, "citationsperyear_3": 7.05, "citationsperyear_4": 7.9525, "citationsperyear_5": 9.0, "totalcitations_0": 50.0, "totalcitations_1": 57.5, "totalcitations_2": 76.0, "totalcitations_3": 95.5, "totalcitations_4": 117.0, "totalcitations_5": 138.5, "totalpapers_0": 16.0, "totalpapers_1": 17.5, "totalpapers_2": 21.0, "totalpapers_3": 23.0, "totalpapers_4": 25.5, "totalpapers_5": 28.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 69.5, "recentcoauthors_1": 59.0, "recentcoauthors_2": 130.5, "recentcoauthors_3": 135.0, "recentcoauthors_4": 43.0, "recentcoauthors_5": 64.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 143.0416666667, "venuehindexmean_1": 118.675, "venuehindexmean_2": 118.5, "venuehindexmean_3": 121.6, "venuehindexmean_4": 124.8, "venuehindexmean_5": 127.8, "totalvenues_0": 3.5, "totalvenues_1": 4.5, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 5.6078822321, "pagerank_1": 5.5235525747, "pagerank_2": 6.9444229421, "pagerank_3": 7.0136069927, "pagerank_4": 7.1983076907, "pagerank_5": 7.598402686}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["AchilleIolascon"], "affiliation": "University of Bari", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 5.0, "hindex_1": 5.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.034, "citationsperpaper_1": 3.161, "citationsperpaper_2": 3.429, "citationsperpaper_3": 4.108, "citationsperpaper_4": 4.6, "citationsperpaper_5": 4.75, "citationsperyear_0": 5.176, "citationsperyear_1": 5.444, "citationsperyear_2": 6.316, "citationsperyear_3": 7.6, "citationsperyear_4": 8.762, "citationsperyear_5": 9.5, "totalcitations_0": 88.0, "totalcitations_1": 98.0, "totalcitations_2": 120.0, "totalcitations_3": 152.0, "totalcitations_4": 184.0, "totalcitations_5": 209.0, "totalpapers_0": 29.0, "totalpapers_1": 31.0, "totalpapers_2": 35.0, "totalpapers_3": 37.0, "totalpapers_4": 40.0, "totalpapers_5": 44.0, "authorage_0": 16.0, "authorage_1": 17.0, "authorage_2": 18.0, "authorage_3": 19.0, "authorage_4": 20.0, "authorage_5": 21.0, "recentcoauthors_0": 81.0, "recentcoauthors_1": 72.0, "recentcoauthors_2": 194.0, "recentcoauthors_3": 199.0, "recentcoauthors_4": 45.0, "recentcoauthors_5": 78.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.75, "venuehindexmean_1": 113.6, "venuehindexmean_2": 117.6, "venuehindexmean_3": 120.6, "venuehindexmean_4": 123.6, "venuehindexmean_5": 126.2, "totalvenues_0": 4.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 9.7114390201, "pagerank_1": 9.4555104827, "pagerank_2": 11.5686393129, "pagerank_3": 11.5665469932, "pagerank_4": 11.562250101, "pagerank_5": 12.167445553}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["HongzheLi"], "affiliation": "University of California, Davis", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 4.0, "hindex_1": 4.0, "hindex_2": 5.0, "hindex_3": 6.0, "hindex_4": 7.0, "hindex_5": 7.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 2.8, "citationsperpaper_1": 3.75, "citationsperpaper_2": 6.75, "citationsperpaper_3": 8.538, "citationsperpaper_4": 10.571, "citationsperpaper_5": 11.875, "citationsperyear_0": 2.545, "citationsperyear_1": 3.75, "citationsperyear_2": 6.231, "citationsperyear_3": 7.929, "citationsperyear_4": 9.867, "citationsperyear_5": 11.875, "totalcitations_0": 28.0, "totalcitations_1": 45.0, "totalcitations_2": 81.0, "totalcitations_3": 111.0, "totalcitations_4": 148.0, "totalcitations_5": 190.0, "totalpapers_0": 10.0, "totalpapers_1": 12.0, "totalpapers_2": 12.0, "totalpapers_3": 13.0, "totalpapers_4": 14.0, "totalpapers_5": 16.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 143.0, "recentcoauthors_1": 117.0, "recentcoauthors_2": 31.0, "recentcoauthors_3": 22.0, "recentcoauthors_4": 43.0, "recentcoauthors_5": 105.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 132.1666666667, "venuehindexmean_1": 133.875, "venuehindexmean_2": 138.0, "venuehindexmean_3": 136.3333333333, "venuehindexmean_4": 132.7, "venuehindexmean_5": 126.8181818182, "totalvenues_0": 6.0, "totalvenues_1": 8.0, "totalvenues_2": 8.0, "totalvenues_3": 9.0, "totalvenues_4": 10.0, "totalvenues_5": 11.0, "pagerank_0": 3.5691028871, "pagerank_1": 3.8007055818, "pagerank_2": 3.4847139726, "pagerank_3": 3.641149278, "pagerank_4": 3.9246762067, "pagerank_5": 4.6769307525}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["HakonHakonarson"], "affiliation": "University of Eastern Finland", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 16.0, "hindex_3": 16.0, "hindex_4": 18.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.4, "citationsperpaper_1": 9.208, "citationsperpaper_2": 11.121, "citationsperpaper_3": 12.111, "citationsperpaper_4": 13.879, "citationsperpaper_5": 16.361, "citationsperyear_0": 17.067, "citationsperyear_1": 30.5, "citationsperyear_2": 43.176, "citationsperyear_3": 54.5, "citationsperyear_4": 66.474, "citationsperyear_5": 79.35, "totalcitations_0": 256.0, "totalcitations_1": 488.0, "totalcitations_2": 734.0, "totalcitations_3": 981.0, "totalcitations_4": 1263.0, "totalcitations_5": 1587.0, "totalpapers_0": 40.0, "totalpapers_1": 53.0, "totalpapers_2": 66.0, "totalpapers_3": 81.0, "totalpapers_4": 91.0, "totalpapers_5": 97.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 1237.0, "recentcoauthors_1": 2163.0, "recentcoauthors_2": 2512.0, "recentcoauthors_3": 2333.0, "recentcoauthors_4": 1487.0, "recentcoauthors_5": 1277.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 106.0833333333, "venuehindexmean_1": 106.1538461538, "venuehindexmean_2": 109.3846153846, "venuehindexmean_3": 110.6, "venuehindexmean_4": 107.0, "venuehindexmean_5": 106.5882352941, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 15.0, "totalvenues_4": 16.0, "totalvenues_5": 17.0, "pagerank_0": 19.5346800037, "pagerank_1": 31.2084826352, "pagerank_2": 37.2594527928, "pagerank_3": 44.8697403226, "pagerank_4": 47.5747666159, "pagerank_5": 50.0898772411}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["HakonHakonarson"], "affiliation": "Erasmus University Rotterdam", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 16.0, "hindex_3": 16.0, "hindex_4": 18.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.4, "citationsperpaper_1": 9.208, "citationsperpaper_2": 11.121, "citationsperpaper_3": 12.111, "citationsperpaper_4": 13.879, "citationsperpaper_5": 16.361, "citationsperyear_0": 17.067, "citationsperyear_1": 30.5, "citationsperyear_2": 43.176, "citationsperyear_3": 54.5, "citationsperyear_4": 66.474, "citationsperyear_5": 79.35, "totalcitations_0": 256.0, "totalcitations_1": 488.0, "totalcitations_2": 734.0, "totalcitations_3": 981.0, "totalcitations_4": 1263.0, "totalcitations_5": 1587.0, "totalpapers_0": 40.0, "totalpapers_1": 53.0, "totalpapers_2": 66.0, "totalpapers_3": 81.0, "totalpapers_4": 91.0, "totalpapers_5": 97.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 1237.0, "recentcoauthors_1": 2163.0, "recentcoauthors_2": 2512.0, "recentcoauthors_3": 2333.0, "recentcoauthors_4": 1487.0, "recentcoauthors_5": 1277.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 106.0833333333, "venuehindexmean_1": 106.1538461538, "venuehindexmean_2": 109.3846153846, "venuehindexmean_3": 110.6, "venuehindexmean_4": 107.0, "venuehindexmean_5": 106.5882352941, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 15.0, "totalvenues_4": 16.0, "totalvenues_5": 17.0, "pagerank_0": 19.5346800037, "pagerank_1": 31.2084826352, "pagerank_2": 37.2594527928, "pagerank_3": 44.8697403226, "pagerank_4": 47.5747666159, "pagerank_5": 50.0898772411}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["HakonHakonarson"], "affiliation": "University of London", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 16.0, "hindex_3": 16.0, "hindex_4": 18.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.4, "citationsperpaper_1": 9.208, "citationsperpaper_2": 11.121, "citationsperpaper_3": 12.111, "citationsperpaper_4": 13.879, "citationsperpaper_5": 16.361, "citationsperyear_0": 17.067, "citationsperyear_1": 30.5, "citationsperyear_2": 43.176, "citationsperyear_3": 54.5, "citationsperyear_4": 66.474, "citationsperyear_5": 79.35, "totalcitations_0": 256.0, "totalcitations_1": 488.0, "totalcitations_2": 734.0, "totalcitations_3": 981.0, "totalcitations_4": 1263.0, "totalcitations_5": 1587.0, "totalpapers_0": 40.0, "totalpapers_1": 53.0, "totalpapers_2": 66.0, "totalpapers_3": 81.0, "totalpapers_4": 91.0, "totalpapers_5": 97.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 1237.0, "recentcoauthors_1": 2163.0, "recentcoauthors_2": 2512.0, "recentcoauthors_3": 2333.0, "recentcoauthors_4": 1487.0, "recentcoauthors_5": 1277.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 106.0833333333, "venuehindexmean_1": 106.1538461538, "venuehindexmean_2": 109.3846153846, "venuehindexmean_3": 110.6, "venuehindexmean_4": 107.0, "venuehindexmean_5": 106.5882352941, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 15.0, "totalvenues_4": 16.0, "totalvenues_5": 17.0, "pagerank_0": 19.5346800037, "pagerank_1": 31.2084826352, "pagerank_2": 37.2594527928, "pagerank_3": 44.8697403226, "pagerank_4": 47.5747666159, "pagerank_5": 50.0898772411}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["HakonHakonarson"], "affiliation": "University of Illinois at Chicago", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 16.0, "hindex_3": 16.0, "hindex_4": 18.0, "hindex_5": 20.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.4, "citationsperpaper_1": 9.208, "citationsperpaper_2": 11.121, "citationsperpaper_3": 12.111, "citationsperpaper_4": 13.879, "citationsperpaper_5": 16.361, "citationsperyear_0": 17.067, "citationsperyear_1": 30.5, "citationsperyear_2": 43.176, "citationsperyear_3": 54.5, "citationsperyear_4": 66.474, "citationsperyear_5": 79.35, "totalcitations_0": 256.0, "totalcitations_1": 488.0, "totalcitations_2": 734.0, "totalcitations_3": 981.0, "totalcitations_4": 1263.0, "totalcitations_5": 1587.0, "totalpapers_0": 40.0, "totalpapers_1": 53.0, "totalpapers_2": 66.0, "totalpapers_3": 81.0, "totalpapers_4": 91.0, "totalpapers_5": 97.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 1237.0, "recentcoauthors_1": 2163.0, "recentcoauthors_2": 2512.0, "recentcoauthors_3": 2333.0, "recentcoauthors_4": 1487.0, "recentcoauthors_5": 1277.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 106.0833333333, "venuehindexmean_1": 106.1538461538, "venuehindexmean_2": 109.3846153846, "venuehindexmean_3": 110.6, "venuehindexmean_4": 107.0, "venuehindexmean_5": 106.5882352941, "totalvenues_0": 12.0, "totalvenues_1": 13.0, "totalvenues_2": 13.0, "totalvenues_3": 15.0, "totalvenues_4": 16.0, "totalvenues_5": 17.0, "pagerank_0": 19.5346800037, "pagerank_1": 31.2084826352, "pagerank_2": 37.2594527928, "pagerank_3": 44.8697403226, "pagerank_4": 47.5747666159, "pagerank_5": 50.0898772411}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["CeciliaKim"], "affiliation": "University of Pisa", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 5.0, "hindex_1": 6.0, "hindex_2": 7.0, "hindex_3": 8.0, "hindex_4": 8.0, "hindex_5": 9.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 5.4, "citationsperpaper_1": 8.538, "citationsperpaper_2": 15.231, "citationsperpaper_3": 18.929, "citationsperpaper_4": 22.643, "citationsperpaper_5": 27.571, "citationsperyear_0": 18.0, "citationsperyear_1": 27.75, "citationsperyear_2": 39.6, "citationsperyear_3": 44.167, "citationsperyear_4": 45.286, "citationsperyear_5": 48.25, "totalcitations_0": 54.0, "totalcitations_1": 111.0, "totalcitations_2": 198.0, "totalcitations_3": 265.0, "totalcitations_4": 317.0, "totalcitations_5": 386.0, "totalpapers_0": 10.0, "totalpapers_1": 13.0, "totalpapers_2": 13.0, "totalpapers_3": 14.0, "totalpapers_4": 14.0, "totalpapers_5": 14.0, "authorage_0": 2.0, "authorage_1": 3.0, "authorage_2": 4.0, "authorage_3": 5.0, "authorage_4": 6.0, "authorage_5": 7.0, "recentcoauthors_0": 366.0, "recentcoauthors_1": 628.0, "recentcoauthors_2": 363.0, "recentcoauthors_3": 10.0, "recentcoauthors_4": 10.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 100.0, "venuehindexmean_1": 103.0, "venuehindexmean_2": 107.2, "venuehindexmean_3": 109.8333333333, "venuehindexmean_4": 113.0, "venuehindexmean_5": 116.1666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.7450844291, "pagerank_1": 8.7913486667, "pagerank_2": 8.0139662186, "pagerank_3": 7.4505736458, "pagerank_4": 7.3060369268, "pagerank_5": 6.853375506}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Wendy B.London", "PatrickMcGrady"], "affiliation": "University of Florida", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 4.5, "hindex_1": 5.0, "hindex_2": 5.5, "hindex_3": 5.5, "hindex_4": 6.5, "hindex_5": 7.5, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.725, "citationsperpaper_1": 9.848, "citationsperpaper_2": 13.519, "citationsperpaper_3": 14.388, "citationsperpaper_4": 13.2285, "citationsperpaper_5": 15.8665, "citationsperyear_0": 6.6135, "citationsperyear_1": 8.7855, "citationsperyear_2": 11.2885, "citationsperyear_3": 11.5, "citationsperyear_4": 12.35, "citationsperyear_5": 14.483, "totalcitations_0": 56.5, "totalcitations_1": 84.0, "totalcitations_2": 120.5, "totalcitations_3": 136.0, "totalcitations_4": 160.0, "totalcitations_5": 204.0, "totalpapers_0": 12.0, "totalpapers_1": 13.5, "totalpapers_2": 15.0, "totalpapers_3": 16.5, "totalpapers_4": 20.0, "totalpapers_5": 22.0, "authorage_0": 7.5, "authorage_1": 8.5, "authorage_2": 9.5, "authorage_3": 10.5, "authorage_4": 11.5, "authorage_5": 12.5, "recentcoauthors_0": 127.5, "recentcoauthors_1": 103.0, "recentcoauthors_2": 45.0, "recentcoauthors_3": 71.5, "recentcoauthors_4": 107.5, "recentcoauthors_5": 102.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 158.5833333333, "venuehindexmean_1": 161.4166666667, "venuehindexmean_2": 165.1666666667, "venuehindexmean_3": 168.8333333333, "venuehindexmean_4": 146.6666666667, "venuehindexmean_5": 150.5714285714, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 4.8186163147, "pagerank_1": 4.9993974423, "pagerank_2": 5.0415443006, "pagerank_3": 5.4578786104, "pagerank_4": 6.3533111655, "pagerank_5": 6.8151247781}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Wendy B.London", "PatrickMcGrady"], "affiliation": "Children's Oncology Group", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 4.5, "hindex_1": 5.0, "hindex_2": 5.5, "hindex_3": 5.5, "hindex_4": 6.5, "hindex_5": 7.5, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.725, "citationsperpaper_1": 9.848, "citationsperpaper_2": 13.519, "citationsperpaper_3": 14.388, "citationsperpaper_4": 13.2285, "citationsperpaper_5": 15.8665, "citationsperyear_0": 6.6135, "citationsperyear_1": 8.7855, "citationsperyear_2": 11.2885, "citationsperyear_3": 11.5, "citationsperyear_4": 12.35, "citationsperyear_5": 14.483, "totalcitations_0": 56.5, "totalcitations_1": 84.0, "totalcitations_2": 120.5, "totalcitations_3": 136.0, "totalcitations_4": 160.0, "totalcitations_5": 204.0, "totalpapers_0": 12.0, "totalpapers_1": 13.5, "totalpapers_2": 15.0, "totalpapers_3": 16.5, "totalpapers_4": 20.0, "totalpapers_5": 22.0, "authorage_0": 7.5, "authorage_1": 8.5, "authorage_2": 9.5, "authorage_3": 10.5, "authorage_4": 11.5, "authorage_5": 12.5, "recentcoauthors_0": 127.5, "recentcoauthors_1": 103.0, "recentcoauthors_2": 45.0, "recentcoauthors_3": 71.5, "recentcoauthors_4": 107.5, "recentcoauthors_5": 102.5, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 158.5833333333, "venuehindexmean_1": 161.4166666667, "venuehindexmean_2": 165.1666666667, "venuehindexmean_3": 168.8333333333, "venuehindexmean_4": 146.6666666667, "venuehindexmean_5": 150.5714285714, "totalvenues_0": 4.0, "totalvenues_1": 4.0, "totalvenues_2": 4.0, "totalvenues_3": 4.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 4.8186163147, "pagerank_1": 4.9993974423, "pagerank_2": 5.0415443006, "pagerank_3": 5.4578786104, "pagerank_4": 6.3533111655, "pagerank_5": 6.8151247781}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Robert W.Schnepp", "Wendy B.London", "Joseph T.Glessner"], "affiliation": "Harvard University", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 7.6666666667, "hindex_3": 8.3333333333, "hindex_4": 9.3333333333, "hindex_5": 10.6666666667, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 7.3963333333, "citationsperpaper_1": 9.0116666667, "citationsperpaper_2": 10.396, "citationsperpaper_3": 10.907, "citationsperpaper_4": 12.1976666667, "citationsperpaper_5": 13.3773333333, "citationsperyear_0": 14.4553333333, "citationsperyear_1": 19.4666666667, "citationsperyear_2": 23.9346666667, "citationsperyear_3": 26.107, "citationsperyear_4": 27.8313333333, "citationsperyear_5": 30.3656666667, "totalcitations_0": 93.3333333333, "totalcitations_1": 137.6666666667, "totalcitations_2": 191.3333333333, "totalcitations_3": 232.6666666667, "totalcitations_4": 276.3333333333, "totalcitations_5": 335.0, "totalpapers_0": 14.6666666667, "totalpapers_1": 17.3333333333, "totalpapers_2": 19.3333333333, "totalpapers_3": 22.0, "totalpapers_4": 24.3333333333, "totalpapers_5": 27.0, "authorage_0": 7.0, "authorage_1": 8.0, "authorage_2": 9.0, "authorage_3": 10.0, "authorage_4": 11.0, "authorage_5": 12.0, "recentcoauthors_0": 263.3333333333, "recentcoauthors_1": 307.0, "recentcoauthors_2": 186.3333333333, "recentcoauthors_3": 94.6666666667, "recentcoauthors_4": 99.6666666667, "recentcoauthors_5": 98.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 147.7888888889, "venuehindexmean_1": 150.6111111111, "venuehindexmean_2": 149.7333333333, "venuehindexmean_3": 144.8746031746, "venuehindexmean_4": 144.7333333333, "venuehindexmean_5": 138.8439153439, "totalvenues_0": 5.3333333333, "totalvenues_1": 5.3333333333, "totalvenues_2": 5.6666666667, "totalvenues_3": 6.0, "totalvenues_4": 6.3333333333, "totalvenues_5": 7.3333333333, "pagerank_0": 6.3889054788, "pagerank_1": 7.7619844287, "pagerank_2": 7.7340050858, "pagerank_3": 8.1049904125, "pagerank_4": 8.5291663657, "pagerank_5": 8.8877606332}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Wendy B.London"], "affiliation": "Boston Children's Hospital", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 6.0, "hindex_1": 7.0, "hindex_2": 7.0, "hindex_3": 7.0, "hindex_4": 9.0, "hindex_5": 10.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.7, "citationsperpaper_1": 4.696, "citationsperpaper_2": 6.038, "citationsperpaper_3": 6.276, "citationsperpaper_4": 6.257, "citationsperpaper_5": 7.333, "citationsperyear_0": 6.727, "citationsperyear_1": 9.0, "citationsperyear_2": 12.077, "citationsperyear_3": 13.0, "citationsperyear_4": 14.6, "citationsperyear_5": 17.875, "totalcitations_0": 74.0, "totalcitations_1": 108.0, "totalcitations_2": 157.0, "totalcitations_3": 182.0, "totalcitations_4": 219.0, "totalcitations_5": 286.0, "totalpapers_0": 20.0, "totalpapers_1": 23.0, "totalpapers_2": 26.0, "totalpapers_3": 29.0, "totalpapers_4": 35.0, "totalpapers_5": 39.0, "authorage_0": 10.0, "authorage_1": 11.0, "authorage_2": 12.0, "authorage_3": 13.0, "authorage_4": 14.0, "authorage_5": 15.0, "recentcoauthors_0": 197.0, "recentcoauthors_1": 174.0, "recentcoauthors_2": 90.0, "recentcoauthors_3": 143.0, "recentcoauthors_4": 201.0, "recentcoauthors_5": 191.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.1666666667, "venuehindexmean_1": 136.8333333333, "venuehindexmean_2": 140.3333333333, "venuehindexmean_3": 143.1666666667, "venuehindexmean_4": 136.0, "venuehindexmean_5": 139.1428571429, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 7.7987116787, "pagerank_1": 8.2988004032, "pagerank_2": 8.5052476828, "pagerank_3": 9.4628307613, "pagerank_4": 10.9888527883, "pagerank_5": 12.0081991671}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["HirokiSasaki"], "affiliation": "National Cancer Research Institute", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 6.0, "hindex_1": 6.0, "hindex_2": 6.0, "hindex_3": 7.0, "hindex_4": 7.0, "hindex_5": 8.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 8.15, "citationsperpaper_1": 8.048, "citationsperpaper_2": 8.136, "citationsperpaper_3": 8.043, "citationsperpaper_4": 8.217, "citationsperpaper_5": 8.292, "citationsperyear_0": 8.579, "citationsperyear_1": 8.45, "citationsperyear_2": 8.524, "citationsperyear_3": 8.409, "citationsperyear_4": 8.217, "citationsperyear_5": 8.292, "totalcitations_0": 163.0, "totalcitations_1": 169.0, "totalcitations_2": 179.0, "totalcitations_3": 185.0, "totalcitations_4": 189.0, "totalcitations_5": 199.0, "totalpapers_0": 20.0, "totalpapers_1": 21.0, "totalpapers_2": 22.0, "totalpapers_3": 23.0, "totalpapers_4": 23.0, "totalpapers_5": 24.0, "authorage_0": 18.0, "authorage_1": 19.0, "authorage_2": 20.0, "authorage_3": 21.0, "authorage_4": 22.0, "authorage_5": 23.0, "recentcoauthors_0": 32.0, "recentcoauthors_1": 39.0, "recentcoauthors_2": 18.0, "recentcoauthors_3": 23.0, "recentcoauthors_4": 12.0, "recentcoauthors_5": 11.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 134.6, "venuehindexmean_1": 137.4, "venuehindexmean_2": 140.6, "venuehindexmean_3": 143.2, "venuehindexmean_4": 146.2, "venuehindexmean_5": 148.6, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 7.2309578535, "pagerank_1": 7.2240352189, "pagerank_2": 7.2633994414, "pagerank_3": 7.320837814, "pagerank_4": 7.1214886178, "pagerank_5": 7.2855557291}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Joseph T.Glessner"], "affiliation": "Broad Institute", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 6.0, "hindex_1": 8.0, "hindex_2": 10.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.6, "citationsperpaper_1": 9.45, "citationsperpaper_2": 14.4, "citationsperpaper_3": 17.045, "citationsperpaper_4": 20.773, "citationsperpaper_5": 23.957, "citationsperyear_0": 24.75, "citationsperyear_1": 37.8, "citationsperyear_2": 48.0, "citationsperyear_3": 53.571, "citationsperyear_4": 57.125, "citationsperyear_5": 61.222, "totalcitations_0": 99.0, "totalcitations_1": 189.0, "totalcitations_2": 288.0, "totalcitations_3": 375.0, "totalcitations_4": 457.0, "totalcitations_5": 551.0, "totalpapers_0": 15.0, "totalpapers_1": 20.0, "totalpapers_2": 20.0, "totalpapers_3": 22.0, "totalpapers_4": 22.0, "totalpapers_5": 23.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 561.0, "recentcoauthors_1": 715.0, "recentcoauthors_2": 416.0, "recentcoauthors_3": 66.0, "recentcoauthors_4": 66.0, "recentcoauthors_5": 65.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 130.0, "venuehindexmean_1": 133.0, "venuehindexmean_2": 137.2, "venuehindexmean_3": 140.6, "venuehindexmean_4": 144.2, "venuehindexmean_5": 140.1666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 6.0, "pagerank_0": 8.510252202, "pagerank_1": 12.3083144072, "pagerank_2": 11.3325214869, "pagerank_3": 11.2012907419, "pagerank_4": 10.8716169089, "pagerank_5": 10.746391293}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["Joseph T.Glessner"], "affiliation": "University of Gothenburg", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 6.0, "hindex_1": 8.0, "hindex_2": 10.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 6.6, "citationsperpaper_1": 9.45, "citationsperpaper_2": 14.4, "citationsperpaper_3": 17.045, "citationsperpaper_4": 20.773, "citationsperpaper_5": 23.957, "citationsperyear_0": 24.75, "citationsperyear_1": 37.8, "citationsperyear_2": 48.0, "citationsperyear_3": 53.571, "citationsperyear_4": 57.125, "citationsperyear_5": 61.222, "totalcitations_0": 99.0, "totalcitations_1": 189.0, "totalcitations_2": 288.0, "totalcitations_3": 375.0, "totalcitations_4": 457.0, "totalcitations_5": 551.0, "totalpapers_0": 15.0, "totalpapers_1": 20.0, "totalpapers_2": 20.0, "totalpapers_3": 22.0, "totalpapers_4": 22.0, "totalpapers_5": 23.0, "authorage_0": 3.0, "authorage_1": 4.0, "authorage_2": 5.0, "authorage_3": 6.0, "authorage_4": 7.0, "authorage_5": 8.0, "recentcoauthors_0": 561.0, "recentcoauthors_1": 715.0, "recentcoauthors_2": 416.0, "recentcoauthors_3": 66.0, "recentcoauthors_4": 66.0, "recentcoauthors_5": 65.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 130.0, "venuehindexmean_1": 133.0, "venuehindexmean_2": 137.2, "venuehindexmean_3": 140.6, "venuehindexmean_4": 144.2, "venuehindexmean_5": 140.1666666667, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 6.0, "pagerank_0": 8.510252202, "pagerank_1": 12.3083144072, "pagerank_2": 11.3325214869, "pagerank_3": 11.2012907419, "pagerank_4": 10.8716169089, "pagerank_5": 10.746391293}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["MarcellaDevoto"], "affiliation": "Sapienza University of Rome", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 9.0, "hindex_1": 10.0, "hindex_2": 11.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 12.95, "citationsperpaper_1": 13.727, "citationsperpaper_2": 14.24, "citationsperpaper_3": 14.615, "citationsperpaper_4": 15.148, "citationsperpaper_5": 16.444, "citationsperyear_0": 10.792, "citationsperyear_1": 12.08, "citationsperyear_2": 13.692, "citationsperyear_3": 14.074, "citationsperyear_4": 14.607, "citationsperyear_5": 15.31, "totalcitations_0": 259.0, "totalcitations_1": 302.0, "totalcitations_2": 356.0, "totalcitations_3": 380.0, "totalcitations_4": 409.0, "totalcitations_5": 444.0, "totalpapers_0": 20.0, "totalpapers_1": 22.0, "totalpapers_2": 25.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 125.0, "recentcoauthors_1": 150.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 59.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.6, "venuehindexmean_1": 111.1666666667, "venuehindexmean_2": 110.4285714286, "venuehindexmean_3": 113.1428571429, "venuehindexmean_4": 116.1428571429, "venuehindexmean_5": 118.8571428571, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 8.7087081801, "pagerank_1": 9.259082639, "pagerank_2": 9.4369303862, "pagerank_3": 8.753078934, "pagerank_4": 8.8128742057, "pagerank_5": 8.3519896141}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["MarcellaDevoto"], "affiliation": "Columbia University", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 9.0, "hindex_1": 10.0, "hindex_2": 11.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 12.95, "citationsperpaper_1": 13.727, "citationsperpaper_2": 14.24, "citationsperpaper_3": 14.615, "citationsperpaper_4": 15.148, "citationsperpaper_5": 16.444, "citationsperyear_0": 10.792, "citationsperyear_1": 12.08, "citationsperyear_2": 13.692, "citationsperyear_3": 14.074, "citationsperyear_4": 14.607, "citationsperyear_5": 15.31, "totalcitations_0": 259.0, "totalcitations_1": 302.0, "totalcitations_2": 356.0, "totalcitations_3": 380.0, "totalcitations_4": 409.0, "totalcitations_5": 444.0, "totalpapers_0": 20.0, "totalpapers_1": 22.0, "totalpapers_2": 25.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 125.0, "recentcoauthors_1": 150.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 59.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.6, "venuehindexmean_1": 111.1666666667, "venuehindexmean_2": 110.4285714286, "venuehindexmean_3": 113.1428571429, "venuehindexmean_4": 116.1428571429, "venuehindexmean_5": 118.8571428571, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 8.7087081801, "pagerank_1": 9.259082639, "pagerank_2": 9.4369303862, "pagerank_3": 8.753078934, "pagerank_4": 8.8128742057, "pagerank_5": 8.3519896141}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["MarcellaDevoto"], "affiliation": "Istituto Giannina Gaslini", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 9.0, "hindex_1": 10.0, "hindex_2": 11.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 12.95, "citationsperpaper_1": 13.727, "citationsperpaper_2": 14.24, "citationsperpaper_3": 14.615, "citationsperpaper_4": 15.148, "citationsperpaper_5": 16.444, "citationsperyear_0": 10.792, "citationsperyear_1": 12.08, "citationsperyear_2": 13.692, "citationsperyear_3": 14.074, "citationsperyear_4": 14.607, "citationsperyear_5": 15.31, "totalcitations_0": 259.0, "totalcitations_1": 302.0, "totalcitations_2": 356.0, "totalcitations_3": 380.0, "totalcitations_4": 409.0, "totalcitations_5": 444.0, "totalpapers_0": 20.0, "totalpapers_1": 22.0, "totalpapers_2": 25.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 125.0, "recentcoauthors_1": 150.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 59.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.6, "venuehindexmean_1": 111.1666666667, "venuehindexmean_2": 110.4285714286, "venuehindexmean_3": 113.1428571429, "venuehindexmean_4": 116.1428571429, "venuehindexmean_5": 118.8571428571, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 8.7087081801, "pagerank_1": 9.259082639, "pagerank_2": 9.4369303862, "pagerank_3": 8.753078934, "pagerank_4": 8.8128742057, "pagerank_5": 8.3519896141}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["MarcellaDevoto"], "affiliation": "Rockefeller University", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 9.0, "hindex_1": 10.0, "hindex_2": 11.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 12.95, "citationsperpaper_1": 13.727, "citationsperpaper_2": 14.24, "citationsperpaper_3": 14.615, "citationsperpaper_4": 15.148, "citationsperpaper_5": 16.444, "citationsperyear_0": 10.792, "citationsperyear_1": 12.08, "citationsperyear_2": 13.692, "citationsperyear_3": 14.074, "citationsperyear_4": 14.607, "citationsperyear_5": 15.31, "totalcitations_0": 259.0, "totalcitations_1": 302.0, "totalcitations_2": 356.0, "totalcitations_3": 380.0, "totalcitations_4": 409.0, "totalcitations_5": 444.0, "totalpapers_0": 20.0, "totalpapers_1": 22.0, "totalpapers_2": 25.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 125.0, "recentcoauthors_1": 150.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 59.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.6, "venuehindexmean_1": 111.1666666667, "venuehindexmean_2": 110.4285714286, "venuehindexmean_3": 113.1428571429, "venuehindexmean_4": 116.1428571429, "venuehindexmean_5": 118.8571428571, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 8.7087081801, "pagerank_1": 9.259082639, "pagerank_2": 9.4369303862, "pagerank_3": 8.753078934, "pagerank_4": 8.8128742057, "pagerank_5": 8.3519896141}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["MarcellaDevoto"], "affiliation": "University of Genoa", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 9.0, "hindex_1": 10.0, "hindex_2": 11.0, "hindex_3": 12.0, "hindex_4": 12.0, "hindex_5": 12.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 12.95, "citationsperpaper_1": 13.727, "citationsperpaper_2": 14.24, "citationsperpaper_3": 14.615, "citationsperpaper_4": 15.148, "citationsperpaper_5": 16.444, "citationsperyear_0": 10.792, "citationsperyear_1": 12.08, "citationsperyear_2": 13.692, "citationsperyear_3": 14.074, "citationsperyear_4": 14.607, "citationsperyear_5": 15.31, "totalcitations_0": 259.0, "totalcitations_1": 302.0, "totalcitations_2": 356.0, "totalcitations_3": 380.0, "totalcitations_4": 409.0, "totalcitations_5": 444.0, "totalpapers_0": 20.0, "totalpapers_1": 22.0, "totalpapers_2": 25.0, "totalpapers_3": 26.0, "totalpapers_4": 27.0, "totalpapers_5": 27.0, "authorage_0": 23.0, "authorage_1": 24.0, "authorage_2": 25.0, "authorage_3": 26.0, "authorage_4": 27.0, "authorage_5": 28.0, "recentcoauthors_0": 125.0, "recentcoauthors_1": 150.0, "recentcoauthors_2": 130.0, "recentcoauthors_3": 59.0, "recentcoauthors_4": 18.0, "recentcoauthors_5": 12.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 125.6, "venuehindexmean_1": 111.1666666667, "venuehindexmean_2": 110.4285714286, "venuehindexmean_3": 113.1428571429, "venuehindexmean_4": 116.1428571429, "venuehindexmean_5": 118.8571428571, "totalvenues_0": 5.0, "totalvenues_1": 6.0, "totalvenues_2": 7.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 8.7087081801, "pagerank_1": 9.259082639, "pagerank_2": 9.4369303862, "pagerank_3": 8.753078934, "pagerank_4": 8.8128742057, "pagerank_5": 8.3519896141}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["NazneenRahman"], "affiliation": "University of Chicago", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 12.0, "hindex_1": 15.0, "hindex_2": 15.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 24.303, "citationsperpaper_1": 27.486, "citationsperpaper_2": 27.775, "citationsperpaper_3": 28.311, "citationsperpaper_4": 27.471, "citationsperpaper_5": 27.5, "citationsperyear_0": 53.467, "citationsperyear_1": 60.125, "citationsperyear_2": 65.353, "citationsperyear_3": 70.778, "citationsperyear_4": 73.737, "citationsperyear_5": 77.0, "totalcitations_0": 802.0, "totalcitations_1": 962.0, "totalcitations_2": 1111.0, "totalcitations_3": 1274.0, "totalcitations_4": 1401.0, "totalcitations_5": 1540.0, "totalpapers_0": 33.0, "totalpapers_1": 35.0, "totalpapers_2": 40.0, "totalpapers_3": 45.0, "totalpapers_4": 51.0, "totalpapers_5": 56.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 508.0, "recentcoauthors_1": 384.0, "recentcoauthors_2": 399.0, "recentcoauthors_3": 1318.0, "recentcoauthors_4": 1060.0, "recentcoauthors_5": 421.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.8333333333, "venuehindexmean_1": 159.8333333333, "venuehindexmean_2": 164.1666666667, "venuehindexmean_3": 148.4285714286, "venuehindexmean_4": 151.7142857143, "venuehindexmean_5": 155.1428571429, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 17.3988122836, "pagerank_1": 17.1713985114, "pagerank_2": 18.8235780442, "pagerank_3": 22.4380290851, "pagerank_4": 22.2136099512, "pagerank_5": 23.7596938554}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["NazneenRahman"], "affiliation": "The Royal Marsden NHS Foundation Trust", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 12.0, "hindex_1": 15.0, "hindex_2": 15.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 24.303, "citationsperpaper_1": 27.486, "citationsperpaper_2": 27.775, "citationsperpaper_3": 28.311, "citationsperpaper_4": 27.471, "citationsperpaper_5": 27.5, "citationsperyear_0": 53.467, "citationsperyear_1": 60.125, "citationsperyear_2": 65.353, "citationsperyear_3": 70.778, "citationsperyear_4": 73.737, "citationsperyear_5": 77.0, "totalcitations_0": 802.0, "totalcitations_1": 962.0, "totalcitations_2": 1111.0, "totalcitations_3": 1274.0, "totalcitations_4": 1401.0, "totalcitations_5": 1540.0, "totalpapers_0": 33.0, "totalpapers_1": 35.0, "totalpapers_2": 40.0, "totalpapers_3": 45.0, "totalpapers_4": 51.0, "totalpapers_5": 56.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 508.0, "recentcoauthors_1": 384.0, "recentcoauthors_2": 399.0, "recentcoauthors_3": 1318.0, "recentcoauthors_4": 1060.0, "recentcoauthors_5": 421.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.8333333333, "venuehindexmean_1": 159.8333333333, "venuehindexmean_2": 164.1666666667, "venuehindexmean_3": 148.4285714286, "venuehindexmean_4": 151.7142857143, "venuehindexmean_5": 155.1428571429, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 17.3988122836, "pagerank_1": 17.1713985114, "pagerank_2": 18.8235780442, "pagerank_3": 22.4380290851, "pagerank_4": 22.2136099512, "pagerank_5": 23.7596938554}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["NazneenRahman"], "affiliation": "National Health Service", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 12.0, "hindex_1": 15.0, "hindex_2": 15.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 24.303, "citationsperpaper_1": 27.486, "citationsperpaper_2": 27.775, "citationsperpaper_3": 28.311, "citationsperpaper_4": 27.471, "citationsperpaper_5": 27.5, "citationsperyear_0": 53.467, "citationsperyear_1": 60.125, "citationsperyear_2": 65.353, "citationsperyear_3": 70.778, "citationsperyear_4": 73.737, "citationsperyear_5": 77.0, "totalcitations_0": 802.0, "totalcitations_1": 962.0, "totalcitations_2": 1111.0, "totalcitations_3": 1274.0, "totalcitations_4": 1401.0, "totalcitations_5": 1540.0, "totalpapers_0": 33.0, "totalpapers_1": 35.0, "totalpapers_2": 40.0, "totalpapers_3": 45.0, "totalpapers_4": 51.0, "totalpapers_5": 56.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 508.0, "recentcoauthors_1": 384.0, "recentcoauthors_2": 399.0, "recentcoauthors_3": 1318.0, "recentcoauthors_4": 1060.0, "recentcoauthors_5": 421.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.8333333333, "venuehindexmean_1": 159.8333333333, "venuehindexmean_2": 164.1666666667, "venuehindexmean_3": 148.4285714286, "venuehindexmean_4": 151.7142857143, "venuehindexmean_5": 155.1428571429, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 17.3988122836, "pagerank_1": 17.1713985114, "pagerank_2": 18.8235780442, "pagerank_3": 22.4380290851, "pagerank_4": 22.2136099512, "pagerank_5": 23.7596938554}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["NazneenRahman"], "affiliation": "Institute of Cancer Research", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 12.0, "hindex_1": 15.0, "hindex_2": 15.0, "hindex_3": 15.0, "hindex_4": 16.0, "hindex_5": 18.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 24.303, "citationsperpaper_1": 27.486, "citationsperpaper_2": 27.775, "citationsperpaper_3": 28.311, "citationsperpaper_4": 27.471, "citationsperpaper_5": 27.5, "citationsperyear_0": 53.467, "citationsperyear_1": 60.125, "citationsperyear_2": 65.353, "citationsperyear_3": 70.778, "citationsperyear_4": 73.737, "citationsperyear_5": 77.0, "totalcitations_0": 802.0, "totalcitations_1": 962.0, "totalcitations_2": 1111.0, "totalcitations_3": 1274.0, "totalcitations_4": 1401.0, "totalcitations_5": 1540.0, "totalpapers_0": 33.0, "totalpapers_1": 35.0, "totalpapers_2": 40.0, "totalpapers_3": 45.0, "totalpapers_4": 51.0, "totalpapers_5": 56.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 508.0, "recentcoauthors_1": 384.0, "recentcoauthors_2": 399.0, "recentcoauthors_3": 1318.0, "recentcoauthors_4": 1060.0, "recentcoauthors_5": 421.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 156.8333333333, "venuehindexmean_1": 159.8333333333, "venuehindexmean_2": 164.1666666667, "venuehindexmean_3": 148.4285714286, "venuehindexmean_4": 151.7142857143, "venuehindexmean_5": 155.1428571429, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 7.0, "totalvenues_4": 7.0, "totalvenues_5": 7.0, "pagerank_0": 17.3988122836, "pagerank_1": 17.1713985114, "pagerank_2": 18.8235780442, "pagerank_3": 22.4380290851, "pagerank_4": 22.2136099512, "pagerank_5": 23.7596938554}}, {"model": "papers.paper", "pk": 1003468, "fields": {"authors": ["KaiWang"], "affiliation": "University of Southern California", "venue": "Nature", "doi": "10.1038/nature09609", "abstract": "of risk allele 5 1.34 (95% confidence interval 1.25\u20131.44)). The signal was enriched in the subset of patients with the most aggressive form of the disease. LMO1 encodes a cysteine-rich transcriptional regulator, and its paralogues (LMO2, LMO3 and LMO4) have each been previously implicated in cancer. In parallel, we analysed genome-wide DNA copy number alterations in 701 primary tumours. We found that the LMO1 locus was aberrant in 12.4% through a duplication event, and that this event was associated with more advanced disease (P , 0.0001) and survival (P 5 0.041). The germline single nucleotide polymorphism (SNP) risk alleles and somatic copy number gains were associated with increased LMO1 expression in neuroblastoma cell lines and primary tumours, consistent with a gain-of-function role in tumorigenesis. Short hairpin RNA (shRNA)-mediated depletion of LMO1 inhibited growth of neuroblastoma cells with high LMO1 expression, whereas forced expression of LMO1 in neuroblastoma cells with low LMO1 expression enhanced proliferation. These data show that common polymorphisms at the LMO1 locus are strongly associated with susceptibility to developing neuroblastoma, but also may influence the likelihood of further somatic alterations at this locus, leading to malignant progression. Multiple somatically acquired chromosomal rearrangements, such as focal amplification of the MYCN oncogene or deletions at chromosome arms 1p or 11q, are each associated with an aggressive neuroblastoma phenotype 2 . Although these somatically acquired genomic alterations are of clinical use as prognostic biomarkers, until recently little was known about the constitutional genetic events that initiate tumorigenesis. Highly penetrant gain-of-function mutations in the anaplastic lymphoma kinase (ALK) tyrosine kinase domain were recently identified as the major cause of familial neuroblastoma, and somatic mutations in this gene implicate it as a target for therapeutic intervention 3\u20136 . In addition, a neuroblastoma GWAS identified common SNPs at 6p22 as being associated with susceptibility to aggressive neuroblastoma in sporadic cases 7 ; follow-up association analysis on the clinically relevant group of patients with an aggressive tumour", "year": 2010, "title": "Integrative genomics identifies LMO1 as a neuroblastoma oncogene", "keywords": ["Single-nucleotide polymorphism", "Familial Neuroblastoma", "Genetics", "Biology", "Allele", "Neuroblastoma", "Cancer research", "Carcinogenesis", "Anaplastic lymphoma kinase", "Gene duplication", "Genome-wide association study"], "citations_0": 0.0, "citations_1": 1.0, "citations_2": 4.0, "citations_3": 1.0, "citations_4": 1.0, "citations_5": 4.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.0018540741, "timescaledpagerank_2": 0.1077118923, "timescaledpagerank_3": 0.0287573289, "timescaledpagerank_4": 0.0353443926, "timescaledpagerank_5": 0.1396647531, "hindex_0": 1.0, "hindex_1": 1.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 15.0, "adopters_2": 54.0, "adopters_3": 60.0, "adopters_4": 13.0, "adopters_5": 0.0, "citationsperpaper_0": 3.5, "citationsperpaper_1": 5.0, "citationsperpaper_2": 8.5, "citationsperpaper_3": 10.0, "citationsperpaper_4": 10.5, "citationsperpaper_5": 13.5, "citationsperyear_0": 3.5, "citationsperyear_1": 3.333, "citationsperyear_2": 4.25, "citationsperyear_3": 4.0, "citationsperyear_4": 3.5, "citationsperyear_5": 3.857, "totalcitations_0": 7.0, "totalcitations_1": 10.0, "totalcitations_2": 17.0, "totalcitations_3": 20.0, "totalcitations_4": 21.0, "totalcitations_5": 27.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 1.0, "authorage_1": 2.0, "authorage_2": 3.0, "authorage_3": 4.0, "authorage_4": 5.0, "authorage_5": 6.0, "recentcoauthors_0": 58.0, "recentcoauthors_1": 32.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.0647630213, "pagerank_1": 0.9853346966, "pagerank_2": 0.913238367, "pagerank_3": 0.8489750838, "pagerank_4": 0.8388810939, "pagerank_5": 0.7975529206}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["John P.O'Doherty", "Colin F.Camerer", "AntonioRangel"], "affiliation": "California Institute of Technology", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 6.0, "hindex_1": 7.3333333333, "hindex_2": 8.3333333333, "hindex_3": 9.3333333333, "hindex_4": 9.6666666667, "hindex_5": 10.3333333333, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 8.601, "citationsperpaper_1": 10.106, "citationsperpaper_2": 11.1173333333, "citationsperpaper_3": 11.0386666667, "citationsperpaper_4": 12.3216666667, "citationsperpaper_5": 13.644, "citationsperyear_0": 19.9, "citationsperyear_1": 23.0153333333, "citationsperyear_2": 25.591, "citationsperyear_3": 27.5233333333, "citationsperyear_4": 29.0686666667, "citationsperyear_5": 30.79, "totalcitations_0": 195.6666666667, "totalcitations_1": 242.0, "totalcitations_2": 293.0, "totalcitations_3": 337.3333333333, "totalcitations_4": 383.3333333333, "totalcitations_5": 435.6666666667, "totalpapers_0": 18.0, "totalpapers_1": 19.6666666667, "totalpapers_2": 22.0, "totalpapers_3": 26.3333333333, "totalpapers_4": 27.3333333333, "totalpapers_5": 28.3333333333, "authorage_0": 7.6666666667, "authorage_1": 8.6666666667, "authorage_2": 9.6666666667, "authorage_3": 10.6666666667, "authorage_4": 11.6666666667, "authorage_5": 12.6666666667, "recentcoauthors_0": 17.6666666667, "recentcoauthors_1": 14.0, "recentcoauthors_2": 28.0, "recentcoauthors_3": 36.0, "recentcoauthors_4": 21.3333333333, "recentcoauthors_5": 10.6666666667, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 162.1166666667, "venuehindexmean_1": 165.2833333333, "venuehindexmean_2": 169.6388888889, "venuehindexmean_3": 173.5722222222, "venuehindexmean_4": 176.7777777778, "venuehindexmean_5": 180.1333333333, "totalvenues_0": 5.0, "totalvenues_1": 5.0, "totalvenues_2": 5.0, "totalvenues_3": 5.0, "totalvenues_4": 5.0, "totalvenues_5": 5.0, "pagerank_0": 3.4242795539, "pagerank_1": 3.6444664205, "pagerank_2": 4.3446212987, "pagerank_3": 5.0005872287, "pagerank_4": 5.3211742576, "pagerank_5": 5.315947463}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["John P.O'Doherty"], "affiliation": "John Radcliffe Hospital", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 15.414, "citationsperpaper_1": 17.967, "citationsperpaper_2": 19.121, "citationsperpaper_3": 17.949, "citationsperpaper_4": 19.475, "citationsperpaper_5": 20.667, "citationsperyear_0": 44.7, "citationsperyear_1": 49.0, "citationsperyear_2": 52.583, "citationsperyear_3": 53.846, "citationsperyear_4": 55.643, "citationsperyear_5": 57.867, "totalcitations_0": 447.0, "totalcitations_1": 539.0, "totalcitations_2": 631.0, "totalcitations_3": 700.0, "totalcitations_4": 779.0, "totalcitations_5": 868.0, "totalpapers_0": 29.0, "totalpapers_1": 30.0, "totalpapers_2": 33.0, "totalpapers_3": 39.0, "totalpapers_4": 40.0, "totalpapers_5": 42.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 15.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 25.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.5, "venuehindexmean_1": 143.0, "venuehindexmean_2": 147.1666666667, "venuehindexmean_3": 151.1666666667, "venuehindexmean_4": 154.3333333333, "venuehindexmean_5": 157.5, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8333999447, "pagerank_1": 5.8811683323, "pagerank_2": 6.3433826283, "pagerank_3": 7.1922786409, "pagerank_4": 7.269336589, "pagerank_5": 7.4375301562}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["John P.O'Doherty"], "affiliation": "University of Oxford", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 15.414, "citationsperpaper_1": 17.967, "citationsperpaper_2": 19.121, "citationsperpaper_3": 17.949, "citationsperpaper_4": 19.475, "citationsperpaper_5": 20.667, "citationsperyear_0": 44.7, "citationsperyear_1": 49.0, "citationsperyear_2": 52.583, "citationsperyear_3": 53.846, "citationsperyear_4": 55.643, "citationsperyear_5": 57.867, "totalcitations_0": 447.0, "totalcitations_1": 539.0, "totalcitations_2": 631.0, "totalcitations_3": 700.0, "totalcitations_4": 779.0, "totalcitations_5": 868.0, "totalpapers_0": 29.0, "totalpapers_1": 30.0, "totalpapers_2": 33.0, "totalpapers_3": 39.0, "totalpapers_4": 40.0, "totalpapers_5": 42.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 15.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 25.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.5, "venuehindexmean_1": 143.0, "venuehindexmean_2": 147.1666666667, "venuehindexmean_3": 151.1666666667, "venuehindexmean_4": 154.3333333333, "venuehindexmean_5": 157.5, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8333999447, "pagerank_1": 5.8811683323, "pagerank_2": 6.3433826283, "pagerank_3": 7.1922786409, "pagerank_4": 7.269336589, "pagerank_5": 7.4375301562}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["John P.O'Doherty"], "affiliation": "University College London", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 15.414, "citationsperpaper_1": 17.967, "citationsperpaper_2": 19.121, "citationsperpaper_3": 17.949, "citationsperpaper_4": 19.475, "citationsperpaper_5": 20.667, "citationsperyear_0": 44.7, "citationsperyear_1": 49.0, "citationsperyear_2": 52.583, "citationsperyear_3": 53.846, "citationsperyear_4": 55.643, "citationsperyear_5": 57.867, "totalcitations_0": 447.0, "totalcitations_1": 539.0, "totalcitations_2": 631.0, "totalcitations_3": 700.0, "totalcitations_4": 779.0, "totalcitations_5": 868.0, "totalpapers_0": 29.0, "totalpapers_1": 30.0, "totalpapers_2": 33.0, "totalpapers_3": 39.0, "totalpapers_4": 40.0, "totalpapers_5": 42.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 15.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 25.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.5, "venuehindexmean_1": 143.0, "venuehindexmean_2": 147.1666666667, "venuehindexmean_3": 151.1666666667, "venuehindexmean_4": 154.3333333333, "venuehindexmean_5": 157.5, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8333999447, "pagerank_1": 5.8811683323, "pagerank_2": 6.3433826283, "pagerank_3": 7.1922786409, "pagerank_4": 7.269336589, "pagerank_5": 7.4375301562}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["John P.O'Doherty"], "affiliation": "Trinity College, Dublin", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 10.0, "hindex_1": 12.0, "hindex_2": 13.0, "hindex_3": 14.0, "hindex_4": 14.0, "hindex_5": 14.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 15.414, "citationsperpaper_1": 17.967, "citationsperpaper_2": 19.121, "citationsperpaper_3": 17.949, "citationsperpaper_4": 19.475, "citationsperpaper_5": 20.667, "citationsperyear_0": 44.7, "citationsperyear_1": 49.0, "citationsperyear_2": 52.583, "citationsperyear_3": 53.846, "citationsperyear_4": 55.643, "citationsperyear_5": 57.867, "totalcitations_0": 447.0, "totalcitations_1": 539.0, "totalcitations_2": 631.0, "totalcitations_3": 700.0, "totalcitations_4": 779.0, "totalcitations_5": 868.0, "totalpapers_0": 29.0, "totalpapers_1": 30.0, "totalpapers_2": 33.0, "totalpapers_3": 39.0, "totalpapers_4": 40.0, "totalpapers_5": 42.0, "authorage_0": 9.0, "authorage_1": 10.0, "authorage_2": 11.0, "authorage_3": 12.0, "authorage_4": 13.0, "authorage_5": 14.0, "recentcoauthors_0": 15.0, "recentcoauthors_1": 12.0, "recentcoauthors_2": 9.0, "recentcoauthors_3": 25.0, "recentcoauthors_4": 22.0, "recentcoauthors_5": 8.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 139.5, "venuehindexmean_1": 143.0, "venuehindexmean_2": 147.1666666667, "venuehindexmean_3": 151.1666666667, "venuehindexmean_4": 154.3333333333, "venuehindexmean_5": 157.5, "totalvenues_0": 6.0, "totalvenues_1": 6.0, "totalvenues_2": 6.0, "totalvenues_3": 6.0, "totalvenues_4": 6.0, "totalvenues_5": 6.0, "pagerank_0": 5.8333999447, "pagerank_1": 5.8811683323, "pagerank_2": 6.3433826283, "pagerank_3": 7.1922786409, "pagerank_4": 7.269336589, "pagerank_5": 7.4375301562}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["ElizabethTricomi"], "affiliation": "University of Pittsburgh", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 6.5, "citationsperpaper_1": 9.5, "citationsperpaper_2": 12.5, "citationsperpaper_3": 13.5, "citationsperpaper_4": 14.5, "citationsperpaper_5": 16.0, "citationsperyear_0": 1.857, "citationsperyear_1": 2.375, "citationsperyear_2": 2.778, "citationsperyear_3": 2.7, "citationsperyear_4": 2.636, "citationsperyear_5": 2.667, "totalcitations_0": 13.0, "totalcitations_1": 19.0, "totalcitations_2": 25.0, "totalcitations_3": 27.0, "totalcitations_4": 29.0, "totalcitations_5": 32.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 3.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 174.0, "venuehindexmean_1": 177.0, "venuehindexmean_2": 180.5, "venuehindexmean_3": 184.5, "venuehindexmean_4": 188.0, "venuehindexmean_5": 191.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.4919388272, "pagerank_1": 0.4774046747, "pagerank_2": 0.4496896905, "pagerank_3": 0.4486868694, "pagerank_4": 0.4452524776, "pagerank_5": 0.440498425}}, {"model": "papers.paper", "pk": 1003739, "fields": {"authors": ["ElizabethTricomi"], "affiliation": "Rutgers University", "venue": "Nature", "doi": "10.1038/nature08785", "abstract": "A popular hypothesis in the social sciences is that humans have social preferences to reduce inequality in outcome distributions because it has a negative impact on their experienced reward. Although there is a large body of behavioural and anthropological evidence consistent with the predictions of these theories, there is no direct neural evidence for the existence of inequality-averse preferences. Such evidence would be especially useful because some behaviours that are consistent with a dislike for unequal outcomes could also be explained by concerns for social image or reciprocity, which do not require a direct aversion towards inequality. Here we use functional MRI to test directly for the existence of inequality-averse social preferences in the human brain. Inequality was created by recruiting pairs of subjects and giving one of them a large monetary endowment. While both subjects evaluated further monetary transfers from the experimenter to themselves and to the other participant, we measured neural responses in the ventral striatum and ventromedial prefrontal cortex, two areas that have been shown to be involved in the valuation of monetary and primary rewards in both social and non-social contexts. Consistent with inequality-averse models of social preferences, we find that activity in these areas was more responsive to transfers to others than to self in the \u2018high-pay\u2019 subject, whereas the activity of the \u2018low-pay\u2019 subject showed the opposite pattern. These results provide direct evidence for the validity of this class of models, and also show that the brain\u2019s reward circuitry is sensitive to both advantageous and disadvantageous inequality.", "year": 2010, "title": "Neural evidence for inequality-averse social preferences", "keywords": ["Inequality", "Cognitive psychology", "Psychology", "Ventrolateral prefrontal cortex", "Valuation (finance)", "Ventromedial prefrontal cortex", "Reciprocity (social psychology)", "Social preferences", "Ventral striatum", "Social cognition"], "citations_0": 0.0, "citations_1": 4.0, "citations_2": 3.0, "citations_3": 0.0, "citations_4": 1.0, "citations_5": 3.0, "timescaledpagerank_0": 0.2972888893, "timescaledpagerank_1": 0.1468349906, "timescaledpagerank_2": 0.4612417721, "timescaledpagerank_3": 0.3604172112, "timescaledpagerank_4": 0.3410518073, "timescaledpagerank_5": 0.5273953874, "hindex_0": 1.0, "hindex_1": 2.0, "hindex_2": 2.0, "hindex_3": 2.0, "hindex_4": 2.0, "hindex_5": 2.0, "adopters_0": 0.0, "adopters_1": 17.0, "adopters_2": 15.0, "adopters_3": 0.0, "adopters_4": 6.0, "adopters_5": 0.0, "citationsperpaper_0": 6.5, "citationsperpaper_1": 9.5, "citationsperpaper_2": 12.5, "citationsperpaper_3": 13.5, "citationsperpaper_4": 14.5, "citationsperpaper_5": 16.0, "citationsperyear_0": 1.857, "citationsperyear_1": 2.375, "citationsperyear_2": 2.778, "citationsperyear_3": 2.7, "citationsperyear_4": 2.636, "citationsperyear_5": 2.667, "totalcitations_0": 13.0, "totalcitations_1": 19.0, "totalcitations_2": 25.0, "totalcitations_3": 27.0, "totalcitations_4": 29.0, "totalcitations_5": 32.0, "totalpapers_0": 2.0, "totalpapers_1": 2.0, "totalpapers_2": 2.0, "totalpapers_3": 2.0, "totalpapers_4": 2.0, "totalpapers_5": 2.0, "authorage_0": 6.0, "authorage_1": 7.0, "authorage_2": 8.0, "authorage_3": 9.0, "authorage_4": 10.0, "authorage_5": 11.0, "recentcoauthors_0": 3.0, "recentcoauthors_1": 3.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 174.0, "venuehindexmean_1": 177.0, "venuehindexmean_2": 180.5, "venuehindexmean_3": 184.5, "venuehindexmean_4": 188.0, "venuehindexmean_5": 191.5, "totalvenues_0": 2.0, "totalvenues_1": 2.0, "totalvenues_2": 2.0, "totalvenues_3": 2.0, "totalvenues_4": 2.0, "totalvenues_5": 2.0, "pagerank_0": 0.4919388272, "pagerank_1": 0.4774046747, "pagerank_2": 0.4496896905, "pagerank_3": 0.4486868694, "pagerank_4": 0.4452524776, "pagerank_5": 0.440498425}}, {"model": "papers.paper", "pk": 1003233, "fields": {"authors": ["TatsuroNakagawa", "KojiSato", "KohjiroUeki", "MasashiFukayama", "NaotoKubota", "MamikoYamaguchi", "HironoriWaki", "ToshimasaYamauchi", "IsekiTakamoto", "MasatoIwabu", "KazushigeTouhara", "TakashiKadowaki", "MikiOkada-Iwabu", "SatoshiIshii", "KenzoHirose", "NaokoYamauchi", "TakaoShimizu", "ShigeyukiNamiki"], "affiliation": "University of Tokyo", "venue": "Nature", "doi": "10.1038/nature08991", "abstract": "Adiponectin is a protein with anti-diabetic properties; its levels are decreased in obesity, insulin resistance and type 2 diabetes. It is shown here that mice with a muscle-specific disruption of adiponectin receptor 1 (AdipoR1) are insulin resistant and less able to endure exercise. The pathway downstream of receptor activation is delineated; the findings suggest that the decreased levels of adiponectin and AdipoR1 seen in obesity may have causal roles in the mitochondrial dysfunction and insulin resistance seen in diabetes.", "year": 2010, "title": "Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2+ and AMPK/SIRT1", "keywords": ["AdipoRon", "Insulin", "Type 2 diabetes", "Biology", "Internal medicine", "Endocrinology", "Insulin resistance", "Adiponectin", "Diabetes mellitus", "AMPK", "Adiponectin receptor 1"], "citations_0": 3.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2370688616, "timescaledpagerank_1": 0.6008966176, "timescaledpagerank_2": 0.5751312722, "timescaledpagerank_3": 0.5882484444, "timescaledpagerank_4": 0.4919137624, "timescaledpagerank_5": 0.4391492586, "hindex_0": 8.2222222222, "hindex_1": 8.8333333333, "hindex_2": 9.3333333333, "hindex_3": 9.6666666667, "hindex_4": 10.2777777778, "hindex_5": 10.5, "adopters_0": 26.0, "adopters_1": 39.0, "adopters_2": 39.0, "adopters_3": 31.0, "adopters_4": 7.0, "adopters_5": 0.0, "citationsperpaper_0": 12.7858888889, "citationsperpaper_1": 13.635, "citationsperpaper_2": 14.9847777778, "citationsperpaper_3": 16.0214444444, "citationsperpaper_4": 16.7721666667, "citationsperpaper_5": 17.4230555556, "citationsperyear_0": 20.5694444444, "citationsperyear_1": 21.7745555556, "citationsperyear_2": 22.4076111111, "citationsperyear_3": 23.2701111111, "citationsperyear_4": 23.6647777778, "citationsperyear_5": 23.7648333333, "totalcitations_0": 394.0, "totalcitations_1": 433.3888888889, "totalcitations_2": 465.7777777778, "totalcitations_3": 503.3888888889, "totalcitations_4": 533.8888888889, "totalcitations_5": 560.2222222222, "totalpapers_0": 25.3333333333, "totalpapers_1": 28.1111111111, "totalpapers_2": 29.1111111111, "totalpapers_3": 30.2777777778, "totalpapers_4": 31.6111111111, "totalpapers_5": 32.3888888889, "authorage_0": 13.0, "authorage_1": 14.0, "authorage_2": 15.0, "authorage_3": 16.0, "authorage_4": 17.0, "authorage_5": 18.0, "recentcoauthors_0": 64.0, "recentcoauthors_1": 99.1666666667, "recentcoauthors_2": 51.6666666667, "recentcoauthors_3": 18.6111111111, "recentcoauthors_4": 62.6111111111, "recentcoauthors_5": 58.8333333333, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 152.2929034745, "venuehindexmean_1": 149.327616073, "venuehindexmean_2": 155.7053181387, "venuehindexmean_3": 157.7312095312, "venuehindexmean_4": 158.371539109, "venuehindexmean_5": 161.7323320198, "totalvenues_0": 6.9444444444, "totalvenues_1": 7.5, "totalvenues_2": 7.7222222222, "totalvenues_3": 7.9444444444, "totalvenues_4": 8.2777777778, "totalvenues_5": 8.3333333333, "pagerank_0": 8.1450637192, "pagerank_1": 8.7847693995, "pagerank_2": 8.6647109669, "pagerank_3": 8.7160105279, "pagerank_4": 8.7783368048, "pagerank_5": 8.7804818737}}, {"model": "papers.paper", "pk": 1003233, "fields": {"authors": ["TatsuroNakagawa"], "affiliation": "Japanese Foundation for Cancer Research", "venue": "Nature", "doi": "10.1038/nature08991", "abstract": "Adiponectin is a protein with anti-diabetic properties; its levels are decreased in obesity, insulin resistance and type 2 diabetes. It is shown here that mice with a muscle-specific disruption of adiponectin receptor 1 (AdipoR1) are insulin resistant and less able to endure exercise. The pathway downstream of receptor activation is delineated; the findings suggest that the decreased levels of adiponectin and AdipoR1 seen in obesity may have causal roles in the mitochondrial dysfunction and insulin resistance seen in diabetes.", "year": 2010, "title": "Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2+ and AMPK/SIRT1", "keywords": ["AdipoRon", "Insulin", "Type 2 diabetes", "Biology", "Internal medicine", "Endocrinology", "Insulin resistance", "Adiponectin", "Diabetes mellitus", "AMPK", "Adiponectin receptor 1"], "citations_0": 3.0, "citations_1": 3.0, "citations_2": 4.0, "citations_3": 5.0, "citations_4": 1.0, "citations_5": 2.0, "timescaledpagerank_0": 0.2370688616, "timescaledpagerank_1": 0.6008966176, "timescaledpagerank_2": 0.5751312722, "timescaledpagerank_3": 0.5882484444, "timescaledpagerank_4": 0.4919137624, "timescaledpagerank_5": 0.4391492586, "hindex_0": 3.0, "hindex_1": 3.0, "hindex_2": 3.0, "hindex_3": 3.0, "hindex_4": 3.0, "hindex_5": 3.0, "adopters_0": 26.0, "adopters_1": 39.0, "adopters_2": 39.0, "adopters_3": 31.0, "adopters_4": 7.0, "adopters_5": 0.0, "citationsperpaper_0": 18.667, "citationsperpaper_1": 24.333, "citationsperpaper_2": 27.0, "citationsperpaper_3": 30.667, "citationsperpaper_4": 35.0, "citationsperpaper_5": 36.0, "citationsperyear_0": 3.733, "citationsperyear_1": 4.563, "citationsperyear_2": 4.765, "citationsperyear_3": 5.111, "citationsperyear_4": 5.526, "citationsperyear_5": 5.4, "totalcitations_0": 56.0, "totalcitations_1": 73.0, "totalcitations_2": 81.0, "totalcitations_3": 92.0, "totalcitations_4": 105.0, "totalcitations_5": 108.0, "totalpapers_0": 3.0, "totalpapers_1": 3.0, "totalpapers_2": 3.0, "totalpapers_3": 3.0, "totalpapers_4": 3.0, "totalpapers_5": 3.0, "authorage_0": 14.0, "authorage_1": 15.0, "authorage_2": 16.0, "authorage_3": 17.0, "authorage_4": 18.0, "authorage_5": 19.0, "recentcoauthors_0": 25.0, "recentcoauthors_1": 25.0, "recentcoauthors_2": 0.0, "recentcoauthors_3": 0.0, "recentcoauthors_4": 0.0, "recentcoauthors_5": 0.0, "venuecitatiosnperpapermean_0": 0.0, "venuecitatiosnperpapermean_1": 0.0, "venuecitatiosnperpapermean_2": 0.0, "venuecitatiosnperpapermean_3": 0.0, "venuecitatiosnperpapermean_4": 0.0, "venuecitatiosnperpapermean_5": 0.0, "venuehindexmean_0": 260.0, "venuehindexmean_1": 264.0, "venuehindexmean_2": 269.0, "venuehindexmean_3": 275.0, "venuehindexmean_4": 280.0, "venuehindexmean_5": 284.0, "totalvenues_0": 1.0, "totalvenues_1": 1.0, "totalvenues_2": 1.0, "totalvenues_3": 1.0, "totalvenues_4": 1.0, "totalvenues_5": 1.0, "pagerank_0": 1.456448393, "pagerank_1": 1.4045610509, "pagerank_2": 1.3706955554, "pagerank_3": 1.3378057633, "pagerank_4": 1.2896184696, "pagerank_5": 1.2534840593}}]